data_2kzh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kzh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.483 HD22 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 CA-C-O 122.237 1.017 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 12.4 ptpt -91.55 97.6 11.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.46 146.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.741 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 p -87.7 170.13 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.29 122.12 2.36 Favored Glycine 0 CA--C 1.482 -1.98 0 O-C-N 124.117 0.886 . . . . 0.0 114.886 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 14' ' ' ASP . 25.1 tp -140.72 128.54 21.77 Favored 'General case' 0 N--CA 1.399 -2.978 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -120.77 12.83 11.44 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 123.093 1.425 . . . . 0.0 109.439 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.2 mtp85 -108.65 112.34 24.61 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.504 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.94 66.74 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 116.552 -0.295 . . . . 0.0 113.793 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.59 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -72.22 -20.03 61.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.274 1.035 . . . . 0.0 108.887 -177.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HB3' HD21 ' A' ' 9' ' ' LEU . 1.3 m-20 -95.53 -45.3 7.13 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.659 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.36 72.53 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.81 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -59.11 -23.94 62.54 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.27 71.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -35.05 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.218 1.009 . . . . 0.0 108.772 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -38.27 81.05 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.332 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.9 -26.19 62.22 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.219 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.46 -23.66 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.146 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 24' ' ' ILE . . . 176.0 -25.88 0.06 OUTLIER Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.038 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.85 21.1 12.52 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-O 121.875 0.845 . . . . 0.0 109.597 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' HD22 ' A' ' 4' ' ' ASN . 25.0 mt -70.52 -60.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.041 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.04 151.31 0.66 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.707 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -117.8 159.62 14.09 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.54 79.98 0.26 Allowed Glycine 0 CA--C 1.505 -0.575 0 CA-C-N 117.535 0.667 . . . . 0.0 111.934 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.44 149.3 40.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.135 0.493 . . . . 0.0 109.986 -174.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.3 mt -117.65 150.19 19.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.244 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -81.87 75.47 8.81 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.194 0.308 . . . . 0.0 111.702 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 87.9 t -98.48 122.13 49.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.69 108.84 0.23 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.271 1.028 . . . . 0.0 113.629 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.7 p 62.55 26.59 15.8 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.586 1.954 . . . . 0.0 114.234 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -90.56 139.83 26.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.2 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.18 16.12 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.244 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -125.57 -3.81 7.23 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.13 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 87.4 m -156.7 120.72 4.35 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.0 137.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 122.27 1.033 . . . . 0.0 111.978 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.4 p-10 -103.52 170.69 7.79 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.08 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 p -43.64 -39.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.611 1.194 . . . . 0.0 112.687 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 44.3 mt-10 -68.81 -48.66 63.02 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.626 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.659 ' O ' HG22 ' A' ' 46' ' ' VAL . 34.2 mt-30 -68.64 -40.15 80.41 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.526 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.54 -40.26 74.79 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -64.91 -29.65 70.61 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.12 -45.16 24.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.894 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 42' ' ' GLN . 48.2 t -59.53 -36.37 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.124 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -71.24 -8.1 51.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.0 -7.24 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.495 0.664 . . . . 0.0 109.304 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.23 -48.15 3.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.207 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.73 10.6 Favored Pre-proline 0 N--CA 1.41 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.42 61.66 3.49 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 123.008 2.472 . . . . 0.0 113.073 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.79 144.39 28.92 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.306 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.643 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -73.5 154.93 39.7 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.131 0.972 . . . . 0.0 109.361 -175.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -118.22 155.39 30.6 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 112.494 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 26' ' ' GLY . 8.4 p -131.19 164.52 34.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.2 147.2 18.9 Favored Glycine 0 C--O 1.204 -1.778 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 45.7 t -125.34 106.35 16.19 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -152.63 140.1 19.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.256 -1.778 . . . . 0.0 112.103 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 4.5 ptt180 -103.18 95.28 6.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.06 151.57 22.37 Favored 'General case' 1 N--CA 1.369 -4.515 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.562 -170.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -85.22 -49.11 8.47 Favored 'General case' 1 C--N 1.233 -4.474 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -99.1 129.08 45.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.998 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 67' ' ' VAL . 11.7 tt -67.55 -32.82 58.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.169 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -19.16 63.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 37.2 t70 -83.01 -27.1 30.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.277 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.03 -43.56 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 63' ' ' ILE . 50.9 t -59.54 -41.21 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.386 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' VAL . 19.3 t70 -50.72 -55.99 14.06 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.611 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 40.9 mmtm -66.02 -44.65 84.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.575 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -56.85 -35.28 68.68 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.973 0.796 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.91 -58.46 2.78 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.474 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 68' ' ' ASP . 68.0 t -49.4 -58.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.447 0.699 . . . . 0.0 112.746 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.2 -16.59 37.28 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 27.7 t 62.28 88.84 0.09 Allowed 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 124.606 1.191 . . . . 0.0 109.059 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 70' ' ' ALA . 77.7 mt -84.07 177.01 8.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.93 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.643 ' HB3' ' NE2' ' A' ' 53' ' ' GLN . . . -115.6 -40.68 3.35 Favored 'General case' 0 CA--C 1.451 -2.85 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -147.05 164.76 31.99 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.892 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.78 135.23 25.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.35 117.3 32.45 Favored 'General case' 0 N--CA 1.388 -3.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.064 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.22 129.98 45.49 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.649 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.1 m-70 -82.76 103.03 11.94 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 89' ' ' ILE . . . -61.42 -12.95 34.83 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.367 -172.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -58.97 -25.78 63.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.993 1.317 . . . . 0.0 111.364 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -59.82 -48.64 80.87 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.89 150.99 0.82 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.48 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 49.4 mt-30 -76.2 -43.41 42.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.98 0.895 . . . . 0.0 111.73 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.45 -21.56 35.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.396 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.488 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 25.9 t80 -57.12 -46.81 82.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.853 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.43 HD11 ' CG ' ' A' ' 117' ' ' PHE . 3.0 mt -61.02 -38.71 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 109.558 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.632 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 17.9 t70 -66.99 -19.54 65.73 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.705 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.454 HG21 ' CD1' ' A' ' 63' ' ' ILE . 85.6 m -89.17 -45.71 9.36 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.972 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 88' ' ' TYR . 4.0 mm? -43.41 -50.0 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.632 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -67.05 -14.23 62.7 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.42 -35.37 27.67 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.98 20.07 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.013 0.911 . . . . 0.0 111.384 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.64 118.17 70.95 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.789 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.76 165.6 20.49 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.937 2.425 . . . . 0.0 111.076 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.14 4.12 1.78 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -84.81 -29.58 25.26 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.81 133.25 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -112.45 -179.74 3.75 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 88.2 mt -126.71 134.57 65.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.53 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.8 m0 -119.89 147.14 45.07 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 118.12 36.33 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.58 106.24 2.52 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.234 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 72.9 m-85 . . . . . 0 CA--C 1.484 -1.56 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -111.71 -170.85 1.73 Allowed 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.944 0.777 . . . . 0.0 110.546 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.4 m80 69.82 19.97 6.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.462 1.105 . . . . 0.0 109.469 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -96.95 156.55 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.272 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.87 -40.8 38.86 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 120.843 0.354 . . . . 0.0 111.331 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 64.0 mttp -147.99 161.28 41.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.25 127.3 55.57 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 m -129.65 173.55 13.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 125' ' ' LEU . 2.4 pt? . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 18' ' ' ALA . 63.6 t30 . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.513 ' HD3' ' OH ' ' A' ' 25' ' ' TYR . 37.6 ttpt -43.9 114.28 0.64 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.725 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 m -117.63 140.72 39.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.213 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.7 m -91.69 168.48 11.45 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 117.354 -1.307 . . . . 0.0 107.995 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.15 106.01 0.01 OUTLIER Glycine 0 C--N 1.385 3.257 0 O-C-N 125.3 1.625 . . . . 0.0 116.036 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.19 130.53 35.46 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -126.4 -18.9 4.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -81.2 117.06 21.42 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.688 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -44.9 -59.3 4.47 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 124.184 0.897 . . . . 0.0 114.513 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.676 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -56.8 -25.92 56.72 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 177.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.15 -34.87 23.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.24 85.0 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 49.2 mtmt -58.9 -30.39 67.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.515 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.21 70.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.622 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.417 ' HA ' HD21 ' A' ' 4' ' ' ASN . . . -77.07 -35.96 56.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.909 0.861 . . . . 0.0 109.784 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.427 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -74.82 -30.56 61.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.841 178.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.8 -14.14 30.28 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.783 0.801 . . . . 0.0 112.102 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.66 -13.52 61.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.978 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.49 26.26 0.98 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.12 27.64 11.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.45 1.1 . . . . 0.0 112.062 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' TYR . 55.3 mt -57.97 -68.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.802 -174.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.513 ' OH ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -178.87 162.12 1.27 Allowed 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.314 1.009 . . . . 0.0 109.151 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.504 ' O ' HG11 ' A' ' 55' ' ' VAL . . . -125.05 150.53 17.21 Favored Glycine 0 C--N 1.313 -0.708 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . -116.84 71.29 0.28 Allowed Glycine 0 CA--C 1.475 -2.441 0 C-N-CA 118.612 -1.756 . . . . 0.0 112.559 -170.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.97 130.78 55.47 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.357 0.598 . . . . 0.0 110.233 -179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.0 pt -102.39 155.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -77.95 74.16 4.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.009 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.7 t -103.2 117.35 48.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 170.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.91 114.24 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.71 1.256 . . . . 0.0 112.826 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.9 p 69.72 17.95 7.63 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 126.181 1.792 . . . . 0.0 113.681 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -83.24 141.41 42.86 Favored Pre-proline 0 N--CA 1.419 -2.014 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.41 4.38 4.09 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.683 1.589 . . . . 0.0 111.193 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.75 5.74 10.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 110.298 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 80.7 m -156.17 117.81 3.93 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.74 137.0 32.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.947 0.88 . . . . 0.0 112.381 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.46 166.34 10.62 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.838 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -45.01 -31.93 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.315 1.446 . . . . 0.0 113.143 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.7 -59.69 3.96 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 123.294 0.637 . . . . 0.0 111.955 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.52 -33.4 71.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.663 0.744 . . . . 0.0 110.12 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.545 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -64.45 -26.44 68.44 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.067 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 44' ' ' GLN . 3.4 tp-100 -63.68 -32.97 74.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.921 0.867 . . . . 0.0 109.493 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.26 -43.25 13.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.434 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 43' ' ' ALA . 9.5 p -70.42 -24.28 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.319 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -15.9 63.4 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.468 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.6 -24.95 28.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.585 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.43 -45.47 12.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -129.13 104.94 18.05 Favored Pre-proline 0 N--CA 1.394 -3.227 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.53 56.23 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.901 2.401 . . . . 0.0 111.963 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.427 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.7 pp -97.09 177.19 5.67 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.215 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.51 128.64 34.52 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.752 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.414 ' CD2' HD13 ' A' ' 28' ' ' LEU . 66.6 m-85 -96.85 127.32 42.72 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 26' ' ' GLY . 9.8 p -119.14 149.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.04 128.14 7.27 Favored Glycine 0 C--N 1.285 -2.256 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.321 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.95 107.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -165.28 158.63 16.51 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.649 -1.22 . . . . 0.0 109.836 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 81' ' ' HIS . 47.2 mtm180 -90.16 93.42 9.36 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -96.75 117.6 31.39 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -80.25 -31.32 38.45 Favored 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.533 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -99.19 123.62 43.62 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.521 ' O ' HG21 ' A' ' 67' ' ' VAL . 7.8 tt -61.9 -34.55 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.4 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.88 -20.25 61.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.176 0.512 . . . . 0.0 110.014 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.38 -35.44 30.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.949 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.9 -47.2 89.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 63' ' ' ILE . 80.5 t -60.1 -42.21 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.78 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' O ' HG21 ' A' ' 72' ' ' VAL . 31.1 t70 -53.87 -59.89 4.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.316 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -67.49 -39.84 85.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.298 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 100' ' ' VAL . . . -61.96 -37.91 86.52 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 123.633 0.583 . . . . 0.0 111.172 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -73.14 -60.6 2.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.604 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 68' ' ' ASP . 58.6 t -55.69 -53.76 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.982 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 73' ' ' LEU . 1.5 tm? -72.9 -29.28 63.02 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.298 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.4 t 67.75 74.88 0.3 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.388 1.09 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -77.81 -168.4 1.22 Allowed 'General case' 0 C--O 1.249 1.074 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.633 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.7 -52.39 1.24 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.19 162.4 31.87 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.722 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.83 136.65 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.1 mp0 -105.21 115.03 29.58 Favored 'General case' 0 N--CA 1.394 -3.259 0 C-N-CA 123.177 0.591 . . . . 0.0 110.69 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.74 123.31 43.86 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 46.8 m-70 -77.77 108.72 11.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 175.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 117' ' ' PHE . . . -51.9 -11.78 1.03 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -51.62 -26.1 8.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.422 1.089 . . . . 0.0 111.932 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -69.12 -49.34 57.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.686 0.279 . . . . 0.0 111.718 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.5 147.88 0.32 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -79.45 -46.0 18.33 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 122.078 0.942 . . . . 0.0 111.35 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 42.3 mt -78.98 -14.32 59.27 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.219 -173.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.504 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.2 t80 -60.78 -39.9 90.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.347 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.47 HD12 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -61.38 -38.07 79.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-O 121.817 0.818 . . . . 0.0 109.967 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 18.2 t70 -65.99 -19.78 65.97 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.328 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 84.2 m -88.03 -41.94 12.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.922 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.434 HD12 HG13 ' A' ' 63' ' ' ILE . 2.6 mm? -51.77 -39.23 58.23 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 122.602 0.361 . . . . 0.0 111.359 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.435 ' CD ' HD12 ' A' ' 102' ' ' ILE . 7.9 mmm180 -46.0 -39.92 9.76 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.734 1.214 . . . . 0.0 111.546 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.07 -33.27 33.52 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.627 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.52 -21.04 18.54 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.705 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.62 141.88 42.2 Favored Pre-proline 0 C--N 1.285 -2.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.228 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.11 165.03 31.63 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 121.968 1.778 . . . . 0.0 110.363 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -12.11 61.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.706 0.765 . . . . 0.0 110.343 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -76.26 -29.13 57.36 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.292 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 70' ' ' ALA . 85.6 t -105.9 132.73 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 CA-C-O 121.196 0.522 . . . . 0.0 109.698 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.77 168.75 8.94 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.413 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.435 HD12 ' CD ' ' A' ' 93' ' ' ARG . 66.6 mt -123.95 132.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.583 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.7 m0 -120.58 157.65 29.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -100.61 111.53 23.78 Favored 'General case' 0 C--N 1.276 -2.587 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 110.39 4.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp . . . . . 0 C--N 1.292 -1.929 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.221 -173.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.541 ' CE1' ' HA3' ' A' ' 82' ' ' GLY . 31.5 m-85 . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -93.7 167.17 11.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.454 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.5 m80 74.12 18.62 3.12 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.448 1.092 . . . . 0.0 111.668 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.06 147.13 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 -42.66 25.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.89 0.376 . . . . 0.0 111.909 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.1 ttmt -149.27 163.3 38.05 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.05 139.18 54.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.04 165.75 30.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 C--N 1.311 -1.078 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.137 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.439 HD22 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -72.7 114.42 10.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.72 -174.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 41.5 t -90.4 118.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.319 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.38 169.16 9.53 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -32.08 106.55 0.02 OUTLIER Glycine 0 C--N 1.364 2.101 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -138.63 134.12 33.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -133.78 14.48 4.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.54 1.162 . . . . 0.0 109.738 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 65.9 mtt180 -107.13 112.22 25.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.32 -39.74 65.92 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 123.642 0.639 . . . . 0.0 113.963 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.44 -19.23 42.9 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.7 0.8 . . . . 0.0 111.082 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 9.7 t70 -87.71 -46.02 9.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.11 72.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.646 1.178 . . . . 0.0 111.367 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -22.39 66.02 Favored 'General case' 0 C--O 1.19 -2.036 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.15 71.32 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.853 0.297 . . . . 0.0 111.567 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.6 -35.75 39.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.279 1.038 . . . . 0.0 109.468 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -70.68 -31.11 67.89 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.687 174.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 -35.23 79.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.091 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.0 64.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.137 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.65 -20.43 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.373 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.78 26.77 13.02 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-O 121.75 0.786 . . . . 0.0 108.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' HD22 ' A' ' 4' ' ' ASN . 30.9 mt -67.28 -64.56 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.796 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.41 154.8 1.04 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.735 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 137.67 9.64 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.75 80.62 0.28 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.985 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -104.84 150.2 25.03 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.557 0.694 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.281 5.5 pt -105.91 151.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.968 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.08 60.42 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.884 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.33 113.85 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 117.401 -1.719 . . . . 0.0 107.447 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.71 118.47 7.71 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.635 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p 63.8 29.82 14.67 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.566 1.546 . . . . 0.0 112.91 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 36' ' ' ARG . 39.7 t -99.85 127.62 33.28 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.32 18.72 1.16 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.566 2.177 . . . . 0.0 111.682 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' SER . 39.7 mtp-105 -118.18 -8.26 10.66 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.899 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 62.0 m -140.54 171.13 14.55 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -136.61 136.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 119.245 0.93 . . . . 0.0 108.653 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.85 174.68 5.76 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.105 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -45.82 -31.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.897 1.279 . . . . 0.0 113.122 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.58 -62.22 1.64 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.633 0.73 . . . . 0.0 110.659 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 46' ' ' VAL . 25.0 mt-30 -64.47 -42.04 96.14 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.274 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -25.23 68.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.91 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 44' ' ' GLN . 0.9 OUTLIER -68.82 -24.28 64.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 109.629 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.84 -49.93 7.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 42' ' ' GLN . 46.7 t -55.36 -35.34 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.786 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptp -58.9 -31.09 68.3 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.6 29.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.408 0.623 . . . . 0.0 110.307 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.32 -39.79 14.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 19' ' ' TYR . . . -145.81 97.22 4.6 Favored Pre-proline 0 N--CA 1.401 -2.893 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.12 71.39 0.86 Allowed 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.406 2.071 . . . . 0.0 113.114 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.17 147.24 29.27 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.776 173.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.99 145.42 48.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.513 -173.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.64 142.03 45.72 Favored 'General case' 0 C--O 1.253 1.256 0 CA-C-O 121.838 0.828 . . . . 0.0 112.306 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 152.24 34.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.48 149.85 17.0 Favored Glycine 0 C--O 1.2 -1.979 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.2 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.91 123.39 44.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -172.43 156.84 3.85 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.665 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 31.2 mtm180 -95.71 92.06 6.4 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -104.27 121.17 42.76 Favored 'General case' 0 N--CA 1.406 -2.631 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.56 -31.92 36.78 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.311 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.55 110.63 19.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.238 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' A' ' 91' ' ' THR . 6.8 tt -58.32 -38.36 68.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.521 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.5 62.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.318 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 16.9 t70 -86.22 -31.19 21.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.155 0.502 . . . . 0.0 109.994 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.54 -46.15 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 63' ' ' ILE . 61.0 t -62.57 -39.87 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.256 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.552 ' O ' HG22 ' A' ' 72' ' ' VAL . 25.8 t70 -52.55 -58.82 5.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.879 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -66.98 -40.92 87.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.842 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 100' ' ' VAL . . . -61.75 -30.77 71.0 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.367 0.667 . . . . 0.0 111.276 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -83.53 -58.74 2.69 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.794 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 68' ' ' ASP . 59.0 t -54.4 -57.92 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.478 0.486 . . . . 0.0 111.291 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.76 -17.14 57.85 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.72 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 29.3 m 59.09 72.21 0.54 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.985 0.897 . . . . 0.0 111.314 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -79.11 -172.44 3.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.206 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -126.68 -35.13 2.35 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.306 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -149.37 166.03 30.25 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.51 135.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -101.44 108.36 19.93 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-O 121.68 0.752 . . . . 0.0 109.602 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.415 HD11 ' HG ' ' A' ' 92' ' ' LEU . 72.5 mt -90.53 120.54 31.7 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.102 -1.408 . . . . 0.0 107.595 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB3' ' CG ' ' A' ' 59' ' ' ARG . 8.8 t60 -83.37 85.85 7.16 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -49.22 -9.14 0.11 Allowed Glycine 0 N--CA 1.47 0.919 0 C-N-CA 128.325 2.869 . . . . 0.0 120.029 -168.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -39.0 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.83 -48.72 79.32 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -175.11 148.65 1.01 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -78.12 -39.21 42.0 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.9 mt -82.69 -15.98 49.88 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.554 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.578 ' O ' ' HB ' ' A' ' 91' ' ' THR . 19.0 t80 -61.29 -39.63 91.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.412 ' HA ' HD22 ' A' ' 92' ' ' LEU . 1.9 mp -63.73 -34.9 70.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.929 0.871 . . . . 0.0 109.626 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.0 t70 -69.56 -18.41 63.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.455 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 63.1 m -83.79 -41.45 17.56 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.299 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -52.69 -41.71 64.13 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 123.272 0.629 . . . . 0.0 110.806 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.504 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.2 mmm180 -43.74 -44.44 6.61 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.11 1.364 . . . . 0.0 112.4 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -75.25 -24.27 57.62 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.913 -171.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.18 -3.57 25.59 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.819 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.4 tp -80.55 130.61 64.12 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 124.567 1.147 . . . . 0.0 109.567 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.49 162.52 37.94 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.379 1.386 . . . . 0.0 109.404 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.82 64.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -76.15 -30.27 58.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.6 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.428 HG22 ' HB1' ' A' ' 70' ' ' ALA . 40.5 t -104.57 147.44 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.468 0 CA-C-O 121.112 0.482 . . . . 0.0 110.109 -171.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -121.13 174.67 6.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 123.796 0.838 . . . . 0.0 108.761 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 93' ' ' ARG . 92.6 mt -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 34.9 m0 -120.57 157.61 29.12 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.885 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -101.81 116.64 33.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.79 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.3 98.8 3.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.113 -173.821 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 95.8 m-85 . . . . . 0 CA--C 1.474 -1.956 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -72.9 163.81 27.58 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.585 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.504 ' CE1' ' HG3' ' A' ' 93' ' ' ARG . 5.9 t-160 65.35 38.47 5.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.98 0.895 . . . . 0.0 110.641 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -102.17 155.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.83 -39.5 15.82 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.783 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -155.53 163.02 40.55 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.52 144.38 50.89 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.788 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.42 175.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.294 -1.838 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.001 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.461 HD22 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.516 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 15.0 ptpt -77.79 98.11 5.44 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.003 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 78.1 t -72.64 109.24 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.765 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.7 m -92.07 170.94 9.44 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 36' ' ' ARG . . . -50.61 116.3 4.13 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.672 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.57 176.65 6.08 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -123.93 -0.92 8.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.82 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 88.9 mtt180 -126.94 115.6 19.51 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.24 82.09 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-O 122.599 1.11 . . . . 0.0 112.32 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.3 mp0 -70.84 -40.18 72.52 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 125.604 1.562 . . . . 0.0 108.96 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 33.0 t70 -74.98 -26.85 59.88 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.507 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -46.02 61.18 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.711 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 22.4 pttp -67.66 -23.61 65.35 Favored 'General case' 0 C--O 1.199 -1.555 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.26 70.05 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.997 0.427 . . . . 0.0 110.693 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.68 -42.46 58.41 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.101 0.953 . . . . 0.0 109.586 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -32.71 72.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.949 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.8 -32.11 70.37 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.17 -25.05 54.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.702 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.92 -28.91 0.02 OUTLIER Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.093 -1.527 . . . . 0.0 113.009 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.46 30.74 17.28 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.921 0.867 . . . . 0.0 108.78 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.461 ' HB ' HD22 ' A' ' 4' ' ' ASN . 40.5 mt -70.75 -59.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.635 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -176.2 160.53 2.21 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.899 0.749 . . . . 0.0 109.9 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -128.79 123.05 4.15 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.4 85.68 0.67 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.17 151.84 33.68 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 4.9 pt -116.58 146.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.031 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -80.32 80.39 6.76 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.051 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.8 t -107.37 114.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.52 118.96 6.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.614 1.196 . . . . 0.0 110.874 -173.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.3 p 66.43 29.25 9.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.718 1.607 . . . . 0.0 113.136 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 40.8 t -92.84 143.69 27.34 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -91.2 0.16 4.78 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 121.52 1.48 . . . . 0.0 112.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 69.7 ttt180 -122.33 6.46 9.63 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 122.17 0.986 . . . . 0.0 109.475 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 57.3 m -146.81 125.57 12.62 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.59 137.15 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.918 0.865 . . . . 0.0 112.844 -172.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -107.4 172.63 6.72 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.593 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 p -49.64 -32.09 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.583 0.753 . . . . 0.0 112.5 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.454 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 53.1 mp0 -62.1 -60.8 3.07 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' O ' HG21 ' A' ' 46' ' ' VAL . 35.6 mt-30 -69.97 -32.72 71.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.188 177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.82 -23.65 67.44 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.258 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -26.36 68.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.489 0.662 . . . . 0.0 109.396 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.28 -49.28 9.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 42' ' ' GLN . 32.3 t -61.47 -32.26 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.963 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.669 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 22.9 ptm -64.35 -23.55 67.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.916 0.389 . . . . 0.0 111.868 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.57 -20.26 21.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.347 0.594 . . . . 0.0 109.482 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.49 -53.77 5.2 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.383 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.65 92.84 22.4 Favored Pre-proline 0 N--CA 1.391 -3.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.23 53.55 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.818 2.345 . . . . 0.0 112.183 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.81 162.94 15.25 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.058 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.23 131.53 47.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.512 0.725 . . . . 0.0 110.718 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 54.5 m-85 -102.85 142.26 34.27 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.095 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.9 138.25 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -113.91 128.73 8.41 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.455 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.97 106.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -163.19 168.02 21.28 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.286 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -85.85 104.77 15.82 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -100.87 150.42 22.85 Favored 'General case' 1 N--CA 1.375 -4.181 0 CA-C-O 122.339 1.066 . . . . 0.0 109.479 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -113.69 -65.97 1.13 Allowed 'General case' 1 C--N 1.235 -4.38 0 CA-C-N 112.165 -2.289 . . . . 0.0 110.402 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -89.32 119.73 30.04 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.823 0.82 . . . . 0.0 111.904 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 tt -66.86 -32.56 58.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.162 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.6 61.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.242 0.544 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.5 -49.75 7.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.555 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.15 -35.76 74.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.039 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.87 -30.9 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.144 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.514 ' O ' HG21 ' A' ' 72' ' ' VAL . 24.2 t70 -72.1 -38.23 69.37 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -65.68 -45.94 80.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -62.51 -23.67 67.08 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.231 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 30.7 ttmt -80.41 -59.1 2.82 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 124.193 0.997 . . . . 0.0 109.784 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 68' ' ' ASP . 65.5 t -59.13 -60.03 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.227 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 1.4 mm? -78.3 -8.2 58.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.985 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.1 p 52.32 73.29 0.34 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.719 0.771 . . . . 0.0 111.985 -172.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.41 173.55 3.22 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.243 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.69 -34.63 2.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.52 46.3 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.486 168.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.68 135.61 39.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.42 117.22 33.96 Favored 'General case' 0 N--CA 1.399 -3.016 0 CA-C-O 121.134 0.492 . . . . 0.0 110.886 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.92 128.2 43.65 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.073 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -83.28 95.48 8.18 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -61.01 -12.93 31.87 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -171.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -54.75 -26.38 33.85 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 117.668 0.734 . . . . 0.0 112.532 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 6.1 mm-40 -56.08 -45.69 79.26 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.487 ' O ' HD13 ' A' ' 89' ' ' ILE . 10.3 tp10 -175.74 135.45 0.3 Allowed 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 123.807 0.843 . . . . 0.0 109.007 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -66.28 -44.16 84.36 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.094 1.357 . . . . 0.0 111.06 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.73 -19.97 47.54 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.465 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.521 ' O ' ' HB ' ' A' ' 91' ' ' THR . 32.6 t80 -65.07 -36.79 85.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.241 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 85' ' ' GLU . 4.9 mp -63.32 -41.51 93.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.51 -21.38 66.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.4 m -81.37 -45.12 16.59 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.457 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 89' ' ' ILE . 3.8 mm? -44.06 -46.22 8.41 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -55.0 -23.78 21.07 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.2 -39.35 21.08 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.134 0.493 . . . . 0.0 111.452 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.33 -2.69 58.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.412 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.14 120.57 82.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.231 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.35 163.66 35.81 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.485 1.457 . . . . 0.0 109.718 173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.1 -7.64 37.89 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -80.69 -30.65 36.41 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.608 0.718 . . . . 0.0 109.753 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 70' ' ' ALA . 18.9 t -104.0 146.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.274 -170.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 168.69 10.71 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.516 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.6 mt -123.07 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.578 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.0 m0 -125.0 164.37 20.31 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 130.96 53.39 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.44 106.87 2.25 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.961 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.417 -2.083 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 N--CA 1.427 -1.618 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.37 177.04 4.91 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.418 -175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.3 t60 73.25 28.42 1.83 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.212 1.482 . . . . 0.0 108.45 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.05 155.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.15 -40.91 62.27 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -158.14 161.96 37.94 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -99.61 154.89 17.91 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 123.701 0.8 . . . . 0.0 109.586 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.4 p -157.76 168.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.783 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.22 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 113.098 -1.864 . . . . 0.0 114.426 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -90.15 115.23 29.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.191 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.9 m -91.56 170.24 10.1 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -30.46 116.44 0.07 OUTLIER Glycine 0 C--N 1.351 1.414 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 -171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.441 HD11 ' OD2' ' A' ' 14' ' ' ASP . 16.7 tp -145.69 148.0 32.57 Favored 'General case' 0 N--CA 1.402 -2.858 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -125.67 -6.72 6.85 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -95.61 114.61 26.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -59.56 -30.5 68.72 Favored Glycine 0 C--O 1.217 -0.959 0 O-C-N 123.373 0.42 . . . . 0.0 112.06 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.8 -30.42 69.85 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.85 1.31 . . . . 0.0 108.045 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD2' HD11 ' A' ' 9' ' ' LEU . 40.6 t0 -91.46 -33.62 15.14 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 112.637 -2.074 . . . . 0.0 108.766 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.95 -34.68 78.29 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.304 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 51.0 mtmt -58.97 -25.51 63.63 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.016 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.27 75.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.974 0.416 . . . . 0.0 111.386 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 -43.94 62.84 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.755 0.788 . . . . 0.0 109.693 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.132 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.61 -29.76 69.88 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.309 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.69 -23.3 63.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.27 -2.88 0.05 OUTLIER Glycine 0 C--O 1.22 -0.766 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.946 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.41 21.24 12.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.565 0.746 . . . . 0.0 110.309 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.67 -67.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.436 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -163.78 -177.53 5.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.484 0.49 . . . . 0.0 110.48 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -140.11 140.88 11.01 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.84 87.84 0.44 Allowed Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.93 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.21 155.17 42.23 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.074 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 4.7 pt -116.75 155.34 18.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -81.48 81.29 7.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.321 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.511 ' CG1' ' H ' ' A' ' 34' ' ' SER . 11.9 p -82.49 152.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.04 89.38 5.36 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.1 p 52.33 72.89 0.37 Allowed 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.511 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 19.9 m -140.26 122.16 9.66 Favored Pre-proline 0 C--O 1.208 -1.089 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 168.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.67 5.83 0.53 Allowed 'Trans proline' 0 C--O 1.207 -1.026 0 C-N-CA 124.038 3.159 . . . . 0.0 115.413 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -101.18 -0.64 35.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.598 0.713 . . . . 0.0 109.677 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.486 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 63.2 m -136.8 166.73 22.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.21 137.16 53.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.524 1.056 . . . . 0.0 111.039 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -115.19 171.15 7.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.89 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 89.0 t -46.64 -32.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 0.0 113.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -56.25 24.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.723 0.773 . . . . 0.0 110.536 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -81.2 -35.29 31.55 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.668 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 46' ' ' VAL . . . -62.46 -27.81 69.38 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.142 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -38.19 80.24 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.63 0.728 . . . . 0.0 109.459 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.82 -45.51 10.82 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 43' ' ' ALA . 3.6 p -65.53 -24.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.744 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.3 ptm -67.8 -18.08 64.73 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.025 0.441 . . . . 0.0 111.347 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.36 -22.87 18.68 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.012 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.47 -46.44 32.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.306 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.34 104.09 17.93 Favored Pre-proline 0 N--CA 1.399 -3.007 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.25 45.02 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.544 2.829 . . . . 0.0 113.247 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.25 171.91 9.44 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.216 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -77.77 140.95 39.51 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 122.964 0.506 . . . . 0.0 110.102 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -108.74 137.53 46.53 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.514 0.673 . . . . 0.0 111.543 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 26' ' ' GLY . 13.4 p -129.43 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.89 133.61 8.35 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.541 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.549 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.2 t -111.6 131.22 63.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -159.64 151.09 19.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -85.39 105.06 15.75 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.17 116.7 17.11 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.495 1.14 . . . . 0.0 109.598 -171.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -106.28 -74.65 0.65 Allowed 'General case' 0 C--N 1.253 -3.625 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.246 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.39 119.55 31.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 92' ' ' LEU . 15.9 tt -62.7 -32.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.659 -177.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -12.98 59.82 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.447 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 33.1 t70 -82.41 -40.32 21.43 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -73.85 -34.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.895 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 63' ' ' ILE . 54.7 t -60.49 -39.95 82.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.569 ' O ' HG21 ' A' ' 72' ' ' VAL . 12.5 t70 -52.97 -51.13 62.56 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.906 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 38.4 mmtm -65.82 -45.46 82.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.001 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -60.88 -32.26 71.71 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.138 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -76.76 -57.65 3.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.824 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' ' 68' ' ' ASP . 58.1 t -57.62 -57.01 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.517 0.727 . . . . 0.0 112.06 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -78.53 -8.82 58.98 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.042 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.0 p 49.27 68.3 0.74 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.959 0.885 . . . . 0.0 110.863 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -71.42 178.3 3.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.048 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.94 -36.4 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.794 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.57 46.01 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.3 p -142.17 139.4 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.85 129.53 45.23 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-O 121.347 0.594 . . . . 0.0 111.564 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 124.6 36.25 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.378 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 83' ' ' ASN . 26.9 t-80 -81.99 92.7 6.82 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 89' ' ' ILE . . . -56.97 -19.68 31.16 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 5.7 t30 -53.92 -29.86 43.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.98 -47.82 78.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.6 tm-20 -176.41 151.18 0.95 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 24.9 mt-30 -77.93 -45.04 25.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 123.994 0.918 . . . . 0.0 111.966 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.1 mt -83.75 -23.34 31.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.131 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.522 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.4 t80 -55.0 -40.19 69.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.395 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.491 HD13 ' CD1' ' A' ' 117' ' ' PHE . 2.6 mp -61.8 -36.97 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.341 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.719 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 23.4 t70 -68.7 -20.69 64.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.778 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.7 m -85.21 -43.18 14.02 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.927 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 63' ' ' ILE . 3.5 mm? -47.08 -50.75 19.29 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.719 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.18 -10.76 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.72 -51.04 10.38 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.64 -24.12 58.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.092 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.7 mt -92.07 127.47 49.27 Favored Pre-proline 0 C--N 1.276 -2.59 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.308 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.15 165.87 29.98 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.542 2.162 . . . . 0.0 110.489 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.94 -16.63 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 111.231 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -64.33 -29.14 70.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.886 0.874 . . . . 0.0 109.826 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.19 134.56 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.185 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.71 170.77 7.91 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mt -123.67 135.42 63.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.571 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -121.96 156.55 33.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.67 129.83 54.75 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.19 102.19 4.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 C--N 1.299 -1.596 0 C-N-CA 123.836 0.854 . . . . 0.0 109.554 -174.994 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.491 ' CD1' HD13 ' A' ' 89' ' ' ILE . 81.9 m-85 . . . . . 0 CA--C 1.493 -1.241 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -110.71 -170.13 1.58 Allowed 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 69.35 27.68 4.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.005 1.383 . . . . 0.0 108.805 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.03 155.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.259 -1.791 . . . . 0.0 107.39 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.31 -40.99 50.08 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.788 0.804 . . . . 0.0 111.093 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.549 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 4.9 ttmp? -153.89 163.31 40.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.82 147.7 50.44 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.22 173.56 13.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.667 0 CA-C-N 118.403 0.547 . . . . 0.0 110.718 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.773 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.47 109.71 3.32 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.852 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 59.0 t -86.0 102.7 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.6 m -96.82 170.12 9.39 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -34.32 116.3 0.18 Allowed Glycine 0 N--CA 1.476 1.367 0 O-C-N 124.218 0.949 . . . . 0.0 114.712 -174.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.6 tp -146.73 157.48 43.7 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -138.32 14.8 2.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.344 1.069 . . . . 0.0 109.724 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.0 mtt180 -115.54 110.44 19.25 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.77 -35.5 74.86 Favored Glycine 0 C--N 1.301 -1.397 0 O-C-N 123.192 0.307 . . . . 0.0 113.39 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.593 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -70.5 -35.13 73.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.223 1.011 . . . . 0.0 108.945 -177.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 16.2 t0 -82.06 -22.63 36.26 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.724 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.63 -44.77 27.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.569 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 20.9 pttp -67.79 -23.28 65.19 Favored 'General case' 0 C--O 1.201 -1.494 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.44 74.69 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.676 0.39 . . . . 0.0 110.956 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.01 69.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -69.09 -34.67 75.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.293 176.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.6 -32.15 73.3 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.489 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.23 -23.66 61.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.58 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.54 -20.97 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . . . 60.24 30.68 20.05 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 121.68 0.752 . . . . 0.0 109.79 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' HD22 ' A' ' 4' ' ' ASN . 31.0 mt -70.62 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.034 -171.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.35 151.33 0.61 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.287 0.992 . . . . 0.0 108.701 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.49 9.49 Favored Glycine 0 N--CA 1.417 -2.622 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.08 81.11 1.08 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.239 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -114.57 150.74 34.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.186 0.517 . . . . 0.0 110.133 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 14.3 mt -118.08 156.14 19.84 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.444 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 20.7 m-85 -82.78 69.3 9.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.432 0.56 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.57 118.63 42.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.683 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.86 96.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.811 1.644 . . . . 0.0 114.24 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.0 p 56.48 23.54 7.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.626 1.57 . . . . 0.0 112.975 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 36' ' ' ARG . 14.8 m -103.32 111.09 64.87 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.74 19.9 0.12 Allowed 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.64 3.56 . . . . 0.0 114.386 -172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 34' ' ' SER . 24.1 mmt180 -91.97 -21.6 20.45 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 170.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -141.29 174.17 10.8 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.441 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -134.18 136.91 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.495 -177.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.1 p-10 -105.13 167.32 9.79 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.258 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 93.3 t -48.41 -34.58 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.925 1.29 . . . . 0.0 112.39 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 17.1 mp0 -62.0 -55.65 27.1 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 123.632 0.773 . . . . 0.0 111.988 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' VAL . 29.6 mt-30 -68.59 -42.22 78.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -20.12 65.37 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.109 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.44 -45.36 11.22 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.568 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 42' ' ' GLN . 14.9 t -64.09 -33.01 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.489 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.403 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . 26.6 ptt? -64.63 -25.38 67.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.167 0.508 . . . . 0.0 110.783 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.95 -24.38 33.02 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.45 -51.93 7.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.182 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.37 104.29 17.84 Favored Pre-proline 0 N--CA 1.395 -3.222 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 48.3 2.23 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.709 2.273 . . . . 0.0 112.293 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -85.07 168.57 14.76 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.527 175.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -79.65 140.43 37.07 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 120.616 0.246 . . . . 0.0 111.565 -177.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.472 ' CD2' HD12 ' A' ' 28' ' ' LEU . 33.2 m-85 -113.15 146.33 39.43 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.077 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.67 164.48 34.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -139.93 148.83 20.39 Favored Glycine 0 CA--C 1.481 -2.079 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.598 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.428 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 39.9 t -124.77 140.29 48.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -168.59 158.4 9.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.769 0.713 . . . . 0.0 109.981 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -86.15 94.72 9.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.452 HD21 ' HG ' ' A' ' 80' ' ' LEU . 84.3 m-20 -79.06 118.65 21.24 Favored 'General case' 0 N--CA 1.395 -3.184 0 CA-C-O 122.563 1.173 . . . . 0.0 110.327 -173.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.93 -61.43 1.58 Allowed 'General case' 0 C--N 1.247 -3.889 0 CA-C-N 112.521 -2.127 . . . . 0.0 106.127 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.22 110.45 18.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.759 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 67' ' ' VAL . 14.6 tt -64.62 -32.04 56.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.084 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.25 -22.32 63.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.212 0.529 . . . . 0.0 110.212 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.0 t70 -83.04 -34.82 26.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.05 -44.02 99.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.4 t -59.81 -45.54 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.472 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.577 ' O ' HG21 ' A' ' 72' ' ' VAL . 16.5 t70 -52.22 -61.27 2.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.196 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.471 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 46.9 mmtm -64.16 -42.09 96.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.679 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -31.26 72.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.555 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -79.4 -57.81 3.52 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.422 0.451 . . . . 0.0 110.182 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 68' ' ' ASP . 60.0 t -53.59 -55.69 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.987 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.31 -16.54 52.15 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.437 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.6 m 59.89 74.43 0.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.179 0.99 . . . . 0.0 110.402 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.1 mt -86.4 -168.49 2.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.936 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB3' ' OE1' ' A' ' 53' ' ' GLN . . . -128.65 -40.29 1.58 Allowed 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.05 161.61 39.0 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.776 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.82 137.43 35.08 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.477 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.76 121.39 39.62 Favored 'General case' 0 N--CA 1.381 -3.917 0 CA-C-O 121.678 0.752 . . . . 0.0 110.248 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' HG ' HD21 ' A' ' 60' ' ' ASN . 1.4 tt -109.49 136.24 49.21 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -77.76 79.16 4.25 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.56 -13.12 1.81 Allowed Glycine 0 C--O 1.214 -1.107 0 CA-C-N 114.003 -1.453 . . . . 0.0 116.567 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -55.35 -24.31 28.65 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.537 1.135 . . . . 0.0 112.769 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -48.76 -49.3 39.16 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.282 1.033 . . . . 0.0 113.172 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -176.88 148.9 0.69 Allowed 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.53 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 9.1 tt0 -77.81 -48.85 15.55 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.421 1.105 . . . . 0.0 112.065 -168.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.82 -17.53 62.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.998 -174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.0 t80 -61.11 -45.0 96.49 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.89 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.63 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-O 121.779 0.799 . . . . 0.0 109.16 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.83 -20.46 66.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.226 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 89.3 m -83.9 -41.31 17.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.457 HD12 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -50.73 -38.37 47.09 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 123.684 0.794 . . . . 0.0 111.773 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -59.14 -34.32 71.92 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.209 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.08 -37.84 45.6 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.279 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.94 -18.96 26.4 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.46 141.32 22.93 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.364 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.38 165.8 31.34 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.07 1.846 . . . . 0.0 110.363 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -11.79 18.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.199 0.999 . . . . 0.0 112.126 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -79.15 -28.55 42.8 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.231 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.22 127.56 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.034 0 CA-C-O 121.44 0.638 . . . . 0.0 109.617 -175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 121' ' ' ASP . . . -111.37 172.58 6.8 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 130.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.477 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 37.6 m0 -116.94 155.76 28.56 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.96 113.68 26.43 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.89 2.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.41 -2.465 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.655 -175.523 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 67.9 m-85 . . . . . 0 N--CA 1.418 -2.048 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.03 166.71 22.49 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.8 m170 66.26 30.05 9.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.707 0.63 . . . . 0.0 112.543 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.8 m -103.72 149.6 7.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 24.3 t70 -85.67 -42.28 14.43 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.258 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -153.59 163.13 40.5 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.544 0.738 . . . . 0.0 111.442 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.74 135.78 49.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.311 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.2 163.45 29.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.5 tp . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -67.59 96.2 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.4 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.14 104.96 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.182 0.992 . . . . 0.0 111.53 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 169.2 10.16 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -31.34 109.47 0.03 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.29 147.58 2.0 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -136.42 -3.2 2.16 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.776 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.29 111.51 5.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.37 -58.07 5.39 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 124.57 1.081 . . . . 0.0 113.971 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.626 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -57.1 -19.9 22.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -92.0 -44.87 8.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.48 74.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.42 -23.37 65.78 Favored 'General case' 0 C--O 1.191 -2.007 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.176 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.64 -35.0 69.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.071 0.463 . . . . 0.0 110.967 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.33 56.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.727 0.775 . . . . 0.0 110.089 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.409 ' CB ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -70.66 -35.95 73.11 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.364 177.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.95 -26.28 62.07 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.403 1.081 . . . . 0.0 111.067 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.09 -22.51 66.41 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.499 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.83 18.27 0.15 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.805 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.87 25.99 7.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.574 1.15 . . . . 0.0 111.727 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -57.93 -67.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.092 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.67 155.66 2.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -122.15 131.33 8.36 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.78 88.47 0.92 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -125.11 149.1 48.19 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 1.9 pt -117.69 157.87 18.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -86.92 87.29 7.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 124.149 0.906 . . . . 0.0 112.114 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 54.7 t -121.86 116.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 169.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.46 113.26 1.35 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 124.447 1.092 . . . . 0.0 113.298 -173.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p 62.94 23.34 13.95 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.864 1.666 . . . . 0.0 113.885 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 78.9 p -86.62 149.27 48.33 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.48 13.73 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.752 1.635 . . . . 0.0 111.705 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.558 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 21.9 ptt180 -119.42 -8.56 10.02 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.014 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 59.5 m -145.51 172.89 12.56 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.21 137.31 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 109.071 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.586 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -103.61 164.91 11.36 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.45 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.0 p -51.51 -35.21 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 124.265 0.978 . . . . 0.0 111.57 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 7.9 mp0 -67.82 -39.2 83.94 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 124.36 1.064 . . . . 0.0 112.011 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 46' ' ' VAL . 51.6 mm-40 -67.33 -51.15 55.91 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 122.67 1.224 . . . . 0.0 107.914 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.44 66.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.462 -2.154 . . . . 0.0 114.449 -168.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 47' ' ' MET . 0.3 OUTLIER -63.75 -31.2 72.3 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.81 -37.94 29.25 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.31 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 42' ' ' GLN . 44.8 t -65.63 -31.67 54.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.16 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 27.1 ptt? -67.83 -17.32 64.47 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.223 0.535 . . . . 0.0 111.76 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.63 46.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.427 0.632 . . . . 0.0 109.469 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.22 -40.62 6.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.305 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.94 98.75 9.41 Favored Pre-proline 0 N--CA 1.406 -2.656 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.11 59.91 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.057 2.504 . . . . 0.0 113.023 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.409 HD22 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -101.42 163.9 12.04 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.366 175.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.91 145.47 46.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.63 0.252 . . . . 0.0 110.576 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.74 140.79 47.98 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.2 p -133.57 144.0 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.72 132.56 11.11 Favored Glycine 0 CA--C 1.475 -2.464 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.417 HG21 ' CB ' ' A' ' 79' ' ' GLN . 7.3 p -140.09 104.05 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.053 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -167.88 178.75 5.03 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -173.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -86.3 93.42 9.08 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.42 117.99 26.57 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -85.77 -63.19 1.36 Allowed 'General case' 0 C--N 1.247 -3.89 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.711 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -89.44 125.32 35.12 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.032 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 67' ' ' VAL . 19.1 tt -63.4 -34.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.064 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.65 -20.11 62.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.62 0.724 . . . . 0.0 110.39 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 18.3 t70 -85.93 -39.48 16.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.158 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 63' ' ' ILE . 14.5 p -77.46 -32.21 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.823 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 63' ' ' ILE . 88.2 t -59.9 -40.92 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' HG21 ' A' ' 72' ' ' VAL . 21.3 t70 -54.09 -50.93 65.68 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.534 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -69.21 -42.1 76.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.139 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -66.37 -22.98 66.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -83.83 -61.74 1.75 Allowed 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 68' ' ' ASP . 67.2 t -54.69 -56.68 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 123.894 0.746 . . . . 0.0 111.548 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 ' HB2' HG23 ' A' ' 40' ' ' VAL . 59.2 tp -83.16 -19.52 36.46 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.69 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 12.7 t 60.09 82.83 0.15 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 122.333 1.063 . . . . 0.0 109.768 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.22 173.01 11.9 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.644 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.24 -31.54 5.95 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -151.54 161.45 42.67 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.921 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 p -143.87 138.73 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.606 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.39 119.81 39.59 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 121.848 -0.533 . . . . 0.0 110.575 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HG ' ' HG ' ' A' ' 92' ' ' LEU . 3.5 mm? -99.86 119.76 38.7 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.347 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -81.53 104.03 11.67 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.77 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.658 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -53.76 -12.25 2.46 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.739 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -55.24 -27.76 48.51 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 110.762 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -72.78 -47.58 45.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 123.076 0.235 . . . . 0.0 110.874 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -179.57 150.03 0.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.62 -44.31 24.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.507 1.146 . . . . 0.0 110.823 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 32.6 mt -80.71 -13.38 59.05 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.934 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.7 t80 -59.04 -42.96 91.51 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.381 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.47 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.5 mp -59.51 -38.19 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.625 0.726 . . . . 0.0 109.476 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 18.8 t70 -63.06 -22.0 66.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.33 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 94.2 m -88.53 -45.14 10.15 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.658 1.183 . . . . 0.0 109.997 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.459 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -45.09 -47.16 11.98 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.48 -24.51 66.63 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.129 -177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 29.7 mt-10 -76.56 -37.74 56.08 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.384 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.1 -36.55 15.67 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.466 0.651 . . . . 0.0 112.255 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.31 121.2 75.24 Favored Pre-proline 0 C--N 1.272 -2.763 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.813 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.47 165.43 20.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.479 2.119 . . . . 0.0 111.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.28 -10.74 17.28 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.493 1.117 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -75.7 -29.56 59.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.56 129.73 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.335 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.99 164.88 11.77 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.338 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.1 mt -116.94 132.66 66.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.606 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 45.4 m0 -122.31 158.94 28.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.728 174.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 105' ' ' ALA . 17.5 tptm -100.97 115.86 31.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.473 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -77.55 98.12 5.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.634 -174.724 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.658 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 31.8 m-85 . . . . . 0 N--CA 1.41 -2.426 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -85.24 153.5 22.57 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 75.77 24.56 1.25 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.269 -2.242 . . . . 0.0 111.604 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.44 143.56 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.85 -32.2 21.84 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.183 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 40.2 ttmt -153.56 160.36 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.325 0.583 . . . . 0.0 109.638 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -111.63 134.76 52.98 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.383 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.31 -176.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 -179.434 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 . . . . . 0 C--O 1.213 -0.849 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -51.03 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.598 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.86 103.22 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.957 0.884 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.81 168.53 11.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.62 106.41 0.01 OUTLIER Glycine 0 N--CA 1.484 1.88 0 C-N-CA 125.578 1.561 . . . . 0.0 116.942 -173.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.54 145.68 51.91 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -125.45 8.74 7.77 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.118 0.961 . . . . 0.0 108.633 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -125.32 107.35 10.61 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.227 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.69 -54.01 8.11 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 124.07 0.843 . . . . 0.0 113.177 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.693 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -63.45 -26.32 68.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -23.11 25.02 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.087 0.946 . . . . 0.0 108.64 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.08 -22.75 60.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.558 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -61.19 -24.18 66.13 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.584 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.12 -34.4 60.21 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.289 0.368 . . . . 0.0 111.748 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.36 67.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.885 0.85 . . . . 0.0 110.047 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -36.15 81.74 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.976 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.24 -28.53 69.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.416 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.2 -23.03 59.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.904 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.32 -11.95 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 118.413 -1.851 . . . . 0.0 113.717 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.18 23.87 14.15 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 121.46 0.647 . . . . 0.0 109.771 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.7 mt -57.8 -53.13 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.122 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 37.9 p90 -170.6 -172.09 1.16 Allowed 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.85 177.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.26 122.06 1.64 Allowed Glycine 0 C--N 1.284 -2.306 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 171.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.99 100.63 1.97 Allowed Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.369 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -131.96 161.98 31.8 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 123.07 0.548 . . . . 0.0 109.893 -178.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 57' ' ' VAL . 4.7 pt -117.4 153.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 86.7 m-85 -81.55 82.44 7.32 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.81 133.45 67.41 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.718 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.415 ' C ' ' HG1' ' A' ' 33' ' ' THR . . . -70.88 136.16 48.45 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.533 0.682 . . . . 0.0 111.26 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.415 ' HG1' ' C ' ' A' ' 32' ' ' ALA . 66.4 p 53.73 9.63 0.2 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 127.204 2.202 . . . . 0.0 116.322 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -94.75 128.54 39.21 Favored Pre-proline 0 C--O 1.211 -0.928 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.863 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.32 0.16 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.345 2.696 . . . . 0.0 113.99 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -104.14 -8.01 19.76 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.304 0.573 . . . . 0.0 110.299 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 57.8 m -139.62 136.05 33.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.891 -0.506 . . . . 0.0 111.185 -171.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.48 ' O ' HD23 ' A' ' 28' ' ' LEU . 2.3 t -108.13 135.4 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -125.28 -170.06 2.1 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 99.1 t -46.92 -34.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 125.152 1.532 . . . . 0.0 111.286 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.84 -64.41 0.95 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 122.367 1.08 . . . . 0.0 111.353 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.562 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.3 mp0 -68.88 -49.45 58.18 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.716 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -24.0 66.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.782 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.36 -34.76 75.84 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.81 -50.37 8.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.075 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 42' ' ' GLN . 24.5 t -58.19 -30.82 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.995 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.1 ptm -68.13 -12.13 60.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.983 0.421 . . . . 0.0 111.646 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.64 -6.67 24.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -42.13 4.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.384 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.76 99.27 15.5 Favored Pre-proline 0 N--CA 1.396 -3.134 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -76.09 71.73 5.57 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 C-N-CA 121.899 1.733 . . . . 0.0 111.675 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.65 160.99 15.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.508 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 25' ' ' TYR 0.253 0.0 OUTLIER -75.71 122.42 23.98 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.103 1.361 . . . . 0.0 108.656 -176.643 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -92.31 137.69 32.15 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.683 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -132.16 136.39 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.53 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -116.27 150.11 18.66 Favored Glycine 0 CA--C 1.481 -2.035 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.652 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 29' ' ' ILE . 41.4 t -130.05 133.79 63.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -172.4 159.49 4.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.588 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.526 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 16.3 ttm180 -104.44 97.01 7.0 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.98 148.11 25.75 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -97.65 -37.68 9.82 Favored 'General case' 1 C--N 1.238 -4.273 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.137 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.68 126.0 42.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.844 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.465 HG13 HD12 ' A' ' 92' ' ' LEU . 7.6 tt -63.97 -34.44 68.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.149 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.61 -15.81 59.73 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.452 0.644 . . . . 0.0 109.772 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 12.3 t70 -75.93 -38.29 57.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.392 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.43 -46.7 69.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.316 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -59.42 -40.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.528 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.8 t70 -52.01 -56.17 15.96 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.08 176.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.5 mmtm -64.82 -43.18 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.347 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.35 85.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 124.182 0.926 . . . . 0.0 111.066 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.65 -52.14 8.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.54 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 68' ' ' ASP . 57.6 t -57.43 -57.51 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.886 0.375 . . . . 0.0 111.227 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -78.75 -12.8 60.04 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.709 -176.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 p 54.69 73.63 0.39 Allowed 'General case' 0 C--O 1.252 1.226 0 CA-C-O 122.309 1.052 . . . . 0.0 111.623 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.75 -174.31 4.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.793 -1.549 . . . . 0.0 111.858 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.66 -38.07 1.73 Allowed 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.678 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.79 159.64 42.54 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 173.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -144.74 137.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.425 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.639 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.76 112.11 24.91 Favored 'General case' 0 N--CA 1.391 -3.414 0 C-N-CA 123.102 0.561 . . . . 0.0 109.575 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.24 130.5 37.11 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.477 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -70.7 103.67 2.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.484 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.484 ' HA2' HD13 ' A' ' 89' ' ' ILE . . . -54.64 -31.87 53.38 Favored Glycine 0 CA--C 1.496 -1.122 0 CA-C-N 114.154 -1.385 . . . . 0.0 114.243 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -48.48 -25.55 1.72 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.534 1.134 . . . . 0.0 113.013 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD3' ' A' ' 59' ' ' ARG . 11.7 tp10 -66.06 -47.3 74.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.534 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -178.5 148.59 0.46 Allowed 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -77.88 -46.53 21.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.0 0.905 . . . . 0.0 112.16 -173.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -79.34 -21.74 45.43 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.245 -171.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.466 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.8 t80 -52.43 -44.51 65.51 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.483 173.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.484 HD13 ' HA2' ' A' ' 82' ' ' GLY . 2.7 mp -64.17 -36.49 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.338 0.589 . . . . 0.0 110.152 -177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.45 -17.41 58.11 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.67 0.748 . . . . 0.0 110.695 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 83.7 m -79.19 -42.17 26.67 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.176 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -43.92 -47.21 8.38 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.517 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' HB2' ' A' ' 119' ' ' HIS . 4.0 mpt_? -52.47 -32.52 40.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -75.46 -29.03 59.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.023 0.439 . . . . 0.0 111.419 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.38 -1.66 28.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.01 0.909 . . . . 0.0 110.562 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 14.7 tp -91.3 133.27 31.85 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.076 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.14 163.53 38.89 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.591 1.527 . . . . 0.0 110.587 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.48 69.9 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.231 1.013 . . . . 0.0 112.67 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -79.66 -13.83 59.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.3 140.58 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.567 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.26 174.09 6.24 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -128.19 135.49 62.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.639 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 51.6 m0 -122.57 162.56 21.59 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.494 -0.882 . . . . 0.0 108.704 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HG2' ' CE2' ' A' ' 123' ' ' TYR . 18.6 tptm -100.82 116.0 31.68 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.437 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -74.56 98.94 3.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -173.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 22.3 m-85 . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -96.75 174.17 6.94 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.964 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.523 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 20.9 m170 72.7 14.74 5.0 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.696 1.599 . . . . 0.0 110.778 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.89 150.33 6.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.237 0.542 . . . . 0.0 111.52 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.57 -29.44 59.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.942 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -159.75 158.54 31.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 104' ' ' LYS . 7.1 m-85 -109.14 128.85 55.36 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.41 -178.04 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 123.33 0.394 . . . . 0.0 109.939 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--N 1.313 -0.978 0 O-C-N 123.49 0.494 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -16.84 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.376 2.27 . . . . 0.0 115.357 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.96 110.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.568 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.3 m -91.11 169.38 10.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -38.41 106.68 0.05 OUTLIER Glycine 0 N--CA 1.473 1.152 0 O-C-N 124.196 0.935 . . . . 0.0 114.539 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.422 HD21 ' H ' ' A' ' 10' ' ' THR . 3.6 tt -138.37 146.23 42.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.422 ' H ' HD21 ' A' ' 9' ' ' LEU . 29.0 p -111.12 -19.82 12.58 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.255 1.026 . . . . 0.0 110.575 -169.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -86.21 108.49 18.39 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.721 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.96 -39.43 89.16 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-O 122.181 0.878 . . . . 0.0 112.833 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -73.57 -18.23 61.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.833 -1.183 . . . . 0.0 110.756 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -92.91 -45.8 7.79 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -28.04 68.38 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.705 1.202 . . . . 0.0 112.175 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.81 -22.89 59.52 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.967 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.69 43.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.462 0.705 . . . . 0.0 112.288 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.25 47.69 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 110.784 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.8 -33.98 34.39 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.012 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.23 -23.41 55.76 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 125.828 1.651 . . . . 0.0 110.524 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.39 62.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.87 26.8 0.75 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.825 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.45 34.16 20.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.358 1.063 . . . . 0.0 111.743 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 21.9 mt -62.58 -69.05 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.233 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.433 ' HB2' ' CD ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.96 155.64 0.99 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.049 -173.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.96 138.43 11.03 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.44 75.83 0.23 Allowed Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.426 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -117.31 144.22 45.11 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 22.0 mt -117.1 152.65 18.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.372 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 4.9 m-85 -82.55 72.29 9.62 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 118.035 0.38 . . . . 0.0 110.245 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 66.1 t -95.76 121.99 46.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 118.459 -1.297 . . . . 0.0 107.692 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.53 108.43 0.17 Allowed 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.429 1.081 . . . . 0.0 112.864 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.2 p 57.82 29.04 16.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.701 1.6 . . . . 0.0 113.915 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -80.97 140.09 49.91 Favored Pre-proline 0 N--CA 1.423 -1.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.32 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.4 7.94 4.85 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 C-N-CA 121.596 1.53 . . . . 0.0 112.297 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -124.65 2.18 8.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 109.858 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 93.9 m -154.12 125.21 7.31 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.33 137.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.61 0.719 . . . . 0.0 111.634 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -104.0 170.95 7.62 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.873 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.32 -35.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.025 1.33 . . . . 0.0 113.224 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.33 -50.71 58.93 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.959 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.29 -32.39 49.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.992 0.901 . . . . 0.0 109.441 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -63.22 -25.87 68.53 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.796 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -39.13 70.35 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.882 0.873 . . . . 0.0 109.714 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -86.5 -46.12 10.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.002 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 43' ' ' ALA . 7.0 p -60.82 -31.89 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.382 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.708 ' SD ' ' HA ' ' A' ' 73' ' ' LEU . 26.5 ptt? -66.16 -27.06 67.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.983 0.42 . . . . 0.0 110.953 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.42 21.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.372 0.606 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.42 -47.26 34.88 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.342 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.0 101.41 22.84 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.33 66.4 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.969 1.779 . . . . 0.0 112.057 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.5 pp -107.73 176.41 5.15 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.408 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.433 ' CD ' ' HB2' ' A' ' 25' ' ' TYR . 4.1 tt0 -76.73 131.83 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.664 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' HD13 ' A' ' 28' ' ' LEU . 61.0 m-85 -105.14 141.96 35.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.487 0.661 . . . . 0.0 110.768 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.11 160.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -137.88 139.25 10.24 Favored Glycine 0 C--N 1.277 -2.717 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.073 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 61.8 t -113.28 127.89 70.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -154.22 147.0 24.3 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.489 -1.285 . . . . 0.0 110.511 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -86.26 102.19 13.73 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 167.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.49 114.56 19.47 Favored 'General case' 0 N--CA 1.387 -3.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -105.43 -58.08 1.95 Allowed 'General case' 0 C--N 1.256 -3.463 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.85 116.35 30.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.297 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 67' ' ' VAL . 18.3 tt -64.63 -31.4 53.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 120.876 0.37 . . . . 0.0 111.168 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.81 -9.5 59.07 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.632 -0.667 . . . . 0.0 110.714 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 11.3 t70 -84.88 -39.13 18.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.72 -35.0 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -63.96 -36.47 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.57 ' O ' HG22 ' A' ' 72' ' ' VAL . 5.3 t70 -53.71 -53.36 53.22 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.975 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 42.2 mmtm -64.72 -44.2 90.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.094 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB3' HG21 ' A' ' 100' ' ' VAL . . . -57.65 -33.49 68.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.666 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.28 -60.66 2.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.168 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 68' ' ' ASP . 60.2 t -54.59 -59.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.647 0.779 . . . . 0.0 112.245 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.708 ' HA ' ' SD ' ' A' ' 47' ' ' MET . 1.4 mm? -78.61 -14.21 59.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.888 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.6 t 57.13 73.58 0.45 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.945 0.879 . . . . 0.0 109.794 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.63 -178.8 4.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.208 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.06 -34.22 2.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.24 160.16 43.63 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.697 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.29 137.18 37.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.564 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.6 mp0 -96.46 118.33 32.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.3 tp -99.78 125.86 45.76 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.734 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 72.5 m80 -87.29 95.75 10.1 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.45 ' CA ' HD13 ' A' ' 89' ' ' ILE . . . -67.69 -12.95 62.73 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.74 -1.118 . . . . 0.0 114.74 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 81' ' ' HIS . 3.4 p-10 -56.36 -25.49 49.63 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.165 0.586 . . . . 0.0 112.438 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.86 82.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 112.887 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.7 tm-20 -171.46 141.5 1.53 Allowed 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.06 -42.01 33.61 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -168.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.02 -24.17 30.63 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-O 121.882 0.848 . . . . 0.0 109.959 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.563 ' O ' ' HB ' ' A' ' 91' ' ' THR . 36.7 t80 -51.43 -32.55 27.09 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 125.98 1.712 . . . . 0.0 112.13 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.45 HD13 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -60.07 -39.66 81.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.415 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 9.9 t70 -67.9 -14.74 63.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.47 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 75.2 m -88.13 -46.57 9.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.23 1.412 . . . . 0.0 109.367 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.453 HD22 ' CE2' ' A' ' 88' ' ' TYR . 3.8 mm? -44.91 -51.01 10.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -56.99 -29.96 63.73 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 121.219 0.533 . . . . 0.0 112.18 -178.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -76.15 -31.12 58.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.483 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.76 -23.79 17.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 92' ' ' LEU . 98.2 mt -76.7 131.44 73.92 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.688 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.04 165.2 10.84 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.724 2.283 . . . . 0.0 112.446 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.02 55.02 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.721 1.208 . . . . 0.0 113.099 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -85.86 -8.58 57.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 70' ' ' ALA . 82.7 t -98.66 124.89 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-O 121.717 0.77 . . . . 0.0 109.263 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.96 172.73 6.66 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.034 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.08 130.94 73.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.564 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.2 m0 -119.9 159.38 24.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -101.18 117.94 36.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.325 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.11 105.72 3.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.3 tt . . . . . 0 N--CA 1.419 -1.998 0 CA-C-O 121.903 0.858 . . . . 0.0 109.772 -175.081 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.403 -2.796 0 N-CA-C 102.833 -3.025 . . . . 0.0 102.833 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 4.5 pt20 -136.22 172.52 12.89 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.456 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 88.9 m-70 69.41 36.55 2.24 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.576 1.551 . . . . 0.0 112.429 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 m -84.74 152.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.46 -47.28 11.55 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.706 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.5 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 67.6 mttm -151.06 163.85 37.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -110.94 162.39 14.88 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.425 HG21 ' H ' ' A' ' 125' ' ' LEU . 13.3 p -141.27 174.14 7.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.425 ' H ' HG21 ' A' ' 124' ' ' VAL . 28.4 tp . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 5.1 t30 . . . . . 0 CA--C 1.489 -1.372 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -37.05 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 112.673 -2.058 . . . . 0.0 112.116 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.58 121.4 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.988 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.55 170.73 9.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.03 135.68 3.42 Favored Glycine 0 C--N 1.357 1.749 0 CA-C-N 119.152 0.887 . . . . 0.0 114.321 -170.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.52 161.31 37.37 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -176.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -129.09 18.53 6.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -137.2 106.17 5.96 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.649 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.41 -48.77 27.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 124.765 1.174 . . . . 0.0 113.04 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.606 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.9 mp0 -63.22 -19.32 64.42 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 125.822 1.649 . . . . 0.0 112.444 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.0 -42.23 9.15 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.77 69.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.764 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.3 -23.06 67.25 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.52 69.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -77.08 -30.13 55.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 0.0 110.789 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.06 -34.46 50.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.02 -30.49 71.56 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.065 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -17.38 64.39 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.426 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.44 15.31 0.5 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.134 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.46 26.56 12.78 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.455 0.702 . . . . 0.0 110.837 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.67 -67.6 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.223 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.53 159.76 1.18 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.258 0.974 . . . . 0.0 108.815 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.6 142.83 14.28 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 108.459 -1.857 . . . . 0.0 108.459 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.62 78.8 0.27 Allowed Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.573 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.34 146.32 41.65 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.114 0.483 . . . . 0.0 109.734 -177.142 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.473 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 pt -117.37 155.01 19.12 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -84.16 76.93 10.04 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.651 1.219 . . . . 0.0 109.689 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.28 121.93 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 98.79 0.02 OUTLIER 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.04 1.463 . . . . 0.0 113.82 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p 58.77 25.26 13.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.858 1.663 . . . . 0.0 114.97 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -90.76 116.07 65.6 Favored Pre-proline 0 C--O 1.199 -1.557 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.99 -7.3 2.33 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 124.273 3.315 . . . . 0.0 116.542 -171.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.23 11.54 27.29 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.637 1.208 . . . . 0.0 109.797 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 66.2 m -140.0 170.92 14.97 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.17 136.57 16.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 119.486 1.039 . . . . 0.0 109.869 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.41 166.87 10.51 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.263 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -42.96 -36.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 O-C-N 125.044 1.465 . . . . 0.0 113.843 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.9 -32.54 61.85 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.564 ' O ' HG22 ' A' ' 46' ' ' VAL . 16.2 mt-30 -83.38 -37.85 22.76 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.713 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.49 64.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.662 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -33.06 74.83 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -77.34 -46.23 23.58 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.75 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 42' ' ' GLN . 6.4 t -63.72 -34.4 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.649 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.24 -16.09 62.48 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.893 -0.504 . . . . 0.0 111.49 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.62 -19.67 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.24 -40.81 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.096 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.16 97.24 9.78 Favored Pre-proline 0 N--CA 1.408 -2.551 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -74.43 53.32 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.852 2.368 . . . . 0.0 113.544 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -90.39 168.97 11.47 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.425 1.09 . . . . 0.0 109.14 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 140.34 49.47 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 122.964 0.505 . . . . 0.0 110.128 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' A' ' 28' ' ' LEU . 15.4 m-85 -112.29 137.84 49.85 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.521 0.677 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.18 148.86 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.31 143.74 15.7 Favored Glycine 0 C--N 1.283 -2.398 0 C-N-CA 119.783 -1.199 . . . . 0.0 112.147 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.3 t -134.97 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -172.59 163.39 5.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 13.9 ptm180 -96.64 93.87 6.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.61 117.64 29.43 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.88 -38.47 70.0 Favored 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.487 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -99.24 129.27 45.46 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.482 HG13 HD13 ' A' ' 92' ' ' LEU . 15.3 tt -64.03 -31.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.081 0.467 . . . . 0.0 110.1 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.97 -11.83 60.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 110.784 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 35.6 t70 -85.39 -41.53 15.36 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.02 -51.84 66.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.295 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.8 t -58.8 -38.25 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.965 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 72' ' ' VAL . 36.3 t70 -65.54 -43.97 88.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.007 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 56.8 mmtt -67.91 -44.81 76.06 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 100' ' ' VAL . . . -58.02 -36.28 72.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.77 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -73.85 -59.59 2.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.8 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 68' ' ' ASP . 87.0 t -54.41 -58.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.56 -3.44 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.833 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 15.8 p 51.4 61.85 3.01 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.79 0.805 . . . . 0.0 111.796 -173.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 174.52 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.542 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.88 -29.42 3.1 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.362 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.25 155.22 43.1 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.28 136.51 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.621 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.25 110.37 22.31 Favored 'General case' 0 N--CA 1.384 -3.738 0 C-N-CA 123.019 0.527 . . . . 0.0 110.044 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.25 123.22 36.38 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.522 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 52.1 m-70 -74.25 94.02 2.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 89' ' ' ILE . . . -55.69 -12.72 5.22 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 117.29 1.676 . . . . 0.0 117.29 -170.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -44.88 -25.48 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.613 1.165 . . . . 0.0 113.694 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.94 -48.24 82.75 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.18 150.04 2.39 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -77.44 -42.9 34.33 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.05 0.928 . . . . 0.0 111.933 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.06 -13.0 54.23 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.784 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.602 ' O ' ' HB ' ' A' ' 91' ' ' THR . 21.9 t80 -59.12 -40.98 87.07 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.308 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.479 HD12 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -63.52 -39.51 85.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.816 0.817 . . . . 0.0 109.229 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.53 -16.78 64.38 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.814 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.2 m -85.27 -39.99 17.11 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.677 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.482 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.09 -39.5 63.42 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 123.137 0.575 . . . . 0.0 110.702 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -43.34 -43.75 5.2 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.659 1.224 . . . . 0.0 111.759 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -71.08 -46.3 62.12 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.354 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 -12.01 27.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.21 130.03 47.54 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.1 164.16 28.74 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.225 1.95 . . . . 0.0 111.462 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.05 -27.2 63.39 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 124.276 1.031 . . . . 0.0 113.338 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -85.34 -7.96 58.71 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 70' ' ' ALA . 92.7 t -104.11 133.35 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -115.74 169.61 9.08 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.307 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -123.14 130.02 74.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.621 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 42.0 m0 -121.14 159.9 24.84 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.416 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.71 115.5 30.6 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.72 103.77 2.66 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.781 0.676 . . . . 0.0 109.245 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 tp . . . . . 0 N--CA 1.421 -1.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 -178.691 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 50.1 m-85 . . . . . 0 N--CA 1.415 -2.204 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.547 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 13.9 pt20 -99.57 -169.07 1.7 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.547 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 94.3 m-70 70.42 34.36 2.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.47 164.36 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.617 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.08 -37.99 14.7 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 38.4 ttmt -161.12 162.66 31.56 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.957 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -107.42 142.83 36.65 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.792 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.9 163.74 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.28 -2.423 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -177.35 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.598 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.1 p-10 . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.98 114.74 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.655 -173.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.506 ' H ' ' HA2' ' A' ' 26' ' ' GLY . 97.6 t -93.91 117.97 38.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.764 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 16.9 p -136.81 166.88 22.57 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.51 106.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.955 0 C-N-CA 126.055 1.788 . . . . 0.0 116.939 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -160.54 159.92 31.26 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -138.72 19.91 2.68 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -114.52 101.76 9.43 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.452 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.87 -44.03 55.26 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.274 0.94 . . . . 0.0 113.853 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.14 -19.81 59.7 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.325 -0.937 . . . . 0.0 110.312 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -83.45 -38.33 22.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.28 70.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.123 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -65.68 -23.77 66.85 Favored 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -26.19 67.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.4 -37.4 25.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.804 0.812 . . . . 0.0 109.417 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CB ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -67.83 -38.96 83.87 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.744 -0.598 . . . . 0.0 110.442 174.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -60.97 -32.74 72.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.056 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.16 62.92 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.735 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.49 -14.34 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.597 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.52 18.2 11.19 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.643 0.777 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.598 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 22.3 mt -63.14 -67.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.375 -170.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.03 161.89 3.73 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 123.627 0.579 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' H ' ' A' ' 6' ' ' VAL . . . -129.97 122.45 3.71 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.52 88.67 1.25 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.42 147.4 41.71 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.285 4.6 pt -117.24 151.69 19.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.12 73.98 10.56 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.605 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -120.93 115.7 47.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.35 106.44 0.12 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 124.94 1.4 . . . . 0.0 113.901 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p 65.54 15.89 10.25 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.005 1.722 . . . . 0.0 115.05 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 t -74.85 138.28 73.24 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.89 -0.89 7.69 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 122.811 2.341 . . . . 0.0 113.727 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 58.6 ttp180 -114.18 -4.51 13.09 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 15.2 m -129.88 130.12 44.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.992 -169.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.63 134.94 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -118.25 179.25 4.16 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.275 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 6.9 p -45.51 -31.74 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 O-C-N 124.666 1.229 . . . . 0.0 113.204 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.22 -61.97 1.61 Allowed 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 123.742 0.817 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -67.96 -37.8 81.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.22 0.534 . . . . 0.0 110.256 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HA ' ' CG1' ' A' ' 46' ' ' VAL . . . -64.06 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.88 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 3.8 tp-100 -67.78 -39.49 84.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.027 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.88 -40.52 14.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.978 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.544 ' CG1' ' HA ' ' A' ' 43' ' ' ALA . 4.5 p -64.56 -22.9 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.727 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 21.6 ptp -67.8 -17.12 64.42 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.543 0.687 . . . . 0.0 110.931 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.37 3.15 40.27 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.499 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.83 -42.6 3.77 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.134 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.39 101.06 5.65 Favored Pre-proline 0 N--CA 1.4 -2.956 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.43 70.07 3.3 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 112.007 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.44 HD22 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -111.99 160.56 17.34 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.202 174.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -67.16 134.93 52.7 Favored 'General case' 0 C--O 1.208 -1.079 0 C-N-CA 123.229 0.612 . . . . 0.0 109.89 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.727 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 61.3 m-85 -108.52 140.6 41.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.077 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 9.5 p -133.96 133.96 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.37 125.89 7.67 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.598 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 18.0 t -112.89 121.58 65.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -173.08 154.33 2.74 Favored 'General case' 0 CA--C 1.493 -1.223 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.361 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.56 104.9 15.74 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 122.458 1.123 . . . . 0.0 108.315 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.85 121.68 42.56 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 113.637 -1.619 . . . . 0.0 110.326 -171.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -99.64 -36.28 9.55 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.274 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 66' ' ' VAL . 8.1 t70 -99.37 111.37 23.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.516 ' O ' HG22 ' A' ' 67' ' ' VAL . 13.6 tt -66.93 -33.6 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.156 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.42 62.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.344 0.593 . . . . 0.0 110.461 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.0 -33.22 24.59 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 62' ' ' ASP . 47.6 t -65.2 -43.46 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 63' ' ' ILE . 61.2 t -59.05 -43.56 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.36 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 72' ' ' VAL . 16.4 t70 -57.89 -61.33 2.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.887 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.17 -42.67 99.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.46 70.03 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -82.8 -56.75 3.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.717 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 68' ' ' ASP . 58.0 t -53.21 -59.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.429 0.692 . . . . 0.0 111.547 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.34 -18.17 61.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.221 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 m 59.72 69.04 0.73 Allowed 'General case' 0 C--O 1.243 0.746 0 CA-C-O 122.336 1.065 . . . . 0.0 109.803 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.71 -176.39 5.35 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.253 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.13 -43.13 1.67 Allowed 'General case' 0 C--O 1.184 -2.35 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -136.25 155.0 50.74 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.79 170.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.473 ' C ' HE21 ' A' ' 79' ' ' GLN . 6.1 p -135.51 137.34 49.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.539 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.5 mm-40 -95.0 128.25 41.68 Favored 'General case' 0 N--CA 1.394 -3.231 0 CA-C-O 121.288 0.566 . . . . 0.0 110.846 -174.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.512 ' CD2' HG13 ' A' ' 89' ' ' ILE . 40.4 tp -113.6 121.32 43.82 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.496 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -85.51 91.82 8.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 -12.87 41.45 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -48.8 -25.99 2.15 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.332 1.053 . . . . 0.0 113.498 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -51.69 -49.95 61.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -175.14 154.36 1.76 Allowed 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.3 mp0 -77.97 -46.49 20.97 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.791 0.805 . . . . 0.0 111.334 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.15 -17.46 54.97 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.244 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.574 ' O ' ' HB ' ' A' ' 91' ' ' THR . 28.3 t80 -59.84 -37.5 79.41 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.559 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 80' ' ' LEU . 1.7 mp -64.24 -37.44 79.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.542 0.687 . . . . 0.0 109.823 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -20.91 60.18 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.884 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 97.5 m -74.42 -43.39 56.51 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.095 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.425 HD11 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -48.59 -44.63 37.09 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.201 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.837 ' NH2' ' HB ' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -55.21 -25.97 36.43 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -86.35 -40.28 15.6 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.77 -18.47 31.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.544 0.687 . . . . 0.0 112.258 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.28 128.87 35.18 Favored Pre-proline 0 C--N 1.275 -2.633 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.82 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.76 165.12 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.221 1.947 . . . . 0.0 110.611 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.55 4.3 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.626 0.77 . . . . 0.0 112.126 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -84.13 -29.08 27.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.4 t -107.89 132.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.324 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.4 160.66 15.47 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.837 ' HB ' ' NH2' ' A' ' 93' ' ' ARG . 4.1 mp -122.58 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.539 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 38.9 m0 -107.75 164.63 12.07 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.26 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -99.54 109.18 21.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.605 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.21 103.39 3.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 N--CA 1.425 -1.676 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.571 -175.709 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.429 ' HB3' HG12 ' A' ' 89' ' ' ILE . 56.3 m-85 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -83.34 172.79 12.16 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.399 0.619 . . . . 0.0 112.453 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.4 m170 74.57 4.98 4.49 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.412 1.485 . . . . 0.0 114.777 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.673 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 20.7 m -68.04 154.34 8.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.984 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.62 -33.2 15.95 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.139 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.3 ttmt -159.24 163.32 35.97 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -124.88 142.97 51.09 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.21 169.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.31 -1.136 0 CA-C-N 118.82 0.736 . . . . 0.0 109.199 177.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 28.5 m-80 . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 10.3 ptpp? -53.97 99.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.924 -173.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.05 125.07 40.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.951 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -90.82 170.41 10.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -36.93 115.93 0.32 Allowed Glycine 0 C--N 1.364 2.124 0 O-C-N 124.28 0.988 . . . . 0.0 114.108 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.0 tp -140.22 162.1 36.07 Favored 'General case' 0 N--CA 1.407 -2.593 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -139.04 21.88 2.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.163 0.982 . . . . 0.0 109.234 -173.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 55.4 mtt180 -125.75 110.36 13.65 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.2 -49.14 45.0 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 124.753 1.168 . . . . 0.0 114.826 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.9 mp0 -81.06 -19.96 42.64 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.478 0.656 . . . . 0.0 110.848 -174.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 43.6 t0 -80.86 -36.69 31.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.47 71.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.654 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.65 -22.69 64.12 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.79 -31.95 41.28 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.85 0.46 . . . . 0.0 111.853 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -78.13 -30.95 49.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.925 0.869 . . . . 0.0 110.62 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -30.69 33.81 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.1 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.02 -26.8 67.87 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.119 0.968 . . . . 0.0 109.296 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 -20.67 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.076 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.94 37.09 0.45 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.21 35.92 21.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.305 1.042 . . . . 0.0 110.768 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 -68.48 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.922 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.459 ' OH ' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -176.71 161.74 2.11 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 123.668 0.605 . . . . 0.0 109.78 -176.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.81 152.42 19.34 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.81 80.95 0.35 Allowed Glycine 0 CA--C 1.491 -1.407 0 C-N-CA 119.386 -1.388 . . . . 0.0 112.412 -172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.75 152.12 40.93 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.173 -0.514 . . . . 0.0 109.943 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.4 pt -114.0 155.45 15.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -81.22 86.65 6.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.787 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -121.0 123.76 70.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.29 103.84 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.714 1.206 . . . . 0.0 114.206 -174.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p 61.93 21.84 12.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 115.077 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 38.1 p -86.09 135.89 36.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.884 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.87 21.17 0.74 Allowed 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.731 2.287 . . . . 0.0 112.524 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' SER . 28.3 mmm180 -125.12 -11.8 6.99 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 176.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.449 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 72.4 m -153.82 117.13 4.58 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.36 137.16 32.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 122.15 0.976 . . . . 0.0 110.945 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.33 171.78 7.14 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.244 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 73' ' ' LEU . 7.7 p -43.85 -33.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.382 1.473 . . . . 0.0 113.405 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.55 -56.98 7.35 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.164 0.507 . . . . 0.0 111.08 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.459 ' O ' HG22 ' A' ' 46' ' ' VAL . 34.9 mt-30 -69.77 -37.09 76.26 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.05 0.452 . . . . 0.0 110.296 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.49 -20.85 65.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.6 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 44' ' ' GLN . 2.7 tp-100 -69.48 -23.78 63.68 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.47 -43.99 12.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.077 0.941 . . . . 0.0 108.664 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 42' ' ' GLN . 20.4 t -65.05 -33.42 63.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.05 -176.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.428 ' N ' ' HH ' ' A' ' 54' ' ' TYR . 4.6 ppp? -66.93 -17.8 65.08 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.084 0.469 . . . . 0.0 111.535 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.85 -25.38 21.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.781 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.47 -39.69 18.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.965 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 103.76 9.22 Favored Pre-proline 0 N--CA 1.398 -3.03 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.42 45.08 0.96 Allowed 'Trans proline' 0 CA--C 1.552 1.387 0 C-N-CA 123.298 2.666 . . . . 0.0 113.255 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -88.53 -179.62 6.1 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.694 0.797 . . . . 0.0 111.842 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -82.76 145.4 29.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.553 0.741 . . . . 0.0 110.936 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.428 ' HH ' ' N ' ' A' ' 47' ' ' MET . 74.8 m-85 -117.17 146.26 43.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.458 0.647 . . . . 0.0 110.252 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 p -133.24 145.52 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.03 140.2 12.56 Favored Glycine 0 C--O 1.196 -2.241 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.006 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.2 t -128.26 122.46 58.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -169.36 156.07 6.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -90.64 93.33 9.22 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.99 0.9 . . . . 0.0 109.694 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -102.15 118.49 37.0 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -87.71 -28.19 21.93 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.579 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.59 122.49 40.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.09 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' ' 67' ' ' VAL . 10.3 tt -64.2 -35.29 73.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.438 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.18 -17.54 61.36 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.486 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.32 -29.5 31.03 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.43 -47.63 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 63' ' ' ILE . 55.5 t -60.53 -37.2 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.879 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.625 ' O ' HG21 ' A' ' 72' ' ' VAL . 18.4 t70 -52.92 -61.33 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.472 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.48 -42.06 92.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.891 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -57.8 -38.92 76.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 124.288 0.992 . . . . 0.0 111.606 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.31 -53.11 5.98 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 123.224 0.328 . . . . 0.0 111.513 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.625 HG21 ' O ' ' A' ' 68' ' ' ASP . 50.0 t -55.08 -56.04 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 40' ' ' VAL . 40.6 tp -79.94 -21.87 43.33 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.3 m 63.23 79.38 0.26 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 122.213 1.006 . . . . 0.0 110.336 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.12 -179.03 6.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.007 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.6 -39.32 2.31 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.52 160.64 40.78 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.273 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.78 136.69 35.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.88 111.62 24.04 Favored 'General case' 0 N--CA 1.391 -3.418 0 C-N-CA 123.257 0.623 . . . . 0.0 109.446 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.99 154.51 19.16 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.205 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -93.47 96.38 9.86 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 172.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.479 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -72.64 -12.32 77.74 Favored Glycine 0 C--N 1.306 -1.107 0 CA-C-N 114.225 -1.352 . . . . 0.0 114.845 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -49.6 -25.83 3.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.584 1.154 . . . . 0.0 111.932 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -52.33 -45.56 65.69 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.544 0.738 . . . . 0.0 112.444 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.53 149.03 0.96 Allowed 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -77.56 -43.64 31.17 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.19 0.995 . . . . 0.0 110.416 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.18 -13.65 60.18 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.605 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.6 t80 -62.64 -41.13 98.87 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.385 174.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.479 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -61.35 -40.97 88.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.96 -19.17 65.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.836 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.4 m -83.04 -42.69 17.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 63' ' ' ILE . 4.1 mm? -53.44 -44.01 68.51 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.453 0.701 . . . . 0.0 111.216 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -43.59 -37.5 2.56 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.245 1.418 . . . . 0.0 111.866 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.95 -45.54 18.33 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.024 -173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.0 -18.31 47.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.61 0.719 . . . . 0.0 112.379 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -99.9 134.7 20.78 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.446 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.18 165.42 31.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.391 2.06 . . . . 0.0 109.668 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.05 -11.3 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.239 0.543 . . . . 0.0 111.255 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.49 -29.41 62.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.872 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.75 127.56 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -105.91 167.4 9.81 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.445 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.27 129.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.612 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.6 m0 -120.65 152.7 37.85 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.869 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.23 124.74 50.06 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.37 98.15 1.05 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.167 -173.375 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 . . . . . 0 N--CA 1.419 -2.025 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -78.43 166.16 22.94 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.768 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 m170 75.57 8.5 3.76 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.896 0.878 . . . . 0.0 112.47 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.57 143.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.08 -43.14 65.32 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.88 -173.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 39.4 ttmt -159.11 164.34 35.39 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -118.3 157.83 26.33 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.54 171.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.025 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.207 -1.163 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -46.34 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.03 121.57 23.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.446 0.641 . . . . 0.0 111.497 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.7 p -101.33 168.35 9.6 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 9' ' ' LEU . . . -2.65 -110.9 0.0 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 125.178 1.371 . . . . 0.0 116.149 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' GLY . 54.4 tp 77.49 165.09 0.23 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.518 0.775 . . . . 0.0 111.229 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -138.07 -14.5 1.36 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.972 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.55 112.24 24.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.732 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -50.34 -41.4 40.03 Favored Glycine 0 C--O 1.209 -1.462 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.719 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.696 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -57.88 -39.94 79.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.513 1.125 . . . . 0.0 108.916 -178.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.2 -30.71 43.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.325 -173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.35 63.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.808 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 9.5 mtmp? -61.02 -24.85 66.49 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.293 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -32.43 74.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.621 0.368 . . . . 0.0 111.507 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.97 72.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.648 1.213 . . . . 0.0 109.722 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -30.29 44.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.063 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.67 -23.1 66.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.375 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.09 65.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.971 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.26 13.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 114.449 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.27 26.48 13.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.852 0.861 . . . . 0.0 110.867 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.93 -67.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.341 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.23 155.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.24 143.59 14.61 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.01 82.89 0.34 Allowed Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.036 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.64 141.93 48.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 120.847 0.356 . . . . 0.0 110.165 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -108.02 151.6 10.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -81.83 79.82 8.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.833 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HB ' ' OG ' ' A' ' 34' ' ' SER . 61.3 t -112.17 129.57 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.81 106.75 0.28 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p 65.38 16.72 10.68 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.958 1.703 . . . . 0.0 114.889 172.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.574 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 22.7 p -83.16 124.43 76.3 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.839 -0.538 . . . . 0.0 110.332 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -9.27 18.78 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.062 1.841 . . . . 0.0 114.886 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -112.74 12.65 19.67 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.485 -0.76 . . . . 0.0 111.662 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.574 ' HB2' ' OG ' ' A' ' 34' ' ' SER . 85.8 m -152.58 118.09 5.31 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.37 138.37 26.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.2 1.0 . . . . 0.0 112.606 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -104.31 168.68 8.94 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.769 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.2 p -53.38 -30.01 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 124.063 0.852 . . . . 0.0 112.03 -171.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 54.6 mp0 -61.88 -55.64 27.58 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 124.541 1.137 . . . . 0.0 112.1 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 31.2 mt-30 -70.39 -38.22 74.64 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 121.464 0.65 . . . . 0.0 109.925 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -61.04 -27.16 68.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.501 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 44' ' ' GLN . 2.3 tp-100 -61.42 -36.36 80.1 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.64 0.776 . . . . 0.0 112.101 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 13.1 pt-20 -86.07 -43.15 13.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.552 1.168 . . . . 0.0 109.011 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 6.9 t -55.22 -32.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.205 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 14.3 ptp -62.99 -31.42 72.54 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.37 0.605 . . . . 0.0 110.721 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.37 58.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.009 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.27 -48.1 7.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.74 99.58 15.32 Favored Pre-proline 0 N--CA 1.391 -3.394 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.23 55.49 3.54 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.811 2.34 . . . . 0.0 111.711 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -96.23 171.29 8.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.35 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -72.29 142.9 48.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.263 0.225 . . . . 0.0 110.453 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -115.11 139.89 49.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.3 p -129.41 146.89 33.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.64 129.66 6.95 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.842 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.6 t -114.37 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -148.81 152.98 37.46 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 29.0 ptt180 -86.29 93.74 9.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.463 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 4.7 m-20 -67.28 116.09 7.67 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 122.865 1.317 . . . . 0.0 112.124 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -108.19 -72.71 0.71 Allowed 'General case' 0 C--N 1.255 -3.515 0 CA-C-N 112.552 -2.113 . . . . 0.0 108.814 171.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.11 108.94 12.97 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.849 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.513 ' O ' HG21 ' A' ' 67' ' ' VAL . 16.5 tt -62.37 -34.71 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.038 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.71 -22.86 63.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.104 0.478 . . . . 0.0 110.7 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 12.7 t70 -85.67 -33.74 21.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.225 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.06 -32.4 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.046 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 63' ' ' ILE . 89.8 t -64.99 -33.52 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 72' ' ' VAL . 11.2 t70 -56.89 -57.99 10.1 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.73 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -60.75 -40.84 93.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -58.16 -39.02 77.74 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.755 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 71' ' ' LYS . 4.7 ttmp? -83.83 -53.58 5.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.616 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 68' ' ' ASP . 44.7 t -56.63 -56.55 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.232 0.613 . . . . 0.0 111.754 -174.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.424 ' HB2' HG23 ' A' ' 40' ' ' VAL . 51.4 tp -80.41 -13.91 58.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.099 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 18.8 p 55.54 77.42 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.378 1.071 . . . . 0.0 112.272 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.77 175.08 8.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.867 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.79 -35.88 2.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.126 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.88 157.76 44.04 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -140.13 141.12 34.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -99.97 128.08 46.1 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.349 0.595 . . . . 0.0 112.053 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.25 122.42 41.39 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.389 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -84.52 98.9 10.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 117' ' ' PHE . . . -62.63 -12.86 42.85 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.591 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.47 -33.19 1.62 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.172 1.389 . . . . 0.0 113.127 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 13.0 mm-40 -66.07 -48.24 71.66 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -179.61 149.89 0.39 Allowed 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.75 -44.86 26.37 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 112.45 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.65 -20.38 43.21 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.746 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.576 ' O ' ' HB ' ' A' ' 91' ' ' THR . 42.9 t80 -58.49 -36.05 73.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.931 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.502 HD12 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -61.17 -37.8 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.609 0.719 . . . . 0.0 109.137 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.61 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 14.7 t70 -70.07 -21.01 63.2 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.088 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.576 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.1 m -78.54 -42.44 29.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.514 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.462 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -48.51 -49.13 37.27 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.559 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.61 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.08 -33.09 37.73 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.229 0.538 . . . . 0.0 112.361 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.16 -42.59 62.61 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.105 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.95 25.87 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.86 135.64 42.5 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.698 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 165.13 33.63 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 121.972 1.781 . . . . 0.0 110.599 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.64 -15.85 54.01 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.034 0.934 . . . . 0.0 112.152 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.12 -30.12 66.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 70' ' ' ALA . 59.2 t -107.33 129.5 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.235 0 CA-C-O 121.376 0.608 . . . . 0.0 110.629 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.71 170.83 8.29 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.77 129.73 72.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.588 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.1 m0 -118.9 157.98 26.6 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.689 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -100.94 123.39 45.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.31 116.96 10.35 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp . . . . . 0 C--N 1.287 -2.15 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.254 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 82' ' ' GLY . 79.5 m-85 . . . . . 0 N--CA 1.417 -2.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.3 164.36 26.79 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.668 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.54 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 23.3 m170 71.54 7.18 5.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.696 1.599 . . . . 0.0 112.201 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.64 152.1 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -81.4 -41.6 21.67 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 120.998 0.428 . . . . 0.0 111.349 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.0 mttt -145.78 163.03 36.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.301 0.64 . . . . 0.0 109.676 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -116.83 139.6 50.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.44 166.87 20.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--N 1.292 -1.907 0 CA-C-O 121.519 0.676 . . . . 0.0 111.72 -176.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 15.0 p-10 . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -57.08 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.502 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -95.37 124.26 47.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.493 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.0 m -92.0 170.52 9.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.93 135.42 8.86 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 119.046 0.839 . . . . 0.0 115.06 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.406 HD11 ' H ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -150.07 153.12 35.92 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.406 ' H ' HD11 ' A' ' 9' ' ' LEU . 8.6 t -118.51 8.03 11.97 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.641 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -117.73 114.64 23.63 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.118 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.24 -39.44 71.4 Favored Glycine 0 C--O 1.216 -1.024 0 O-C-N 123.626 0.578 . . . . 0.0 113.639 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.647 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -66.2 -26.09 67.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 122.005 0.907 . . . . 0.0 109.264 -177.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -89.57 -51.96 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.493 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.13 69.53 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -22.39 62.49 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.374 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.07 -30.78 27.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.971 0.508 . . . . 0.0 111.451 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 -43.28 64.77 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.542 0.687 . . . . 0.0 109.824 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -34.03 73.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.71 -23.46 66.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 125.172 1.389 . . . . 0.0 110.018 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.89 -13.94 59.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.94 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.53 10.4 0.27 Allowed Glycine 0 C--O 1.225 -0.458 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.535 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.2 19.37 8.74 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.491 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 37.8 mt -57.86 -67.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.16 -171.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.01 157.69 2.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 55' ' ' VAL . . . -132.05 140.9 12.2 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.46 91.08 0.51 Allowed Glycine 0 CA--C 1.471 -2.673 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 155.88 34.73 Favored 'General case' 0 N--CA 1.401 -2.921 0 CA-C-N 114.567 -0.816 . . . . 0.0 109.182 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.579 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 3.5 pt -116.95 151.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.485 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 49.7 m-85 -84.19 79.02 9.67 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.427 1.079 . . . . 0.0 109.796 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.8 t -109.8 119.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.58 103.84 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.829 1.331 . . . . 0.0 113.483 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.6 p 59.39 29.28 18.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.638 1.575 . . . . 0.0 113.491 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -107.26 104.11 51.02 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.07 3.93 0.66 Allowed 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.776 2.984 . . . . 0.0 115.029 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -84.43 -10.64 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 46.6 m -138.4 172.13 13.35 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.89 136.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.57 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -106.7 164.09 12.38 Favored 'General case' 0 CA--C 1.465 -2.327 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.742 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG22 HD22 ' A' ' 73' ' ' LEU . 11.4 p -45.58 -35.44 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 124.806 1.316 . . . . 0.0 112.049 -174.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.97 -38.81 86.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' HG21 ' A' ' 46' ' ' VAL . 32.9 mt-30 -80.79 -34.94 33.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.339 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -62.38 -32.81 73.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.023 -175.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -62.98 -31.08 72.12 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.96 -47.3 59.73 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.116 0.96 . . . . 0.0 108.641 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 42' ' ' GLN . 40.9 t -65.0 -30.5 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.819 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 24.6 ptt? -67.08 -17.6 64.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.304 0.574 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.87 25.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.996 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.55 -43.33 6.9 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.298 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 93.76 39.74 Favored Pre-proline 0 N--CA 1.386 -3.628 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.75 57.06 3.02 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.455 2.104 . . . . 0.0 111.968 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.71 179.26 5.04 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.471 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 5.4 tt0 -82.94 143.27 30.81 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 20.6 m-85 -113.65 138.08 50.69 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 26' ' ' GLY . 12.8 p -132.41 139.86 49.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -125.18 141.13 12.82 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.541 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.579 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 29.2 t -124.43 134.82 65.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -167.09 159.64 13.25 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.661 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -85.93 93.59 8.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -87.99 125.67 34.66 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.834 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -94.94 -58.0 2.28 Favored 'General case' 1 C--N 1.241 -4.111 0 CA-C-N 112.775 -2.011 . . . . 0.0 108.96 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.87 123.37 43.08 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.559 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.452 HG13 HD13 ' A' ' 92' ' ' LEU . 17.4 tt -64.23 -29.74 48.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.33 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.17 -13.82 58.95 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.078 0.466 . . . . 0.0 110.315 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 14.0 t70 -86.25 -39.25 16.75 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.816 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.82 -37.63 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.293 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.13 -32.0 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.3 t70 -54.8 -55.64 27.93 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.472 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 43.2 mmtm -63.59 -41.56 98.33 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -56.98 -38.92 73.7 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.316 1.01 . . . . 0.0 110.996 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -81.96 -52.88 6.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.354 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 68' ' ' ASP . 77.5 t -56.1 -54.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.403 HD22 HG22 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -82.9 -11.47 58.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.41 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t 61.97 74.67 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.683 0.754 . . . . 0.0 109.498 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.5 mt -82.74 179.91 7.63 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.439 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.74 -32.96 2.31 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.7 160.53 43.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.3 171.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 6.2 p -150.0 141.02 16.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.662 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.82 111.36 23.68 Favored 'General case' 0 N--CA 1.385 -3.691 0 CA-C-O 121.824 0.821 . . . . 0.0 109.353 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.486 HD11 ' HG ' ' A' ' 92' ' ' LEU . 36.3 mt -115.72 89.17 3.04 Favored 'General case' 0 CA--C 1.422 -3.945 0 N-CA-C 101.369 -3.567 . . . . 0.0 101.369 -169.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -98.04 174.37 6.58 Favored 'General case' 1 N--CA 1.362 -4.859 0 C-N-CA 117.873 -1.531 . . . . 0.0 113.299 -167.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -48.96 -10.51 0.14 Allowed Glycine 1 C--N 1.243 -4.584 0 CA-C-N 110.863 -2.881 . . . . 0.0 117.468 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -44.72 -44.73 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -49.72 6.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.956 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.475 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 1.1 tm-20 178.94 170.33 0.89 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -77.88 -49.85 13.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.519 1.152 . . . . 0.0 109.389 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 37.1 mt -72.97 -13.6 61.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.99 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.556 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 25.4 t80 -60.34 -48.99 79.36 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.418 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.9 mp -59.75 -36.69 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.682 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 24.4 t70 -60.08 -27.1 66.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.636 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.9 m -88.15 -43.68 11.47 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 124.708 1.203 . . . . 0.0 110.141 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 88' ' ' TYR . 4.1 mm? -43.93 -44.0 6.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.682 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 1.7 mpt_? -56.55 -29.74 62.31 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.271 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -77.95 -35.13 50.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.382 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.81 0.86 50.01 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.433 0.635 . . . . 0.0 110.806 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.2 tp -75.79 124.49 88.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 124.053 0.941 . . . . 0.0 109.479 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.01 161.57 44.41 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.078 1.852 . . . . 0.0 110.988 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.22 70.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 124.464 1.106 . . . . 0.0 113.354 -172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -88.86 -10.9 46.31 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.442 HG21 ' HB1' ' A' ' 70' ' ' ALA . 65.6 t -107.68 140.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.86 172.67 6.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.404 HG12 HD12 ' A' ' 80' ' ' LEU . 53.8 mt -116.41 131.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.662 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 40.8 m0 -121.02 159.17 26.19 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.393 171.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HB2' HG11 ' A' ' 120' ' ' VAL . 40.0 ttpt -100.73 115.18 29.66 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 107.63 5.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 N--CA 1.417 -2.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 -175.093 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 N--CA 1.424 -1.742 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -115.01 -178.64 3.41 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.625 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t60 65.44 28.42 11.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.221 1.408 . . . . 0.0 108.505 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 104' ' ' LYS . 27.3 m -87.26 149.99 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.77 -41.29 45.28 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.402 0.62 . . . . 0.0 111.058 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 45.2 mmtm -143.78 162.32 36.32 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -127.13 138.68 53.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.96 171.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--N 1.312 -1.044 0 O-C-N 123.411 0.445 . . . . 0.0 110.602 -179.339 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.635 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.18 98.06 0.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.935 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.12 124.7 53.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.736 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.1 p -91.99 169.8 10.36 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 37' ' ' CYS . . . -46.76 126.7 10.07 Favored Glycine 0 CA--C 1.493 -1.299 0 O-C-N 123.64 0.588 . . . . 0.0 113.771 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.3 tp -143.06 161.0 39.32 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -134.35 -18.9 1.95 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.683 0.754 . . . . 0.0 109.948 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.73 105.69 9.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.937 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 16' ' ' LYS . . . -48.37 -44.85 28.44 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 124.64 1.114 . . . . 0.0 114.224 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.7 mp0 -76.18 -22.27 55.53 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.335 0.588 . . . . 0.0 110.856 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.52 -30.46 23.41 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.15 48.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 17.5 ptpt -64.69 -22.51 67.0 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 -37.71 78.89 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.801 0.334 . . . . 0.0 110.567 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.98 -38.01 66.81 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 110.181 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.72 -34.61 77.2 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.9 -31.29 72.42 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.486 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.28 64.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.069 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.32 -21.7 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.467 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.93 27.04 16.41 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.985 0.898 . . . . 0.0 109.019 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.535 ' HB ' HD22 ' A' ' 4' ' ' ASN . 28.5 mt -69.92 -59.64 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.909 -171.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -178.36 161.92 1.45 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 145.72 16.28 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.35 73.99 0.21 Allowed Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.482 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 154.94 26.55 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-O 121.172 0.511 . . . . 0.0 110.264 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.566 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 5.7 pt -116.78 152.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -79.57 79.43 6.04 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 124.741 1.275 . . . . 0.0 111.239 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.25 116.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 115.09 2.75 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.777 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.4 p 66.02 14.67 9.73 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.086 1.754 . . . . 0.0 115.126 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 36' ' ' ARG . 50.8 m -93.58 114.67 63.58 Favored Pre-proline 0 C--O 1.197 -1.696 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.35 26.48 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 124.28 3.32 . . . . 0.0 115.285 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.553 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 20.4 ptt180 -124.92 -5.15 7.46 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' SG ' ' HG3' ' A' ' 36' ' ' ARG . 60.8 m -136.65 166.75 22.83 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -143.94 136.4 23.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.559 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -102.46 170.52 8.0 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.685 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 73' ' ' LEU . 5.9 p -56.41 -31.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 123.809 0.693 . . . . 0.0 111.1 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 4.3 mp0 -70.88 -46.87 61.84 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 124.149 0.979 . . . . 0.0 111.505 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 49.7 mm-40 -61.76 -49.31 76.92 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -63.89 -21.47 66.48 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.287 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 47' ' ' MET . 3.8 tp-100 -63.99 -39.32 93.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.527 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.8 pt-20 -85.93 -45.41 11.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.754 0.788 . . . . 0.0 110.427 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 95.4 t -48.97 -35.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 125.307 1.443 . . . . 0.0 112.249 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 16.5 ptp -64.22 -20.56 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 120.823 0.344 . . . . 0.0 111.493 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.37 -28.74 28.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.34 -45.5 13.68 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.75 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -133.66 98.12 15.16 Favored Pre-proline 0 N--CA 1.397 -3.119 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.69 46.73 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.88 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.33 152.28 24.21 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.686 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.7 140.41 49.7 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.411 0.625 . . . . 0.0 112.428 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.04 143.73 39.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -113.46 128.78 8.5 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.782 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.566 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 21.2 t -113.74 106.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.57 146.59 15.09 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.471 -173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.11 93.37 8.26 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 15.4 m120 -90.25 154.91 19.38 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 122.656 1.217 . . . . 0.0 110.526 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.5 ' CD2' ' H ' ' A' ' 62' ' ' ASP . 16.1 p-80 -100.89 -73.43 0.64 Allowed 'General case' 0 C--N 1.245 -3.953 0 CA-C-N 111.445 -2.616 . . . . 0.0 112.17 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' H ' ' CD2' ' A' ' 61' ' ' HIS . 45.0 t0 -81.77 131.91 35.27 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.486 HG13 HD13 ' A' ' 92' ' ' LEU . 5.9 tt -60.02 -32.68 50.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.041 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.61 -18.76 61.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.326 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.6 -35.21 53.11 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.436 0.636 . . . . 0.0 109.288 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.52 -44.05 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 63' ' ' ILE . 95.7 t -60.55 -39.28 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.577 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 72' ' ' VAL . 15.3 t70 -57.1 -61.79 2.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.172 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.72 -39.7 94.93 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.36 -35.02 76.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.812 0.695 . . . . 0.0 111.417 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -82.37 -56.54 3.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -53.32 -56.47 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.352 0.661 . . . . 0.0 111.628 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 40' ' ' VAL . 45.4 tp -82.78 -17.31 44.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.488 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 39.9 m 60.59 80.55 0.21 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.226 1.012 . . . . 0.0 111.182 -176.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.46 -175.06 5.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.578 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' ' OE1' ' A' ' 53' ' ' GLN . . . -127.97 -36.79 1.96 Allowed 'General case' 0 C--O 1.193 -1.912 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -146.0 159.27 43.49 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.36 0.6 . . . . 0.0 111.534 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.479 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.4 p -140.58 138.64 35.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 13.2 mm-40 -98.46 105.59 17.75 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 123.459 0.703 . . . . 0.0 109.393 -175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.502 ' CD1' ' HG ' ' A' ' 92' ' ' LEU . 75.2 mt -116.13 139.52 50.23 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.941 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 p80 175.54 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.121 0.888 . . . . 0.0 110.165 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.71 -55.39 5.44 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 120.434 2.933 . . . . 0.0 120.434 -166.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 60' ' ' ASN . 2.8 t-20 -82.79 -69.1 0.65 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.97 -48.93 12.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -168.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -177.89 172.0 1.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 21.6 mt-30 -78.44 -43.98 25.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 125.242 1.417 . . . . 0.0 107.235 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 54.7 mt -71.42 -14.39 62.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.326 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.596 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 22.9 t80 -65.38 -40.25 93.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.982 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.424 ' HA ' HD22 ' A' ' 92' ' ' LEU . 1.7 mp -63.0 -30.38 49.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.628 0.728 . . . . 0.0 110.015 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.67 ' HA ' ' NH1' ' A' ' 93' ' ' ARG . 23.9 t70 -67.54 -22.64 65.4 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 85.9 m -89.63 -44.92 9.72 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.305 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 88' ' ' TYR . 3.2 mm? -47.89 -46.37 31.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.67 ' NH1' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.02 -24.33 64.42 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.069 -173.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.04 -34.43 38.28 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.988 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.96 -22.17 22.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.854 0.835 . . . . 0.0 111.409 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -88.09 140.13 30.74 Favored Pre-proline 0 C--N 1.276 -2.614 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.707 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.43 164.91 34.14 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 121.134 1.223 . . . . 0.0 109.018 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.1 3.95 6.28 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.496 0.665 . . . . 0.0 111.638 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -86.07 -24.85 26.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.1 t -105.09 131.88 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.54 171.36 7.91 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.52 133.42 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.6 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.9 m0 -121.05 155.37 34.54 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.162 -1.415 . . . . 0.0 109.622 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -102.39 123.28 45.89 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 115.21 8.87 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 170.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.293 -1.867 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 33.3 m-85 . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -110.12 157.16 19.67 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.4 m80 69.05 33.77 3.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 111.818 -2.446 . . . . 0.0 111.113 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.49 142.06 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.73 -43.09 66.46 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.379 0.609 . . . . 0.0 111.153 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.2 mttm -145.14 163.18 35.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -124.68 143.39 50.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.56 174.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--N 1.311 -1.081 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.932 178.894 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.605 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.2 p-10 . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 21.3 pttp -67.89 91.99 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.11 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.36 125.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.169 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.38 169.26 10.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 37' ' ' CYS . . . -19.53 105.85 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 O-C-N 124.919 1.387 . . . . 0.0 116.037 -169.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.22 135.86 18.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 9.45 2.7 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.912 0.863 . . . . 0.0 110.123 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -86.41 112.52 21.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.34 -53.5 5.8 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.419 1.009 . . . . 0.0 114.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.23 -19.91 60.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.799 0.839 . . . . 0.0 111.871 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.73 -36.51 17.31 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.73 -47.96 67.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.805 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -63.35 -23.45 67.42 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.828 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.3 69.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.229 0.537 . . . . 0.0 110.805 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.06 -37.41 58.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.442 ' CB ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -72.13 -33.33 67.71 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.296 0.57 . . . . 0.0 109.926 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.92 -25.69 67.26 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.19 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.66 -24.09 56.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.905 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.63 1.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 119.103 -1.522 . . . . 0.0 113.884 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.08 11.72 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.768 0.827 . . . . 0.0 111.463 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.605 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 23.1 mt -63.57 -69.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.845 -172.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.82 156.26 1.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -121.7 146.68 17.17 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.67 72.08 0.21 Allowed Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.249 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.462 HD11 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.47 144.36 39.39 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 121.216 0.532 . . . . 0.0 109.6 -179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.632 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 31.3 mt -117.62 157.04 19.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.755 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.628 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 24.3 m-85 -83.59 56.14 3.49 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.677 0.672 . . . . 0.0 111.137 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.16 120.33 33.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -44.0 96.74 0.01 OUTLIER 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.083 1.489 . . . . 0.0 113.892 -172.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 p 55.85 23.78 6.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.577 1.551 . . . . 0.0 114.368 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -100.53 109.98 58.93 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.96 2.33 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.902 3.068 . . . . 0.0 115.079 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.4 ptm85 -74.19 -19.66 60.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -142.87 174.56 10.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.48 136.72 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 119.331 0.969 . . . . 0.0 110.292 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -101.15 167.45 10.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.001 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 73' ' ' LEU . 7.3 p -51.57 -29.6 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.209 0.943 . . . . 0.0 112.996 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -65.96 -50.13 65.44 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.005 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 46' ' ' VAL . 32.7 mt-30 -73.03 -40.04 65.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.231 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.92 64.6 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.834 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -37.68 70.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.076 0.95 . . . . 0.0 109.402 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.37 -43.19 17.71 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.032 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 42' ' ' GLN . 12.0 t -65.28 -39.07 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.928 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.404 ' SD ' HD11 ' A' ' 73' ' ' LEU . 27.6 ptt? -62.2 -24.02 66.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.445 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.86 -25.8 29.98 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.209 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.61 -42.51 14.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.126 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.23 99.93 19.08 Favored Pre-proline 0 N--CA 1.39 -3.472 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.47 50.04 2.23 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' A' ' 19' ' ' TYR . 1.4 pp -91.98 174.76 7.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.616 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' A' ' 76' ' ' ALA . 17.8 mt-30 -71.33 127.87 34.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.701 0.286 . . . . 0.0 111.446 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.41 ' OH ' HG13 ' A' ' 46' ' ' VAL . 45.1 m-85 -100.93 141.52 33.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.405 HG11 ' O ' ' A' ' 26' ' ' GLY . 6.2 p -127.03 158.73 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.51 135.25 7.47 Favored Glycine 0 CA--C 1.462 -3.228 0 C-N-CA 119.26 -1.448 . . . . 0.0 112.617 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' ILE . 44.4 t -115.26 142.59 27.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 28.2 t80 -172.06 157.05 4.22 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.982 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -85.98 93.2 8.9 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 58' ' ' PHE . 50.0 m-80 -89.53 118.1 28.92 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -92.17 -59.47 2.09 Favored 'General case' 1 C--N 1.237 -4.311 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.573 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.88 125.39 38.48 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.001 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 67' ' ' VAL . 15.6 tt -65.65 -29.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.258 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -19.32 59.06 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.812 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.05 -26.05 39.87 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.804 0.812 . . . . 0.0 108.875 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.06 -44.73 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 63' ' ' ILE . 70.0 t -60.3 -36.77 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.3 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.8 t70 -54.86 -58.31 8.1 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.373 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -65.74 -40.91 92.6 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.63 -29.42 70.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.778 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -84.15 -59.96 2.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.954 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 68' ' ' ASP . 52.2 t -50.55 -59.83 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.502 0.721 . . . . 0.0 111.909 -176.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 40' ' ' VAL . 33.3 tp -78.3 -21.26 49.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.6 m 59.56 73.65 0.47 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.006 0.908 . . . . 0.0 109.835 -173.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.13 -179.14 2.69 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.835 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 53' ' ' GLN . . . -127.7 -44.19 1.52 Allowed 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -137.25 157.61 46.26 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.717 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.6 p -141.83 140.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.555 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.07 124.7 49.03 Favored 'General case' 0 N--CA 1.395 -3.187 0 O-C-N 121.874 -0.516 . . . . 0.0 110.914 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.91 137.34 42.03 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.499 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.26 99.46 12.24 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -60.17 -12.98 25.98 Favored Glycine 0 C--N 1.312 -0.789 0 CA-C-N 114.811 -1.086 . . . . 0.0 115.494 -175.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.92 -26.3 62.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.948 0.404 . . . . 0.0 110.186 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.13 -47.27 85.33 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 39.5 tt0 178.31 146.44 0.14 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.43 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 47.8 mt-30 -76.12 -44.25 39.43 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 122.485 1.136 . . . . 0.0 109.594 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 45.6 mt -72.84 -13.33 61.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.092 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' O ' ' HB ' ' A' ' 91' ' ' THR . 29.5 t80 -64.97 -39.22 93.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.692 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.458 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -61.83 -38.74 81.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.727 0.775 . . . . 0.0 109.391 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.4 t70 -64.01 -22.12 66.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.096 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.9 m -86.29 -42.08 14.04 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.056 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -49.87 -38.29 34.9 Favored 'General case' 0 C--O 1.21 -1.007 0 C-N-CA 123.196 0.599 . . . . 0.0 111.953 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 18.2 mmm-85 -63.93 -27.18 68.97 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.906 0.86 . . . . 0.0 111.368 -176.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -79.65 -47.84 14.71 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.776 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.71 -22.78 29.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.38 130.15 31.56 Favored Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.179 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.73 165.85 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.639 2.226 . . . . 0.0 111.492 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.64 -17.56 47.96 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.986 0.914 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -70.73 -29.33 65.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.288 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.47 136.76 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -113.22 167.97 10.11 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.442 HD11 ' NE ' ' A' ' 93' ' ' ARG . 2.3 mp -125.72 133.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.555 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 43.0 m0 -121.96 164.71 17.15 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -115.36 124.64 51.75 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.57 107.54 4.5 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.802 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.2 tp . . . . . 0 C--N 1.28 -2.436 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.995 -177.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 94.7 m-85 . . . . . 0 N--CA 1.415 -2.217 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -76.14 163.63 26.9 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.601 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.2 m170 67.47 21.7 9.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.047 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.75 149.95 3.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -85.55 -45.52 11.69 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.497 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.7 mttm -146.14 161.95 39.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.064 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -106.98 145.4 32.31 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.47 161.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.301 -1.521 0 CA-C-O 121.221 0.534 . . . . 0.0 111.448 -177.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -57.24 99.79 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.106 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.6 131.19 51.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.857 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m -91.6 170.65 9.76 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.52 127.58 3.78 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.735 0.647 . . . . 0.0 114.076 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.4 tp -134.65 173.15 11.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -138.83 13.85 2.69 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.232 1.015 . . . . 0.0 109.467 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 99.1 mtt180 -124.62 112.66 17.06 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.537 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.12 -41.7 99.55 Favored Glycine 0 C--N 1.302 -1.345 0 CA-C-O 122.207 0.893 . . . . 0.0 112.816 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -69.51 -35.16 75.25 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.524 1.13 . . . . 0.0 109.407 -176.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 13.0 t70 -77.13 -30.29 55.06 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.38 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.12 -32.61 72.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.429 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 9.8 mtmp? -62.22 -31.93 72.53 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.568 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.772 0.32 . . . . 0.0 111.565 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.6 52.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.418 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.464 176.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.86 -30.42 71.41 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 124.168 0.987 . . . . 0.0 110.361 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.34 60.9 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.082 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.89 -19.17 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.636 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.95 25.48 15.08 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-O 121.832 0.825 . . . . 0.0 109.416 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.18 -67.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.026 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.71 157.63 1.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 124.124 0.89 . . . . 0.0 110.014 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -117.68 163.9 12.71 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.71 78.36 0.38 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.237 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.87 151.86 39.13 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 120.895 0.379 . . . . 0.0 110.026 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.519 HG13 ' SG ' ' A' ' 37' ' ' CYS . 2.2 pt -116.97 154.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 176.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.6 86.72 7.28 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 124.16 0.913 . . . . 0.0 109.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 91.5 t -116.54 122.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.16 107.17 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 0.0 112.86 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p 62.2 27.33 16.42 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.598 1.559 . . . . 0.0 113.298 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -79.0 140.9 58.04 Favored Pre-proline 0 C--N 1.308 -1.21 0 O-C-N 121.885 -0.509 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.68 8.31 4.49 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 0.0 111.152 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -120.4 -4.92 9.87 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.807 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' SG ' HG13 ' A' ' 29' ' ' ILE . 61.6 m -153.27 128.28 9.65 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -173.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.46 137.9 30.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.353 0.597 . . . . 0.0 111.026 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.98 169.51 8.53 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.886 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -47.87 -30.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.256 1.022 . . . . 0.0 113.115 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.01 -36.74 67.06 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.2 mt-30 -86.0 -34.21 20.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -25.88 68.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.58 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -30.82 71.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.806 0.843 . . . . 0.0 109.211 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -78.46 -50.92 10.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 42' ' ' GLN . 43.0 t -58.6 -35.01 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.602 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -64.28 -26.74 68.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.74 -14.72 25.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.39 0.614 . . . . 0.0 110.028 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.98 -48.79 6.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.663 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -131.77 104.03 14.4 Favored Pre-proline 0 N--CA 1.398 -3.069 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -176.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.55 65.36 4.67 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.012 1.808 . . . . 0.0 112.395 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.66 162.41 13.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.599 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.2 151.82 28.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.92 148.71 42.65 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 121.978 -0.451 . . . . 0.0 110.248 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 26' ' ' GLY . 12.2 p -133.5 154.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -129.92 141.73 12.93 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.153 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 25.6 t -136.43 126.67 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -173.04 173.75 3.62 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -87.48 120.15 28.49 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -95.64 117.35 30.3 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -99.23 -59.02 1.8 Allowed 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.2 114.14 26.58 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.389 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 67' ' ' VAL . 16.8 tt -65.8 -30.43 50.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.935 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.33 65.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.06 -41.51 22.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.8 -46.73 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.942 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 63' ' ' ILE . 88.5 t -59.9 -41.22 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.678 0.611 . . . . 0.0 109.61 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.564 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.1 t70 -54.6 -60.75 2.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 123.841 0.713 . . . . 0.0 110.98 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -63.55 -47.77 80.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.239 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -60.3 -29.85 69.11 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 124.04 0.837 . . . . 0.0 111.855 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -84.04 -57.07 3.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.404 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 68' ' ' ASP . 66.2 t -51.26 -58.62 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.008 0.523 . . . . 0.0 112.179 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 tp -81.23 -19.44 43.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 31.6 t 61.01 77.69 0.32 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.165 0.986 . . . . 0.0 111.25 -175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -78.56 -167.62 1.14 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 124.822 1.249 . . . . 0.0 110.872 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 100' ' ' VAL . . . -127.69 -74.83 0.58 Allowed 'General case' 1 C--O 1.148 -4.256 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 170.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -104.3 158.06 16.71 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 118.352 -1.339 . . . . 0.0 111.875 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -139.75 138.6 38.76 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.79 132.67 43.19 Favored 'General case' 0 N--CA 1.392 -3.341 0 CA-C-O 121.591 0.71 . . . . 0.0 112.342 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.82 115.3 30.0 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.681 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -81.55 97.48 7.85 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 89' ' ' ILE . . . -54.95 -11.73 3.24 Favored Glycine 0 C--N 1.313 -0.739 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -42.69 -29.7 0.32 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.469 1.508 . . . . 0.0 114.586 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.44 -48.62 69.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -178.37 154.08 0.79 Allowed 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -78.39 -46.07 20.85 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 122.208 1.004 . . . . 0.0 109.913 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' OE2' ' A' ' 85' ' ' GLU . 38.9 mt -77.58 -13.61 59.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.944 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.6 t80 -62.9 -35.91 81.61 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.983 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.476 HD13 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -64.82 -33.24 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.958 0.885 . . . . 0.0 109.646 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.55 -15.66 62.79 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.878 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 92.5 m -89.32 -46.6 8.64 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 124.498 1.119 . . . . 0.0 110.208 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.416 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -44.54 -56.47 4.3 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.15 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -6.44 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.41 -35.39 17.13 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.87 -16.04 27.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.955 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.89 143.2 37.38 Favored Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.069 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.65 165.99 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.729 2.286 . . . . 0.0 111.111 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -9.14 15.52 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.542 0.737 . . . . 0.0 112.65 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -82.24 -29.24 31.42 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 46.8 t -93.32 136.5 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -170.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -123.41 166.92 14.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.284 1.033 . . . . 0.0 108.367 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.82 133.19 63.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.58 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.7 m0 -117.67 150.0 39.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.303 -1.359 . . . . 0.0 107.93 170.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.69 116.9 33.68 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.67 103.1 2.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp . . . . . 0 N--CA 1.427 -1.617 0 CA-C-O 121.456 0.646 . . . . 0.0 111.25 -171.092 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.474 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 26.2 m-85 . . . . . 0 N--CA 1.426 -1.648 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.42 178.56 5.32 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.867 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 m170 68.24 20.98 8.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 111.822 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 145.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.425 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.77 -41.48 17.55 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.949 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 65.1 mttp -145.54 162.81 36.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.029 0.442 . . . . 0.0 110.859 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -114.49 136.45 53.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.236 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 174.6 12.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 121.104 0.478 . . . . 0.0 111.56 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 2.9 p-10 . . . . . 0 CA--C 1.504 -0.819 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -38.49 98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.317 -2.22 . . . . 0.0 113.753 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.5 112.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.135 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -91.0 169.02 11.23 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -40.66 119.78 1.47 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 -172.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -158.37 146.2 18.27 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -133.21 15.38 4.16 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.51 1.147 . . . . 0.0 110.367 -172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 81.2 mtt180 -107.56 115.65 30.53 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.44 -52.99 34.05 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-O 122.138 0.854 . . . . 0.0 111.784 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.8 mp0 -55.86 -25.21 41.26 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 126.107 1.763 . . . . 0.0 112.773 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 9.1 t0 -94.14 -43.86 8.28 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.01 73.34 Favored 'General case' 0 C--O 1.251 1.139 0 C-N-CA 124.583 1.153 . . . . 0.0 112.138 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.07 -24.4 64.55 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.881 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.73 -26.57 68.42 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 -45.36 12.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.427 0.632 . . . . 0.0 109.329 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -35.59 75.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.184 176.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.96 -30.09 13.98 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.251 1.421 . . . . 0.0 111.862 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.61 -22.95 62.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.18 7.46 0.09 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.46 -1.353 . . . . 0.0 113.879 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.56 23.03 11.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.306 1.043 . . . . 0.0 111.765 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.467 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 36.7 mt -57.85 -66.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.471 -170.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.02 152.91 1.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.575 0.547 . . . . 0.0 110.642 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.44 153.32 18.11 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.23 85.2 0.36 Allowed Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.21 150.47 32.28 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.31 0.576 . . . . 0.0 109.842 -177.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 3.3 pt -115.99 150.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.027 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -82.73 76.69 9.56 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.788 -171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.36 120.42 63.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.74 97.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.554 1.542 . . . . 0.0 114.498 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 74.5 p 62.02 9.82 3.29 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 127.013 2.125 . . . . 0.0 116.021 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -68.51 136.49 90.75 Favored Pre-proline 0 C--O 1.206 -1.235 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.68 4.02 0.98 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.169 2.579 . . . . 0.0 115.429 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 2.6 tpm_? -124.93 9.77 8.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.611 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' HA3' ' A' ' 8' ' ' GLY . 65.9 m -141.3 154.13 45.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.22 137.14 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.712 0.767 . . . . 0.0 109.587 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -119.26 177.13 5.01 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.459 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' HD23 ' A' ' 73' ' ' LEU . 68.9 t -38.37 -40.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.021 1.451 . . . . 0.0 113.423 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.12 -58.93 5.18 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.611 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 33' ' ' THR . 32.2 mt-30 -74.36 -33.89 63.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.072 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -65.1 -31.64 72.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -63.0 -35.6 80.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.85 -44.8 12.14 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.611 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.8 p -64.87 -30.61 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -69.47 -21.42 63.71 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.02 -9.29 58.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.196 0.522 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.99 -46.07 4.57 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.27 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.9 99.13 20.55 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.41 67.42 6.27 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.156 1.904 . . . . 0.0 112.247 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.98 165.88 10.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.528 174.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 161.67 27.62 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.679 0.218 . . . . 0.0 110.932 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.82 143.49 50.77 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 26' ' ' GLY . 10.2 p -133.65 156.26 41.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -126.34 136.54 9.59 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.767 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.5 t -123.94 128.54 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 32.8 t80 -171.59 162.04 6.33 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.258 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -96.39 92.2 6.2 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 17.4 m120 -102.84 124.79 49.01 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.508 ' CD2' HD21 ' A' ' 83' ' ' ASN . 65.7 m80 -94.33 -46.09 7.19 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.184 178.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.67 124.61 29.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.512 HG13 HD12 ' A' ' 92' ' ' LEU . 10.3 tt -64.67 -33.9 66.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.053 0.454 . . . . 0.0 110.278 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.93 64.2 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.684 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.78 -36.69 36.75 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.39 -48.37 77.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.506 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 63' ' ' ILE . 61.3 t -60.23 -39.82 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.16 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 72' ' ' VAL . 20.8 t70 -54.34 -61.47 2.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 111.319 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.2 -38.93 92.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.253 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -35.08 79.89 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.492 0.495 . . . . 0.0 111.672 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.24 -50.98 11.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 68' ' ' ASP . 54.8 t -61.26 -55.72 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.15 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 40' ' ' VAL . 86.7 mt -79.61 -8.51 59.23 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p 52.7 67.7 0.95 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.976 0.893 . . . . 0.0 111.907 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.18 -177.56 6.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.309 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.29 -36.92 1.88 Allowed 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.09 160.3 41.14 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.67 140.72 33.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.715 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -104.35 105.25 15.31 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.59 97.99 6.46 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -124.96 -22.77 4.4 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.154 0.502 . . . . 0.0 112.094 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.38 -55.96 1.62 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -168.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.508 HD21 ' CD2' ' A' ' 61' ' ' HIS . 20.6 p-10 -83.25 -69.91 0.6 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -159.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.308 36.0 mm-40 -88.67 -49.41 6.88 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -157.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -174.97 166.35 3.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 119.505 1.048 . . . . 0.0 109.448 -173.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 19.4 mm-40 -73.92 -48.45 30.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 71.4 mt -81.87 -12.8 58.29 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.138 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' O ' ' HB ' ' A' ' 91' ' ' THR . 23.3 t80 -59.62 -35.95 75.36 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.503 ' HA ' HD22 ' A' ' 92' ' ' LEU . 1.7 mp -63.73 -34.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.727 0.775 . . . . 0.0 110.246 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.505 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 28.8 t70 -64.7 -22.96 67.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.594 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.1 m -83.54 -40.12 19.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.487 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.512 HD12 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.05 -43.65 66.81 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 122.976 0.51 . . . . 0.0 110.631 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -43.98 -39.2 3.92 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.438 1.495 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.43 -44.45 35.81 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.091 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.39 -7.97 58.03 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.58 147.96 35.92 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.42 163.75 38.0 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.268 1.312 . . . . 0.0 109.2 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.46 66.88 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.146 0.579 . . . . 0.0 112.54 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -88.72 1.63 54.81 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.7 t -110.9 127.97 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 173.94 6.67 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.346 0.593 . . . . 0.0 111.99 -170.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.05 133.08 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.502 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 49.2 m0 -121.52 157.31 30.95 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -100.4 116.22 31.85 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.6 110.78 4.39 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 169.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 121.765 0.793 . . . . 0.0 112.548 -170.36 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 85.7 m-85 . . . . . 0 N--CA 1.407 -2.603 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -72.02 136.64 46.77 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . 0.295 18.0 m170 79.48 33.35 0.21 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 111.816 -2.447 . . . . 0.0 112.596 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.78 137.95 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.97 -48.02 48.02 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.787 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -150.84 162.44 40.75 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -111.89 149.15 32.27 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.33 178.77 5.14 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 125' ' ' LEU . 1.9 pt? . . . . . 0 C--N 1.3 -1.573 0 CA-C-N 119.007 0.821 . . . . 0.0 109.944 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER . . . . . 0 CA--C 1.487 -1.459 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -57.88 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.861 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 m -91.26 138.0 20.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.67 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 73.6 m -91.09 170.0 10.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -31.35 106.61 0.02 OUTLIER Glycine 0 C--N 1.358 1.762 0 O-C-N 124.395 1.059 . . . . 0.0 115.725 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -120.02 144.02 47.76 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -113.82 -19.62 11.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.315 1.055 . . . . 0.0 110.583 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.48 117.49 29.99 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.197 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -64.84 -30.39 77.84 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.204 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 mm-40 -73.43 -23.74 60.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 122.762 1.268 . . . . 0.0 108.195 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -88.49 -39.94 13.82 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.466 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.67 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.307 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 52.1 mtmt -61.12 -28.05 68.82 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.985 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.54 63.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.734 0.302 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HA ' ' OD1' ' A' ' 4' ' ' ASN . . . -78.91 -39.98 33.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.996 0.903 . . . . 0.0 109.143 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -67.68 -30.74 70.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.174 175.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.31 -25.1 21.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.963 1.305 . . . . 0.0 111.847 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -14.04 62.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.839 0.456 . . . . 0.0 111.516 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.37 31.9 0.88 Allowed Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.07 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.61 36.64 24.04 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.94 -69.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.663 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.8 161.36 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 124.032 0.833 . . . . 0.0 110.244 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.01 150.55 17.01 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.06 75.58 0.28 Allowed Glycine 0 CA--C 1.494 -1.274 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.628 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 153.27 34.88 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.649 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.543 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.1 pt -116.88 157.32 17.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.31 77.13 7.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.825 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 59.0 t -109.54 118.43 56.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.06 112.07 1.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.273 0.983 . . . . 0.0 112.355 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.3 p 64.05 26.4 14.02 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.196 1.798 . . . . 0.0 112.979 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -84.6 139.05 37.99 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.78 7.66 4.24 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.786 1.657 . . . . 0.0 112.13 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 9.7 ptm180 -118.54 -6.05 10.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.175 0.512 . . . . 0.0 109.902 174.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 79.4 m -151.22 119.6 6.4 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.28 137.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 122.113 0.959 . . . . 0.0 111.25 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.7 p-10 -104.78 169.14 8.62 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.39 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.425 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 99.5 t -47.76 -35.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 124.922 1.289 . . . . 0.0 112.391 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 41.2 mt-10 -66.67 -48.47 69.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.29 -40.85 67.26 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.284 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.06 64.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.838 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -30.58 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.4 -51.51 6.18 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.3 -35.29 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.024 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.421 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . 27.1 ptt? -64.97 -24.29 67.47 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.68 19.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.04 -51.71 23.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.245 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -132.65 107.37 13.0 Favored Pre-proline 0 N--CA 1.407 -2.587 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.16 56.41 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.689 2.26 . . . . 0.0 113.397 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.411 HD21 ' CB ' ' A' ' 19' ' ' TYR . 1.7 pp -91.49 169.96 10.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -85.63 146.95 26.62 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.421 ' HH ' ' HA ' ' A' ' 47' ' ' MET . 80.0 m-85 -117.49 144.94 44.55 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.384 0.611 . . . . 0.0 111.761 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.26 163.59 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -140.04 128.74 3.99 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.347 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 43.5 t -105.42 123.16 59.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -149.91 151.5 33.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.13 109.54 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.17 117.13 27.93 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.86 -59.91 1.76 Allowed 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.377 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -95.44 115.08 26.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 67' ' ' VAL . 16.5 tt -63.95 -30.98 51.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.212 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.84 -16.8 60.68 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.212 0.53 . . . . 0.0 110.092 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.2 t70 -85.29 -31.95 22.79 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.55 -43.75 80.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.202 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 63' ' ' ILE . 97.5 t -57.41 -43.94 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.598 ' O ' HG22 ' A' ' 72' ' ' VAL . 9.9 t70 -52.39 -61.26 2.39 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.902 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 45.2 mmtm -62.15 -44.58 96.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.253 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -63.76 -27.45 69.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.348 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -84.16 -60.31 2.13 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.135 0.574 . . . . 0.0 110.915 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -54.91 -55.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.616 0.766 . . . . 0.0 111.813 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.48 -21.58 35.51 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 17.0 m 61.8 84.76 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.001 0.905 . . . . 0.0 110.77 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.0 -170.17 2.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.86 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -125.15 -40.53 2.14 Favored 'General case' 0 CA--C 1.462 -2.417 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.66 33.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.922 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.7 p -142.85 135.67 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.7 mp0 -101.29 116.98 34.05 Favored 'General case' 0 N--CA 1.386 -3.631 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.3 158.51 15.83 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.542 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -97.86 93.68 6.48 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.438 ' CA ' HD12 ' A' ' 89' ' ' ILE . . . -69.59 -12.83 67.62 Favored Glycine 0 C--N 1.311 -0.849 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -49.82 -26.57 4.09 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.072 0.949 . . . . 0.0 112.19 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -51.85 -45.78 64.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 88' ' ' TYR . 37.1 tt0 -177.57 132.63 0.16 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.4 -35.53 79.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.085 0.945 . . . . 0.0 110.664 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.48 -15.62 57.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.591 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 38.8 t80 -68.62 -31.89 71.37 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.438 HD12 ' CA ' ' A' ' 82' ' ' GLY . 2.2 mp -64.34 -40.39 88.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.02 -13.64 62.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.79 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 93.9 m -86.98 -44.02 11.93 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.872 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -47.02 -48.08 22.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.783 0.433 . . . . 0.0 110.62 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.572 ' NH1' HD12 ' A' ' 102' ' ' ILE . 1.7 mpt_? -43.15 -31.1 0.53 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.24 -38.84 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.082 0.468 . . . . 0.0 111.419 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.99 -18.13 22.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.67 0.748 . . . . 0.0 112.496 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.42 129.3 30.75 Favored Pre-proline 0 C--N 1.27 -2.889 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.66 165.53 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.056 1.837 . . . . 0.0 110.264 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.54 -3.37 17.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.269 0.557 . . . . 0.0 111.139 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -79.87 -23.12 42.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.953 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.78 141.87 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.0 169.9 9.27 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.475 0.31 . . . . 0.0 110.37 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.572 HD12 ' NH1' ' A' ' 93' ' ' ARG . 3.0 mp -122.65 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.593 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.4 m0 -120.86 162.45 19.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -99.7 120.81 40.29 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.8 100.56 3.48 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.296 -1.751 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.676 -175.387 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 . . . . . 0 CA--C 1.475 -1.931 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -84.53 155.58 22.06 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.373 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 62.6 47.85 4.69 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.197 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.23 155.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.98 -25.4 34.81 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.426 ' HB3' ' CG ' ' A' ' 103' ' ' TRP . 41.1 ttmt -169.76 163.41 9.86 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -127.9 144.46 51.1 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.48 175.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--N 1.308 -1.208 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.944 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 . . . . . 0 CA--C 1.498 -1.021 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.97 130.48 15.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.558 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 26.3 t -100.74 109.15 24.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.351 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.2 m -93.76 168.68 10.84 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -23.56 106.63 0.01 OUTLIER Glycine 0 C--N 1.371 2.503 0 O-C-N 124.496 1.123 . . . . 0.0 115.795 -171.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.2 tp -154.37 141.55 19.45 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -136.17 8.68 3.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.82 0.819 . . . . 0.0 109.238 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 95.1 mtt180 -92.43 112.79 24.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.53 -37.1 80.8 Favored Glycine 0 C--N 1.298 -1.556 0 O-C-N 123.194 0.308 . . . . 0.0 113.131 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.61 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -68.58 -26.89 65.61 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.184 0.994 . . . . 0.0 109.391 -177.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.428 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 8.1 t0 -90.27 -39.01 13.02 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.105 -175.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.08 -42.45 89.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -62.34 -23.92 67.04 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.1 69.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.494 . . . . 0.0 110.28 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.01 -40.99 30.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.752 0.787 . . . . 0.0 110.346 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.454 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -68.9 -31.76 70.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.733 177.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.75 -16.18 47.26 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.08 -6.15 53.74 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.63 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 15.0 1.56 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.43 -1.366 . . . . 0.0 113.286 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.51 28.73 17.38 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.178 0.991 . . . . 0.0 110.783 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.69 -69.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.258 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.79 163.37 1.83 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 124.039 0.837 . . . . 0.0 109.184 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.96 126.8 5.56 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.93 85.25 0.82 Allowed Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -119.01 146.92 44.64 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.332 0.1 OUTLIER -116.92 148.92 19.32 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 179.653 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.76 87.73 2.23 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.315 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.59 120.86 66.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.02 106.56 0.17 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.537 1.148 . . . . 0.0 113.625 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.0 p 63.91 19.63 11.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.489 1.916 . . . . 0.0 114.189 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.8 p -87.15 146.57 40.57 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.749 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.28 13.52 2.07 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.049 1.833 . . . . 0.0 109.929 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -100.15 -25.84 14.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.123 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 82.8 m -155.97 141.75 17.97 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.16 137.7 35.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.287 -171.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.43 168.72 9.34 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.777 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 73' ' ' LEU . 4.5 p -52.76 -33.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 124.338 1.024 . . . . 0.0 111.781 -171.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -69.62 -42.1 74.8 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.704 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.571 ' O ' HG21 ' A' ' 46' ' ' VAL . 35.8 mt-30 -74.35 -41.34 61.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.768 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.08 66.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.39 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -64.29 -30.83 71.87 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.87 -42.3 27.69 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 42' ' ' GLN . 22.1 t -64.22 -35.37 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.935 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -16.3 64.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.39 -17.02 37.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.649 . . . . 0.0 109.586 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.82 -32.2 11.47 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.429 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 93.9 11.54 Favored Pre-proline 0 N--CA 1.39 -3.462 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.68 61.74 5.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.503 2.135 . . . . 0.0 111.739 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD23 ' CB ' ' A' ' 19' ' ' TYR . 1.1 pp -100.88 173.15 6.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.935 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -79.69 138.01 37.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.1 0.56 . . . . 0.0 111.101 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CD2' HD13 ' A' ' 28' ' ' LEU . 22.8 m-85 -108.89 140.62 42.1 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.99 137.82 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.66 122.07 6.48 Favored Glycine 0 N--CA 1.412 -2.913 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.645 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 15.2 t -114.23 106.46 20.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -160.54 146.17 14.87 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.55 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -91.19 91.88 8.42 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.48 159.4 26.98 Favored 'General case' 0 N--CA 1.387 -3.622 0 CA-C-O 123.427 1.584 . . . . 0.0 111.911 -173.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -110.63 -73.68 0.67 Allowed 'General case' 1 C--N 1.23 -4.625 0 CA-C-N 110.792 -2.913 . . . . 0.0 111.105 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.01 132.78 36.76 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.465 HG13 HD12 ' A' ' 92' ' ' LEU . 10.6 tt -67.44 -31.16 51.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.78 -19.72 65.13 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 18.6 t70 -82.42 -39.98 21.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.491 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -46.98 85.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.974 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 63' ' ' ILE . 75.5 t -60.39 -40.18 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.624 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 72' ' ' VAL . 16.4 t70 -56.26 -61.64 2.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.78 177.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 44.1 mmtm -62.34 -40.36 96.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.382 0.273 . . . . 0.0 111.448 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB1' HG23 ' A' ' 100' ' ' VAL . . . -61.85 -41.1 97.42 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.299 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -80.46 -48.71 12.43 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.681 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 68' ' ' ASP . 81.3 t -56.13 -54.94 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 123.403 0.44 . . . . 0.0 111.286 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 40' ' ' VAL . 47.7 tp -82.54 -14.26 55.22 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.302 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 t 61.95 63.9 1.06 Allowed 'General case' 0 C--O 1.254 1.317 0 CA-C-O 121.891 0.853 . . . . 0.0 109.279 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.18 179.63 0.92 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.358 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.13 -39.73 2.21 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.01 156.35 45.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.417 173.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.504 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.3 p -140.38 141.95 32.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.3 mm-40 -104.12 109.45 21.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 122.971 0.508 . . . . 0.0 111.664 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.48 136.99 52.4 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 175.88 -29.7 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.301 0 CA-C-O 121.678 0.751 . . . . 0.0 109.899 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.02 -55.67 1.95 Allowed Glycine 0 C--N 1.286 -2.228 0 N-CA-C 119.749 2.659 . . . . 0.0 119.749 -166.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -82.55 -69.76 0.6 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 119.316 3.08 . . . . 0.0 119.316 -160.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.52 -49.6 6.58 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -161.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 1.0 OUTLIER -168.09 172.27 8.88 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.518 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 36.3 mt-30 -76.87 -48.99 16.75 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.387 1.075 . . . . 0.0 108.867 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.2 mt -75.96 -13.97 60.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.691 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' THR . 25.9 t80 -59.03 -37.07 76.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.673 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.53 -34.45 70.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.444 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 21.4 t70 -69.1 -22.73 63.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 87.2 m -83.8 -44.33 14.48 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.115 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -44.86 -50.12 10.5 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.657 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -54.15 -29.18 44.48 Favored 'General case' 0 N--CA 1.516 2.825 0 CA-C-O 121.284 0.564 . . . . 0.0 112.258 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 28.5 mt-10 -76.72 -30.44 56.64 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.521 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 -9.25 19.02 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.559 0.695 . . . . 0.0 112.561 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.6 tp -94.85 129.29 36.4 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.525 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.0 165.1 22.53 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.828 1.685 . . . . 0.0 111.153 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.93 -5.15 32.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.159 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -81.01 -29.4 35.17 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.457 HG23 ' HB1' ' A' ' 70' ' ' ALA . 38.9 t -108.06 135.37 46.99 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.042 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 169.02 8.81 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 94.4 mt -122.94 128.27 75.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.619 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -116.74 161.01 19.92 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.221 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 120' ' ' VAL . 7.9 tmtm? -102.5 112.21 24.84 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.85 115.56 13.43 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 C--N 1.283 -2.293 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.067 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 75.7 m-85 . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -98.13 169.49 9.57 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.3 t60 63.51 31.96 14.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 110.078 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 104' ' ' LYS . 31.5 m -83.15 154.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.947 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.76 -41.22 62.76 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.158 0.504 . . . . 0.0 110.454 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -150.32 163.02 39.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.48 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.83 137.43 54.93 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.59 171.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.645 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.505 -0.787 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.61 -175.64 19.76 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.695 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.5 mp0 -50.09 -62.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.398 1.479 . . . . 0.0 111.501 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.483 HD22 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -149.28 25.83 0.88 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.237 1.017 . . . . 0.0 108.607 -175.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 12.4 ptpt -91.55 97.6 11.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.46 146.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.741 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 p -87.7 170.13 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.29 122.12 2.36 Favored Glycine 0 CA--C 1.482 -1.98 0 O-C-N 124.117 0.886 . . . . 0.0 114.886 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' A' ' 14' ' ' ASP . 25.1 tp -140.72 128.54 21.77 Favored 'General case' 0 N--CA 1.399 -2.978 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -120.77 12.83 11.44 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 123.093 1.425 . . . . 0.0 109.439 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.2 mtp85 -108.65 112.34 24.61 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.504 176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.94 66.74 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 116.552 -0.295 . . . . 0.0 113.793 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.59 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -72.22 -20.03 61.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.274 1.035 . . . . 0.0 108.887 -177.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HB3' HD21 ' A' ' 9' ' ' LEU . 1.3 m-20 -95.53 -45.3 7.13 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.659 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.36 72.53 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.81 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -59.11 -23.94 62.54 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.27 71.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -35.05 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.218 1.009 . . . . 0.0 108.772 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.43 -38.27 81.05 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.332 176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.9 -26.19 62.22 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.219 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.46 -23.66 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.146 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 24' ' ' ILE . . . 176.0 -25.88 0.06 OUTLIER Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.038 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 63.85 21.1 12.52 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-O 121.875 0.845 . . . . 0.0 109.597 -175.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.483 ' HB ' HD22 ' A' ' 4' ' ' ASN . 25.0 mt -70.52 -60.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.041 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.04 151.31 0.66 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.707 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -117.8 159.62 14.09 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.54 79.98 0.26 Allowed Glycine 0 CA--C 1.505 -0.575 0 CA-C-N 117.535 0.667 . . . . 0.0 111.934 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.44 149.3 40.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.135 0.493 . . . . 0.0 109.986 -174.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.3 mt -117.65 150.19 19.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.244 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -81.87 75.47 8.81 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.194 0.308 . . . . 0.0 111.702 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 87.9 t -98.48 122.13 49.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.69 108.84 0.23 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.271 1.028 . . . . 0.0 113.629 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.7 p 62.55 26.59 15.8 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.586 1.954 . . . . 0.0 114.234 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -90.56 139.83 26.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.2 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.18 16.12 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.244 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -125.57 -3.81 7.23 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.13 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 87.4 m -156.7 120.72 4.35 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.0 137.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 122.27 1.033 . . . . 0.0 111.978 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.4 p-10 -103.52 170.69 7.79 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.08 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 p -43.64 -39.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.611 1.194 . . . . 0.0 112.687 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 44.3 mt-10 -68.81 -48.66 63.02 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.626 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.659 ' O ' HG22 ' A' ' 46' ' ' VAL . 34.2 mt-30 -68.64 -40.15 80.41 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.526 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.54 -40.26 74.79 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -64.91 -29.65 70.61 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 179.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.12 -45.16 24.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.894 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 42' ' ' GLN . 48.2 t -59.53 -36.37 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.124 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -71.24 -8.1 51.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.0 -7.24 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.495 0.664 . . . . 0.0 109.304 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.23 -48.15 3.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.207 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.91 104.73 10.6 Favored Pre-proline 0 N--CA 1.41 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.42 61.66 3.49 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 123.008 2.472 . . . . 0.0 113.073 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.79 144.39 28.92 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.306 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.643 ' NE2' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -73.5 154.93 39.7 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.131 0.972 . . . . 0.0 109.361 -175.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -118.22 155.39 30.6 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 112.494 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 26' ' ' GLY . 8.4 p -131.19 164.52 34.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.2 147.2 18.9 Favored Glycine 0 C--O 1.204 -1.778 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 45.7 t -125.34 106.35 16.19 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -152.63 140.1 19.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.256 -1.778 . . . . 0.0 112.103 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 4.5 ptt180 -103.18 95.28 6.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.06 151.57 22.37 Favored 'General case' 1 N--CA 1.369 -4.515 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.562 -170.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -85.22 -49.11 8.47 Favored 'General case' 1 C--N 1.233 -4.474 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -99.1 129.08 45.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.998 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 67' ' ' VAL . 11.7 tt -67.55 -32.82 58.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.169 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -19.16 63.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.451 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 37.2 t70 -83.01 -27.1 30.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.277 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.03 -43.56 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 63' ' ' ILE . 50.9 t -59.54 -41.21 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.386 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 72' ' ' VAL . 19.3 t70 -50.72 -55.99 14.06 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.611 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 40.9 mmtm -66.02 -44.65 84.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.575 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -56.85 -35.28 68.68 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.973 0.796 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.91 -58.46 2.78 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.474 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 68' ' ' ASP . 68.0 t -49.4 -58.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.447 0.699 . . . . 0.0 112.746 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.2 -16.59 37.28 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 27.7 t 62.28 88.84 0.09 Allowed 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 124.606 1.191 . . . . 0.0 109.059 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 70' ' ' ALA . 77.7 mt -84.07 177.01 8.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.93 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.643 ' HB3' ' NE2' ' A' ' 53' ' ' GLN . . . -115.6 -40.68 3.35 Favored 'General case' 0 CA--C 1.451 -2.85 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -147.05 164.76 31.99 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.892 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.78 135.23 25.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.35 117.3 32.45 Favored 'General case' 0 N--CA 1.388 -3.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.064 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.22 129.98 45.49 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.649 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.1 m-70 -82.76 103.03 11.94 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 89' ' ' ILE . . . -61.42 -12.95 34.83 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.367 -172.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -58.97 -25.78 63.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.993 1.317 . . . . 0.0 111.364 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -59.82 -48.64 80.87 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.89 150.99 0.82 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.48 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 49.4 mt-30 -76.2 -43.41 42.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.98 0.895 . . . . 0.0 111.73 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.45 -21.56 35.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.396 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.488 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 25.9 t80 -57.12 -46.81 82.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.853 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.43 HD11 ' CG ' ' A' ' 117' ' ' PHE . 3.0 mt -61.02 -38.71 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 109.558 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.632 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 17.9 t70 -66.99 -19.54 65.73 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.705 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.454 HG21 ' CD1' ' A' ' 63' ' ' ILE . 85.6 m -89.17 -45.71 9.36 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.972 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' CZ ' ' A' ' 88' ' ' TYR . 4.0 mm? -43.41 -50.0 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.632 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -67.05 -14.23 62.7 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.42 -35.37 27.67 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.98 20.07 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.013 0.911 . . . . 0.0 111.384 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.64 118.17 70.95 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.789 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.76 165.6 20.49 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.937 2.425 . . . . 0.0 111.076 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.14 4.12 1.78 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -84.81 -29.58 25.26 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.81 133.25 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -112.45 -179.74 3.75 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 88.2 mt -126.71 134.57 65.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.53 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.8 m0 -119.89 147.14 45.07 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 118.12 36.33 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.58 106.24 2.52 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.234 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -91.15 107.57 19.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -76.03 143.14 41.59 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.39 115.23 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-O 121.838 0.828 . . . . 0.0 110.129 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.31 179.01 16.37 Favored Glycine 0 N--CA 1.415 -2.763 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.656 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.04 -27.88 61.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.197 0.522 . . . . 0.0 110.214 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.8 p -121.14 147.12 46.0 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.0 102.41 45.72 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.15 137.85 26.91 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.377 2.051 . . . . 0.0 111.466 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.7 -40.33 76.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.533 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -140.57 127.3 20.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 121.475 0.655 . . . . 0.0 110.675 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.32 -68.19 0.94 Allowed 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.48 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 72.9 m-85 -135.09 120.04 18.58 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -111.71 -170.85 1.73 Allowed 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.944 0.777 . . . . 0.0 110.546 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.4 m80 69.82 19.97 6.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.462 1.105 . . . . 0.0 109.469 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -96.95 156.55 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.272 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.87 -40.8 38.86 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 120.843 0.354 . . . . 0.0 111.331 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 64.0 mttp -147.99 161.28 41.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.25 127.3 55.57 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 m -129.65 173.55 13.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 125' ' ' LEU . 2.4 pt? -81.73 167.18 19.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.74 125.13 30.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.977 0.418 . . . . 0.0 110.183 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -117.2 23.64 11.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.268 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.69 20.56 7.74 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.847 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 69.3 114.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.702 0 C-N-CA 125.233 1.413 . . . . 0.0 112.121 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.47 145.11 4.07 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.339 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.26 27.8 3.95 Favored Glycine 0 C--O 1.245 0.833 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -157.3 171.37 20.53 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.86 65.93 3.44 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 123.364 0.415 . . . . 0.0 113.403 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.685 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--O 1.246 0.893 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.11 178.7 15.51 Favored Glycine 0 N--CA 1.418 -2.566 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.435 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.79 161.85 21.87 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.91 0.386 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.417 HD21 ' HA ' ' A' ' 18' ' ' ALA . 63.6 t30 -128.57 39.11 3.87 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.513 ' HD3' ' OH ' ' A' ' 25' ' ' TYR . 37.6 ttpt -43.9 114.28 0.64 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.725 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 m -117.63 140.72 39.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.213 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.7 m -91.69 168.48 11.45 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 117.354 -1.307 . . . . 0.0 107.995 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.15 106.01 0.01 OUTLIER Glycine 0 C--N 1.385 3.257 0 O-C-N 125.3 1.625 . . . . 0.0 116.036 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.19 130.53 35.46 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -126.4 -18.9 4.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -81.2 117.06 21.42 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.688 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -44.9 -59.3 4.47 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 124.184 0.897 . . . . 0.0 114.513 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.676 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -56.8 -25.92 56.72 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 177.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.15 -34.87 23.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.08 -42.24 85.0 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.332 -179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 49.2 mtmt -58.9 -30.39 67.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.515 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.21 70.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.622 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.417 ' HA ' HD21 ' A' ' 4' ' ' ASN . . . -77.07 -35.96 56.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.909 0.861 . . . . 0.0 109.784 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.427 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -74.82 -30.56 61.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.841 178.22 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.8 -14.14 30.28 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.783 0.801 . . . . 0.0 112.102 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.66 -13.52 61.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.978 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.49 26.26 0.98 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.12 27.64 11.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.45 1.1 . . . . 0.0 112.062 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 25' ' ' TYR . 55.3 mt -57.97 -68.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.802 -174.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.513 ' OH ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -178.87 162.12 1.27 Allowed 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.314 1.009 . . . . 0.0 109.151 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.504 ' O ' HG11 ' A' ' 55' ' ' VAL . . . -125.05 150.53 17.21 Favored Glycine 0 C--N 1.313 -0.708 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . -116.84 71.29 0.28 Allowed Glycine 0 CA--C 1.475 -2.441 0 C-N-CA 118.612 -1.756 . . . . 0.0 112.559 -170.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -108.97 130.78 55.47 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.357 0.598 . . . . 0.0 110.233 -179.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.0 pt -102.39 155.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -77.95 74.16 4.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.009 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.7 t -103.2 117.35 48.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 170.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.91 114.24 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.71 1.256 . . . . 0.0 112.826 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.9 p 69.72 17.95 7.63 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 126.181 1.792 . . . . 0.0 113.681 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -83.24 141.41 42.86 Favored Pre-proline 0 N--CA 1.419 -2.014 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.41 4.38 4.09 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.683 1.589 . . . . 0.0 111.193 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.75 5.74 10.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 110.298 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 80.7 m -156.17 117.81 3.93 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.74 137.0 32.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.947 0.88 . . . . 0.0 112.381 -168.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.46 166.34 10.62 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.838 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -45.01 -31.93 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.315 1.446 . . . . 0.0 113.143 -175.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.7 -59.69 3.96 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 123.294 0.637 . . . . 0.0 111.955 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.52 -33.4 71.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.663 0.744 . . . . 0.0 110.12 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.545 ' HA ' HG11 ' A' ' 46' ' ' VAL . . . -64.45 -26.44 68.44 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.067 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.409 HE21 ' HB2' ' A' ' 44' ' ' GLN . 3.4 tp-100 -63.68 -32.97 74.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.921 0.867 . . . . 0.0 109.493 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.26 -43.25 13.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.434 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 43' ' ' ALA . 9.5 p -70.42 -24.28 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.319 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -15.9 63.4 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.468 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.6 -24.95 28.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.585 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.43 -45.47 12.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -129.13 104.94 18.05 Favored Pre-proline 0 N--CA 1.394 -3.227 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.53 56.23 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.901 2.401 . . . . 0.0 111.963 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.427 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.7 pp -97.09 177.19 5.67 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.215 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.51 128.64 34.52 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.752 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.414 ' CD2' HD13 ' A' ' 28' ' ' LEU . 66.6 m-85 -96.85 127.32 42.72 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 26' ' ' GLY . 9.8 p -119.14 149.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.04 128.14 7.27 Favored Glycine 0 C--N 1.285 -2.256 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.321 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.95 107.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -165.28 158.63 16.51 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.649 -1.22 . . . . 0.0 109.836 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HG2' ' HB2' ' A' ' 81' ' ' HIS . 47.2 mtm180 -90.16 93.42 9.36 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -96.75 117.6 31.39 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -80.25 -31.32 38.45 Favored 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.533 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -99.19 123.62 43.62 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.521 ' O ' HG21 ' A' ' 67' ' ' VAL . 7.8 tt -61.9 -34.55 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.4 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.88 -20.25 61.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.176 0.512 . . . . 0.0 110.014 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.38 -35.44 30.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.949 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.9 -47.2 89.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 63' ' ' ILE . 80.5 t -60.1 -42.21 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.78 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' O ' HG21 ' A' ' 72' ' ' VAL . 31.1 t70 -53.87 -59.89 4.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.316 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -67.49 -39.84 85.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.298 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 100' ' ' VAL . . . -61.96 -37.91 86.52 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 123.633 0.583 . . . . 0.0 111.172 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -73.14 -60.6 2.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.604 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.56 HG21 ' O ' ' A' ' 68' ' ' ASP . 58.6 t -55.69 -53.76 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.982 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 73' ' ' LEU . 1.5 tm? -72.9 -29.28 63.02 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.298 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.4 t 67.75 74.88 0.3 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.388 1.09 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -77.81 -168.4 1.22 Allowed 'General case' 0 C--O 1.249 1.074 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.633 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.7 -52.39 1.24 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.19 162.4 31.87 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.722 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.83 136.65 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.583 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.1 mp0 -105.21 115.03 29.58 Favored 'General case' 0 N--CA 1.394 -3.259 0 C-N-CA 123.177 0.591 . . . . 0.0 110.69 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.74 123.31 43.86 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 46.8 m-70 -77.77 108.72 11.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 175.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' ' CE1' ' A' ' 117' ' ' PHE . . . -51.9 -11.78 1.03 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -51.62 -26.1 8.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.422 1.089 . . . . 0.0 111.932 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -69.12 -49.34 57.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.686 0.279 . . . . 0.0 111.718 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -179.5 147.88 0.32 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -177.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -79.45 -46.0 18.33 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 122.078 0.942 . . . . 0.0 111.35 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 42.3 mt -78.98 -14.32 59.27 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.219 -173.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.504 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.2 t80 -60.78 -39.9 90.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.347 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.47 HD12 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -61.38 -38.07 79.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-O 121.817 0.818 . . . . 0.0 109.967 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 18.2 t70 -65.99 -19.78 65.97 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.328 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.504 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 84.2 m -88.03 -41.94 12.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.922 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.434 HD12 HG13 ' A' ' 63' ' ' ILE . 2.6 mm? -51.77 -39.23 58.23 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 122.602 0.361 . . . . 0.0 111.359 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.435 ' CD ' HD12 ' A' ' 102' ' ' ILE . 7.9 mmm180 -46.0 -39.92 9.76 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.734 1.214 . . . . 0.0 111.546 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.07 -33.27 33.52 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.627 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.52 -21.04 18.54 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.705 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.62 141.88 42.2 Favored Pre-proline 0 C--N 1.285 -2.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.228 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.11 165.03 31.63 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 121.968 1.778 . . . . 0.0 110.363 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -12.11 61.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.706 0.765 . . . . 0.0 110.343 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -76.26 -29.13 57.36 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.292 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 70' ' ' ALA . 85.6 t -105.9 132.73 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 CA-C-O 121.196 0.522 . . . . 0.0 109.698 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.77 168.75 8.94 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.413 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.435 HD12 ' CD ' ' A' ' 93' ' ' ARG . 66.6 mt -123.95 132.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.583 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.7 m0 -120.58 157.65 29.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -100.61 111.53 23.78 Favored 'General case' 0 C--N 1.276 -2.587 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 110.39 4.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.96 95.33 4.78 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.221 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.4 m -73.05 168.86 18.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 168.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 111' ' ' THR . 17.4 m -41.43 115.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.021 0.915 . . . . 0.0 113.01 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -44.94 -56.05 6.06 Favored Glycine 0 CA--C 1.487 -1.713 0 CA-C-N 113.731 -1.577 . . . . 0.0 116.446 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.78 -3.26 17.91 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.441 HG21 ' O ' ' A' ' 108' ' ' VAL . 4.6 t -90.71 -11.34 39.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 117.911 -1.516 . . . . 0.0 109.423 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.54 142.0 23.68 Favored Pre-proline 0 N--CA 1.436 -1.127 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 163.58 13.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.217 2.611 . . . . 0.0 111.154 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.8 75.02 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.025 0.441 . . . . 0.0 111.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -116.49 118.91 33.97 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.07 -61.51 0.88 Allowed 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.034 -172.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.541 ' CE1' ' HA3' ' A' ' 82' ' ' GLY . 31.5 m-85 -127.58 96.1 4.44 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -93.7 167.17 11.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.454 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.5 m80 74.12 18.62 3.12 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.448 1.092 . . . . 0.0 111.668 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.06 147.13 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 -42.66 25.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.89 0.376 . . . . 0.0 111.909 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.1 ttmt -149.27 163.3 38.05 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.05 139.18 54.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.04 165.75 30.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.14 146.52 54.17 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.137 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.63 120.58 10.3 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -75.77 14.75 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.08 78.54 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -93.63 115.54 28.02 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.95 40.97 13.07 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 177.38 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.58 117.65 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.12 1.368 . . . . 0.0 112.542 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.76 -39.42 0.12 Allowed Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.61 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.1 92.87 1.17 Allowed Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.01 117.43 17.72 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.439 HD22 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -149.82 29.75 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -72.7 114.42 10.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.72 -174.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.415 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 41.5 t -90.4 118.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.319 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.38 169.16 9.53 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -32.08 106.55 0.02 OUTLIER Glycine 0 C--N 1.364 2.101 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 -171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -138.63 134.12 33.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -133.78 14.48 4.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.54 1.162 . . . . 0.0 109.738 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.477 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 65.9 mtt180 -107.13 112.22 25.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.32 -39.74 65.92 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 123.642 0.639 . . . . 0.0 113.963 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.44 -19.23 42.9 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.7 0.8 . . . . 0.0 111.082 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 9.7 t70 -87.71 -46.02 9.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.11 72.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.646 1.178 . . . . 0.0 111.367 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -22.39 66.02 Favored 'General case' 0 C--O 1.19 -2.036 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.15 71.32 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.853 0.297 . . . . 0.0 111.567 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.6 -35.75 39.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.279 1.038 . . . . 0.0 109.468 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 0.5 OUTLIER -70.68 -31.11 67.89 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.687 174.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 -35.23 79.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.091 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.0 64.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.137 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.65 -20.43 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.373 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.78 26.77 13.02 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-O 121.75 0.786 . . . . 0.0 108.882 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' HD22 ' A' ' 4' ' ' ASN . 30.9 mt -67.28 -64.56 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.796 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.41 154.8 1.04 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.735 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 137.67 9.64 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.75 80.62 0.28 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.985 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -104.84 150.2 25.03 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.557 0.694 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.281 5.5 pt -105.91 151.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.968 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -80.08 60.42 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.884 -172.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.33 113.85 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 117.401 -1.719 . . . . 0.0 107.447 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.71 118.47 7.71 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.635 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p 63.8 29.82 14.67 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.566 1.546 . . . . 0.0 112.91 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 36' ' ' ARG . 39.7 t -99.85 127.62 33.28 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.32 18.72 1.16 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.566 2.177 . . . . 0.0 111.682 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' H ' ' C ' ' A' ' 34' ' ' SER . 39.7 mtp-105 -118.18 -8.26 10.66 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.899 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 62.0 m -140.54 171.13 14.55 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.2 t -136.61 136.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 119.245 0.93 . . . . 0.0 108.653 177.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.85 174.68 5.76 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.105 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -45.82 -31.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.897 1.279 . . . . 0.0 113.122 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.58 -62.22 1.64 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.633 0.73 . . . . 0.0 110.659 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 46' ' ' VAL . 25.0 mt-30 -64.47 -42.04 96.14 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.274 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -25.23 68.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.91 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 44' ' ' GLN . 0.9 OUTLIER -68.82 -24.28 64.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 109.629 179.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.84 -49.93 7.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 42' ' ' GLN . 46.7 t -55.36 -35.34 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.786 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptp -58.9 -31.09 68.3 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.6 29.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.408 0.623 . . . . 0.0 110.307 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.32 -39.79 14.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 19' ' ' TYR . . . -145.81 97.22 4.6 Favored Pre-proline 0 N--CA 1.401 -2.893 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.12 71.39 0.86 Allowed 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.406 2.071 . . . . 0.0 113.114 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.17 147.24 29.27 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.776 173.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.99 145.42 48.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.513 -173.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.64 142.03 45.72 Favored 'General case' 0 C--O 1.253 1.256 0 CA-C-O 121.838 0.828 . . . . 0.0 112.306 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 152.24 34.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.48 149.85 17.0 Favored Glycine 0 C--O 1.2 -1.979 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.2 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.91 123.39 44.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -172.43 156.84 3.85 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.665 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.443 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 31.2 mtm180 -95.71 92.06 6.4 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -104.27 121.17 42.76 Favored 'General case' 0 N--CA 1.406 -2.631 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.56 -31.92 36.78 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.311 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.55 110.63 19.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.238 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' CD1' HG21 ' A' ' 91' ' ' THR . 6.8 tt -58.32 -38.36 68.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.521 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.5 62.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.318 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 16.9 t70 -86.22 -31.19 21.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.155 0.502 . . . . 0.0 109.994 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.54 -46.15 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 63' ' ' ILE . 61.0 t -62.57 -39.87 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.256 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.552 ' O ' HG22 ' A' ' 72' ' ' VAL . 25.8 t70 -52.55 -58.82 5.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.879 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -66.98 -40.92 87.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.842 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 100' ' ' VAL . . . -61.75 -30.77 71.0 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.367 0.667 . . . . 0.0 111.276 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -83.53 -58.74 2.69 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.794 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 68' ' ' ASP . 59.0 t -54.4 -57.92 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.478 0.486 . . . . 0.0 111.291 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.8 tp -77.76 -17.14 57.85 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.72 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 29.3 m 59.09 72.21 0.54 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.985 0.897 . . . . 0.0 111.314 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 71.4 mt -79.11 -172.44 3.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.206 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -126.68 -35.13 2.35 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.306 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -149.37 166.03 30.25 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.51 135.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -101.44 108.36 19.93 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-O 121.68 0.752 . . . . 0.0 109.602 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.415 HD11 ' HG ' ' A' ' 92' ' ' LEU . 72.5 mt -90.53 120.54 31.7 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.102 -1.408 . . . . 0.0 107.595 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.443 ' HB3' ' CG ' ' A' ' 59' ' ' ARG . 8.8 t60 -83.37 85.85 7.16 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -49.22 -9.14 0.11 Allowed Glycine 0 N--CA 1.47 0.919 0 C-N-CA 128.325 2.869 . . . . 0.0 120.029 -168.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -39.0 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.83 -48.72 79.32 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -175.11 148.65 1.01 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.462 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -78.12 -39.21 42.0 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.9 mt -82.69 -15.98 49.88 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.554 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.578 ' O ' ' HB ' ' A' ' 91' ' ' THR . 19.0 t80 -61.29 -39.63 91.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.412 ' HA ' HD22 ' A' ' 92' ' ' LEU . 1.9 mp -63.73 -34.9 70.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.929 0.871 . . . . 0.0 109.626 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.404 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.0 t70 -69.56 -18.41 63.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.455 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.578 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 63.1 m -83.79 -41.45 17.56 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.299 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.511 HD11 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -52.69 -41.71 64.13 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 123.272 0.629 . . . . 0.0 110.806 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.504 ' HG3' ' CE1' ' A' ' 119' ' ' HIS . 4.2 mmm180 -43.74 -44.44 6.61 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.11 1.364 . . . . 0.0 112.4 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -75.25 -24.27 57.62 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.913 -171.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.18 -3.57 25.59 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.819 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.4 tp -80.55 130.61 64.12 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 124.567 1.147 . . . . 0.0 109.567 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.49 162.52 37.94 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.379 1.386 . . . . 0.0 109.404 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.82 64.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -76.15 -30.27 58.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.6 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.428 HG22 ' HB1' ' A' ' 70' ' ' ALA . 40.5 t -104.57 147.44 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.468 0 CA-C-O 121.112 0.482 . . . . 0.0 110.109 -171.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -121.13 174.67 6.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 123.796 0.838 . . . . 0.0 108.761 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.425 HD11 ' HD2' ' A' ' 93' ' ' ARG . 92.6 mt -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 34.9 m0 -120.57 157.61 29.12 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.885 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -101.81 116.64 33.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.79 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.3 98.8 3.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.65 115.76 27.28 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.113 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 m -77.55 117.12 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.77 144.5 12.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.132 0.492 . . . . 0.0 111.443 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.68 8.25 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -79.89 -44.55 20.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.1 m -97.07 134.29 40.62 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.748 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.3 130.54 65.2 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.68 136.57 67.63 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.961 2.441 . . . . 0.0 113.258 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.89 72.88 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.813 0.816 . . . . 0.0 108.923 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.49 149.5 24.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -103.3 -85.07 0.46 Allowed 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 95.8 m-85 -149.24 122.63 9.04 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -72.9 163.81 27.58 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.585 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.504 ' CE1' ' HG3' ' A' ' 93' ' ' ARG . 5.9 t-160 65.35 38.47 5.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.98 0.895 . . . . 0.0 110.641 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -102.17 155.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.83 -39.5 15.82 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.783 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -155.53 163.02 40.55 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.52 144.38 50.89 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.788 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.42 175.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.99 130.85 34.42 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -65.86 110.17 2.76 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.238 0.542 . . . . 0.0 110.793 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.65 142.38 30.3 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.89 37.53 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -122.2 137.28 54.89 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.37 179.31 28.98 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 151.88 147.19 4.52 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.75 -19.12 16.89 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.355 0.598 . . . . 0.0 109.718 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -171.18 97.01 0.11 Allowed Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.828 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tmm? . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.23 36.62 0.87 Allowed Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.6 110.69 20.0 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.849 0.833 . . . . 0.0 109.347 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.461 HD22 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.2 28.5 0.91 Allowed 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.516 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 15.0 ptpt -77.79 98.11 5.44 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.003 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 78.1 t -72.64 109.24 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.765 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.7 m -92.07 170.94 9.44 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 36' ' ' ARG . . . -50.61 116.3 4.13 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.672 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.57 176.65 6.08 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -123.93 -0.92 8.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.82 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 88.9 mtt180 -126.94 115.6 19.51 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.24 82.09 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-O 122.599 1.11 . . . . 0.0 112.32 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.3 mp0 -70.84 -40.18 72.52 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 125.604 1.562 . . . . 0.0 108.96 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 33.0 t70 -74.98 -26.85 59.88 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.507 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -46.02 61.18 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.711 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 22.4 pttp -67.66 -23.61 65.35 Favored 'General case' 0 C--O 1.199 -1.555 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.26 70.05 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.997 0.427 . . . . 0.0 110.693 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.68 -42.46 58.41 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.101 0.953 . . . . 0.0 109.586 178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -32.71 72.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.949 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.8 -32.11 70.37 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.17 -25.05 54.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.702 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.92 -28.91 0.02 OUTLIER Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.093 -1.527 . . . . 0.0 113.009 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.46 30.74 17.28 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.921 0.867 . . . . 0.0 108.78 -176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.461 ' HB ' HD22 ' A' ' 4' ' ' ASN . 40.5 mt -70.75 -59.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.635 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -176.2 160.53 2.21 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.899 0.749 . . . . 0.0 109.9 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -128.79 123.05 4.15 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.4 85.68 0.67 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.17 151.84 33.68 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.216 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 4.9 pt -116.58 146.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.031 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -80.32 80.39 6.76 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.051 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.8 t -107.37 114.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.52 118.96 6.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.614 1.196 . . . . 0.0 110.874 -173.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.3 p 66.43 29.25 9.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.718 1.607 . . . . 0.0 113.136 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.455 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 40.8 t -92.84 143.69 27.34 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -91.2 0.16 4.78 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 121.52 1.48 . . . . 0.0 112.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 69.7 ttt180 -122.33 6.46 9.63 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 122.17 0.986 . . . . 0.0 109.475 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.459 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 57.3 m -146.81 125.57 12.62 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.6 t -105.59 137.15 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.918 0.865 . . . . 0.0 112.844 -172.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -107.4 172.63 6.72 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.593 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 p -49.64 -32.09 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.583 0.753 . . . . 0.0 112.5 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 53.1 mp0 -62.1 -60.8 3.07 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' O ' HG21 ' A' ' 46' ' ' VAL . 35.6 mt-30 -69.97 -32.72 71.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.188 177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.82 -23.65 67.44 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.258 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -26.36 68.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.489 0.662 . . . . 0.0 109.396 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.28 -49.28 9.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 42' ' ' GLN . 32.3 t -61.47 -32.26 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.963 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.669 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 22.9 ptm -64.35 -23.55 67.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.916 0.389 . . . . 0.0 111.868 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.57 -20.26 21.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.347 0.594 . . . . 0.0 109.482 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.49 -53.77 5.2 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.383 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.65 92.84 22.4 Favored Pre-proline 0 N--CA 1.391 -3.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.23 53.55 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.818 2.345 . . . . 0.0 112.183 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.81 162.94 15.25 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.058 176.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -64.23 131.53 47.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.512 0.725 . . . . 0.0 110.718 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.669 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 54.5 m-85 -102.85 142.26 34.27 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.095 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.9 138.25 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -113.91 128.73 8.41 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.455 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.97 106.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -163.19 168.02 21.28 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.286 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -85.85 104.77 15.82 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -100.87 150.42 22.85 Favored 'General case' 1 N--CA 1.375 -4.181 0 CA-C-O 122.339 1.066 . . . . 0.0 109.479 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -113.69 -65.97 1.13 Allowed 'General case' 1 C--N 1.235 -4.38 0 CA-C-N 112.165 -2.289 . . . . 0.0 110.402 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -89.32 119.73 30.04 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.823 0.82 . . . . 0.0 111.904 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.1 tt -66.86 -32.56 58.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.162 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.6 61.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.242 0.544 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.5 -49.75 7.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.555 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.15 -35.76 74.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.039 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.87 -30.9 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.144 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.514 ' O ' HG21 ' A' ' 72' ' ' VAL . 24.2 t70 -72.1 -38.23 69.37 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -65.68 -45.94 80.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -62.51 -23.67 67.08 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.231 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 30.7 ttmt -80.41 -59.1 2.82 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 124.193 0.997 . . . . 0.0 109.784 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 68' ' ' ASP . 65.5 t -59.13 -60.03 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.227 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 1.4 mm? -78.3 -8.2 58.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.985 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.1 p 52.32 73.29 0.34 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.719 0.771 . . . . 0.0 111.985 -172.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' CD2' ' HB2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.41 173.55 3.22 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.243 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.69 -34.63 2.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.52 46.3 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.486 168.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.68 135.61 39.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.42 117.22 33.96 Favored 'General case' 0 N--CA 1.399 -3.016 0 CA-C-O 121.134 0.492 . . . . 0.0 110.886 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -96.92 128.2 43.65 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.073 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -83.28 95.48 8.18 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -61.01 -12.93 31.87 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -171.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -54.75 -26.38 33.85 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 117.668 0.734 . . . . 0.0 112.532 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 84' ' ' GLU . 6.1 mm-40 -56.08 -45.69 79.26 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.487 ' O ' HD13 ' A' ' 89' ' ' ILE . 10.3 tp10 -175.74 135.45 0.3 Allowed 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 123.807 0.843 . . . . 0.0 109.007 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -66.28 -44.16 84.36 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.094 1.357 . . . . 0.0 111.06 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.73 -19.97 47.54 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.465 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.521 ' O ' ' HB ' ' A' ' 91' ' ' THR . 32.6 t80 -65.07 -36.79 85.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.241 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 85' ' ' GLU . 4.9 mp -63.32 -41.51 93.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.51 -21.38 66.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.521 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.4 m -81.37 -45.12 16.59 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.457 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 89' ' ' ILE . 3.8 mm? -44.06 -46.22 8.41 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -55.0 -23.78 21.07 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.2 -39.35 21.08 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.134 0.493 . . . . 0.0 111.452 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.33 -2.69 58.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.412 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.14 120.57 82.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.231 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.35 163.66 35.81 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.485 1.457 . . . . 0.0 109.718 173.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.1 -7.64 37.89 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -80.69 -30.65 36.41 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.608 0.718 . . . . 0.0 109.753 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 70' ' ' ALA . 18.9 t -104.0 146.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.274 -170.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 168.69 10.71 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.516 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.6 mt -123.07 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.578 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.0 m0 -125.0 164.37 20.31 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 130.96 53.39 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.44 106.87 2.25 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.961 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 93.81 4.71 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.527 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 16.1 t -80.89 155.26 26.62 Favored 'General case' 0 N--CA 1.404 -2.734 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.521 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -64.04 157.25 4.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.982 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.51 -178.12 47.87 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.43 -56.46 4.52 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.444 0.622 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 p -111.05 122.29 47.51 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -100.32 104.14 27.95 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.76 149.5 86.85 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.846 2.364 . . . . 0.0 112.6 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.33 -44.91 61.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.568 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.39 120.82 32.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.708 0.766 . . . . 0.0 111.565 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.08 -58.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.463 174.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -122.19 94.58 4.34 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.37 177.04 4.91 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.418 -175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.3 t60 73.25 28.42 1.83 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.212 1.482 . . . . 0.0 108.45 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.05 155.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.15 -40.91 62.27 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -158.14 161.96 37.94 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -99.61 154.89 17.91 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 123.701 0.8 . . . . 0.0 109.586 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.4 p -157.76 168.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.68 165.4 11.82 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.527 ' OD2' ' HA ' ' A' ' 107' ' ' SER . 3.1 p30 -69.07 125.05 25.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.86 -15.99 40.06 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.106 0.479 . . . . 0.0 110.852 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 155.35 -153.62 24.91 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -81.81 82.44 7.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.366 0.603 . . . . 0.0 110.108 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.55 89.97 0.64 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.918 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.1 3.88 90.12 Favored Glycine 0 C--N 1.314 -0.679 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -94.36 178.93 5.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 105.73 -41.44 2.17 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.422 -1.862 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.561 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 125' ' ' LEU . 67.4 mtt . . . . . 0 CA--C 1.501 -0.923 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.73 114.62 2.39 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -86.2 -75.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.103 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -120.25 29.25 7.59 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.22 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 113.098 -1.864 . . . . 0.0 114.426 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -90.15 115.23 29.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.191 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.9 m -91.56 170.24 10.1 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -30.46 116.44 0.07 OUTLIER Glycine 0 C--N 1.351 1.414 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 -171.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.441 HD11 ' OD2' ' A' ' 14' ' ' ASP . 16.7 tp -145.69 148.0 32.57 Favored 'General case' 0 N--CA 1.402 -2.858 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -125.67 -6.72 6.85 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -95.61 114.61 26.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -59.56 -30.5 68.72 Favored Glycine 0 C--O 1.217 -0.959 0 O-C-N 123.373 0.42 . . . . 0.0 112.06 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.8 -30.42 69.85 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.85 1.31 . . . . 0.0 108.045 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD2' HD11 ' A' ' 9' ' ' LEU . 40.6 t0 -91.46 -33.62 15.14 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 112.637 -2.074 . . . . 0.0 108.766 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.95 -34.68 78.29 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.304 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 51.0 mtmt -58.97 -25.51 63.63 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.016 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.27 75.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.974 0.416 . . . . 0.0 111.386 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 -43.94 62.84 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.755 0.788 . . . . 0.0 109.693 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.132 176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.61 -29.76 69.88 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.309 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.69 -23.3 63.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.27 -2.88 0.05 OUTLIER Glycine 0 C--O 1.22 -0.766 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.946 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.41 21.24 12.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.565 0.746 . . . . 0.0 110.309 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.67 -67.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.436 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -163.78 -177.53 5.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.484 0.49 . . . . 0.0 110.48 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -140.11 140.88 11.01 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.84 87.84 0.44 Allowed Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.93 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.21 155.17 42.23 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.074 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 4.7 pt -116.75 155.34 18.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -81.48 81.29 7.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.321 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.511 ' CG1' ' H ' ' A' ' 34' ' ' SER . 11.9 p -82.49 152.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.04 89.38 5.36 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.1 p 52.33 72.89 0.37 Allowed 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.511 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 19.9 m -140.26 122.16 9.66 Favored Pre-proline 0 C--O 1.208 -1.089 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 168.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.67 5.83 0.53 Allowed 'Trans proline' 0 C--O 1.207 -1.026 0 C-N-CA 124.038 3.159 . . . . 0.0 115.413 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -101.18 -0.64 35.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.598 0.713 . . . . 0.0 109.677 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.486 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 63.2 m -136.8 166.73 22.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -133.21 137.16 53.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.524 1.056 . . . . 0.0 111.039 -178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -115.19 171.15 7.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.89 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 89.0 t -46.64 -32.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 0.0 113.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -56.25 24.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.723 0.773 . . . . 0.0 110.536 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -81.2 -35.29 31.55 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.668 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.535 ' HA ' HG13 ' A' ' 46' ' ' VAL . . . -62.46 -27.81 69.38 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.142 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -38.19 80.24 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.63 0.728 . . . . 0.0 109.459 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.82 -45.51 10.82 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.535 HG13 ' HA ' ' A' ' 43' ' ' ALA . 3.6 p -65.53 -24.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.744 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.3 ptm -67.8 -18.08 64.73 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.025 0.441 . . . . 0.0 111.347 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.36 -22.87 18.68 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.012 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.47 -46.44 32.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.306 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.34 104.09 17.93 Favored Pre-proline 0 N--CA 1.399 -3.007 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.25 45.02 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.544 2.829 . . . . 0.0 113.247 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.25 171.91 9.44 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.216 177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -77.77 140.95 39.51 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 122.964 0.506 . . . . 0.0 110.102 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -108.74 137.53 46.53 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.514 0.673 . . . . 0.0 111.543 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 26' ' ' GLY . 13.4 p -129.43 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.89 133.61 8.35 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.541 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.549 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.2 t -111.6 131.22 63.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -159.64 151.09 19.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -85.39 105.06 15.75 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.17 116.7 17.11 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.495 1.14 . . . . 0.0 109.598 -171.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -106.28 -74.65 0.65 Allowed 'General case' 0 C--N 1.253 -3.625 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.246 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.39 119.55 31.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.465 HG13 HD11 ' A' ' 92' ' ' LEU . 15.9 tt -62.7 -32.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.659 -177.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -12.98 59.82 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.447 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 33.1 t70 -82.41 -40.32 21.43 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -73.85 -34.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.895 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 63' ' ' ILE . 54.7 t -60.49 -39.95 82.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.569 ' O ' HG21 ' A' ' 72' ' ' VAL . 12.5 t70 -52.97 -51.13 62.56 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.906 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 38.4 mmtm -65.82 -45.46 82.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.001 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -60.88 -32.26 71.71 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.138 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -76.76 -57.65 3.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.824 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' ' 68' ' ' ASP . 58.1 t -57.62 -57.01 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.517 0.727 . . . . 0.0 112.06 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -78.53 -8.82 58.98 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.042 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.0 p 49.27 68.3 0.74 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.959 0.885 . . . . 0.0 110.863 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -71.42 178.3 3.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.048 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.94 -36.4 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.794 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.23 155.57 46.01 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 172.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.3 p -142.17 139.4 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.571 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.85 129.53 45.23 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-O 121.347 0.594 . . . . 0.0 111.564 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 124.6 36.25 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.378 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 83' ' ' ASN . 26.9 t-80 -81.99 92.7 6.82 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.447 ' HA2' HD12 ' A' ' 89' ' ' ILE . . . -56.97 -19.68 31.16 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.445 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 5.7 t30 -53.92 -29.86 43.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.98 -47.82 78.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.6 tm-20 -176.41 151.18 0.95 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 24.9 mt-30 -77.93 -45.04 25.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 123.994 0.918 . . . . 0.0 111.966 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.1 mt -83.75 -23.34 31.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.131 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.522 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.4 t80 -55.0 -40.19 69.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.395 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.491 HD13 ' CD1' ' A' ' 117' ' ' PHE . 2.6 mp -61.8 -36.97 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.341 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.719 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 23.4 t70 -68.7 -20.69 64.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.778 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.7 m -85.21 -43.18 14.02 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.927 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 63' ' ' ILE . 3.5 mm? -47.08 -50.75 19.29 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.719 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.18 -10.76 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.014 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.72 -51.04 10.38 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.64 -24.12 58.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.092 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.7 mt -92.07 127.47 49.27 Favored Pre-proline 0 C--N 1.276 -2.59 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.308 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.15 165.87 29.98 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.542 2.162 . . . . 0.0 110.489 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.94 -16.63 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 111.231 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -64.33 -29.14 70.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.886 0.874 . . . . 0.0 109.826 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.19 134.56 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.185 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -111.71 170.77 7.91 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mt -123.67 135.42 63.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.571 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -121.96 156.55 33.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' HZ3' ' CD ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -119.67 129.83 54.75 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -74.19 102.19 4.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.8 tp -72.11 117.94 14.36 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 123.836 0.854 . . . . 0.0 109.554 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -59.02 107.28 0.51 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.768 0.794 . . . . 0.0 109.643 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.1 m -77.37 153.17 5.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.56 1.5 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -90.1 -73.93 0.5 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -167.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.3 m -89.91 86.58 6.66 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.342 0.592 . . . . 0.0 110.976 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.8 tp -119.76 99.23 49.5 Favored Pre-proline 0 N--CA 1.432 -1.326 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.241 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.56 163.83 16.57 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 123.374 2.716 . . . . 0.0 111.058 176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.59 -35.81 42.93 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.049 0.94 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.25 154.48 46.88 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.409 ' CD ' ' HZ3' ' A' ' 104' ' ' LYS . 31.6 mt-10 -113.19 -69.69 0.85 Allowed 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.491 ' CD1' HD13 ' A' ' 89' ' ' ILE . 81.9 m-85 -145.12 122.89 11.89 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -110.71 -170.13 1.58 Allowed 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 69.35 27.68 4.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.005 1.383 . . . . 0.0 108.805 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.03 155.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.259 -1.791 . . . . 0.0 107.39 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.31 -40.99 50.08 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.788 0.804 . . . . 0.0 111.093 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.549 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 4.9 ttmp? -153.89 163.31 40.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.82 147.7 50.44 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.22 173.56 13.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.443 HD12 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -78.13 151.64 33.21 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 118.403 0.547 . . . . 0.0 110.718 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.474 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 33.8 t70 -66.95 89.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.361 0.6 . . . . 0.0 110.332 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -106.23 121.88 45.08 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.24 80.08 0.26 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.91 145.3 46.93 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 138.23 -72.03 0.45 Allowed Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.17 -66.19 1.59 Allowed Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.939 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -156.99 134.78 10.89 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.83 -56.13 3.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.309 -1.153 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.729 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.1 -92.63 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.108 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.256 41.5 mt-10 68.54 111.05 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.699 1.238 . . . . 0.0 112.547 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.531 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -148.52 37.9 0.84 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.47 109.71 3.32 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.852 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 59.0 t -86.0 102.7 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.6 m -96.82 170.12 9.39 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -34.32 116.3 0.18 Allowed Glycine 0 N--CA 1.476 1.367 0 O-C-N 124.218 0.949 . . . . 0.0 114.712 -174.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.6 tp -146.73 157.48 43.7 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -138.32 14.8 2.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.344 1.069 . . . . 0.0 109.724 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.48 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.0 mtt180 -115.54 110.44 19.25 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.77 -35.5 74.86 Favored Glycine 0 C--N 1.301 -1.397 0 O-C-N 123.192 0.307 . . . . 0.0 113.39 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.593 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -70.5 -35.13 73.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.223 1.011 . . . . 0.0 108.945 -177.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 16.2 t0 -82.06 -22.63 36.26 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.724 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.63 -44.77 27.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.569 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 20.9 pttp -67.79 -23.28 65.19 Favored 'General case' 0 C--O 1.201 -1.494 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.44 74.69 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.676 0.39 . . . . 0.0 110.956 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.01 69.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -69.09 -34.67 75.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.293 176.085 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.6 -32.15 73.3 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.489 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.23 -23.66 61.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.58 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.54 -20.97 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . . . 60.24 30.68 20.05 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 121.68 0.752 . . . . 0.0 109.79 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' HD22 ' A' ' 4' ' ' ASN . 31.0 mt -70.62 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.034 -171.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.35 151.33 0.61 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.287 0.992 . . . . 0.0 108.701 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.49 9.49 Favored Glycine 0 N--CA 1.417 -2.622 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.08 81.11 1.08 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.239 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -114.57 150.74 34.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.186 0.517 . . . . 0.0 110.133 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 14.3 mt -118.08 156.14 19.84 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.444 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.528 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 20.7 m-85 -82.78 69.3 9.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.432 0.56 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.57 118.63 42.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.683 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.86 96.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.811 1.644 . . . . 0.0 114.24 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.0 p 56.48 23.54 7.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.626 1.57 . . . . 0.0 112.975 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.459 ' C ' ' H ' ' A' ' 36' ' ' ARG . 14.8 m -103.32 111.09 64.87 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.74 19.9 0.12 Allowed 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.64 3.56 . . . . 0.0 114.386 -172.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 34' ' ' SER . 24.1 mmt180 -91.97 -21.6 20.45 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 170.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -141.29 174.17 10.8 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.441 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -134.18 136.91 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.495 -177.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.1 p-10 -105.13 167.32 9.79 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.258 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 93.3 t -48.41 -34.58 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.925 1.29 . . . . 0.0 112.39 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 17.1 mp0 -62.0 -55.65 27.1 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 123.632 0.773 . . . . 0.0 111.988 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' VAL . 29.6 mt-30 -68.59 -42.22 78.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -20.12 65.37 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.109 -176.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.44 -45.36 11.22 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.568 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 42' ' ' GLN . 14.9 t -64.09 -33.01 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.489 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.403 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . 26.6 ptt? -64.63 -25.38 67.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.167 0.508 . . . . 0.0 110.783 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.95 -24.38 33.02 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.45 -51.93 7.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.182 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.37 104.29 17.84 Favored Pre-proline 0 N--CA 1.395 -3.222 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 48.3 2.23 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.709 2.273 . . . . 0.0 112.293 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.474 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 0.9 OUTLIER -85.07 168.57 14.76 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.527 175.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -79.65 140.43 37.07 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 120.616 0.246 . . . . 0.0 111.565 -177.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.472 ' CD2' HD12 ' A' ' 28' ' ' LEU . 33.2 m-85 -113.15 146.33 39.43 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.077 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.67 164.48 34.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -139.93 148.83 20.39 Favored Glycine 0 CA--C 1.481 -2.079 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.598 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.428 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 39.9 t -124.77 140.29 48.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -168.59 158.4 9.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.769 0.713 . . . . 0.0 109.981 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -86.15 94.72 9.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.452 HD21 ' HG ' ' A' ' 80' ' ' LEU . 84.3 m-20 -79.06 118.65 21.24 Favored 'General case' 0 N--CA 1.395 -3.184 0 CA-C-O 122.563 1.173 . . . . 0.0 110.327 -173.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.93 -61.43 1.58 Allowed 'General case' 0 C--N 1.247 -3.889 0 CA-C-N 112.521 -2.127 . . . . 0.0 106.127 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.22 110.45 18.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.759 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 67' ' ' VAL . 14.6 tt -64.62 -32.04 56.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.084 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.25 -22.32 63.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.212 0.529 . . . . 0.0 110.212 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.0 t70 -83.04 -34.82 26.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.05 -44.02 99.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.4 t -59.81 -45.54 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.472 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.577 ' O ' HG21 ' A' ' 72' ' ' VAL . 16.5 t70 -52.22 -61.27 2.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.196 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.471 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 46.9 mmtm -64.16 -42.09 96.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.679 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.03 -31.26 72.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.555 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -79.4 -57.81 3.52 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.422 0.451 . . . . 0.0 110.182 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 68' ' ' ASP . 60.0 t -53.59 -55.69 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.987 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.31 -16.54 52.15 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.437 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.6 m 59.89 74.43 0.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.179 0.99 . . . . 0.0 110.402 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.1 mt -86.4 -168.49 2.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.936 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.492 ' HB3' ' OE1' ' A' ' 53' ' ' GLN . . . -128.65 -40.29 1.58 Allowed 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.05 161.61 39.0 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.776 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.0 p -140.82 137.43 35.08 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.477 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.76 121.39 39.62 Favored 'General case' 0 N--CA 1.381 -3.917 0 CA-C-O 121.678 0.752 . . . . 0.0 110.248 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' HG ' HD21 ' A' ' 60' ' ' ASN . 1.4 tt -109.49 136.24 49.21 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -77.76 79.16 4.25 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.56 -13.12 1.81 Allowed Glycine 0 C--O 1.214 -1.107 0 CA-C-N 114.003 -1.453 . . . . 0.0 116.567 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -55.35 -24.31 28.65 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.537 1.135 . . . . 0.0 112.769 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -48.76 -49.3 39.16 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.282 1.033 . . . . 0.0 113.172 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -176.88 148.9 0.69 Allowed 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.53 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 9.1 tt0 -77.81 -48.85 15.55 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.421 1.105 . . . . 0.0 112.065 -168.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.82 -17.53 62.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.998 -174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.0 t80 -61.11 -45.0 96.49 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.89 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.63 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-O 121.779 0.799 . . . . 0.0 109.16 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.83 -20.46 66.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.226 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 89.3 m -83.9 -41.31 17.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.457 HD12 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -50.73 -38.37 47.09 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 123.684 0.794 . . . . 0.0 111.773 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -59.14 -34.32 71.92 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.209 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.08 -37.84 45.6 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.279 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.94 -18.96 26.4 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.46 141.32 22.93 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.364 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.38 165.8 31.34 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.07 1.846 . . . . 0.0 110.363 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -11.79 18.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.199 0.999 . . . . 0.0 112.126 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -79.15 -28.55 42.8 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.231 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -104.22 127.56 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.034 0 CA-C-O 121.44 0.638 . . . . 0.0 109.617 -175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.423 ' HB3' ' CB ' ' A' ' 121' ' ' ASP . . . -111.37 172.58 6.8 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.5 mp -128.21 130.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.477 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 37.6 m0 -116.94 155.76 28.56 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.96 113.68 26.43 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.89 2.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.09 101.33 12.35 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.655 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -70.01 136.73 50.71 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -52.48 145.24 2.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -171.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.22 132.86 1.39 Allowed Glycine 0 N--CA 1.419 -2.484 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.718 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -100.48 -16.35 17.58 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.96 0.886 . . . . 0.0 108.725 177.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.7 t -85.35 26.74 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.382 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.77 158.29 37.03 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.18 156.36 22.83 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.228 1.952 . . . . 0.0 111.533 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 -30.22 56.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.383 0.611 . . . . 0.0 110.205 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -117.44 130.43 56.47 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -134.87 -60.44 0.78 Allowed 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.885 0.85 . . . . 0.0 109.697 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 67.9 m-85 -124.87 112.29 16.47 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.334 -173.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.03 166.71 22.49 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.8 m170 66.26 30.05 9.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.707 0.63 . . . . 0.0 112.543 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.8 m -103.72 149.6 7.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 24.3 t70 -85.67 -42.28 14.43 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.258 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -153.59 163.13 40.5 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.544 0.738 . . . . 0.0 111.442 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.74 135.78 49.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.311 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.2 163.45 29.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.48 148.21 28.26 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.56 102.74 0.09 Allowed 'General case' 0 C--O 1.243 0.734 0 O-C-N 123.973 0.796 . . . . 0.0 109.243 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -77.43 92.42 3.97 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 121.688 0.756 . . . . 0.0 110.585 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 164.65 -60.71 0.25 Allowed Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 67.45 3.23 3.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.201 1.0 . . . . 0.0 112.324 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.64 135.43 12.14 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.02 -5.79 68.85 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.67 108.06 7.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 155.15 176.57 27.5 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.029 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 C--O 1.241 0.647 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.16 -60.77 1.16 Allowed Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -110.77 175.19 5.52 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.205 0.526 . . . . 0.0 111.141 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -153.28 44.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 ptmt -67.59 96.2 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.4 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.14 104.96 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.182 0.992 . . . . 0.0 111.53 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 169.2 10.16 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -31.34 109.47 0.03 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.29 147.58 2.0 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -136.42 -3.2 2.16 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.776 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.29 111.51 5.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.37 -58.07 5.39 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 124.57 1.081 . . . . 0.0 113.971 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.626 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -57.1 -19.9 22.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -92.0 -44.87 8.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.48 74.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.42 -23.37 65.78 Favored 'General case' 0 C--O 1.191 -2.007 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.176 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.64 -35.0 69.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.071 0.463 . . . . 0.0 110.967 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.33 56.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.727 0.775 . . . . 0.0 110.089 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.409 ' CB ' HD22 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -70.66 -35.95 73.11 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.364 177.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.95 -26.28 62.07 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.403 1.081 . . . . 0.0 111.067 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.09 -22.51 66.41 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.499 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.83 18.27 0.15 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.805 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.87 25.99 7.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.574 1.15 . . . . 0.0 111.727 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -57.93 -67.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.092 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.67 155.66 2.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -122.15 131.33 8.36 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.78 88.47 0.92 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -125.11 149.1 48.19 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 1.9 pt -117.69 157.87 18.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -86.92 87.29 7.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 124.149 0.906 . . . . 0.0 112.114 -174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 54.7 t -121.86 116.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 169.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.46 113.26 1.35 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 124.447 1.092 . . . . 0.0 113.298 -173.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p 62.94 23.34 13.95 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.864 1.666 . . . . 0.0 113.885 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 78.9 p -86.62 149.27 48.33 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.48 13.73 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.752 1.635 . . . . 0.0 111.705 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.558 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 21.9 ptt180 -119.42 -8.56 10.02 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.014 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.559 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 59.5 m -145.51 172.89 12.56 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.21 137.31 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 109.071 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.586 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -103.61 164.91 11.36 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.45 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.0 p -51.51 -35.21 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 124.265 0.978 . . . . 0.0 111.57 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 7.9 mp0 -67.82 -39.2 83.94 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 124.36 1.064 . . . . 0.0 112.011 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 46' ' ' VAL . 51.6 mm-40 -67.33 -51.15 55.91 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 122.67 1.224 . . . . 0.0 107.914 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.44 66.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.462 -2.154 . . . . 0.0 114.449 -168.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 47' ' ' MET . 0.3 OUTLIER -63.75 -31.2 72.3 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.81 -37.94 29.25 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.31 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 42' ' ' GLN . 44.8 t -65.63 -31.67 54.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.16 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 27.1 ptt? -67.83 -17.32 64.47 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.223 0.535 . . . . 0.0 111.76 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.63 46.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.427 0.632 . . . . 0.0 109.469 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.22 -40.62 6.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.305 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.94 98.75 9.41 Favored Pre-proline 0 N--CA 1.406 -2.656 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.11 59.91 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.057 2.504 . . . . 0.0 113.023 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.409 HD22 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -101.42 163.9 12.04 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.366 175.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.91 145.47 46.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.63 0.252 . . . . 0.0 110.576 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.74 140.79 47.98 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.2 p -133.57 144.0 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -109.72 132.56 11.11 Favored Glycine 0 CA--C 1.475 -2.464 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG21 ' CB ' ' A' ' 79' ' ' GLN . 7.3 p -140.09 104.05 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.053 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -167.88 178.75 5.03 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -173.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -86.3 93.42 9.08 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.42 117.99 26.57 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -85.77 -63.19 1.36 Allowed 'General case' 0 C--N 1.247 -3.89 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.711 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -89.44 125.32 35.12 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.032 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 67' ' ' VAL . 19.1 tt -63.4 -34.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.064 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.65 -20.11 62.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.62 0.724 . . . . 0.0 110.39 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 18.3 t70 -85.93 -39.48 16.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.158 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 63' ' ' ILE . 14.5 p -77.46 -32.21 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.823 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 63' ' ' ILE . 88.2 t -59.9 -40.92 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.542 ' O ' HG21 ' A' ' 72' ' ' VAL . 21.3 t70 -54.09 -50.93 65.68 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.534 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -69.21 -42.1 76.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.139 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.662 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -66.37 -22.98 66.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -83.83 -61.74 1.75 Allowed 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 68' ' ' ASP . 67.2 t -54.69 -56.68 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 123.894 0.746 . . . . 0.0 111.548 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 ' HB2' HG23 ' A' ' 40' ' ' VAL . 59.2 tp -83.16 -19.52 36.46 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.69 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 12.7 t 60.09 82.83 0.15 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 122.333 1.063 . . . . 0.0 109.768 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.22 173.01 11.9 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.644 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.24 -31.54 5.95 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -151.54 161.45 42.67 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.921 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 p -143.87 138.73 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.606 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.39 119.81 39.59 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 121.848 -0.533 . . . . 0.0 110.575 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.428 ' HG ' ' HG ' ' A' ' 92' ' ' LEU . 3.5 mm? -99.86 119.76 38.7 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.347 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -81.53 104.03 11.67 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.77 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.658 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -53.76 -12.25 2.46 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.739 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -55.24 -27.76 48.51 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 110.762 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -72.78 -47.58 45.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 123.076 0.235 . . . . 0.0 110.874 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.48 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -179.57 150.03 0.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.62 -44.31 24.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.507 1.146 . . . . 0.0 110.823 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.48 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 32.6 mt -80.71 -13.38 59.05 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.934 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.448 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.7 t80 -59.04 -42.96 91.51 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.381 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.47 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.5 mp -59.51 -38.19 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.625 0.726 . . . . 0.0 109.476 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 18.8 t70 -63.06 -22.0 66.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.33 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 94.2 m -88.53 -45.14 10.15 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.658 1.183 . . . . 0.0 109.997 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.459 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -45.09 -47.16 11.98 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.48 -24.51 66.63 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.129 -177.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 29.7 mt-10 -76.56 -37.74 56.08 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.384 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.1 -36.55 15.67 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.466 0.651 . . . . 0.0 112.255 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.31 121.2 75.24 Favored Pre-proline 0 C--N 1.272 -2.763 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.813 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.47 165.43 20.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.479 2.119 . . . . 0.0 111.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.28 -10.74 17.28 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.493 1.117 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -75.7 -29.56 59.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.56 129.73 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.335 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.99 164.88 11.77 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.338 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 71.1 mt -116.94 132.66 66.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.606 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 45.4 m0 -122.31 158.94 28.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.728 174.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.473 ' HE2' ' O ' ' A' ' 105' ' ' ALA . 17.5 tptm -100.97 115.86 31.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.473 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -77.55 98.12 5.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.2 115.41 20.59 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.634 -174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.6 m -76.16 132.72 40.15 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -58.49 127.82 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.97 163.59 10.38 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.122 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -98.73 11.99 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.917 0.865 . . . . 0.0 110.751 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.7 m -70.85 -19.76 62.61 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.817 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.65 131.34 27.16 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.98 163.18 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.925 2.416 . . . . 0.0 111.344 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.2 72.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.437 0.695 . . . . 0.0 111.727 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -120.61 138.63 53.8 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -136.23 -68.62 0.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.658 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 31.8 m-85 -112.55 120.2 40.79 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -85.24 153.5 22.57 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 75.77 24.56 1.25 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.269 -2.242 . . . . 0.0 111.604 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.44 143.56 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.85 -32.2 21.84 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.183 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.485 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 40.2 ttmt -153.56 160.36 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.325 0.583 . . . . 0.0 109.638 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -111.63 134.76 52.98 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.383 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.31 -176.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.8 mt -91.21 162.65 14.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -65.69 118.88 10.21 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.267 0.627 . . . . 0.0 110.032 177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.95 122.01 41.65 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.67 -80.17 0.19 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.62 101.01 12.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.67 93.69 0.22 Allowed Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.84 25.71 0.27 Allowed Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.4 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.11 -28.36 42.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 0.0 109.488 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.06 53.62 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.317 -0.845 0 C-N-CA 124.351 1.06 . . . . 0.0 111.289 -176.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 tpp . . . . . 0 CA--C 1.499 -1.011 0 CA-C-O 121.038 0.446 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.9 34.62 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -121.16 118.3 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.631 0.729 . . . . 0.0 112.766 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -130.51 24.09 5.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -51.03 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.598 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -99.86 103.22 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.957 0.884 . . . . 0.0 111.148 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.81 168.53 11.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.62 106.41 0.01 OUTLIER Glycine 0 N--CA 1.484 1.88 0 C-N-CA 125.578 1.561 . . . . 0.0 116.942 -173.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.54 145.68 51.91 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -125.45 8.74 7.77 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.118 0.961 . . . . 0.0 108.633 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -125.32 107.35 10.61 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.227 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.69 -54.01 8.11 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 124.07 0.843 . . . . 0.0 113.177 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.693 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -63.45 -26.32 68.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -87.09 -23.11 25.02 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.087 0.946 . . . . 0.0 108.64 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.08 -22.75 60.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.558 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -61.19 -24.18 66.13 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.584 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.12 -34.4 60.21 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.289 0.368 . . . . 0.0 111.748 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.36 67.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.885 0.85 . . . . 0.0 110.047 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -36.15 81.74 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.976 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.24 -28.53 69.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.416 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.2 -23.03 59.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.904 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.32 -11.95 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 118.413 -1.851 . . . . 0.0 113.717 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.18 23.87 14.15 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 121.46 0.647 . . . . 0.0 109.771 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 12.7 mt -57.8 -53.13 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.122 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 37.9 p90 -170.6 -172.09 1.16 Allowed 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.85 177.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.26 122.06 1.64 Allowed Glycine 0 C--N 1.284 -2.306 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 171.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.99 100.63 1.97 Allowed Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.369 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -131.96 161.98 31.8 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 123.07 0.548 . . . . 0.0 109.893 -178.275 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 57' ' ' VAL . 4.7 pt -117.4 153.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.458 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 86.7 m-85 -81.55 82.44 7.32 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.6 t -127.81 133.45 67.41 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.718 168.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.415 ' C ' ' HG1' ' A' ' 33' ' ' THR . . . -70.88 136.16 48.45 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.533 0.682 . . . . 0.0 111.26 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.415 ' HG1' ' C ' ' A' ' 32' ' ' ALA . 66.4 p 53.73 9.63 0.2 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 127.204 2.202 . . . . 0.0 116.322 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -94.75 128.54 39.21 Favored Pre-proline 0 C--O 1.211 -0.928 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.863 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.32 0.16 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.345 2.696 . . . . 0.0 113.99 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -104.14 -8.01 19.76 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.304 0.573 . . . . 0.0 110.299 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.578 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 57.8 m -139.62 136.05 33.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.891 -0.506 . . . . 0.0 111.185 -171.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.48 ' O ' HD23 ' A' ' 28' ' ' LEU . 2.3 t -108.13 135.4 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -125.28 -170.06 2.1 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 99.1 t -46.92 -34.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 125.152 1.532 . . . . 0.0 111.286 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.84 -64.41 0.95 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 122.367 1.08 . . . . 0.0 111.353 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.562 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.3 mp0 -68.88 -49.45 58.18 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.716 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -24.0 66.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.782 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.36 -34.76 75.84 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.81 -50.37 8.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.075 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 42' ' ' GLN . 24.5 t -58.19 -30.82 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.995 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.1 ptm -68.13 -12.13 60.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.983 0.421 . . . . 0.0 111.646 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.64 -6.67 24.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -42.13 4.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.384 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.76 99.27 15.5 Favored Pre-proline 0 N--CA 1.396 -3.134 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -76.09 71.73 5.57 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 C-N-CA 121.899 1.733 . . . . 0.0 111.675 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.65 160.99 15.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.508 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.483 ' HB3' ' HA ' ' A' ' 25' ' ' TYR 0.253 0.0 OUTLIER -75.71 122.42 23.98 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.103 1.361 . . . . 0.0 108.656 -176.643 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -92.31 137.69 32.15 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.683 -176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -132.16 136.39 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.53 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -116.27 150.11 18.66 Favored Glycine 0 CA--C 1.481 -2.035 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.652 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 29' ' ' ILE . 41.4 t -130.05 133.79 63.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -172.4 159.49 4.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.588 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.526 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 16.3 ttm180 -104.44 97.01 7.0 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.98 148.11 25.75 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -97.65 -37.68 9.82 Favored 'General case' 1 C--N 1.238 -4.273 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.137 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -97.68 126.0 42.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.844 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.465 HG13 HD12 ' A' ' 92' ' ' LEU . 7.6 tt -63.97 -34.44 68.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.149 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.61 -15.81 59.73 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.452 0.644 . . . . 0.0 109.772 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 12.3 t70 -75.93 -38.29 57.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.392 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.43 -46.7 69.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.316 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -59.42 -40.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.528 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.608 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.8 t70 -52.01 -56.17 15.96 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.08 176.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.5 mmtm -64.82 -43.18 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.347 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.35 85.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 124.182 0.926 . . . . 0.0 111.066 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.65 -52.14 8.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.54 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 68' ' ' ASP . 57.6 t -57.43 -57.51 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.886 0.375 . . . . 0.0 111.227 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -78.75 -12.8 60.04 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.709 -176.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 p 54.69 73.63 0.39 Allowed 'General case' 0 C--O 1.252 1.226 0 CA-C-O 122.309 1.052 . . . . 0.0 111.623 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.75 -174.31 4.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.793 -1.549 . . . . 0.0 111.858 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.66 -38.07 1.73 Allowed 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.678 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.79 159.64 42.54 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 173.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -144.74 137.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.425 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.639 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.76 112.11 24.91 Favored 'General case' 0 N--CA 1.391 -3.414 0 C-N-CA 123.102 0.561 . . . . 0.0 109.575 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.24 130.5 37.11 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.477 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -70.7 103.67 2.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.484 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.484 ' HA2' HD13 ' A' ' 89' ' ' ILE . . . -54.64 -31.87 53.38 Favored Glycine 0 CA--C 1.496 -1.122 0 CA-C-N 114.154 -1.385 . . . . 0.0 114.243 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -48.48 -25.55 1.72 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.534 1.134 . . . . 0.0 113.013 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD3' ' A' ' 59' ' ' ARG . 11.7 tp10 -66.06 -47.3 74.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.534 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -178.5 148.59 0.46 Allowed 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -77.88 -46.53 21.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.0 0.905 . . . . 0.0 112.16 -173.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -79.34 -21.74 45.43 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.245 -171.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.466 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.8 t80 -52.43 -44.51 65.51 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.483 173.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.484 HD13 ' HA2' ' A' ' 82' ' ' GLY . 2.7 mp -64.17 -36.49 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.338 0.589 . . . . 0.0 110.152 -177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.45 -17.41 58.11 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.67 0.748 . . . . 0.0 110.695 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.466 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 83.7 m -79.19 -42.17 26.67 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.176 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -43.92 -47.21 8.38 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.517 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.523 ' NH1' ' HB2' ' A' ' 119' ' ' HIS . 4.0 mpt_? -52.47 -32.52 40.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -75.46 -29.03 59.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.023 0.439 . . . . 0.0 111.419 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.38 -1.66 28.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.01 0.909 . . . . 0.0 110.562 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 14.7 tp -91.3 133.27 31.85 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.076 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.14 163.53 38.89 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.591 1.527 . . . . 0.0 110.587 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.48 69.9 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.231 1.013 . . . . 0.0 112.67 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -79.66 -13.83 59.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.3 140.58 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.567 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.26 174.09 6.24 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -128.19 135.49 62.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.639 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 51.6 m0 -122.57 162.56 21.59 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.494 -0.882 . . . . 0.0 108.704 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.472 ' HG2' ' CE2' ' A' ' 123' ' ' TYR . 18.6 tptm -100.82 116.0 31.68 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.437 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -74.56 98.94 3.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tt -80.65 105.46 11.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 m -75.3 107.79 7.65 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.49 143.42 13.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.889 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.26 -79.82 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.847 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.29 -62.65 1.21 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -161.93 -173.89 3.9 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.4 tp -110.68 118.84 47.81 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.09 162.21 2.08 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 124.029 3.153 . . . . 0.0 114.269 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.58 75.99 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -140.58 122.2 15.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.439 ' HG3' ' H ' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -129.41 -89.04 0.51 Allowed 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.706 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 22.3 m-85 -125.58 95.06 4.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -96.75 174.17 6.94 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.964 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.523 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 20.9 m170 72.7 14.74 5.0 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.696 1.599 . . . . 0.0 110.778 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.89 150.33 6.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.237 0.542 . . . . 0.0 111.52 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.57 -29.44 59.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.942 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -159.75 158.54 31.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.472 ' CE2' ' HG2' ' A' ' 104' ' ' LYS . 7.1 m-85 -109.14 128.85 55.36 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.41 -178.04 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 123.33 0.394 . . . . 0.0 109.939 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp -72.29 150.49 43.52 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 123.49 0.494 . . . . 0.0 110.589 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -80.92 98.61 7.96 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -93.26 87.75 5.77 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.068 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.39 35.84 0.11 Allowed Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.97 107.86 18.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.2 -51.37 0.09 OUTLIER Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.519 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.34 63.15 Favored Glycine 0 C--O 1.241 0.543 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.21 38.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.231 -0.485 . . . . 0.0 110.209 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.29 25.97 Favored Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 C--N 1.295 -1.776 0 O-C-N 123.694 0.291 . . . . 0.0 110.356 -179.031 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.067 0.46 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.51 64.73 0.02 OUTLIER Glycine 0 CA--C 1.482 -1.974 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -69.33 143.31 53.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.431 -0.884 . . . . 0.0 112.272 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.71 25.86 11.22 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -16.84 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.376 2.27 . . . . 0.0 115.357 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.96 110.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.568 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.3 m -91.11 169.38 10.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -38.41 106.68 0.05 OUTLIER Glycine 0 N--CA 1.473 1.152 0 O-C-N 124.196 0.935 . . . . 0.0 114.539 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.422 HD21 ' H ' ' A' ' 10' ' ' THR . 3.6 tt -138.37 146.23 42.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.422 ' H ' HD21 ' A' ' 9' ' ' LEU . 29.0 p -111.12 -19.82 12.58 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.255 1.026 . . . . 0.0 110.575 -169.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.4 mtm180 -86.21 108.49 18.39 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.721 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.96 -39.43 89.16 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-O 122.181 0.878 . . . . 0.0 112.833 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -73.57 -18.23 61.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.833 -1.183 . . . . 0.0 110.756 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -92.91 -45.8 7.79 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -28.04 68.38 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.705 1.202 . . . . 0.0 112.175 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.81 -22.89 59.52 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.967 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.69 43.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.462 0.705 . . . . 0.0 112.288 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.25 47.69 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 110.784 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.8 -33.98 34.39 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.012 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.23 -23.41 55.76 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 125.828 1.651 . . . . 0.0 110.524 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.39 62.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.87 26.8 0.75 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.825 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.45 34.16 20.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.358 1.063 . . . . 0.0 111.743 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 21.9 mt -62.58 -69.05 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.233 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.433 ' HB2' ' CD ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.96 155.64 0.99 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.049 -173.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.96 138.43 11.03 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.44 75.83 0.23 Allowed Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.426 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.466 HD13 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -117.31 144.22 45.11 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 22.0 mt -117.1 152.65 18.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.372 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 4.9 m-85 -82.55 72.29 9.62 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 118.035 0.38 . . . . 0.0 110.245 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 66.1 t -95.76 121.99 46.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 118.459 -1.297 . . . . 0.0 107.692 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.53 108.43 0.17 Allowed 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.429 1.081 . . . . 0.0 112.864 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.2 p 57.82 29.04 16.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.701 1.6 . . . . 0.0 113.915 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -80.97 140.09 49.91 Favored Pre-proline 0 N--CA 1.423 -1.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.32 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.4 7.94 4.85 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 C-N-CA 121.596 1.53 . . . . 0.0 112.297 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -124.65 2.18 8.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 109.858 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 93.9 m -154.12 125.21 7.31 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.33 137.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.61 0.719 . . . . 0.0 111.634 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -104.0 170.95 7.62 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.873 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.32 -35.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.025 1.33 . . . . 0.0 113.224 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.33 -50.71 58.93 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.959 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.29 -32.39 49.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.992 0.901 . . . . 0.0 109.441 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -63.22 -25.87 68.53 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.796 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -39.13 70.35 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.882 0.873 . . . . 0.0 109.714 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -86.5 -46.12 10.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.002 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 43' ' ' ALA . 7.0 p -60.82 -31.89 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.382 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.708 ' SD ' ' HA ' ' A' ' 73' ' ' LEU . 26.5 ptt? -66.16 -27.06 67.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.983 0.42 . . . . 0.0 110.953 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.42 21.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.372 0.606 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.42 -47.26 34.88 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.342 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.0 101.41 22.84 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.33 66.4 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.969 1.779 . . . . 0.0 112.057 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.449 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.5 pp -107.73 176.41 5.15 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.408 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.433 ' CD ' ' HB2' ' A' ' 25' ' ' TYR . 4.1 tt0 -76.73 131.83 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.664 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.466 ' CD2' HD13 ' A' ' 28' ' ' LEU . 61.0 m-85 -105.14 141.96 35.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.487 0.661 . . . . 0.0 110.768 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 p -129.11 160.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -137.88 139.25 10.24 Favored Glycine 0 C--N 1.277 -2.717 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.073 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 61.8 t -113.28 127.89 70.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -154.22 147.0 24.3 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.489 -1.285 . . . . 0.0 110.511 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -86.26 102.19 13.73 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 167.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -80.49 114.56 19.47 Favored 'General case' 0 N--CA 1.387 -3.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -105.43 -58.08 1.95 Allowed 'General case' 0 C--N 1.256 -3.463 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.85 116.35 30.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.297 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' ' 67' ' ' VAL . 18.3 tt -64.63 -31.4 53.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 120.876 0.37 . . . . 0.0 111.168 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.81 -9.5 59.07 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.632 -0.667 . . . . 0.0 110.714 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 11.3 t70 -84.88 -39.13 18.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.72 -35.0 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -63.96 -36.47 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.57 ' O ' HG22 ' A' ' 72' ' ' VAL . 5.3 t70 -53.71 -53.36 53.22 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.975 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 42.2 mmtm -64.72 -44.2 90.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.094 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB3' HG21 ' A' ' 100' ' ' VAL . . . -57.65 -33.49 68.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.666 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.28 -60.66 2.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.168 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 68' ' ' ASP . 60.2 t -54.59 -59.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.647 0.779 . . . . 0.0 112.245 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.708 ' HA ' ' SD ' ' A' ' 47' ' ' MET . 1.4 mm? -78.61 -14.21 59.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.888 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.6 t 57.13 73.58 0.45 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.945 0.879 . . . . 0.0 109.794 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.63 -178.8 4.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.208 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.06 -34.22 2.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -149.24 160.16 43.63 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.697 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.29 137.18 37.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.564 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.6 mp0 -96.46 118.33 32.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.3 tp -99.78 125.86 45.76 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.734 -170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 72.5 m80 -87.29 95.75 10.1 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.45 ' CA ' HD13 ' A' ' 89' ' ' ILE . . . -67.69 -12.95 62.73 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.74 -1.118 . . . . 0.0 114.74 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.485 ' OD1' ' HB3' ' A' ' 81' ' ' HIS . 3.4 p-10 -56.36 -25.49 49.63 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.165 0.586 . . . . 0.0 112.438 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.86 82.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 112.887 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.7 tm-20 -171.46 141.5 1.53 Allowed 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.06 -42.01 33.61 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -168.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.02 -24.17 30.63 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-O 121.882 0.848 . . . . 0.0 109.959 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.563 ' O ' ' HB ' ' A' ' 91' ' ' THR . 36.7 t80 -51.43 -32.55 27.09 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 125.98 1.712 . . . . 0.0 112.13 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.45 HD13 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -60.07 -39.66 81.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.415 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 9.9 t70 -67.9 -14.74 63.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.47 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 75.2 m -88.13 -46.57 9.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.23 1.412 . . . . 0.0 109.367 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.453 HD22 ' CE2' ' A' ' 88' ' ' TYR . 3.8 mm? -44.91 -51.01 10.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.525 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -56.99 -29.96 63.73 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 121.219 0.533 . . . . 0.0 112.18 -178.283 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -76.15 -31.12 58.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.483 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.76 -23.79 17.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 92' ' ' LEU . 98.2 mt -76.7 131.44 73.92 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.688 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.04 165.2 10.84 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.724 2.283 . . . . 0.0 112.446 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.02 55.02 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.721 1.208 . . . . 0.0 113.099 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -85.86 -8.58 57.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 70' ' ' ALA . 82.7 t -98.66 124.89 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-O 121.717 0.77 . . . . 0.0 109.263 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.96 172.73 6.66 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.034 -176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.08 130.94 73.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.564 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.2 m0 -119.9 159.38 24.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -101.18 117.94 36.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.325 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.11 105.72 3.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.73 95.85 9.52 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.903 0.858 . . . . 0.0 109.772 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 49.0 m -67.69 117.87 10.2 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.923 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.55 127.5 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.16 142.1 3.48 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.6 89.56 5.12 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.225 1.012 . . . . 0.0 112.732 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 t -143.2 152.53 41.86 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.71 93.38 48.69 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.08 122.1 3.27 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 C-N-CA 121.795 1.663 . . . . 0.0 109.799 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.89 -34.59 73.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.419 ' HG2' ' N ' ' A' ' 116' ' ' GLU . 37.7 ttm180 -171.38 166.48 6.98 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.419 ' N ' ' HG2' ' A' ' 115' ' ' ARG . 40.1 mt-10 -144.86 -56.5 0.34 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 102.55 -3.129 . . . . 0.0 102.55 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.09 165.99 23.46 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 102.833 -3.025 . . . . 0.0 102.833 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 4.5 pt20 -136.22 172.52 12.89 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.456 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 88.9 m-70 69.41 36.55 2.24 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.576 1.551 . . . . 0.0 112.429 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 m -84.74 152.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.46 -47.28 11.55 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.706 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.5 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 67.6 mttm -151.06 163.85 37.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -110.94 162.39 14.88 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.425 HG21 ' H ' ' A' ' 125' ' ' LEU . 13.3 p -141.27 174.14 7.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.483 ' HG ' ' H ' ' A' ' 126' ' ' ASP . 28.4 tp -76.61 -178.08 4.55 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.483 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 26.6 t70 -69.69 99.99 1.41 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.251 0.548 . . . . 0.0 111.531 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -113.2 154.89 25.98 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.38 179.14 30.77 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -96.34 21.02 9.58 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.889 0.345 . . . . 0.0 110.558 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.75 77.27 1.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.912 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -152.8 33.79 0.81 Allowed Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.87 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.67 176.32 11.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 -76.11 2.27 Favored Glycine 0 C--N 1.31 -0.88 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--N 1.293 -1.85 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.61 78.0 0.26 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.65 178.48 8.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.415 0.626 . . . . 0.0 109.774 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 5.1 t30 -148.85 48.28 1.0 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -37.05 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 112.673 -2.058 . . . . 0.0 112.116 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.58 121.4 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.988 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.55 170.73 9.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.03 135.68 3.42 Favored Glycine 0 C--N 1.357 1.749 0 CA-C-N 119.152 0.887 . . . . 0.0 114.321 -170.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.52 161.31 37.37 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -176.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -129.09 18.53 6.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -137.2 106.17 5.96 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.649 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.41 -48.77 27.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 124.765 1.174 . . . . 0.0 113.04 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.606 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.9 mp0 -63.22 -19.32 64.42 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 125.822 1.649 . . . . 0.0 112.444 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.0 -42.23 9.15 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.77 69.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.764 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.3 -23.06 67.25 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.52 69.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -77.08 -30.13 55.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 0.0 110.789 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.06 -34.46 50.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.02 -30.49 71.56 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.065 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -17.38 64.39 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.426 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.44 15.31 0.5 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.134 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.46 26.56 12.78 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.455 0.702 . . . . 0.0 110.837 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.67 -67.6 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.223 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.53 159.76 1.18 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.258 0.974 . . . . 0.0 108.815 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.6 142.83 14.28 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 108.459 -1.857 . . . . 0.0 108.459 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.62 78.8 0.27 Allowed Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.573 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.504 HD12 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -115.34 146.32 41.65 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.114 0.483 . . . . 0.0 109.734 -177.142 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.473 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 pt -117.37 155.01 19.12 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -84.16 76.93 10.04 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.651 1.219 . . . . 0.0 109.689 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.28 121.93 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 98.79 0.02 OUTLIER 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.04 1.463 . . . . 0.0 113.82 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p 58.77 25.26 13.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.858 1.663 . . . . 0.0 114.97 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -90.76 116.07 65.6 Favored Pre-proline 0 C--O 1.199 -1.557 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.99 -7.3 2.33 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 124.273 3.315 . . . . 0.0 116.542 -171.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.23 11.54 27.29 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.637 1.208 . . . . 0.0 109.797 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 66.2 m -140.0 170.92 14.97 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.17 136.57 16.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 119.486 1.039 . . . . 0.0 109.869 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.41 166.87 10.51 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.263 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -42.96 -36.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 O-C-N 125.044 1.465 . . . . 0.0 113.843 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.9 -32.54 61.85 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.564 ' O ' HG22 ' A' ' 46' ' ' VAL . 16.2 mt-30 -83.38 -37.85 22.76 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.713 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.49 64.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.662 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -33.06 74.83 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -77.34 -46.23 23.58 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.75 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 42' ' ' GLN . 6.4 t -63.72 -34.4 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.649 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.24 -16.09 62.48 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.893 -0.504 . . . . 0.0 111.49 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.62 -19.67 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.24 -40.81 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.096 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.16 97.24 9.78 Favored Pre-proline 0 N--CA 1.408 -2.551 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -74.43 53.32 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.852 2.368 . . . . 0.0 113.544 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -90.39 168.97 11.47 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.425 1.09 . . . . 0.0 109.14 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.75 140.34 49.47 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 122.964 0.505 . . . . 0.0 110.128 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.504 ' CD2' HD12 ' A' ' 28' ' ' LEU . 15.4 m-85 -112.29 137.84 49.85 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.521 0.677 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.18 148.86 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.31 143.74 15.7 Favored Glycine 0 C--N 1.283 -2.398 0 C-N-CA 119.783 -1.199 . . . . 0.0 112.147 178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.3 t -134.97 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -172.59 163.39 5.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 13.9 ptm180 -96.64 93.87 6.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.61 117.64 29.43 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.88 -38.47 70.0 Favored 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.487 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -99.24 129.27 45.46 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.482 HG13 HD13 ' A' ' 92' ' ' LEU . 15.3 tt -64.03 -31.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.081 0.467 . . . . 0.0 110.1 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.97 -11.83 60.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 110.784 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 35.6 t70 -85.39 -41.53 15.36 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.02 -51.84 66.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.295 176.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.8 t -58.8 -38.25 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.965 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.508 ' O ' HG23 ' A' ' 72' ' ' VAL . 36.3 t70 -65.54 -43.97 88.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.007 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 56.8 mmtt -67.91 -44.81 76.06 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.418 ' HB2' HG22 ' A' ' 100' ' ' VAL . . . -58.02 -36.28 72.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.77 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -73.85 -59.59 2.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.8 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 68' ' ' ASP . 87.0 t -54.41 -58.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.56 -3.44 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.833 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 15.8 p 51.4 61.85 3.01 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.79 0.805 . . . . 0.0 111.796 -173.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 174.52 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.542 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.88 -29.42 3.1 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.362 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.25 155.22 43.1 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.28 136.51 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.621 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.25 110.37 22.31 Favored 'General case' 0 N--CA 1.384 -3.738 0 C-N-CA 123.019 0.527 . . . . 0.0 110.044 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.25 123.22 36.38 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.522 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.437 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 52.1 m-70 -74.25 94.02 2.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' HA2' HD12 ' A' ' 89' ' ' ILE . . . -55.69 -12.72 5.22 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 117.29 1.676 . . . . 0.0 117.29 -170.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -44.88 -25.48 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.613 1.165 . . . . 0.0 113.694 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.94 -48.24 82.75 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -172.18 150.04 2.39 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -77.44 -42.9 34.33 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.05 0.928 . . . . 0.0 111.933 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.06 -13.0 54.23 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.784 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.602 ' O ' ' HB ' ' A' ' 91' ' ' THR . 21.9 t80 -59.12 -40.98 87.07 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.308 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.479 HD12 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -63.52 -39.51 85.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.816 0.817 . . . . 0.0 109.229 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.53 -16.78 64.38 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.814 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.2 m -85.27 -39.99 17.11 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.677 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.482 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.09 -39.5 63.42 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 123.137 0.575 . . . . 0.0 110.702 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.7 mmm180 -43.34 -43.75 5.2 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.659 1.224 . . . . 0.0 111.759 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -71.08 -46.3 62.12 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.354 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 -12.01 27.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.21 130.03 47.54 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.1 164.16 28.74 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.225 1.95 . . . . 0.0 111.462 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.05 -27.2 63.39 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 124.276 1.031 . . . . 0.0 113.338 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -85.34 -7.96 58.71 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 70' ' ' ALA . 92.7 t -104.11 133.35 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -115.74 169.61 9.08 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.307 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 84.7 mt -123.14 130.02 74.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.621 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 42.0 m0 -121.14 159.9 24.84 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.416 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.71 115.5 30.6 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.72 103.77 2.66 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.781 0.676 . . . . 0.0 109.245 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 tp -84.19 104.51 14.29 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.416 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 23.3 t -57.39 120.52 8.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.0 m -47.88 129.81 4.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 132.35 118.88 1.99 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -71.98 -6.07 39.46 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 m -72.79 -24.8 60.97 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 114.54 30.57 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 137.43 80.31 Favored 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 123.177 2.585 . . . . 0.0 114.416 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.5 -16.09 59.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.298 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.46 118.57 30.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.678 0.751 . . . . 0.0 110.316 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -160.63 -57.78 0.06 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 50.1 m-85 -118.7 101.34 8.03 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 112.182 -2.281 . . . . 0.0 106.475 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.547 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 13.9 pt20 -99.57 -169.07 1.7 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.547 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 94.3 m-70 70.42 34.36 2.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.47 164.36 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.617 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.08 -37.99 14.7 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 38.4 ttmt -161.12 162.66 31.56 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.957 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -107.42 142.83 36.65 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.792 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.9 163.74 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.9 mt -87.54 150.07 23.95 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.416 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 16.7 t70 -69.8 105.99 2.96 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.619 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.24 18.84 17.57 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.082 0.468 . . . . 0.0 109.815 176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -136.34 55.38 0.71 Allowed Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -61.76 113.15 2.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.309 0.576 . . . . 0.0 110.511 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.72 4.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.978 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.5 44.39 3.36 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.69 142.16 33.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.75 50.41 0.27 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--N 1.301 -1.509 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.928 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 C--O 1.237 0.444 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.46 91.09 0.34 Allowed Glycine 0 CA--C 1.481 -2.041 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 67.8 -170.17 0.19 Allowed 'General case' 0 C--O 1.25 1.094 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -166.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.598 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.1 p-10 -156.97 41.04 0.33 Allowed 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.98 114.74 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.655 -173.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.506 ' H ' ' HA2' ' A' ' 26' ' ' GLY . 97.6 t -93.91 117.97 38.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.764 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 16.9 p -136.81 166.88 22.57 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.51 106.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.955 0 C-N-CA 126.055 1.788 . . . . 0.0 116.939 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.41 HD21 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -160.54 159.92 31.26 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -138.72 19.91 2.68 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -114.52 101.76 9.43 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.452 -174.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.87 -44.03 55.26 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.274 0.94 . . . . 0.0 113.853 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.14 -19.81 59.7 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.325 -0.937 . . . . 0.0 110.312 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -83.45 -38.33 22.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.42 -50.28 70.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.123 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -65.68 -23.77 66.85 Favored 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -26.19 67.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.4 -37.4 25.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.804 0.812 . . . . 0.0 109.417 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CB ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -67.83 -38.96 83.87 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.744 -0.598 . . . . 0.0 110.442 174.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -60.97 -32.74 72.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.056 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.16 62.92 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.735 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.49 -14.34 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.597 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.52 18.2 11.19 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.643 0.777 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.598 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 22.3 mt -63.14 -67.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.375 -170.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -174.03 161.89 3.73 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 123.627 0.579 . . . . 0.0 110.538 -178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' H ' ' A' ' 6' ' ' VAL . . . -129.97 122.45 3.71 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.52 88.67 1.25 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.42 147.4 41.71 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.285 4.6 pt -117.24 151.69 19.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -85.12 73.98 10.56 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.605 -174.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.402 ' HB ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -120.93 115.7 47.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.35 106.44 0.12 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 124.94 1.4 . . . . 0.0 113.901 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p 65.54 15.89 10.25 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.005 1.722 . . . . 0.0 115.05 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 24.9 t -74.85 138.28 73.24 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.89 -0.89 7.69 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 122.811 2.341 . . . . 0.0 113.727 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 58.6 ttp180 -114.18 -4.51 13.09 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 15.2 m -129.88 130.12 44.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.992 -169.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.63 134.94 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -118.25 179.25 4.16 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.275 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 6.9 p -45.51 -31.74 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 O-C-N 124.666 1.229 . . . . 0.0 113.204 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.22 -61.97 1.61 Allowed 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 123.742 0.817 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -67.96 -37.8 81.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.22 0.534 . . . . 0.0 110.256 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' HA ' ' CG1' ' A' ' 46' ' ' VAL . . . -64.06 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.88 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.455 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 3.8 tp-100 -67.78 -39.49 84.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.027 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.88 -40.52 14.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.978 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.544 ' CG1' ' HA ' ' A' ' 43' ' ' ALA . 4.5 p -64.56 -22.9 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.727 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 21.6 ptp -67.8 -17.12 64.42 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.543 0.687 . . . . 0.0 110.931 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.37 3.15 40.27 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.499 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.83 -42.6 3.77 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.134 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.39 101.06 5.65 Favored Pre-proline 0 N--CA 1.4 -2.956 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.43 70.07 3.3 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 112.007 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.44 HD22 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -111.99 160.56 17.34 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.202 174.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -67.16 134.93 52.7 Favored 'General case' 0 C--O 1.208 -1.079 0 C-N-CA 123.229 0.612 . . . . 0.0 109.89 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.727 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 61.3 m-85 -108.52 140.6 41.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.077 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 9.5 p -133.96 133.96 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -110.37 125.89 7.67 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.598 -178.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.513 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 18.0 t -112.89 121.58 65.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -173.08 154.33 2.74 Favored 'General case' 0 CA--C 1.493 -1.223 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.361 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.56 104.9 15.74 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 122.458 1.123 . . . . 0.0 108.315 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.85 121.68 42.56 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 113.637 -1.619 . . . . 0.0 110.326 -171.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -99.64 -36.28 9.55 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.274 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 66' ' ' VAL . 8.1 t70 -99.37 111.37 23.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.516 ' O ' HG22 ' A' ' 67' ' ' VAL . 13.6 tt -66.93 -33.6 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.156 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.42 62.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.344 0.593 . . . . 0.0 110.461 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.0 -33.22 24.59 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 62' ' ' ASP . 47.6 t -65.2 -43.46 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 63' ' ' ILE . 61.2 t -59.05 -43.56 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.36 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' O ' HG22 ' A' ' 72' ' ' VAL . 16.4 t70 -57.89 -61.33 2.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.887 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.17 -42.67 99.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.46 70.03 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -82.8 -56.75 3.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.717 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 68' ' ' ASP . 58.0 t -53.21 -59.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.429 0.692 . . . . 0.0 111.547 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -72.34 -18.17 61.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.221 177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 m 59.72 69.04 0.73 Allowed 'General case' 0 C--O 1.243 0.746 0 CA-C-O 122.336 1.065 . . . . 0.0 109.803 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.71 -176.39 5.35 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.253 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.13 -43.13 1.67 Allowed 'General case' 0 C--O 1.184 -2.35 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -136.25 155.0 50.74 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.79 170.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.473 ' C ' HE21 ' A' ' 79' ' ' GLN . 6.1 p -135.51 137.34 49.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.539 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.5 mm-40 -95.0 128.25 41.68 Favored 'General case' 0 N--CA 1.394 -3.231 0 CA-C-O 121.288 0.566 . . . . 0.0 110.846 -174.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.512 ' CD2' HG13 ' A' ' 89' ' ' ILE . 40.4 tp -113.6 121.32 43.82 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.496 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -85.51 91.82 8.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.42 -12.87 41.45 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -167.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -48.8 -25.99 2.15 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.332 1.053 . . . . 0.0 113.498 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -51.69 -49.95 61.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -175.14 154.36 1.76 Allowed 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.3 mp0 -77.97 -46.49 20.97 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.791 0.805 . . . . 0.0 111.334 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.15 -17.46 54.97 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.244 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.574 ' O ' ' HB ' ' A' ' 91' ' ' THR . 28.3 t80 -59.84 -37.5 79.41 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.559 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' A' ' 80' ' ' LEU . 1.7 mp -64.24 -37.44 79.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.542 0.687 . . . . 0.0 109.823 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -20.91 60.18 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.884 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 97.5 m -74.42 -43.39 56.51 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.095 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.425 HD11 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -48.59 -44.63 37.09 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.201 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.837 ' NH2' ' HB ' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -55.21 -25.97 36.43 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -86.35 -40.28 15.6 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.77 -18.47 31.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.544 0.687 . . . . 0.0 112.258 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.28 128.87 35.18 Favored Pre-proline 0 C--N 1.275 -2.633 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.82 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.76 165.12 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.221 1.947 . . . . 0.0 110.611 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.55 4.3 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.626 0.77 . . . . 0.0 112.126 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -84.13 -29.08 27.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.4 t -107.89 132.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.324 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.4 160.66 15.47 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.837 ' HB ' ' NH2' ' A' ' 93' ' ' ARG . 4.1 mp -122.58 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.539 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 38.9 m0 -107.75 164.63 12.07 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.26 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -99.54 109.18 21.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.605 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.21 103.39 3.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.8 tp -74.1 94.05 2.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.571 -175.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.6 m -70.23 113.03 7.0 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 104.251 -2.499 . . . . 0.0 104.251 169.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.34 116.34 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 122.295 1.045 . . . . 0.0 113.765 -170.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.3 135.49 12.64 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.56 -32.99 68.7 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 123.203 0.601 . . . . 0.0 109.838 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.2 m -142.5 101.59 3.91 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.33 119.96 79.57 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -173.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.73 162.13 30.1 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.864 2.376 . . . . 0.0 110.476 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.56 28.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.465 0.65 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -108.58 119.24 38.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.537 0.684 . . . . 0.0 110.039 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.24 -77.91 0.34 Allowed 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.022 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.429 ' HB3' HG12 ' A' ' 89' ' ' ILE . 56.3 m-85 -142.61 103.8 4.28 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -83.34 172.79 12.16 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.399 0.619 . . . . 0.0 112.453 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.4 m170 74.57 4.98 4.49 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.412 1.485 . . . . 0.0 114.777 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.673 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 20.7 m -68.04 154.34 8.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.984 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.62 -33.2 15.95 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.139 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.469 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.3 ttmt -159.24 163.32 35.97 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -124.88 142.97 51.09 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.21 169.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -71.57 151.9 43.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.82 0.736 . . . . 0.0 109.199 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.11 104.57 0.49 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.9 115.05 3.13 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.69 0.796 . . . . 0.0 111.616 -173.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -159.05 53.2 0.38 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.24 127.75 33.87 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.3 41.74 7.3 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.89 42.47 0.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -158.23 -90.58 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.78 -39.35 6.23 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.41 -2.462 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 170.107 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.14 -141.51 4.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.619 0.566 . . . . 0.0 114.448 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -78.18 141.05 38.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.562 0.696 . . . . 0.0 111.213 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 28.5 m-80 -135.32 33.71 3.05 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 10.3 ptpp? -53.97 99.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.924 -173.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.05 125.07 40.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.951 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -90.82 170.41 10.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -36.93 115.93 0.32 Allowed Glycine 0 C--N 1.364 2.124 0 O-C-N 124.28 0.988 . . . . 0.0 114.108 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.0 tp -140.22 162.1 36.07 Favored 'General case' 0 N--CA 1.407 -2.593 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -139.04 21.88 2.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.163 0.982 . . . . 0.0 109.234 -173.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 55.4 mtt180 -125.75 110.36 13.65 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.2 -49.14 45.0 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 124.753 1.168 . . . . 0.0 114.826 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.428 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.9 mp0 -81.06 -19.96 42.64 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.478 0.656 . . . . 0.0 110.848 -174.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 43.6 t0 -80.86 -36.69 31.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.47 71.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.654 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.65 -22.69 64.12 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.79 -31.95 41.28 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.85 0.46 . . . . 0.0 111.853 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -78.13 -30.95 49.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.925 0.869 . . . . 0.0 110.62 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -30.69 33.81 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.1 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.02 -26.8 67.87 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.119 0.968 . . . . 0.0 109.296 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 -20.67 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.076 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.94 37.09 0.45 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.21 35.92 21.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.305 1.042 . . . . 0.0 110.768 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 -68.48 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.922 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.459 ' OH ' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -176.71 161.74 2.11 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 123.668 0.605 . . . . 0.0 109.78 -176.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.81 152.42 19.34 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.81 80.95 0.35 Allowed Glycine 0 CA--C 1.491 -1.407 0 C-N-CA 119.386 -1.388 . . . . 0.0 112.412 -172.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.75 152.12 40.93 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.173 -0.514 . . . . 0.0 109.943 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.4 pt -114.0 155.45 15.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -81.22 86.65 6.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.787 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -121.0 123.76 70.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.29 103.84 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.714 1.206 . . . . 0.0 114.206 -174.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p 61.93 21.84 12.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 115.077 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 38.1 p -86.09 135.89 36.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.884 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.87 21.17 0.74 Allowed 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.731 2.287 . . . . 0.0 112.524 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 34' ' ' SER . 28.3 mmm180 -125.12 -11.8 6.99 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 176.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.449 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 72.4 m -153.82 117.13 4.58 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.36 137.16 32.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 122.15 0.976 . . . . 0.0 110.945 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.33 171.78 7.14 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.244 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' A' ' 73' ' ' LEU . 7.7 p -43.85 -33.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.382 1.473 . . . . 0.0 113.405 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.55 -56.98 7.35 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.164 0.507 . . . . 0.0 111.08 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.459 ' O ' HG22 ' A' ' 46' ' ' VAL . 34.9 mt-30 -69.77 -37.09 76.26 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.05 0.452 . . . . 0.0 110.296 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.49 -20.85 65.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.6 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 44' ' ' GLN . 2.7 tp-100 -69.48 -23.78 63.68 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.47 -43.99 12.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.077 0.941 . . . . 0.0 108.664 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 42' ' ' GLN . 20.4 t -65.05 -33.42 63.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.05 -176.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.428 ' N ' ' HH ' ' A' ' 54' ' ' TYR . 4.6 ppp? -66.93 -17.8 65.08 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.084 0.469 . . . . 0.0 111.535 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.85 -25.38 21.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.781 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.47 -39.69 18.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.965 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 103.76 9.22 Favored Pre-proline 0 N--CA 1.398 -3.03 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.42 45.08 0.96 Allowed 'Trans proline' 0 CA--C 1.552 1.387 0 C-N-CA 123.298 2.666 . . . . 0.0 113.255 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -88.53 -179.62 6.1 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.694 0.797 . . . . 0.0 111.842 -178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -82.76 145.4 29.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.553 0.741 . . . . 0.0 110.936 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.428 ' HH ' ' N ' ' A' ' 47' ' ' MET . 74.8 m-85 -117.17 146.26 43.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.458 0.647 . . . . 0.0 110.252 176.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 p -133.24 145.52 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -124.03 140.2 12.56 Favored Glycine 0 C--O 1.196 -2.241 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.006 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.2 t -128.26 122.46 58.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -169.36 156.07 6.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -90.64 93.33 9.22 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.99 0.9 . . . . 0.0 109.694 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -102.15 118.49 37.0 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -87.71 -28.19 21.93 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.579 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.59 122.49 40.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.09 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' ' 67' ' ' VAL . 10.3 tt -64.2 -35.29 73.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.438 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.18 -17.54 61.36 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.486 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.32 -29.5 31.03 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.43 -47.63 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 63' ' ' ILE . 55.5 t -60.53 -37.2 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.879 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.625 ' O ' HG21 ' A' ' 72' ' ' VAL . 18.4 t70 -52.92 -61.33 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.472 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.48 -42.06 92.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.891 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -57.8 -38.92 76.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 124.288 0.992 . . . . 0.0 111.606 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.31 -53.11 5.98 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 123.224 0.328 . . . . 0.0 111.513 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.625 HG21 ' O ' ' A' ' 68' ' ' ASP . 50.0 t -55.08 -56.04 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HB2' HG21 ' A' ' 40' ' ' VAL . 40.6 tp -79.94 -21.87 43.33 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.3 m 63.23 79.38 0.26 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 122.213 1.006 . . . . 0.0 110.336 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.12 -179.03 6.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.007 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.6 -39.32 2.31 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.52 160.64 40.78 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.273 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.78 136.69 35.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.88 111.62 24.04 Favored 'General case' 0 N--CA 1.391 -3.418 0 C-N-CA 123.257 0.623 . . . . 0.0 109.446 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.99 154.51 19.16 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.205 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -93.47 96.38 9.86 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 172.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.479 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -72.64 -12.32 77.74 Favored Glycine 0 C--N 1.306 -1.107 0 CA-C-N 114.225 -1.352 . . . . 0.0 114.845 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -49.6 -25.83 3.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.584 1.154 . . . . 0.0 111.932 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -52.33 -45.56 65.69 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.544 0.738 . . . . 0.0 112.444 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.53 149.03 0.96 Allowed 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -77.56 -43.64 31.17 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.19 0.995 . . . . 0.0 110.416 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.18 -13.65 60.18 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.605 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.6 t80 -62.64 -41.13 98.87 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.385 174.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.479 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -61.35 -40.97 88.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.96 -19.17 65.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.836 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.4 m -83.04 -42.69 17.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 63' ' ' ILE . 4.1 mm? -53.44 -44.01 68.51 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.453 0.701 . . . . 0.0 111.216 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -43.59 -37.5 2.56 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.245 1.418 . . . . 0.0 111.866 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.95 -45.54 18.33 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.024 -173.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.0 -18.31 47.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.61 0.719 . . . . 0.0 112.379 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -99.9 134.7 20.78 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.446 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.18 165.42 31.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.391 2.06 . . . . 0.0 109.668 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.05 -11.3 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.239 0.543 . . . . 0.0 111.255 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.49 -29.41 62.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.872 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.75 127.56 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -105.91 167.4 9.81 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.445 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 93.6 mt -125.27 129.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.612 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.6 m0 -120.65 152.7 37.85 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.869 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.23 124.74 50.06 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.37 98.15 1.05 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt -86.28 113.87 22.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.167 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.3 t -73.21 132.82 43.64 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.3 m -36.69 121.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 O-C-N 124.647 1.217 . . . . 0.0 113.455 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.68 64.43 3.61 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.756 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -92.02 -66.45 0.92 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 t -104.08 -24.32 13.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.176 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -89.47 157.82 46.66 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.54 156.34 21.67 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.484 2.122 . . . . 0.0 111.492 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.34 -37.72 19.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.554 0.692 . . . . 0.0 109.218 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.28 124.36 45.65 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -136.3 -62.3 0.67 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.16 117.12 33.82 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.045 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -78.43 166.16 22.94 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.768 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 m170 75.57 8.5 3.76 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.896 0.878 . . . . 0.0 112.47 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.57 143.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.08 -43.14 65.32 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.88 -173.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 39.4 ttmt -159.11 164.34 35.39 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -118.3 157.83 26.33 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.54 171.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -76.14 143.46 41.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.03 112.56 17.44 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -110.58 19.26 18.89 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.362 0.601 . . . . 0.0 110.344 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.61 -5.28 51.66 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -62.26 141.68 58.12 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 123.098 0.559 . . . . 0.0 111.509 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.93 -32.5 0.5 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 115.62 160.55 12.57 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.43 105.36 17.55 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.42 105.7 1.65 Allowed Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.35 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.524 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 C--O 1.237 0.438 0 CA-C-O 120.445 0.164 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.07 -54.04 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -47.21 121.58 3.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.412 1.085 . . . . 0.0 111.148 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -146.04 43.19 1.23 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -46.34 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.03 121.57 23.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.446 0.641 . . . . 0.0 111.497 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.7 p -101.33 168.35 9.6 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 9' ' ' LEU . . . -2.65 -110.9 0.0 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 125.178 1.371 . . . . 0.0 116.149 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' GLY . 54.4 tp 77.49 165.09 0.23 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.518 0.775 . . . . 0.0 111.229 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -138.07 -14.5 1.36 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.972 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.55 112.24 24.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.732 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.597 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -50.34 -41.4 40.03 Favored Glycine 0 C--O 1.209 -1.462 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.719 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.696 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -57.88 -39.94 79.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.513 1.125 . . . . 0.0 108.916 -178.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -79.2 -30.71 43.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.325 -173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.35 63.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.808 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 9.5 mtmp? -61.02 -24.85 66.49 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.293 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -32.43 74.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.621 0.368 . . . . 0.0 111.507 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.97 72.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.648 1.213 . . . . 0.0 109.722 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -30.29 44.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.063 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.67 -23.1 66.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.375 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.09 65.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.971 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.26 13.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 114.449 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.27 26.48 13.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.852 0.861 . . . . 0.0 110.867 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.93 -67.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.341 -174.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -176.23 155.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -174.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.412 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.24 143.59 14.61 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.01 82.89 0.34 Allowed Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.036 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.64 141.93 48.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 120.847 0.356 . . . . 0.0 110.165 -178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.439 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -108.02 151.6 10.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -81.83 79.82 8.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.833 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HB ' ' OG ' ' A' ' 34' ' ' SER . 61.3 t -112.17 129.57 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.81 106.75 0.28 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p 65.38 16.72 10.68 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.958 1.703 . . . . 0.0 114.889 172.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.574 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 22.7 p -83.16 124.43 76.3 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.839 -0.538 . . . . 0.0 110.332 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -9.27 18.78 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.062 1.841 . . . . 0.0 114.886 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -112.74 12.65 19.67 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.485 -0.76 . . . . 0.0 111.662 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.574 ' HB2' ' OG ' ' A' ' 34' ' ' SER . 85.8 m -152.58 118.09 5.31 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.37 138.37 26.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.2 1.0 . . . . 0.0 112.606 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -104.31 168.68 8.94 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.769 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.2 p -53.38 -30.01 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 124.063 0.852 . . . . 0.0 112.03 -171.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.443 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 54.6 mp0 -61.88 -55.64 27.58 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 124.541 1.137 . . . . 0.0 112.1 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.642 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 31.2 mt-30 -70.39 -38.22 74.64 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 121.464 0.65 . . . . 0.0 109.925 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -61.04 -27.16 68.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.501 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.459 HE21 ' HB2' ' A' ' 44' ' ' GLN . 2.3 tp-100 -61.42 -36.36 80.1 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.64 0.776 . . . . 0.0 112.101 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.642 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 13.1 pt-20 -86.07 -43.15 13.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.552 1.168 . . . . 0.0 109.011 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 6.9 t -55.22 -32.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.205 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 14.3 ptp -62.99 -31.42 72.54 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.37 0.605 . . . . 0.0 110.721 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.37 58.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.009 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.27 -48.1 7.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.74 99.58 15.32 Favored Pre-proline 0 N--CA 1.391 -3.394 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.23 55.49 3.54 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.811 2.34 . . . . 0.0 111.711 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 pp -96.23 171.29 8.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.35 176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -72.29 142.9 48.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.263 0.225 . . . . 0.0 110.453 178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -115.11 139.89 49.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.3 p -129.41 146.89 33.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.64 129.66 6.95 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.842 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.6 t -114.37 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -148.81 152.98 37.46 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 29.0 ptt180 -86.29 93.74 9.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.463 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 4.7 m-20 -67.28 116.09 7.67 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 122.865 1.317 . . . . 0.0 112.124 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -108.19 -72.71 0.71 Allowed 'General case' 0 C--N 1.255 -3.515 0 CA-C-N 112.552 -2.113 . . . . 0.0 108.814 171.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.11 108.94 12.97 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.849 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.513 ' O ' HG21 ' A' ' 67' ' ' VAL . 16.5 tt -62.37 -34.71 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.038 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.71 -22.86 63.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.104 0.478 . . . . 0.0 110.7 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 12.7 t70 -85.67 -33.74 21.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.225 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.06 -32.4 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.046 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 63' ' ' ILE . 89.8 t -64.99 -33.52 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.612 ' O ' HG22 ' A' ' 72' ' ' VAL . 11.2 t70 -56.89 -57.99 10.1 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.73 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -60.75 -40.84 93.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -58.16 -39.02 77.74 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.755 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' A' ' 71' ' ' LYS . 4.7 ttmp? -83.83 -53.58 5.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.616 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 68' ' ' ASP . 44.7 t -56.63 -56.55 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.232 0.613 . . . . 0.0 111.754 -174.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.424 ' HB2' HG23 ' A' ' 40' ' ' VAL . 51.4 tp -80.41 -13.91 58.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.099 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 18.8 p 55.54 77.42 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.378 1.071 . . . . 0.0 112.272 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.6 mt -74.77 175.08 8.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.867 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -122.79 -35.88 2.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.126 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.88 157.76 44.04 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -140.13 141.12 34.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.533 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -99.97 128.08 46.1 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.349 0.595 . . . . 0.0 112.053 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -98.25 122.42 41.39 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.389 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -84.52 98.9 10.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 117' ' ' PHE . . . -62.63 -12.86 42.85 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.591 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.47 -33.19 1.62 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.172 1.389 . . . . 0.0 113.127 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 13.0 mm-40 -66.07 -48.24 71.66 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -179.61 149.89 0.39 Allowed 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.75 -44.86 26.37 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 112.45 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.65 -20.38 43.21 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.746 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.576 ' O ' ' HB ' ' A' ' 91' ' ' THR . 42.9 t80 -58.49 -36.05 73.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.931 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.502 HD12 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -61.17 -37.8 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.609 0.719 . . . . 0.0 109.137 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.61 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 14.7 t70 -70.07 -21.01 63.2 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.088 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.576 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.1 m -78.54 -42.44 29.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.514 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.462 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -48.51 -49.13 37.27 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.559 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.61 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.08 -33.09 37.73 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.229 0.538 . . . . 0.0 112.361 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -73.16 -42.59 62.61 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.105 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.95 25.87 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.86 135.64 42.5 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.698 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 165.13 33.63 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 121.972 1.781 . . . . 0.0 110.599 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.64 -15.85 54.01 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.034 0.934 . . . . 0.0 112.152 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.12 -30.12 66.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 70' ' ' ALA . 59.2 t -107.33 129.5 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.235 0 CA-C-O 121.376 0.608 . . . . 0.0 110.629 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.71 170.83 8.29 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.6 mt -125.77 129.73 72.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.588 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.1 m0 -118.9 157.98 26.6 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.689 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -100.94 123.39 45.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.31 116.96 10.35 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -89.23 95.58 10.36 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.529 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 50.2 m -67.7 150.81 48.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.431 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.82 115.29 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-O 122.563 1.173 . . . . 0.0 110.72 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.32 93.06 0.09 OUTLIER Glycine 0 N--CA 1.415 -2.712 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -72.28 -12.55 61.2 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -170.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.1 m -102.22 8.54 40.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.129 0.966 . . . . 0.0 109.52 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.54 149.39 39.3 Favored Pre-proline 0 C--O 1.25 1.114 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.39 148.36 54.53 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.803 1.669 . . . . 0.0 110.798 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.37 -28.04 66.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.364 0.602 . . . . 0.0 110.115 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -112.55 127.25 56.02 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -131.46 -58.29 0.99 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 82' ' ' GLY . 79.5 m-85 -99.37 111.94 24.22 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.3 164.36 26.79 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.668 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.54 ' HB2' ' NH2' ' A' ' 93' ' ' ARG . 23.3 m170 71.54 7.18 5.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.696 1.599 . . . . 0.0 112.201 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.64 152.1 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -81.4 -41.6 21.67 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 120.998 0.428 . . . . 0.0 111.349 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.0 mttt -145.78 163.03 36.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.301 0.64 . . . . 0.0 109.676 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -116.83 139.6 50.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.44 166.87 20.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.57 163.07 28.43 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.519 0.676 . . . . 0.0 111.72 -176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.529 ' HB2' ' HA ' ' A' ' 107' ' ' SER . 12.1 t70 -68.91 97.21 0.82 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.396 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -82.93 -47.35 11.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.65 -155.98 46.99 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.955 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 168.31 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.091 2.156 . . . . 0.0 105.883 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.24 49.11 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -90.29 -143.26 10.46 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.369 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -111.79 108.02 17.28 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.481 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.7 162.81 34.82 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.763 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.28 73.46 0.46 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -70.64 121.78 18.55 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.728 0.775 . . . . 0.0 111.612 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 15.0 p-10 -125.81 28.28 6.2 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 173.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -57.08 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.502 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -95.37 124.26 47.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.493 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.0 m -92.0 170.52 9.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.93 135.42 8.86 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 119.046 0.839 . . . . 0.0 115.06 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.406 HD11 ' H ' ' A' ' 10' ' ' THR . 0.2 OUTLIER -150.07 153.12 35.92 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.406 ' H ' HD11 ' A' ' 9' ' ' LEU . 8.6 t -118.51 8.03 11.97 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.641 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.7 mtm180 -117.73 114.64 23.63 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.118 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.24 -39.44 71.4 Favored Glycine 0 C--O 1.216 -1.024 0 O-C-N 123.626 0.578 . . . . 0.0 113.639 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.647 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -66.2 -26.09 67.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 122.005 0.907 . . . . 0.0 109.264 -177.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -89.57 -51.96 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.493 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.13 69.53 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -22.39 62.49 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.374 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.07 -30.78 27.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.971 0.508 . . . . 0.0 111.451 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 -43.28 64.77 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.542 0.687 . . . . 0.0 109.824 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -34.03 73.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.71 -23.46 66.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 125.172 1.389 . . . . 0.0 110.018 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.89 -13.94 59.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.94 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.53 10.4 0.27 Allowed Glycine 0 C--O 1.225 -0.458 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.535 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.2 19.37 8.74 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.491 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 37.8 mt -57.86 -67.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.16 -171.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.01 157.69 2.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.523 ' O ' HG11 ' A' ' 55' ' ' VAL . . . -132.05 140.9 12.2 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.46 91.08 0.51 Allowed Glycine 0 CA--C 1.471 -2.673 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 155.88 34.73 Favored 'General case' 0 N--CA 1.401 -2.921 0 CA-C-N 114.567 -0.816 . . . . 0.0 109.182 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.579 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 3.5 pt -116.95 151.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.485 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 49.7 m-85 -84.19 79.02 9.67 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.427 1.079 . . . . 0.0 109.796 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.8 t -109.8 119.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.58 103.84 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.829 1.331 . . . . 0.0 113.483 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.6 p 59.39 29.28 18.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.638 1.575 . . . . 0.0 113.491 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -107.26 104.11 51.02 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.07 3.93 0.66 Allowed 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.776 2.984 . . . . 0.0 115.029 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -84.43 -10.64 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 46.6 m -138.4 172.13 13.35 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' CG1' ' HB3' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.89 136.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.57 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -106.7 164.09 12.38 Favored 'General case' 0 CA--C 1.465 -2.327 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.742 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG22 HD22 ' A' ' 73' ' ' LEU . 11.4 p -45.58 -35.44 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 124.806 1.316 . . . . 0.0 112.049 -174.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.97 -38.81 86.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' O ' HG21 ' A' ' 46' ' ' VAL . 32.9 mt-30 -80.79 -34.94 33.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.339 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . . . -62.38 -32.81 73.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.023 -175.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -62.98 -31.08 72.12 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.2 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.96 -47.3 59.73 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.116 0.96 . . . . 0.0 108.641 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 42' ' ' GLN . 40.9 t -65.0 -30.5 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.819 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 24.6 ptt? -67.08 -17.6 64.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.304 0.574 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.87 25.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.996 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.55 -43.33 6.9 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.298 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.52 93.76 39.74 Favored Pre-proline 0 N--CA 1.386 -3.628 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.75 57.06 3.02 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.455 2.104 . . . . 0.0 111.968 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.71 179.26 5.04 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.471 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 5.4 tt0 -82.94 143.27 30.81 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.541 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 20.6 m-85 -113.65 138.08 50.69 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 26' ' ' GLY . 12.8 p -132.41 139.86 49.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.485 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -125.18 141.13 12.82 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.541 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.579 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 29.2 t -124.43 134.82 65.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -167.09 159.64 13.25 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.661 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -85.93 93.59 8.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -87.99 125.67 34.66 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.834 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -94.94 -58.0 2.28 Favored 'General case' 1 C--N 1.241 -4.111 0 CA-C-N 112.775 -2.011 . . . . 0.0 108.96 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.87 123.37 43.08 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.559 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.452 HG13 HD13 ' A' ' 92' ' ' LEU . 17.4 tt -64.23 -29.74 48.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.33 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.17 -13.82 58.95 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.078 0.466 . . . . 0.0 110.315 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 14.0 t70 -86.25 -39.25 16.75 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.816 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -77.82 -37.63 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.293 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.13 -32.0 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.3 t70 -54.8 -55.64 27.93 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.472 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 43.2 mmtm -63.59 -41.56 98.33 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -56.98 -38.92 73.7 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.316 1.01 . . . . 0.0 110.996 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -81.96 -52.88 6.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.354 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 68' ' ' ASP . 77.5 t -56.1 -54.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 HD22 HG22 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -82.9 -11.47 58.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.41 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t 61.97 74.67 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.683 0.754 . . . . 0.0 109.498 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.5 mt -82.74 179.91 7.63 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.439 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.74 -32.96 2.31 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -148.7 160.53 43.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.3 171.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 6.2 p -150.0 141.02 16.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.662 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.82 111.36 23.68 Favored 'General case' 0 N--CA 1.385 -3.691 0 CA-C-O 121.824 0.821 . . . . 0.0 109.353 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.486 HD11 ' HG ' ' A' ' 92' ' ' LEU . 36.3 mt -115.72 89.17 3.04 Favored 'General case' 0 CA--C 1.422 -3.945 0 N-CA-C 101.369 -3.567 . . . . 0.0 101.369 -169.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -98.04 174.37 6.58 Favored 'General case' 1 N--CA 1.362 -4.859 0 C-N-CA 117.873 -1.531 . . . . 0.0 113.299 -167.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -48.96 -10.51 0.14 Allowed Glycine 1 C--N 1.243 -4.584 0 CA-C-N 110.863 -2.881 . . . . 0.0 117.468 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -44.72 -44.73 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -49.72 6.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.956 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.475 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 1.1 tm-20 178.94 170.33 0.89 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -77.88 -49.85 13.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.519 1.152 . . . . 0.0 109.389 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 37.1 mt -72.97 -13.6 61.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.99 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.556 ' CZ ' HD22 ' A' ' 92' ' ' LEU . 25.4 t80 -60.34 -48.99 79.36 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.418 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.9 mp -59.75 -36.69 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.682 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 24.4 t70 -60.08 -27.1 66.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.636 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.9 m -88.15 -43.68 11.47 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 124.708 1.203 . . . . 0.0 110.141 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.556 HD22 ' CZ ' ' A' ' 88' ' ' TYR . 4.1 mm? -43.93 -44.0 6.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.682 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 1.7 mpt_? -56.55 -29.74 62.31 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.271 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -77.95 -35.13 50.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.382 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.81 0.86 50.01 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.433 0.635 . . . . 0.0 110.806 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 27.2 tp -75.79 124.49 88.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 124.053 0.941 . . . . 0.0 109.479 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.01 161.57 44.41 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.078 1.852 . . . . 0.0 110.988 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.22 70.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 124.464 1.106 . . . . 0.0 113.354 -172.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -88.86 -10.9 46.31 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.442 HG21 ' HB1' ' A' ' 70' ' ' ALA . 65.6 t -107.68 140.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.86 172.67 6.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.404 HG12 HD12 ' A' ' 80' ' ' LEU . 53.8 mt -116.41 131.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.662 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 40.8 m0 -121.02 159.17 26.19 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.393 171.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.4 ' HB2' HG11 ' A' ' 120' ' ' VAL . 40.0 ttpt -100.73 115.18 29.66 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 107.63 5.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp -78.48 95.38 5.13 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -76.09 108.37 8.95 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.1 m -65.23 141.32 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.286 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.68 -161.87 11.96 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.56 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.15 -26.61 56.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 t -133.2 120.97 21.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.127 0.489 . . . . 0.0 110.072 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.17 96.68 13.78 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.51 154.51 21.07 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.894 2.396 . . . . 0.0 112.867 -175.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.69 -39.93 14.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.115 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -122.88 118.77 28.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -161.59 -58.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -124.86 94.04 4.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -115.01 -178.64 3.41 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.625 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t60 65.44 28.42 11.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.221 1.408 . . . . 0.0 108.505 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 104' ' ' LYS . 27.3 m -87.26 149.99 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.77 -41.29 45.28 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.402 0.62 . . . . 0.0 111.058 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.496 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 45.2 mmtm -143.78 162.32 36.32 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -127.13 138.68 53.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.96 171.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.35 140.11 50.09 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.411 0.445 . . . . 0.0 110.602 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.41 124.94 20.68 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.164 0.986 . . . . 0.0 110.724 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -109.71 0.79 19.1 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.118 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.76 -47.0 88.02 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -132.47 -83.72 0.48 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.93 -107.65 0.22 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.403 1.064 . . . . 0.0 113.735 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.12 -94.33 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.5 -171.8 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.989 0.916 . . . . 0.0 112.902 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.06 -75.96 2.27 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.063 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 123.372 0.669 . . . . 0.0 110.109 -178.394 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.78 42.5 25.71 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.392 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.47 -162.72 1.06 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.635 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -166.92 46.95 0.06 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -172.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.18 98.06 0.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.935 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.12 124.7 53.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.736 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.1 p -91.99 169.8 10.36 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 37' ' ' CYS . . . -46.76 126.7 10.07 Favored Glycine 0 CA--C 1.493 -1.299 0 O-C-N 123.64 0.588 . . . . 0.0 113.771 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.3 tp -143.06 161.0 39.32 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -134.35 -18.9 1.95 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.683 0.754 . . . . 0.0 109.948 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.73 105.69 9.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.937 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 16' ' ' LYS . . . -48.37 -44.85 28.44 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 124.64 1.114 . . . . 0.0 114.224 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.7 mp0 -76.18 -22.27 55.53 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.335 0.588 . . . . 0.0 110.856 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.52 -30.46 23.41 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.15 48.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 17.5 ptpt -64.69 -22.51 67.0 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 -37.71 78.89 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.801 0.334 . . . . 0.0 110.567 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.98 -38.01 66.81 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 110.181 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.401 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.72 -34.61 77.2 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.9 -31.29 72.42 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.486 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.28 64.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.069 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.32 -21.7 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.467 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.93 27.04 16.41 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.985 0.898 . . . . 0.0 109.019 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.535 ' HB ' HD22 ' A' ' 4' ' ' ASN . 28.5 mt -69.92 -59.64 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.909 -171.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -178.36 161.92 1.45 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 145.72 16.28 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.35 73.99 0.21 Allowed Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.482 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 154.94 26.55 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-O 121.172 0.511 . . . . 0.0 110.264 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.566 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 5.7 pt -116.78 152.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -79.57 79.43 6.04 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 124.741 1.275 . . . . 0.0 111.239 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.25 116.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 115.09 2.75 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.777 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.4 p 66.02 14.67 9.73 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.086 1.754 . . . . 0.0 115.126 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 36' ' ' ARG . 50.8 m -93.58 114.67 63.58 Favored Pre-proline 0 C--O 1.197 -1.696 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.35 26.48 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 124.28 3.32 . . . . 0.0 115.285 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.553 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 20.4 ptt180 -124.92 -5.15 7.46 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' SG ' ' HG3' ' A' ' 36' ' ' ARG . 60.8 m -136.65 166.75 22.83 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.43 HG22 ' CB ' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -143.94 136.4 23.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.559 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -102.46 170.52 8.0 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.685 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.498 HG22 ' HB2' ' A' ' 73' ' ' LEU . 5.9 p -56.41 -31.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 123.809 0.693 . . . . 0.0 111.1 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 4.3 mp0 -70.88 -46.87 61.84 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 124.149 0.979 . . . . 0.0 111.505 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.545 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 49.7 mm-40 -61.76 -49.31 76.92 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.52 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -63.89 -21.47 66.48 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.287 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 47' ' ' MET . 3.8 tp-100 -63.99 -39.32 93.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.527 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.8 pt-20 -85.93 -45.41 11.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.754 0.788 . . . . 0.0 110.427 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 95.4 t -48.97 -35.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 125.307 1.443 . . . . 0.0 112.249 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 16.5 ptp -64.22 -20.56 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 120.823 0.344 . . . . 0.0 111.493 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.37 -28.74 28.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.34 -45.5 13.68 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.75 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -133.66 98.12 15.16 Favored Pre-proline 0 N--CA 1.397 -3.119 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.69 46.73 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.88 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.33 152.28 24.21 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.686 177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' OE1' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.7 140.41 49.7 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.411 0.625 . . . . 0.0 112.428 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.04 143.73 39.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -113.46 128.78 8.5 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.782 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.566 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 21.2 t -113.74 106.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.57 146.59 15.09 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.471 -173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.0 mtm180 -93.11 93.37 8.26 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 15.4 m120 -90.25 154.91 19.38 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 122.656 1.217 . . . . 0.0 110.526 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.5 ' CD2' ' H ' ' A' ' 62' ' ' ASP . 16.1 p-80 -100.89 -73.43 0.64 Allowed 'General case' 0 C--N 1.245 -3.953 0 CA-C-N 111.445 -2.616 . . . . 0.0 112.17 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' H ' ' CD2' ' A' ' 61' ' ' HIS . 45.0 t0 -81.77 131.91 35.27 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.486 HG13 HD13 ' A' ' 92' ' ' LEU . 5.9 tt -60.02 -32.68 50.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.041 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.61 -18.76 61.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.326 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.6 -35.21 53.11 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.436 0.636 . . . . 0.0 109.288 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.52 -44.05 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 63' ' ' ILE . 95.7 t -60.55 -39.28 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.577 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 72' ' ' VAL . 15.3 t70 -57.1 -61.79 2.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.172 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -63.72 -39.7 94.93 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 -176.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.36 -35.02 76.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.812 0.695 . . . . 0.0 111.417 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -82.37 -56.54 3.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -53.32 -56.47 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.352 0.661 . . . . 0.0 111.628 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 40' ' ' VAL . 45.4 tp -82.78 -17.31 44.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.488 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 39.9 m 60.59 80.55 0.21 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.226 1.012 . . . . 0.0 111.182 -176.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.46 -175.06 5.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.578 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.423 ' HB1' ' OE1' ' A' ' 53' ' ' GLN . . . -127.97 -36.79 1.96 Allowed 'General case' 0 C--O 1.193 -1.912 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -146.0 159.27 43.49 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.36 0.6 . . . . 0.0 111.534 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.479 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.4 p -140.58 138.64 35.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 13.2 mm-40 -98.46 105.59 17.75 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 123.459 0.703 . . . . 0.0 109.393 -175.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.502 ' CD1' ' HG ' ' A' ' 92' ' ' LEU . 75.2 mt -116.13 139.52 50.23 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.941 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 p80 175.54 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.121 0.888 . . . . 0.0 110.165 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -74.71 -55.39 5.44 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 120.434 2.933 . . . . 0.0 120.434 -166.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 60' ' ' ASN . 2.8 t-20 -82.79 -69.1 0.65 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.97 -48.93 12.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -168.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -177.89 172.0 1.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.248 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 21.6 mt-30 -78.44 -43.98 25.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 125.242 1.417 . . . . 0.0 107.235 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 54.7 mt -71.42 -14.39 62.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.326 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.596 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 22.9 t80 -65.38 -40.25 93.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.982 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.424 ' HA ' HD22 ' A' ' 92' ' ' LEU . 1.7 mp -63.0 -30.38 49.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.628 0.728 . . . . 0.0 110.015 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.67 ' HA ' ' NH1' ' A' ' 93' ' ' ARG . 23.9 t70 -67.54 -22.64 65.4 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 85.9 m -89.63 -44.92 9.72 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.305 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 88' ' ' TYR . 3.2 mm? -47.89 -46.37 31.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.67 ' NH1' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.02 -24.33 64.42 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.069 -173.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.04 -34.43 38.28 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.988 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.96 -22.17 22.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.854 0.835 . . . . 0.0 111.409 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -88.09 140.13 30.74 Favored Pre-proline 0 C--N 1.276 -2.614 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.707 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.43 164.91 34.14 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 121.134 1.223 . . . . 0.0 109.018 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.1 3.95 6.28 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.496 0.665 . . . . 0.0 111.638 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -86.07 -24.85 26.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.1 t -105.09 131.88 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.54 171.36 7.91 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 65.1 mt -124.52 133.42 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.6 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.9 m0 -121.05 155.37 34.54 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.162 -1.415 . . . . 0.0 109.622 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -102.39 123.28 45.89 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 115.21 8.87 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 170.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.73 108.79 21.13 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -73.03 135.46 44.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.54 154.9 7.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.62 -168.0 33.19 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.805 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -98.64 -36.81 9.75 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 123.525 0.73 . . . . 0.0 110.023 -178.154 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 p -82.42 94.88 7.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.516 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.75 140.08 40.73 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.345 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 144.47 68.43 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.491 2.128 . . . . 0.0 112.231 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.95 -45.67 12.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 179.52 118.73 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.531 1.132 . . . . 0.0 107.998 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 3.0 mm-40 -133.71 -60.65 0.82 Allowed 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 33.3 m-85 -111.03 106.63 15.77 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -110.12 157.16 19.67 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.4 m80 69.05 33.77 3.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 111.818 -2.446 . . . . 0.0 111.113 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.49 142.06 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.73 -43.09 66.46 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.379 0.609 . . . . 0.0 111.153 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.2 mttm -145.14 163.18 35.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -124.68 143.39 50.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.56 174.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.42 144.77 39.78 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.932 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.88 135.06 47.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.255 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.72 -34.67 77.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.13 -64.13 2.49 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -114.02 87.83 2.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -131.11 -27.43 0.7 Allowed Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.936 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 -69.68 0.51 Allowed Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -156.8 -28.1 0.09 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.255 0.55 . . . . 0.0 109.776 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.84 43.37 18.02 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 C--O 1.239 0.546 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.9 59.11 0.37 Allowed Glycine 0 CA--C 1.498 -1.021 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 67.74 156.32 0.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.29 1.436 . . . . 0.0 110.917 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.605 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.2 p-10 -115.13 25.37 10.93 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 21.3 pttp -67.89 91.99 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.11 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.36 125.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.169 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.0 m -91.38 169.26 10.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 37' ' ' CYS . . . -19.53 105.85 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 O-C-N 124.919 1.387 . . . . 0.0 116.037 -169.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.22 135.86 18.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 9.45 2.7 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.912 0.863 . . . . 0.0 110.123 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -86.41 112.52 21.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.34 -53.5 5.8 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.419 1.009 . . . . 0.0 114.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.23 -19.91 60.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.799 0.839 . . . . 0.0 111.871 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.73 -36.51 17.31 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.73 -47.96 67.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.805 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -63.35 -23.45 67.42 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.828 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.3 69.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.229 0.537 . . . . 0.0 110.805 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.06 -37.41 58.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.442 ' CB ' HD22 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -72.13 -33.33 67.71 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.296 0.57 . . . . 0.0 109.926 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.92 -25.69 67.26 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.19 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.66 -24.09 56.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.905 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.63 1.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 119.103 -1.522 . . . . 0.0 113.884 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.08 11.72 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.768 0.827 . . . . 0.0 111.463 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.605 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 23.1 mt -63.57 -69.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.845 -172.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -177.82 156.26 1.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -176.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -121.7 146.68 17.17 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.67 72.08 0.21 Allowed Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.249 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.462 HD11 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.47 144.36 39.39 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 121.216 0.532 . . . . 0.0 109.6 -179.296 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.632 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 31.3 mt -117.62 157.04 19.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.755 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.628 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.526 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 24.3 m-85 -83.59 56.14 3.49 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.677 0.672 . . . . 0.0 111.137 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.16 120.33 33.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -44.0 96.74 0.01 OUTLIER 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.083 1.489 . . . . 0.0 113.892 -172.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 p 55.85 23.78 6.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.577 1.551 . . . . 0.0 114.368 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -100.53 109.98 58.93 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.96 2.33 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.902 3.068 . . . . 0.0 115.079 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.4 ptm85 -74.19 -19.66 60.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.632 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -142.87 174.56 10.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.48 136.72 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 119.331 0.969 . . . . 0.0 110.292 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -101.15 167.45 10.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.001 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG22 ' HB2' ' A' ' 73' ' ' LEU . 7.3 p -51.57 -29.6 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.209 0.943 . . . . 0.0 112.996 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -65.96 -50.13 65.44 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.005 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 46' ' ' VAL . 32.7 mt-30 -73.03 -40.04 65.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.231 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.92 64.6 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.834 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -37.68 70.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.076 0.95 . . . . 0.0 109.402 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.37 -43.19 17.71 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.032 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 42' ' ' GLN . 12.0 t -65.28 -39.07 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.928 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.404 ' SD ' HD11 ' A' ' 73' ' ' LEU . 27.6 ptt? -62.2 -24.02 66.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.445 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.86 -25.8 29.98 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.209 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.61 -42.51 14.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.126 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.23 99.93 19.08 Favored Pre-proline 0 N--CA 1.39 -3.472 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.47 50.04 2.23 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' A' ' 19' ' ' TYR . 1.4 pp -91.98 174.76 7.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.616 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.418 ' HG2' ' CB ' ' A' ' 76' ' ' ALA . 17.8 mt-30 -71.33 127.87 34.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.701 0.286 . . . . 0.0 111.446 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' OH ' HG13 ' A' ' 46' ' ' VAL . 45.1 m-85 -100.93 141.52 33.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.405 HG11 ' O ' ' A' ' 26' ' ' GLY . 6.2 p -127.03 158.73 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.51 135.25 7.47 Favored Glycine 0 CA--C 1.462 -3.228 0 C-N-CA 119.26 -1.448 . . . . 0.0 112.617 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 29' ' ' ILE . 44.4 t -115.26 142.59 27.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 28.2 t80 -172.06 157.05 4.22 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.982 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -85.98 93.2 8.9 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 58' ' ' PHE . 50.0 m-80 -89.53 118.1 28.92 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -92.17 -59.47 2.09 Favored 'General case' 1 C--N 1.237 -4.311 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.573 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.88 125.39 38.48 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.001 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 67' ' ' VAL . 15.6 tt -65.65 -29.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.258 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -19.32 59.06 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.812 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.05 -26.05 39.87 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.804 0.812 . . . . 0.0 108.875 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.06 -44.73 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 63' ' ' ILE . 70.0 t -60.3 -36.77 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.3 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.8 t70 -54.86 -58.31 8.1 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.373 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -65.74 -40.91 92.6 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.63 -29.42 70.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.778 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -84.15 -59.96 2.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.954 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 68' ' ' ASP . 52.2 t -50.55 -59.83 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.502 0.721 . . . . 0.0 111.909 -176.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.466 ' HB2' HG22 ' A' ' 40' ' ' VAL . 33.3 tp -78.3 -21.26 49.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.587 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.6 m 59.56 73.65 0.47 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.006 0.908 . . . . 0.0 109.835 -173.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.2 mt -72.13 -179.14 2.69 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.835 -178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' CB ' ' HG2' ' A' ' 53' ' ' GLN . . . -127.7 -44.19 1.52 Allowed 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -137.25 157.61 46.26 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.717 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.6 p -141.83 140.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.555 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.07 124.7 49.03 Favored 'General case' 0 N--CA 1.395 -3.187 0 O-C-N 121.874 -0.516 . . . . 0.0 110.914 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -103.91 137.34 42.03 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.499 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.26 99.46 12.24 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -60.17 -12.98 25.98 Favored Glycine 0 C--N 1.312 -0.789 0 CA-C-N 114.811 -1.086 . . . . 0.0 115.494 -175.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.92 -26.3 62.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.948 0.404 . . . . 0.0 110.186 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.13 -47.27 85.33 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 39.5 tt0 178.31 146.44 0.14 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.43 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 47.8 mt-30 -76.12 -44.25 39.43 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 122.485 1.136 . . . . 0.0 109.594 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 45.6 mt -72.84 -13.33 61.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.092 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' O ' ' HB ' ' A' ' 91' ' ' THR . 29.5 t80 -64.97 -39.22 93.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.692 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.458 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -61.83 -38.74 81.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.727 0.775 . . . . 0.0 109.391 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.4 t70 -64.01 -22.12 66.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.096 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.9 m -86.29 -42.08 14.04 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.056 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -49.87 -38.29 34.9 Favored 'General case' 0 C--O 1.21 -1.007 0 C-N-CA 123.196 0.599 . . . . 0.0 111.953 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 93' ' ' ARG . 18.2 mmm-85 -63.93 -27.18 68.97 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.906 0.86 . . . . 0.0 111.368 -176.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -79.65 -47.84 14.71 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.776 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.71 -22.78 29.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.38 130.15 31.56 Favored Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.179 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.73 165.85 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.639 2.226 . . . . 0.0 111.492 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.64 -17.56 47.96 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.986 0.914 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -70.73 -29.33 65.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.288 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.6 t -107.47 136.76 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -113.22 167.97 10.11 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.442 HD11 ' NE ' ' A' ' 93' ' ' ARG . 2.3 mp -125.72 133.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.555 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 43.0 m0 -121.96 164.71 17.15 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -115.36 124.64 51.75 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.57 107.54 4.5 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.802 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.2 tp -96.01 101.08 12.7 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.995 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 m -67.06 144.39 56.16 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.78 149.05 7.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 121.637 0.732 . . . . 0.0 112.444 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.68 94.49 0.1 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -18.34 63.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.241 0.616 . . . . 0.0 112.601 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 m -78.39 -11.69 59.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 121.264 0.554 . . . . 0.0 110.568 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 98.5 mt -73.66 134.99 78.43 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.19 153.56 62.16 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.752 1.635 . . . . 0.0 110.618 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.78 68.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.12 122.5 42.42 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.27 -52.38 1.51 Allowed 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 94.7 m-85 -129.13 119.2 23.72 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.515 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -76.14 163.63 26.9 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.601 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.2 m170 67.47 21.7 9.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.047 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.75 149.95 3.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -85.55 -45.52 11.69 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.497 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.425 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.7 mttm -146.14 161.95 39.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.064 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -106.98 145.4 32.31 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.47 161.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.84 174.54 11.52 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.221 0.534 . . . . 0.0 111.448 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.08 124.09 24.85 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.526 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.6 12.98 3.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.843 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -147.22 -44.44 0.03 OUTLIER Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.341 -1.409 . . . . 0.0 115.151 -172.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -149.79 109.86 4.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.777 0.789 . . . . 0.0 109.941 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.62 105.03 3.2 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.39 -149.58 6.8 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.34 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.82 74.44 0.41 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.139 0.976 . . . . 0.0 110.99 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 122.8 -41.4 1.81 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--N 1.308 -1.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.232 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttm . . . . . 0 CA--C 1.511 -0.539 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.46 -167.55 19.43 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 67.18 145.67 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.717 1.207 . . . . 0.0 111.72 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -148.99 37.2 0.78 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -57.24 99.79 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.106 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.6 131.19 51.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.857 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m -91.6 170.65 9.76 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.52 127.58 3.78 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.735 0.647 . . . . 0.0 114.076 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.423 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.4 tp -134.65 173.15 11.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -138.83 13.85 2.69 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.232 1.015 . . . . 0.0 109.467 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 99.1 mtt180 -124.62 112.66 17.06 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.537 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.12 -41.7 99.55 Favored Glycine 0 C--N 1.302 -1.345 0 CA-C-O 122.207 0.893 . . . . 0.0 112.816 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.454 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -69.51 -35.16 75.25 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.524 1.13 . . . . 0.0 109.407 -176.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 13.0 t70 -77.13 -30.29 55.06 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.38 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.12 -32.61 72.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.429 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 9.8 mtmp? -62.22 -31.93 72.53 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.568 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.772 0.32 . . . . 0.0 111.565 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.6 52.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.418 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.464 176.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.86 -30.42 71.41 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 124.168 0.987 . . . . 0.0 110.361 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.34 60.9 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.082 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.89 -19.17 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.636 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.95 25.48 15.08 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-O 121.832 0.825 . . . . 0.0 109.416 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.18 -67.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.026 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.71 157.63 1.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 124.124 0.89 . . . . 0.0 110.014 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 55' ' ' VAL . . . -117.68 163.9 12.71 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.71 78.36 0.38 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.237 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.87 151.86 39.13 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 120.895 0.379 . . . . 0.0 110.026 -176.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.519 HG13 ' SG ' ' A' ' 37' ' ' CYS . 2.2 pt -116.97 154.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 176.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -84.6 86.72 7.28 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 124.16 0.913 . . . . 0.0 109.855 -175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 91.5 t -116.54 122.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.16 107.17 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 0.0 112.86 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p 62.2 27.33 16.42 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.598 1.559 . . . . 0.0 113.298 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -79.0 140.9 58.04 Favored Pre-proline 0 C--N 1.308 -1.21 0 O-C-N 121.885 -0.509 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.68 8.31 4.49 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 0.0 111.152 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -120.4 -4.92 9.87 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.807 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' SG ' HG13 ' A' ' 29' ' ' ILE . 61.6 m -153.27 128.28 9.65 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -173.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.46 137.9 30.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.353 0.597 . . . . 0.0 111.026 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.98 169.51 8.53 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.886 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -47.87 -30.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.256 1.022 . . . . 0.0 113.115 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.01 -36.74 67.06 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.2 mt-30 -86.0 -34.21 20.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -25.88 68.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.58 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -30.82 71.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.806 0.843 . . . . 0.0 109.211 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -78.46 -50.92 10.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 42' ' ' GLN . 43.0 t -58.6 -35.01 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.602 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -64.28 -26.74 68.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.74 -14.72 25.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.39 0.614 . . . . 0.0 110.028 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.98 -48.79 6.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.663 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -131.77 104.03 14.4 Favored Pre-proline 0 N--CA 1.398 -3.069 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -176.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.55 65.36 4.67 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.012 1.808 . . . . 0.0 112.395 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.66 162.41 13.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.599 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.2 151.82 28.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -177.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.92 148.71 42.65 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 121.978 -0.451 . . . . 0.0 110.248 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 26' ' ' GLY . 12.2 p -133.5 154.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -129.92 141.73 12.93 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.153 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.498 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 25.6 t -136.43 126.67 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -173.04 173.75 3.62 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -87.48 120.15 28.49 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -95.64 117.35 30.3 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -99.23 -59.02 1.8 Allowed 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.2 114.14 26.58 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.389 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 67' ' ' VAL . 16.8 tt -65.8 -30.43 50.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.935 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.33 65.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.06 -41.51 22.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.8 -46.73 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.942 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 63' ' ' ILE . 88.5 t -59.9 -41.22 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.678 0.611 . . . . 0.0 109.61 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.564 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.1 t70 -54.6 -60.75 2.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 123.841 0.713 . . . . 0.0 110.98 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -63.55 -47.77 80.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.239 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -60.3 -29.85 69.11 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 124.04 0.837 . . . . 0.0 111.855 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -84.04 -57.07 3.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.404 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 68' ' ' ASP . 66.2 t -51.26 -58.62 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.008 0.523 . . . . 0.0 112.179 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 tp -81.23 -19.44 43.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 31.6 t 61.01 77.69 0.32 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.165 0.986 . . . . 0.0 111.25 -175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -78.56 -167.62 1.14 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 124.822 1.249 . . . . 0.0 110.872 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.73 ' O ' ' HA ' ' A' ' 100' ' ' VAL . . . -127.69 -74.83 0.58 Allowed 'General case' 1 C--O 1.148 -4.256 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 170.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -104.3 158.06 16.71 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 118.352 -1.339 . . . . 0.0 111.875 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -139.75 138.6 38.76 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.58 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.79 132.67 43.19 Favored 'General case' 0 N--CA 1.392 -3.341 0 CA-C-O 121.591 0.71 . . . . 0.0 112.342 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -105.82 115.3 30.0 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.681 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -81.55 97.48 7.85 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 89' ' ' ILE . . . -54.95 -11.73 3.24 Favored Glycine 0 C--N 1.313 -0.739 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -42.69 -29.7 0.32 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.469 1.508 . . . . 0.0 114.586 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.44 -48.62 69.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.41 ' OE2' ' HB2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -178.37 154.08 0.79 Allowed 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -78.39 -46.07 20.85 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 122.208 1.004 . . . . 0.0 109.913 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' OE2' ' A' ' 85' ' ' GLU . 38.9 mt -77.58 -13.61 59.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.944 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.6 t80 -62.9 -35.91 81.61 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.983 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.476 HD13 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -64.82 -33.24 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.958 0.885 . . . . 0.0 109.646 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.55 -15.66 62.79 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.878 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 92.5 m -89.32 -46.6 8.64 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 124.498 1.119 . . . . 0.0 110.208 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.416 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -44.54 -56.47 4.3 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.15 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -6.44 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -88.41 -35.39 17.13 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.87 -16.04 27.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.955 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -85.89 143.2 37.38 Favored Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.069 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.65 165.99 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.729 2.286 . . . . 0.0 111.111 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -9.14 15.52 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.542 0.737 . . . . 0.0 112.65 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -82.24 -29.24 31.42 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 46.8 t -93.32 136.5 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -170.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -123.41 166.92 14.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.284 1.033 . . . . 0.0 108.367 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.82 133.19 63.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.58 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.7 m0 -117.67 150.0 39.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.303 -1.359 . . . . 0.0 107.93 170.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.414 ' HZ2' ' CD ' ' A' ' 116' ' ' GLU . 1.0 OUTLIER -100.69 116.9 33.68 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.512 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.67 103.1 2.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp -78.97 95.52 5.5 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.456 0.646 . . . . 0.0 111.25 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 m -61.27 148.46 41.05 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.541 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.53 157.27 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.48 122.15 1.39 Allowed Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.75 -34.32 62.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 p -89.01 84.32 6.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.4 tp -135.09 133.89 21.18 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -67.78 153.42 75.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.64 2.227 . . . . 0.0 113.045 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.63 76.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.257 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -136.01 123.01 21.43 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.537 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.414 ' CD ' ' HZ2' ' A' ' 104' ' ' LYS . 22.2 mt-10 -113.74 -51.9 2.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.474 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 26.2 m-85 -127.65 109.69 11.94 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.503 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.42 178.56 5.32 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.867 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 m170 68.24 20.98 8.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 111.822 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 145.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.425 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.77 -41.48 17.55 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.949 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 65.1 mttp -145.54 162.81 36.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.029 0.442 . . . . 0.0 110.859 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -114.49 136.45 53.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.236 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 174.6 12.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.43 145.5 39.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.104 0.478 . . . . 0.0 111.56 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.26 149.75 31.75 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.681 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -84.59 95.01 8.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.18 119.67 6.11 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.139 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -110.32 -0.04 17.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.536 1.16 . . . . 0.0 107.922 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.25 160.5 33.34 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 156.6 -92.19 0.12 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.491 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.66 27.76 5.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.342 0.591 . . . . 0.0 109.817 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.32 -57.09 3.54 Favored Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.41 -2.428 0 C-N-CA 123.313 0.645 . . . . 0.0 109.292 176.178 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 120.711 0.291 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.23 139.57 16.89 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 68.86 114.51 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.739 1.215 . . . . 0.0 109.406 -174.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.467 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 2.9 p-10 -119.77 31.36 6.58 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -38.49 98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.317 -2.22 . . . . 0.0 113.753 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -84.5 112.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.135 173.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -91.0 169.02 11.23 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -40.66 119.78 1.47 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 -172.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -158.37 146.2 18.27 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -133.21 15.38 4.16 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.51 1.147 . . . . 0.0 110.367 -172.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 81.2 mtt180 -107.56 115.65 30.53 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.44 -52.99 34.05 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-O 122.138 0.854 . . . . 0.0 111.784 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.58 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.8 mp0 -55.86 -25.21 41.26 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 126.107 1.763 . . . . 0.0 112.773 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 9.1 t0 -94.14 -43.86 8.28 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.01 73.34 Favored 'General case' 0 C--O 1.251 1.139 0 C-N-CA 124.583 1.153 . . . . 0.0 112.138 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.07 -24.4 64.55 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.881 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.73 -26.57 68.42 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 -45.36 12.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.427 0.632 . . . . 0.0 109.329 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.28 -35.59 75.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.184 176.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.96 -30.09 13.98 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.251 1.421 . . . . 0.0 111.862 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.61 -22.95 62.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.18 7.46 0.09 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.46 -1.353 . . . . 0.0 113.879 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.56 23.03 11.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.306 1.043 . . . . 0.0 111.765 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.467 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 36.7 mt -57.85 -66.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.471 -170.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.02 152.91 1.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.575 0.547 . . . . 0.0 110.642 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.404 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.44 153.32 18.11 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.23 85.2 0.36 Allowed Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.21 150.47 32.28 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.31 0.576 . . . . 0.0 109.842 -177.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 3.3 pt -115.99 150.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.027 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -82.73 76.69 9.56 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.788 -171.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.36 120.42 63.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.74 97.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.554 1.542 . . . . 0.0 114.498 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 74.5 p 62.02 9.82 3.29 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 127.013 2.125 . . . . 0.0 116.021 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -68.51 136.49 90.75 Favored Pre-proline 0 C--O 1.206 -1.235 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.68 4.02 0.98 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.169 2.579 . . . . 0.0 115.429 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 2.6 tpm_? -124.93 9.77 8.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.611 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' HA3' ' A' ' 8' ' ' GLY . 65.9 m -141.3 154.13 45.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -136.22 137.14 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.712 0.767 . . . . 0.0 109.587 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -119.26 177.13 5.01 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.459 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' HD23 ' A' ' 73' ' ' LEU . 68.9 t -38.37 -40.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.021 1.451 . . . . 0.0 113.423 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.12 -58.93 5.18 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.611 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 33' ' ' THR . 32.2 mt-30 -74.36 -33.89 63.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.072 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -65.1 -31.64 72.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.425 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -63.0 -35.6 80.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.85 -44.8 12.14 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.611 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.8 p -64.87 -30.61 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -69.47 -21.42 63.71 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.02 -9.29 58.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.196 0.522 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.99 -46.07 4.57 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.27 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.9 99.13 20.55 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.41 67.42 6.27 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.156 1.904 . . . . 0.0 112.247 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.98 165.88 10.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.528 174.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 161.67 27.62 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.679 0.218 . . . . 0.0 110.932 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.82 143.49 50.77 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 HG12 ' O ' ' A' ' 26' ' ' GLY . 10.2 p -133.65 156.26 41.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -126.34 136.54 9.59 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.767 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.5 t -123.94 128.54 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.448 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 32.8 t80 -171.59 162.04 6.33 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.258 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -96.39 92.2 6.2 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 17.4 m120 -102.84 124.79 49.01 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.508 ' CD2' HD21 ' A' ' 83' ' ' ASN . 65.7 m80 -94.33 -46.09 7.19 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.184 178.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.67 124.61 29.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.512 HG13 HD12 ' A' ' 92' ' ' LEU . 10.3 tt -64.67 -33.9 66.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.053 0.454 . . . . 0.0 110.278 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.93 64.2 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.684 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.78 -36.69 36.75 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.39 -48.37 77.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.506 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 63' ' ' ILE . 61.3 t -60.23 -39.82 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.16 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 72' ' ' VAL . 20.8 t70 -54.34 -61.47 2.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 111.319 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.2 -38.93 92.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.253 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -35.08 79.89 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.492 0.495 . . . . 0.0 111.672 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.24 -50.98 11.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 68' ' ' ASP . 54.8 t -61.26 -55.72 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.15 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 40' ' ' VAL . 86.7 mt -79.61 -8.51 59.23 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p 52.7 67.7 0.95 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.976 0.893 . . . . 0.0 111.907 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.18 -177.56 6.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.309 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.29 -36.92 1.88 Allowed 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.09 160.3 41.14 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.67 140.72 33.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.715 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -104.35 105.25 15.31 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.59 97.99 6.46 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -124.96 -22.77 4.4 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.154 0.502 . . . . 0.0 112.094 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.38 -55.96 1.62 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -168.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.508 HD21 ' CD2' ' A' ' 61' ' ' HIS . 20.6 p-10 -83.25 -69.91 0.6 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -159.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.308 36.0 mm-40 -88.67 -49.41 6.88 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -157.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -174.97 166.35 3.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 119.505 1.048 . . . . 0.0 109.448 -173.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.519 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 19.4 mm-40 -73.92 -48.45 30.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 71.4 mt -81.87 -12.8 58.29 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.138 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' O ' ' HB ' ' A' ' 91' ' ' THR . 23.3 t80 -59.62 -35.95 75.36 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.503 ' HA ' HD22 ' A' ' 92' ' ' LEU . 1.7 mp -63.73 -34.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.727 0.775 . . . . 0.0 110.246 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.505 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 28.8 t70 -64.7 -22.96 67.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.594 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.1 m -83.54 -40.12 19.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.487 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.512 HD12 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.05 -43.65 66.81 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 122.976 0.51 . . . . 0.0 110.631 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -43.98 -39.2 3.92 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.438 1.495 . . . . 0.0 112.098 176.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.43 -44.45 35.81 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.091 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.39 -7.97 58.03 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.58 147.96 35.92 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.42 163.75 38.0 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.268 1.312 . . . . 0.0 109.2 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.46 66.88 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.146 0.579 . . . . 0.0 112.54 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -88.72 1.63 54.81 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.7 t -110.9 127.97 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 173.94 6.67 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.346 0.593 . . . . 0.0 111.99 -170.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.05 133.08 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.502 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 49.2 m0 -121.52 157.31 30.95 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -100.4 116.22 31.85 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.401 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -68.6 110.78 4.39 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 169.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -69.57 93.92 0.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.765 0.793 . . . . 0.0 112.548 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -78.81 125.18 29.03 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.88 156.48 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 123.62 0.575 . . . . 0.0 111.554 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.81 139.91 2.75 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.89 153.73 21.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 m 76.89 25.97 0.81 Allowed 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.541 1.162 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.15 135.92 22.18 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.03 162.17 41.12 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 121.914 1.743 . . . . 0.0 111.176 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.87 77.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -97.54 121.65 39.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 27.6 mt-10 -125.41 -73.14 0.64 Allowed 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 85.7 m-85 -87.52 102.49 14.63 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -72.02 136.64 46.77 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . 0.295 18.0 m170 79.48 33.35 0.21 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 111.816 -2.447 . . . . 0.0 112.596 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.78 137.95 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.97 -48.02 48.02 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.787 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -150.84 162.44 40.75 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -111.89 149.15 32.27 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.33 178.77 5.14 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 125' ' ' LEU . 1.9 pt? -73.89 164.15 27.0 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 119.007 0.821 . . . . 0.0 109.944 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 10.6 t70 -65.85 109.67 2.57 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -105.51 19.21 20.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.38 175.52 34.67 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -146.67 106.97 4.03 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.05 114.83 2.67 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.08 139.01 9.68 Favored Glycine 0 C--N 1.298 -1.564 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.1 -27.58 13.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -114.64 177.27 17.41 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.172 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 121.49 0.662 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.75 -41.94 1.42 Allowed Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.49 -166.81 0.19 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.252 1.421 . . . . 0.0 113.512 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -132.02 38.46 3.51 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -57.88 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.861 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 m -91.26 138.0 20.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.67 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 73.6 m -91.09 170.0 10.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -31.35 106.61 0.02 OUTLIER Glycine 0 C--N 1.358 1.762 0 O-C-N 124.395 1.059 . . . . 0.0 115.725 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -120.02 144.02 47.76 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -113.82 -19.62 11.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.315 1.055 . . . . 0.0 110.583 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.48 117.49 29.99 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.197 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.498 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -64.84 -30.39 77.84 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.204 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 mm-40 -73.43 -23.74 60.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 122.762 1.268 . . . . 0.0 108.195 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -88.49 -39.94 13.82 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.466 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.67 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.307 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 52.1 mtmt -61.12 -28.05 68.82 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.985 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.54 63.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.734 0.302 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.448 ' HA ' ' OD1' ' A' ' 4' ' ' ASN . . . -78.91 -39.98 33.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.996 0.903 . . . . 0.0 109.143 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -67.68 -30.74 70.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.174 175.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.31 -25.1 21.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.963 1.305 . . . . 0.0 111.847 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -14.04 62.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.839 0.456 . . . . 0.0 111.516 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.37 31.9 0.88 Allowed Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.07 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.61 36.64 24.04 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.94 -69.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.663 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.8 161.36 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 124.032 0.833 . . . . 0.0 110.244 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.01 150.55 17.01 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.06 75.58 0.28 Allowed Glycine 0 CA--C 1.494 -1.274 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.628 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 153.27 34.88 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.649 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.543 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.1 pt -116.88 157.32 17.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -80.31 77.13 7.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.825 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 59.0 t -109.54 118.43 56.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.06 112.07 1.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.273 0.983 . . . . 0.0 112.355 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.3 p 64.05 26.4 14.02 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.196 1.798 . . . . 0.0 112.979 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -84.6 139.05 37.99 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.78 7.66 4.24 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.786 1.657 . . . . 0.0 112.13 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 9.7 ptm180 -118.54 -6.05 10.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.175 0.512 . . . . 0.0 109.902 174.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.42 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 79.4 m -151.22 119.6 6.4 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.28 137.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 122.113 0.959 . . . . 0.0 111.25 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.7 p-10 -104.78 169.14 8.62 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.39 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.425 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 99.5 t -47.76 -35.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 124.922 1.289 . . . . 0.0 112.391 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 41.2 mt-10 -66.67 -48.47 69.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.29 -40.85 67.26 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.284 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.06 64.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.838 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -30.58 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.4 -51.51 6.18 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.3 -35.29 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.024 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.421 ' HA ' ' HH ' ' A' ' 54' ' ' TYR . 27.1 ptt? -64.97 -24.29 67.47 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.68 19.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.04 -51.71 23.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.245 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 19' ' ' TYR . . . -132.65 107.37 13.0 Favored Pre-proline 0 N--CA 1.407 -2.587 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.16 56.41 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.689 2.26 . . . . 0.0 113.397 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.411 HD21 ' CB ' ' A' ' 19' ' ' TYR . 1.7 pp -91.49 169.96 10.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -85.63 146.95 26.62 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.421 ' HH ' ' HA ' ' A' ' 47' ' ' MET . 80.0 m-85 -117.49 144.94 44.55 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.384 0.611 . . . . 0.0 111.761 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.26 163.59 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -140.04 128.74 3.99 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.347 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.543 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 43.5 t -105.42 123.16 59.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -149.91 151.5 33.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.13 109.54 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.17 117.13 27.93 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.86 -59.91 1.76 Allowed 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.377 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -95.44 115.08 26.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 67' ' ' VAL . 16.5 tt -63.95 -30.98 51.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.212 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.84 -16.8 60.68 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.212 0.53 . . . . 0.0 110.092 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.2 t70 -85.29 -31.95 22.79 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.55 -43.75 80.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.202 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 63' ' ' ILE . 97.5 t -57.41 -43.94 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.598 ' O ' HG22 ' A' ' 72' ' ' VAL . 9.9 t70 -52.39 -61.26 2.39 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.902 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 45.2 mmtm -62.15 -44.58 96.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.253 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -63.76 -27.45 69.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.348 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -84.16 -60.31 2.13 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.135 0.574 . . . . 0.0 110.915 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -54.91 -55.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.616 0.766 . . . . 0.0 111.813 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.48 -21.58 35.51 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 17.0 m 61.8 84.76 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.001 0.905 . . . . 0.0 110.77 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.0 -170.17 2.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.86 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.428 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -125.15 -40.53 2.14 Favored 'General case' 0 CA--C 1.462 -2.417 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.66 33.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.922 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.7 p -142.85 135.67 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.593 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.7 mp0 -101.29 116.98 34.05 Favored 'General case' 0 N--CA 1.386 -3.631 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.3 158.51 15.83 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.542 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -97.86 93.68 6.48 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.438 ' CA ' HD12 ' A' ' 89' ' ' ILE . . . -69.59 -12.83 67.62 Favored Glycine 0 C--N 1.311 -0.849 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -49.82 -26.57 4.09 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.072 0.949 . . . . 0.0 112.19 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -51.85 -45.78 64.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 88' ' ' TYR . 37.1 tt0 -177.57 132.63 0.16 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.4 -35.53 79.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.085 0.945 . . . . 0.0 110.664 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.48 -15.62 57.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.591 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 38.8 t80 -68.62 -31.89 71.37 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.438 HD12 ' CA ' ' A' ' 82' ' ' GLY . 2.2 mp -64.34 -40.39 88.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.02 -13.64 62.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.79 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 93.9 m -86.98 -44.02 11.93 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.872 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -47.02 -48.08 22.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.783 0.433 . . . . 0.0 110.62 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.572 ' NH1' HD12 ' A' ' 102' ' ' ILE . 1.7 mpt_? -43.15 -31.1 0.53 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.24 -38.84 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.082 0.468 . . . . 0.0 111.419 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.99 -18.13 22.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.67 0.748 . . . . 0.0 112.496 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.42 129.3 30.75 Favored Pre-proline 0 C--N 1.27 -2.889 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.66 165.53 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.056 1.837 . . . . 0.0 110.264 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.54 -3.37 17.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.269 0.557 . . . . 0.0 111.139 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -79.87 -23.12 42.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.953 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.78 141.87 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.0 169.9 9.27 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.475 0.31 . . . . 0.0 110.37 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.572 HD12 ' NH1' ' A' ' 93' ' ' ARG . 3.0 mp -122.65 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.593 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.4 m0 -120.86 162.45 19.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -99.7 120.81 40.29 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.8 100.56 3.48 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.69 107.35 18.59 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.676 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.0 t -85.66 148.8 25.72 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.35 121.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.22 0.533 . . . . 0.0 112.272 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 128.35 6.82 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.95 -22.55 39.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.52 0.676 . . . . 0.0 110.552 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.4 m -91.81 138.42 31.56 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.55 116.58 57.73 Favored Pre-proline 0 C--N 1.314 -0.939 0 O-C-N 123.018 0.199 . . . . 0.0 110.633 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -79.38 133.83 10.94 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.245 1.963 . . . . 0.0 110.822 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.96 -37.89 54.36 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -172.75 147.63 1.77 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.158 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -117.46 -63.09 1.48 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -131.48 114.27 14.71 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -84.53 155.58 22.06 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.373 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 62.6 47.85 4.69 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.197 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.23 155.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.98 -25.4 34.81 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.426 ' HB3' ' CG ' ' A' ' 103' ' ' TRP . 41.1 ttmt -169.76 163.41 9.86 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -127.9 144.46 51.1 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.48 175.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.18 135.38 47.55 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.27 115.16 10.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -111.41 151.42 28.53 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.55 -58.27 0.28 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 147.77 44.03 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.45 74.29 0.31 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.627 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.83 -52.16 9.9 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.96 79.64 1.47 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.79 -62.83 0.79 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -174.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.257 1.476 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.523 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 C--O 1.234 0.284 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.14 -112.02 3.49 Favored Glycine 0 CA--C 1.489 -1.581 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.02 156.09 39.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.014 174.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -150.12 49.39 0.91 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 175.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.97 130.48 15.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.558 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 26.3 t -100.74 109.15 24.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.351 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.2 m -93.76 168.68 10.84 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -23.56 106.63 0.01 OUTLIER Glycine 0 C--N 1.371 2.503 0 O-C-N 124.496 1.123 . . . . 0.0 115.795 -171.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.2 tp -154.37 141.55 19.45 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -136.17 8.68 3.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.82 0.819 . . . . 0.0 109.238 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.428 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 95.1 mtt180 -92.43 112.79 24.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.53 -37.1 80.8 Favored Glycine 0 C--N 1.298 -1.556 0 O-C-N 123.194 0.308 . . . . 0.0 113.131 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.61 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -68.58 -26.89 65.61 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.184 0.994 . . . . 0.0 109.391 -177.654 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.428 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 8.1 t0 -90.27 -39.01 13.02 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.105 -175.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.08 -42.45 89.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -62.34 -23.92 67.04 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.1 69.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.494 . . . . 0.0 110.28 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.01 -40.99 30.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.752 0.787 . . . . 0.0 110.346 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.454 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -68.9 -31.76 70.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.733 177.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.75 -16.18 47.26 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.08 -6.15 53.74 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.63 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 15.0 1.56 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.43 -1.366 . . . . 0.0 113.286 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.51 28.73 17.38 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.178 0.991 . . . . 0.0 110.783 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.69 -69.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.258 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.79 163.37 1.83 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 124.039 0.837 . . . . 0.0 109.184 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.96 126.8 5.56 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.93 85.25 0.82 Allowed Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.573 HD13 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -119.01 146.92 44.64 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.332 0.1 OUTLIER -116.92 148.92 19.32 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 179.653 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.76 87.73 2.23 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.315 -174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.59 120.86 66.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.02 106.56 0.17 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.537 1.148 . . . . 0.0 113.625 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.0 p 63.91 19.63 11.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.489 1.916 . . . . 0.0 114.189 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.8 p -87.15 146.57 40.57 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.749 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.28 13.52 2.07 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.049 1.833 . . . . 0.0 109.929 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -100.15 -25.84 14.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.123 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 82.8 m -155.97 141.75 17.97 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -106.16 137.7 35.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.287 -171.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.43 168.72 9.34 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.777 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 73' ' ' LEU . 4.5 p -52.76 -33.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 124.338 1.024 . . . . 0.0 111.781 -171.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -69.62 -42.1 74.8 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.704 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.571 ' O ' HG21 ' A' ' 46' ' ' VAL . 35.8 mt-30 -74.35 -41.34 61.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.768 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.08 66.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.39 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 HE21 ' HB3' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -64.29 -30.83 71.87 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.87 -42.3 27.69 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 42' ' ' GLN . 22.1 t -64.22 -35.37 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.935 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -16.3 64.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.39 -17.02 37.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.649 . . . . 0.0 109.586 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.82 -32.2 11.47 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.429 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 93.9 11.54 Favored Pre-proline 0 N--CA 1.39 -3.462 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.68 61.74 5.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.503 2.135 . . . . 0.0 111.739 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD23 ' CB ' ' A' ' 19' ' ' TYR . 1.1 pp -100.88 173.15 6.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.935 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -79.69 138.01 37.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.1 0.56 . . . . 0.0 111.101 -177.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.573 ' CD2' HD13 ' A' ' 28' ' ' LEU . 22.8 m-85 -108.89 140.62 42.1 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.99 137.82 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.66 122.07 6.48 Favored Glycine 0 N--CA 1.412 -2.913 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.645 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 15.2 t -114.23 106.46 20.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -160.54 146.17 14.87 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.55 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -91.19 91.88 8.42 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.48 159.4 26.98 Favored 'General case' 0 N--CA 1.387 -3.622 0 CA-C-O 123.427 1.584 . . . . 0.0 111.911 -173.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -110.63 -73.68 0.67 Allowed 'General case' 1 C--N 1.23 -4.625 0 CA-C-N 110.792 -2.913 . . . . 0.0 111.105 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.01 132.78 36.76 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.465 HG13 HD12 ' A' ' 92' ' ' LEU . 10.6 tt -67.44 -31.16 51.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.78 -19.72 65.13 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 18.6 t70 -82.42 -39.98 21.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.491 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -46.98 85.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.974 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 63' ' ' ILE . 75.5 t -60.39 -40.18 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.624 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 72' ' ' VAL . 16.4 t70 -56.26 -61.64 2.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.78 177.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 44.1 mmtm -62.34 -40.36 96.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.382 0.273 . . . . 0.0 111.448 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.457 ' HB1' HG23 ' A' ' 100' ' ' VAL . . . -61.85 -41.1 97.42 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.299 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -80.46 -48.71 12.43 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.681 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 68' ' ' ASP . 81.3 t -56.13 -54.94 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 123.403 0.44 . . . . 0.0 111.286 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 40' ' ' VAL . 47.7 tp -82.54 -14.26 55.22 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.302 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 t 61.95 63.9 1.06 Allowed 'General case' 0 C--O 1.254 1.317 0 CA-C-O 121.891 0.853 . . . . 0.0 109.279 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.18 179.63 0.92 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.358 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.13 -39.73 2.21 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -142.01 156.35 45.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.417 173.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.504 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.3 p -140.38 141.95 32.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.3 mm-40 -104.12 109.45 21.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 122.971 0.508 . . . . 0.0 111.664 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.48 136.99 52.4 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 175.88 -29.7 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.301 0 CA-C-O 121.678 0.751 . . . . 0.0 109.899 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.02 -55.67 1.95 Allowed Glycine 0 C--N 1.286 -2.228 0 N-CA-C 119.749 2.659 . . . . 0.0 119.749 -166.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -82.55 -69.76 0.6 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 119.316 3.08 . . . . 0.0 119.316 -160.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.52 -49.6 6.58 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -161.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 1.0 OUTLIER -168.09 172.27 8.88 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.518 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 36.3 mt-30 -76.87 -48.99 16.75 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.387 1.075 . . . . 0.0 108.867 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.2 mt -75.96 -13.97 60.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.691 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' THR . 25.9 t80 -59.03 -37.07 76.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.673 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 mp -65.53 -34.45 70.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.444 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 21.4 t70 -69.1 -22.73 63.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 87.2 m -83.8 -44.33 14.48 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.115 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD12 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -44.86 -50.12 10.5 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.657 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -54.15 -29.18 44.48 Favored 'General case' 0 N--CA 1.516 2.825 0 CA-C-O 121.284 0.564 . . . . 0.0 112.258 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.424 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 28.5 mt-10 -76.72 -30.44 56.64 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.521 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 -9.25 19.02 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.559 0.695 . . . . 0.0 112.561 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.6 tp -94.85 129.29 36.4 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.525 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.0 165.1 22.53 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.828 1.685 . . . . 0.0 111.153 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.93 -5.15 32.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.159 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -81.01 -29.4 35.17 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.457 HG23 ' HB1' ' A' ' 70' ' ' ALA . 38.9 t -108.06 135.37 46.99 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.042 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.11 169.02 8.81 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 94.4 mt -122.94 128.27 75.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.619 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -116.74 161.01 19.92 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.221 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.409 ' HB2' HG13 ' A' ' 120' ' ' VAL . 7.9 tmtm? -102.5 112.21 24.84 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.85 115.56 13.43 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.8 94.95 8.83 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -70.22 141.59 52.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.504 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.0 m -75.06 124.53 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.526 0.679 . . . . 0.0 111.017 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.9 173.21 39.93 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -92.19 -36.02 13.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 117.15 0.475 . . . . 0.0 112.218 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 t -83.38 120.86 26.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.9 mt -118.9 104.66 46.42 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.592 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.99 144.46 23.98 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.455 2.103 . . . . 0.0 109.723 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.5 73.73 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -125.34 144.12 50.65 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -131.31 -70.94 0.58 Allowed 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 75.7 m-85 -124.5 113.91 18.73 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -98.13 169.49 9.57 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.3 t60 63.51 31.96 14.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 110.078 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 104' ' ' LYS . 31.5 m -83.15 154.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.947 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.76 -41.22 62.76 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.158 0.504 . . . . 0.0 110.454 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.51 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -150.32 163.02 39.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.48 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.83 137.43 54.93 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.59 171.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.86 177.83 8.79 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.79 77.46 0.46 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -87.58 -4.82 58.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 122.243 1.02 . . . . 0.0 109.86 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -178.58 160.32 26.12 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 106.162 -2.775 . . . . 0.0 106.162 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -158.47 128.91 6.09 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 118.715 1.258 . . . . 0.0 109.949 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.27 119.98 1.44 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 165.68 -179.13 40.17 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.49 152.89 27.12 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.935 0.368 . . . . 0.0 110.175 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.28 -50.19 0.41 Allowed Glycine 0 C--N 1.298 -1.577 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.779 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.578 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 CA-C-O 122.237 1.017 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 12.4 ptpt -91.55 97.6 11.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.46 146.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.741 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 p -87.7 170.13 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.29 122.12 2.36 Favored Glycine 0 CA--C 1.482 -1.98 0 O-C-N 124.117 0.886 . . . . 0.0 114.886 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 14' ' ' ASP . 25.1 tp -140.72 128.54 21.77 Favored 'General case' 0 N--CA 1.399 -2.978 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -120.77 12.83 11.44 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 123.093 1.425 . . . . 0.0 109.439 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 33.2 mtp85 -108.65 112.34 24.61 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.504 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.94 66.74 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 116.552 -0.295 . . . . 0.0 113.793 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.22 -20.03 61.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.274 1.035 . . . . 0.0 108.887 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.508 ' HB3' HD21 ' A' ' 9' ' ' LEU . 1.3 m-20 -95.53 -45.3 7.13 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.659 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.36 72.53 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.81 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -59.11 -23.94 62.54 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.27 71.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -35.05 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.218 1.009 . . . . 0.0 108.772 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -68.43 -38.27 81.05 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.332 176.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.9 -26.19 62.22 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.219 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.46 -23.66 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.146 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' HA3' HG13 ' A' ' 24' ' ' ILE . . . 176.0 -25.88 0.06 OUTLIER Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.038 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 63.85 21.1 12.52 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-O 121.875 0.845 . . . . 0.0 109.597 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.578 ' HB ' HD21 ' A' ' 4' ' ' ASN . 25.0 mt -70.52 -60.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.041 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.04 151.31 0.66 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.707 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -117.8 159.62 14.09 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.54 79.98 0.26 Allowed Glycine 0 CA--C 1.505 -0.575 0 CA-C-N 117.535 0.667 . . . . 0.0 111.934 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.44 149.3 40.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.135 0.493 . . . . 0.0 109.986 -174.644 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.3 mt -117.65 150.19 19.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.244 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 7.9 m-85 -81.87 75.47 8.81 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.194 0.308 . . . . 0.0 111.702 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 87.9 t -98.48 122.13 49.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.69 108.84 0.23 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.271 1.028 . . . . 0.0 113.629 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.7 p 62.55 26.59 15.8 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.586 1.954 . . . . 0.0 114.234 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -90.56 139.83 26.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.2 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.18 16.12 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.244 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -125.57 -3.81 7.23 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.13 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 87.4 m -156.7 120.72 4.35 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.0 137.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 122.27 1.033 . . . . 0.0 111.978 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.4 p-10 -103.52 170.69 7.79 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.08 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 p -43.64 -39.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.611 1.194 . . . . 0.0 112.687 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 44.3 mt-10 -68.81 -48.66 63.02 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.626 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.662 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.2 mt-30 -68.64 -40.15 80.41 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.526 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.54 -40.26 74.79 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 5.4 pt20 -64.91 -29.65 70.61 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.12 -45.16 24.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.894 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 42' ' ' GLN . 48.2 t -59.53 -36.37 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.124 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -71.24 -8.1 51.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.0 -7.24 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.495 0.664 . . . . 0.0 109.304 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.23 -48.15 3.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.207 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -134.91 104.73 10.6 Favored Pre-proline 0 N--CA 1.41 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.42 61.66 3.49 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 123.008 2.472 . . . . 0.0 113.073 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.79 144.39 28.92 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.306 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 2.9 tm0? -73.5 154.93 39.7 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.131 0.972 . . . . 0.0 109.361 -175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -118.22 155.39 30.6 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 112.494 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 26' ' ' GLY . 8.4 p -131.19 164.52 34.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.2 147.2 18.9 Favored Glycine 0 C--O 1.204 -1.778 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 45.7 t -125.34 106.35 16.19 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -152.63 140.1 19.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.256 -1.778 . . . . 0.0 112.103 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 4.5 ptt180 -103.18 95.28 6.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.06 151.57 22.37 Favored 'General case' 1 N--CA 1.369 -4.515 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.562 -170.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -85.22 -49.11 8.47 Favored 'General case' 1 C--N 1.233 -4.474 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -99.1 129.08 45.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.998 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' VAL . 11.7 tt -67.55 -32.82 58.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.169 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -19.16 63.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 37.2 t70 -83.01 -27.1 30.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.277 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.03 -43.56 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 63' ' ' ILE . 50.9 t -59.54 -41.21 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.386 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.562 ' O ' HG23 ' A' ' 72' ' ' VAL . 19.3 t70 -50.72 -55.99 14.06 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.611 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 40.9 mmtm -66.02 -44.65 84.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.575 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.85 -35.28 68.68 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.973 0.796 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.91 -58.46 2.78 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.474 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 68' ' ' ASP . 68.0 t -49.4 -58.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.447 0.699 . . . . 0.0 112.746 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.2 -16.59 37.28 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 27.7 t 62.28 88.84 0.09 Allowed 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 124.606 1.191 . . . . 0.0 109.059 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.489 ' HG ' ' HA ' ' A' ' 70' ' ' ALA . 77.7 mt -84.07 177.01 8.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.93 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.473 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -115.6 -40.68 3.35 Favored 'General case' 0 CA--C 1.451 -2.85 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -147.05 164.76 31.99 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.892 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.78 135.23 25.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.35 117.3 32.45 Favored 'General case' 0 N--CA 1.388 -3.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.064 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.22 129.98 45.49 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.649 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.1 m-70 -82.76 103.03 11.94 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -61.42 -12.95 34.83 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.367 -172.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -58.97 -25.78 63.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.993 1.317 . . . . 0.0 111.364 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -59.82 -48.64 80.87 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.89 150.99 0.82 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 49.4 mt-30 -76.2 -43.41 42.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.98 0.895 . . . . 0.0 111.73 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.45 -21.56 35.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.396 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.9 t80 -57.12 -46.81 82.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.853 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.492 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.0 mt -61.02 -38.71 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 109.558 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.652 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 17.9 t70 -66.99 -19.54 65.73 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.705 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.6 m -89.17 -45.71 9.36 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.972 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -43.41 -50.0 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -67.05 -14.23 62.7 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.42 -35.37 27.67 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.98 20.07 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.013 0.911 . . . . 0.0 111.384 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.64 118.17 70.95 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.789 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.76 165.6 20.49 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.937 2.425 . . . . 0.0 111.076 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.14 4.12 1.78 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -84.81 -29.58 25.26 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.81 133.25 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -112.45 -179.74 3.75 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 88.2 mt -126.71 134.57 65.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.8 m0 -119.89 147.14 45.07 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 118.12 36.33 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.58 106.24 2.52 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.234 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 72.9 m-85 . . . . . 0 CA--C 1.484 -1.56 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -111.71 -170.85 1.73 Allowed 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.944 0.777 . . . . 0.0 110.546 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.4 m80 69.82 19.97 6.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.462 1.105 . . . . 0.0 109.469 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -96.95 156.55 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.272 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.87 -40.8 38.86 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 120.843 0.354 . . . . 0.0 111.331 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 64.0 mttp -147.99 161.28 41.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.25 127.3 55.57 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 m -129.65 173.55 13.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.4 pt? . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 18' ' ' ALA . 63.6 t30 . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 37.6 ttpt -43.9 114.28 0.64 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.725 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 m -117.63 140.72 39.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.213 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.7 m -91.69 168.48 11.45 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 117.354 -1.307 . . . . 0.0 107.995 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.15 106.01 0.01 OUTLIER Glycine 0 C--N 1.385 3.257 0 O-C-N 125.3 1.625 . . . . 0.0 116.036 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -135.19 130.53 35.46 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -174.32 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -126.4 -18.9 4.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -81.2 117.06 21.42 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.688 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -44.9 -59.3 4.47 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 124.184 0.897 . . . . 0.0 114.513 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -56.8 -25.92 56.72 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 177.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB2' HD11 ' A' ' 9' ' ' LEU . 1.8 m-20 -84.15 -34.87 23.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 9' ' ' LEU . . . -67.08 -42.24 85.0 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.332 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 49.2 mtmt -58.9 -30.39 67.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.515 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.21 70.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.622 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HA ' HD22 ' A' ' 4' ' ' ASN . . . -77.07 -35.96 56.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.909 0.861 . . . . 0.0 109.784 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -74.82 -30.56 61.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.841 178.22 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.8 -14.14 30.28 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.783 0.801 . . . . 0.0 112.102 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.66 -13.52 61.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.978 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.49 26.26 0.98 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.12 27.64 11.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.45 1.1 . . . . 0.0 112.062 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.97 -68.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.802 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.523 ' OH ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -178.87 162.12 1.27 Allowed 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.314 1.009 . . . . 0.0 109.151 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.05 150.53 17.21 Favored Glycine 0 C--N 1.313 -0.708 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . -116.84 71.29 0.28 Allowed Glycine 0 CA--C 1.475 -2.441 0 C-N-CA 118.612 -1.756 . . . . 0.0 112.559 -170.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -108.97 130.78 55.47 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.357 0.598 . . . . 0.0 110.233 -179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.0 pt -102.39 155.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -77.95 74.16 4.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.009 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.7 t -103.2 117.35 48.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 170.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.91 114.24 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.71 1.256 . . . . 0.0 112.826 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.9 p 69.72 17.95 7.63 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 126.181 1.792 . . . . 0.0 113.681 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -83.24 141.41 42.86 Favored Pre-proline 0 N--CA 1.419 -2.014 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.41 4.38 4.09 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.683 1.589 . . . . 0.0 111.193 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.75 5.74 10.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 110.298 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 80.7 m -156.17 117.81 3.93 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 28' ' ' LEU . 1.5 t -102.74 137.0 32.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.947 0.88 . . . . 0.0 112.381 -168.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.46 166.34 10.62 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.838 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.5 p -45.01 -31.93 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.315 1.446 . . . . 0.0 113.143 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.7 -59.69 3.96 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 123.294 0.637 . . . . 0.0 111.955 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -70.52 -33.4 71.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.663 0.744 . . . . 0.0 110.12 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.923 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.45 -26.44 68.44 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.067 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -63.68 -32.97 74.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.921 0.867 . . . . 0.0 109.493 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.26 -43.25 13.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.434 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.923 HG12 ' HA ' ' A' ' 43' ' ' ALA . 9.5 p -70.42 -24.28 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.319 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -15.9 63.4 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.468 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.6 -24.95 28.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.585 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.43 -45.47 12.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.13 104.94 18.05 Favored Pre-proline 0 N--CA 1.394 -3.227 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.53 56.23 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.901 2.401 . . . . 0.0 111.963 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pp -97.09 177.19 5.67 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.215 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.51 128.64 34.52 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.752 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 28' ' ' LEU . 66.6 m-85 -96.85 127.32 42.72 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 26' ' ' GLY . 9.8 p -119.14 149.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.04 128.14 7.27 Favored Glycine 0 C--N 1.285 -2.256 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.321 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.95 107.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -165.28 158.63 16.51 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.649 -1.22 . . . . 0.0 109.836 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' HB2' ' A' ' 81' ' ' HIS . 47.2 mtm180 -90.16 93.42 9.36 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB2' HG22 ' A' ' 66' ' ' VAL . 16.3 m120 -96.75 117.6 31.39 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -80.25 -31.32 38.45 Favored 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.533 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -99.19 123.62 43.62 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 91' ' ' THR . 7.8 tt -61.9 -34.55 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.4 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.88 -20.25 61.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.176 0.512 . . . . 0.0 110.014 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.38 -35.44 30.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.949 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 60' ' ' ASN . 26.1 t -64.9 -47.2 89.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 63' ' ' ILE . 80.5 t -60.1 -42.21 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.78 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 72' ' ' VAL . 31.1 t70 -53.87 -59.89 4.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.316 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -67.49 -39.84 85.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.298 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.96 -37.91 86.52 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 123.633 0.583 . . . . 0.0 111.172 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -73.14 -60.6 2.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.604 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.6 t -55.69 -53.76 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.982 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 73' ' ' LEU . 1.5 tm? -72.9 -29.28 63.02 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.298 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.4 t 67.75 74.88 0.3 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.388 1.09 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 73' ' ' LEU . 91.6 mt -77.81 -168.4 1.22 Allowed 'General case' 0 C--O 1.249 1.074 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.633 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.7 -52.39 1.24 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.19 162.4 31.87 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.722 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.83 136.65 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.561 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.1 mp0 -105.21 115.03 29.58 Favored 'General case' 0 N--CA 1.394 -3.259 0 C-N-CA 123.177 0.591 . . . . 0.0 110.69 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.74 123.31 43.86 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 46.8 m-70 -77.77 108.72 11.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 175.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -51.9 -11.78 1.03 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -51.62 -26.1 8.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.422 1.089 . . . . 0.0 111.932 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -69.12 -49.34 57.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.686 0.279 . . . . 0.0 111.718 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.5 147.88 0.32 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -79.45 -46.0 18.33 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 122.078 0.942 . . . . 0.0 111.35 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 42.3 mt -78.98 -14.32 59.27 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.219 -173.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.2 t80 -60.78 -39.9 90.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.347 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.576 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -61.38 -38.07 79.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-O 121.817 0.818 . . . . 0.0 109.967 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 18.2 t70 -65.99 -19.78 65.97 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.328 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.562 HG22 ' CD1' ' A' ' 63' ' ' ILE . 84.2 m -88.03 -41.94 12.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.922 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 2.6 mm? -51.77 -39.23 58.23 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 122.602 0.361 . . . . 0.0 111.359 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.73 ' HD2' HD12 ' A' ' 102' ' ' ILE . 7.9 mmm180 -46.0 -39.92 9.76 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.734 1.214 . . . . 0.0 111.546 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.07 -33.27 33.52 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.627 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.52 -21.04 18.54 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.705 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.62 141.88 42.2 Favored Pre-proline 0 C--N 1.285 -2.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.228 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.11 165.03 31.63 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 121.968 1.778 . . . . 0.0 110.363 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -12.11 61.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.706 0.765 . . . . 0.0 110.343 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -76.26 -29.13 57.36 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.292 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 70' ' ' ALA . 85.6 t -105.9 132.73 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 CA-C-O 121.196 0.522 . . . . 0.0 109.698 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.77 168.75 8.94 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.413 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.73 HD12 ' HD2' ' A' ' 93' ' ' ARG . 66.6 mt -123.95 132.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.561 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.7 m0 -120.58 157.65 29.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -100.61 111.53 23.78 Favored 'General case' 0 C--N 1.276 -2.587 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 110.39 4.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp . . . . . 0 C--N 1.292 -1.929 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.221 -173.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CE1' ' HA3' ' A' ' 82' ' ' GLY . 31.5 m-85 . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -93.7 167.17 11.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.454 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.5 m80 74.12 18.62 3.12 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.448 1.092 . . . . 0.0 111.668 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.06 147.13 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 -42.66 25.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.89 0.376 . . . . 0.0 111.909 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.1 ttmt -149.27 163.3 38.05 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.05 139.18 54.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.04 165.75 30.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 C--N 1.311 -1.078 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.137 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.542 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -72.7 114.42 10.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.72 -174.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 41.5 t -90.4 118.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.319 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.38 169.16 9.53 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -32.08 106.55 0.02 OUTLIER Glycine 0 C--N 1.364 2.101 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 -171.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -138.63 134.12 33.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -133.78 14.48 4.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.54 1.162 . . . . 0.0 109.738 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 65.9 mtt180 -107.13 112.22 25.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.32 -39.74 65.92 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 123.642 0.639 . . . . 0.0 113.963 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -81.44 -19.23 42.9 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.7 0.8 . . . . 0.0 111.082 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' HD11 ' A' ' 9' ' ' LEU . 9.7 t70 -87.71 -46.02 9.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.11 72.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.646 1.178 . . . . 0.0 111.367 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -22.39 66.02 Favored 'General case' 0 C--O 1.19 -2.036 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.15 71.32 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.853 0.297 . . . . 0.0 111.567 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.6 -35.75 39.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.279 1.038 . . . . 0.0 109.468 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -70.68 -31.11 67.89 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.687 174.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 -35.23 79.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.091 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.0 64.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.137 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.65 -20.43 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.373 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . . . 64.78 26.77 13.02 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-O 121.75 0.786 . . . . 0.0 108.882 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' HB ' HD21 ' A' ' 4' ' ' ASN . 30.9 mt -67.28 -64.56 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.796 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.41 154.8 1.04 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.735 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 137.67 9.64 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.75 80.62 0.28 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.985 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.493 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -104.84 150.2 25.03 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.557 0.694 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.281 5.5 pt -105.91 151.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.968 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 78.1 m-85 -80.08 60.42 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.884 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.33 113.85 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 117.401 -1.719 . . . . 0.0 107.447 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.71 118.47 7.71 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.635 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p 63.8 29.82 14.67 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.566 1.546 . . . . 0.0 112.91 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -99.85 127.62 33.28 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.32 18.72 1.16 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.566 2.177 . . . . 0.0 111.682 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -118.18 -8.26 10.66 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.899 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 62.0 m -140.54 171.13 14.55 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.473 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.2 t -136.61 136.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 119.245 0.93 . . . . 0.0 108.653 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.85 174.68 5.76 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.105 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -45.82 -31.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.897 1.279 . . . . 0.0 113.122 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.58 -62.22 1.64 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.633 0.73 . . . . 0.0 110.659 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 25.0 mt-30 -64.47 -42.04 96.14 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.274 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -25.23 68.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.91 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -24.28 64.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 109.629 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.84 -49.93 7.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' GLN . 46.7 t -55.36 -35.34 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.786 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptp -58.9 -31.09 68.3 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.6 29.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.408 0.623 . . . . 0.0 110.307 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.32 -39.79 14.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -145.81 97.22 4.6 Favored Pre-proline 0 N--CA 1.401 -2.893 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.12 71.39 0.86 Allowed 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.406 2.071 . . . . 0.0 113.114 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.17 147.24 29.27 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.776 173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.99 145.42 48.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.513 -173.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.64 142.03 45.72 Favored 'General case' 0 C--O 1.253 1.256 0 CA-C-O 121.838 0.828 . . . . 0.0 112.306 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 152.24 34.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.48 149.85 17.0 Favored Glycine 0 C--O 1.2 -1.979 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.2 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.9 t -133.91 123.39 44.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -172.43 156.84 3.85 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.665 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 31.2 mtm180 -95.71 92.06 6.4 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -104.27 121.17 42.76 Favored 'General case' 0 N--CA 1.406 -2.631 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.56 -31.92 36.78 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.311 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.55 110.63 19.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.238 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.68 HG13 HD13 ' A' ' 92' ' ' LEU . 6.8 tt -58.32 -38.36 68.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.521 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.5 62.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.318 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 16.9 t70 -86.22 -31.19 21.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.155 0.502 . . . . 0.0 109.994 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.54 -46.15 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.0 t -62.57 -39.87 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.256 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 25.8 t70 -52.55 -58.82 5.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.879 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -66.98 -40.92 87.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.842 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.75 -30.77 71.0 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.367 0.667 . . . . 0.0 111.276 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -83.53 -58.74 2.69 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.794 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 59.0 t -54.4 -57.92 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.478 0.486 . . . . 0.0 111.291 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 75' ' ' LEU . 29.8 tp -77.76 -17.14 57.85 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.72 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m 59.09 72.21 0.54 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.985 0.897 . . . . 0.0 111.314 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 73' ' ' LEU . 71.4 mt -79.11 -172.44 3.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.206 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.467 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -126.68 -35.13 2.35 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.306 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -149.37 166.03 30.25 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.51 135.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -101.44 108.36 19.93 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-O 121.68 0.752 . . . . 0.0 109.602 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 92' ' ' LEU . 72.5 mt -90.53 120.54 31.7 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.102 -1.408 . . . . 0.0 107.595 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB3' ' CG ' ' A' ' 59' ' ' ARG . 8.8 t60 -83.37 85.85 7.16 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -49.22 -9.14 0.11 Allowed Glycine 0 N--CA 1.47 0.919 0 C-N-CA 128.325 2.869 . . . . 0.0 120.029 -168.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -39.0 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.83 -48.72 79.32 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -175.11 148.65 1.01 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 94.8 mt-30 -78.12 -39.21 42.0 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.9 mt -82.69 -15.98 49.88 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.554 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.568 ' O ' ' HB ' ' A' ' 91' ' ' THR . 19.0 t80 -61.29 -39.63 91.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.43 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -63.73 -34.9 70.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.929 0.871 . . . . 0.0 109.626 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.0 t70 -69.56 -18.41 63.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.455 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.576 HG22 ' CD1' ' A' ' 63' ' ' ILE . 63.1 m -83.79 -41.45 17.56 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.299 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.68 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -52.69 -41.71 64.13 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 123.272 0.629 . . . . 0.0 110.806 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.742 ' HD2' HD12 ' A' ' 102' ' ' ILE . 4.2 mmm180 -43.74 -44.44 6.61 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.11 1.364 . . . . 0.0 112.4 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -75.25 -24.27 57.62 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.913 -171.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -103.18 -3.57 25.59 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.819 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.4 tp -80.55 130.61 64.12 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 124.567 1.147 . . . . 0.0 109.567 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.49 162.52 37.94 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.379 1.386 . . . . 0.0 109.404 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.82 64.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -76.15 -30.27 58.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.6 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.511 HG21 ' HB1' ' A' ' 70' ' ' ALA . 40.5 t -104.57 147.44 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.468 0 CA-C-O 121.112 0.482 . . . . 0.0 110.109 -171.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -121.13 174.67 6.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 123.796 0.838 . . . . 0.0 108.761 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.742 HD12 ' HD2' ' A' ' 93' ' ' ARG . 92.6 mt -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 34.9 m0 -120.57 157.61 29.12 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.885 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -101.81 116.64 33.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.79 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.3 98.8 3.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.113 -173.821 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 95.8 m-85 . . . . . 0 CA--C 1.474 -1.956 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 90' ' ' ASP . 3.7 pm0 -72.9 163.81 27.58 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.585 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.506 ' CE1' ' HG3' ' A' ' 93' ' ' ARG . 5.9 t-160 65.35 38.47 5.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.98 0.895 . . . . 0.0 110.641 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -102.17 155.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.83 -39.5 15.82 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.783 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -155.53 163.02 40.55 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.52 144.38 50.89 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.788 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.42 175.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.294 -1.838 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.001 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.57 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 15.0 ptpt -77.79 98.11 5.44 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.003 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 78.1 t -72.64 109.24 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.765 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.7 m -92.07 170.94 9.44 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -50.61 116.3 4.13 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.672 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.57 176.65 6.08 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -123.93 -0.92 8.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.82 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 88.9 mtt180 -126.94 115.6 19.51 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.24 82.09 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-O 122.599 1.11 . . . . 0.0 112.32 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -70.84 -40.18 72.52 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 125.604 1.562 . . . . 0.0 108.96 -176.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 33.0 t70 -74.98 -26.85 59.88 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.507 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -46.02 61.18 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.711 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 22.4 pttp -67.66 -23.61 65.35 Favored 'General case' 0 C--O 1.199 -1.555 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.26 70.05 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.997 0.427 . . . . 0.0 110.693 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 4' ' ' ASN . . . -74.68 -42.46 58.41 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.101 0.953 . . . . 0.0 109.586 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -68.44 -32.71 72.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.949 176.476 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.8 -32.11 70.37 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.17 -25.05 54.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.702 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.92 -28.91 0.02 OUTLIER Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.093 -1.527 . . . . 0.0 113.009 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 62.46 30.74 17.28 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.921 0.867 . . . . 0.0 108.78 -176.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.57 ' HB ' HD21 ' A' ' 4' ' ' ASN . 40.5 mt -70.75 -59.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.635 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 2.3 p90 -176.2 160.53 2.21 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.899 0.749 . . . . 0.0 109.9 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -128.79 123.05 4.15 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.4 85.68 0.67 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.17 151.84 33.68 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 4.9 pt -116.58 146.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.031 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -80.32 80.39 6.76 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.051 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.8 t -107.37 114.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.52 118.96 6.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.614 1.196 . . . . 0.0 110.874 -173.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.3 p 66.43 29.25 9.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.718 1.607 . . . . 0.0 113.136 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 40.8 t -92.84 143.69 27.34 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -91.2 0.16 4.78 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 121.52 1.48 . . . . 0.0 112.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 69.7 ttt180 -122.33 6.46 9.63 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 122.17 0.986 . . . . 0.0 109.475 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 57.3 m -146.81 125.57 12.62 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.6 t -105.59 137.15 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.918 0.865 . . . . 0.0 112.844 -172.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -107.4 172.63 6.72 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.593 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 p -49.64 -32.09 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.583 0.753 . . . . 0.0 112.5 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 53.1 mp0 -62.1 -60.8 3.07 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.6 mt-30 -69.97 -32.72 71.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.188 177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.82 -23.65 67.44 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.258 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.66 -26.36 68.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.489 0.662 . . . . 0.0 109.396 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.28 -49.28 9.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' GLN . 32.3 t -61.47 -32.26 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.963 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.667 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 22.9 ptm -64.35 -23.55 67.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.916 0.389 . . . . 0.0 111.868 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.57 -20.26 21.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.347 0.594 . . . . 0.0 109.482 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.49 -53.77 5.2 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.383 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -133.65 92.84 22.4 Favored Pre-proline 0 N--CA 1.391 -3.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.23 53.55 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.818 2.345 . . . . 0.0 112.183 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -89.81 162.94 15.25 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.058 176.435 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 4.7 tt0 -64.23 131.53 47.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.512 0.725 . . . . 0.0 110.718 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 54.5 m-85 -102.85 142.26 34.27 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.095 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.9 138.25 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -113.91 128.73 8.41 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.455 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.97 106.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -163.19 168.02 21.28 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.286 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -85.85 104.77 15.82 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -100.87 150.42 22.85 Favored 'General case' 1 N--CA 1.375 -4.181 0 CA-C-O 122.339 1.066 . . . . 0.0 109.479 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -113.69 -65.97 1.13 Allowed 'General case' 1 C--N 1.235 -4.38 0 CA-C-N 112.165 -2.289 . . . . 0.0 110.402 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -89.32 119.73 30.04 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.823 0.82 . . . . 0.0 111.904 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 92' ' ' LEU . 15.1 tt -66.86 -32.56 58.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.162 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.6 61.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.242 0.544 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.5 -49.75 7.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.555 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.15 -35.76 74.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.039 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.87 -30.9 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.144 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 72' ' ' VAL . 24.2 t70 -72.1 -38.23 69.37 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -65.68 -45.94 80.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -62.51 -23.67 67.08 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.231 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 30.7 ttmt -80.41 -59.1 2.82 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 124.193 0.997 . . . . 0.0 109.784 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 68' ' ' ASP . 65.5 t -59.13 -60.03 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.227 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 1.4 mm? -78.3 -8.2 58.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.985 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.1 p 52.32 73.29 0.34 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.719 0.771 . . . . 0.0 111.985 -172.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.41 173.55 3.22 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.243 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.69 -34.63 2.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.52 46.3 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.486 168.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.68 135.61 39.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.42 117.22 33.96 Favored 'General case' 0 N--CA 1.399 -3.016 0 CA-C-O 121.134 0.492 . . . . 0.0 110.886 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -96.92 128.2 43.65 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.073 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -83.28 95.48 8.18 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -61.01 -12.93 31.87 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -171.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -54.75 -26.38 33.85 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 117.668 0.734 . . . . 0.0 112.532 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -56.08 -45.69 79.26 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 89' ' ' ILE . 10.3 tp10 -175.74 135.45 0.3 Allowed 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 123.807 0.843 . . . . 0.0 109.007 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -66.28 -44.16 84.36 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.094 1.357 . . . . 0.0 111.06 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.73 -19.97 47.54 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.465 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . 32.6 t80 -65.07 -36.79 85.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.241 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.9 mp -63.32 -41.51 93.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.51 -21.38 66.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.4 m -81.37 -45.12 16.59 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.457 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.06 -46.22 8.41 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.479 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 4.5 mpt_? -55.0 -23.78 21.07 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.2 -39.35 21.08 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.134 0.493 . . . . 0.0 111.452 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.33 -2.69 58.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.412 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.14 120.57 82.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.231 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.35 163.66 35.81 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.485 1.457 . . . . 0.0 109.718 173.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.1 -7.64 37.89 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -80.69 -30.65 36.41 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.608 0.718 . . . . 0.0 109.753 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 70' ' ' ALA . 18.9 t -104.0 146.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.274 -170.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 168.69 10.71 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.516 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.438 HG23 HD23 ' A' ' 80' ' ' LEU . 79.6 mt -123.07 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.562 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.0 m0 -125.0 164.37 20.31 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 130.96 53.39 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.44 106.87 2.25 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.961 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.417 -2.083 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 N--CA 1.427 -1.618 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.37 177.04 4.91 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.418 -175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.3 t60 73.25 28.42 1.83 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.212 1.482 . . . . 0.0 108.45 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.05 155.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.15 -40.91 62.27 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -158.14 161.96 37.94 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -99.61 154.89 17.91 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 123.701 0.8 . . . . 0.0 109.586 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.4 p -157.76 168.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.783 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.22 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 113.098 -1.864 . . . . 0.0 114.426 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -90.15 115.23 29.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.191 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.9 m -91.56 170.24 10.1 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -30.46 116.44 0.07 OUTLIER Glycine 0 C--N 1.351 1.414 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 -171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.447 HD11 ' OD2' ' A' ' 14' ' ' ASP . 16.7 tp -145.69 148.0 32.57 Favored 'General case' 0 N--CA 1.402 -2.858 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -125.67 -6.72 6.85 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -95.61 114.61 26.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.555 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -59.56 -30.5 68.72 Favored Glycine 0 C--O 1.217 -0.959 0 O-C-N 123.373 0.42 . . . . 0.0 112.06 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -67.8 -30.42 69.85 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.85 1.31 . . . . 0.0 108.045 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.447 ' OD2' HD11 ' A' ' 9' ' ' LEU . 40.6 t0 -91.46 -33.62 15.14 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 112.637 -2.074 . . . . 0.0 108.766 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.95 -34.68 78.29 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.304 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 51.0 mtmt -58.97 -25.51 63.63 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.016 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.27 75.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.974 0.416 . . . . 0.0 111.386 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 -43.94 62.84 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.755 0.788 . . . . 0.0 109.693 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.132 176.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.61 -29.76 69.88 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.309 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.69 -23.3 63.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.27 -2.88 0.05 OUTLIER Glycine 0 C--O 1.22 -0.766 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.946 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.41 21.24 12.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.565 0.746 . . . . 0.0 110.309 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.67 -67.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.436 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -163.78 -177.53 5.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.484 0.49 . . . . 0.0 110.48 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -140.11 140.88 11.01 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.84 87.84 0.44 Allowed Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.93 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.21 155.17 42.23 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.074 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.567 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 4.7 pt -116.75 155.34 18.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.42 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 41.4 m-85 -81.48 81.29 7.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.321 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 37' ' ' CYS . 11.9 p -82.49 152.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.04 89.38 5.36 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.1 p 52.33 72.89 0.37 Allowed 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.507 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 19.9 m -140.26 122.16 9.66 Favored Pre-proline 0 C--O 1.208 -1.089 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 168.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.67 5.83 0.53 Allowed 'Trans proline' 0 C--O 1.207 -1.026 0 C-N-CA 124.038 3.159 . . . . 0.0 115.413 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -101.18 -0.64 35.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.598 0.713 . . . . 0.0 109.677 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 63.2 m -136.8 166.73 22.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -133.21 137.16 53.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.524 1.056 . . . . 0.0 111.039 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -115.19 171.15 7.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.89 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 89.0 t -46.64 -32.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 0.0 113.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -56.25 24.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.723 0.773 . . . . 0.0 110.536 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -81.2 -35.29 31.55 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.668 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -62.46 -27.81 69.38 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.142 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.49 -38.19 80.24 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.63 0.728 . . . . 0.0 109.459 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.82 -45.51 10.82 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.6 p -65.53 -24.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.744 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.3 ptm -67.8 -18.08 64.73 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.025 0.441 . . . . 0.0 111.347 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.36 -22.87 18.68 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.012 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.47 -46.44 32.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.306 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.34 104.09 17.93 Favored Pre-proline 0 N--CA 1.399 -3.007 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.25 45.02 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.544 2.829 . . . . 0.0 113.247 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.8 pp -89.25 171.91 9.44 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.216 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -77.77 140.95 39.51 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 122.964 0.506 . . . . 0.0 110.102 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -108.74 137.53 46.53 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.514 0.673 . . . . 0.0 111.543 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.4 p -129.43 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.89 133.61 8.35 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.541 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.567 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.2 t -111.6 131.22 63.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -159.64 151.09 19.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -85.39 105.06 15.75 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.17 116.7 17.11 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.495 1.14 . . . . 0.0 109.598 -171.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -106.28 -74.65 0.65 Allowed 'General case' 0 C--N 1.253 -3.625 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.246 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.39 119.55 31.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.524 HG13 HD13 ' A' ' 92' ' ' LEU . 15.9 tt -62.7 -32.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.659 -177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -12.98 59.82 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.447 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 33.1 t70 -82.41 -40.32 21.43 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -73.85 -34.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.895 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' ILE . 54.7 t -60.49 -39.95 82.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.5 t70 -52.97 -51.13 62.56 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.906 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 38.4 mmtm -65.82 -45.46 82.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.001 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.88 -32.26 71.71 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.138 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -76.76 -57.65 3.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.824 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.1 t -57.62 -57.01 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.517 0.727 . . . . 0.0 112.06 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -78.53 -8.82 58.98 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.042 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.0 p 49.27 68.3 0.74 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.959 0.885 . . . . 0.0 110.863 -174.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -71.42 178.3 3.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.048 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.94 -36.4 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.794 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.23 155.57 46.01 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.3 p -142.17 139.4 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.85 129.53 45.23 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-O 121.347 0.594 . . . . 0.0 111.564 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 124.6 36.25 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.378 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 83' ' ' ASN . 26.9 t-80 -81.99 92.7 6.82 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -56.97 -19.68 31.16 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 5.7 t30 -53.92 -29.86 43.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.98 -47.82 78.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.6 tm-20 -176.41 151.18 0.95 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 99.1 mt-30 -77.93 -45.04 25.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 123.994 0.918 . . . . 0.0 111.966 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.1 mt -83.75 -23.34 31.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.131 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.4 t80 -55.0 -40.19 69.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.395 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.528 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 mp -61.8 -36.97 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.341 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.74 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 23.4 t70 -68.7 -20.69 64.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.778 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.7 m -85.21 -43.18 14.02 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.927 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.524 HD13 HG13 ' A' ' 63' ' ' ILE . 3.5 mm? -47.08 -50.75 19.29 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.74 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.18 -10.76 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.014 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.72 -51.04 10.38 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.64 -24.12 58.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.092 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.7 mt -92.07 127.47 49.27 Favored Pre-proline 0 C--N 1.276 -2.59 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.308 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.15 165.87 29.98 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.542 2.162 . . . . 0.0 110.489 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.94 -16.63 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 111.231 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -64.33 -29.14 70.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.886 0.874 . . . . 0.0 109.826 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.19 134.56 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.185 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -111.71 170.77 7.91 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mt -123.67 135.42 63.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.565 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -121.96 156.55 33.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.67 129.83 54.75 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.19 102.19 4.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 C--N 1.299 -1.596 0 C-N-CA 123.836 0.854 . . . . 0.0 109.554 -174.994 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 89' ' ' ILE . 81.9 m-85 . . . . . 0 CA--C 1.493 -1.241 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -110.71 -170.13 1.58 Allowed 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.0 m80 69.35 27.68 4.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.005 1.383 . . . . 0.0 108.805 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.03 155.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.259 -1.791 . . . . 0.0 107.39 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.31 -40.99 50.08 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.788 0.804 . . . . 0.0 111.093 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 4.9 ttmp? -153.89 163.31 40.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.82 147.7 50.44 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.22 173.56 13.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.667 0 CA-C-N 118.403 0.547 . . . . 0.0 110.718 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.626 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.773 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.47 109.71 3.32 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.852 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 59.0 t -86.0 102.7 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.6 m -96.82 170.12 9.39 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -34.32 116.3 0.18 Allowed Glycine 0 N--CA 1.476 1.367 0 O-C-N 124.218 0.949 . . . . 0.0 114.712 -174.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.6 tp -146.73 157.48 43.7 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -138.32 14.8 2.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.344 1.069 . . . . 0.0 109.724 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.0 mtt180 -115.54 110.44 19.25 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.77 -35.5 74.86 Favored Glycine 0 C--N 1.301 -1.397 0 O-C-N 123.192 0.307 . . . . 0.0 113.39 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -70.5 -35.13 73.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.223 1.011 . . . . 0.0 108.945 -177.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 16.2 t0 -82.06 -22.63 36.26 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.724 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.63 -44.77 27.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.569 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 20.9 pttp -67.79 -23.28 65.19 Favored 'General case' 0 C--O 1.201 -1.494 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.44 74.69 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.676 0.39 . . . . 0.0 110.956 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.01 69.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -69.09 -34.67 75.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.293 176.085 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.6 -32.15 73.3 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.489 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.23 -23.66 61.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.58 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.54 -20.97 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . . . 60.24 30.68 20.05 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 121.68 0.752 . . . . 0.0 109.79 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.626 ' HB ' HD21 ' A' ' 4' ' ' ASN . 31.0 mt -70.62 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.034 -171.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.35 151.33 0.61 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.287 0.992 . . . . 0.0 108.701 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.49 9.49 Favored Glycine 0 N--CA 1.417 -2.622 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.08 81.11 1.08 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.239 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -114.57 150.74 34.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.186 0.517 . . . . 0.0 110.133 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 57' ' ' VAL . 14.3 mt -118.08 156.14 19.84 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.444 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 20.7 m-85 -82.78 69.3 9.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.432 0.56 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.57 118.63 42.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.683 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.86 96.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.811 1.644 . . . . 0.0 114.24 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.0 p 56.48 23.54 7.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.626 1.57 . . . . 0.0 112.975 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' ARG . 14.8 m -103.32 111.09 64.87 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.74 19.9 0.12 Allowed 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.64 3.56 . . . . 0.0 114.386 -172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' SER . 24.1 mmt180 -91.97 -21.6 20.45 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 170.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -141.29 174.17 10.8 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.643 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -134.18 136.91 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.495 -177.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -105.13 167.32 9.79 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.258 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 69' ' ' LYS . 93.3 t -48.41 -34.58 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.925 1.29 . . . . 0.0 112.39 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.0 -55.65 27.1 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 123.632 0.773 . . . . 0.0 111.988 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 46' ' ' VAL . 29.6 mt-30 -68.59 -42.22 78.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -63.55 -20.12 65.37 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.109 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.44 -45.36 11.22 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.568 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' GLN . 14.9 t -64.09 -33.01 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.489 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -64.63 -25.38 67.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.167 0.508 . . . . 0.0 110.783 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.95 -24.38 33.02 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.45 -51.93 7.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.182 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.37 104.29 17.84 Favored Pre-proline 0 N--CA 1.395 -3.222 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 48.3 2.23 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.709 2.273 . . . . 0.0 112.293 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -85.07 168.57 14.76 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.527 175.082 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.607 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -79.65 140.43 37.07 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 120.616 0.246 . . . . 0.0 111.565 -177.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.483 ' CD2' HD11 ' A' ' 28' ' ' LEU . 33.2 m-85 -113.15 146.33 39.43 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.077 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.67 164.48 34.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.58 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -139.93 148.83 20.39 Favored Glycine 0 CA--C 1.481 -2.079 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.598 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' A' ' 29' ' ' ILE . 39.9 t -124.77 140.29 48.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -168.59 158.4 9.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.769 0.713 . . . . 0.0 109.981 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -86.15 94.72 9.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.48 HD22 ' HG ' ' A' ' 80' ' ' LEU . 84.3 m-20 -79.06 118.65 21.24 Favored 'General case' 0 N--CA 1.395 -3.184 0 CA-C-O 122.563 1.173 . . . . 0.0 110.327 -173.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.93 -61.43 1.58 Allowed 'General case' 0 C--N 1.247 -3.889 0 CA-C-N 112.521 -2.127 . . . . 0.0 106.127 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.22 110.45 18.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.759 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 92' ' ' LEU . 14.6 tt -64.62 -32.04 56.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.084 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.25 -22.32 63.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.212 0.529 . . . . 0.0 110.212 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.0 t70 -83.04 -34.82 26.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.05 -44.02 99.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.4 t -59.81 -45.54 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.472 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.5 t70 -52.22 -61.27 2.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.196 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HD2' HG21 ' A' ' 40' ' ' VAL . 46.9 mmtm -64.16 -42.09 96.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.679 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.03 -31.26 72.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.555 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -79.4 -57.81 3.52 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.422 0.451 . . . . 0.0 110.182 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.0 t -53.59 -55.69 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.987 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -81.31 -16.54 52.15 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.437 -179.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.6 m 59.89 74.43 0.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.179 0.99 . . . . 0.0 110.402 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.1 mt -86.4 -168.49 2.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.936 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.607 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . . . -128.65 -40.29 1.58 Allowed 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.05 161.61 39.0 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.776 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.0 p -140.82 137.43 35.08 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.76 121.39 39.62 Favored 'General case' 0 N--CA 1.381 -3.917 0 CA-C-O 121.678 0.752 . . . . 0.0 110.248 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.48 ' HG ' HD22 ' A' ' 60' ' ' ASN . 1.4 tt -109.49 136.24 49.21 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -77.76 79.16 4.25 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.56 -13.12 1.81 Allowed Glycine 0 C--O 1.214 -1.107 0 CA-C-N 114.003 -1.453 . . . . 0.0 116.567 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -55.35 -24.31 28.65 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.537 1.135 . . . . 0.0 112.769 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -48.76 -49.3 39.16 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.282 1.033 . . . . 0.0 113.172 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -176.88 148.9 0.69 Allowed 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.514 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 52.6 tt0 -77.81 -48.85 15.55 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.421 1.105 . . . . 0.0 112.065 -168.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.82 -17.53 62.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.998 -174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.51 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.0 t80 -61.11 -45.0 96.49 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.89 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.63 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-O 121.779 0.799 . . . . 0.0 109.16 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.83 -20.46 66.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.226 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 89.3 m -83.9 -41.31 17.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.583 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -50.73 -38.37 47.09 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 123.684 0.794 . . . . 0.0 111.773 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -59.14 -34.32 71.92 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.209 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.08 -37.84 45.6 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.279 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.94 -18.96 26.4 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 102' ' ' ILE . 95.2 mt -96.46 141.32 22.93 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.364 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.38 165.8 31.34 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.07 1.846 . . . . 0.0 110.363 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -11.79 18.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.199 0.999 . . . . 0.0 112.126 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -79.15 -28.55 42.8 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.231 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.1 t -104.22 127.56 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.034 0 CA-C-O 121.44 0.638 . . . . 0.0 109.617 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 121' ' ' ASP . . . -111.37 172.58 6.8 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 96' ' ' LEU . 3.5 mp -128.21 130.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.459 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 37.6 m0 -116.94 155.76 28.56 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.96 113.68 26.43 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.89 2.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.41 -2.465 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.655 -175.523 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 67.9 m-85 . . . . . 0 N--CA 1.418 -2.048 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.03 166.71 22.49 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.8 m170 66.26 30.05 9.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.707 0.63 . . . . 0.0 112.543 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.8 m -103.72 149.6 7.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 24.3 t70 -85.67 -42.28 14.43 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.258 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -153.59 163.13 40.5 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.544 0.738 . . . . 0.0 111.442 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.74 135.78 49.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.311 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.2 163.45 29.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.5 tp . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 27' ' ' GLY . 9.5 ptmt -67.59 96.2 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.4 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.14 104.96 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.182 0.992 . . . . 0.0 111.53 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 169.2 10.16 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -31.34 109.47 0.03 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.29 147.58 2.0 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -136.42 -3.2 2.16 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.776 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.29 111.51 5.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.37 -58.07 5.39 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 124.57 1.081 . . . . 0.0 113.971 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.411 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.1 -19.9 22.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -92.0 -44.87 8.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.48 74.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.42 -23.37 65.78 Favored 'General case' 0 C--O 1.191 -2.007 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.176 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.64 -35.0 69.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.071 0.463 . . . . 0.0 110.967 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.33 56.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.727 0.775 . . . . 0.0 110.089 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -70.66 -35.95 73.11 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.364 177.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.95 -26.28 62.07 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.403 1.081 . . . . 0.0 111.067 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.09 -22.51 66.41 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.499 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.83 18.27 0.15 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.805 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.87 25.99 7.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.574 1.15 . . . . 0.0 111.727 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -57.93 -67.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.092 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.67 155.66 2.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -122.15 131.33 8.36 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -97.78 88.47 0.92 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.467 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -125.11 149.1 48.19 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 1.9 pt -117.69 157.87 18.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 49.6 m-85 -86.92 87.29 7.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 124.149 0.906 . . . . 0.0 112.114 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 54.7 t -121.86 116.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 169.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.46 113.26 1.35 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 124.447 1.092 . . . . 0.0 113.298 -173.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p 62.94 23.34 13.95 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.864 1.666 . . . . 0.0 113.885 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 78.9 p -86.62 149.27 48.33 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.48 13.73 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.752 1.635 . . . . 0.0 111.705 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 21.9 ptt180 -119.42 -8.56 10.02 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.014 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 59.5 m -145.51 172.89 12.56 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.21 137.31 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 109.071 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -103.61 164.91 11.36 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.45 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.0 p -51.51 -35.21 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 124.265 0.978 . . . . 0.0 111.57 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 7.9 mp0 -67.82 -39.2 83.94 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 124.36 1.064 . . . . 0.0 112.011 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 46' ' ' VAL . 51.6 mm-40 -67.33 -51.15 55.91 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 122.67 1.224 . . . . 0.0 107.914 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.44 66.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.462 -2.154 . . . . 0.0 114.449 -168.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 47' ' ' MET . 6.1 pt20 -63.75 -31.2 72.3 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.81 -37.94 29.25 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.31 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 42' ' ' GLN . 44.8 t -65.63 -31.67 54.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.16 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 27.1 ptt? -67.83 -17.32 64.47 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.223 0.535 . . . . 0.0 111.76 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.63 46.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.427 0.632 . . . . 0.0 109.469 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.22 -40.62 6.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.305 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -137.94 98.75 9.41 Favored Pre-proline 0 N--CA 1.406 -2.656 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.11 59.91 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.057 2.504 . . . . 0.0 113.023 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.42 163.9 12.04 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.366 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.91 145.47 46.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.63 0.252 . . . . 0.0 110.576 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.74 140.79 47.98 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.2 p -133.57 144.0 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 30' ' ' PHE . . . -109.72 132.56 11.11 Favored Glycine 0 CA--C 1.475 -2.464 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 79' ' ' GLN . 7.3 p -140.09 104.05 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.053 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -167.88 178.75 5.03 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -173.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -86.3 93.42 9.08 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.42 117.99 26.57 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -85.77 -63.19 1.36 Allowed 'General case' 0 C--N 1.247 -3.89 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.711 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -89.44 125.32 35.12 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.032 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 67' ' ' VAL . 19.1 tt -63.4 -34.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.064 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.65 -20.11 62.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.62 0.724 . . . . 0.0 110.39 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 18.3 t70 -85.93 -39.48 16.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.158 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' ILE . 14.5 p -77.46 -32.21 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.823 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.2 t -59.9 -40.92 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 21.3 t70 -54.09 -50.93 65.68 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.534 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.1 mmtm -69.21 -42.1 76.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.139 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -66.37 -22.98 66.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -83.83 -61.74 1.75 Allowed 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 67.2 t -54.69 -56.68 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 123.894 0.746 . . . . 0.0 111.548 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HB2' HG23 ' A' ' 40' ' ' VAL . 59.2 tp -83.16 -19.52 36.46 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.69 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 12.7 t 60.09 82.83 0.15 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 122.333 1.063 . . . . 0.0 109.768 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.22 173.01 11.9 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.644 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.24 -31.54 5.95 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -151.54 161.45 42.67 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.921 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 66' ' ' VAL . 6.5 p -143.87 138.73 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.39 119.81 39.59 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 121.848 -0.533 . . . . 0.0 110.575 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.486 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -99.86 119.76 38.7 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.347 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -81.53 104.03 11.67 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.77 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -53.76 -12.25 2.46 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.739 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -55.24 -27.76 48.51 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 110.762 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -72.78 -47.58 45.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 123.076 0.235 . . . . 0.0 110.874 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.57 150.03 0.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -78.62 -44.31 24.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.507 1.146 . . . . 0.0 110.823 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 32.6 mt -80.71 -13.38 59.05 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.934 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 24.7 t80 -59.04 -42.96 91.51 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.381 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.527 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -59.51 -38.19 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.625 0.726 . . . . 0.0 109.476 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 18.8 t70 -63.06 -22.0 66.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.33 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.462 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 94.2 m -88.53 -45.14 10.15 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.658 1.183 . . . . 0.0 109.997 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -45.09 -47.16 11.98 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.48 -24.51 66.63 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.129 -177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 29.7 mt-10 -76.56 -37.74 56.08 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.384 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.1 -36.55 15.67 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.466 0.651 . . . . 0.0 112.255 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.31 121.2 75.24 Favored Pre-proline 0 C--N 1.272 -2.763 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.813 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.47 165.43 20.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.479 2.119 . . . . 0.0 111.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.28 -10.74 17.28 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.493 1.117 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -75.7 -29.56 59.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.448 HG21 ' HB1' ' A' ' 70' ' ' ALA . 61.6 t -100.56 129.73 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.335 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.99 164.88 11.77 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.338 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 80' ' ' LEU . 71.1 mt -116.94 132.66 66.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 45.4 m0 -122.31 158.94 28.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.728 174.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 105' ' ' ALA . 17.5 tptm -100.97 115.86 31.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -77.55 98.12 5.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.634 -174.724 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.666 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 31.8 m-85 . . . . . 0 N--CA 1.41 -2.426 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -85.24 153.5 22.57 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 69.8 m80 75.77 24.56 1.25 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.269 -2.242 . . . . 0.0 111.604 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.44 143.56 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.85 -32.2 21.84 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.183 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 40.2 ttmt -153.56 160.36 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.325 0.583 . . . . 0.0 109.638 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -111.63 134.76 52.98 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.383 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.31 -176.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 -179.434 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 . . . . . 0 C--O 1.213 -0.849 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -51.03 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.598 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 7.6 p -99.86 103.22 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.957 0.884 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.81 168.53 11.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -6.62 106.41 0.01 OUTLIER Glycine 0 N--CA 1.484 1.88 0 C-N-CA 125.578 1.561 . . . . 0.0 116.942 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.54 145.68 51.91 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -125.45 8.74 7.77 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.118 0.961 . . . . 0.0 108.633 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 11' ' ' ARG . 64.9 mtt180 -125.32 107.35 10.61 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.227 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.69 -54.01 8.11 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 124.07 0.843 . . . . 0.0 113.177 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -63.45 -26.32 68.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 30.1 t70 -87.09 -23.11 25.02 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.087 0.946 . . . . 0.0 108.64 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.08 -22.75 60.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.558 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -61.19 -24.18 66.13 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.584 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.12 -34.4 60.21 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.289 0.368 . . . . 0.0 111.748 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.36 67.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.885 0.85 . . . . 0.0 110.047 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -36.15 81.74 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.976 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.24 -28.53 69.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.416 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.2 -23.03 59.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.904 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.32 -11.95 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 118.413 -1.851 . . . . 0.0 113.717 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.18 23.87 14.15 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 121.46 0.647 . . . . 0.0 109.771 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 24' ' ' ILE . 12.7 mt -57.8 -53.13 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.122 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 37.9 p90 -170.6 -172.09 1.16 Allowed 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.85 177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.26 122.06 1.64 Allowed Glycine 0 C--N 1.284 -2.306 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 171.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.99 100.63 1.97 Allowed Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.369 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -131.96 161.98 31.8 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 123.07 0.548 . . . . 0.0 109.893 -178.275 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 pt -117.4 153.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 86.7 m-85 -81.55 82.44 7.32 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -127.81 133.45 67.41 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.718 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.4 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . . . -70.88 136.16 48.45 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.533 0.682 . . . . 0.0 111.26 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p 53.73 9.63 0.2 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 127.204 2.202 . . . . 0.0 116.322 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -94.75 128.54 39.21 Favored Pre-proline 0 C--O 1.211 -0.928 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.863 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.32 0.16 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.345 2.696 . . . . 0.0 113.99 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -104.14 -8.01 19.76 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.304 0.573 . . . . 0.0 110.299 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 57.8 m -139.62 136.05 33.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.891 -0.506 . . . . 0.0 111.185 -171.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.492 ' O ' HD23 ' A' ' 28' ' ' LEU . 2.3 t -108.13 135.4 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 4.0 p30 -125.28 -170.06 2.1 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 99.1 t -46.92 -34.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 125.152 1.532 . . . . 0.0 111.286 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.84 -64.41 0.95 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 122.367 1.08 . . . . 0.0 111.353 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.3 mp0 -68.88 -49.45 58.18 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.716 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -24.0 66.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.782 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -61.36 -34.76 75.84 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.81 -50.37 8.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.075 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 42' ' ' GLN . 24.5 t -58.19 -30.82 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.995 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.1 ptm -68.13 -12.13 60.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.983 0.421 . . . . 0.0 111.646 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.64 -6.67 24.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -42.13 4.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.384 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.76 99.27 15.5 Favored Pre-proline 0 N--CA 1.396 -3.134 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -76.09 71.73 5.57 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 C-N-CA 121.899 1.733 . . . . 0.0 111.675 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.65 160.99 15.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.508 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HB3' ' HA ' ' A' ' 25' ' ' TYR 0.253 1.3 tm0? -75.71 122.42 23.98 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.103 1.361 . . . . 0.0 108.656 -176.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.45 ' HD2' HD11 ' A' ' 28' ' ' LEU . 91.5 m-85 -92.31 137.69 32.15 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.683 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -132.16 136.39 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.53 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -116.27 150.11 18.66 Favored Glycine 0 CA--C 1.481 -2.035 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.652 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 29' ' ' ILE . 41.4 t -130.05 133.79 63.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -172.4 159.49 4.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.588 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.526 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 16.3 ttm180 -104.44 97.01 7.0 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.98 148.11 25.75 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -97.65 -37.68 9.82 Favored 'General case' 1 C--N 1.238 -4.273 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.137 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' ASP . 9.5 t70 -97.68 126.0 42.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.844 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 HD13 ' A' ' 92' ' ' LEU . 7.6 tt -63.97 -34.44 68.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.149 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.61 -15.81 59.73 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.452 0.644 . . . . 0.0 109.772 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 12.3 t70 -75.93 -38.29 57.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.392 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.43 -46.7 69.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.316 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -59.42 -40.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.528 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.8 t70 -52.01 -56.17 15.96 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.08 176.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.5 mmtm -64.82 -43.18 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.347 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.35 85.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 124.182 0.926 . . . . 0.0 111.066 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.65 -52.14 8.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.54 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 68' ' ' ASP . 57.6 t -57.43 -57.51 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.886 0.375 . . . . 0.0 111.227 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -78.75 -12.8 60.04 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.709 -176.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 p 54.69 73.63 0.39 Allowed 'General case' 0 C--O 1.252 1.226 0 CA-C-O 122.309 1.052 . . . . 0.0 111.623 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.75 -174.31 4.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.793 -1.549 . . . . 0.0 111.858 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.66 -38.07 1.73 Allowed 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.678 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.79 159.64 42.54 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 173.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -144.74 137.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.425 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.616 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.76 112.11 24.91 Favored 'General case' 0 N--CA 1.391 -3.414 0 C-N-CA 123.102 0.561 . . . . 0.0 109.575 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.24 130.5 37.11 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.477 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -70.7 103.67 2.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.484 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.64 -31.87 53.38 Favored Glycine 0 CA--C 1.496 -1.122 0 CA-C-N 114.154 -1.385 . . . . 0.0 114.243 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -48.48 -25.55 1.72 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.534 1.134 . . . . 0.0 113.013 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD3' ' A' ' 59' ' ' ARG . 11.7 tp10 -66.06 -47.3 74.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.534 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -178.5 148.59 0.46 Allowed 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 27.8 mp0 -77.88 -46.53 21.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.0 0.905 . . . . 0.0 112.16 -173.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -79.34 -21.74 45.43 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.245 -171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.8 t80 -52.43 -44.51 65.51 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.483 173.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.7 mp -64.17 -36.49 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.338 0.589 . . . . 0.0 110.152 -177.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.45 -17.41 58.11 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.67 0.748 . . . . 0.0 110.695 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 83.7 m -79.19 -42.17 26.67 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.176 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.563 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -43.92 -47.21 8.38 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.517 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 119' ' ' HIS . 4.0 mpt_? -52.47 -32.52 40.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -75.46 -29.03 59.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.023 0.439 . . . . 0.0 111.419 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.38 -1.66 28.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.01 0.909 . . . . 0.0 110.562 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 14.7 tp -91.3 133.27 31.85 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.076 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.14 163.53 38.89 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.591 1.527 . . . . 0.0 110.587 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.48 69.9 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.231 1.013 . . . . 0.0 112.67 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -79.66 -13.83 59.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.3 140.58 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.567 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.26 174.09 6.24 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -128.19 135.49 62.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.616 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 51.6 m0 -122.57 162.56 21.59 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.494 -0.882 . . . . 0.0 108.704 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 123' ' ' TYR . 18.6 tptm -100.82 116.0 31.68 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.445 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -74.56 98.94 3.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -173.726 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 22.3 m-85 . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -96.75 174.17 6.94 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.964 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 20.9 m170 72.7 14.74 5.0 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.696 1.599 . . . . 0.0 110.778 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.89 150.33 6.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.237 0.542 . . . . 0.0 111.52 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.57 -29.44 59.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.942 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -159.75 158.54 31.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 104' ' ' LYS . 7.1 m-85 -109.14 128.85 55.36 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.41 -178.04 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 123.33 0.394 . . . . 0.0 109.939 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--N 1.313 -0.978 0 O-C-N 123.49 0.494 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -16.84 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.376 2.27 . . . . 0.0 115.357 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.96 110.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.568 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.3 m -91.11 169.38 10.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -38.41 106.68 0.05 OUTLIER Glycine 0 N--CA 1.473 1.152 0 O-C-N 124.196 0.935 . . . . 0.0 114.539 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 11' ' ' ARG . 3.6 tt -138.37 146.23 42.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 p -111.12 -19.82 12.58 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.255 1.026 . . . . 0.0 110.575 -169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 9' ' ' LEU . 71.4 mtm180 -86.21 108.49 18.39 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.721 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.96 -39.43 89.16 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-O 122.181 0.878 . . . . 0.0 112.833 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -73.57 -18.23 61.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.833 -1.183 . . . . 0.0 110.756 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -92.91 -45.8 7.79 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -28.04 68.38 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.705 1.202 . . . . 0.0 112.175 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.81 -22.89 59.52 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.967 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.69 43.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.462 0.705 . . . . 0.0 112.288 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.25 47.69 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 110.784 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.8 -33.98 34.39 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.012 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.23 -23.41 55.76 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 125.828 1.651 . . . . 0.0 110.524 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.39 62.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.87 26.8 0.75 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.825 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.45 34.16 20.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.358 1.063 . . . . 0.0 111.743 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 21.9 mt -62.58 -69.05 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.233 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' HB2' ' CD ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.96 155.64 0.99 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.049 -173.032 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.96 138.43 11.03 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.44 75.83 0.23 Allowed Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.426 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -117.31 144.22 45.11 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 22.0 mt -117.1 152.65 18.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.372 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 4.9 m-85 -82.55 72.29 9.62 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 118.035 0.38 . . . . 0.0 110.245 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 66.1 t -95.76 121.99 46.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 118.459 -1.297 . . . . 0.0 107.692 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.53 108.43 0.17 Allowed 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.429 1.081 . . . . 0.0 112.864 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.2 p 57.82 29.04 16.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.701 1.6 . . . . 0.0 113.915 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -80.97 140.09 49.91 Favored Pre-proline 0 N--CA 1.423 -1.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.32 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.4 7.94 4.85 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 C-N-CA 121.596 1.53 . . . . 0.0 112.297 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -124.65 2.18 8.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 109.858 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 93.9 m -154.12 125.21 7.31 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.33 137.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.61 0.719 . . . . 0.0 111.634 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -104.0 170.95 7.62 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.873 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.32 -35.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.025 1.33 . . . . 0.0 113.224 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.33 -50.71 58.93 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.959 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -78.29 -32.39 49.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.992 0.901 . . . . 0.0 109.441 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.948 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -63.22 -25.87 68.53 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.796 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -55.6 -39.13 70.35 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.882 0.873 . . . . 0.0 109.714 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -86.5 -46.12 10.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.002 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.948 HG12 ' HA ' ' A' ' 43' ' ' ALA . 7.0 p -60.82 -31.89 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.382 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 73' ' ' LEU . 26.5 ptt? -66.16 -27.06 67.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.983 0.42 . . . . 0.0 110.953 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.42 21.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.372 0.606 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.42 -47.26 34.88 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.342 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.0 101.41 22.84 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.33 66.4 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.969 1.779 . . . . 0.0 112.057 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.462 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.5 pp -107.73 176.41 5.15 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.408 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' TYR . 4.1 tt0 -76.73 131.83 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.664 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD11 ' A' ' 28' ' ' LEU . 61.0 m-85 -105.14 141.96 35.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.487 0.661 . . . . 0.0 110.768 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.6 p -129.11 160.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.88 139.25 10.24 Favored Glycine 0 C--N 1.277 -2.717 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.073 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HB ' HG23 ' A' ' 29' ' ' ILE . 61.8 t -113.28 127.89 70.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -154.22 147.0 24.3 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.489 -1.285 . . . . 0.0 110.511 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -86.26 102.19 13.73 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 167.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.6 OUTLIER -80.49 114.56 19.47 Favored 'General case' 0 N--CA 1.387 -3.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.55 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -105.43 -58.08 1.95 Allowed 'General case' 0 C--N 1.256 -3.463 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.85 116.35 30.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.297 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 67' ' ' VAL . 18.3 tt -64.63 -31.4 53.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 120.876 0.37 . . . . 0.0 111.168 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.81 -9.5 59.07 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.632 -0.667 . . . . 0.0 110.714 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 11.3 t70 -84.88 -39.13 18.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.72 -35.0 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -63.96 -36.47 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.3 t70 -53.71 -53.36 53.22 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.975 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 42.2 mmtm -64.72 -44.2 90.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.094 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -57.65 -33.49 68.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.666 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.28 -60.66 2.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.168 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.2 t -54.59 -59.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.647 0.779 . . . . 0.0 112.245 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HA ' ' SD ' ' A' ' 47' ' ' MET . 1.4 mm? -78.61 -14.21 59.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.888 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.6 t 57.13 73.58 0.45 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.945 0.879 . . . . 0.0 109.794 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.63 -178.8 4.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.208 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -128.06 -34.22 2.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -149.24 160.16 43.63 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.697 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.29 137.18 37.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.6 mp0 -96.46 118.33 32.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 89' ' ' ILE . 34.3 tp -99.78 125.86 45.76 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.734 -170.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.493 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 72.5 m80 -87.29 95.75 10.1 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -67.69 -12.95 62.73 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.74 -1.118 . . . . 0.0 114.74 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 81' ' ' HIS . 3.4 p-10 -56.36 -25.49 49.63 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.165 0.586 . . . . 0.0 112.438 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.86 82.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 112.887 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.7 tm-20 -171.46 141.5 1.53 Allowed 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -78.06 -42.01 33.61 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -168.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.02 -24.17 30.63 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-O 121.882 0.848 . . . . 0.0 109.959 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 91' ' ' THR . 36.7 t80 -51.43 -32.55 27.09 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 125.98 1.712 . . . . 0.0 112.13 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.508 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -60.07 -39.66 81.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.415 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 9.9 t70 -67.9 -14.74 63.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.47 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 75.2 m -88.13 -46.57 9.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.23 1.412 . . . . 0.0 109.367 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.469 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.91 -51.01 10.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.619 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -56.99 -29.96 63.73 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 121.219 0.533 . . . . 0.0 112.18 -178.283 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -76.15 -31.12 58.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.483 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -94.76 -23.79 17.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 92' ' ' LEU . 98.2 mt -76.7 131.44 73.92 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.688 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.04 165.2 10.84 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.724 2.283 . . . . 0.0 112.446 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.02 55.02 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.721 1.208 . . . . 0.0 113.099 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -85.86 -8.58 57.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.534 HG21 ' HB1' ' A' ' 70' ' ' ALA . 82.7 t -98.66 124.89 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-O 121.717 0.77 . . . . 0.0 109.263 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.96 172.73 6.66 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.034 -176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.08 130.94 73.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.2 m0 -119.9 159.38 24.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -101.18 117.94 36.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.325 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.11 105.72 3.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.3 tt . . . . . 0 N--CA 1.419 -1.998 0 CA-C-O 121.903 0.858 . . . . 0.0 109.772 -175.081 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.403 -2.796 0 N-CA-C 102.833 -3.025 . . . . 0.0 102.833 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -136.22 172.52 12.89 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.4 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 36.8 m80 69.41 36.55 2.24 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.576 1.551 . . . . 0.0 112.429 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 m -84.74 152.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.46 -47.28 11.55 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.706 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 67.6 mttm -151.06 163.85 37.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -110.94 162.39 14.88 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 125' ' ' LEU . 13.3 p -141.27 174.14 7.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.44 ' H ' HG22 ' A' ' 124' ' ' VAL . 28.4 tp . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 5.1 t30 . . . . . 0 CA--C 1.489 -1.372 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -37.05 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 112.673 -2.058 . . . . 0.0 112.116 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.58 121.4 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.988 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.55 170.73 9.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.03 135.68 3.42 Favored Glycine 0 C--N 1.357 1.749 0 CA-C-N 119.152 0.887 . . . . 0.0 114.321 -170.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.52 161.31 37.37 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -176.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -129.09 18.53 6.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -137.2 106.17 5.96 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.649 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.41 -48.77 27.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 124.765 1.174 . . . . 0.0 113.04 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -63.22 -19.32 64.42 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 125.822 1.649 . . . . 0.0 112.444 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.0 -42.23 9.15 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.77 69.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.764 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.3 -23.06 67.25 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.52 69.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -77.08 -30.13 55.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 0.0 110.789 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.06 -34.46 50.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.02 -30.49 71.56 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.065 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -17.38 64.39 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.426 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.44 15.31 0.5 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.134 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.46 26.56 12.78 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.455 0.702 . . . . 0.0 110.837 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.67 -67.6 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.223 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -178.53 159.76 1.18 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.258 0.974 . . . . 0.0 108.815 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.6 142.83 14.28 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 108.459 -1.857 . . . . 0.0 108.459 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.62 78.8 0.27 Allowed Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.573 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.553 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -115.34 146.32 41.65 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.114 0.483 . . . . 0.0 109.734 -177.142 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 pt -117.37 155.01 19.12 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 38.5 m-85 -84.16 76.93 10.04 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.651 1.219 . . . . 0.0 109.689 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.28 121.93 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 98.79 0.02 OUTLIER 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.04 1.463 . . . . 0.0 113.82 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p 58.77 25.26 13.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.858 1.663 . . . . 0.0 114.97 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -90.76 116.07 65.6 Favored Pre-proline 0 C--O 1.199 -1.557 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.99 -7.3 2.33 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 124.273 3.315 . . . . 0.0 116.542 -171.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.23 11.54 27.29 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.637 1.208 . . . . 0.0 109.797 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 66.2 m -140.0 170.92 14.97 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.17 136.57 16.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 119.486 1.039 . . . . 0.0 109.869 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.41 166.87 10.51 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.263 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -42.96 -36.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 O-C-N 125.044 1.465 . . . . 0.0 113.843 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.9 -32.54 61.85 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 46' ' ' VAL . 16.2 mt-30 -83.38 -37.85 22.76 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.713 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.49 64.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.662 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -63.8 -33.06 74.83 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -77.34 -46.23 23.58 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.75 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' GLN . 6.4 t -63.72 -34.4 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.649 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.24 -16.09 62.48 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.893 -0.504 . . . . 0.0 111.49 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.62 -19.67 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.24 -40.81 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.096 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.16 97.24 9.78 Favored Pre-proline 0 N--CA 1.408 -2.551 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -74.43 53.32 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.852 2.368 . . . . 0.0 113.544 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.1 pp -90.39 168.97 11.47 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.425 1.09 . . . . 0.0 109.14 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -71.75 140.34 49.47 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 122.964 0.505 . . . . 0.0 110.128 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.501 ' CD2' HD11 ' A' ' 28' ' ' LEU . 15.4 m-85 -112.29 137.84 49.85 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.521 0.677 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.18 148.86 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -122.31 143.74 15.7 Favored Glycine 0 C--N 1.283 -2.398 0 C-N-CA 119.783 -1.199 . . . . 0.0 112.147 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.495 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.3 t -134.97 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -172.59 163.39 5.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 13.9 ptm180 -96.64 93.87 6.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HB2' HG22 ' A' ' 66' ' ' VAL . 14.1 m120 -90.61 117.64 29.43 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.88 -38.47 70.0 Favored 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.487 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -99.24 129.27 45.46 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.567 HG13 HD13 ' A' ' 92' ' ' LEU . 15.3 tt -64.03 -31.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.081 0.467 . . . . 0.0 110.1 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.97 -11.83 60.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 110.784 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 35.6 t70 -85.39 -41.53 15.36 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 60' ' ' ASN . 21.7 t -63.02 -51.84 66.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.295 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.8 t -58.8 -38.25 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.965 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 72' ' ' VAL . 36.3 t70 -65.54 -43.97 88.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.007 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 56.8 mmtt -67.91 -44.81 76.06 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.02 -36.28 72.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.77 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -73.85 -59.59 2.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.8 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 68' ' ' ASP . 87.0 t -54.41 -58.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.56 -3.44 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.833 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 p 51.4 61.85 3.01 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.79 0.805 . . . . 0.0 111.796 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 174.52 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.542 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 53' ' ' GLN . . . -125.88 -29.42 3.1 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.362 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.25 155.22 43.1 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.28 136.51 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.25 110.37 22.31 Favored 'General case' 0 N--CA 1.384 -3.738 0 C-N-CA 123.019 0.527 . . . . 0.0 110.044 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.25 123.22 36.38 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.522 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 52.1 m-70 -74.25 94.02 2.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.61 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -55.69 -12.72 5.22 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 117.29 1.676 . . . . 0.0 117.29 -170.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -44.88 -25.48 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.613 1.165 . . . . 0.0 113.694 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.94 -48.24 82.75 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -172.18 150.04 2.39 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.271 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 93.9 mt-30 -77.44 -42.9 34.33 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.05 0.928 . . . . 0.0 111.933 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.06 -13.0 54.23 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.784 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 21.9 t80 -59.12 -40.98 87.07 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.308 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -63.52 -39.51 85.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.816 0.817 . . . . 0.0 109.229 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.53 -16.78 64.38 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.814 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.2 m -85.27 -39.99 17.11 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.677 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.09 -39.5 63.42 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 123.137 0.575 . . . . 0.0 110.702 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HD2' ' CD1' ' A' ' 102' ' ' ILE . 6.7 mmm180 -43.34 -43.75 5.2 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.659 1.224 . . . . 0.0 111.759 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -71.08 -46.3 62.12 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.354 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 -12.01 27.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.21 130.03 47.54 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HG2' HG23 ' A' ' 100' ' ' VAL . 37.3 Cg_endo -66.1 164.16 28.74 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.225 1.95 . . . . 0.0 111.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.05 -27.2 63.39 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 124.276 1.031 . . . . 0.0 113.338 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -85.34 -7.96 58.71 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.586 HG21 ' HB1' ' A' ' 70' ' ' ALA . 92.7 t -104.11 133.35 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -115.74 169.61 9.08 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.307 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.421 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 84.7 mt -123.14 130.02 74.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.585 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 42.0 m0 -121.14 159.9 24.84 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.416 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.71 115.5 30.6 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.72 103.77 2.66 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.781 0.676 . . . . 0.0 109.245 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 tp . . . . . 0 N--CA 1.421 -1.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 -178.691 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 50.1 m-85 . . . . . 0 N--CA 1.415 -2.204 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 13.9 pt20 -99.57 -169.07 1.7 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.564 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 94.3 m-70 70.42 34.36 2.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.47 164.36 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.617 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.08 -37.99 14.7 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 38.4 ttmt -161.12 162.66 31.56 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.957 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -107.42 142.83 36.65 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.792 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.9 163.74 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.28 -2.423 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -177.35 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.606 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.1 p-10 . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.98 114.74 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.655 -173.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.591 ' H ' ' HA2' ' A' ' 26' ' ' GLY . 97.6 t -93.91 117.97 38.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.764 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 16.9 p -136.81 166.88 22.57 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.51 106.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.955 0 C-N-CA 126.055 1.788 . . . . 0.0 116.939 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -160.54 159.92 31.26 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -138.72 19.91 2.68 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.2 mtp180 -114.52 101.76 9.43 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.452 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.87 -44.03 55.26 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.274 0.94 . . . . 0.0 113.853 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -75.14 -19.81 59.7 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.325 -0.937 . . . . 0.0 110.312 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 36.4 t70 -83.45 -38.33 22.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -63.42 -50.28 70.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.123 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 12.2 pttp -65.68 -23.77 66.85 Favored 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -26.19 67.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.4 -37.4 25.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.804 0.812 . . . . 0.0 109.417 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -67.83 -38.96 83.87 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.744 -0.598 . . . . 0.0 110.442 174.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -60.97 -32.74 72.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.056 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.16 62.92 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.735 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.49 -14.34 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.597 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.52 18.2 11.19 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.643 0.777 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.606 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 22.3 mt -63.14 -67.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.375 -170.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.6 p90 -174.03 161.89 3.73 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 123.627 0.579 . . . . 0.0 110.538 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.591 ' HA2' ' H ' ' A' ' 6' ' ' VAL . . . -129.97 122.45 3.71 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.52 88.67 1.25 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -116.42 147.4 41.71 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.285 4.6 pt -117.24 151.69 19.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.434 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 48.9 m-85 -85.12 73.98 10.56 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.605 -174.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HB ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -120.93 115.7 47.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.35 106.44 0.12 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 124.94 1.4 . . . . 0.0 113.901 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p 65.54 15.89 10.25 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.005 1.722 . . . . 0.0 115.05 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 24.9 t -74.85 138.28 73.24 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.89 -0.89 7.69 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 122.811 2.341 . . . . 0.0 113.727 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 58.6 ttp180 -114.18 -4.51 13.09 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 15.2 m -129.88 130.12 44.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.992 -169.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.63 134.94 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -118.25 179.25 4.16 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.275 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 73' ' ' LEU . 6.9 p -45.51 -31.74 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 O-C-N 124.666 1.229 . . . . 0.0 113.204 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.22 -61.97 1.61 Allowed 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 123.742 0.817 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -67.96 -37.8 81.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.22 0.534 . . . . 0.0 110.256 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.06 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.88 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 3.8 tp-100 -67.78 -39.49 84.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.027 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.88 -40.52 14.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.978 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.5 p -64.56 -22.9 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.748 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 21.6 ptp -67.8 -17.12 64.42 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.543 0.687 . . . . 0.0 110.931 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.37 3.15 40.27 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.499 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.83 -42.6 3.77 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.134 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -142.39 101.06 5.65 Favored Pre-proline 0 N--CA 1.4 -2.956 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.43 70.07 3.3 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 112.007 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -111.99 160.56 17.34 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.202 174.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 2.6 tt0 -67.16 134.93 52.7 Favored 'General case' 0 C--O 1.208 -1.079 0 C-N-CA 123.229 0.612 . . . . 0.0 109.89 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 61.3 m-85 -108.52 140.6 41.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.077 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 9.5 p -133.96 133.96 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -110.37 125.89 7.67 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.598 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 18.0 t -112.89 121.58 65.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -173.08 154.33 2.74 Favored 'General case' 0 CA--C 1.493 -1.223 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.361 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.56 104.9 15.74 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 122.458 1.123 . . . . 0.0 108.315 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.85 121.68 42.56 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 113.637 -1.619 . . . . 0.0 110.326 -171.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -99.64 -36.28 9.55 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.274 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.1 t70 -99.37 111.37 23.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 67' ' ' VAL . 13.6 tt -66.93 -33.6 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.156 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.42 62.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.344 0.593 . . . . 0.0 110.461 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.0 -33.22 24.59 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 62' ' ' ASP . 47.6 t -65.2 -43.46 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.2 t -59.05 -43.56 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.36 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -57.89 -61.33 2.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.887 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.17 -42.67 99.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.66 -29.46 70.03 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -82.8 -56.75 3.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.717 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.0 t -53.21 -59.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.429 0.692 . . . . 0.0 111.547 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 40' ' ' VAL . 1.8 mm? -72.34 -18.17 61.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.221 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 m 59.72 69.04 0.73 Allowed 'General case' 0 C--O 1.243 0.746 0 CA-C-O 122.336 1.065 . . . . 0.0 109.803 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.71 -176.39 5.35 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.253 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.13 -43.13 1.67 Allowed 'General case' 0 C--O 1.184 -2.35 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -136.25 155.0 50.74 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.79 170.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' C ' HE21 ' A' ' 79' ' ' GLN . 6.1 p -135.51 137.34 49.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.5 mm-40 -95.0 128.25 41.68 Favored 'General case' 0 N--CA 1.394 -3.231 0 CA-C-O 121.288 0.566 . . . . 0.0 110.846 -174.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 89' ' ' ILE . 40.4 tp -113.6 121.32 43.82 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.496 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -85.51 91.82 8.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.42 -12.87 41.45 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -167.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -48.8 -25.99 2.15 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.332 1.053 . . . . 0.0 113.498 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -51.69 -49.95 61.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -175.14 154.36 1.76 Allowed 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.3 mp0 -77.97 -46.49 20.97 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.791 0.805 . . . . 0.0 111.334 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.15 -17.46 54.97 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.244 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' O ' ' HB ' ' A' ' 91' ' ' THR . 28.3 t80 -59.84 -37.5 79.41 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.559 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 80' ' ' LEU . 1.7 mp -64.24 -37.44 79.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.542 0.687 . . . . 0.0 109.823 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -20.91 60.18 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.884 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 97.5 m -74.42 -43.39 56.51 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.095 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.518 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -48.59 -44.63 37.09 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.201 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.803 ' NH2' ' HB ' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -55.21 -25.97 36.43 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -86.35 -40.28 15.6 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.77 -18.47 31.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.544 0.687 . . . . 0.0 112.258 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.28 128.87 35.18 Favored Pre-proline 0 C--N 1.275 -2.633 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.82 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.76 165.12 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.221 1.947 . . . . 0.0 110.611 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.55 4.3 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.626 0.77 . . . . 0.0 112.126 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -84.13 -29.08 27.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 70' ' ' ALA . 79.4 t -107.89 132.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.324 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.4 160.66 15.47 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.803 ' HB ' ' NH2' ' A' ' 93' ' ' ARG . 4.1 mp -122.58 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.554 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 38.9 m0 -107.75 164.63 12.07 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.26 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -99.54 109.18 21.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.605 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.21 103.39 3.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 N--CA 1.425 -1.676 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.571 -175.709 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 89' ' ' ILE . 56.3 m-85 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -83.34 172.79 12.16 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.399 0.619 . . . . 0.0 112.453 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.4 m170 74.57 4.98 4.49 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.412 1.485 . . . . 0.0 114.777 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.643 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 20.7 m -68.04 154.34 8.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.984 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.62 -33.2 15.95 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.139 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.3 ttmt -159.24 163.32 35.97 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -124.88 142.97 51.09 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.21 169.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.31 -1.136 0 CA-C-N 118.82 0.736 . . . . 0.0 109.199 177.741 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 28.5 m-80 . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 10.3 ptpp? -53.97 99.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.924 -173.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.05 125.07 40.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.951 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -90.82 170.41 10.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -36.93 115.93 0.32 Allowed Glycine 0 C--N 1.364 2.124 0 O-C-N 124.28 0.988 . . . . 0.0 114.108 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.0 tp -140.22 162.1 36.07 Favored 'General case' 0 N--CA 1.407 -2.593 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -139.04 21.88 2.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.163 0.982 . . . . 0.0 109.234 -173.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.612 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 55.4 mtt180 -125.75 110.36 13.65 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.2 -49.14 45.0 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 124.753 1.168 . . . . 0.0 114.826 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 21.2 mp0 -81.06 -19.96 42.64 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.478 0.656 . . . . 0.0 110.848 -174.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 43.6 t0 -80.86 -36.69 31.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.47 71.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.654 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.65 -22.69 64.12 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.79 -31.95 41.28 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.85 0.46 . . . . 0.0 111.853 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -78.13 -30.95 49.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.925 0.869 . . . . 0.0 110.62 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -30.69 33.81 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.1 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.02 -26.8 67.87 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.119 0.968 . . . . 0.0 109.296 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 -20.67 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.076 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.94 37.09 0.45 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.21 35.92 21.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.305 1.042 . . . . 0.0 110.768 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 -68.48 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.922 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.467 ' OH ' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -176.71 161.74 2.11 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 123.668 0.605 . . . . 0.0 109.78 -176.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.81 152.42 19.34 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 5' ' ' LYS . . . -128.81 80.95 0.35 Allowed Glycine 0 CA--C 1.491 -1.407 0 C-N-CA 119.386 -1.388 . . . . 0.0 112.412 -172.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.75 152.12 40.93 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.173 -0.514 . . . . 0.0 109.943 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.4 pt -114.0 155.45 15.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 54.8 m-85 -81.22 86.65 6.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.787 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -121.0 123.76 70.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.29 103.84 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.714 1.206 . . . . 0.0 114.206 -174.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p 61.93 21.84 12.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 115.077 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 135.89 36.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.884 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.87 21.17 0.74 Allowed 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.731 2.287 . . . . 0.0 112.524 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -125.12 -11.8 6.99 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 72.4 m -153.82 117.13 4.58 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.36 137.16 32.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 122.15 0.976 . . . . 0.0 110.945 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.33 171.78 7.14 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.244 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.7 p -43.85 -33.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.382 1.473 . . . . 0.0 113.405 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.55 -56.98 7.35 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.164 0.507 . . . . 0.0 111.08 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.8 mt-30 -69.77 -37.09 76.26 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.05 0.452 . . . . 0.0 110.296 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.49 -20.85 65.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.6 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -69.48 -23.78 63.68 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.47 -43.99 12.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.077 0.941 . . . . 0.0 108.664 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 42' ' ' GLN . 20.4 t -65.05 -33.42 63.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.05 -176.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.93 -17.8 65.08 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.084 0.469 . . . . 0.0 111.535 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.85 -25.38 21.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.781 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.47 -39.69 18.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.965 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 103.76 9.22 Favored Pre-proline 0 N--CA 1.398 -3.03 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.42 45.08 0.96 Allowed 'Trans proline' 0 CA--C 1.552 1.387 0 C-N-CA 123.298 2.666 . . . . 0.0 113.255 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -88.53 -179.62 6.1 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.694 0.797 . . . . 0.0 111.842 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -82.76 145.4 29.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.553 0.741 . . . . 0.0 110.936 178.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.17 146.26 43.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.458 0.647 . . . . 0.0 110.252 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 p -133.24 145.52 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.03 140.2 12.56 Favored Glycine 0 C--O 1.196 -2.241 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.006 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.2 t -128.26 122.46 58.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -169.36 156.07 6.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -90.64 93.33 9.22 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.99 0.9 . . . . 0.0 109.694 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -102.15 118.49 37.0 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -87.71 -28.19 21.93 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.579 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.59 122.49 40.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.09 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.2 -35.29 73.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.438 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.18 -17.54 61.36 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.486 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.32 -29.5 31.03 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.43 -47.63 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 63' ' ' ILE . 55.5 t -60.53 -37.2 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.879 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 72' ' ' VAL . 18.4 t70 -52.92 -61.33 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.472 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.48 -42.06 92.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.891 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -57.8 -38.92 76.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 124.288 0.992 . . . . 0.0 111.606 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.31 -53.11 5.98 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 123.224 0.328 . . . . 0.0 111.513 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 68' ' ' ASP . 50.0 t -55.08 -56.04 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 40' ' ' VAL . 40.6 tp -79.94 -21.87 43.33 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.3 m 63.23 79.38 0.26 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 122.213 1.006 . . . . 0.0 110.336 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.12 -179.03 6.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.007 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.6 -39.32 2.31 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.52 160.64 40.78 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.273 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.78 136.69 35.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.88 111.62 24.04 Favored 'General case' 0 N--CA 1.391 -3.418 0 C-N-CA 123.257 0.623 . . . . 0.0 109.446 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.99 154.51 19.16 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.205 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -93.47 96.38 9.86 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 172.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.497 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -72.64 -12.32 77.74 Favored Glycine 0 C--N 1.306 -1.107 0 CA-C-N 114.225 -1.352 . . . . 0.0 114.845 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -49.6 -25.83 3.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.584 1.154 . . . . 0.0 111.932 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -52.33 -45.56 65.69 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.544 0.738 . . . . 0.0 112.444 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.53 149.03 0.96 Allowed 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.56 -43.64 31.17 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.19 0.995 . . . . 0.0 110.416 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.18 -13.65 60.18 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.605 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.588 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.6 t80 -62.64 -41.13 98.87 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.385 174.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.497 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -61.35 -40.97 88.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.96 -19.17 65.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.836 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.4 m -83.04 -42.69 17.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.605 HD13 HG13 ' A' ' 63' ' ' ILE . 4.1 mm? -53.44 -44.01 68.51 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.453 0.701 . . . . 0.0 111.216 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' HD12 ' A' ' 102' ' ' ILE . 8.2 mmm180 -43.59 -37.5 2.56 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.245 1.418 . . . . 0.0 111.866 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.95 -45.54 18.33 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.024 -173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.0 -18.31 47.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.61 0.719 . . . . 0.0 112.379 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -99.9 134.7 20.78 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.446 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.18 165.42 31.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.391 2.06 . . . . 0.0 109.668 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.05 -11.3 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.239 0.543 . . . . 0.0 111.255 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.49 -29.41 62.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.872 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.75 127.56 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -105.91 167.4 9.81 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.445 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.443 HD12 ' HD2' ' A' ' 93' ' ' ARG . 93.6 mt -125.27 129.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.597 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.6 m0 -120.65 152.7 37.85 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.869 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.23 124.74 50.06 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.37 98.15 1.05 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.167 -173.375 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 . . . . . 0 N--CA 1.419 -2.025 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -78.43 166.16 22.94 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.768 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 m170 75.57 8.5 3.76 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.896 0.878 . . . . 0.0 112.47 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.57 143.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.08 -43.14 65.32 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.88 -173.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 39.4 ttmt -159.11 164.34 35.39 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -118.3 157.83 26.33 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.54 171.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.025 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.207 -1.163 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -46.34 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.03 121.57 23.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.446 0.641 . . . . 0.0 111.497 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.7 p -101.33 168.35 9.6 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 9' ' ' LEU . . . -2.65 -110.9 0.0 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 125.178 1.371 . . . . 0.0 116.149 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' GLY . 54.4 tp 77.49 165.09 0.23 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.518 0.775 . . . . 0.0 111.229 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -138.07 -14.5 1.36 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.972 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.55 112.24 24.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.732 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.606 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -50.34 -41.4 40.03 Favored Glycine 0 C--O 1.209 -1.462 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.719 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -57.88 -39.94 79.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.513 1.125 . . . . 0.0 108.916 -178.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 9' ' ' LEU . 13.2 t70 -79.2 -30.71 43.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.325 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.35 63.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.808 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 9.5 mtmp? -61.02 -24.85 66.49 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.293 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -32.43 74.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.621 0.368 . . . . 0.0 111.507 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.97 72.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.648 1.213 . . . . 0.0 109.722 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -30.29 44.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.063 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.67 -23.1 66.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.375 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.09 65.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.971 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.26 13.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 114.449 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.27 26.48 13.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.852 0.861 . . . . 0.0 110.867 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 47.9 mt -63.93 -67.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.341 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -176.23 155.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -174.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.24 143.59 14.61 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.01 82.89 0.34 Allowed Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.036 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.478 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -118.64 141.93 48.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 120.847 0.356 . . . . 0.0 110.165 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.451 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -108.02 151.6 10.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -81.83 79.82 8.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.833 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 34' ' ' SER . 61.3 t -112.17 129.57 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.81 106.75 0.28 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p 65.38 16.72 10.68 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.958 1.703 . . . . 0.0 114.889 172.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 22.7 p -83.16 124.43 76.3 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.839 -0.538 . . . . 0.0 110.332 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -9.27 18.78 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.062 1.841 . . . . 0.0 114.886 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -112.74 12.65 19.67 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.485 -0.76 . . . . 0.0 111.662 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HB2' ' OG ' ' A' ' 34' ' ' SER . 85.8 m -152.58 118.09 5.31 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.37 138.37 26.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.2 1.0 . . . . 0.0 112.606 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -104.31 168.68 8.94 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.769 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.2 p -53.38 -30.01 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 124.063 0.852 . . . . 0.0 112.03 -171.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 54.6 mp0 -61.88 -55.64 27.58 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 124.541 1.137 . . . . 0.0 112.1 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.6 mt-30 -70.39 -38.22 74.64 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 121.464 0.65 . . . . 0.0 109.925 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -61.04 -27.16 68.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.501 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 47' ' ' MET . 8.4 tp60 -61.42 -36.36 80.1 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.64 0.776 . . . . 0.0 112.101 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 13.1 pt-20 -86.07 -43.15 13.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.552 1.168 . . . . 0.0 109.011 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 6.9 t -55.22 -32.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.205 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 14.3 ptp -62.99 -31.42 72.54 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.37 0.605 . . . . 0.0 110.721 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.37 58.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.009 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.27 -48.1 7.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.74 99.58 15.32 Favored Pre-proline 0 N--CA 1.391 -3.394 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.23 55.49 3.54 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.811 2.34 . . . . 0.0 111.711 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -96.23 171.29 8.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.35 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 2.9 tt0 -72.29 142.9 48.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.263 0.225 . . . . 0.0 110.453 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB2' HD23 ' A' ' 75' ' ' LEU . 16.8 m-85 -115.11 139.89 49.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.3 p -129.41 146.89 33.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.64 129.66 6.95 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.842 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.6 t -114.37 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -148.81 152.98 37.46 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 29.0 ptt180 -86.29 93.74 9.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -67.28 116.09 7.67 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 122.865 1.317 . . . . 0.0 112.124 -172.368 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -108.19 -72.71 0.71 Allowed 'General case' 0 C--N 1.255 -3.515 0 CA-C-N 112.552 -2.113 . . . . 0.0 108.814 171.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.11 108.94 12.97 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.849 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -62.37 -34.71 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.038 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.71 -22.86 63.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.104 0.478 . . . . 0.0 110.7 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 12.7 t70 -85.67 -33.74 21.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.225 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.06 -32.4 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.046 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' ILE . 89.8 t -64.99 -33.52 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.2 t70 -56.89 -57.99 10.1 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.73 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -60.75 -40.84 93.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.16 -39.02 77.74 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.755 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -83.83 -53.58 5.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.616 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 68' ' ' ASP . 44.7 t -56.63 -56.55 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.232 0.613 . . . . 0.0 111.754 -174.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 40' ' ' VAL . 51.4 tp -80.41 -13.91 58.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.099 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 18.8 p 55.54 77.42 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.378 1.071 . . . . 0.0 112.272 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 54' ' ' TYR . 92.6 mt -74.77 175.08 8.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.867 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -122.79 -35.88 2.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.126 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.88 157.76 44.04 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -140.13 141.12 34.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -99.97 128.08 46.1 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.349 0.595 . . . . 0.0 112.053 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -98.25 122.42 41.39 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.389 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -84.52 98.9 10.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.652 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.63 -12.86 42.85 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.591 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.47 -33.19 1.62 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.172 1.389 . . . . 0.0 113.127 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 13.0 mm-40 -66.07 -48.24 71.66 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -179.61 149.89 0.39 Allowed 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.75 -44.86 26.37 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 112.45 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.65 -20.38 43.21 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.746 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.561 ' O ' ' HB ' ' A' ' 91' ' ' THR . 42.9 t80 -58.49 -36.05 73.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.931 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.652 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -61.17 -37.8 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.609 0.719 . . . . 0.0 109.137 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.622 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 14.7 t70 -70.07 -21.01 63.2 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.088 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.561 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.1 m -78.54 -42.44 29.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.514 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -48.51 -49.13 37.27 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.559 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.08 -33.09 37.73 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.229 0.538 . . . . 0.0 112.361 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 33.6 mt-10 -73.16 -42.59 62.61 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.105 -174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.95 25.87 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.86 135.64 42.5 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.698 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 165.13 33.63 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 121.972 1.781 . . . . 0.0 110.599 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.64 -15.85 54.01 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.034 0.934 . . . . 0.0 112.152 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -71.12 -30.12 66.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.2 t -107.33 129.5 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.235 0 CA-C-O 121.376 0.608 . . . . 0.0 110.629 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.71 170.83 8.29 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.461 HG23 HD23 ' A' ' 80' ' ' LEU . 73.6 mt -125.77 129.73 72.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.1 m0 -118.9 157.98 26.6 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.689 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -100.94 123.39 45.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.31 116.96 10.35 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp . . . . . 0 C--N 1.287 -2.15 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.254 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 82' ' ' GLY . 79.5 m-85 . . . . . 0 N--CA 1.417 -2.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.3 164.36 26.79 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.668 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 93' ' ' ARG . 23.3 m170 71.54 7.18 5.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.696 1.599 . . . . 0.0 112.201 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.64 152.1 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -81.4 -41.6 21.67 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 120.998 0.428 . . . . 0.0 111.349 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.0 mttt -145.78 163.03 36.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.301 0.64 . . . . 0.0 109.676 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -116.83 139.6 50.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.44 166.87 20.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--N 1.292 -1.907 0 CA-C-O 121.519 0.676 . . . . 0.0 111.72 -176.952 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.417 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 15.0 p-10 . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -57.08 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.502 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -95.37 124.26 47.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.493 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.0 m -92.0 170.52 9.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.93 135.42 8.86 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 119.046 0.839 . . . . 0.0 115.06 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -150.07 153.12 35.92 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' HD13 ' A' ' 9' ' ' LEU . 8.6 t -118.51 8.03 11.97 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.641 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.433 ' H ' HD12 ' A' ' 9' ' ' LEU . 71.7 mtm180 -117.73 114.64 23.63 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.118 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.24 -39.44 71.4 Favored Glycine 0 C--O 1.216 -1.024 0 O-C-N 123.626 0.578 . . . . 0.0 113.639 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -66.2 -26.09 67.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 122.005 0.907 . . . . 0.0 109.264 -177.507 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -89.57 -51.96 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.493 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.13 69.53 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.99 -22.39 62.49 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.374 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.07 -30.78 27.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.971 0.508 . . . . 0.0 111.451 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 -43.28 64.77 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.542 0.687 . . . . 0.0 109.824 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -34.03 73.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.71 -23.46 66.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 125.172 1.389 . . . . 0.0 110.018 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.89 -13.94 59.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.94 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.53 10.4 0.27 Allowed Glycine 0 C--O 1.225 -0.458 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.535 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.2 19.37 8.74 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.491 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 37.8 mt -57.86 -67.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.16 -171.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.01 157.69 2.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -132.05 140.9 12.2 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.46 91.08 0.51 Allowed Glycine 0 CA--C 1.471 -2.673 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 155.88 34.73 Favored 'General case' 0 N--CA 1.401 -2.921 0 CA-C-N 114.567 -0.816 . . . . 0.0 109.182 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.602 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 3.5 pt -116.95 151.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.554 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 49.7 m-85 -84.19 79.02 9.67 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.427 1.079 . . . . 0.0 109.796 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.8 t -109.8 119.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.58 103.84 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.829 1.331 . . . . 0.0 113.483 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.6 p 59.39 29.28 18.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.638 1.575 . . . . 0.0 113.491 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -107.26 104.11 51.02 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.07 3.93 0.66 Allowed 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.776 2.984 . . . . 0.0 115.029 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -84.43 -10.64 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 46.6 m -138.4 172.13 13.35 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.89 136.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.57 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -106.7 164.09 12.38 Favored 'General case' 0 CA--C 1.465 -2.327 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.742 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 HD23 ' A' ' 73' ' ' LEU . 11.4 p -45.58 -35.44 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 124.806 1.316 . . . . 0.0 112.049 -174.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.97 -38.81 86.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.1 mt-30 -80.79 -34.94 33.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.339 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -62.38 -32.81 73.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.023 -175.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 47' ' ' MET . 2.2 pt20 -62.98 -31.08 72.12 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.96 -47.3 59.73 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.116 0.96 . . . . 0.0 108.641 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 42' ' ' GLN . 40.9 t -65.0 -30.5 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.819 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 24.6 ptt? -67.08 -17.6 64.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.304 0.574 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.87 25.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.996 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.55 -43.33 6.9 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.298 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -127.52 93.76 39.74 Favored Pre-proline 0 N--CA 1.386 -3.628 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.75 57.06 3.02 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.455 2.104 . . . . 0.0 111.968 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.3 pp -96.71 179.26 5.04 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.471 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -82.94 143.27 30.81 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 20.6 m-85 -113.65 138.08 50.69 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.8 p -132.41 139.86 49.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -125.18 141.13 12.82 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.541 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.602 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 29.2 t -124.43 134.82 65.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -167.09 159.64 13.25 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.661 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -85.93 93.59 8.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -87.99 125.67 34.66 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.834 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -94.94 -58.0 2.28 Favored 'General case' 1 C--N 1.241 -4.111 0 CA-C-N 112.775 -2.011 . . . . 0.0 108.96 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.87 123.37 43.08 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.559 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 92' ' ' LEU . 17.4 tt -64.23 -29.74 48.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.33 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.17 -13.82 58.95 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.078 0.466 . . . . 0.0 110.315 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 14.0 t70 -86.25 -39.25 16.75 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.816 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 80' ' ' LEU . 14.9 p -77.82 -37.63 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.293 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.13 -32.0 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 9.3 t70 -54.8 -55.64 27.93 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.472 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 43.2 mmtm -63.59 -41.56 98.33 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -56.98 -38.92 73.7 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.316 1.01 . . . . 0.0 110.996 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -81.96 -52.88 6.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.354 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 77.5 t -56.1 -54.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -82.9 -11.47 58.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.41 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t 61.97 74.67 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.683 0.754 . . . . 0.0 109.498 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.5 mt -82.74 179.91 7.63 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.439 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.74 -32.96 2.31 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.7 160.53 43.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.3 171.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 6.2 p -150.0 141.02 16.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.82 111.36 23.68 Favored 'General case' 0 N--CA 1.385 -3.691 0 CA-C-O 121.824 0.821 . . . . 0.0 109.353 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.592 HD13 ' HG ' ' A' ' 92' ' ' LEU . 36.3 mt -115.72 89.17 3.04 Favored 'General case' 0 CA--C 1.422 -3.945 0 N-CA-C 101.369 -3.567 . . . . 0.0 101.369 -169.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -98.04 174.37 6.58 Favored 'General case' 1 N--CA 1.362 -4.859 0 C-N-CA 117.873 -1.531 . . . . 0.0 113.299 -167.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -48.96 -10.51 0.14 Allowed Glycine 1 C--N 1.243 -4.584 0 CA-C-N 110.863 -2.881 . . . . 0.0 117.468 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -44.72 -44.73 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -49.72 6.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.956 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 1.1 tm-20 178.94 170.33 0.89 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -77.88 -49.85 13.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.519 1.152 . . . . 0.0 109.389 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 37.1 mt -72.97 -13.6 61.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.99 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.4 t80 -60.34 -48.99 79.36 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 1.9 mp -59.75 -36.69 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.687 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 24.4 t70 -60.08 -27.1 66.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.636 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.9 m -88.15 -43.68 11.47 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 124.708 1.203 . . . . 0.0 110.141 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 80' ' ' LEU . 4.1 mm? -43.93 -44.0 6.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.687 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 1.7 mpt_? -56.55 -29.74 62.31 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.271 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -77.95 -35.13 50.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.382 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.81 0.86 50.01 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.433 0.635 . . . . 0.0 110.806 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.415 HD22 HG13 ' A' ' 102' ' ' ILE . 27.2 tp -75.79 124.49 88.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 124.053 0.941 . . . . 0.0 109.479 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.01 161.57 44.41 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.078 1.852 . . . . 0.0 110.988 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.22 70.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 124.464 1.106 . . . . 0.0 113.354 -172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -88.86 -10.9 46.31 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.494 HG21 ' HB1' ' A' ' 70' ' ' ALA . 65.6 t -107.68 140.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.86 172.67 6.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.55 HG12 HD12 ' A' ' 80' ' ' LEU . 53.8 mt -116.41 131.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.652 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 40.8 m0 -121.02 159.17 26.19 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.393 171.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 120' ' ' VAL . 40.0 ttpt -100.73 115.18 29.66 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 107.63 5.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 N--CA 1.417 -2.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 -175.093 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 N--CA 1.424 -1.742 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -115.01 -178.64 3.41 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.625 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t60 65.44 28.42 11.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.221 1.408 . . . . 0.0 108.505 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 104' ' ' LYS . 27.3 m -87.26 149.99 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.77 -41.29 45.28 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.402 0.62 . . . . 0.0 111.058 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 45.2 mmtm -143.78 162.32 36.32 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -127.13 138.68 53.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.96 171.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--N 1.312 -1.044 0 O-C-N 123.411 0.445 . . . . 0.0 110.602 -179.339 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.72 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.18 98.06 0.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.935 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.12 124.7 53.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.736 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.1 p -91.99 169.8 10.36 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 37' ' ' CYS . . . -46.76 126.7 10.07 Favored Glycine 0 CA--C 1.493 -1.299 0 O-C-N 123.64 0.588 . . . . 0.0 113.771 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.3 tp -143.06 161.0 39.32 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -134.35 -18.9 1.95 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.683 0.754 . . . . 0.0 109.948 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.73 105.69 9.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.937 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 16' ' ' LYS . . . -48.37 -44.85 28.44 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 124.64 1.114 . . . . 0.0 114.224 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 17.4 mp0 -76.18 -22.27 55.53 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.335 0.588 . . . . 0.0 110.856 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.52 -30.46 23.41 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.15 48.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 17.5 ptpt -64.69 -22.51 67.0 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 -37.71 78.89 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.801 0.334 . . . . 0.0 110.567 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.98 -38.01 66.81 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 110.181 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HD1' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -67.72 -34.61 77.2 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.9 -31.29 72.42 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.486 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.28 64.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.069 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.32 -21.7 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.467 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB2' ' HD1' ' A' ' 19' ' ' TYR . . . 61.93 27.04 16.41 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.985 0.898 . . . . 0.0 109.019 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.72 ' HB ' HD21 ' A' ' 4' ' ' ASN . 28.5 mt -69.92 -59.64 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.909 -171.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -178.36 161.92 1.45 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 145.72 16.28 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.35 73.99 0.21 Allowed Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.482 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.79 154.94 26.55 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-O 121.172 0.511 . . . . 0.0 110.264 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 5.7 pt -116.78 152.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -79.57 79.43 6.04 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 124.741 1.275 . . . . 0.0 111.239 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.25 116.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 115.09 2.75 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.777 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.4 p 66.02 14.67 9.73 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.086 1.754 . . . . 0.0 115.126 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.8 m -93.58 114.67 63.58 Favored Pre-proline 0 C--O 1.197 -1.696 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.35 26.48 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 124.28 3.32 . . . . 0.0 115.285 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 20.4 ptt180 -124.92 -5.15 7.46 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 36' ' ' ARG . 60.8 m -136.65 166.75 22.83 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -143.94 136.4 23.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -102.46 170.52 8.0 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.685 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 73' ' ' LEU . 5.9 p -56.41 -31.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 123.809 0.693 . . . . 0.0 111.1 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 4.3 mp0 -70.88 -46.87 61.84 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 124.149 0.979 . . . . 0.0 111.505 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 49.7 mm-40 -61.76 -49.31 76.92 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -63.89 -21.47 66.48 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.287 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 47' ' ' MET . 18.1 tp60 -63.99 -39.32 93.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.527 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.8 pt-20 -85.93 -45.41 11.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.754 0.788 . . . . 0.0 110.427 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 95.4 t -48.97 -35.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 125.307 1.443 . . . . 0.0 112.249 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 16.5 ptp -64.22 -20.56 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 120.823 0.344 . . . . 0.0 111.493 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.37 -28.74 28.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.34 -45.5 13.68 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.75 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -133.66 98.12 15.16 Favored Pre-proline 0 N--CA 1.397 -3.119 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.69 46.73 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.88 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -84.33 152.28 24.21 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.686 177.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.7 140.41 49.7 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.411 0.625 . . . . 0.0 112.428 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.04 143.73 39.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -113.46 128.78 8.5 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.782 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.585 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 21.2 t -113.74 106.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.57 146.59 15.09 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.471 -173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.406 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 59.0 mtm180 -93.11 93.37 8.26 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 15.4 m120 -90.25 154.91 19.38 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 122.656 1.217 . . . . 0.0 110.526 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.89 -73.43 0.64 Allowed 'General case' 0 C--N 1.245 -3.953 0 CA-C-N 111.445 -2.616 . . . . 0.0 112.17 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.77 131.91 35.27 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 92' ' ' LEU . 5.9 tt -60.02 -32.68 50.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.041 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.61 -18.76 61.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.326 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.6 -35.21 53.11 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.436 0.636 . . . . 0.0 109.288 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.52 -44.05 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.7 t -60.55 -39.28 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.577 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 15.3 t70 -57.1 -61.79 2.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.172 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 45.6 mmtm -63.72 -39.7 94.93 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 -176.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.36 -35.02 76.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.812 0.695 . . . . 0.0 111.417 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -82.37 -56.54 3.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -53.32 -56.47 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.352 0.661 . . . . 0.0 111.628 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.718 ' HB2' HG23 ' A' ' 40' ' ' VAL . 45.4 tp -82.78 -17.31 44.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.488 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 39.9 m 60.59 80.55 0.21 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.226 1.012 . . . . 0.0 111.182 -176.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 73' ' ' LEU . 74.1 mt -85.46 -175.06 5.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.578 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -127.97 -36.79 1.96 Allowed 'General case' 0 C--O 1.193 -1.912 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -146.0 159.27 43.49 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.36 0.6 . . . . 0.0 111.534 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.4 p -140.58 138.64 35.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.689 HE22 ' HB2' ' A' ' 103' ' ' TRP . 7.2 mm100 -98.46 105.59 17.75 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 123.459 0.703 . . . . 0.0 109.393 -175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HG ' ' A' ' 92' ' ' LEU . 75.2 mt -116.13 139.52 50.23 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.941 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 p80 175.54 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.121 0.888 . . . . 0.0 110.165 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 59' ' ' ARG . . . -74.71 -55.39 5.44 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 120.434 2.933 . . . . 0.0 120.434 -166.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ASN . 2.8 t-20 -82.79 -69.1 0.65 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.97 -48.93 12.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -168.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -177.89 172.0 1.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.248 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.566 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 96.4 mt-30 -78.44 -43.98 25.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 125.242 1.417 . . . . 0.0 107.235 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 54.7 mt -71.42 -14.39 62.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.326 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 22.9 t80 -65.38 -40.25 93.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.982 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.469 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.0 -30.38 49.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.628 0.728 . . . . 0.0 110.015 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.68 ' HA ' ' NH1' ' A' ' 93' ' ' ARG . 23.9 t70 -67.54 -22.64 65.4 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.47 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.9 m -89.63 -44.92 9.72 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.305 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 88' ' ' TYR . 3.2 mm? -47.89 -46.37 31.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.68 ' NH1' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.02 -24.33 64.42 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.069 -173.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.04 -34.43 38.28 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.988 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.96 -22.17 22.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.854 0.835 . . . . 0.0 111.409 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -88.09 140.13 30.74 Favored Pre-proline 0 C--N 1.276 -2.614 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.707 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.43 164.91 34.14 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 121.134 1.223 . . . . 0.0 109.018 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.1 3.95 6.28 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.496 0.665 . . . . 0.0 111.638 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -86.07 -24.85 26.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 70' ' ' ALA . 97.1 t -105.09 131.88 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.54 171.36 7.91 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 93' ' ' ARG . 65.1 mt -124.52 133.42 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.689 ' HB2' HE22 ' A' ' 79' ' ' GLN . 36.9 m0 -121.05 155.37 34.54 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.162 -1.415 . . . . 0.0 109.622 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -102.39 123.28 45.89 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 115.21 8.87 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 170.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.293 -1.867 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 33.3 m-85 . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -110.12 157.16 19.67 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.4 m80 69.05 33.77 3.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 111.818 -2.446 . . . . 0.0 111.113 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.49 142.06 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.73 -43.09 66.46 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.379 0.609 . . . . 0.0 111.153 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.2 mttm -145.14 163.18 35.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -124.68 143.39 50.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.56 174.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--N 1.311 -1.081 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.932 178.894 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.619 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.2 p-10 . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 21.3 pttp -67.89 91.99 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.11 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.36 125.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.169 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 70.0 m -91.38 169.26 10.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.519 ' H ' ' HA ' ' A' ' 37' ' ' CYS . . . -19.53 105.85 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 O-C-N 124.919 1.387 . . . . 0.0 116.037 -169.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.22 135.86 18.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 9.45 2.7 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.912 0.863 . . . . 0.0 110.123 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -86.41 112.52 21.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.34 -53.5 5.8 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.419 1.009 . . . . 0.0 114.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -74.23 -19.91 60.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.799 0.839 . . . . 0.0 111.871 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.73 -36.51 17.31 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.73 -47.96 67.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.805 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 21.5 ptmt -63.35 -23.45 67.42 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.828 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.3 69.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.229 0.537 . . . . 0.0 110.805 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.06 -37.41 58.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -72.13 -33.33 67.71 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.296 0.57 . . . . 0.0 109.926 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.92 -25.69 67.26 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.19 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.66 -24.09 56.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.905 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.63 1.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 119.103 -1.522 . . . . 0.0 113.884 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.08 11.72 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.768 0.827 . . . . 0.0 111.463 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.619 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 23.1 mt -63.57 -69.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.845 -172.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.82 156.26 1.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -176.384 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -121.7 146.68 17.17 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.67 72.08 0.21 Allowed Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.249 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.547 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.47 144.36 39.39 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 121.216 0.532 . . . . 0.0 109.6 -179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.649 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 31.3 mt -117.62 157.04 19.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.755 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.628 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 24.3 m-85 -83.59 56.14 3.49 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.677 0.672 . . . . 0.0 111.137 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.16 120.33 33.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -44.0 96.74 0.01 OUTLIER 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.083 1.489 . . . . 0.0 113.892 -172.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 p 55.85 23.78 6.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.577 1.551 . . . . 0.0 114.368 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -100.53 109.98 58.93 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.96 2.33 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.902 3.068 . . . . 0.0 115.079 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 12.4 ptm85 -74.19 -19.66 60.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -142.87 174.56 10.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.48 136.72 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 119.331 0.969 . . . . 0.0 110.292 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -101.15 167.45 10.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.001 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.3 p -51.57 -29.6 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.209 0.943 . . . . 0.0 112.996 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -65.96 -50.13 65.44 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.005 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.7 mt-30 -73.03 -40.04 65.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.231 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.92 64.6 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.834 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -56.47 -37.68 70.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.076 0.95 . . . . 0.0 109.402 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.37 -43.19 17.71 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.032 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 42' ' ' GLN . 12.0 t -65.28 -39.07 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.928 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.413 ' SD ' HD12 ' A' ' 73' ' ' LEU . 27.6 ptt? -62.2 -24.02 66.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.445 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.86 -25.8 29.98 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.209 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.61 -42.51 14.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.126 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -130.23 99.93 19.08 Favored Pre-proline 0 N--CA 1.39 -3.472 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.47 50.04 2.23 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -91.98 174.76 7.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.616 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 17.3 mt-30 -71.33 127.87 34.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.701 0.286 . . . . 0.0 111.446 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' OH ' HG12 ' A' ' 46' ' ' VAL . 45.1 m-85 -100.93 141.52 33.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.2 p -127.03 158.73 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.51 135.25 7.47 Favored Glycine 0 CA--C 1.462 -3.228 0 C-N-CA 119.26 -1.448 . . . . 0.0 112.617 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.571 ' HB ' HG23 ' A' ' 29' ' ' ILE . 44.4 t -115.26 142.59 27.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -172.06 157.05 4.22 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.982 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -85.98 93.2 8.9 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' ND2' HG22 ' A' ' 66' ' ' VAL . 23.2 m120 -89.53 118.1 28.92 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -92.17 -59.47 2.09 Favored 'General case' 1 C--N 1.237 -4.311 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.573 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.88 125.39 38.48 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.001 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.551 HG13 HD13 ' A' ' 92' ' ' LEU . 15.6 tt -65.65 -29.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.258 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -19.32 59.06 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.812 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.05 -26.05 39.87 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.804 0.812 . . . . 0.0 108.875 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 ' ND2' ' A' ' 60' ' ' ASN . 15.3 t -75.06 -44.73 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.0 t -60.3 -36.77 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.3 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.8 t70 -54.86 -58.31 8.1 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.373 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -65.74 -40.91 92.6 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.63 -29.42 70.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.778 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -84.15 -59.96 2.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.954 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' ASP . 52.2 t -50.55 -59.83 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.502 0.721 . . . . 0.0 111.909 -176.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.611 ' HB2' HG23 ' A' ' 40' ' ' VAL . 33.3 tp -78.3 -21.26 49.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.6 m 59.56 73.65 0.47 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.006 0.908 . . . . 0.0 109.835 -173.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 HD23 ' A' ' 73' ' ' LEU . 73.2 mt -72.13 -179.14 2.69 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.835 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' CB ' ' HG2' ' A' ' 53' ' ' GLN . . . -127.7 -44.19 1.52 Allowed 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -137.25 157.61 46.26 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.717 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.6 p -141.83 140.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.07 124.7 49.03 Favored 'General case' 0 N--CA 1.395 -3.187 0 O-C-N 121.874 -0.516 . . . . 0.0 110.914 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -103.91 137.34 42.03 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.499 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.26 99.46 12.24 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -60.17 -12.98 25.98 Favored Glycine 0 C--N 1.312 -0.789 0 CA-C-N 114.811 -1.086 . . . . 0.0 115.494 -175.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.92 -26.3 62.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.948 0.404 . . . . 0.0 110.186 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.13 -47.27 85.33 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 39.5 tt0 178.31 146.44 0.14 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.451 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 47.8 mt-30 -76.12 -44.25 39.43 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 122.485 1.136 . . . . 0.0 109.594 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 45.6 mt -72.84 -13.33 61.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.092 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 29.5 t80 -64.97 -39.22 93.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.692 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -61.83 -38.74 81.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.727 0.775 . . . . 0.0 109.391 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.4 t70 -64.01 -22.12 66.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.096 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.9 m -86.29 -42.08 14.04 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.056 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.551 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -49.87 -38.29 34.9 Favored 'General case' 0 C--O 1.21 -1.007 0 C-N-CA 123.196 0.599 . . . . 0.0 111.953 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' NE ' HD13 ' A' ' 102' ' ' ILE . 18.2 mmm-85 -63.93 -27.18 68.97 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.906 0.86 . . . . 0.0 111.368 -176.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -79.65 -47.84 14.71 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.776 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.71 -22.78 29.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.38 130.15 31.56 Favored Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.179 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.73 165.85 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.639 2.226 . . . . 0.0 111.492 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.64 -17.56 47.96 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.986 0.914 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -70.73 -29.33 65.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.288 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' A' ' 70' ' ' ALA . 72.6 t -107.47 136.76 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -113.22 167.97 10.11 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.563 HG23 HD23 ' A' ' 80' ' ' LEU . 2.3 mp -125.72 133.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.543 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 43.0 m0 -121.96 164.71 17.15 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -115.36 124.64 51.75 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.57 107.54 4.5 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.802 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.2 tp . . . . . 0 C--N 1.28 -2.436 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.995 -177.435 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 94.7 m-85 . . . . . 0 N--CA 1.415 -2.217 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -76.14 163.63 26.9 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.601 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.2 m170 67.47 21.7 9.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.047 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.75 149.95 3.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -85.55 -45.52 11.69 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.497 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.7 mttm -146.14 161.95 39.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.064 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -106.98 145.4 32.31 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.47 161.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.301 -1.521 0 CA-C-O 121.221 0.534 . . . . 0.0 111.448 -177.718 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -57.24 99.79 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.106 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.6 131.19 51.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.857 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m -91.6 170.65 9.76 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.52 127.58 3.78 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.735 0.647 . . . . 0.0 114.076 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.504 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.4 tp -134.65 173.15 11.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -138.83 13.85 2.69 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.232 1.015 . . . . 0.0 109.467 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 99.1 mtt180 -124.62 112.66 17.06 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.537 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.12 -41.7 99.55 Favored Glycine 0 C--N 1.302 -1.345 0 CA-C-O 122.207 0.893 . . . . 0.0 112.816 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -69.51 -35.16 75.25 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.524 1.13 . . . . 0.0 109.407 -176.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 13.0 t70 -77.13 -30.29 55.06 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.38 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.12 -32.61 72.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.429 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 9.8 mtmp? -62.22 -31.93 72.53 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.568 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.772 0.32 . . . . 0.0 111.565 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.6 52.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.464 176.071 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.86 -30.42 71.41 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 124.168 0.987 . . . . 0.0 110.361 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.34 60.9 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.082 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.89 -19.17 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.636 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.95 25.48 15.08 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-O 121.832 0.825 . . . . 0.0 109.416 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.18 -67.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.026 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.71 157.63 1.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 124.124 0.89 . . . . 0.0 110.014 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -117.68 163.9 12.71 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.71 78.36 0.38 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.237 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.482 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.87 151.86 39.13 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 120.895 0.379 . . . . 0.0 110.026 -176.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -116.97 154.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 176.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CE1' ' HA3' ' A' ' 56' ' ' GLY . 20.1 m-85 -84.6 86.72 7.28 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 124.16 0.913 . . . . 0.0 109.855 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 91.5 t -116.54 122.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.16 107.17 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 0.0 112.86 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p 62.2 27.33 16.42 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.598 1.559 . . . . 0.0 113.298 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -79.0 140.9 58.04 Favored Pre-proline 0 C--N 1.308 -1.21 0 O-C-N 121.885 -0.509 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.68 8.31 4.49 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 0.0 111.152 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -120.4 -4.92 9.87 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.807 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 61.6 m -153.27 128.28 9.65 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -173.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.46 137.9 30.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.353 0.597 . . . . 0.0 111.026 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.98 169.51 8.53 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.886 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -47.87 -30.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.256 1.022 . . . . 0.0 113.115 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.01 -36.74 67.06 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.2 mt-30 -86.0 -34.21 20.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -25.88 68.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.58 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -62.86 -30.82 71.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.806 0.843 . . . . 0.0 109.211 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -78.46 -50.92 10.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' GLN . 43.0 t -58.6 -35.01 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.602 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -64.28 -26.74 68.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.74 -14.72 25.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.39 0.614 . . . . 0.0 110.028 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.98 -48.79 6.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.663 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -131.77 104.03 14.4 Favored Pre-proline 0 N--CA 1.398 -3.069 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -176.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.55 65.36 4.67 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.012 1.808 . . . . 0.0 112.395 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.66 162.41 13.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.599 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 2.4 tm0? -81.2 151.82 28.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -177.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.92 148.71 42.65 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 121.978 -0.451 . . . . 0.0 110.248 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.2 p -133.5 154.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -129.92 141.73 12.93 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.153 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 25.6 t -136.43 126.67 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -173.04 173.75 3.62 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -87.48 120.15 28.49 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -95.64 117.35 30.3 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -99.23 -59.02 1.8 Allowed 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.2 114.14 26.58 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.389 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' HG22 ' A' ' 91' ' ' THR . 16.8 tt -65.8 -30.43 50.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.935 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.33 65.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.06 -41.51 22.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.8 -46.73 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.942 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.5 t -59.9 -41.22 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.678 0.611 . . . . 0.0 109.61 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.1 t70 -54.6 -60.75 2.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 123.841 0.713 . . . . 0.0 110.98 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -63.55 -47.77 80.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.239 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -60.3 -29.85 69.11 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 124.04 0.837 . . . . 0.0 111.855 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -84.04 -57.07 3.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.404 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 68' ' ' ASP . 66.2 t -51.26 -58.62 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.008 0.523 . . . . 0.0 112.179 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 tp -81.23 -19.44 43.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 31.6 t 61.01 77.69 0.32 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.165 0.986 . . . . 0.0 111.25 -175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -78.56 -167.62 1.14 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 124.822 1.249 . . . . 0.0 110.872 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.759 ' O ' ' HA ' ' A' ' 100' ' ' VAL . . . -127.69 -74.83 0.58 Allowed 'General case' 1 C--O 1.148 -4.256 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 170.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -104.3 158.06 16.71 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 118.352 -1.339 . . . . 0.0 111.875 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -139.75 138.6 38.76 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.79 132.67 43.19 Favored 'General case' 0 N--CA 1.392 -3.341 0 CA-C-O 121.591 0.71 . . . . 0.0 112.342 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -105.82 115.3 30.0 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.681 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -81.55 97.48 7.85 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.95 -11.73 3.24 Favored Glycine 0 C--N 1.313 -0.739 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -42.69 -29.7 0.32 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.469 1.508 . . . . 0.0 114.586 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.44 -48.62 69.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -178.37 154.08 0.79 Allowed 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.476 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -78.39 -46.07 20.85 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 122.208 1.004 . . . . 0.0 109.913 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.408 ' HB2' ' OE2' ' A' ' 85' ' ' GLU . 38.9 mt -77.58 -13.61 59.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.944 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.55 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.6 t80 -62.9 -35.91 81.61 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.983 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.58 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -64.82 -33.24 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.958 0.885 . . . . 0.0 109.646 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 93' ' ' ARG . 25.0 t70 -70.55 -15.66 62.79 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.878 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 92.5 m -89.32 -46.6 8.64 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 124.498 1.119 . . . . 0.0 110.208 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -44.54 -56.47 4.3 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.15 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -68.01 -6.44 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 40.4 mt-10 -88.41 -35.39 17.13 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.87 -16.04 27.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.955 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 97.8 mt -85.89 143.2 37.38 Favored Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.069 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.45 ' HG2' HG23 ' A' ' 100' ' ' VAL . 33.6 Cg_endo -66.65 165.99 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.729 2.286 . . . . 0.0 111.111 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -9.14 15.52 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.542 0.737 . . . . 0.0 112.65 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -82.24 -29.24 31.42 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 46.8 t -93.32 136.5 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -170.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -123.41 166.92 14.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.284 1.033 . . . . 0.0 108.367 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.489 HG23 HD23 ' A' ' 80' ' ' LEU . 1.8 mp -115.82 133.19 63.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.568 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.7 m0 -117.67 150.0 39.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.303 -1.359 . . . . 0.0 107.93 170.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.69 116.9 33.68 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.67 103.1 2.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp . . . . . 0 N--CA 1.427 -1.617 0 CA-C-O 121.456 0.646 . . . . 0.0 111.25 -171.092 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 26.2 m-85 . . . . . 0 N--CA 1.426 -1.648 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.42 178.56 5.32 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.867 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 m170 68.24 20.98 8.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 111.822 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 145.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.425 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.77 -41.48 17.55 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.949 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 65.1 mttp -145.54 162.81 36.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.029 0.442 . . . . 0.0 110.859 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -114.49 136.45 53.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.236 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 174.6 12.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD13 ' H ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 121.104 0.478 . . . . 0.0 111.56 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 2.9 p-10 . . . . . 0 CA--C 1.504 -0.819 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -38.49 98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.317 -2.22 . . . . 0.0 113.753 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 26' ' ' GLY . 3.1 m -84.5 112.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.135 173.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -91.0 169.02 11.23 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -40.66 119.78 1.47 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 -172.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -158.37 146.2 18.27 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -133.21 15.38 4.16 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.51 1.147 . . . . 0.0 110.367 -172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 81.2 mtt180 -107.56 115.65 30.53 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.44 -52.99 34.05 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-O 122.138 0.854 . . . . 0.0 111.784 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -55.86 -25.21 41.26 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 126.107 1.763 . . . . 0.0 112.773 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 9.1 t0 -94.14 -43.86 8.28 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.01 73.34 Favored 'General case' 0 C--O 1.251 1.139 0 C-N-CA 124.583 1.153 . . . . 0.0 112.138 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.07 -24.4 64.55 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.881 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.73 -26.57 68.42 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 -45.36 12.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.427 0.632 . . . . 0.0 109.329 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -60.28 -35.59 75.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.184 176.043 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.96 -30.09 13.98 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.251 1.421 . . . . 0.0 111.862 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.61 -22.95 62.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.18 7.46 0.09 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.46 -1.353 . . . . 0.0 113.879 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.56 23.03 11.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.306 1.043 . . . . 0.0 111.765 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 36.7 mt -57.85 -66.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.471 -170.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.02 152.91 1.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.575 0.547 . . . . 0.0 110.642 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 6' ' ' VAL . . . -125.44 153.32 18.11 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.23 85.2 0.36 Allowed Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.21 150.47 32.28 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.31 0.576 . . . . 0.0 109.842 -177.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.3 pt -115.99 150.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.027 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -82.73 76.69 9.56 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.788 -171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 37' ' ' CYS . 52.3 t -119.36 120.42 63.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.74 97.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.554 1.542 . . . . 0.0 114.498 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.5 p 62.02 9.82 3.29 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 127.013 2.125 . . . . 0.0 116.021 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -68.51 136.49 90.75 Favored Pre-proline 0 C--O 1.206 -1.235 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.68 4.02 0.98 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.169 2.579 . . . . 0.0 115.429 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.648 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 2.6 tpm_? -124.93 9.77 8.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.611 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' HA3' ' A' ' 8' ' ' GLY . 65.9 m -141.3 154.13 45.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.4 t -136.22 137.14 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.712 0.767 . . . . 0.0 109.587 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -119.26 177.13 5.01 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.459 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 73' ' ' LEU . 68.9 t -38.37 -40.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.021 1.451 . . . . 0.0 113.423 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.12 -58.93 5.18 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.611 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -74.36 -33.89 63.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.072 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -65.1 -31.64 72.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.2 tp60 -63.0 -35.6 80.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.85 -44.8 12.14 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.611 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.8 p -64.87 -30.61 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -69.47 -21.42 63.71 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.02 -9.29 58.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.196 0.522 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.99 -46.07 4.57 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.27 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.9 99.13 20.55 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.41 67.42 6.27 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.156 1.904 . . . . 0.0 112.247 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.98 165.88 10.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.528 174.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.65 161.67 27.62 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.679 0.218 . . . . 0.0 110.932 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.82 143.49 50.77 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 26' ' ' GLY . 10.2 p -133.65 156.26 41.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -126.34 136.54 9.59 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.767 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.511 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.5 t -123.94 128.54 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 32.8 t80 -171.59 162.04 6.33 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.258 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 83' ' ' ASN . 58.2 ttt180 -96.39 92.2 6.2 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 17.4 m120 -102.84 124.79 49.01 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -94.33 -46.09 7.19 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.184 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.67 124.61 29.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.67 -33.9 66.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.053 0.454 . . . . 0.0 110.278 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.93 64.2 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.684 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.78 -36.69 36.75 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.39 -48.37 77.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.506 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.3 t -60.23 -39.82 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.16 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 72' ' ' VAL . 20.8 t70 -54.34 -61.47 2.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 111.319 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.2 -38.93 92.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.253 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -35.08 79.89 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.492 0.495 . . . . 0.0 111.672 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.24 -50.98 11.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 54.8 t -61.26 -55.72 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.15 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 40' ' ' VAL . 86.7 mt -79.61 -8.51 59.23 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p 52.7 67.7 0.95 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.976 0.893 . . . . 0.0 111.907 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.18 -177.56 6.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.309 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.29 -36.92 1.88 Allowed 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.09 160.3 41.14 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 174.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.67 140.72 33.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.715 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -104.35 105.25 15.31 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.59 97.99 6.46 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -124.96 -22.77 4.4 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.154 0.502 . . . . 0.0 112.094 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.38 -55.96 1.62 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -168.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.454 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 20.6 p-10 -83.25 -69.91 0.6 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -159.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.308 36.0 mm-40 -88.67 -49.41 6.88 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -157.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -174.97 166.35 3.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 119.505 1.048 . . . . 0.0 109.448 -173.354 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.51 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 19.4 mm-40 -73.92 -48.45 30.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 71.4 mt -81.87 -12.8 58.29 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.138 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 91' ' ' THR . 23.3 t80 -59.62 -35.95 75.36 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.73 -34.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.727 0.775 . . . . 0.0 110.246 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 28.8 t70 -64.7 -22.96 67.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.594 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.1 m -83.54 -40.12 19.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.487 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.05 -43.65 66.81 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 122.976 0.51 . . . . 0.0 110.631 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.687 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.6 mmm180 -43.98 -39.2 3.92 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.438 1.495 . . . . 0.0 112.098 176.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.43 -44.45 35.81 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.091 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.39 -7.97 58.03 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.58 147.96 35.92 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.42 163.75 38.0 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.268 1.312 . . . . 0.0 109.2 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.46 66.88 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.146 0.579 . . . . 0.0 112.54 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -88.72 1.63 54.81 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.7 t -110.9 127.97 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -119.4 173.94 6.67 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.346 0.593 . . . . 0.0 111.99 -170.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.687 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.6 mp -126.05 133.08 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.502 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 49.2 m0 -121.52 157.31 30.95 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -100.4 116.22 31.85 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.6 110.78 4.39 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 169.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 121.765 0.793 . . . . 0.0 112.548 -170.36 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 85.7 m-85 . . . . . 0 N--CA 1.407 -2.603 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -72.02 136.64 46.77 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . 0.295 18.0 m170 79.48 33.35 0.21 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 111.816 -2.447 . . . . 0.0 112.596 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.78 137.95 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.97 -48.02 48.02 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.787 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -150.84 162.44 40.75 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -111.89 149.15 32.27 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.484 HG22 HD23 ' A' ' 125' ' ' LEU . 11.0 p -133.33 178.77 5.14 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 125' ' ' LEU . 1.9 pt? . . . . . 0 C--N 1.3 -1.573 0 CA-C-N 119.007 0.821 . . . . 0.0 109.944 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER . . . . . 0 CA--C 1.487 -1.459 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -57.88 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.861 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 m -91.26 138.0 20.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.67 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 73.6 m -91.09 170.0 10.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -31.35 106.61 0.02 OUTLIER Glycine 0 C--N 1.358 1.762 0 O-C-N 124.395 1.059 . . . . 0.0 115.725 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -120.02 144.02 47.76 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -113.82 -19.62 11.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.315 1.055 . . . . 0.0 110.583 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 98.9 mtt180 -92.48 117.49 29.99 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.197 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -64.84 -30.39 77.84 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.204 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 3.6 mm100 -73.43 -23.74 60.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 122.762 1.268 . . . . 0.0 108.195 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 5.7 t0 -88.49 -39.94 13.82 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.466 -174.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.67 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.307 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 52.1 mtmt -61.12 -28.05 68.82 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.985 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.54 63.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.734 0.302 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 4' ' ' ASN . . . -78.91 -39.98 33.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.996 0.903 . . . . 0.0 109.143 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -67.68 -30.74 70.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.174 175.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.31 -25.1 21.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.963 1.305 . . . . 0.0 111.847 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -14.04 62.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.839 0.456 . . . . 0.0 111.516 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.37 31.9 0.88 Allowed Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.07 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.61 36.64 24.04 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.94 -69.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.663 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.8 161.36 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 124.032 0.833 . . . . 0.0 110.244 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.01 150.55 17.01 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.06 75.58 0.28 Allowed Glycine 0 CA--C 1.494 -1.274 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.628 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 153.27 34.88 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.649 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.1 pt -116.88 157.32 17.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 50.5 m-85 -80.31 77.13 7.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.825 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 59.0 t -109.54 118.43 56.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.06 112.07 1.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.273 0.983 . . . . 0.0 112.355 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.3 p 64.05 26.4 14.02 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.196 1.798 . . . . 0.0 112.979 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -84.6 139.05 37.99 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.78 7.66 4.24 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.786 1.657 . . . . 0.0 112.13 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 9.7 ptm180 -118.54 -6.05 10.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.175 0.512 . . . . 0.0 109.902 174.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 79.4 m -151.22 119.6 6.4 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.28 137.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 122.113 0.959 . . . . 0.0 111.25 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.7 p-10 -104.78 169.14 8.62 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.39 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 ' HD2' ' A' ' 69' ' ' LYS . 99.5 t -47.76 -35.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 124.922 1.289 . . . . 0.0 112.391 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 41.2 mt-10 -66.67 -48.47 69.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.29 -40.85 67.26 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.284 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.06 64.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.838 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -59.69 -30.58 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.4 -51.51 6.18 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.3 -35.29 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.024 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -64.97 -24.29 67.47 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.68 19.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.04 -51.71 23.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.245 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -132.65 107.37 13.0 Favored Pre-proline 0 N--CA 1.407 -2.587 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.16 56.41 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.689 2.26 . . . . 0.0 113.397 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.7 pp -91.49 169.96 10.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 1.4 tm0? -85.63 146.95 26.62 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.49 144.94 44.55 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.384 0.611 . . . . 0.0 111.761 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.26 163.59 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.04 128.74 3.99 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.347 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 43.5 t -105.42 123.16 59.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -149.91 151.5 33.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.13 109.54 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.17 117.13 27.93 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.86 -59.91 1.76 Allowed 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.377 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -95.44 115.08 26.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -63.95 -30.98 51.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.212 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.84 -16.8 60.68 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.212 0.53 . . . . 0.0 110.092 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.2 t70 -85.29 -31.95 22.79 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.55 -43.75 80.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.202 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 63' ' ' ILE . 97.5 t -57.41 -43.94 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.9 t70 -52.39 -61.26 2.39 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.902 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 40' ' ' VAL . 45.2 mmtm -62.15 -44.58 96.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.253 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -63.76 -27.45 69.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.348 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -84.16 -60.31 2.13 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.135 0.574 . . . . 0.0 110.915 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -54.91 -55.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.616 0.766 . . . . 0.0 111.813 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -82.48 -21.58 35.51 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 17.0 m 61.8 84.76 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.001 0.905 . . . . 0.0 110.77 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.0 -170.17 2.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.86 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . . . -125.15 -40.53 2.14 Favored 'General case' 0 CA--C 1.462 -2.417 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.66 33.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.922 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.7 p -142.85 135.67 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.7 mp0 -101.29 116.98 34.05 Favored 'General case' 0 N--CA 1.386 -3.631 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.3 158.51 15.83 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.542 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -97.86 93.68 6.48 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -69.59 -12.83 67.62 Favored Glycine 0 C--N 1.311 -0.849 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -49.82 -26.57 4.09 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.072 0.949 . . . . 0.0 112.19 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -51.85 -45.78 64.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 37.1 tt0 -177.57 132.63 0.16 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -67.4 -35.53 79.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.085 0.945 . . . . 0.0 110.664 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.48 -15.62 57.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.591 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 38.8 t80 -68.62 -31.89 71.37 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.2 mp -64.34 -40.39 88.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.02 -13.64 62.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.79 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 93.9 m -86.98 -44.02 11.93 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.872 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -47.02 -48.08 22.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.783 0.433 . . . . 0.0 110.62 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.7 mpt_? -43.15 -31.1 0.53 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.24 -38.84 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.082 0.468 . . . . 0.0 111.419 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.99 -18.13 22.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.67 0.748 . . . . 0.0 112.496 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.42 129.3 30.75 Favored Pre-proline 0 C--N 1.27 -2.889 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.66 165.53 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.056 1.837 . . . . 0.0 110.264 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.54 -3.37 17.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.269 0.557 . . . . 0.0 111.139 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -79.87 -23.12 42.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.953 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.78 141.87 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.0 169.9 9.27 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.475 0.31 . . . . 0.0 110.37 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.615 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.0 mp -122.65 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.584 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.4 m0 -120.86 162.45 19.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -99.7 120.81 40.29 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.8 100.56 3.48 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.296 -1.751 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.676 -175.387 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 . . . . . 0 CA--C 1.475 -1.931 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -84.53 155.58 22.06 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.373 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 62.6 47.85 4.69 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.197 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.23 155.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.98 -25.4 34.81 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 103' ' ' TRP . 41.1 ttmt -169.76 163.41 9.86 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -127.9 144.46 51.1 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.48 175.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--N 1.308 -1.208 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.944 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.407 ' CG ' ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.498 -1.021 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.97 130.48 15.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.558 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 26.3 t -100.74 109.15 24.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.351 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.2 m -93.76 168.68 10.84 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -23.56 106.63 0.01 OUTLIER Glycine 0 C--N 1.371 2.503 0 O-C-N 124.496 1.123 . . . . 0.0 115.795 -171.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.2 tp -154.37 141.55 19.45 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -136.17 8.68 3.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.82 0.819 . . . . 0.0 109.238 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 95.1 mtt180 -92.43 112.79 24.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.53 -37.1 80.8 Favored Glycine 0 C--N 1.298 -1.556 0 O-C-N 123.194 0.308 . . . . 0.0 113.131 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -26.89 65.61 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.184 0.994 . . . . 0.0 109.391 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.469 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 8.1 t0 -90.27 -39.01 13.02 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.105 -175.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.08 -42.45 89.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -62.34 -23.92 67.04 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.1 69.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.494 . . . . 0.0 110.28 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG ' ' A' ' 4' ' ' ASN . . . -79.01 -40.99 30.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.752 0.787 . . . . 0.0 110.346 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -68.9 -31.76 70.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.733 177.251 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.75 -16.18 47.26 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.08 -6.15 53.74 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.63 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 15.0 1.56 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.43 -1.366 . . . . 0.0 113.286 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.51 28.73 17.38 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.178 0.991 . . . . 0.0 110.783 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.69 -69.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.258 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.5 p90 -177.79 163.37 1.83 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 124.039 0.837 . . . . 0.0 109.184 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.96 126.8 5.56 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.93 85.25 0.82 Allowed Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -119.01 146.92 44.64 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CG2' ' HB ' ' A' ' 57' ' ' VAL 0.332 0.1 OUTLIER -116.92 148.92 19.32 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 179.653 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 52.8 m-85 -74.76 87.73 2.23 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.315 -174.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.7 t -117.59 120.86 66.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.02 106.56 0.17 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.537 1.148 . . . . 0.0 113.625 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.0 p 63.91 19.63 11.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.489 1.916 . . . . 0.0 114.189 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.8 p -87.15 146.57 40.57 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.749 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.28 13.52 2.07 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.049 1.833 . . . . 0.0 109.929 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -100.15 -25.84 14.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.123 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 82.8 m -155.97 141.75 17.97 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -106.16 137.7 35.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.287 -171.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.43 168.72 9.34 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.777 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 73' ' ' LEU . 4.5 p -52.76 -33.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 124.338 1.024 . . . . 0.0 111.781 -171.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -69.62 -42.1 74.8 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.704 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 46' ' ' VAL . 38.0 mt-30 -74.35 -41.34 61.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.768 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.08 66.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.39 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.29 -30.83 71.87 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.87 -42.3 27.69 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 42' ' ' GLN . 22.1 t -64.22 -35.37 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.935 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -16.3 64.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.39 -17.02 37.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.649 . . . . 0.0 109.586 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.82 -32.2 11.47 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.429 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 93.9 11.54 Favored Pre-proline 0 N--CA 1.39 -3.462 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.68 61.74 5.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.503 2.135 . . . . 0.0 111.739 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 19' ' ' TYR . 1.1 pp -100.88 173.15 6.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.935 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' ALA . 35.8 tt0 -79.69 138.01 37.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.1 0.56 . . . . 0.0 111.101 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 28' ' ' LEU . 22.8 m-85 -108.89 140.62 42.1 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.99 137.82 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -108.66 122.07 6.48 Favored Glycine 0 N--CA 1.412 -2.913 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.645 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 79' ' ' GLN . 15.2 t -114.23 106.46 20.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -160.54 146.17 14.87 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.55 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -91.19 91.88 8.42 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.48 159.4 26.98 Favored 'General case' 0 N--CA 1.387 -3.622 0 CA-C-O 123.427 1.584 . . . . 0.0 111.911 -173.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -110.63 -73.68 0.67 Allowed 'General case' 1 C--N 1.23 -4.625 0 CA-C-N 110.792 -2.913 . . . . 0.0 111.105 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.01 132.78 36.76 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 92' ' ' LEU . 10.6 tt -67.44 -31.16 51.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.78 -19.72 65.13 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 18.6 t70 -82.42 -39.98 21.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.491 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -46.98 85.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.974 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 63' ' ' ILE . 75.5 t -60.39 -40.18 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.624 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -56.26 -61.64 2.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.78 177.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 44.1 mmtm -62.34 -40.36 96.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.382 0.273 . . . . 0.0 111.448 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.85 -41.1 97.42 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.299 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -80.46 -48.71 12.43 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.681 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 68' ' ' ASP . 81.3 t -56.13 -54.94 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 123.403 0.44 . . . . 0.0 111.286 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.623 ' HB2' HG23 ' A' ' 40' ' ' VAL . 47.7 tp -82.54 -14.26 55.22 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.302 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 t 61.95 63.9 1.06 Allowed 'General case' 0 C--O 1.254 1.317 0 CA-C-O 121.891 0.853 . . . . 0.0 109.279 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.479 HD21 HD23 ' A' ' 73' ' ' LEU . 92.3 mt -66.18 179.63 0.92 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.358 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' CB ' ' HG3' ' A' ' 53' ' ' GLN . . . -125.13 -39.73 2.21 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -142.01 156.35 45.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.417 173.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 7.3 p -140.38 141.95 32.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.632 HE22 ' HB2' ' A' ' 103' ' ' TRP . 7.9 mm100 -104.12 109.45 21.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 122.971 0.508 . . . . 0.0 111.664 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 92' ' ' LEU . 3.2 mm? -114.48 136.99 52.4 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 175.88 -29.7 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.301 0 CA-C-O 121.678 0.751 . . . . 0.0 109.899 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.02 -55.67 1.95 Allowed Glycine 0 C--N 1.286 -2.228 0 N-CA-C 119.749 2.659 . . . . 0.0 119.749 -166.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -82.55 -69.76 0.6 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 119.316 3.08 . . . . 0.0 119.316 -160.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.52 -49.6 6.58 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -161.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 1.0 OUTLIER -168.09 172.27 8.88 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.511 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 36.3 mt-30 -76.87 -48.99 16.75 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.387 1.075 . . . . 0.0 108.867 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.2 mt -75.96 -13.97 60.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.691 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.472 ' O ' ' HB ' ' A' ' 91' ' ' THR . 25.9 t80 -59.03 -37.07 76.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.673 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 80' ' ' LEU . 1.8 mp -65.53 -34.45 70.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 21.4 t70 -69.1 -22.73 63.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 87.2 m -83.8 -44.33 14.48 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.115 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.54 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -44.86 -50.12 10.5 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -54.15 -29.18 44.48 Favored 'General case' 0 N--CA 1.516 2.825 0 CA-C-O 121.284 0.564 . . . . 0.0 112.258 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 28.5 mt-10 -76.72 -30.44 56.64 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.521 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 -9.25 19.02 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.559 0.695 . . . . 0.0 112.561 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.6 tp -94.85 129.29 36.4 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.525 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.0 165.1 22.53 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.828 1.685 . . . . 0.0 111.153 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.93 -5.15 32.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.159 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -81.01 -29.4 35.17 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 70' ' ' ALA . 38.9 t -108.06 135.37 46.99 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.042 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.11 169.02 8.81 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 94.4 mt -122.94 128.27 75.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.632 ' HB2' HE22 ' A' ' 79' ' ' GLN . 41.8 m0 -116.74 161.01 19.92 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.221 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' HG11 ' A' ' 120' ' ' VAL . 7.9 tmtm? -102.5 112.21 24.84 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.85 115.56 13.43 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 C--N 1.283 -2.293 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.067 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 75.7 m-85 . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -98.13 169.49 9.57 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HB3' ' NH2' ' A' ' 93' ' ' ARG . 37.3 t60 63.51 31.96 14.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 104' ' ' LYS . 31.5 m -83.15 154.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.947 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.76 -41.22 62.76 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.158 0.504 . . . . 0.0 110.454 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -150.32 163.02 39.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.48 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.83 137.43 54.93 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.59 171.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.645 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.505 -0.787 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.61 -175.64 19.76 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.695 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.5 mp0 -50.09 -62.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.398 1.479 . . . . 0.0 111.501 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.578 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -149.28 25.83 0.88 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.237 1.017 . . . . 0.0 108.607 -175.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 12.4 ptpt -91.55 97.6 11.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.46 146.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.741 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 p -87.7 170.13 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.29 122.12 2.36 Favored Glycine 0 CA--C 1.482 -1.98 0 O-C-N 124.117 0.886 . . . . 0.0 114.886 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 14' ' ' ASP . 25.1 tp -140.72 128.54 21.77 Favored 'General case' 0 N--CA 1.399 -2.978 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -120.77 12.83 11.44 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 123.093 1.425 . . . . 0.0 109.439 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 33.2 mtp85 -108.65 112.34 24.61 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.504 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.94 66.74 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 116.552 -0.295 . . . . 0.0 113.793 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.22 -20.03 61.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.274 1.035 . . . . 0.0 108.887 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.508 ' HB3' HD21 ' A' ' 9' ' ' LEU . 1.3 m-20 -95.53 -45.3 7.13 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.659 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.36 72.53 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.81 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -59.11 -23.94 62.54 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.27 71.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -35.05 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.218 1.009 . . . . 0.0 108.772 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -68.43 -38.27 81.05 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.332 176.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.9 -26.19 62.22 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.219 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.46 -23.66 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.146 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' HA3' HG13 ' A' ' 24' ' ' ILE . . . 176.0 -25.88 0.06 OUTLIER Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.038 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 63.85 21.1 12.52 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-O 121.875 0.845 . . . . 0.0 109.597 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.578 ' HB ' HD21 ' A' ' 4' ' ' ASN . 25.0 mt -70.52 -60.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.041 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.04 151.31 0.66 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.707 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -117.8 159.62 14.09 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.54 79.98 0.26 Allowed Glycine 0 CA--C 1.505 -0.575 0 CA-C-N 117.535 0.667 . . . . 0.0 111.934 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.59 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.44 149.3 40.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.135 0.493 . . . . 0.0 109.986 -174.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.3 mt -117.65 150.19 19.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.244 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 7.9 m-85 -81.87 75.47 8.81 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.194 0.308 . . . . 0.0 111.702 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 87.9 t -98.48 122.13 49.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.69 108.84 0.23 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.271 1.028 . . . . 0.0 113.629 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.7 p 62.55 26.59 15.8 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.586 1.954 . . . . 0.0 114.234 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -90.56 139.83 26.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.2 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.18 16.12 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.244 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -125.57 -3.81 7.23 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.13 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 87.4 m -156.7 120.72 4.35 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.0 137.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 122.27 1.033 . . . . 0.0 111.978 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.4 p-10 -103.52 170.69 7.79 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.08 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 p -43.64 -39.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.611 1.194 . . . . 0.0 112.687 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 44.3 mt-10 -68.81 -48.66 63.02 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.626 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.662 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.2 mt-30 -68.64 -40.15 80.41 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.526 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.54 -40.26 74.79 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 5.4 pt20 -64.91 -29.65 70.61 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.12 -45.16 24.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.894 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 42' ' ' GLN . 48.2 t -59.53 -36.37 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.124 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -71.24 -8.1 51.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.0 -7.24 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.495 0.664 . . . . 0.0 109.304 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.23 -48.15 3.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.207 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -134.91 104.73 10.6 Favored Pre-proline 0 N--CA 1.41 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.42 61.66 3.49 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 123.008 2.472 . . . . 0.0 113.073 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.79 144.39 28.92 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.306 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.473 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 2.9 tm0? -73.5 154.93 39.7 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.131 0.972 . . . . 0.0 109.361 -175.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -118.22 155.39 30.6 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 112.494 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 26' ' ' GLY . 8.4 p -131.19 164.52 34.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.2 147.2 18.9 Favored Glycine 0 C--O 1.204 -1.778 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 45.7 t -125.34 106.35 16.19 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -152.63 140.1 19.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.256 -1.778 . . . . 0.0 112.103 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 4.5 ptt180 -103.18 95.28 6.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.06 151.57 22.37 Favored 'General case' 1 N--CA 1.369 -4.515 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.562 -170.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -85.22 -49.11 8.47 Favored 'General case' 1 C--N 1.233 -4.474 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -99.1 129.08 45.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.998 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' VAL . 11.7 tt -67.55 -32.82 58.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.169 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -19.16 63.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 37.2 t70 -83.01 -27.1 30.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.277 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.03 -43.56 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 63' ' ' ILE . 50.9 t -59.54 -41.21 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.386 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.562 ' O ' HG23 ' A' ' 72' ' ' VAL . 19.3 t70 -50.72 -55.99 14.06 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.611 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 40.9 mmtm -66.02 -44.65 84.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.575 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.85 -35.28 68.68 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.973 0.796 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.91 -58.46 2.78 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.474 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 68' ' ' ASP . 68.0 t -49.4 -58.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.447 0.699 . . . . 0.0 112.746 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.2 -16.59 37.28 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 27.7 t 62.28 88.84 0.09 Allowed 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 124.606 1.191 . . . . 0.0 109.059 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.489 ' HG ' ' HA ' ' A' ' 70' ' ' ALA . 77.7 mt -84.07 177.01 8.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.93 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.473 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -115.6 -40.68 3.35 Favored 'General case' 0 CA--C 1.451 -2.85 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -147.05 164.76 31.99 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.892 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.78 135.23 25.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.35 117.3 32.45 Favored 'General case' 0 N--CA 1.388 -3.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.064 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.22 129.98 45.49 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.649 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.1 m-70 -82.76 103.03 11.94 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -61.42 -12.95 34.83 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.367 -172.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -58.97 -25.78 63.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.993 1.317 . . . . 0.0 111.364 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -59.82 -48.64 80.87 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.89 150.99 0.82 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 49.4 mt-30 -76.2 -43.41 42.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.98 0.895 . . . . 0.0 111.73 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.45 -21.56 35.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.396 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.9 t80 -57.12 -46.81 82.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.853 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.492 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.0 mt -61.02 -38.71 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 109.558 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.652 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 17.9 t70 -66.99 -19.54 65.73 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.705 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.6 m -89.17 -45.71 9.36 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.972 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -43.41 -50.0 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -67.05 -14.23 62.7 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.42 -35.37 27.67 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.98 20.07 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.013 0.911 . . . . 0.0 111.384 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.64 118.17 70.95 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.789 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.76 165.6 20.49 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.937 2.425 . . . . 0.0 111.076 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.14 4.12 1.78 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -84.81 -29.58 25.26 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.81 133.25 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -112.45 -179.74 3.75 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 88.2 mt -126.71 134.57 65.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.8 m0 -119.89 147.14 45.07 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 118.12 36.33 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.58 106.24 2.52 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.234 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -91.15 107.57 19.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -76.03 143.14 41.59 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.39 115.23 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-O 121.838 0.828 . . . . 0.0 110.129 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.31 179.01 16.37 Favored Glycine 0 N--CA 1.415 -2.763 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.656 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.04 -27.88 61.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.197 0.522 . . . . 0.0 110.214 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.8 p -121.14 147.12 46.0 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.0 102.41 45.72 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.15 137.85 26.91 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.377 2.051 . . . . 0.0 111.466 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.7 -40.33 76.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.533 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -140.57 127.3 20.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 121.475 0.655 . . . . 0.0 110.675 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.32 -68.19 0.94 Allowed 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 72.9 m-85 -135.09 120.04 18.58 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -111.71 -170.85 1.73 Allowed 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.944 0.777 . . . . 0.0 110.546 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.4 m80 69.82 19.97 6.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.462 1.105 . . . . 0.0 109.469 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -96.95 156.55 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.272 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.87 -40.8 38.86 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 120.843 0.354 . . . . 0.0 111.331 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 64.0 mttp -147.99 161.28 41.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.25 127.3 55.57 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 m -129.65 173.55 13.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.4 pt? -81.73 167.18 19.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.74 125.13 30.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.977 0.418 . . . . 0.0 110.183 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -117.2 23.64 11.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.268 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.69 20.56 7.74 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.847 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 69.3 114.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.702 0 C-N-CA 125.233 1.413 . . . . 0.0 112.121 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.47 145.11 4.07 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.339 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.26 27.8 3.95 Favored Glycine 0 C--O 1.245 0.833 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -157.3 171.37 20.53 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.86 65.93 3.44 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 123.364 0.415 . . . . 0.0 113.403 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.685 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--O 1.246 0.893 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.11 178.7 15.51 Favored Glycine 0 N--CA 1.418 -2.566 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.435 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.79 161.85 21.87 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.91 0.386 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 18' ' ' ALA . 63.6 t30 -128.57 39.11 3.87 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 37.6 ttpt -43.9 114.28 0.64 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.725 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 m -117.63 140.72 39.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.213 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.7 m -91.69 168.48 11.45 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 117.354 -1.307 . . . . 0.0 107.995 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.15 106.01 0.01 OUTLIER Glycine 0 C--N 1.385 3.257 0 O-C-N 125.3 1.625 . . . . 0.0 116.036 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -135.19 130.53 35.46 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -174.32 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -126.4 -18.9 4.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -81.2 117.06 21.42 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.688 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -44.9 -59.3 4.47 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 124.184 0.897 . . . . 0.0 114.513 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -56.8 -25.92 56.72 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 177.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB2' HD11 ' A' ' 9' ' ' LEU . 1.8 m-20 -84.15 -34.87 23.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 9' ' ' LEU . . . -67.08 -42.24 85.0 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.332 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 49.2 mtmt -58.9 -30.39 67.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.515 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.21 70.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.622 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HA ' HD22 ' A' ' 4' ' ' ASN . . . -77.07 -35.96 56.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.909 0.861 . . . . 0.0 109.784 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -74.82 -30.56 61.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.841 178.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.8 -14.14 30.28 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.783 0.801 . . . . 0.0 112.102 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.66 -13.52 61.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.978 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.49 26.26 0.98 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.12 27.64 11.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.45 1.1 . . . . 0.0 112.062 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.97 -68.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.802 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.523 ' OH ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -178.87 162.12 1.27 Allowed 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.314 1.009 . . . . 0.0 109.151 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.05 150.53 17.21 Favored Glycine 0 C--N 1.313 -0.708 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . -116.84 71.29 0.28 Allowed Glycine 0 CA--C 1.475 -2.441 0 C-N-CA 118.612 -1.756 . . . . 0.0 112.559 -170.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -108.97 130.78 55.47 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.357 0.598 . . . . 0.0 110.233 -179.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.0 pt -102.39 155.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -77.95 74.16 4.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.009 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.7 t -103.2 117.35 48.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 170.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.91 114.24 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.71 1.256 . . . . 0.0 112.826 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.9 p 69.72 17.95 7.63 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 126.181 1.792 . . . . 0.0 113.681 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -83.24 141.41 42.86 Favored Pre-proline 0 N--CA 1.419 -2.014 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.41 4.38 4.09 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.683 1.589 . . . . 0.0 111.193 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.75 5.74 10.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 110.298 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 80.7 m -156.17 117.81 3.93 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 28' ' ' LEU . 1.5 t -102.74 137.0 32.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.947 0.88 . . . . 0.0 112.381 -168.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.46 166.34 10.62 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.838 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.5 p -45.01 -31.93 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.315 1.446 . . . . 0.0 113.143 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.7 -59.69 3.96 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 123.294 0.637 . . . . 0.0 111.955 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -70.52 -33.4 71.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.663 0.744 . . . . 0.0 110.12 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.923 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.45 -26.44 68.44 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.067 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -63.68 -32.97 74.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.921 0.867 . . . . 0.0 109.493 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.26 -43.25 13.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.434 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.923 HG12 ' HA ' ' A' ' 43' ' ' ALA . 9.5 p -70.42 -24.28 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.319 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -15.9 63.4 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.468 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.6 -24.95 28.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.585 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.43 -45.47 12.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.13 104.94 18.05 Favored Pre-proline 0 N--CA 1.394 -3.227 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.53 56.23 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.901 2.401 . . . . 0.0 111.963 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pp -97.09 177.19 5.67 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.215 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -77.51 128.64 34.52 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.752 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 28' ' ' LEU . 66.6 m-85 -96.85 127.32 42.72 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 26' ' ' GLY . 9.8 p -119.14 149.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.04 128.14 7.27 Favored Glycine 0 C--N 1.285 -2.256 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.321 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.95 107.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -165.28 158.63 16.51 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.649 -1.22 . . . . 0.0 109.836 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' HB2' ' A' ' 81' ' ' HIS . 47.2 mtm180 -90.16 93.42 9.36 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB2' HG22 ' A' ' 66' ' ' VAL . 16.3 m120 -96.75 117.6 31.39 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -80.25 -31.32 38.45 Favored 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.533 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -99.19 123.62 43.62 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 91' ' ' THR . 7.8 tt -61.9 -34.55 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.4 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.88 -20.25 61.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.176 0.512 . . . . 0.0 110.014 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.38 -35.44 30.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.949 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 60' ' ' ASN . 26.1 t -64.9 -47.2 89.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 63' ' ' ILE . 80.5 t -60.1 -42.21 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.78 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 72' ' ' VAL . 31.1 t70 -53.87 -59.89 4.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.316 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -67.49 -39.84 85.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.298 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.96 -37.91 86.52 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 123.633 0.583 . . . . 0.0 111.172 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -73.14 -60.6 2.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.604 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.6 t -55.69 -53.76 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.982 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 73' ' ' LEU . 1.5 tm? -72.9 -29.28 63.02 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.298 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.4 t 67.75 74.88 0.3 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.388 1.09 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 73' ' ' LEU . 91.6 mt -77.81 -168.4 1.22 Allowed 'General case' 0 C--O 1.249 1.074 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.633 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.7 -52.39 1.24 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.19 162.4 31.87 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.722 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.83 136.65 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.561 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.1 mp0 -105.21 115.03 29.58 Favored 'General case' 0 N--CA 1.394 -3.259 0 C-N-CA 123.177 0.591 . . . . 0.0 110.69 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.74 123.31 43.86 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 46.8 m-70 -77.77 108.72 11.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 175.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -51.9 -11.78 1.03 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -51.62 -26.1 8.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.422 1.089 . . . . 0.0 111.932 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -69.12 -49.34 57.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.686 0.279 . . . . 0.0 111.718 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.5 147.88 0.32 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -79.45 -46.0 18.33 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 122.078 0.942 . . . . 0.0 111.35 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 42.3 mt -78.98 -14.32 59.27 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.219 -173.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.2 t80 -60.78 -39.9 90.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.347 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.576 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -61.38 -38.07 79.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-O 121.817 0.818 . . . . 0.0 109.967 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 18.2 t70 -65.99 -19.78 65.97 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.328 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.562 HG22 ' CD1' ' A' ' 63' ' ' ILE . 84.2 m -88.03 -41.94 12.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.922 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 2.6 mm? -51.77 -39.23 58.23 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 122.602 0.361 . . . . 0.0 111.359 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.73 ' HD2' HD12 ' A' ' 102' ' ' ILE . 7.9 mmm180 -46.0 -39.92 9.76 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.734 1.214 . . . . 0.0 111.546 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.07 -33.27 33.52 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.627 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.52 -21.04 18.54 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.705 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.62 141.88 42.2 Favored Pre-proline 0 C--N 1.285 -2.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.228 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.11 165.03 31.63 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 121.968 1.778 . . . . 0.0 110.363 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -12.11 61.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.706 0.765 . . . . 0.0 110.343 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -76.26 -29.13 57.36 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.292 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 70' ' ' ALA . 85.6 t -105.9 132.73 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 CA-C-O 121.196 0.522 . . . . 0.0 109.698 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.77 168.75 8.94 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.413 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.73 HD12 ' HD2' ' A' ' 93' ' ' ARG . 66.6 mt -123.95 132.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.561 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.7 m0 -120.58 157.65 29.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -100.61 111.53 23.78 Favored 'General case' 0 C--N 1.276 -2.587 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 110.39 4.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.96 95.33 4.78 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.221 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.4 m -73.05 168.86 18.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 168.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 111' ' ' THR . 17.4 m -41.43 115.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.021 0.915 . . . . 0.0 113.01 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -44.94 -56.05 6.06 Favored Glycine 0 CA--C 1.487 -1.713 0 CA-C-N 113.731 -1.577 . . . . 0.0 116.446 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.78 -3.26 17.91 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 108' ' ' VAL . 4.6 t -90.71 -11.34 39.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 117.911 -1.516 . . . . 0.0 109.423 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.54 142.0 23.68 Favored Pre-proline 0 N--CA 1.436 -1.127 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 163.58 13.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.217 2.611 . . . . 0.0 111.154 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.8 75.02 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.025 0.441 . . . . 0.0 111.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -116.49 118.91 33.97 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -132.07 -61.51 0.88 Allowed 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.034 -172.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CE1' ' HA3' ' A' ' 82' ' ' GLY . 31.5 m-85 -127.58 96.1 4.44 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -93.7 167.17 11.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.454 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.5 m80 74.12 18.62 3.12 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.448 1.092 . . . . 0.0 111.668 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.06 147.13 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 -42.66 25.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.89 0.376 . . . . 0.0 111.909 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.1 ttmt -149.27 163.3 38.05 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.05 139.18 54.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.04 165.75 30.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.14 146.52 54.17 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.137 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.63 120.58 10.3 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -75.77 14.75 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.08 78.54 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -93.63 115.54 28.02 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.95 40.97 13.07 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 177.38 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.58 117.65 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.12 1.368 . . . . 0.0 112.542 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.76 -39.42 0.12 Allowed Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.61 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.1 92.87 1.17 Allowed Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.01 117.43 17.72 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.542 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -149.82 29.75 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -72.7 114.42 10.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.72 -174.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 41.5 t -90.4 118.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.319 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.38 169.16 9.53 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -32.08 106.55 0.02 OUTLIER Glycine 0 C--N 1.364 2.101 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 -171.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -138.63 134.12 33.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -133.78 14.48 4.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.54 1.162 . . . . 0.0 109.738 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 65.9 mtt180 -107.13 112.22 25.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.32 -39.74 65.92 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 123.642 0.639 . . . . 0.0 113.963 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 18.5 mp0 -81.44 -19.23 42.9 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.7 0.8 . . . . 0.0 111.082 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' HD11 ' A' ' 9' ' ' LEU . 9.7 t70 -87.71 -46.02 9.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.11 72.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.646 1.178 . . . . 0.0 111.367 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -22.39 66.02 Favored 'General case' 0 C--O 1.19 -2.036 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.15 71.32 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.853 0.297 . . . . 0.0 111.567 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.6 -35.75 39.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.279 1.038 . . . . 0.0 109.468 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -70.68 -31.11 67.89 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.687 174.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 -35.23 79.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.091 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.0 64.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.137 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.65 -20.43 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.373 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . . . 64.78 26.77 13.02 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-O 121.75 0.786 . . . . 0.0 108.882 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' HB ' HD21 ' A' ' 4' ' ' ASN . 30.9 mt -67.28 -64.56 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.796 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.41 154.8 1.04 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.735 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 137.67 9.64 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.75 80.62 0.28 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.985 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.493 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -104.84 150.2 25.03 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.557 0.694 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.281 5.5 pt -105.91 151.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.968 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 78.1 m-85 -80.08 60.42 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.884 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.33 113.85 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 117.401 -1.719 . . . . 0.0 107.447 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.71 118.47 7.71 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.635 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p 63.8 29.82 14.67 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.566 1.546 . . . . 0.0 112.91 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -99.85 127.62 33.28 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.32 18.72 1.16 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.566 2.177 . . . . 0.0 111.682 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -118.18 -8.26 10.66 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.899 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 62.0 m -140.54 171.13 14.55 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.473 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.2 t -136.61 136.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 119.245 0.93 . . . . 0.0 108.653 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.85 174.68 5.76 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.105 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -45.82 -31.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.897 1.279 . . . . 0.0 113.122 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.58 -62.22 1.64 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.633 0.73 . . . . 0.0 110.659 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 25.0 mt-30 -64.47 -42.04 96.14 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.274 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -25.23 68.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.91 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -24.28 64.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 109.629 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.84 -49.93 7.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' GLN . 46.7 t -55.36 -35.34 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.786 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptp -58.9 -31.09 68.3 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.6 29.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.408 0.623 . . . . 0.0 110.307 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.32 -39.79 14.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -145.81 97.22 4.6 Favored Pre-proline 0 N--CA 1.401 -2.893 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.12 71.39 0.86 Allowed 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.406 2.071 . . . . 0.0 113.114 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.17 147.24 29.27 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.776 173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.99 145.42 48.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.513 -173.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.64 142.03 45.72 Favored 'General case' 0 C--O 1.253 1.256 0 CA-C-O 121.838 0.828 . . . . 0.0 112.306 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 152.24 34.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.48 149.85 17.0 Favored Glycine 0 C--O 1.2 -1.979 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.2 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.9 t -133.91 123.39 44.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -172.43 156.84 3.85 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.665 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 31.2 mtm180 -95.71 92.06 6.4 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -104.27 121.17 42.76 Favored 'General case' 0 N--CA 1.406 -2.631 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.56 -31.92 36.78 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.311 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.55 110.63 19.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.238 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.68 HG13 HD13 ' A' ' 92' ' ' LEU . 6.8 tt -58.32 -38.36 68.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.521 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.5 62.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.318 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 16.9 t70 -86.22 -31.19 21.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.155 0.502 . . . . 0.0 109.994 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.54 -46.15 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.0 t -62.57 -39.87 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.256 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 25.8 t70 -52.55 -58.82 5.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.879 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -66.98 -40.92 87.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.842 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.75 -30.77 71.0 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.367 0.667 . . . . 0.0 111.276 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -83.53 -58.74 2.69 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.794 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 59.0 t -54.4 -57.92 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.478 0.486 . . . . 0.0 111.291 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 75' ' ' LEU . 29.8 tp -77.76 -17.14 57.85 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.72 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m 59.09 72.21 0.54 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.985 0.897 . . . . 0.0 111.314 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 73' ' ' LEU . 71.4 mt -79.11 -172.44 3.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.206 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.467 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -126.68 -35.13 2.35 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.306 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -149.37 166.03 30.25 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.51 135.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -101.44 108.36 19.93 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-O 121.68 0.752 . . . . 0.0 109.602 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 92' ' ' LEU . 72.5 mt -90.53 120.54 31.7 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.102 -1.408 . . . . 0.0 107.595 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB3' ' CG ' ' A' ' 59' ' ' ARG . 8.8 t60 -83.37 85.85 7.16 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -49.22 -9.14 0.11 Allowed Glycine 0 N--CA 1.47 0.919 0 C-N-CA 128.325 2.869 . . . . 0.0 120.029 -168.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -39.0 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.83 -48.72 79.32 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -175.11 148.65 1.01 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -78.12 -39.21 42.0 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.9 mt -82.69 -15.98 49.88 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.554 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.568 ' O ' ' HB ' ' A' ' 91' ' ' THR . 19.0 t80 -61.29 -39.63 91.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.43 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -63.73 -34.9 70.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.929 0.871 . . . . 0.0 109.626 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.0 t70 -69.56 -18.41 63.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.455 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.576 HG22 ' CD1' ' A' ' 63' ' ' ILE . 63.1 m -83.79 -41.45 17.56 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.299 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.68 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -52.69 -41.71 64.13 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 123.272 0.629 . . . . 0.0 110.806 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.742 ' HD2' HD12 ' A' ' 102' ' ' ILE . 4.2 mmm180 -43.74 -44.44 6.61 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.11 1.364 . . . . 0.0 112.4 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -75.25 -24.27 57.62 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.913 -171.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -103.18 -3.57 25.59 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.819 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.4 tp -80.55 130.61 64.12 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 124.567 1.147 . . . . 0.0 109.567 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.49 162.52 37.94 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.379 1.386 . . . . 0.0 109.404 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.82 64.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -76.15 -30.27 58.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.6 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.511 HG21 ' HB1' ' A' ' 70' ' ' ALA . 40.5 t -104.57 147.44 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.468 0 CA-C-O 121.112 0.482 . . . . 0.0 110.109 -171.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -121.13 174.67 6.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 123.796 0.838 . . . . 0.0 108.761 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.742 HD12 ' HD2' ' A' ' 93' ' ' ARG . 92.6 mt -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 34.9 m0 -120.57 157.61 29.12 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.885 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -101.81 116.64 33.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.79 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -75.3 98.8 3.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 172.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.65 115.76 27.28 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.113 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 m -77.55 117.12 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.77 144.5 12.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.132 0.492 . . . . 0.0 111.443 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.68 8.25 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -79.89 -44.55 20.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.1 m -97.07 134.29 40.62 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.748 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.3 130.54 65.2 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.68 136.57 67.63 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.961 2.441 . . . . 0.0 113.258 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.89 72.88 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.813 0.816 . . . . 0.0 108.923 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.49 149.5 24.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -103.3 -85.07 0.46 Allowed 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 95.8 m-85 -149.24 122.63 9.04 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 90' ' ' ASP . 3.7 pm0 -72.9 163.81 27.58 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.585 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.506 ' CE1' ' HG3' ' A' ' 93' ' ' ARG . 5.9 t-160 65.35 38.47 5.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.98 0.895 . . . . 0.0 110.641 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -102.17 155.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.83 -39.5 15.82 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.783 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -155.53 163.02 40.55 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.52 144.38 50.89 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.788 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.42 175.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.99 130.85 34.42 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 22.4 t70 -65.86 110.17 2.76 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.238 0.542 . . . . 0.0 110.793 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.65 142.38 30.3 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.89 37.53 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -122.2 137.28 54.89 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.37 179.31 28.98 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 151.88 147.19 4.52 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.75 -19.12 16.89 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.355 0.598 . . . . 0.0 109.718 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -171.18 97.01 0.11 Allowed Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.828 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tmm? . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.23 36.62 0.87 Allowed Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.6 110.69 20.0 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.849 0.833 . . . . 0.0 109.347 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.57 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.2 28.5 0.91 Allowed 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 15.0 ptpt -77.79 98.11 5.44 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.003 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 78.1 t -72.64 109.24 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.765 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.7 m -92.07 170.94 9.44 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -50.61 116.3 4.13 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.672 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.57 176.65 6.08 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -123.93 -0.92 8.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.82 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 88.9 mtt180 -126.94 115.6 19.51 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.24 82.09 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-O 122.599 1.11 . . . . 0.0 112.32 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 0.9 OUTLIER -70.84 -40.18 72.52 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 125.604 1.562 . . . . 0.0 108.96 -176.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 33.0 t70 -74.98 -26.85 59.88 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.507 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -46.02 61.18 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.711 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 22.4 pttp -67.66 -23.61 65.35 Favored 'General case' 0 C--O 1.199 -1.555 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.26 70.05 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.997 0.427 . . . . 0.0 110.693 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 4' ' ' ASN . . . -74.68 -42.46 58.41 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.101 0.953 . . . . 0.0 109.586 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -68.44 -32.71 72.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.949 176.476 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.8 -32.11 70.37 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.17 -25.05 54.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.702 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.92 -28.91 0.02 OUTLIER Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.093 -1.527 . . . . 0.0 113.009 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 62.46 30.74 17.28 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.921 0.867 . . . . 0.0 108.78 -176.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.57 ' HB ' HD21 ' A' ' 4' ' ' ASN . 40.5 mt -70.75 -59.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.635 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 2.3 p90 -176.2 160.53 2.21 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.899 0.749 . . . . 0.0 109.9 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -128.79 123.05 4.15 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.4 85.68 0.67 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.17 151.84 33.68 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 4.9 pt -116.58 146.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.031 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -80.32 80.39 6.76 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.051 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.8 t -107.37 114.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.52 118.96 6.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.614 1.196 . . . . 0.0 110.874 -173.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.3 p 66.43 29.25 9.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.718 1.607 . . . . 0.0 113.136 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 40.8 t -92.84 143.69 27.34 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -91.2 0.16 4.78 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 121.52 1.48 . . . . 0.0 112.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 69.7 ttt180 -122.33 6.46 9.63 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 122.17 0.986 . . . . 0.0 109.475 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 57.3 m -146.81 125.57 12.62 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.6 t -105.59 137.15 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.918 0.865 . . . . 0.0 112.844 -172.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -107.4 172.63 6.72 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.593 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 p -49.64 -32.09 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.583 0.753 . . . . 0.0 112.5 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 53.1 mp0 -62.1 -60.8 3.07 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.6 mt-30 -69.97 -32.72 71.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.188 177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.82 -23.65 67.44 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.258 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -64.66 -26.36 68.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.489 0.662 . . . . 0.0 109.396 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.28 -49.28 9.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' GLN . 32.3 t -61.47 -32.26 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.963 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.667 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 22.9 ptm -64.35 -23.55 67.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.916 0.389 . . . . 0.0 111.868 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.57 -20.26 21.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.347 0.594 . . . . 0.0 109.482 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.49 -53.77 5.2 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.383 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -133.65 92.84 22.4 Favored Pre-proline 0 N--CA 1.391 -3.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.23 53.55 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.818 2.345 . . . . 0.0 112.183 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -89.81 162.94 15.25 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.058 176.435 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 4.7 tt0 -64.23 131.53 47.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.512 0.725 . . . . 0.0 110.718 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 54.5 m-85 -102.85 142.26 34.27 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.095 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.9 138.25 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -113.91 128.73 8.41 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.455 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.97 106.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -163.19 168.02 21.28 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.286 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -85.85 104.77 15.82 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -100.87 150.42 22.85 Favored 'General case' 1 N--CA 1.375 -4.181 0 CA-C-O 122.339 1.066 . . . . 0.0 109.479 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -113.69 -65.97 1.13 Allowed 'General case' 1 C--N 1.235 -4.38 0 CA-C-N 112.165 -2.289 . . . . 0.0 110.402 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -89.32 119.73 30.04 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.823 0.82 . . . . 0.0 111.904 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 92' ' ' LEU . 15.1 tt -66.86 -32.56 58.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.162 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.6 61.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.242 0.544 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.5 -49.75 7.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.555 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.15 -35.76 74.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.039 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.87 -30.9 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.144 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 72' ' ' VAL . 24.2 t70 -72.1 -38.23 69.37 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -65.68 -45.94 80.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -62.51 -23.67 67.08 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.231 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 30.7 ttmt -80.41 -59.1 2.82 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 124.193 0.997 . . . . 0.0 109.784 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 68' ' ' ASP . 65.5 t -59.13 -60.03 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.227 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 1.4 mm? -78.3 -8.2 58.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.985 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.1 p 52.32 73.29 0.34 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.719 0.771 . . . . 0.0 111.985 -172.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.41 173.55 3.22 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.243 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.69 -34.63 2.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.52 46.3 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.486 168.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.68 135.61 39.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.42 117.22 33.96 Favored 'General case' 0 N--CA 1.399 -3.016 0 CA-C-O 121.134 0.492 . . . . 0.0 110.886 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -96.92 128.2 43.65 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.073 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -83.28 95.48 8.18 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -61.01 -12.93 31.87 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -171.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -54.75 -26.38 33.85 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 117.668 0.734 . . . . 0.0 112.532 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -56.08 -45.69 79.26 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 89' ' ' ILE . 10.3 tp10 -175.74 135.45 0.3 Allowed 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 123.807 0.843 . . . . 0.0 109.007 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -66.28 -44.16 84.36 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.094 1.357 . . . . 0.0 111.06 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.73 -19.97 47.54 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.465 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . 32.6 t80 -65.07 -36.79 85.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.241 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.9 mp -63.32 -41.51 93.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.51 -21.38 66.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.4 m -81.37 -45.12 16.59 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.457 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.06 -46.22 8.41 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.479 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 4.5 mpt_? -55.0 -23.78 21.07 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.2 -39.35 21.08 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.134 0.493 . . . . 0.0 111.452 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.33 -2.69 58.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.412 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.14 120.57 82.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.231 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.35 163.66 35.81 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.485 1.457 . . . . 0.0 109.718 173.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.1 -7.64 37.89 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -80.69 -30.65 36.41 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.608 0.718 . . . . 0.0 109.753 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 70' ' ' ALA . 18.9 t -104.0 146.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.274 -170.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 168.69 10.71 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.516 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.438 HG23 HD23 ' A' ' 80' ' ' LEU . 79.6 mt -123.07 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.562 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.0 m0 -125.0 164.37 20.31 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 130.96 53.39 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.44 106.87 2.25 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.961 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 93.81 4.71 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.551 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 16.1 t -80.89 155.26 26.62 Favored 'General case' 0 N--CA 1.404 -2.734 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.521 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -64.04 157.25 4.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.982 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.51 -178.12 47.87 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.43 -56.46 4.52 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.444 0.622 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 p -111.05 122.29 47.51 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -100.32 104.14 27.95 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.76 149.5 86.85 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.846 2.364 . . . . 0.0 112.6 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.33 -44.91 61.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.568 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.39 120.82 32.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.708 0.766 . . . . 0.0 111.565 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.08 -58.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.463 174.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -122.19 94.58 4.34 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.37 177.04 4.91 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.418 -175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.3 t60 73.25 28.42 1.83 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.212 1.482 . . . . 0.0 108.45 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.05 155.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.15 -40.91 62.27 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -158.14 161.96 37.94 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -99.61 154.89 17.91 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 123.701 0.8 . . . . 0.0 109.586 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.4 p -157.76 168.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.68 165.4 11.82 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.551 ' OD2' ' HA ' ' A' ' 107' ' ' SER . 3.1 p30 -69.07 125.05 25.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.86 -15.99 40.06 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.106 0.479 . . . . 0.0 110.852 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 155.35 -153.62 24.91 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 132' ' ' ALA . 13.4 mm100 -81.81 82.44 7.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.366 0.603 . . . . 0.0 110.108 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.55 89.97 0.64 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.918 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.1 3.88 90.12 Favored Glycine 0 C--N 1.314 -0.679 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 129' ' ' GLN . . . -94.36 178.93 5.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 105.73 -41.44 2.17 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.422 -1.862 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.561 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 125' ' ' LEU . 67.4 mtt . . . . . 0 CA--C 1.501 -0.923 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.73 114.62 2.39 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -86.2 -75.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.103 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -120.25 29.25 7.59 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.22 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 113.098 -1.864 . . . . 0.0 114.426 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -90.15 115.23 29.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.191 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.9 m -91.56 170.24 10.1 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -30.46 116.44 0.07 OUTLIER Glycine 0 C--N 1.351 1.414 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 -171.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.447 HD11 ' OD2' ' A' ' 14' ' ' ASP . 16.7 tp -145.69 148.0 32.57 Favored 'General case' 0 N--CA 1.402 -2.858 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -125.67 -6.72 6.85 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -95.61 114.61 26.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -59.56 -30.5 68.72 Favored Glycine 0 C--O 1.217 -0.959 0 O-C-N 123.373 0.42 . . . . 0.0 112.06 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -67.8 -30.42 69.85 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.85 1.31 . . . . 0.0 108.045 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.447 ' OD2' HD11 ' A' ' 9' ' ' LEU . 40.6 t0 -91.46 -33.62 15.14 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 112.637 -2.074 . . . . 0.0 108.766 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.95 -34.68 78.29 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.304 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 51.0 mtmt -58.97 -25.51 63.63 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.016 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.27 75.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.974 0.416 . . . . 0.0 111.386 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 -43.94 62.84 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.755 0.788 . . . . 0.0 109.693 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.132 176.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.61 -29.76 69.88 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.309 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.69 -23.3 63.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.27 -2.88 0.05 OUTLIER Glycine 0 C--O 1.22 -0.766 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.946 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.41 21.24 12.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.565 0.746 . . . . 0.0 110.309 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.67 -67.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.436 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -163.78 -177.53 5.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.484 0.49 . . . . 0.0 110.48 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -140.11 140.88 11.01 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.84 87.84 0.44 Allowed Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.93 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.21 155.17 42.23 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.074 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.567 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 4.7 pt -116.75 155.34 18.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.42 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 41.4 m-85 -81.48 81.29 7.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.321 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 37' ' ' CYS . 11.9 p -82.49 152.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.04 89.38 5.36 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.1 p 52.33 72.89 0.37 Allowed 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.507 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 19.9 m -140.26 122.16 9.66 Favored Pre-proline 0 C--O 1.208 -1.089 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 168.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.67 5.83 0.53 Allowed 'Trans proline' 0 C--O 1.207 -1.026 0 C-N-CA 124.038 3.159 . . . . 0.0 115.413 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -101.18 -0.64 35.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.598 0.713 . . . . 0.0 109.677 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 63.2 m -136.8 166.73 22.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -133.21 137.16 53.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.524 1.056 . . . . 0.0 111.039 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -115.19 171.15 7.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.89 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 89.0 t -46.64 -32.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 0.0 113.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -56.25 24.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.723 0.773 . . . . 0.0 110.536 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -81.2 -35.29 31.55 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.668 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -62.46 -27.81 69.38 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.142 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -59.49 -38.19 80.24 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.63 0.728 . . . . 0.0 109.459 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.82 -45.51 10.82 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.6 p -65.53 -24.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.744 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.3 ptm -67.8 -18.08 64.73 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.025 0.441 . . . . 0.0 111.347 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.36 -22.87 18.68 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.012 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.47 -46.44 32.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.306 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.34 104.09 17.93 Favored Pre-proline 0 N--CA 1.399 -3.007 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.25 45.02 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.544 2.829 . . . . 0.0 113.247 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.8 pp -89.25 171.91 9.44 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.216 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -77.77 140.95 39.51 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 122.964 0.506 . . . . 0.0 110.102 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -108.74 137.53 46.53 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.514 0.673 . . . . 0.0 111.543 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.4 p -129.43 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.89 133.61 8.35 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.541 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.567 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.2 t -111.6 131.22 63.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -159.64 151.09 19.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -85.39 105.06 15.75 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.17 116.7 17.11 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.495 1.14 . . . . 0.0 109.598 -171.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -106.28 -74.65 0.65 Allowed 'General case' 0 C--N 1.253 -3.625 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.246 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.39 119.55 31.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.524 HG13 HD13 ' A' ' 92' ' ' LEU . 15.9 tt -62.7 -32.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.659 -177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -12.98 59.82 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.447 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 33.1 t70 -82.41 -40.32 21.43 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -73.85 -34.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.895 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' ILE . 54.7 t -60.49 -39.95 82.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.5 t70 -52.97 -51.13 62.56 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.906 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 38.4 mmtm -65.82 -45.46 82.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.001 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.88 -32.26 71.71 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.138 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -76.76 -57.65 3.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.824 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.1 t -57.62 -57.01 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.517 0.727 . . . . 0.0 112.06 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -78.53 -8.82 58.98 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.042 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.0 p 49.27 68.3 0.74 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.959 0.885 . . . . 0.0 110.863 -174.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -71.42 178.3 3.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.048 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.94 -36.4 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.794 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.23 155.57 46.01 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.3 p -142.17 139.4 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.85 129.53 45.23 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-O 121.347 0.594 . . . . 0.0 111.564 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 124.6 36.25 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.378 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 83' ' ' ASN . 26.9 t-80 -81.99 92.7 6.82 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -56.97 -19.68 31.16 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 5.7 t30 -53.92 -29.86 43.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.98 -47.82 78.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.6 tm-20 -176.41 151.18 0.95 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 99.1 mt-30 -77.93 -45.04 25.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 123.994 0.918 . . . . 0.0 111.966 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.1 mt -83.75 -23.34 31.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.131 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.4 t80 -55.0 -40.19 69.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.395 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.528 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 mp -61.8 -36.97 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.341 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.74 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 23.4 t70 -68.7 -20.69 64.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.778 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.7 m -85.21 -43.18 14.02 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.927 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.524 HD13 HG13 ' A' ' 63' ' ' ILE . 3.5 mm? -47.08 -50.75 19.29 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.74 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.18 -10.76 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.014 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.72 -51.04 10.38 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.64 -24.12 58.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.092 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.7 mt -92.07 127.47 49.27 Favored Pre-proline 0 C--N 1.276 -2.59 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.308 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.15 165.87 29.98 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.542 2.162 . . . . 0.0 110.489 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.94 -16.63 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 111.231 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -64.33 -29.14 70.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.886 0.874 . . . . 0.0 109.826 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.19 134.56 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.185 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -111.71 170.77 7.91 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mt -123.67 135.42 63.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.565 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -121.96 156.55 33.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.67 129.83 54.75 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -74.19 102.19 4.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.8 tp -72.11 117.94 14.36 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 123.836 0.854 . . . . 0.0 109.554 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -59.02 107.28 0.51 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.768 0.794 . . . . 0.0 109.643 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 125' ' ' LEU . 27.1 m -77.37 153.17 5.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.56 1.5 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -90.1 -73.93 0.5 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -167.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.3 m -89.91 86.58 6.66 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.342 0.592 . . . . 0.0 110.976 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.8 tp -119.76 99.23 49.5 Favored Pre-proline 0 N--CA 1.432 -1.326 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.241 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.56 163.83 16.57 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 123.374 2.716 . . . . 0.0 111.058 176.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.59 -35.81 42.93 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.049 0.94 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.25 154.48 46.88 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -113.19 -69.69 0.85 Allowed 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 89' ' ' ILE . 81.9 m-85 -145.12 122.89 11.89 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -110.71 -170.13 1.58 Allowed 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 76.0 m80 69.35 27.68 4.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.005 1.383 . . . . 0.0 108.805 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.03 155.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.259 -1.791 . . . . 0.0 107.39 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.31 -40.99 50.08 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.788 0.804 . . . . 0.0 111.093 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 4.9 ttmp? -153.89 163.31 40.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.82 147.7 50.44 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.22 173.56 13.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.447 HD12 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -78.13 151.64 33.21 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 118.403 0.547 . . . . 0.0 110.718 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.494 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 33.8 t70 -66.95 89.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.361 0.6 . . . . 0.0 110.332 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -106.23 121.88 45.08 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.24 80.08 0.26 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.91 145.3 46.93 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 138.23 -72.03 0.45 Allowed Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.17 -66.19 1.59 Allowed Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.939 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -156.99 134.78 10.89 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.83 -56.13 3.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.309 -1.153 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.729 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.1 -92.63 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.108 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.256 41.5 mt-10 68.54 111.05 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.699 1.238 . . . . 0.0 112.547 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.626 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.52 37.9 0.84 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.47 109.71 3.32 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.852 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 59.0 t -86.0 102.7 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.6 m -96.82 170.12 9.39 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -34.32 116.3 0.18 Allowed Glycine 0 N--CA 1.476 1.367 0 O-C-N 124.218 0.949 . . . . 0.0 114.712 -174.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.6 tp -146.73 157.48 43.7 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -138.32 14.8 2.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.344 1.069 . . . . 0.0 109.724 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.0 mtt180 -115.54 110.44 19.25 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.77 -35.5 74.86 Favored Glycine 0 C--N 1.301 -1.397 0 O-C-N 123.192 0.307 . . . . 0.0 113.39 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -70.5 -35.13 73.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.223 1.011 . . . . 0.0 108.945 -177.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 16.2 t0 -82.06 -22.63 36.26 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.724 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.63 -44.77 27.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.569 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 20.9 pttp -67.79 -23.28 65.19 Favored 'General case' 0 C--O 1.201 -1.494 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.44 74.69 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.676 0.39 . . . . 0.0 110.956 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.01 69.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -69.09 -34.67 75.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.293 176.085 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.6 -32.15 73.3 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.489 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.23 -23.66 61.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.58 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.54 -20.97 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . . . 60.24 30.68 20.05 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 121.68 0.752 . . . . 0.0 109.79 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.626 ' HB ' HD21 ' A' ' 4' ' ' ASN . 31.0 mt -70.62 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.034 -171.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.35 151.33 0.61 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.287 0.992 . . . . 0.0 108.701 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.49 9.49 Favored Glycine 0 N--CA 1.417 -2.622 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.08 81.11 1.08 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.239 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -114.57 150.74 34.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.186 0.517 . . . . 0.0 110.133 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 57' ' ' VAL . 14.3 mt -118.08 156.14 19.84 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.444 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 20.7 m-85 -82.78 69.3 9.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.432 0.56 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.57 118.63 42.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.683 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.86 96.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.811 1.644 . . . . 0.0 114.24 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.0 p 56.48 23.54 7.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.626 1.57 . . . . 0.0 112.975 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' ARG . 14.8 m -103.32 111.09 64.87 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.74 19.9 0.12 Allowed 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.64 3.56 . . . . 0.0 114.386 -172.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' SER . 24.1 mmt180 -91.97 -21.6 20.45 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 170.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -141.29 174.17 10.8 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.643 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -134.18 136.91 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.495 -177.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -105.13 167.32 9.79 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.258 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 69' ' ' LYS . 93.3 t -48.41 -34.58 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.925 1.29 . . . . 0.0 112.39 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.0 -55.65 27.1 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 123.632 0.773 . . . . 0.0 111.988 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 46' ' ' VAL . 29.6 mt-30 -68.59 -42.22 78.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -63.55 -20.12 65.37 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.109 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.44 -45.36 11.22 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.568 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' GLN . 14.9 t -64.09 -33.01 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.489 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -64.63 -25.38 67.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.167 0.508 . . . . 0.0 110.783 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.95 -24.38 33.02 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.45 -51.93 7.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.182 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.37 104.29 17.84 Favored Pre-proline 0 N--CA 1.395 -3.222 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 48.3 2.23 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.709 2.273 . . . . 0.0 112.293 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -85.07 168.57 14.76 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.527 175.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.607 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 1.0 OUTLIER -79.65 140.43 37.07 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 120.616 0.246 . . . . 0.0 111.565 -177.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.483 ' CD2' HD11 ' A' ' 28' ' ' LEU . 33.2 m-85 -113.15 146.33 39.43 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.077 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.67 164.48 34.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.58 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -139.93 148.83 20.39 Favored Glycine 0 CA--C 1.481 -2.079 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.598 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' A' ' 29' ' ' ILE . 39.9 t -124.77 140.29 48.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -168.59 158.4 9.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.769 0.713 . . . . 0.0 109.981 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -86.15 94.72 9.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.48 HD22 ' HG ' ' A' ' 80' ' ' LEU . 84.3 m-20 -79.06 118.65 21.24 Favored 'General case' 0 N--CA 1.395 -3.184 0 CA-C-O 122.563 1.173 . . . . 0.0 110.327 -173.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.93 -61.43 1.58 Allowed 'General case' 0 C--N 1.247 -3.889 0 CA-C-N 112.521 -2.127 . . . . 0.0 106.127 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.22 110.45 18.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.759 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 92' ' ' LEU . 14.6 tt -64.62 -32.04 56.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.084 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.25 -22.32 63.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.212 0.529 . . . . 0.0 110.212 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.0 t70 -83.04 -34.82 26.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.05 -44.02 99.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.4 t -59.81 -45.54 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.472 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.5 t70 -52.22 -61.27 2.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.196 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HD2' HG21 ' A' ' 40' ' ' VAL . 46.9 mmtm -64.16 -42.09 96.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.679 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.03 -31.26 72.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.555 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -79.4 -57.81 3.52 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.422 0.451 . . . . 0.0 110.182 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.0 t -53.59 -55.69 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.987 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -81.31 -16.54 52.15 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.437 -179.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.6 m 59.89 74.43 0.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.179 0.99 . . . . 0.0 110.402 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.1 mt -86.4 -168.49 2.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.936 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.607 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . . . -128.65 -40.29 1.58 Allowed 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.05 161.61 39.0 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.776 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.0 p -140.82 137.43 35.08 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 176.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.76 121.39 39.62 Favored 'General case' 0 N--CA 1.381 -3.917 0 CA-C-O 121.678 0.752 . . . . 0.0 110.248 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.48 ' HG ' HD22 ' A' ' 60' ' ' ASN . 1.4 tt -109.49 136.24 49.21 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -77.76 79.16 4.25 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.56 -13.12 1.81 Allowed Glycine 0 C--O 1.214 -1.107 0 CA-C-N 114.003 -1.453 . . . . 0.0 116.567 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -55.35 -24.31 28.65 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.537 1.135 . . . . 0.0 112.769 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -48.76 -49.3 39.16 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.282 1.033 . . . . 0.0 113.172 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -176.88 148.9 0.69 Allowed 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.514 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 52.6 tt0 -77.81 -48.85 15.55 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.421 1.105 . . . . 0.0 112.065 -168.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.82 -17.53 62.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.998 -174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.51 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.0 t80 -61.11 -45.0 96.49 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.89 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.63 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-O 121.779 0.799 . . . . 0.0 109.16 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.83 -20.46 66.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.226 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 89.3 m -83.9 -41.31 17.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.583 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -50.73 -38.37 47.09 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 123.684 0.794 . . . . 0.0 111.773 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -59.14 -34.32 71.92 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.209 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.08 -37.84 45.6 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.279 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.94 -18.96 26.4 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 102' ' ' ILE . 95.2 mt -96.46 141.32 22.93 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.364 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.38 165.8 31.34 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.07 1.846 . . . . 0.0 110.363 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -11.79 18.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.199 0.999 . . . . 0.0 112.126 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -79.15 -28.55 42.8 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.231 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.1 t -104.22 127.56 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.034 0 CA-C-O 121.44 0.638 . . . . 0.0 109.617 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 121' ' ' ASP . . . -111.37 172.58 6.8 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 96' ' ' LEU . 3.5 mp -128.21 130.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.459 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 37.6 m0 -116.94 155.76 28.56 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.96 113.68 26.43 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.89 2.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.09 101.33 12.35 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.655 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -70.01 136.73 50.71 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -52.48 145.24 2.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -171.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.22 132.86 1.39 Allowed Glycine 0 N--CA 1.419 -2.484 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.718 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -100.48 -16.35 17.58 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.96 0.886 . . . . 0.0 108.725 177.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.7 t -85.35 26.74 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.382 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.77 158.29 37.03 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.18 156.36 22.83 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.228 1.952 . . . . 0.0 111.533 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 -30.22 56.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.383 0.611 . . . . 0.0 110.205 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -117.44 130.43 56.47 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -134.87 -60.44 0.78 Allowed 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.885 0.85 . . . . 0.0 109.697 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 67.9 m-85 -124.87 112.29 16.47 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.334 -173.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.03 166.71 22.49 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.8 m170 66.26 30.05 9.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.707 0.63 . . . . 0.0 112.543 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.8 m -103.72 149.6 7.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 24.3 t70 -85.67 -42.28 14.43 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.258 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -153.59 163.13 40.5 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.544 0.738 . . . . 0.0 111.442 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.74 135.78 49.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.311 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.2 163.45 29.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.48 148.21 28.26 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.56 102.74 0.09 Allowed 'General case' 0 C--O 1.243 0.734 0 O-C-N 123.973 0.796 . . . . 0.0 109.243 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -77.43 92.42 3.97 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 121.688 0.756 . . . . 0.0 110.585 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 164.65 -60.71 0.25 Allowed Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 67.45 3.23 3.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.201 1.0 . . . . 0.0 112.324 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.64 135.43 12.14 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.02 -5.79 68.85 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.67 108.06 7.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 155.15 176.57 27.5 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.029 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 C--O 1.241 0.647 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.16 -60.77 1.16 Allowed Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -110.77 175.19 5.52 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.205 0.526 . . . . 0.0 111.141 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -153.28 44.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 27' ' ' GLY . 9.5 ptmt -67.59 96.2 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.4 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.14 104.96 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.182 0.992 . . . . 0.0 111.53 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 169.2 10.16 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -31.34 109.47 0.03 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.29 147.58 2.0 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -136.42 -3.2 2.16 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.776 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.29 111.51 5.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.37 -58.07 5.39 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 124.57 1.081 . . . . 0.0 113.971 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.411 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.5 OUTLIER -57.1 -19.9 22.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -92.0 -44.87 8.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.48 74.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.42 -23.37 65.78 Favored 'General case' 0 C--O 1.191 -2.007 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.176 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.64 -35.0 69.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.071 0.463 . . . . 0.0 110.967 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.33 56.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.727 0.775 . . . . 0.0 110.089 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -70.66 -35.95 73.11 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.364 177.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.95 -26.28 62.07 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.403 1.081 . . . . 0.0 111.067 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.09 -22.51 66.41 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.499 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.83 18.27 0.15 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.805 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.87 25.99 7.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.574 1.15 . . . . 0.0 111.727 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -57.93 -67.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.092 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.67 155.66 2.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -122.15 131.33 8.36 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -97.78 88.47 0.92 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.467 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -125.11 149.1 48.19 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 1.9 pt -117.69 157.87 18.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 49.6 m-85 -86.92 87.29 7.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 124.149 0.906 . . . . 0.0 112.114 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 54.7 t -121.86 116.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 169.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.46 113.26 1.35 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 124.447 1.092 . . . . 0.0 113.298 -173.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p 62.94 23.34 13.95 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.864 1.666 . . . . 0.0 113.885 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 78.9 p -86.62 149.27 48.33 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.48 13.73 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.752 1.635 . . . . 0.0 111.705 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 21.9 ptt180 -119.42 -8.56 10.02 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.014 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 59.5 m -145.51 172.89 12.56 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.21 137.31 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 109.071 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -103.61 164.91 11.36 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.45 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.0 p -51.51 -35.21 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 124.265 0.978 . . . . 0.0 111.57 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 7.9 mp0 -67.82 -39.2 83.94 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 124.36 1.064 . . . . 0.0 112.011 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 46' ' ' VAL . 51.6 mm-40 -67.33 -51.15 55.91 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 122.67 1.224 . . . . 0.0 107.914 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.44 66.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.462 -2.154 . . . . 0.0 114.449 -168.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.479 ' O ' ' HG2' ' A' ' 47' ' ' MET . 6.1 pt20 -63.75 -31.2 72.3 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.81 -37.94 29.25 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.31 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 42' ' ' GLN . 44.8 t -65.63 -31.67 54.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.16 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 27.1 ptt? -67.83 -17.32 64.47 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.223 0.535 . . . . 0.0 111.76 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.63 46.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.427 0.632 . . . . 0.0 109.469 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.22 -40.62 6.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.305 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -137.94 98.75 9.41 Favored Pre-proline 0 N--CA 1.406 -2.656 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.11 59.91 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.057 2.504 . . . . 0.0 113.023 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.42 163.9 12.04 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.366 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.91 145.47 46.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.63 0.252 . . . . 0.0 110.576 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.74 140.79 47.98 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.2 p -133.57 144.0 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 30' ' ' PHE . . . -109.72 132.56 11.11 Favored Glycine 0 CA--C 1.475 -2.464 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 79' ' ' GLN . 7.3 p -140.09 104.05 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.053 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -167.88 178.75 5.03 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -173.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -86.3 93.42 9.08 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.42 117.99 26.57 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -85.77 -63.19 1.36 Allowed 'General case' 0 C--N 1.247 -3.89 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.711 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -89.44 125.32 35.12 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.032 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 67' ' ' VAL . 19.1 tt -63.4 -34.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.064 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.65 -20.11 62.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.62 0.724 . . . . 0.0 110.39 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 18.3 t70 -85.93 -39.48 16.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.158 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' ILE . 14.5 p -77.46 -32.21 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.823 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.2 t -59.9 -40.92 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 21.3 t70 -54.09 -50.93 65.68 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.534 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.1 mmtm -69.21 -42.1 76.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.139 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -66.37 -22.98 66.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -83.83 -61.74 1.75 Allowed 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 67.2 t -54.69 -56.68 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 123.894 0.746 . . . . 0.0 111.548 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HB2' HG23 ' A' ' 40' ' ' VAL . 59.2 tp -83.16 -19.52 36.46 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.69 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 12.7 t 60.09 82.83 0.15 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 122.333 1.063 . . . . 0.0 109.768 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.22 173.01 11.9 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.644 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.24 -31.54 5.95 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -151.54 161.45 42.67 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.921 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 66' ' ' VAL . 6.5 p -143.87 138.73 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.39 119.81 39.59 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 121.848 -0.533 . . . . 0.0 110.575 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.486 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -99.86 119.76 38.7 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.347 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -81.53 104.03 11.67 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.77 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -53.76 -12.25 2.46 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.739 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -55.24 -27.76 48.51 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 110.762 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -72.78 -47.58 45.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 123.076 0.235 . . . . 0.0 110.874 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.57 150.03 0.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -78.62 -44.31 24.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.507 1.146 . . . . 0.0 110.823 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 32.6 mt -80.71 -13.38 59.05 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.934 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 24.7 t80 -59.04 -42.96 91.51 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.381 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.527 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -59.51 -38.19 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.625 0.726 . . . . 0.0 109.476 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 18.8 t70 -63.06 -22.0 66.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.33 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.462 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 94.2 m -88.53 -45.14 10.15 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.658 1.183 . . . . 0.0 109.997 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -45.09 -47.16 11.98 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.48 -24.51 66.63 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.129 -177.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 29.7 mt-10 -76.56 -37.74 56.08 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.384 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.1 -36.55 15.67 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.466 0.651 . . . . 0.0 112.255 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.31 121.2 75.24 Favored Pre-proline 0 C--N 1.272 -2.763 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.813 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.47 165.43 20.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.479 2.119 . . . . 0.0 111.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.28 -10.74 17.28 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.493 1.117 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -75.7 -29.56 59.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.448 HG21 ' HB1' ' A' ' 70' ' ' ALA . 61.6 t -100.56 129.73 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.335 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.99 164.88 11.77 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.338 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 80' ' ' LEU . 71.1 mt -116.94 132.66 66.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 45.4 m0 -122.31 158.94 28.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.728 174.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 105' ' ' ALA . 17.5 tptm -100.97 115.86 31.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -77.55 98.12 5.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.2 115.41 20.59 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.634 -174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 4.6 m -76.16 132.72 40.15 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -58.49 127.82 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.97 163.59 10.38 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.122 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -98.73 11.99 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.917 0.865 . . . . 0.0 110.751 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.7 m -70.85 -19.76 62.61 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.817 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.65 131.34 27.16 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.98 163.18 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.925 2.416 . . . . 0.0 111.344 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.2 72.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.437 0.695 . . . . 0.0 111.727 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -120.61 138.63 53.8 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HB2' ' H ' ' A' ' 117' ' ' PHE . 26.5 mt-10 -136.23 -68.62 0.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -174.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.666 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 31.8 m-85 -112.55 120.2 40.79 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -85.24 153.5 22.57 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 69.8 m80 75.77 24.56 1.25 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.269 -2.242 . . . . 0.0 111.604 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.44 143.56 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.85 -32.2 21.84 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.183 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 40.2 ttmt -153.56 160.36 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.325 0.583 . . . . 0.0 109.638 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -111.63 134.76 52.98 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.383 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.31 -176.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.8 mt -91.21 162.65 14.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 9.7 t70 -65.69 118.88 10.21 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.267 0.627 . . . . 0.0 110.032 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -98.95 122.01 41.65 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.67 -80.17 0.19 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.62 101.01 12.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.67 93.69 0.22 Allowed Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.84 25.71 0.27 Allowed Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.4 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.11 -28.36 42.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 0.0 109.488 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.06 53.62 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.317 -0.845 0 C-N-CA 124.351 1.06 . . . . 0.0 111.289 -176.861 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 tpp . . . . . 0 CA--C 1.499 -1.011 0 CA-C-O 121.038 0.446 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.9 34.62 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -121.16 118.3 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.631 0.729 . . . . 0.0 112.766 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -130.51 24.09 5.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -51.03 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.598 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 7.6 p -99.86 103.22 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.957 0.884 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.81 168.53 11.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -6.62 106.41 0.01 OUTLIER Glycine 0 N--CA 1.484 1.88 0 C-N-CA 125.578 1.561 . . . . 0.0 116.942 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.54 145.68 51.91 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -125.45 8.74 7.77 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.118 0.961 . . . . 0.0 108.633 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 11' ' ' ARG . 64.9 mtt180 -125.32 107.35 10.61 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.227 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.69 -54.01 8.11 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 124.07 0.843 . . . . 0.0 113.177 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -63.45 -26.32 68.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 30.1 t70 -87.09 -23.11 25.02 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.087 0.946 . . . . 0.0 108.64 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.08 -22.75 60.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.558 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -61.19 -24.18 66.13 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.584 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.12 -34.4 60.21 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.289 0.368 . . . . 0.0 111.748 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.36 67.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.885 0.85 . . . . 0.0 110.047 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -36.15 81.74 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.976 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.24 -28.53 69.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.416 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.2 -23.03 59.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.904 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.32 -11.95 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 118.413 -1.851 . . . . 0.0 113.717 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.18 23.87 14.15 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 121.46 0.647 . . . . 0.0 109.771 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 24' ' ' ILE . 12.7 mt -57.8 -53.13 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.122 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 37.9 p90 -170.6 -172.09 1.16 Allowed 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.85 177.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.26 122.06 1.64 Allowed Glycine 0 C--N 1.284 -2.306 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 171.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.99 100.63 1.97 Allowed Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.369 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -131.96 161.98 31.8 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 123.07 0.548 . . . . 0.0 109.893 -178.275 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 pt -117.4 153.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 86.7 m-85 -81.55 82.44 7.32 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -127.81 133.45 67.41 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.718 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.4 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . . . -70.88 136.16 48.45 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.533 0.682 . . . . 0.0 111.26 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p 53.73 9.63 0.2 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 127.204 2.202 . . . . 0.0 116.322 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -94.75 128.54 39.21 Favored Pre-proline 0 C--O 1.211 -0.928 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.863 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.32 0.16 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.345 2.696 . . . . 0.0 113.99 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -104.14 -8.01 19.76 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.304 0.573 . . . . 0.0 110.299 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 57.8 m -139.62 136.05 33.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.891 -0.506 . . . . 0.0 111.185 -171.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' O ' HD23 ' A' ' 28' ' ' LEU . 2.3 t -108.13 135.4 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 4.0 p30 -125.28 -170.06 2.1 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 99.1 t -46.92 -34.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 125.152 1.532 . . . . 0.0 111.286 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.84 -64.41 0.95 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 122.367 1.08 . . . . 0.0 111.353 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.3 mp0 -68.88 -49.45 58.18 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.716 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -24.0 66.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.782 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.0 OUTLIER -61.36 -34.76 75.84 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.81 -50.37 8.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.075 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 42' ' ' GLN . 24.5 t -58.19 -30.82 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.995 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.1 ptm -68.13 -12.13 60.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.983 0.421 . . . . 0.0 111.646 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.64 -6.67 24.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -42.13 4.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.384 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.76 99.27 15.5 Favored Pre-proline 0 N--CA 1.396 -3.134 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -76.09 71.73 5.57 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 C-N-CA 121.899 1.733 . . . . 0.0 111.675 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.65 160.99 15.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.508 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HB3' ' HA ' ' A' ' 25' ' ' TYR 0.253 1.3 tm0? -75.71 122.42 23.98 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.103 1.361 . . . . 0.0 108.656 -176.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.45 ' HD2' HD11 ' A' ' 28' ' ' LEU . 91.5 m-85 -92.31 137.69 32.15 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.683 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -132.16 136.39 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.53 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -116.27 150.11 18.66 Favored Glycine 0 CA--C 1.481 -2.035 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.652 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 29' ' ' ILE . 41.4 t -130.05 133.79 63.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -172.4 159.49 4.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.588 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.526 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 16.3 ttm180 -104.44 97.01 7.0 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.98 148.11 25.75 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -97.65 -37.68 9.82 Favored 'General case' 1 C--N 1.238 -4.273 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.137 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' ASP . 9.5 t70 -97.68 126.0 42.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.844 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 HD13 ' A' ' 92' ' ' LEU . 7.6 tt -63.97 -34.44 68.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.149 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.61 -15.81 59.73 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.452 0.644 . . . . 0.0 109.772 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 12.3 t70 -75.93 -38.29 57.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.392 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.43 -46.7 69.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.316 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -59.42 -40.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.528 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.8 t70 -52.01 -56.17 15.96 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.08 176.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.5 mmtm -64.82 -43.18 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.347 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.35 85.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 124.182 0.926 . . . . 0.0 111.066 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.65 -52.14 8.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.54 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 68' ' ' ASP . 57.6 t -57.43 -57.51 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.886 0.375 . . . . 0.0 111.227 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.9 OUTLIER -78.75 -12.8 60.04 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.709 -176.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 p 54.69 73.63 0.39 Allowed 'General case' 0 C--O 1.252 1.226 0 CA-C-O 122.309 1.052 . . . . 0.0 111.623 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.75 -174.31 4.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.793 -1.549 . . . . 0.0 111.858 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.66 -38.07 1.73 Allowed 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.678 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.79 159.64 42.54 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 173.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -144.74 137.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.425 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.616 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.76 112.11 24.91 Favored 'General case' 0 N--CA 1.391 -3.414 0 C-N-CA 123.102 0.561 . . . . 0.0 109.575 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.24 130.5 37.11 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.477 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -70.7 103.67 2.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.484 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.64 -31.87 53.38 Favored Glycine 0 CA--C 1.496 -1.122 0 CA-C-N 114.154 -1.385 . . . . 0.0 114.243 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -48.48 -25.55 1.72 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.534 1.134 . . . . 0.0 113.013 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD3' ' A' ' 59' ' ' ARG . 11.7 tp10 -66.06 -47.3 74.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.534 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -178.5 148.59 0.46 Allowed 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 27.8 mp0 -77.88 -46.53 21.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.0 0.905 . . . . 0.0 112.16 -173.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -79.34 -21.74 45.43 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.245 -171.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.8 t80 -52.43 -44.51 65.51 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.483 173.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.7 mp -64.17 -36.49 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.338 0.589 . . . . 0.0 110.152 -177.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.45 -17.41 58.11 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.67 0.748 . . . . 0.0 110.695 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 83.7 m -79.19 -42.17 26.67 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.176 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.563 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -43.92 -47.21 8.38 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.517 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 119' ' ' HIS . 4.0 mpt_? -52.47 -32.52 40.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -75.46 -29.03 59.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.023 0.439 . . . . 0.0 111.419 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.38 -1.66 28.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.01 0.909 . . . . 0.0 110.562 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 14.7 tp -91.3 133.27 31.85 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.076 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.14 163.53 38.89 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.591 1.527 . . . . 0.0 110.587 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.48 69.9 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.231 1.013 . . . . 0.0 112.67 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -79.66 -13.83 59.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.3 140.58 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.567 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.26 174.09 6.24 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -128.19 135.49 62.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.616 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 51.6 m0 -122.57 162.56 21.59 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.494 -0.882 . . . . 0.0 108.704 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 123' ' ' TYR . 18.6 tptm -100.82 116.0 31.68 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -74.56 98.94 3.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tt -80.65 105.46 11.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 m -75.3 107.79 7.65 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.49 143.42 13.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.889 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.26 -79.82 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.847 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.29 -62.65 1.21 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -161.93 -173.89 3.9 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.4 tp -110.68 118.84 47.81 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.09 162.21 2.08 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 124.029 3.153 . . . . 0.0 114.269 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.58 75.99 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -140.58 122.2 15.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -129.41 -89.04 0.51 Allowed 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.706 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.446 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 22.3 m-85 -125.58 95.06 4.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -96.75 174.17 6.94 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.964 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 20.9 m170 72.7 14.74 5.0 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.696 1.599 . . . . 0.0 110.778 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.89 150.33 6.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.237 0.542 . . . . 0.0 111.52 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.57 -29.44 59.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.942 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -159.75 158.54 31.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 104' ' ' LYS . 7.1 m-85 -109.14 128.85 55.36 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.41 -178.04 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 123.33 0.394 . . . . 0.0 109.939 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp -72.29 150.49 43.52 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 123.49 0.494 . . . . 0.0 110.589 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 8.7 t70 -80.92 98.61 7.96 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 166.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -93.26 87.75 5.77 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.068 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.39 35.84 0.11 Allowed Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.97 107.86 18.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.2 -51.37 0.09 OUTLIER Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.519 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.34 63.15 Favored Glycine 0 C--O 1.241 0.543 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.21 38.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.231 -0.485 . . . . 0.0 110.209 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.29 25.97 Favored Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 C--N 1.295 -1.776 0 O-C-N 123.694 0.291 . . . . 0.0 110.356 -179.031 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.067 0.46 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.51 64.73 0.02 OUTLIER Glycine 0 CA--C 1.482 -1.974 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -69.33 143.31 53.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.431 -0.884 . . . . 0.0 112.272 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -111.71 25.86 11.22 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -16.84 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.376 2.27 . . . . 0.0 115.357 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.96 110.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.568 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.3 m -91.11 169.38 10.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -38.41 106.68 0.05 OUTLIER Glycine 0 N--CA 1.473 1.152 0 O-C-N 124.196 0.935 . . . . 0.0 114.539 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 11' ' ' ARG . 3.6 tt -138.37 146.23 42.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 p -111.12 -19.82 12.58 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.255 1.026 . . . . 0.0 110.575 -169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 9' ' ' LEU . 71.4 mtm180 -86.21 108.49 18.39 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.721 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.96 -39.43 89.16 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-O 122.181 0.878 . . . . 0.0 112.833 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -73.57 -18.23 61.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.833 -1.183 . . . . 0.0 110.756 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -92.91 -45.8 7.79 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -28.04 68.38 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.705 1.202 . . . . 0.0 112.175 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.81 -22.89 59.52 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.967 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.69 43.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.462 0.705 . . . . 0.0 112.288 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.25 47.69 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 110.784 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.8 -33.98 34.39 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.012 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.23 -23.41 55.76 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 125.828 1.651 . . . . 0.0 110.524 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.39 62.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.87 26.8 0.75 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.825 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.45 34.16 20.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.358 1.063 . . . . 0.0 111.743 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 21.9 mt -62.58 -69.05 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.233 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' HB2' ' CD ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.96 155.64 0.99 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.049 -173.032 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.96 138.43 11.03 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.44 75.83 0.23 Allowed Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.426 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -117.31 144.22 45.11 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 22.0 mt -117.1 152.65 18.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.372 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 4.9 m-85 -82.55 72.29 9.62 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 118.035 0.38 . . . . 0.0 110.245 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 66.1 t -95.76 121.99 46.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 118.459 -1.297 . . . . 0.0 107.692 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.53 108.43 0.17 Allowed 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.429 1.081 . . . . 0.0 112.864 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.2 p 57.82 29.04 16.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.701 1.6 . . . . 0.0 113.915 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -80.97 140.09 49.91 Favored Pre-proline 0 N--CA 1.423 -1.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.32 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.4 7.94 4.85 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 C-N-CA 121.596 1.53 . . . . 0.0 112.297 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -124.65 2.18 8.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 109.858 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 93.9 m -154.12 125.21 7.31 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.33 137.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.61 0.719 . . . . 0.0 111.634 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -104.0 170.95 7.62 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.873 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.32 -35.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.025 1.33 . . . . 0.0 113.224 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.33 -50.71 58.93 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.959 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -78.29 -32.39 49.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.992 0.901 . . . . 0.0 109.441 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.948 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -63.22 -25.87 68.53 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.796 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 tp60 -55.6 -39.13 70.35 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.882 0.873 . . . . 0.0 109.714 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -86.5 -46.12 10.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.002 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.948 HG12 ' HA ' ' A' ' 43' ' ' ALA . 7.0 p -60.82 -31.89 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.382 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 73' ' ' LEU . 26.5 ptt? -66.16 -27.06 67.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.983 0.42 . . . . 0.0 110.953 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.42 21.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.372 0.606 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.42 -47.26 34.88 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.342 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.0 101.41 22.84 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.33 66.4 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.969 1.779 . . . . 0.0 112.057 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.462 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.5 pp -107.73 176.41 5.15 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.408 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' TYR . 4.1 tt0 -76.73 131.83 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.664 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD11 ' A' ' 28' ' ' LEU . 61.0 m-85 -105.14 141.96 35.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.487 0.661 . . . . 0.0 110.768 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.6 p -129.11 160.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.88 139.25 10.24 Favored Glycine 0 C--N 1.277 -2.717 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.073 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HB ' HG23 ' A' ' 29' ' ' ILE . 61.8 t -113.28 127.89 70.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -154.22 147.0 24.3 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.489 -1.285 . . . . 0.0 110.511 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -86.26 102.19 13.73 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 167.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 60' ' ' ASN . 0.6 OUTLIER -80.49 114.56 19.47 Favored 'General case' 0 N--CA 1.387 -3.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.55 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -105.43 -58.08 1.95 Allowed 'General case' 0 C--N 1.256 -3.463 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.85 116.35 30.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.297 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 67' ' ' VAL . 18.3 tt -64.63 -31.4 53.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 120.876 0.37 . . . . 0.0 111.168 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.81 -9.5 59.07 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.632 -0.667 . . . . 0.0 110.714 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 11.3 t70 -84.88 -39.13 18.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.72 -35.0 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -63.96 -36.47 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.3 t70 -53.71 -53.36 53.22 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.975 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 42.2 mmtm -64.72 -44.2 90.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.094 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -57.65 -33.49 68.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.666 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.28 -60.66 2.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.168 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.2 t -54.59 -59.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.647 0.779 . . . . 0.0 112.245 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HA ' ' SD ' ' A' ' 47' ' ' MET . 1.4 mm? -78.61 -14.21 59.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.888 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.6 t 57.13 73.58 0.45 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.945 0.879 . . . . 0.0 109.794 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.63 -178.8 4.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.208 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -128.06 -34.22 2.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -149.24 160.16 43.63 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.697 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.29 137.18 37.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.6 mp0 -96.46 118.33 32.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 89' ' ' ILE . 34.3 tp -99.78 125.86 45.76 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.734 -170.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.493 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 72.5 m80 -87.29 95.75 10.1 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -67.69 -12.95 62.73 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.74 -1.118 . . . . 0.0 114.74 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 81' ' ' HIS . 3.4 p-10 -56.36 -25.49 49.63 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.165 0.586 . . . . 0.0 112.438 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.86 82.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 112.887 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.7 tm-20 -171.46 141.5 1.53 Allowed 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -78.06 -42.01 33.61 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -168.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.02 -24.17 30.63 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-O 121.882 0.848 . . . . 0.0 109.959 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 91' ' ' THR . 36.7 t80 -51.43 -32.55 27.09 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 125.98 1.712 . . . . 0.0 112.13 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.508 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -60.07 -39.66 81.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.415 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 9.9 t70 -67.9 -14.74 63.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.47 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 75.2 m -88.13 -46.57 9.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.23 1.412 . . . . 0.0 109.367 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.469 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.91 -51.01 10.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.619 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -56.99 -29.96 63.73 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 121.219 0.533 . . . . 0.0 112.18 -178.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -76.15 -31.12 58.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.483 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -94.76 -23.79 17.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 92' ' ' LEU . 98.2 mt -76.7 131.44 73.92 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.688 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.04 165.2 10.84 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.724 2.283 . . . . 0.0 112.446 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.02 55.02 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.721 1.208 . . . . 0.0 113.099 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -85.86 -8.58 57.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.534 HG21 ' HB1' ' A' ' 70' ' ' ALA . 82.7 t -98.66 124.89 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-O 121.717 0.77 . . . . 0.0 109.263 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.96 172.73 6.66 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.034 -176.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.08 130.94 73.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.2 m0 -119.9 159.38 24.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -101.18 117.94 36.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.325 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.11 105.72 3.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.73 95.85 9.52 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.903 0.858 . . . . 0.0 109.772 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 49.0 m -67.69 117.87 10.2 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.923 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.55 127.5 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.16 142.1 3.48 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.6 89.56 5.12 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.225 1.012 . . . . 0.0 112.732 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 t -143.2 152.53 41.86 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.71 93.38 48.69 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.08 122.1 3.27 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 C-N-CA 121.795 1.663 . . . . 0.0 109.799 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.89 -34.59 73.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 116' ' ' GLU . 37.7 ttm180 -171.38 166.48 6.98 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' N ' ' HG2' ' A' ' 115' ' ' ARG . 40.1 mt-10 -144.86 -56.5 0.34 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 102.55 -3.129 . . . . 0.0 102.55 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.09 165.99 23.46 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 102.833 -3.025 . . . . 0.0 102.833 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -136.22 172.52 12.89 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.4 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 36.8 m80 69.41 36.55 2.24 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.576 1.551 . . . . 0.0 112.429 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 m -84.74 152.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.46 -47.28 11.55 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.706 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 67.6 mttm -151.06 163.85 37.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -110.94 162.39 14.88 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 125' ' ' LEU . 13.3 p -141.27 174.14 7.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.523 ' HG ' ' H ' ' A' ' 126' ' ' ASP . 28.4 tp -76.61 -178.08 4.55 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.523 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 26.6 t70 -69.69 99.99 1.41 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.251 0.548 . . . . 0.0 111.531 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -113.2 154.89 25.98 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.38 179.14 30.77 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -96.34 21.02 9.58 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.889 0.345 . . . . 0.0 110.558 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.75 77.27 1.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.912 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -152.8 33.79 0.81 Allowed Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.87 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.67 176.32 11.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 -76.11 2.27 Favored Glycine 0 C--N 1.31 -0.88 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--N 1.293 -1.85 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.61 78.0 0.26 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.65 178.48 8.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.415 0.626 . . . . 0.0 109.774 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 5.1 t30 -148.85 48.28 1.0 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -37.05 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 112.673 -2.058 . . . . 0.0 112.116 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.58 121.4 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.988 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.55 170.73 9.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.03 135.68 3.42 Favored Glycine 0 C--N 1.357 1.749 0 CA-C-N 119.152 0.887 . . . . 0.0 114.321 -170.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.52 161.31 37.37 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -176.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -129.09 18.53 6.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -137.2 106.17 5.96 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.649 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.41 -48.77 27.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 124.765 1.174 . . . . 0.0 113.04 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -63.22 -19.32 64.42 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 125.822 1.649 . . . . 0.0 112.444 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.0 -42.23 9.15 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.77 69.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.764 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.3 -23.06 67.25 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.52 69.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -77.08 -30.13 55.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 0.0 110.789 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.06 -34.46 50.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.02 -30.49 71.56 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.065 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -17.38 64.39 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.426 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.44 15.31 0.5 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.134 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.46 26.56 12.78 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.455 0.702 . . . . 0.0 110.837 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.67 -67.6 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.223 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -178.53 159.76 1.18 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.258 0.974 . . . . 0.0 108.815 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.6 142.83 14.28 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 108.459 -1.857 . . . . 0.0 108.459 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.62 78.8 0.27 Allowed Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.573 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.553 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -115.34 146.32 41.65 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.114 0.483 . . . . 0.0 109.734 -177.142 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 pt -117.37 155.01 19.12 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 38.5 m-85 -84.16 76.93 10.04 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.651 1.219 . . . . 0.0 109.689 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.28 121.93 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 98.79 0.02 OUTLIER 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.04 1.463 . . . . 0.0 113.82 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p 58.77 25.26 13.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.858 1.663 . . . . 0.0 114.97 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -90.76 116.07 65.6 Favored Pre-proline 0 C--O 1.199 -1.557 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.99 -7.3 2.33 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 124.273 3.315 . . . . 0.0 116.542 -171.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.23 11.54 27.29 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.637 1.208 . . . . 0.0 109.797 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 66.2 m -140.0 170.92 14.97 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.17 136.57 16.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 119.486 1.039 . . . . 0.0 109.869 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.41 166.87 10.51 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.263 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -42.96 -36.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 O-C-N 125.044 1.465 . . . . 0.0 113.843 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.9 -32.54 61.85 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 46' ' ' VAL . 16.2 mt-30 -83.38 -37.85 22.76 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.713 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.49 64.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.662 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -63.8 -33.06 74.83 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -77.34 -46.23 23.58 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.75 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' GLN . 6.4 t -63.72 -34.4 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.649 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.24 -16.09 62.48 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.893 -0.504 . . . . 0.0 111.49 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.62 -19.67 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.24 -40.81 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.096 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.16 97.24 9.78 Favored Pre-proline 0 N--CA 1.408 -2.551 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -74.43 53.32 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.852 2.368 . . . . 0.0 113.544 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.1 pp -90.39 168.97 11.47 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.425 1.09 . . . . 0.0 109.14 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -71.75 140.34 49.47 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 122.964 0.505 . . . . 0.0 110.128 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.501 ' CD2' HD11 ' A' ' 28' ' ' LEU . 15.4 m-85 -112.29 137.84 49.85 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.521 0.677 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.18 148.86 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -122.31 143.74 15.7 Favored Glycine 0 C--N 1.283 -2.398 0 C-N-CA 119.783 -1.199 . . . . 0.0 112.147 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.495 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.3 t -134.97 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -172.59 163.39 5.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 13.9 ptm180 -96.64 93.87 6.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HB2' HG22 ' A' ' 66' ' ' VAL . 14.1 m120 -90.61 117.64 29.43 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.88 -38.47 70.0 Favored 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.487 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -99.24 129.27 45.46 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.567 HG13 HD13 ' A' ' 92' ' ' LEU . 15.3 tt -64.03 -31.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.081 0.467 . . . . 0.0 110.1 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.97 -11.83 60.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 110.784 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 35.6 t70 -85.39 -41.53 15.36 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 60' ' ' ASN . 21.7 t -63.02 -51.84 66.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.295 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.8 t -58.8 -38.25 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.965 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 72' ' ' VAL . 36.3 t70 -65.54 -43.97 88.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.007 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 56.8 mmtt -67.91 -44.81 76.06 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.02 -36.28 72.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.77 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -73.85 -59.59 2.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.8 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 68' ' ' ASP . 87.0 t -54.41 -58.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.56 -3.44 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.833 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 p 51.4 61.85 3.01 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.79 0.805 . . . . 0.0 111.796 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 174.52 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.542 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 53' ' ' GLN . . . -125.88 -29.42 3.1 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.362 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.25 155.22 43.1 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.28 136.51 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.25 110.37 22.31 Favored 'General case' 0 N--CA 1.384 -3.738 0 C-N-CA 123.019 0.527 . . . . 0.0 110.044 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.25 123.22 36.38 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.522 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 52.1 m-70 -74.25 94.02 2.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.61 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -55.69 -12.72 5.22 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 117.29 1.676 . . . . 0.0 117.29 -170.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -44.88 -25.48 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.613 1.165 . . . . 0.0 113.694 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.94 -48.24 82.75 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -172.18 150.04 2.39 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.271 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 93.9 mt-30 -77.44 -42.9 34.33 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.05 0.928 . . . . 0.0 111.933 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.06 -13.0 54.23 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.784 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 21.9 t80 -59.12 -40.98 87.07 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.308 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -63.52 -39.51 85.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.816 0.817 . . . . 0.0 109.229 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.53 -16.78 64.38 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.814 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.2 m -85.27 -39.99 17.11 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.677 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.09 -39.5 63.42 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 123.137 0.575 . . . . 0.0 110.702 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HD2' ' CD1' ' A' ' 102' ' ' ILE . 6.7 mmm180 -43.34 -43.75 5.2 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.659 1.224 . . . . 0.0 111.759 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -71.08 -46.3 62.12 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.354 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 -12.01 27.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.21 130.03 47.54 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HG2' HG23 ' A' ' 100' ' ' VAL . 37.3 Cg_endo -66.1 164.16 28.74 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.225 1.95 . . . . 0.0 111.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.05 -27.2 63.39 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 124.276 1.031 . . . . 0.0 113.338 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -85.34 -7.96 58.71 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.586 HG21 ' HB1' ' A' ' 70' ' ' ALA . 92.7 t -104.11 133.35 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -115.74 169.61 9.08 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.307 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.421 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 84.7 mt -123.14 130.02 74.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.585 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 42.0 m0 -121.14 159.9 24.84 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.416 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.71 115.5 30.6 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.72 103.77 2.66 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.781 0.676 . . . . 0.0 109.245 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 tp -84.19 104.51 14.29 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 23.3 t -57.39 120.52 8.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.0 m -47.88 129.81 4.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 132.35 118.88 1.99 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -71.98 -6.07 39.46 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 m -72.79 -24.8 60.97 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 114.54 30.57 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 137.43 80.31 Favored 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 123.177 2.585 . . . . 0.0 114.416 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.5 -16.09 59.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.298 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.46 118.57 30.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.678 0.751 . . . . 0.0 110.316 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -160.63 -57.78 0.06 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 50.1 m-85 -118.7 101.34 8.03 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 112.182 -2.281 . . . . 0.0 106.475 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 13.9 pt20 -99.57 -169.07 1.7 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.564 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 94.3 m-70 70.42 34.36 2.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.47 164.36 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.617 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.08 -37.99 14.7 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 38.4 ttmt -161.12 162.66 31.56 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.957 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -107.42 142.83 36.65 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.792 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.9 163.74 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.9 mt -87.54 150.07 23.95 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 16.7 t70 -69.8 105.99 2.96 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.619 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.24 18.84 17.57 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.082 0.468 . . . . 0.0 109.815 176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -136.34 55.38 0.71 Allowed Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -61.76 113.15 2.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.309 0.576 . . . . 0.0 110.511 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.72 4.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.978 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.5 44.39 3.36 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.69 142.16 33.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.75 50.41 0.27 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--N 1.301 -1.509 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.928 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 C--O 1.237 0.444 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.46 91.09 0.34 Allowed Glycine 0 CA--C 1.481 -2.041 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 67.8 -170.17 0.19 Allowed 'General case' 0 C--O 1.25 1.094 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -166.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.606 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.1 p-10 -156.97 41.04 0.33 Allowed 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.98 114.74 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.655 -173.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.591 ' H ' ' HA2' ' A' ' 26' ' ' GLY . 97.6 t -93.91 117.97 38.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.764 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 16.9 p -136.81 166.88 22.57 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.51 106.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.955 0 C-N-CA 126.055 1.788 . . . . 0.0 116.939 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -160.54 159.92 31.26 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -138.72 19.91 2.68 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.2 mtp180 -114.52 101.76 9.43 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.452 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.87 -44.03 55.26 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.274 0.94 . . . . 0.0 113.853 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -75.14 -19.81 59.7 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.325 -0.937 . . . . 0.0 110.312 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 36.4 t70 -83.45 -38.33 22.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -63.42 -50.28 70.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.123 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 12.2 pttp -65.68 -23.77 66.85 Favored 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -26.19 67.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.4 -37.4 25.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.804 0.812 . . . . 0.0 109.417 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -67.83 -38.96 83.87 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.744 -0.598 . . . . 0.0 110.442 174.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -60.97 -32.74 72.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.056 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.16 62.92 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.735 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.49 -14.34 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.597 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.52 18.2 11.19 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.643 0.777 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.606 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 22.3 mt -63.14 -67.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.375 -170.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.6 p90 -174.03 161.89 3.73 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 123.627 0.579 . . . . 0.0 110.538 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.591 ' HA2' ' H ' ' A' ' 6' ' ' VAL . . . -129.97 122.45 3.71 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.52 88.67 1.25 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -116.42 147.4 41.71 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.285 4.6 pt -117.24 151.69 19.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.434 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 48.9 m-85 -85.12 73.98 10.56 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.605 -174.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HB ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -120.93 115.7 47.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.35 106.44 0.12 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 124.94 1.4 . . . . 0.0 113.901 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p 65.54 15.89 10.25 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.005 1.722 . . . . 0.0 115.05 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 24.9 t -74.85 138.28 73.24 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.89 -0.89 7.69 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 122.811 2.341 . . . . 0.0 113.727 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 58.6 ttp180 -114.18 -4.51 13.09 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 15.2 m -129.88 130.12 44.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.992 -169.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.63 134.94 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -118.25 179.25 4.16 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.275 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 73' ' ' LEU . 6.9 p -45.51 -31.74 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 O-C-N 124.666 1.229 . . . . 0.0 113.204 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.22 -61.97 1.61 Allowed 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 123.742 0.817 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -67.96 -37.8 81.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.22 0.534 . . . . 0.0 110.256 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.06 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.88 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 3.8 tp-100 -67.78 -39.49 84.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.027 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.88 -40.52 14.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.978 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.5 p -64.56 -22.9 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.748 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 21.6 ptp -67.8 -17.12 64.42 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.543 0.687 . . . . 0.0 110.931 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.37 3.15 40.27 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.499 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.83 -42.6 3.77 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.134 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -142.39 101.06 5.65 Favored Pre-proline 0 N--CA 1.4 -2.956 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.43 70.07 3.3 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 112.007 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -111.99 160.56 17.34 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.202 174.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 2.6 tt0 -67.16 134.93 52.7 Favored 'General case' 0 C--O 1.208 -1.079 0 C-N-CA 123.229 0.612 . . . . 0.0 109.89 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 61.3 m-85 -108.52 140.6 41.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.077 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 9.5 p -133.96 133.96 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -110.37 125.89 7.67 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.598 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 18.0 t -112.89 121.58 65.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -173.08 154.33 2.74 Favored 'General case' 0 CA--C 1.493 -1.223 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.361 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.56 104.9 15.74 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 122.458 1.123 . . . . 0.0 108.315 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.85 121.68 42.56 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 113.637 -1.619 . . . . 0.0 110.326 -171.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -99.64 -36.28 9.55 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.274 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.1 t70 -99.37 111.37 23.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 67' ' ' VAL . 13.6 tt -66.93 -33.6 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.156 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.42 62.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.344 0.593 . . . . 0.0 110.461 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.0 -33.22 24.59 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 62' ' ' ASP . 47.6 t -65.2 -43.46 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.2 t -59.05 -43.56 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.36 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -57.89 -61.33 2.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.887 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.17 -42.67 99.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.66 -29.46 70.03 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -82.8 -56.75 3.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.717 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.0 t -53.21 -59.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.429 0.692 . . . . 0.0 111.547 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 40' ' ' VAL . 1.8 mm? -72.34 -18.17 61.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.221 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 m 59.72 69.04 0.73 Allowed 'General case' 0 C--O 1.243 0.746 0 CA-C-O 122.336 1.065 . . . . 0.0 109.803 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.71 -176.39 5.35 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.253 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.13 -43.13 1.67 Allowed 'General case' 0 C--O 1.184 -2.35 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -136.25 155.0 50.74 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.79 170.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' C ' HE21 ' A' ' 79' ' ' GLN . 6.1 p -135.51 137.34 49.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.5 mm-40 -95.0 128.25 41.68 Favored 'General case' 0 N--CA 1.394 -3.231 0 CA-C-O 121.288 0.566 . . . . 0.0 110.846 -174.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 89' ' ' ILE . 40.4 tp -113.6 121.32 43.82 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.496 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -85.51 91.82 8.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.42 -12.87 41.45 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -167.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -48.8 -25.99 2.15 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.332 1.053 . . . . 0.0 113.498 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -51.69 -49.95 61.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -175.14 154.36 1.76 Allowed 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.3 mp0 -77.97 -46.49 20.97 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.791 0.805 . . . . 0.0 111.334 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.15 -17.46 54.97 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.244 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' O ' ' HB ' ' A' ' 91' ' ' THR . 28.3 t80 -59.84 -37.5 79.41 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.559 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 80' ' ' LEU . 1.7 mp -64.24 -37.44 79.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.542 0.687 . . . . 0.0 109.823 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -20.91 60.18 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.884 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 97.5 m -74.42 -43.39 56.51 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.095 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.518 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -48.59 -44.63 37.09 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.201 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.803 ' NH2' ' HB ' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -55.21 -25.97 36.43 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -86.35 -40.28 15.6 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.77 -18.47 31.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.544 0.687 . . . . 0.0 112.258 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.28 128.87 35.18 Favored Pre-proline 0 C--N 1.275 -2.633 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.82 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.76 165.12 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.221 1.947 . . . . 0.0 110.611 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.55 4.3 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.626 0.77 . . . . 0.0 112.126 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -84.13 -29.08 27.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 70' ' ' ALA . 79.4 t -107.89 132.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.324 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.4 160.66 15.47 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.803 ' HB ' ' NH2' ' A' ' 93' ' ' ARG . 4.1 mp -122.58 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.554 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 38.9 m0 -107.75 164.63 12.07 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.26 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -99.54 109.18 21.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.605 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.21 103.39 3.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.8 tp -74.1 94.05 2.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.571 -175.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.6 m -70.23 113.03 7.0 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 104.251 -2.499 . . . . 0.0 104.251 169.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.34 116.34 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 122.295 1.045 . . . . 0.0 113.765 -170.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.3 135.49 12.64 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.56 -32.99 68.7 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 123.203 0.601 . . . . 0.0 109.838 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.2 m -142.5 101.59 3.91 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 95.8 mt -76.33 119.96 79.57 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 2.6 Cg_exo -77.73 162.13 30.1 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.864 2.376 . . . . 0.0 110.476 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.56 28.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.465 0.65 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -108.58 119.24 38.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.537 0.684 . . . . 0.0 110.039 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.24 -77.91 0.34 Allowed 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.022 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 89' ' ' ILE . 56.3 m-85 -142.61 103.8 4.28 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -83.34 172.79 12.16 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.399 0.619 . . . . 0.0 112.453 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.4 m170 74.57 4.98 4.49 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.412 1.485 . . . . 0.0 114.777 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.643 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 20.7 m -68.04 154.34 8.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.984 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.62 -33.2 15.95 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.139 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.3 ttmt -159.24 163.32 35.97 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -124.88 142.97 51.09 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.21 169.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -71.57 151.9 43.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.82 0.736 . . . . 0.0 109.199 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.11 104.57 0.49 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.9 115.05 3.13 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.69 0.796 . . . . 0.0 111.616 -173.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -159.05 53.2 0.38 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.24 127.75 33.87 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.3 41.74 7.3 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.89 42.47 0.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -158.23 -90.58 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.78 -39.35 6.23 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.41 -2.462 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 170.107 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.14 -141.51 4.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.619 0.566 . . . . 0.0 114.448 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -78.18 141.05 38.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.562 0.696 . . . . 0.0 111.213 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 28.5 m-80 -135.32 33.71 3.05 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 10.3 ptpp? -53.97 99.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.924 -173.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.05 125.07 40.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.951 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -90.82 170.41 10.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -36.93 115.93 0.32 Allowed Glycine 0 C--N 1.364 2.124 0 O-C-N 124.28 0.988 . . . . 0.0 114.108 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.0 tp -140.22 162.1 36.07 Favored 'General case' 0 N--CA 1.407 -2.593 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -139.04 21.88 2.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.163 0.982 . . . . 0.0 109.234 -173.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.612 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 55.4 mtt180 -125.75 110.36 13.65 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.2 -49.14 45.0 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 124.753 1.168 . . . . 0.0 114.826 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 21.2 mp0 -81.06 -19.96 42.64 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.478 0.656 . . . . 0.0 110.848 -174.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 43.6 t0 -80.86 -36.69 31.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.47 71.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.654 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.65 -22.69 64.12 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.79 -31.95 41.28 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.85 0.46 . . . . 0.0 111.853 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -78.13 -30.95 49.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.925 0.869 . . . . 0.0 110.62 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -30.69 33.81 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.1 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.02 -26.8 67.87 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.119 0.968 . . . . 0.0 109.296 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 -20.67 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.076 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.94 37.09 0.45 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.21 35.92 21.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.305 1.042 . . . . 0.0 110.768 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 -68.48 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.922 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.467 ' OH ' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -176.71 161.74 2.11 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 123.668 0.605 . . . . 0.0 109.78 -176.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.81 152.42 19.34 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 5' ' ' LYS . . . -128.81 80.95 0.35 Allowed Glycine 0 CA--C 1.491 -1.407 0 C-N-CA 119.386 -1.388 . . . . 0.0 112.412 -172.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.75 152.12 40.93 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.173 -0.514 . . . . 0.0 109.943 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.4 pt -114.0 155.45 15.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 54.8 m-85 -81.22 86.65 6.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.787 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -121.0 123.76 70.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.29 103.84 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.714 1.206 . . . . 0.0 114.206 -174.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p 61.93 21.84 12.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 115.077 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 135.89 36.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.884 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.87 21.17 0.74 Allowed 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.731 2.287 . . . . 0.0 112.524 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -125.12 -11.8 6.99 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 72.4 m -153.82 117.13 4.58 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.36 137.16 32.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 122.15 0.976 . . . . 0.0 110.945 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.33 171.78 7.14 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.244 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.7 p -43.85 -33.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.382 1.473 . . . . 0.0 113.405 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.55 -56.98 7.35 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.164 0.507 . . . . 0.0 111.08 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.8 mt-30 -69.77 -37.09 76.26 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.05 0.452 . . . . 0.0 110.296 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.49 -20.85 65.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.6 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -69.48 -23.78 63.68 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.47 -43.99 12.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.077 0.941 . . . . 0.0 108.664 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 42' ' ' GLN . 20.4 t -65.05 -33.42 63.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.05 -176.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.93 -17.8 65.08 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.084 0.469 . . . . 0.0 111.535 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.85 -25.38 21.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.781 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.47 -39.69 18.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.965 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 103.76 9.22 Favored Pre-proline 0 N--CA 1.398 -3.03 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.42 45.08 0.96 Allowed 'Trans proline' 0 CA--C 1.552 1.387 0 C-N-CA 123.298 2.666 . . . . 0.0 113.255 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -88.53 -179.62 6.1 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.694 0.797 . . . . 0.0 111.842 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 25' ' ' TYR . 0.3 OUTLIER -82.76 145.4 29.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.553 0.741 . . . . 0.0 110.936 178.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.17 146.26 43.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.458 0.647 . . . . 0.0 110.252 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 p -133.24 145.52 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.03 140.2 12.56 Favored Glycine 0 C--O 1.196 -2.241 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.006 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.2 t -128.26 122.46 58.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -169.36 156.07 6.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -90.64 93.33 9.22 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.99 0.9 . . . . 0.0 109.694 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -102.15 118.49 37.0 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -87.71 -28.19 21.93 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.579 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.59 122.49 40.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.09 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.2 -35.29 73.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.438 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.18 -17.54 61.36 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.486 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.32 -29.5 31.03 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.43 -47.63 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 63' ' ' ILE . 55.5 t -60.53 -37.2 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.879 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 72' ' ' VAL . 18.4 t70 -52.92 -61.33 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.472 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.48 -42.06 92.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.891 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -57.8 -38.92 76.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 124.288 0.992 . . . . 0.0 111.606 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.31 -53.11 5.98 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 123.224 0.328 . . . . 0.0 111.513 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 68' ' ' ASP . 50.0 t -55.08 -56.04 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 40' ' ' VAL . 40.6 tp -79.94 -21.87 43.33 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.3 m 63.23 79.38 0.26 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 122.213 1.006 . . . . 0.0 110.336 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.12 -179.03 6.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.007 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.6 -39.32 2.31 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.52 160.64 40.78 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.273 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.78 136.69 35.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.88 111.62 24.04 Favored 'General case' 0 N--CA 1.391 -3.418 0 C-N-CA 123.257 0.623 . . . . 0.0 109.446 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.99 154.51 19.16 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.205 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -93.47 96.38 9.86 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 172.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.497 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -72.64 -12.32 77.74 Favored Glycine 0 C--N 1.306 -1.107 0 CA-C-N 114.225 -1.352 . . . . 0.0 114.845 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -49.6 -25.83 3.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.584 1.154 . . . . 0.0 111.932 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -52.33 -45.56 65.69 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.544 0.738 . . . . 0.0 112.444 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.53 149.03 0.96 Allowed 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -77.56 -43.64 31.17 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.19 0.995 . . . . 0.0 110.416 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.18 -13.65 60.18 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.605 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.588 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.6 t80 -62.64 -41.13 98.87 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.385 174.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.497 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -61.35 -40.97 88.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.96 -19.17 65.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.836 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.4 m -83.04 -42.69 17.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.605 HD13 HG13 ' A' ' 63' ' ' ILE . 4.1 mm? -53.44 -44.01 68.51 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.453 0.701 . . . . 0.0 111.216 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' HD12 ' A' ' 102' ' ' ILE . 8.2 mmm180 -43.59 -37.5 2.56 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.245 1.418 . . . . 0.0 111.866 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.95 -45.54 18.33 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.024 -173.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.0 -18.31 47.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.61 0.719 . . . . 0.0 112.379 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -99.9 134.7 20.78 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.446 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.18 165.42 31.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.391 2.06 . . . . 0.0 109.668 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.05 -11.3 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.239 0.543 . . . . 0.0 111.255 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.49 -29.41 62.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.872 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.75 127.56 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -105.91 167.4 9.81 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.445 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.443 HD12 ' HD2' ' A' ' 93' ' ' ARG . 93.6 mt -125.27 129.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.597 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.6 m0 -120.65 152.7 37.85 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.869 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.23 124.74 50.06 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.37 98.15 1.05 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt -86.28 113.87 22.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.167 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.3 t -73.21 132.82 43.64 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.3 m -36.69 121.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 O-C-N 124.647 1.217 . . . . 0.0 113.455 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.68 64.43 3.61 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.756 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -92.02 -66.45 0.92 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 t -104.08 -24.32 13.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.176 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -89.47 157.82 46.66 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.54 156.34 21.67 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.484 2.122 . . . . 0.0 111.492 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.34 -37.72 19.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.554 0.692 . . . . 0.0 109.218 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.28 124.36 45.65 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -136.3 -62.3 0.67 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.16 117.12 33.82 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.045 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -78.43 166.16 22.94 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.768 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 m170 75.57 8.5 3.76 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.896 0.878 . . . . 0.0 112.47 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.57 143.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.08 -43.14 65.32 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.88 -173.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 39.4 ttmt -159.11 164.34 35.39 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -118.3 157.83 26.33 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.54 171.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -76.14 143.46 41.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.03 112.56 17.44 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -110.58 19.26 18.89 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.362 0.601 . . . . 0.0 110.344 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.61 -5.28 51.66 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -62.26 141.68 58.12 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 123.098 0.559 . . . . 0.0 111.509 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.93 -32.5 0.5 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 115.62 160.55 12.57 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.43 105.36 17.55 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.42 105.7 1.65 Allowed Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.35 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.524 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 C--O 1.237 0.438 0 CA-C-O 120.445 0.164 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.07 -54.04 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -47.21 121.58 3.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.412 1.085 . . . . 0.0 111.148 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -146.04 43.19 1.23 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -46.34 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.03 121.57 23.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.446 0.641 . . . . 0.0 111.497 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.7 p -101.33 168.35 9.6 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 9' ' ' LEU . . . -2.65 -110.9 0.0 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 125.178 1.371 . . . . 0.0 116.149 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' GLY . 54.4 tp 77.49 165.09 0.23 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.518 0.775 . . . . 0.0 111.229 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -138.07 -14.5 1.36 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.972 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.55 112.24 24.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.732 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.606 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -50.34 -41.4 40.03 Favored Glycine 0 C--O 1.209 -1.462 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.719 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -57.88 -39.94 79.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.513 1.125 . . . . 0.0 108.916 -178.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 9' ' ' LEU . 13.2 t70 -79.2 -30.71 43.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.325 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.35 63.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.808 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 9.5 mtmp? -61.02 -24.85 66.49 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.293 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -32.43 74.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.621 0.368 . . . . 0.0 111.507 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.97 72.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.648 1.213 . . . . 0.0 109.722 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -30.29 44.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.063 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.67 -23.1 66.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.375 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.09 65.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.971 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.26 13.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 114.449 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.27 26.48 13.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.852 0.861 . . . . 0.0 110.867 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 47.9 mt -63.93 -67.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.341 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -176.23 155.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -174.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.24 143.59 14.61 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.01 82.89 0.34 Allowed Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.036 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.478 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -118.64 141.93 48.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 120.847 0.356 . . . . 0.0 110.165 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.451 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -108.02 151.6 10.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -81.83 79.82 8.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.833 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 34' ' ' SER . 61.3 t -112.17 129.57 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.81 106.75 0.28 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p 65.38 16.72 10.68 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.958 1.703 . . . . 0.0 114.889 172.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 22.7 p -83.16 124.43 76.3 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.839 -0.538 . . . . 0.0 110.332 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -9.27 18.78 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.062 1.841 . . . . 0.0 114.886 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -112.74 12.65 19.67 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.485 -0.76 . . . . 0.0 111.662 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HB2' ' OG ' ' A' ' 34' ' ' SER . 85.8 m -152.58 118.09 5.31 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.37 138.37 26.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.2 1.0 . . . . 0.0 112.606 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -104.31 168.68 8.94 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.769 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.2 p -53.38 -30.01 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 124.063 0.852 . . . . 0.0 112.03 -171.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 54.6 mp0 -61.88 -55.64 27.58 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 124.541 1.137 . . . . 0.0 112.1 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 29.6 mt-30 -70.39 -38.22 74.64 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 121.464 0.65 . . . . 0.0 109.925 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -61.04 -27.16 68.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.501 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 47' ' ' MET . 8.4 tp60 -61.42 -36.36 80.1 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.64 0.776 . . . . 0.0 112.101 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 13.1 pt-20 -86.07 -43.15 13.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.552 1.168 . . . . 0.0 109.011 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 6.9 t -55.22 -32.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.205 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 14.3 ptp -62.99 -31.42 72.54 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.37 0.605 . . . . 0.0 110.721 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.37 58.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.009 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.27 -48.1 7.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.74 99.58 15.32 Favored Pre-proline 0 N--CA 1.391 -3.394 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.23 55.49 3.54 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.811 2.34 . . . . 0.0 111.711 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -96.23 171.29 8.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.35 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 2.9 tt0 -72.29 142.9 48.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.263 0.225 . . . . 0.0 110.453 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB2' HD23 ' A' ' 75' ' ' LEU . 16.8 m-85 -115.11 139.89 49.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.3 p -129.41 146.89 33.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.64 129.66 6.95 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.842 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.6 t -114.37 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -148.81 152.98 37.46 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 29.0 ptt180 -86.29 93.74 9.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 0.8 OUTLIER -67.28 116.09 7.67 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 122.865 1.317 . . . . 0.0 112.124 -172.368 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -108.19 -72.71 0.71 Allowed 'General case' 0 C--N 1.255 -3.515 0 CA-C-N 112.552 -2.113 . . . . 0.0 108.814 171.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.11 108.94 12.97 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.849 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -62.37 -34.71 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.038 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.71 -22.86 63.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.104 0.478 . . . . 0.0 110.7 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 12.7 t70 -85.67 -33.74 21.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.225 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.06 -32.4 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.046 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' ILE . 89.8 t -64.99 -33.52 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.2 t70 -56.89 -57.99 10.1 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.73 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -60.75 -40.84 93.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.16 -39.02 77.74 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.755 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -83.83 -53.58 5.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.616 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 68' ' ' ASP . 44.7 t -56.63 -56.55 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.232 0.613 . . . . 0.0 111.754 -174.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 40' ' ' VAL . 51.4 tp -80.41 -13.91 58.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.099 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 18.8 p 55.54 77.42 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.378 1.071 . . . . 0.0 112.272 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 54' ' ' TYR . 92.6 mt -74.77 175.08 8.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.867 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -122.79 -35.88 2.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.126 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.88 157.76 44.04 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -140.13 141.12 34.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -99.97 128.08 46.1 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.349 0.595 . . . . 0.0 112.053 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -98.25 122.42 41.39 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.389 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -84.52 98.9 10.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.652 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.63 -12.86 42.85 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.591 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.47 -33.19 1.62 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.172 1.389 . . . . 0.0 113.127 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 13.0 mm-40 -66.07 -48.24 71.66 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -179.61 149.89 0.39 Allowed 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.75 -44.86 26.37 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 112.45 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.65 -20.38 43.21 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.746 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.561 ' O ' ' HB ' ' A' ' 91' ' ' THR . 42.9 t80 -58.49 -36.05 73.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.931 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.652 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -61.17 -37.8 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.609 0.719 . . . . 0.0 109.137 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.622 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 14.7 t70 -70.07 -21.01 63.2 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.088 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.561 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.1 m -78.54 -42.44 29.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.514 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -48.51 -49.13 37.27 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.559 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.08 -33.09 37.73 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.229 0.538 . . . . 0.0 112.361 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 33.6 mt-10 -73.16 -42.59 62.61 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.105 -174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.95 25.87 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.86 135.64 42.5 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.698 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 165.13 33.63 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 121.972 1.781 . . . . 0.0 110.599 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.64 -15.85 54.01 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.034 0.934 . . . . 0.0 112.152 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -71.12 -30.12 66.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.2 t -107.33 129.5 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.235 0 CA-C-O 121.376 0.608 . . . . 0.0 110.629 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.71 170.83 8.29 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.461 HG23 HD23 ' A' ' 80' ' ' LEU . 73.6 mt -125.77 129.73 72.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.1 m0 -118.9 157.98 26.6 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.689 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -100.94 123.39 45.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.31 116.96 10.35 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -89.23 95.58 10.36 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.573 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 50.2 m -67.7 150.81 48.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.431 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.82 115.29 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-O 122.563 1.173 . . . . 0.0 110.72 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.32 93.06 0.09 OUTLIER Glycine 0 N--CA 1.415 -2.712 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -72.28 -12.55 61.2 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -170.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.1 m -102.22 8.54 40.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.129 0.966 . . . . 0.0 109.52 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 4.2 mm? -91.54 149.39 39.3 Favored Pre-proline 0 C--O 1.25 1.114 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 7.7 Cg_exo -71.39 148.36 54.53 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.803 1.669 . . . . 0.0 110.798 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.37 -28.04 66.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.364 0.602 . . . . 0.0 110.115 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -112.55 127.25 56.02 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -131.46 -58.29 0.99 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 82' ' ' GLY . 79.5 m-85 -99.37 111.94 24.22 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.3 164.36 26.79 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.668 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 93' ' ' ARG . 23.3 m170 71.54 7.18 5.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.696 1.599 . . . . 0.0 112.201 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.64 152.1 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -81.4 -41.6 21.67 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 120.998 0.428 . . . . 0.0 111.349 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.0 mttt -145.78 163.03 36.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.301 0.64 . . . . 0.0 109.676 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -116.83 139.6 50.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.44 166.87 20.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.57 163.07 28.43 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.519 0.676 . . . . 0.0 111.72 -176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.573 ' HB2' ' HA ' ' A' ' 107' ' ' SER . 12.1 t70 -68.91 97.21 0.82 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.396 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -82.93 -47.35 11.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.65 -155.98 46.99 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.955 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 168.31 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.091 2.156 . . . . 0.0 105.883 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.24 49.11 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -90.29 -143.26 10.46 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.369 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -111.79 108.02 17.28 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.481 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.7 162.81 34.82 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.763 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.28 73.46 0.46 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -70.64 121.78 18.55 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.728 0.775 . . . . 0.0 111.612 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.417 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 15.0 p-10 -125.81 28.28 6.2 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 173.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -57.08 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.502 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -95.37 124.26 47.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.493 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.0 m -92.0 170.52 9.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.93 135.42 8.86 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 119.046 0.839 . . . . 0.0 115.06 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -150.07 153.12 35.92 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' HD13 ' A' ' 9' ' ' LEU . 8.6 t -118.51 8.03 11.97 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.641 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.433 ' H ' HD12 ' A' ' 9' ' ' LEU . 71.7 mtm180 -117.73 114.64 23.63 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.118 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.24 -39.44 71.4 Favored Glycine 0 C--O 1.216 -1.024 0 O-C-N 123.626 0.578 . . . . 0.0 113.639 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.407 ' H ' ' CD ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -66.2 -26.09 67.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 122.005 0.907 . . . . 0.0 109.264 -177.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -89.57 -51.96 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.493 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.13 69.53 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.99 -22.39 62.49 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.374 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.07 -30.78 27.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.971 0.508 . . . . 0.0 111.451 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 -43.28 64.77 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.542 0.687 . . . . 0.0 109.824 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -34.03 73.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.71 -23.46 66.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 125.172 1.389 . . . . 0.0 110.018 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.89 -13.94 59.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.94 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.53 10.4 0.27 Allowed Glycine 0 C--O 1.225 -0.458 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.535 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.2 19.37 8.74 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.491 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 37.8 mt -57.86 -67.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.16 -171.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.01 157.69 2.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -132.05 140.9 12.2 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.46 91.08 0.51 Allowed Glycine 0 CA--C 1.471 -2.673 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 155.88 34.73 Favored 'General case' 0 N--CA 1.401 -2.921 0 CA-C-N 114.567 -0.816 . . . . 0.0 109.182 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.602 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 3.5 pt -116.95 151.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.554 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 49.7 m-85 -84.19 79.02 9.67 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.427 1.079 . . . . 0.0 109.796 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.8 t -109.8 119.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.58 103.84 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.829 1.331 . . . . 0.0 113.483 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.6 p 59.39 29.28 18.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.638 1.575 . . . . 0.0 113.491 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -107.26 104.11 51.02 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.07 3.93 0.66 Allowed 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.776 2.984 . . . . 0.0 115.029 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -84.43 -10.64 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 46.6 m -138.4 172.13 13.35 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.89 136.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.57 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -106.7 164.09 12.38 Favored 'General case' 0 CA--C 1.465 -2.327 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.742 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 HD23 ' A' ' 73' ' ' LEU . 11.4 p -45.58 -35.44 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 124.806 1.316 . . . . 0.0 112.049 -174.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.97 -38.81 86.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.1 mt-30 -80.79 -34.94 33.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.339 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -62.38 -32.81 73.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.023 -175.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 47' ' ' MET . 2.2 pt20 -62.98 -31.08 72.12 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.96 -47.3 59.73 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.116 0.96 . . . . 0.0 108.641 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 42' ' ' GLN . 40.9 t -65.0 -30.5 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.819 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 24.6 ptt? -67.08 -17.6 64.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.304 0.574 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.87 25.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.996 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.55 -43.33 6.9 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.298 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -127.52 93.76 39.74 Favored Pre-proline 0 N--CA 1.386 -3.628 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.75 57.06 3.02 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.455 2.104 . . . . 0.0 111.968 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.3 pp -96.71 179.26 5.04 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.471 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 0.5 OUTLIER -82.94 143.27 30.81 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 20.6 m-85 -113.65 138.08 50.69 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.8 p -132.41 139.86 49.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -125.18 141.13 12.82 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.541 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.602 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 29.2 t -124.43 134.82 65.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -167.09 159.64 13.25 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.661 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -85.93 93.59 8.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -87.99 125.67 34.66 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.834 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -94.94 -58.0 2.28 Favored 'General case' 1 C--N 1.241 -4.111 0 CA-C-N 112.775 -2.011 . . . . 0.0 108.96 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.87 123.37 43.08 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.559 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 92' ' ' LEU . 17.4 tt -64.23 -29.74 48.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.33 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.17 -13.82 58.95 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.078 0.466 . . . . 0.0 110.315 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 14.0 t70 -86.25 -39.25 16.75 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.816 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 80' ' ' LEU . 14.9 p -77.82 -37.63 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.293 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.13 -32.0 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 9.3 t70 -54.8 -55.64 27.93 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.472 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 43.2 mmtm -63.59 -41.56 98.33 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -56.98 -38.92 73.7 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.316 1.01 . . . . 0.0 110.996 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -81.96 -52.88 6.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.354 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 77.5 t -56.1 -54.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -82.9 -11.47 58.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.41 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t 61.97 74.67 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.683 0.754 . . . . 0.0 109.498 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.5 mt -82.74 179.91 7.63 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.439 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.74 -32.96 2.31 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.7 160.53 43.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.3 171.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 6.2 p -150.0 141.02 16.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.82 111.36 23.68 Favored 'General case' 0 N--CA 1.385 -3.691 0 CA-C-O 121.824 0.821 . . . . 0.0 109.353 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.592 HD13 ' HG ' ' A' ' 92' ' ' LEU . 36.3 mt -115.72 89.17 3.04 Favored 'General case' 0 CA--C 1.422 -3.945 0 N-CA-C 101.369 -3.567 . . . . 0.0 101.369 -169.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -98.04 174.37 6.58 Favored 'General case' 1 N--CA 1.362 -4.859 0 C-N-CA 117.873 -1.531 . . . . 0.0 113.299 -167.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -48.96 -10.51 0.14 Allowed Glycine 1 C--N 1.243 -4.584 0 CA-C-N 110.863 -2.881 . . . . 0.0 117.468 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -44.72 -44.73 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -49.72 6.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.956 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 1.1 tm-20 178.94 170.33 0.89 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -77.88 -49.85 13.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.519 1.152 . . . . 0.0 109.389 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 37.1 mt -72.97 -13.6 61.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.99 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.4 t80 -60.34 -48.99 79.36 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 1.9 mp -59.75 -36.69 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.687 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 24.4 t70 -60.08 -27.1 66.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.636 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.9 m -88.15 -43.68 11.47 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 124.708 1.203 . . . . 0.0 110.141 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 80' ' ' LEU . 4.1 mm? -43.93 -44.0 6.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.687 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 1.7 mpt_? -56.55 -29.74 62.31 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.271 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -77.95 -35.13 50.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.382 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.81 0.86 50.01 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.433 0.635 . . . . 0.0 110.806 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.415 HD22 HG13 ' A' ' 102' ' ' ILE . 27.2 tp -75.79 124.49 88.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 124.053 0.941 . . . . 0.0 109.479 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.01 161.57 44.41 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.078 1.852 . . . . 0.0 110.988 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.22 70.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 124.464 1.106 . . . . 0.0 113.354 -172.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -88.86 -10.9 46.31 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG21 ' HB1' ' A' ' 70' ' ' ALA . 65.6 t -107.68 140.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.86 172.67 6.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.55 HG12 HD12 ' A' ' 80' ' ' LEU . 53.8 mt -116.41 131.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.652 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 40.8 m0 -121.02 159.17 26.19 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.393 171.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 120' ' ' VAL . 40.0 ttpt -100.73 115.18 29.66 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 107.63 5.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp -78.48 95.38 5.13 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -76.09 108.37 8.95 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.1 m -65.23 141.32 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.286 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.68 -161.87 11.96 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.56 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.15 -26.61 56.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 t -133.2 120.97 21.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.127 0.489 . . . . 0.0 110.072 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.17 96.68 13.78 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.51 154.51 21.07 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.894 2.396 . . . . 0.0 112.867 -175.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.69 -39.93 14.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.115 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -122.88 118.77 28.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -161.59 -58.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -124.86 94.04 4.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -115.01 -178.64 3.41 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.625 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t60 65.44 28.42 11.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.221 1.408 . . . . 0.0 108.505 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 104' ' ' LYS . 27.3 m -87.26 149.99 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.77 -41.29 45.28 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.402 0.62 . . . . 0.0 111.058 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 45.2 mmtm -143.78 162.32 36.32 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -127.13 138.68 53.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.96 171.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.35 140.11 50.09 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.411 0.445 . . . . 0.0 110.602 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.41 124.94 20.68 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.164 0.986 . . . . 0.0 110.724 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -109.71 0.79 19.1 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.118 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.76 -47.0 88.02 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -132.47 -83.72 0.48 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.93 -107.65 0.22 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.403 1.064 . . . . 0.0 113.735 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.12 -94.33 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.5 -171.8 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.989 0.916 . . . . 0.0 112.902 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.06 -75.96 2.27 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.063 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 123.372 0.669 . . . . 0.0 110.109 -178.394 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.78 42.5 25.71 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.392 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.47 -162.72 1.06 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.483 HD22 ' H ' ' A' ' 25' ' ' TYR . 21.9 p-10 -166.92 46.95 0.06 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -172.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.18 98.06 0.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.935 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.12 124.7 53.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.736 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.1 p -91.99 169.8 10.36 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 37' ' ' CYS . . . -46.76 126.7 10.07 Favored Glycine 0 CA--C 1.493 -1.299 0 O-C-N 123.64 0.588 . . . . 0.0 113.771 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.3 tp -143.06 161.0 39.32 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -134.35 -18.9 1.95 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.683 0.754 . . . . 0.0 109.948 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.73 105.69 9.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.937 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 16' ' ' LYS . . . -48.37 -44.85 28.44 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 124.64 1.114 . . . . 0.0 114.224 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 17.4 mp0 -76.18 -22.27 55.53 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.335 0.588 . . . . 0.0 110.856 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.52 -30.46 23.41 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.15 48.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 17.5 ptpt -64.69 -22.51 67.0 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 -37.71 78.89 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.801 0.334 . . . . 0.0 110.567 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.98 -38.01 66.81 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 110.181 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HD1' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -67.72 -34.61 77.2 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.9 -31.29 72.42 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.486 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.28 64.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.069 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.32 -21.7 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.467 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB2' ' HD1' ' A' ' 19' ' ' TYR . . . 61.93 27.04 16.41 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.985 0.898 . . . . 0.0 109.019 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 28.5 mt -69.92 -59.64 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.909 -171.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.483 ' H ' HD22 ' A' ' 4' ' ' ASN . 3.0 p90 -178.36 161.92 1.45 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 145.72 16.28 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.35 73.99 0.21 Allowed Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.482 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.498 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.79 154.94 26.55 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-O 121.172 0.511 . . . . 0.0 110.264 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 5.7 pt -116.78 152.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -79.57 79.43 6.04 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 124.741 1.275 . . . . 0.0 111.239 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.25 116.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 115.09 2.75 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.777 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.4 p 66.02 14.67 9.73 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.086 1.754 . . . . 0.0 115.126 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.8 m -93.58 114.67 63.58 Favored Pre-proline 0 C--O 1.197 -1.696 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.35 26.48 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 124.28 3.32 . . . . 0.0 115.285 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 20.4 ptt180 -124.92 -5.15 7.46 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 36' ' ' ARG . 60.8 m -136.65 166.75 22.83 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -143.94 136.4 23.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -102.46 170.52 8.0 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.685 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 73' ' ' LEU . 5.9 p -56.41 -31.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 123.809 0.693 . . . . 0.0 111.1 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 4.3 mp0 -70.88 -46.87 61.84 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 124.149 0.979 . . . . 0.0 111.505 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 49.7 mm-40 -61.76 -49.31 76.92 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -63.89 -21.47 66.48 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.287 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 47' ' ' MET . 18.1 tp60 -63.99 -39.32 93.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.527 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.8 pt-20 -85.93 -45.41 11.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.754 0.788 . . . . 0.0 110.427 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 95.4 t -48.97 -35.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 125.307 1.443 . . . . 0.0 112.249 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 16.5 ptp -64.22 -20.56 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 120.823 0.344 . . . . 0.0 111.493 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.37 -28.74 28.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.34 -45.5 13.68 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.75 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -133.66 98.12 15.16 Favored Pre-proline 0 N--CA 1.397 -3.119 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.69 46.73 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.88 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -84.33 152.28 24.21 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.686 177.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.7 140.41 49.7 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.411 0.625 . . . . 0.0 112.428 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.04 143.73 39.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -113.46 128.78 8.5 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.782 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.585 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 21.2 t -113.74 106.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.57 146.59 15.09 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.471 -173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.406 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 59.0 mtm180 -93.11 93.37 8.26 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 15.4 m120 -90.25 154.91 19.38 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 122.656 1.217 . . . . 0.0 110.526 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.89 -73.43 0.64 Allowed 'General case' 0 C--N 1.245 -3.953 0 CA-C-N 111.445 -2.616 . . . . 0.0 112.17 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.77 131.91 35.27 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 92' ' ' LEU . 5.9 tt -60.02 -32.68 50.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.041 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.61 -18.76 61.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.326 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.6 -35.21 53.11 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.436 0.636 . . . . 0.0 109.288 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.52 -44.05 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.7 t -60.55 -39.28 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.577 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 15.3 t70 -57.1 -61.79 2.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.172 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 45.6 mmtm -63.72 -39.7 94.93 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 -176.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.36 -35.02 76.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.812 0.695 . . . . 0.0 111.417 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -82.37 -56.54 3.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -53.32 -56.47 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.352 0.661 . . . . 0.0 111.628 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.718 ' HB2' HG23 ' A' ' 40' ' ' VAL . 45.4 tp -82.78 -17.31 44.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.488 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 39.9 m 60.59 80.55 0.21 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.226 1.012 . . . . 0.0 111.182 -176.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 73' ' ' LEU . 74.1 mt -85.46 -175.06 5.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.578 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -127.97 -36.79 1.96 Allowed 'General case' 0 C--O 1.193 -1.912 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -146.0 159.27 43.49 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.36 0.6 . . . . 0.0 111.534 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.4 p -140.58 138.64 35.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.689 HE22 ' HB2' ' A' ' 103' ' ' TRP . 7.2 mm100 -98.46 105.59 17.75 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 123.459 0.703 . . . . 0.0 109.393 -175.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HG ' ' A' ' 92' ' ' LEU . 75.2 mt -116.13 139.52 50.23 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.941 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 p80 175.54 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.121 0.888 . . . . 0.0 110.165 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 59' ' ' ARG . . . -74.71 -55.39 5.44 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 120.434 2.933 . . . . 0.0 120.434 -166.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ASN . 2.8 t-20 -82.79 -69.1 0.65 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.97 -48.93 12.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -168.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -177.89 172.0 1.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.248 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.566 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 96.4 mt-30 -78.44 -43.98 25.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 125.242 1.417 . . . . 0.0 107.235 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 54.7 mt -71.42 -14.39 62.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.326 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 22.9 t80 -65.38 -40.25 93.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.982 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.469 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.0 -30.38 49.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.628 0.728 . . . . 0.0 110.015 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.68 ' HA ' ' NH1' ' A' ' 93' ' ' ARG . 23.9 t70 -67.54 -22.64 65.4 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.47 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.9 m -89.63 -44.92 9.72 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.305 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 88' ' ' TYR . 3.2 mm? -47.89 -46.37 31.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.68 ' NH1' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.02 -24.33 64.42 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.069 -173.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.04 -34.43 38.28 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.988 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.96 -22.17 22.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.854 0.835 . . . . 0.0 111.409 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -88.09 140.13 30.74 Favored Pre-proline 0 C--N 1.276 -2.614 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.707 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.43 164.91 34.14 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 121.134 1.223 . . . . 0.0 109.018 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.1 3.95 6.28 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.496 0.665 . . . . 0.0 111.638 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -86.07 -24.85 26.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 70' ' ' ALA . 97.1 t -105.09 131.88 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.54 171.36 7.91 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 93' ' ' ARG . 65.1 mt -124.52 133.42 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.689 ' HB2' HE22 ' A' ' 79' ' ' GLN . 36.9 m0 -121.05 155.37 34.54 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.162 -1.415 . . . . 0.0 109.622 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -102.39 123.28 45.89 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 115.21 8.87 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 170.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.73 108.79 21.13 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -73.03 135.46 44.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.54 154.9 7.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.62 -168.0 33.19 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.805 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -98.64 -36.81 9.75 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 123.525 0.73 . . . . 0.0 110.023 -178.154 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 p -82.42 94.88 7.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.516 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.75 140.08 40.73 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.345 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 144.47 68.43 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.491 2.128 . . . . 0.0 112.231 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.95 -45.67 12.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 179.52 118.73 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.531 1.132 . . . . 0.0 107.998 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 3.0 mm-40 -133.71 -60.65 0.82 Allowed 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 33.3 m-85 -111.03 106.63 15.77 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -110.12 157.16 19.67 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.4 m80 69.05 33.77 3.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 111.818 -2.446 . . . . 0.0 111.113 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.49 142.06 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.73 -43.09 66.46 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.379 0.609 . . . . 0.0 111.153 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.2 mttm -145.14 163.18 35.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -124.68 143.39 50.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.56 174.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.42 144.77 39.78 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.932 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.88 135.06 47.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.255 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.72 -34.67 77.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.13 -64.13 2.49 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -114.02 87.83 2.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -131.11 -27.43 0.7 Allowed Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.936 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 -69.68 0.51 Allowed Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -156.8 -28.1 0.09 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.255 0.55 . . . . 0.0 109.776 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.84 43.37 18.02 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.724 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 C--O 1.239 0.546 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.9 59.11 0.37 Allowed Glycine 0 CA--C 1.498 -1.021 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 67.74 156.32 0.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.29 1.436 . . . . 0.0 110.917 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.619 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.2 p-10 -115.13 25.37 10.93 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 21.3 pttp -67.89 91.99 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.11 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.36 125.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.169 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 70.0 m -91.38 169.26 10.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' H ' ' HA ' ' A' ' 37' ' ' CYS . . . -19.53 105.85 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 O-C-N 124.919 1.387 . . . . 0.0 116.037 -169.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.22 135.86 18.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 9.45 2.7 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.912 0.863 . . . . 0.0 110.123 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -86.41 112.52 21.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.34 -53.5 5.8 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.419 1.009 . . . . 0.0 114.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -74.23 -19.91 60.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.799 0.839 . . . . 0.0 111.871 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.73 -36.51 17.31 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.73 -47.96 67.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.805 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 21.5 ptmt -63.35 -23.45 67.42 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.828 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.3 69.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.229 0.537 . . . . 0.0 110.805 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.06 -37.41 58.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -72.13 -33.33 67.71 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.296 0.57 . . . . 0.0 109.926 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.92 -25.69 67.26 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.19 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.66 -24.09 56.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.905 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.63 1.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 119.103 -1.522 . . . . 0.0 113.884 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.08 11.72 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.768 0.827 . . . . 0.0 111.463 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.619 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 23.1 mt -63.57 -69.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.845 -172.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.82 156.26 1.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -176.384 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -121.7 146.68 17.17 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.67 72.08 0.21 Allowed Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.249 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.547 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.47 144.36 39.39 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 121.216 0.532 . . . . 0.0 109.6 -179.296 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.649 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 31.3 mt -117.62 157.04 19.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.755 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.628 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 24.3 m-85 -83.59 56.14 3.49 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.677 0.672 . . . . 0.0 111.137 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.16 120.33 33.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -44.0 96.74 0.01 OUTLIER 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.083 1.489 . . . . 0.0 113.892 -172.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 p 55.85 23.78 6.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.577 1.551 . . . . 0.0 114.368 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -100.53 109.98 58.93 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.96 2.33 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.902 3.068 . . . . 0.0 115.079 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 12.4 ptm85 -74.19 -19.66 60.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -142.87 174.56 10.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.48 136.72 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 119.331 0.969 . . . . 0.0 110.292 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -101.15 167.45 10.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.001 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.3 p -51.57 -29.6 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.209 0.943 . . . . 0.0 112.996 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -65.96 -50.13 65.44 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.005 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.7 mt-30 -73.03 -40.04 65.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.231 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.92 64.6 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.834 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -56.47 -37.68 70.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.076 0.95 . . . . 0.0 109.402 176.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.37 -43.19 17.71 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.032 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 42' ' ' GLN . 12.0 t -65.28 -39.07 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.928 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.413 ' SD ' HD12 ' A' ' 73' ' ' LEU . 27.6 ptt? -62.2 -24.02 66.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.445 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.86 -25.8 29.98 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.209 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.61 -42.51 14.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.126 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -130.23 99.93 19.08 Favored Pre-proline 0 N--CA 1.39 -3.472 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.47 50.04 2.23 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -91.98 174.76 7.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.616 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 17.3 mt-30 -71.33 127.87 34.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.701 0.286 . . . . 0.0 111.446 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' OH ' HG12 ' A' ' 46' ' ' VAL . 45.1 m-85 -100.93 141.52 33.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.2 p -127.03 158.73 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.51 135.25 7.47 Favored Glycine 0 CA--C 1.462 -3.228 0 C-N-CA 119.26 -1.448 . . . . 0.0 112.617 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.571 ' HB ' HG23 ' A' ' 29' ' ' ILE . 44.4 t -115.26 142.59 27.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -172.06 157.05 4.22 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.982 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -85.98 93.2 8.9 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' ND2' HG22 ' A' ' 66' ' ' VAL . 23.2 m120 -89.53 118.1 28.92 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -92.17 -59.47 2.09 Favored 'General case' 1 C--N 1.237 -4.311 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.573 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.88 125.39 38.48 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.001 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.551 HG13 HD13 ' A' ' 92' ' ' LEU . 15.6 tt -65.65 -29.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.258 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -19.32 59.06 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.812 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.05 -26.05 39.87 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.804 0.812 . . . . 0.0 108.875 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.516 HG22 ' ND2' ' A' ' 60' ' ' ASN . 15.3 t -75.06 -44.73 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.0 t -60.3 -36.77 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.3 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.8 t70 -54.86 -58.31 8.1 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.373 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -65.74 -40.91 92.6 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.63 -29.42 70.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.778 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -84.15 -59.96 2.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.954 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' ASP . 52.2 t -50.55 -59.83 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.502 0.721 . . . . 0.0 111.909 -176.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.611 ' HB2' HG23 ' A' ' 40' ' ' VAL . 33.3 tp -78.3 -21.26 49.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.6 m 59.56 73.65 0.47 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.006 0.908 . . . . 0.0 109.835 -173.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 HD23 ' A' ' 73' ' ' LEU . 73.2 mt -72.13 -179.14 2.69 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.835 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' CB ' ' HG2' ' A' ' 53' ' ' GLN . . . -127.7 -44.19 1.52 Allowed 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -137.25 157.61 46.26 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.717 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.6 p -141.83 140.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.07 124.7 49.03 Favored 'General case' 0 N--CA 1.395 -3.187 0 O-C-N 121.874 -0.516 . . . . 0.0 110.914 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -103.91 137.34 42.03 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.499 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.26 99.46 12.24 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -60.17 -12.98 25.98 Favored Glycine 0 C--N 1.312 -0.789 0 CA-C-N 114.811 -1.086 . . . . 0.0 115.494 -175.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.92 -26.3 62.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.948 0.404 . . . . 0.0 110.186 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.13 -47.27 85.33 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 39.5 tt0 178.31 146.44 0.14 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.451 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 47.8 mt-30 -76.12 -44.25 39.43 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 122.485 1.136 . . . . 0.0 109.594 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 45.6 mt -72.84 -13.33 61.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.092 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 29.5 t80 -64.97 -39.22 93.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.692 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -61.83 -38.74 81.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.727 0.775 . . . . 0.0 109.391 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.4 t70 -64.01 -22.12 66.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.096 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.9 m -86.29 -42.08 14.04 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.056 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.551 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -49.87 -38.29 34.9 Favored 'General case' 0 C--O 1.21 -1.007 0 C-N-CA 123.196 0.599 . . . . 0.0 111.953 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' NE ' HD13 ' A' ' 102' ' ' ILE . 18.2 mmm-85 -63.93 -27.18 68.97 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.906 0.86 . . . . 0.0 111.368 -176.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -79.65 -47.84 14.71 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.776 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.71 -22.78 29.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.38 130.15 31.56 Favored Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.179 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.73 165.85 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.639 2.226 . . . . 0.0 111.492 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.64 -17.56 47.96 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.986 0.914 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -70.73 -29.33 65.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.288 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' A' ' 70' ' ' ALA . 72.6 t -107.47 136.76 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -113.22 167.97 10.11 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.563 HG23 HD23 ' A' ' 80' ' ' LEU . 2.3 mp -125.72 133.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.543 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 43.0 m0 -121.96 164.71 17.15 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -115.36 124.64 51.75 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.57 107.54 4.5 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.802 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.2 tp -96.01 101.08 12.7 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.995 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 m -67.06 144.39 56.16 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.78 149.05 7.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 121.637 0.732 . . . . 0.0 112.444 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.68 94.49 0.1 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -18.34 63.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.241 0.616 . . . . 0.0 112.601 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 m -78.39 -11.69 59.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 121.264 0.554 . . . . 0.0 110.568 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 98.5 mt -73.66 134.99 78.43 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.19 153.56 62.16 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.752 1.635 . . . . 0.0 110.618 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.78 68.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.12 122.5 42.42 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.27 -52.38 1.51 Allowed 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 94.7 m-85 -129.13 119.2 23.72 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.515 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -76.14 163.63 26.9 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.601 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.2 m170 67.47 21.7 9.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.047 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.75 149.95 3.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -85.55 -45.52 11.69 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.497 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.7 mttm -146.14 161.95 39.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.064 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -106.98 145.4 32.31 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.47 161.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.84 174.54 11.52 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.221 0.534 . . . . 0.0 111.448 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.08 124.09 24.85 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.526 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.6 12.98 3.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.843 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -147.22 -44.44 0.03 OUTLIER Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.341 -1.409 . . . . 0.0 115.151 -172.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -149.79 109.86 4.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.777 0.789 . . . . 0.0 109.941 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.62 105.03 3.2 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.39 -149.58 6.8 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.34 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.82 74.44 0.41 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.139 0.976 . . . . 0.0 110.99 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 122.8 -41.4 1.81 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--N 1.308 -1.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.232 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttm . . . . . 0 CA--C 1.511 -0.539 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.46 -167.55 19.43 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 67.18 145.67 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.717 1.207 . . . . 0.0 111.72 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -148.99 37.2 0.78 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -57.24 99.79 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.106 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.6 131.19 51.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.857 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m -91.6 170.65 9.76 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.52 127.58 3.78 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.735 0.647 . . . . 0.0 114.076 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.504 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.4 tp -134.65 173.15 11.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -138.83 13.85 2.69 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.232 1.015 . . . . 0.0 109.467 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 99.1 mtt180 -124.62 112.66 17.06 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.537 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.12 -41.7 99.55 Favored Glycine 0 C--N 1.302 -1.345 0 CA-C-O 122.207 0.893 . . . . 0.0 112.816 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -69.51 -35.16 75.25 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.524 1.13 . . . . 0.0 109.407 -176.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 13.0 t70 -77.13 -30.29 55.06 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.38 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.12 -32.61 72.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.429 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 9.8 mtmp? -62.22 -31.93 72.53 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.568 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.772 0.32 . . . . 0.0 111.565 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.6 52.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.464 176.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.86 -30.42 71.41 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 124.168 0.987 . . . . 0.0 110.361 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.34 60.9 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.082 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.89 -19.17 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.636 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.95 25.48 15.08 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-O 121.832 0.825 . . . . 0.0 109.416 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.18 -67.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.026 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.71 157.63 1.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 124.124 0.89 . . . . 0.0 110.014 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -117.68 163.9 12.71 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.71 78.36 0.38 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.237 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.482 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.87 151.86 39.13 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 120.895 0.379 . . . . 0.0 110.026 -176.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.524 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -116.97 154.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 176.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CE1' ' HA3' ' A' ' 56' ' ' GLY . 20.1 m-85 -84.6 86.72 7.28 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 124.16 0.913 . . . . 0.0 109.855 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 91.5 t -116.54 122.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.16 107.17 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 0.0 112.86 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p 62.2 27.33 16.42 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.598 1.559 . . . . 0.0 113.298 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -79.0 140.9 58.04 Favored Pre-proline 0 C--N 1.308 -1.21 0 O-C-N 121.885 -0.509 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.68 8.31 4.49 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 0.0 111.152 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -120.4 -4.92 9.87 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.807 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 61.6 m -153.27 128.28 9.65 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -173.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.46 137.9 30.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.353 0.597 . . . . 0.0 111.026 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.98 169.51 8.53 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.886 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -47.87 -30.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.256 1.022 . . . . 0.0 113.115 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.01 -36.74 67.06 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.2 mt-30 -86.0 -34.21 20.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -25.88 68.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.58 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -62.86 -30.82 71.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.806 0.843 . . . . 0.0 109.211 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -78.46 -50.92 10.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' GLN . 43.0 t -58.6 -35.01 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.602 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -64.28 -26.74 68.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.74 -14.72 25.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.39 0.614 . . . . 0.0 110.028 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.98 -48.79 6.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.663 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -131.77 104.03 14.4 Favored Pre-proline 0 N--CA 1.398 -3.069 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -176.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.55 65.36 4.67 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.012 1.808 . . . . 0.0 112.395 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.66 162.41 13.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.599 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.572 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 2.4 tm0? -81.2 151.82 28.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -177.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.92 148.71 42.65 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 121.978 -0.451 . . . . 0.0 110.248 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.2 p -133.5 154.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -129.92 141.73 12.93 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.153 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 25.6 t -136.43 126.67 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -173.04 173.75 3.62 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -87.48 120.15 28.49 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -95.64 117.35 30.3 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -99.23 -59.02 1.8 Allowed 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.2 114.14 26.58 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.389 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' HG22 ' A' ' 91' ' ' THR . 16.8 tt -65.8 -30.43 50.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.935 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.33 65.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.06 -41.51 22.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.8 -46.73 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.942 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.5 t -59.9 -41.22 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.678 0.611 . . . . 0.0 109.61 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.1 t70 -54.6 -60.75 2.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 123.841 0.713 . . . . 0.0 110.98 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -63.55 -47.77 80.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.239 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -60.3 -29.85 69.11 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 124.04 0.837 . . . . 0.0 111.855 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -84.04 -57.07 3.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.404 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 68' ' ' ASP . 66.2 t -51.26 -58.62 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.008 0.523 . . . . 0.0 112.179 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 tp -81.23 -19.44 43.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 31.6 t 61.01 77.69 0.32 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.165 0.986 . . . . 0.0 111.25 -175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -78.56 -167.62 1.14 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 124.822 1.249 . . . . 0.0 110.872 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.759 ' O ' ' HA ' ' A' ' 100' ' ' VAL . . . -127.69 -74.83 0.58 Allowed 'General case' 1 C--O 1.148 -4.256 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 170.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -104.3 158.06 16.71 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 118.352 -1.339 . . . . 0.0 111.875 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -139.75 138.6 38.76 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.79 132.67 43.19 Favored 'General case' 0 N--CA 1.392 -3.341 0 CA-C-O 121.591 0.71 . . . . 0.0 112.342 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -105.82 115.3 30.0 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.681 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -81.55 97.48 7.85 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.95 -11.73 3.24 Favored Glycine 0 C--N 1.313 -0.739 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -42.69 -29.7 0.32 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.469 1.508 . . . . 0.0 114.586 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.44 -48.62 69.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -178.37 154.08 0.79 Allowed 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.476 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -78.39 -46.07 20.85 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 122.208 1.004 . . . . 0.0 109.913 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.408 ' HB2' ' OE2' ' A' ' 85' ' ' GLU . 38.9 mt -77.58 -13.61 59.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.944 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.55 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.6 t80 -62.9 -35.91 81.61 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.983 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.58 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -64.82 -33.24 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.958 0.885 . . . . 0.0 109.646 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 93' ' ' ARG . 25.0 t70 -70.55 -15.66 62.79 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.878 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 92.5 m -89.32 -46.6 8.64 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 124.498 1.119 . . . . 0.0 110.208 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -44.54 -56.47 4.3 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.15 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -68.01 -6.44 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 40.4 mt-10 -88.41 -35.39 17.13 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.87 -16.04 27.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.955 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 97.8 mt -85.89 143.2 37.38 Favored Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.069 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.45 ' HG2' HG23 ' A' ' 100' ' ' VAL . 33.6 Cg_endo -66.65 165.99 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.729 2.286 . . . . 0.0 111.111 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -9.14 15.52 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.542 0.737 . . . . 0.0 112.65 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -82.24 -29.24 31.42 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 46.8 t -93.32 136.5 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -170.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -123.41 166.92 14.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.284 1.033 . . . . 0.0 108.367 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.489 HG23 HD23 ' A' ' 80' ' ' LEU . 1.8 mp -115.82 133.19 63.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.568 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.7 m0 -117.67 150.0 39.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.303 -1.359 . . . . 0.0 107.93 170.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.69 116.9 33.68 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.67 103.1 2.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp -78.97 95.52 5.5 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.456 0.646 . . . . 0.0 111.25 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 m -61.27 148.46 41.05 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.541 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.53 157.27 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.48 122.15 1.39 Allowed Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.75 -34.32 62.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 p -89.01 84.32 6.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 18.4 tp -135.09 133.89 21.18 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 20.3 Cg_exo -67.78 153.42 75.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.64 2.227 . . . . 0.0 113.045 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.63 76.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.257 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -136.01 123.01 21.43 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.537 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -113.74 -51.9 2.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 26.2 m-85 -127.65 109.69 11.94 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.503 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.42 178.56 5.32 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.867 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 m170 68.24 20.98 8.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 111.822 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 145.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.425 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.77 -41.48 17.55 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.949 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 65.1 mttp -145.54 162.81 36.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.029 0.442 . . . . 0.0 110.859 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -114.49 136.45 53.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.236 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 174.6 12.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD13 ' H ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -76.43 145.5 39.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.104 0.478 . . . . 0.0 111.56 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.26 149.75 31.75 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.681 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -84.59 95.01 8.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.18 119.67 6.11 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.139 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -110.32 -0.04 17.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.536 1.16 . . . . 0.0 107.922 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.25 160.5 33.34 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 156.6 -92.19 0.12 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.491 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.66 27.76 5.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.342 0.591 . . . . 0.0 109.817 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.32 -57.09 3.54 Favored Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.41 -2.428 0 C-N-CA 123.313 0.645 . . . . 0.0 109.292 176.178 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 120.711 0.291 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.23 139.57 16.89 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' HB3' ' HG3' ' A' ' 5' ' ' LYS . 8.9 mm-40 68.86 114.51 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.739 1.215 . . . . 0.0 109.406 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 2.9 p-10 -119.77 31.36 6.58 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' A' ' 3' ' ' GLU . 9.8 mtmp? -38.49 98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.317 -2.22 . . . . 0.0 113.753 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 26' ' ' GLY . 3.1 m -84.5 112.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.135 173.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -91.0 169.02 11.23 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -40.66 119.78 1.47 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 -172.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -158.37 146.2 18.27 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -133.21 15.38 4.16 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.51 1.147 . . . . 0.0 110.367 -172.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 81.2 mtt180 -107.56 115.65 30.53 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.44 -52.99 34.05 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-O 122.138 0.854 . . . . 0.0 111.784 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.3 mp0 -55.86 -25.21 41.26 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 126.107 1.763 . . . . 0.0 112.773 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 9.1 t0 -94.14 -43.86 8.28 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.01 73.34 Favored 'General case' 0 C--O 1.251 1.139 0 C-N-CA 124.583 1.153 . . . . 0.0 112.138 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.07 -24.4 64.55 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.881 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.73 -26.57 68.42 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 -45.36 12.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.427 0.632 . . . . 0.0 109.329 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -60.28 -35.59 75.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.184 176.043 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.96 -30.09 13.98 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.251 1.421 . . . . 0.0 111.862 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.61 -22.95 62.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.18 7.46 0.09 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.46 -1.353 . . . . 0.0 113.879 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.56 23.03 11.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.306 1.043 . . . . 0.0 111.765 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 36.7 mt -57.85 -66.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.471 -170.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.02 152.91 1.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.575 0.547 . . . . 0.0 110.642 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 6' ' ' VAL . . . -125.44 153.32 18.11 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.23 85.2 0.36 Allowed Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.21 150.47 32.28 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.31 0.576 . . . . 0.0 109.842 -177.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.3 pt -115.99 150.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.027 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -82.73 76.69 9.56 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.788 -171.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 37' ' ' CYS . 52.3 t -119.36 120.42 63.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.74 97.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.554 1.542 . . . . 0.0 114.498 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.5 p 62.02 9.82 3.29 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 127.013 2.125 . . . . 0.0 116.021 174.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -68.51 136.49 90.75 Favored Pre-proline 0 C--O 1.206 -1.235 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.68 4.02 0.98 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.169 2.579 . . . . 0.0 115.429 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.648 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 2.6 tpm_? -124.93 9.77 8.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.611 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' HA3' ' A' ' 8' ' ' GLY . 65.9 m -141.3 154.13 45.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.4 t -136.22 137.14 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.712 0.767 . . . . 0.0 109.587 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -119.26 177.13 5.01 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.459 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 73' ' ' LEU . 68.9 t -38.37 -40.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.021 1.451 . . . . 0.0 113.423 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.12 -58.93 5.18 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.611 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -74.36 -33.89 63.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.072 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -65.1 -31.64 72.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 1.2 tp60 -63.0 -35.6 80.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.85 -44.8 12.14 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.611 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.8 p -64.87 -30.61 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -69.47 -21.42 63.71 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.02 -9.29 58.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.196 0.522 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.99 -46.07 4.57 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.27 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.9 99.13 20.55 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.41 67.42 6.27 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.156 1.904 . . . . 0.0 112.247 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.98 165.88 10.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.528 174.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -77.65 161.67 27.62 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.679 0.218 . . . . 0.0 110.932 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.82 143.49 50.77 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 26' ' ' GLY . 10.2 p -133.65 156.26 41.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -126.34 136.54 9.59 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.767 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.511 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.5 t -123.94 128.54 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.455 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 32.8 t80 -171.59 162.04 6.33 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.258 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 83' ' ' ASN . 58.2 ttt180 -96.39 92.2 6.2 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 17.4 m120 -102.84 124.79 49.01 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -94.33 -46.09 7.19 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.184 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.67 124.61 29.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.67 -33.9 66.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.053 0.454 . . . . 0.0 110.278 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.93 64.2 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.684 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.78 -36.69 36.75 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.39 -48.37 77.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.506 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.3 t -60.23 -39.82 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.16 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 72' ' ' VAL . 20.8 t70 -54.34 -61.47 2.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 111.319 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.2 -38.93 92.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.253 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -35.08 79.89 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.492 0.495 . . . . 0.0 111.672 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.24 -50.98 11.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 54.8 t -61.26 -55.72 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.15 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 40' ' ' VAL . 86.7 mt -79.61 -8.51 59.23 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p 52.7 67.7 0.95 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.976 0.893 . . . . 0.0 111.907 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.18 -177.56 6.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.309 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.29 -36.92 1.88 Allowed 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.09 160.3 41.14 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 174.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.67 140.72 33.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.715 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -104.35 105.25 15.31 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.59 97.99 6.46 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -124.96 -22.77 4.4 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.154 0.502 . . . . 0.0 112.094 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.38 -55.96 1.62 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -168.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.454 ' HB3' ' HG3' ' A' ' 59' ' ' ARG . 20.6 p-10 -83.25 -69.91 0.6 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -159.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.308 36.0 mm-40 -88.67 -49.41 6.88 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -157.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -174.97 166.35 3.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 119.505 1.048 . . . . 0.0 109.448 -173.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.51 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 19.4 mm-40 -73.92 -48.45 30.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 71.4 mt -81.87 -12.8 58.29 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.138 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 91' ' ' THR . 23.3 t80 -59.62 -35.95 75.36 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.73 -34.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.727 0.775 . . . . 0.0 110.246 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 28.8 t70 -64.7 -22.96 67.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.594 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.1 m -83.54 -40.12 19.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.487 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.05 -43.65 66.81 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 122.976 0.51 . . . . 0.0 110.631 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.687 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.6 mmm180 -43.98 -39.2 3.92 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.438 1.495 . . . . 0.0 112.098 176.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.43 -44.45 35.81 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.091 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.39 -7.97 58.03 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.58 147.96 35.92 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.42 163.75 38.0 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.268 1.312 . . . . 0.0 109.2 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.46 66.88 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.146 0.579 . . . . 0.0 112.54 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -88.72 1.63 54.81 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.7 t -110.9 127.97 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -119.4 173.94 6.67 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.346 0.593 . . . . 0.0 111.99 -170.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.687 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.6 mp -126.05 133.08 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.502 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 49.2 m0 -121.52 157.31 30.95 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -100.4 116.22 31.85 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -68.6 110.78 4.39 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 169.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -69.57 93.92 0.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.765 0.793 . . . . 0.0 112.548 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -78.81 125.18 29.03 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.88 156.48 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 123.62 0.575 . . . . 0.0 111.554 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.81 139.91 2.75 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.89 153.73 21.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 m 76.89 25.97 0.81 Allowed 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.541 1.162 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.15 135.92 22.18 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.03 162.17 41.12 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 121.914 1.743 . . . . 0.0 111.176 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.87 77.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -97.54 121.65 39.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 27.6 mt-10 -125.41 -73.14 0.64 Allowed 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 85.7 m-85 -87.52 102.49 14.63 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -72.02 136.64 46.77 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . 0.295 18.0 m170 79.48 33.35 0.21 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 111.816 -2.447 . . . . 0.0 112.596 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.78 137.95 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.97 -48.02 48.02 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.787 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -150.84 162.44 40.75 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -111.89 149.15 32.27 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.484 HG22 HD23 ' A' ' 125' ' ' LEU . 11.0 p -133.33 178.77 5.14 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 125' ' ' LEU . 1.9 pt? -73.89 164.15 27.0 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 119.007 0.821 . . . . 0.0 109.944 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.407 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 10.6 t70 -65.85 109.67 2.57 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -105.51 19.21 20.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.38 175.52 34.67 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -146.67 106.97 4.03 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.05 114.83 2.67 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.08 139.01 9.68 Favored Glycine 0 C--N 1.298 -1.564 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.1 -27.58 13.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -114.64 177.27 17.41 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.172 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 121.49 0.662 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.75 -41.94 1.42 Allowed Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.49 -166.81 0.19 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.252 1.421 . . . . 0.0 113.512 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -132.02 38.46 3.51 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -57.88 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.861 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 m -91.26 138.0 20.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.67 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 73.6 m -91.09 170.0 10.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -31.35 106.61 0.02 OUTLIER Glycine 0 C--N 1.358 1.762 0 O-C-N 124.395 1.059 . . . . 0.0 115.725 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -120.02 144.02 47.76 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -113.82 -19.62 11.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.315 1.055 . . . . 0.0 110.583 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 98.9 mtt180 -92.48 117.49 29.99 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.197 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -64.84 -30.39 77.84 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.204 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 3.6 mm100 -73.43 -23.74 60.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 122.762 1.268 . . . . 0.0 108.195 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 5.7 t0 -88.49 -39.94 13.82 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.466 -174.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.67 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.307 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 52.1 mtmt -61.12 -28.05 68.82 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.985 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.54 63.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.734 0.302 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 4' ' ' ASN . . . -78.91 -39.98 33.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.996 0.903 . . . . 0.0 109.143 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -67.68 -30.74 70.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.174 175.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.31 -25.1 21.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.963 1.305 . . . . 0.0 111.847 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -14.04 62.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.839 0.456 . . . . 0.0 111.516 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.37 31.9 0.88 Allowed Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.07 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.61 36.64 24.04 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.94 -69.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.663 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.8 161.36 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 124.032 0.833 . . . . 0.0 110.244 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.01 150.55 17.01 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.06 75.58 0.28 Allowed Glycine 0 CA--C 1.494 -1.274 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.628 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 153.27 34.88 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.649 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.1 pt -116.88 157.32 17.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 50.5 m-85 -80.31 77.13 7.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.825 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 59.0 t -109.54 118.43 56.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.06 112.07 1.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.273 0.983 . . . . 0.0 112.355 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.3 p 64.05 26.4 14.02 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.196 1.798 . . . . 0.0 112.979 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -84.6 139.05 37.99 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.78 7.66 4.24 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.786 1.657 . . . . 0.0 112.13 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 9.7 ptm180 -118.54 -6.05 10.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.175 0.512 . . . . 0.0 109.902 174.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 79.4 m -151.22 119.6 6.4 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.28 137.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 122.113 0.959 . . . . 0.0 111.25 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.7 p-10 -104.78 169.14 8.62 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.39 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 ' HD2' ' A' ' 69' ' ' LYS . 99.5 t -47.76 -35.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 124.922 1.289 . . . . 0.0 112.391 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 41.2 mt-10 -66.67 -48.47 69.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.29 -40.85 67.26 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.284 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.06 64.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.838 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -59.69 -30.58 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.4 -51.51 6.18 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.3 -35.29 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.024 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -64.97 -24.29 67.47 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.68 19.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.04 -51.71 23.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.245 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -132.65 107.37 13.0 Favored Pre-proline 0 N--CA 1.407 -2.587 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.16 56.41 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.689 2.26 . . . . 0.0 113.397 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.7 pp -91.49 169.96 10.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 1.4 tm0? -85.63 146.95 26.62 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.49 144.94 44.55 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.384 0.611 . . . . 0.0 111.761 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.26 163.59 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.04 128.74 3.99 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.347 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 43.5 t -105.42 123.16 59.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -149.91 151.5 33.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.13 109.54 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.17 117.13 27.93 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.86 -59.91 1.76 Allowed 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.377 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -95.44 115.08 26.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -63.95 -30.98 51.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.212 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.84 -16.8 60.68 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.212 0.53 . . . . 0.0 110.092 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.2 t70 -85.29 -31.95 22.79 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.55 -43.75 80.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.202 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 63' ' ' ILE . 97.5 t -57.41 -43.94 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.9 t70 -52.39 -61.26 2.39 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.902 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 40' ' ' VAL . 45.2 mmtm -62.15 -44.58 96.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.253 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -63.76 -27.45 69.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.348 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -84.16 -60.31 2.13 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.135 0.574 . . . . 0.0 110.915 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -54.91 -55.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.616 0.766 . . . . 0.0 111.813 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -82.48 -21.58 35.51 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 17.0 m 61.8 84.76 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.001 0.905 . . . . 0.0 110.77 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.0 -170.17 2.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.86 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.575 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . . . -125.15 -40.53 2.14 Favored 'General case' 0 CA--C 1.462 -2.417 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.66 33.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.922 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.7 p -142.85 135.67 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.7 mp0 -101.29 116.98 34.05 Favored 'General case' 0 N--CA 1.386 -3.631 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.3 158.51 15.83 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.542 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -97.86 93.68 6.48 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -69.59 -12.83 67.62 Favored Glycine 0 C--N 1.311 -0.849 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -49.82 -26.57 4.09 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.072 0.949 . . . . 0.0 112.19 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -51.85 -45.78 64.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 37.1 tt0 -177.57 132.63 0.16 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -67.4 -35.53 79.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.085 0.945 . . . . 0.0 110.664 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.48 -15.62 57.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.591 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 38.8 t80 -68.62 -31.89 71.37 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.2 mp -64.34 -40.39 88.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.02 -13.64 62.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.79 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 93.9 m -86.98 -44.02 11.93 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.872 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -47.02 -48.08 22.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.783 0.433 . . . . 0.0 110.62 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.7 mpt_? -43.15 -31.1 0.53 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.24 -38.84 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.082 0.468 . . . . 0.0 111.419 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.99 -18.13 22.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.67 0.748 . . . . 0.0 112.496 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.42 129.3 30.75 Favored Pre-proline 0 C--N 1.27 -2.889 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.66 165.53 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.056 1.837 . . . . 0.0 110.264 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.54 -3.37 17.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.269 0.557 . . . . 0.0 111.139 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -79.87 -23.12 42.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.953 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.78 141.87 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.0 169.9 9.27 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.475 0.31 . . . . 0.0 110.37 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.615 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.0 mp -122.65 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.584 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.4 m0 -120.86 162.45 19.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -99.7 120.81 40.29 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.8 100.56 3.48 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.69 107.35 18.59 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.676 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.0 t -85.66 148.8 25.72 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.35 121.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.22 0.533 . . . . 0.0 112.272 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 128.35 6.82 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.95 -22.55 39.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.52 0.676 . . . . 0.0 110.552 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.4 m -91.81 138.42 31.56 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.55 116.58 57.73 Favored Pre-proline 0 C--N 1.314 -0.939 0 O-C-N 123.018 0.199 . . . . 0.0 110.633 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -79.38 133.83 10.94 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.245 1.963 . . . . 0.0 110.822 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.96 -37.89 54.36 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -172.75 147.63 1.77 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.158 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -117.46 -63.09 1.48 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -131.48 114.27 14.71 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -84.53 155.58 22.06 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.373 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 62.6 47.85 4.69 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.197 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.23 155.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.98 -25.4 34.81 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 103' ' ' TRP . 41.1 ttmt -169.76 163.41 9.86 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -127.9 144.46 51.1 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.48 175.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.18 135.38 47.55 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.27 115.16 10.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -111.41 151.42 28.53 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.55 -58.27 0.28 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -119.47 147.77 44.03 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.45 74.29 0.31 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.627 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.83 -52.16 9.9 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.96 79.64 1.47 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.79 -62.83 0.79 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -174.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.257 1.476 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.523 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 C--O 1.234 0.284 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.14 -112.02 3.49 Favored Glycine 0 CA--C 1.489 -1.581 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.02 156.09 39.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.014 174.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' CG ' ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -150.12 49.39 0.91 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 175.484 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.97 130.48 15.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.558 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 26.3 t -100.74 109.15 24.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.351 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.2 m -93.76 168.68 10.84 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -23.56 106.63 0.01 OUTLIER Glycine 0 C--N 1.371 2.503 0 O-C-N 124.496 1.123 . . . . 0.0 115.795 -171.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.2 tp -154.37 141.55 19.45 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -136.17 8.68 3.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.82 0.819 . . . . 0.0 109.238 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 95.1 mtt180 -92.43 112.79 24.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.53 -37.1 80.8 Favored Glycine 0 C--N 1.298 -1.556 0 O-C-N 123.194 0.308 . . . . 0.0 113.131 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.58 -26.89 65.61 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.184 0.994 . . . . 0.0 109.391 -177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.469 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 8.1 t0 -90.27 -39.01 13.02 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.105 -175.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.08 -42.45 89.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -62.34 -23.92 67.04 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.1 69.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.494 . . . . 0.0 110.28 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG ' ' A' ' 4' ' ' ASN . . . -79.01 -40.99 30.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.752 0.787 . . . . 0.0 110.346 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -68.9 -31.76 70.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.733 177.251 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.75 -16.18 47.26 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.08 -6.15 53.74 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.63 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 15.0 1.56 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.43 -1.366 . . . . 0.0 113.286 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.51 28.73 17.38 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.178 0.991 . . . . 0.0 110.783 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.69 -69.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.258 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.5 p90 -177.79 163.37 1.83 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 124.039 0.837 . . . . 0.0 109.184 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.96 126.8 5.56 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.93 85.25 0.82 Allowed Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -119.01 146.92 44.64 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CG2' ' HB ' ' A' ' 57' ' ' VAL 0.332 0.1 OUTLIER -116.92 148.92 19.32 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 179.653 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 52.8 m-85 -74.76 87.73 2.23 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.315 -174.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.7 t -117.59 120.86 66.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.02 106.56 0.17 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.537 1.148 . . . . 0.0 113.625 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.0 p 63.91 19.63 11.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.489 1.916 . . . . 0.0 114.189 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.8 p -87.15 146.57 40.57 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.749 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.28 13.52 2.07 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.049 1.833 . . . . 0.0 109.929 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -100.15 -25.84 14.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.123 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 82.8 m -155.97 141.75 17.97 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -106.16 137.7 35.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.287 -171.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.43 168.72 9.34 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.777 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 73' ' ' LEU . 4.5 p -52.76 -33.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 124.338 1.024 . . . . 0.0 111.781 -171.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -69.62 -42.1 74.8 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.704 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 46' ' ' VAL . 38.0 mt-30 -74.35 -41.34 61.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.768 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.08 66.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.39 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -64.29 -30.83 71.87 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.87 -42.3 27.69 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 42' ' ' GLN . 22.1 t -64.22 -35.37 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.935 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -16.3 64.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.39 -17.02 37.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.649 . . . . 0.0 109.586 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.82 -32.2 11.47 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.429 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 93.9 11.54 Favored Pre-proline 0 N--CA 1.39 -3.462 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.68 61.74 5.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.503 2.135 . . . . 0.0 111.739 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 19' ' ' TYR . 1.1 pp -100.88 173.15 6.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.935 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' ALA . 35.8 tt0 -79.69 138.01 37.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.1 0.56 . . . . 0.0 111.101 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 28' ' ' LEU . 22.8 m-85 -108.89 140.62 42.1 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.99 137.82 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -108.66 122.07 6.48 Favored Glycine 0 N--CA 1.412 -2.913 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.645 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 79' ' ' GLN . 15.2 t -114.23 106.46 20.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -160.54 146.17 14.87 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.55 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -91.19 91.88 8.42 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.48 159.4 26.98 Favored 'General case' 0 N--CA 1.387 -3.622 0 CA-C-O 123.427 1.584 . . . . 0.0 111.911 -173.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -110.63 -73.68 0.67 Allowed 'General case' 1 C--N 1.23 -4.625 0 CA-C-N 110.792 -2.913 . . . . 0.0 111.105 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.01 132.78 36.76 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 92' ' ' LEU . 10.6 tt -67.44 -31.16 51.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.78 -19.72 65.13 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 18.6 t70 -82.42 -39.98 21.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.491 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -46.98 85.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.974 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 63' ' ' ILE . 75.5 t -60.39 -40.18 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.624 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -56.26 -61.64 2.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.78 177.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 44.1 mmtm -62.34 -40.36 96.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.382 0.273 . . . . 0.0 111.448 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.85 -41.1 97.42 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.299 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -80.46 -48.71 12.43 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.681 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 68' ' ' ASP . 81.3 t -56.13 -54.94 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 123.403 0.44 . . . . 0.0 111.286 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.623 ' HB2' HG23 ' A' ' 40' ' ' VAL . 47.7 tp -82.54 -14.26 55.22 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.302 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 t 61.95 63.9 1.06 Allowed 'General case' 0 C--O 1.254 1.317 0 CA-C-O 121.891 0.853 . . . . 0.0 109.279 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.479 HD21 HD23 ' A' ' 73' ' ' LEU . 92.3 mt -66.18 179.63 0.92 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.358 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' CB ' ' HG3' ' A' ' 53' ' ' GLN . . . -125.13 -39.73 2.21 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -142.01 156.35 45.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.417 173.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 102' ' ' ILE . 7.3 p -140.38 141.95 32.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.632 HE22 ' HB2' ' A' ' 103' ' ' TRP . 7.9 mm100 -104.12 109.45 21.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 122.971 0.508 . . . . 0.0 111.664 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 92' ' ' LEU . 3.2 mm? -114.48 136.99 52.4 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 175.88 -29.7 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.301 0 CA-C-O 121.678 0.751 . . . . 0.0 109.899 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.02 -55.67 1.95 Allowed Glycine 0 C--N 1.286 -2.228 0 N-CA-C 119.749 2.659 . . . . 0.0 119.749 -166.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -82.55 -69.76 0.6 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 119.316 3.08 . . . . 0.0 119.316 -160.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.52 -49.6 6.58 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -161.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 1.0 OUTLIER -168.09 172.27 8.88 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 36.3 mt-30 -76.87 -48.99 16.75 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.387 1.075 . . . . 0.0 108.867 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.2 mt -75.96 -13.97 60.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.691 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.472 ' O ' ' HB ' ' A' ' 91' ' ' THR . 25.9 t80 -59.03 -37.07 76.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.673 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 80' ' ' LEU . 1.8 mp -65.53 -34.45 70.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 21.4 t70 -69.1 -22.73 63.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 87.2 m -83.8 -44.33 14.48 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.115 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.54 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -44.86 -50.12 10.5 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -54.15 -29.18 44.48 Favored 'General case' 0 N--CA 1.516 2.825 0 CA-C-O 121.284 0.564 . . . . 0.0 112.258 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 28.5 mt-10 -76.72 -30.44 56.64 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.521 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 -9.25 19.02 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.559 0.695 . . . . 0.0 112.561 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.6 tp -94.85 129.29 36.4 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.525 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.0 165.1 22.53 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.828 1.685 . . . . 0.0 111.153 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.93 -5.15 32.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.159 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.1 m80 -81.01 -29.4 35.17 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 70' ' ' ALA . 38.9 t -108.06 135.37 46.99 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.042 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.11 169.02 8.81 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 94.4 mt -122.94 128.27 75.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.632 ' HB2' HE22 ' A' ' 79' ' ' GLN . 41.8 m0 -116.74 161.01 19.92 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.221 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' HG11 ' A' ' 120' ' ' VAL . 7.9 tmtm? -102.5 112.21 24.84 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.85 115.56 13.43 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.8 94.95 8.83 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -70.22 141.59 52.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.504 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.0 m -75.06 124.53 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.526 0.679 . . . . 0.0 111.017 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.9 173.21 39.93 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -92.19 -36.02 13.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 117.15 0.475 . . . . 0.0 112.218 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 t -83.38 120.86 26.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.9 mt -118.9 104.66 46.42 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.592 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.99 144.46 23.98 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.455 2.103 . . . . 0.0 109.723 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.5 73.73 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -125.34 144.12 50.65 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -131.31 -70.94 0.58 Allowed 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 75.7 m-85 -124.5 113.91 18.73 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -98.13 169.49 9.57 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HB3' ' NH2' ' A' ' 93' ' ' ARG . 37.3 t60 63.51 31.96 14.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 104' ' ' LYS . 31.5 m -83.15 154.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.947 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.76 -41.22 62.76 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.158 0.504 . . . . 0.0 110.454 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -150.32 163.02 39.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.48 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.83 137.43 54.93 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.59 171.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.86 177.83 8.79 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.79 77.46 0.46 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -87.58 -4.82 58.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 122.243 1.02 . . . . 0.0 109.86 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -178.58 160.32 26.12 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 106.162 -2.775 . . . . 0.0 106.162 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -158.47 128.91 6.09 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 118.715 1.258 . . . . 0.0 109.949 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.27 119.98 1.44 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 165.68 -179.13 40.17 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.49 152.89 27.12 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.935 0.368 . . . . 0.0 110.175 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.28 -50.19 0.41 Allowed Glycine 0 C--N 1.298 -1.577 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.779 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.578 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.5 -0.977 0 CA-C-O 122.237 1.017 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 12.4 ptpt -91.55 97.6 11.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.46 146.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.741 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 p -87.7 170.13 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.29 122.12 2.36 Favored Glycine 0 CA--C 1.482 -1.98 0 O-C-N 124.117 0.886 . . . . 0.0 114.886 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 14' ' ' ASP . 25.1 tp -140.72 128.54 21.77 Favored 'General case' 0 N--CA 1.399 -2.978 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -120.77 12.83 11.44 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 123.093 1.425 . . . . 0.0 109.439 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 33.2 mtp85 -108.65 112.34 24.61 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.504 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.94 66.74 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 116.552 -0.295 . . . . 0.0 113.793 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.618 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -72.22 -20.03 61.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.274 1.035 . . . . 0.0 108.887 -177.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.508 ' HB3' HD21 ' A' ' 9' ' ' LEU . 1.3 m-20 -95.53 -45.3 7.13 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.659 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.36 72.53 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.81 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -59.11 -23.94 62.54 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.27 71.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -35.05 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.218 1.009 . . . . 0.0 108.772 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -68.43 -38.27 81.05 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.332 176.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.9 -26.19 62.22 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.219 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.46 -23.66 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.146 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' HA3' HG13 ' A' ' 24' ' ' ILE . . . 176.0 -25.88 0.06 OUTLIER Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.038 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 63.85 21.1 12.52 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-O 121.875 0.845 . . . . 0.0 109.597 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.578 ' HB ' HD21 ' A' ' 4' ' ' ASN . 25.0 mt -70.52 -60.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.041 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.04 151.31 0.66 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.707 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -117.8 159.62 14.09 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.54 79.98 0.26 Allowed Glycine 0 CA--C 1.505 -0.575 0 CA-C-N 117.535 0.667 . . . . 0.0 111.934 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.59 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.44 149.3 40.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.135 0.493 . . . . 0.0 109.986 -174.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.3 mt -117.65 150.19 19.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.244 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 7.9 m-85 -81.87 75.47 8.81 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.194 0.308 . . . . 0.0 111.702 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 87.9 t -98.48 122.13 49.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.69 108.84 0.23 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.271 1.028 . . . . 0.0 113.629 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.7 p 62.55 26.59 15.8 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.586 1.954 . . . . 0.0 114.234 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -90.56 139.83 26.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.2 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.18 16.12 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.244 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -125.57 -3.81 7.23 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.13 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 87.4 m -156.7 120.72 4.35 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.0 137.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 122.27 1.033 . . . . 0.0 111.978 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.4 p-10 -103.52 170.69 7.79 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.08 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 p -43.64 -39.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.611 1.194 . . . . 0.0 112.687 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 44.3 mt-10 -68.81 -48.66 63.02 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.626 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.662 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.2 mt-30 -68.64 -40.15 80.41 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.526 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.54 -40.26 74.79 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -64.91 -29.65 70.61 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.12 -45.16 24.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.894 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 42' ' ' GLN . 48.2 t -59.53 -36.37 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.124 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -71.24 -8.1 51.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.0 -7.24 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.495 0.664 . . . . 0.0 109.304 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.23 -48.15 3.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.207 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -134.91 104.73 10.6 Favored Pre-proline 0 N--CA 1.41 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.42 61.66 3.49 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 123.008 2.472 . . . . 0.0 113.073 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.79 144.39 28.92 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.306 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.629 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -73.5 154.93 39.7 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.131 0.972 . . . . 0.0 109.361 -175.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -118.22 155.39 30.6 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 112.494 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 26' ' ' GLY . 8.4 p -131.19 164.52 34.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.2 147.2 18.9 Favored Glycine 0 C--O 1.204 -1.778 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 45.7 t -125.34 106.35 16.19 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -152.63 140.1 19.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.256 -1.778 . . . . 0.0 112.103 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 4.5 ptt180 -103.18 95.28 6.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.06 151.57 22.37 Favored 'General case' 1 N--CA 1.369 -4.515 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.562 -170.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -85.22 -49.11 8.47 Favored 'General case' 1 C--N 1.233 -4.474 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -99.1 129.08 45.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.998 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' VAL . 11.7 tt -67.55 -32.82 58.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.169 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -19.16 63.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 37.2 t70 -83.01 -27.1 30.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.277 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.03 -43.56 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 63' ' ' ILE . 50.9 t -59.54 -41.21 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.386 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.562 ' O ' HG23 ' A' ' 72' ' ' VAL . 19.3 t70 -50.72 -55.99 14.06 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.611 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 40.9 mmtm -66.02 -44.65 84.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.575 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.85 -35.28 68.68 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.973 0.796 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.91 -58.46 2.78 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.474 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 68' ' ' ASP . 68.0 t -49.4 -58.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.447 0.699 . . . . 0.0 112.746 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.2 -16.59 37.28 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 27.7 t 62.28 88.84 0.09 Allowed 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 124.606 1.191 . . . . 0.0 109.059 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.489 ' HG ' ' HA ' ' A' ' 70' ' ' ALA . 77.7 mt -84.07 177.01 8.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.93 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.629 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . . . -115.6 -40.68 3.35 Favored 'General case' 0 CA--C 1.451 -2.85 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -147.05 164.76 31.99 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.892 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.78 135.23 25.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.35 117.3 32.45 Favored 'General case' 0 N--CA 1.388 -3.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.064 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.22 129.98 45.49 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.649 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.1 m-70 -82.76 103.03 11.94 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -61.42 -12.95 34.83 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.367 -172.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -58.97 -25.78 63.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.993 1.317 . . . . 0.0 111.364 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -59.82 -48.64 80.87 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.89 150.99 0.82 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 49.4 mt-30 -76.2 -43.41 42.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.98 0.895 . . . . 0.0 111.73 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.45 -21.56 35.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.396 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.9 t80 -57.12 -46.81 82.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.853 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.492 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.0 mt -61.02 -38.71 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 109.558 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.652 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 17.9 t70 -66.99 -19.54 65.73 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.705 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.6 m -89.17 -45.71 9.36 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.972 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -43.41 -50.0 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -67.05 -14.23 62.7 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.42 -35.37 27.67 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.98 20.07 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.013 0.911 . . . . 0.0 111.384 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.64 118.17 70.95 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.789 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.76 165.6 20.49 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.937 2.425 . . . . 0.0 111.076 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.14 4.12 1.78 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -84.81 -29.58 25.26 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.81 133.25 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -112.45 -179.74 3.75 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 88.2 mt -126.71 134.57 65.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.8 m0 -119.89 147.14 45.07 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 118.12 36.33 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.58 106.24 2.52 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.234 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp . . . . . 0 N--CA 1.417 -2.081 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.842 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 72.9 m-85 . . . . . 0 CA--C 1.484 -1.56 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -111.71 -170.85 1.73 Allowed 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.944 0.777 . . . . 0.0 110.546 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.4 m80 69.82 19.97 6.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.462 1.105 . . . . 0.0 109.469 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -96.95 156.55 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.272 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.87 -40.8 38.86 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 120.843 0.354 . . . . 0.0 111.331 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 64.0 mttp -147.99 161.28 41.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.25 127.3 55.57 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 m -129.65 173.55 13.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.4 pt? . . . . . 0 C--N 1.303 -1.448 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 18' ' ' ALA . 63.6 t30 . . . . . 0 CA--C 1.495 -1.148 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 37.6 ttpt -43.9 114.28 0.64 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.725 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 m -117.63 140.72 39.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.213 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.7 m -91.69 168.48 11.45 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 117.354 -1.307 . . . . 0.0 107.995 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.15 106.01 0.01 OUTLIER Glycine 0 C--N 1.385 3.257 0 O-C-N 125.3 1.625 . . . . 0.0 116.036 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -135.19 130.53 35.46 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -174.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -126.4 -18.9 4.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -81.2 117.06 21.42 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.688 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -44.9 -59.3 4.47 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 124.184 0.897 . . . . 0.0 114.513 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.753 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -56.8 -25.92 56.72 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 177.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB2' HD11 ' A' ' 9' ' ' LEU . 1.8 m-20 -84.15 -34.87 23.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 9' ' ' LEU . . . -67.08 -42.24 85.0 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.332 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 49.2 mtmt -58.9 -30.39 67.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.515 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.21 70.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.622 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HA ' HD22 ' A' ' 4' ' ' ASN . . . -77.07 -35.96 56.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.909 0.861 . . . . 0.0 109.784 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -74.82 -30.56 61.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.841 178.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.8 -14.14 30.28 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.783 0.801 . . . . 0.0 112.102 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.66 -13.52 61.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.978 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.49 26.26 0.98 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.12 27.64 11.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.45 1.1 . . . . 0.0 112.062 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.97 -68.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.802 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.523 ' OH ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -178.87 162.12 1.27 Allowed 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.314 1.009 . . . . 0.0 109.151 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.05 150.53 17.21 Favored Glycine 0 C--N 1.313 -0.708 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . -116.84 71.29 0.28 Allowed Glycine 0 CA--C 1.475 -2.441 0 C-N-CA 118.612 -1.756 . . . . 0.0 112.559 -170.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -108.97 130.78 55.47 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.357 0.598 . . . . 0.0 110.233 -179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.0 pt -102.39 155.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -77.95 74.16 4.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.009 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.7 t -103.2 117.35 48.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 170.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.91 114.24 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.71 1.256 . . . . 0.0 112.826 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.9 p 69.72 17.95 7.63 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 126.181 1.792 . . . . 0.0 113.681 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -83.24 141.41 42.86 Favored Pre-proline 0 N--CA 1.419 -2.014 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.41 4.38 4.09 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.683 1.589 . . . . 0.0 111.193 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.75 5.74 10.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 110.298 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 80.7 m -156.17 117.81 3.93 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 28' ' ' LEU . 1.5 t -102.74 137.0 32.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.947 0.88 . . . . 0.0 112.381 -168.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.46 166.34 10.62 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.838 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.5 p -45.01 -31.93 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.315 1.446 . . . . 0.0 113.143 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.7 -59.69 3.96 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 123.294 0.637 . . . . 0.0 111.955 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.52 -33.4 71.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.663 0.744 . . . . 0.0 110.12 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.923 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.45 -26.44 68.44 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.067 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB2' HE21 ' A' ' 44' ' ' GLN . 3.4 tp-100 -63.68 -32.97 74.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.921 0.867 . . . . 0.0 109.493 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.26 -43.25 13.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.434 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.923 HG12 ' HA ' ' A' ' 43' ' ' ALA . 9.5 p -70.42 -24.28 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.319 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -15.9 63.4 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.468 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.6 -24.95 28.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.585 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.43 -45.47 12.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.13 104.94 18.05 Favored Pre-proline 0 N--CA 1.394 -3.227 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.53 56.23 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.901 2.401 . . . . 0.0 111.963 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pp -97.09 177.19 5.67 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.215 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.51 128.64 34.52 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.752 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 28' ' ' LEU . 66.6 m-85 -96.85 127.32 42.72 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 26' ' ' GLY . 9.8 p -119.14 149.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.04 128.14 7.27 Favored Glycine 0 C--N 1.285 -2.256 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.321 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.95 107.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -165.28 158.63 16.51 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.649 -1.22 . . . . 0.0 109.836 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' HB2' ' A' ' 81' ' ' HIS . 47.2 mtm180 -90.16 93.42 9.36 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB2' HG22 ' A' ' 66' ' ' VAL . 16.3 m120 -96.75 117.6 31.39 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -80.25 -31.32 38.45 Favored 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.533 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -99.19 123.62 43.62 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 91' ' ' THR . 7.8 tt -61.9 -34.55 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.4 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.88 -20.25 61.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.176 0.512 . . . . 0.0 110.014 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.38 -35.44 30.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.949 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 60' ' ' ASN . 26.1 t -64.9 -47.2 89.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 63' ' ' ILE . 80.5 t -60.1 -42.21 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.78 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 72' ' ' VAL . 31.1 t70 -53.87 -59.89 4.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.316 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -67.49 -39.84 85.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.298 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.96 -37.91 86.52 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 123.633 0.583 . . . . 0.0 111.172 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -73.14 -60.6 2.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.604 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.6 t -55.69 -53.76 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.982 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 73' ' ' LEU . 1.5 tm? -72.9 -29.28 63.02 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.298 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.4 t 67.75 74.88 0.3 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.388 1.09 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 73' ' ' LEU . 91.6 mt -77.81 -168.4 1.22 Allowed 'General case' 0 C--O 1.249 1.074 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.633 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.7 -52.39 1.24 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.19 162.4 31.87 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.722 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.83 136.65 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.561 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.1 mp0 -105.21 115.03 29.58 Favored 'General case' 0 N--CA 1.394 -3.259 0 C-N-CA 123.177 0.591 . . . . 0.0 110.69 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.74 123.31 43.86 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 46.8 m-70 -77.77 108.72 11.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 175.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -51.9 -11.78 1.03 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -51.62 -26.1 8.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.422 1.089 . . . . 0.0 111.932 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -69.12 -49.34 57.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.686 0.279 . . . . 0.0 111.718 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.5 147.88 0.32 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -79.45 -46.0 18.33 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 122.078 0.942 . . . . 0.0 111.35 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 42.3 mt -78.98 -14.32 59.27 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.219 -173.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.2 t80 -60.78 -39.9 90.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.347 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.576 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -61.38 -38.07 79.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-O 121.817 0.818 . . . . 0.0 109.967 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 18.2 t70 -65.99 -19.78 65.97 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.328 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.562 HG22 ' CD1' ' A' ' 63' ' ' ILE . 84.2 m -88.03 -41.94 12.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.922 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 2.6 mm? -51.77 -39.23 58.23 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 122.602 0.361 . . . . 0.0 111.359 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.73 ' HD2' HD12 ' A' ' 102' ' ' ILE . 7.9 mmm180 -46.0 -39.92 9.76 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.734 1.214 . . . . 0.0 111.546 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.07 -33.27 33.52 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.627 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.52 -21.04 18.54 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.705 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.62 141.88 42.2 Favored Pre-proline 0 C--N 1.285 -2.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.228 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.45 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 35.5 Cg_endo -69.11 165.03 31.63 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 121.968 1.778 . . . . 0.0 110.363 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -12.11 61.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.706 0.765 . . . . 0.0 110.343 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 97' ' ' PRO . 3.2 m-70 -76.26 -29.13 57.36 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.292 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 70' ' ' ALA . 85.6 t -105.9 132.73 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 CA-C-O 121.196 0.522 . . . . 0.0 109.698 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.77 168.75 8.94 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.413 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.73 HD12 ' HD2' ' A' ' 93' ' ' ARG . 66.6 mt -123.95 132.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.561 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.7 m0 -120.58 157.65 29.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -100.61 111.53 23.78 Favored 'General case' 0 C--N 1.276 -2.587 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 110.39 4.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp . . . . . 0 C--N 1.292 -1.929 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.221 -173.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CE1' ' HA3' ' A' ' 82' ' ' GLY . 31.5 m-85 . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -93.7 167.17 11.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.454 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.5 m80 74.12 18.62 3.12 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.448 1.092 . . . . 0.0 111.668 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.06 147.13 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 -42.66 25.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.89 0.376 . . . . 0.0 111.909 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.1 ttmt -149.27 163.3 38.05 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.05 139.18 54.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.04 165.75 30.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 C--N 1.311 -1.078 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.137 -179.878 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.542 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.508 -0.662 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -72.7 114.42 10.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.72 -174.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 41.5 t -90.4 118.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.319 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.38 169.16 9.53 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -32.08 106.55 0.02 OUTLIER Glycine 0 C--N 1.364 2.101 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 -171.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -138.63 134.12 33.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -133.78 14.48 4.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.54 1.162 . . . . 0.0 109.738 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 65.9 mtt180 -107.13 112.22 25.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.32 -39.74 65.92 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 123.642 0.639 . . . . 0.0 113.963 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.44 -19.23 42.9 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.7 0.8 . . . . 0.0 111.082 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' HD11 ' A' ' 9' ' ' LEU . 9.7 t70 -87.71 -46.02 9.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.11 72.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.646 1.178 . . . . 0.0 111.367 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -22.39 66.02 Favored 'General case' 0 C--O 1.19 -2.036 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.15 71.32 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.853 0.297 . . . . 0.0 111.567 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.6 -35.75 39.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.279 1.038 . . . . 0.0 109.468 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -70.68 -31.11 67.89 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.687 174.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 -35.23 79.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.091 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.0 64.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.137 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.65 -20.43 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.373 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . . . 64.78 26.77 13.02 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-O 121.75 0.786 . . . . 0.0 108.882 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.542 ' HB ' HD21 ' A' ' 4' ' ' ASN . 30.9 mt -67.28 -64.56 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.796 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.41 154.8 1.04 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.735 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 137.67 9.64 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.75 80.62 0.28 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.985 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.493 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -104.84 150.2 25.03 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.557 0.694 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.281 5.5 pt -105.91 151.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.968 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 78.1 m-85 -80.08 60.42 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.884 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.33 113.85 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 117.401 -1.719 . . . . 0.0 107.447 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.71 118.47 7.71 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.635 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p 63.8 29.82 14.67 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.566 1.546 . . . . 0.0 112.91 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -99.85 127.62 33.28 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.32 18.72 1.16 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.566 2.177 . . . . 0.0 111.682 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -118.18 -8.26 10.66 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.899 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 62.0 m -140.54 171.13 14.55 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.473 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.2 t -136.61 136.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 119.245 0.93 . . . . 0.0 108.653 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.85 174.68 5.76 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.105 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -45.82 -31.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.897 1.279 . . . . 0.0 113.122 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.58 -62.22 1.64 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.633 0.73 . . . . 0.0 110.659 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 25.0 mt-30 -64.47 -42.04 96.14 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.274 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -25.23 68.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.91 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -24.28 64.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 109.629 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.84 -49.93 7.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' GLN . 46.7 t -55.36 -35.34 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.786 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptp -58.9 -31.09 68.3 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.6 29.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.408 0.623 . . . . 0.0 110.307 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.32 -39.79 14.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -145.81 97.22 4.6 Favored Pre-proline 0 N--CA 1.401 -2.893 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.12 71.39 0.86 Allowed 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.406 2.071 . . . . 0.0 113.114 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.17 147.24 29.27 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.776 173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.99 145.42 48.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.513 -173.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.64 142.03 45.72 Favored 'General case' 0 C--O 1.253 1.256 0 CA-C-O 121.838 0.828 . . . . 0.0 112.306 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 152.24 34.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.48 149.85 17.0 Favored Glycine 0 C--O 1.2 -1.979 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.2 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.9 t -133.91 123.39 44.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -172.43 156.84 3.85 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.665 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.453 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 31.2 mtm180 -95.71 92.06 6.4 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -104.27 121.17 42.76 Favored 'General case' 0 N--CA 1.406 -2.631 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.56 -31.92 36.78 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.311 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.55 110.63 19.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.238 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.68 HG13 HD13 ' A' ' 92' ' ' LEU . 6.8 tt -58.32 -38.36 68.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.521 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.5 62.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.318 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 16.9 t70 -86.22 -31.19 21.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.155 0.502 . . . . 0.0 109.994 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.54 -46.15 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.0 t -62.57 -39.87 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.256 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 25.8 t70 -52.55 -58.82 5.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.879 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -66.98 -40.92 87.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.842 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.75 -30.77 71.0 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.367 0.667 . . . . 0.0 111.276 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -83.53 -58.74 2.69 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.794 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 59.0 t -54.4 -57.92 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.478 0.486 . . . . 0.0 111.291 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 75' ' ' LEU . 29.8 tp -77.76 -17.14 57.85 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.72 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m 59.09 72.21 0.54 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.985 0.897 . . . . 0.0 111.314 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 73' ' ' LEU . 71.4 mt -79.11 -172.44 3.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.206 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.467 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -126.68 -35.13 2.35 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.306 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -149.37 166.03 30.25 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.51 135.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -101.44 108.36 19.93 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-O 121.68 0.752 . . . . 0.0 109.602 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 92' ' ' LEU . 72.5 mt -90.53 120.54 31.7 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.102 -1.408 . . . . 0.0 107.595 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB3' ' CG ' ' A' ' 59' ' ' ARG . 8.8 t60 -83.37 85.85 7.16 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -49.22 -9.14 0.11 Allowed Glycine 0 N--CA 1.47 0.919 0 C-N-CA 128.325 2.869 . . . . 0.0 120.029 -168.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -39.0 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.83 -48.72 79.32 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -175.11 148.65 1.01 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -78.12 -39.21 42.0 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.9 mt -82.69 -15.98 49.88 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.554 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.568 ' O ' ' HB ' ' A' ' 91' ' ' THR . 19.0 t80 -61.29 -39.63 91.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.43 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -63.73 -34.9 70.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.929 0.871 . . . . 0.0 109.626 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.0 t70 -69.56 -18.41 63.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.455 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.576 HG22 ' CD1' ' A' ' 63' ' ' ILE . 63.1 m -83.79 -41.45 17.56 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.299 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.68 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -52.69 -41.71 64.13 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 123.272 0.629 . . . . 0.0 110.806 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.742 ' HD2' HD12 ' A' ' 102' ' ' ILE . 4.2 mmm180 -43.74 -44.44 6.61 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.11 1.364 . . . . 0.0 112.4 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -75.25 -24.27 57.62 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.913 -171.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -103.18 -3.57 25.59 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.819 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.4 tp -80.55 130.61 64.12 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 124.567 1.147 . . . . 0.0 109.567 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.49 162.52 37.94 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.379 1.386 . . . . 0.0 109.404 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.82 64.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -76.15 -30.27 58.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.6 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.511 HG21 ' HB1' ' A' ' 70' ' ' ALA . 40.5 t -104.57 147.44 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.468 0 CA-C-O 121.112 0.482 . . . . 0.0 110.109 -171.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -121.13 174.67 6.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 123.796 0.838 . . . . 0.0 108.761 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.742 HD12 ' HD2' ' A' ' 93' ' ' ARG . 92.6 mt -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 34.9 m0 -120.57 157.61 29.12 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.885 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -101.81 116.64 33.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.79 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.3 98.8 3.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 172.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt . . . . . 0 C--N 1.3 -1.563 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.113 -173.821 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 95.8 m-85 . . . . . 0 CA--C 1.474 -1.956 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 90' ' ' ASP . 3.7 pm0 -72.9 163.81 27.58 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.585 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.506 ' CE1' ' HG3' ' A' ' 93' ' ' ARG . 5.9 t-160 65.35 38.47 5.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.98 0.895 . . . . 0.0 110.641 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -102.17 155.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.83 -39.5 15.82 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.783 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -155.53 163.02 40.55 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.52 144.38 50.89 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.788 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.42 175.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.294 -1.838 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.001 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.57 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.102 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 15.0 ptpt -77.79 98.11 5.44 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.003 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 78.1 t -72.64 109.24 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.765 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.7 m -92.07 170.94 9.44 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -50.61 116.3 4.13 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.672 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.57 176.65 6.08 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -123.93 -0.92 8.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.82 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 88.9 mtt180 -126.94 115.6 19.51 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.24 82.09 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-O 122.599 1.11 . . . . 0.0 112.32 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.3 mp0 -70.84 -40.18 72.52 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 125.604 1.562 . . . . 0.0 108.96 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 33.0 t70 -74.98 -26.85 59.88 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.507 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -46.02 61.18 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.711 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 22.4 pttp -67.66 -23.61 65.35 Favored 'General case' 0 C--O 1.199 -1.555 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.26 70.05 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.997 0.427 . . . . 0.0 110.693 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 4' ' ' ASN . . . -74.68 -42.46 58.41 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.101 0.953 . . . . 0.0 109.586 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -68.44 -32.71 72.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.949 176.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.8 -32.11 70.37 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.17 -25.05 54.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.702 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.92 -28.91 0.02 OUTLIER Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.093 -1.527 . . . . 0.0 113.009 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 62.46 30.74 17.28 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.921 0.867 . . . . 0.0 108.78 -176.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.57 ' HB ' HD21 ' A' ' 4' ' ' ASN . 40.5 mt -70.75 -59.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.635 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 2.3 p90 -176.2 160.53 2.21 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.899 0.749 . . . . 0.0 109.9 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -128.79 123.05 4.15 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.4 85.68 0.67 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.17 151.84 33.68 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 4.9 pt -116.58 146.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.031 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -80.32 80.39 6.76 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.051 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.8 t -107.37 114.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.52 118.96 6.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.614 1.196 . . . . 0.0 110.874 -173.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.3 p 66.43 29.25 9.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.718 1.607 . . . . 0.0 113.136 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 40.8 t -92.84 143.69 27.34 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -91.2 0.16 4.78 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 121.52 1.48 . . . . 0.0 112.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 69.7 ttt180 -122.33 6.46 9.63 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 122.17 0.986 . . . . 0.0 109.475 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 57.3 m -146.81 125.57 12.62 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.6 t -105.59 137.15 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.918 0.865 . . . . 0.0 112.844 -172.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -107.4 172.63 6.72 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.593 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 p -49.64 -32.09 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.583 0.753 . . . . 0.0 112.5 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 53.1 mp0 -62.1 -60.8 3.07 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.6 mt-30 -69.97 -32.72 71.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.188 177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.82 -23.65 67.44 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.258 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -26.36 68.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.489 0.662 . . . . 0.0 109.396 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.28 -49.28 9.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' GLN . 32.3 t -61.47 -32.26 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.963 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.667 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 22.9 ptm -64.35 -23.55 67.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.916 0.389 . . . . 0.0 111.868 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.57 -20.26 21.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.347 0.594 . . . . 0.0 109.482 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.49 -53.77 5.2 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.383 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -133.65 92.84 22.4 Favored Pre-proline 0 N--CA 1.391 -3.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.23 53.55 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.818 2.345 . . . . 0.0 112.183 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -89.81 162.94 15.25 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.058 176.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 4.7 tt0 -64.23 131.53 47.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.512 0.725 . . . . 0.0 110.718 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 54.5 m-85 -102.85 142.26 34.27 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.095 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.9 138.25 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -113.91 128.73 8.41 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.455 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.97 106.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -163.19 168.02 21.28 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.286 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -85.85 104.77 15.82 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -100.87 150.42 22.85 Favored 'General case' 1 N--CA 1.375 -4.181 0 CA-C-O 122.339 1.066 . . . . 0.0 109.479 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -113.69 -65.97 1.13 Allowed 'General case' 1 C--N 1.235 -4.38 0 CA-C-N 112.165 -2.289 . . . . 0.0 110.402 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -89.32 119.73 30.04 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.823 0.82 . . . . 0.0 111.904 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 92' ' ' LEU . 15.1 tt -66.86 -32.56 58.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.162 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.6 61.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.242 0.544 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.5 -49.75 7.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.555 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.15 -35.76 74.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.039 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.87 -30.9 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.144 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 72' ' ' VAL . 24.2 t70 -72.1 -38.23 69.37 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -65.68 -45.94 80.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -62.51 -23.67 67.08 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.231 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 30.7 ttmt -80.41 -59.1 2.82 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 124.193 0.997 . . . . 0.0 109.784 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 68' ' ' ASP . 65.5 t -59.13 -60.03 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.227 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 1.4 mm? -78.3 -8.2 58.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.985 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.1 p 52.32 73.29 0.34 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.719 0.771 . . . . 0.0 111.985 -172.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.41 173.55 3.22 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.243 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.69 -34.63 2.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.52 46.3 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.486 168.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.68 135.61 39.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.42 117.22 33.96 Favored 'General case' 0 N--CA 1.399 -3.016 0 CA-C-O 121.134 0.492 . . . . 0.0 110.886 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.438 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -96.92 128.2 43.65 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.073 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -83.28 95.48 8.18 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.499 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -61.01 -12.93 31.87 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -171.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -54.75 -26.38 33.85 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 117.668 0.734 . . . . 0.0 112.532 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -56.08 -45.69 79.26 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 89' ' ' ILE . 10.3 tp10 -175.74 135.45 0.3 Allowed 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 123.807 0.843 . . . . 0.0 109.007 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -66.28 -44.16 84.36 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.094 1.357 . . . . 0.0 111.06 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.73 -19.97 47.54 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.465 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . 32.6 t80 -65.07 -36.79 85.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.241 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.9 mp -63.32 -41.51 93.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.51 -21.38 66.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.4 m -81.37 -45.12 16.59 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.457 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.06 -46.22 8.41 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.479 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 4.5 mpt_? -55.0 -23.78 21.07 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.2 -39.35 21.08 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.134 0.493 . . . . 0.0 111.452 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.33 -2.69 58.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.412 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.14 120.57 82.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.231 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.35 163.66 35.81 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.485 1.457 . . . . 0.0 109.718 173.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.1 -7.64 37.89 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -80.69 -30.65 36.41 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.608 0.718 . . . . 0.0 109.753 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 70' ' ' ALA . 18.9 t -104.0 146.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.274 -170.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 168.69 10.71 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.516 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.438 HG23 HD23 ' A' ' 80' ' ' LEU . 79.6 mt -123.07 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.562 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.0 m0 -125.0 164.37 20.31 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 130.96 53.39 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.44 106.87 2.25 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.961 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.417 -2.083 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 . . . . . 0 N--CA 1.427 -1.618 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.411 ' H ' ' NE2' ' A' ' 118' ' ' GLN . 0.5 OUTLIER -108.37 177.04 4.91 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.418 -175.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.3 t60 73.25 28.42 1.83 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.212 1.482 . . . . 0.0 108.45 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.05 155.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.15 -40.91 62.27 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -158.14 161.96 37.94 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -99.61 154.89 17.91 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 123.701 0.8 . . . . 0.0 109.586 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.4 p -157.76 168.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--N 1.278 -2.521 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.783 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 . . . . . 0 N--CA 1.44 -0.941 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.22 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 113.098 -1.864 . . . . 0.0 114.426 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -90.15 115.23 29.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.191 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.9 m -91.56 170.24 10.1 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -30.46 116.44 0.07 OUTLIER Glycine 0 C--N 1.351 1.414 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 -171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.447 HD11 ' OD2' ' A' ' 14' ' ' ASP . 16.7 tp -145.69 148.0 32.57 Favored 'General case' 0 N--CA 1.402 -2.858 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -125.67 -6.72 6.85 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -95.61 114.61 26.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.555 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -59.56 -30.5 68.72 Favored Glycine 0 C--O 1.217 -0.959 0 O-C-N 123.373 0.42 . . . . 0.0 112.06 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.8 -30.42 69.85 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.85 1.31 . . . . 0.0 108.045 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.447 ' OD2' HD11 ' A' ' 9' ' ' LEU . 40.6 t0 -91.46 -33.62 15.14 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 112.637 -2.074 . . . . 0.0 108.766 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.95 -34.68 78.29 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.304 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 51.0 mtmt -58.97 -25.51 63.63 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.016 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.27 75.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.974 0.416 . . . . 0.0 111.386 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 -43.94 62.84 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.755 0.788 . . . . 0.0 109.693 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.426 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.132 176.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.61 -29.76 69.88 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.309 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.69 -23.3 63.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.27 -2.88 0.05 OUTLIER Glycine 0 C--O 1.22 -0.766 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.946 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.41 21.24 12.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.565 0.746 . . . . 0.0 110.309 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.67 -67.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.436 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -163.78 -177.53 5.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.484 0.49 . . . . 0.0 110.48 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -140.11 140.88 11.01 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.84 87.84 0.44 Allowed Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.93 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.21 155.17 42.23 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.074 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.567 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 4.7 pt -116.75 155.34 18.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.42 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 41.4 m-85 -81.48 81.29 7.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.321 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 37' ' ' CYS . 11.9 p -82.49 152.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.04 89.38 5.36 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.1 p 52.33 72.89 0.37 Allowed 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.507 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 19.9 m -140.26 122.16 9.66 Favored Pre-proline 0 C--O 1.208 -1.089 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 168.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.67 5.83 0.53 Allowed 'Trans proline' 0 C--O 1.207 -1.026 0 C-N-CA 124.038 3.159 . . . . 0.0 115.413 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -101.18 -0.64 35.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.598 0.713 . . . . 0.0 109.677 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 63.2 m -136.8 166.73 22.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -133.21 137.16 53.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.524 1.056 . . . . 0.0 111.039 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -115.19 171.15 7.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.89 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 89.0 t -46.64 -32.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 0.0 113.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -56.25 24.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.723 0.773 . . . . 0.0 110.536 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -81.2 -35.29 31.55 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.668 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -62.46 -27.81 69.38 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.142 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -38.19 80.24 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.63 0.728 . . . . 0.0 109.459 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.82 -45.51 10.82 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.6 p -65.53 -24.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.744 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.3 ptm -67.8 -18.08 64.73 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.025 0.441 . . . . 0.0 111.347 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.36 -22.87 18.68 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.012 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.47 -46.44 32.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.306 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.34 104.09 17.93 Favored Pre-proline 0 N--CA 1.399 -3.007 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.25 45.02 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.544 2.829 . . . . 0.0 113.247 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.8 pp -89.25 171.91 9.44 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.216 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -77.77 140.95 39.51 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 122.964 0.506 . . . . 0.0 110.102 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -108.74 137.53 46.53 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.514 0.673 . . . . 0.0 111.543 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.4 p -129.43 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.89 133.61 8.35 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.541 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.567 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.2 t -111.6 131.22 63.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -159.64 151.09 19.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -85.39 105.06 15.75 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.17 116.7 17.11 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.495 1.14 . . . . 0.0 109.598 -171.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -106.28 -74.65 0.65 Allowed 'General case' 0 C--N 1.253 -3.625 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.246 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.39 119.55 31.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.524 HG13 HD13 ' A' ' 92' ' ' LEU . 15.9 tt -62.7 -32.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.659 -177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -12.98 59.82 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.447 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 33.1 t70 -82.41 -40.32 21.43 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -73.85 -34.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.895 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' ILE . 54.7 t -60.49 -39.95 82.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.5 t70 -52.97 -51.13 62.56 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.906 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 38.4 mmtm -65.82 -45.46 82.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.001 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.88 -32.26 71.71 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.138 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -76.76 -57.65 3.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.824 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.1 t -57.62 -57.01 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.517 0.727 . . . . 0.0 112.06 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -78.53 -8.82 58.98 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.042 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.0 p 49.27 68.3 0.74 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.959 0.885 . . . . 0.0 110.863 -174.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -71.42 178.3 3.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.048 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.94 -36.4 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.794 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.23 155.57 46.01 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.3 p -142.17 139.4 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.85 129.53 45.23 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-O 121.347 0.594 . . . . 0.0 111.564 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 124.6 36.25 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.378 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 83' ' ' ASN . 26.9 t-80 -81.99 92.7 6.82 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -56.97 -19.68 31.16 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 5.7 t30 -53.92 -29.86 43.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.98 -47.82 78.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.6 tm-20 -176.41 151.18 0.95 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 24.9 mt-30 -77.93 -45.04 25.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 123.994 0.918 . . . . 0.0 111.966 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.1 mt -83.75 -23.34 31.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.131 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.4 t80 -55.0 -40.19 69.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.395 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.528 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 mp -61.8 -36.97 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.341 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.74 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 23.4 t70 -68.7 -20.69 64.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.778 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.7 m -85.21 -43.18 14.02 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.927 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.524 HD13 HG13 ' A' ' 63' ' ' ILE . 3.5 mm? -47.08 -50.75 19.29 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.74 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.18 -10.76 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.72 -51.04 10.38 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.64 -24.12 58.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.092 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.7 mt -92.07 127.47 49.27 Favored Pre-proline 0 C--N 1.276 -2.59 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.308 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.15 165.87 29.98 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.542 2.162 . . . . 0.0 110.489 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.94 -16.63 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 111.231 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -64.33 -29.14 70.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.886 0.874 . . . . 0.0 109.826 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.19 134.56 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.185 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -111.71 170.77 7.91 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mt -123.67 135.42 63.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.565 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -121.96 156.55 33.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.67 129.83 54.75 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.19 102.19 4.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 C--N 1.299 -1.596 0 C-N-CA 123.836 0.854 . . . . 0.0 109.554 -174.994 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 89' ' ' ILE . 81.9 m-85 . . . . . 0 CA--C 1.493 -1.241 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -110.71 -170.13 1.58 Allowed 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 69.35 27.68 4.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.005 1.383 . . . . 0.0 108.805 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.03 155.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.259 -1.791 . . . . 0.0 107.39 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.31 -40.99 50.08 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.788 0.804 . . . . 0.0 111.093 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 4.9 ttmp? -153.89 163.31 40.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.82 147.7 50.44 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.22 173.56 13.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.667 0 CA-C-N 118.403 0.547 . . . . 0.0 110.718 -179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.626 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.505 -0.773 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.47 109.71 3.32 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.852 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 59.0 t -86.0 102.7 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.6 m -96.82 170.12 9.39 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -34.32 116.3 0.18 Allowed Glycine 0 N--CA 1.476 1.367 0 O-C-N 124.218 0.949 . . . . 0.0 114.712 -174.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.6 tp -146.73 157.48 43.7 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -138.32 14.8 2.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.344 1.069 . . . . 0.0 109.724 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.0 mtt180 -115.54 110.44 19.25 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.77 -35.5 74.86 Favored Glycine 0 C--N 1.301 -1.397 0 O-C-N 123.192 0.307 . . . . 0.0 113.39 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.601 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -70.5 -35.13 73.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.223 1.011 . . . . 0.0 108.945 -177.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 16.2 t0 -82.06 -22.63 36.26 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.724 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.63 -44.77 27.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.569 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 20.9 pttp -67.79 -23.28 65.19 Favored 'General case' 0 C--O 1.201 -1.494 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.44 74.69 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.676 0.39 . . . . 0.0 110.956 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.01 69.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -69.09 -34.67 75.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.293 176.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.6 -32.15 73.3 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.489 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.23 -23.66 61.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.58 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.54 -20.97 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . . . 60.24 30.68 20.05 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 121.68 0.752 . . . . 0.0 109.79 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.626 ' HB ' HD21 ' A' ' 4' ' ' ASN . 31.0 mt -70.62 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.034 -171.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.35 151.33 0.61 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.287 0.992 . . . . 0.0 108.701 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.49 9.49 Favored Glycine 0 N--CA 1.417 -2.622 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.08 81.11 1.08 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.239 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -114.57 150.74 34.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.186 0.517 . . . . 0.0 110.133 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 57' ' ' VAL . 14.3 mt -118.08 156.14 19.84 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.444 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 20.7 m-85 -82.78 69.3 9.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.432 0.56 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.57 118.63 42.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.683 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.86 96.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.811 1.644 . . . . 0.0 114.24 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.0 p 56.48 23.54 7.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.626 1.57 . . . . 0.0 112.975 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' ARG . 14.8 m -103.32 111.09 64.87 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.74 19.9 0.12 Allowed 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.64 3.56 . . . . 0.0 114.386 -172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' SER . 24.1 mmt180 -91.97 -21.6 20.45 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 170.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -141.29 174.17 10.8 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.643 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -134.18 136.91 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.495 -177.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -105.13 167.32 9.79 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.258 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 69' ' ' LYS . 93.3 t -48.41 -34.58 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.925 1.29 . . . . 0.0 112.39 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.0 -55.65 27.1 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 123.632 0.773 . . . . 0.0 111.988 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 46' ' ' VAL . 29.6 mt-30 -68.59 -42.22 78.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -63.55 -20.12 65.37 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.109 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.44 -45.36 11.22 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.568 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' GLN . 14.9 t -64.09 -33.01 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.489 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -64.63 -25.38 67.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.167 0.508 . . . . 0.0 110.783 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.95 -24.38 33.02 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.45 -51.93 7.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.182 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.37 104.29 17.84 Favored Pre-proline 0 N--CA 1.395 -3.222 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 48.3 2.23 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.709 2.273 . . . . 0.0 112.293 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.479 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -85.07 168.57 14.76 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.527 175.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -79.65 140.43 37.07 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 120.616 0.246 . . . . 0.0 111.565 -177.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.483 ' CD2' HD11 ' A' ' 28' ' ' LEU . 33.2 m-85 -113.15 146.33 39.43 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.077 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.67 164.48 34.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.58 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -139.93 148.83 20.39 Favored Glycine 0 CA--C 1.481 -2.079 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.598 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' A' ' 29' ' ' ILE . 39.9 t -124.77 140.29 48.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -168.59 158.4 9.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.769 0.713 . . . . 0.0 109.981 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -86.15 94.72 9.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.48 HD22 ' HG ' ' A' ' 80' ' ' LEU . 84.3 m-20 -79.06 118.65 21.24 Favored 'General case' 0 N--CA 1.395 -3.184 0 CA-C-O 122.563 1.173 . . . . 0.0 110.327 -173.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.93 -61.43 1.58 Allowed 'General case' 0 C--N 1.247 -3.889 0 CA-C-N 112.521 -2.127 . . . . 0.0 106.127 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.22 110.45 18.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.759 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 92' ' ' LEU . 14.6 tt -64.62 -32.04 56.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.084 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.25 -22.32 63.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.212 0.529 . . . . 0.0 110.212 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.0 t70 -83.04 -34.82 26.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.05 -44.02 99.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.4 t -59.81 -45.54 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.472 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.5 t70 -52.22 -61.27 2.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.196 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HD2' HG21 ' A' ' 40' ' ' VAL . 46.9 mmtm -64.16 -42.09 96.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.679 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.03 -31.26 72.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.555 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -79.4 -57.81 3.52 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.422 0.451 . . . . 0.0 110.182 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.0 t -53.59 -55.69 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.987 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -81.31 -16.54 52.15 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.437 -179.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.6 m 59.89 74.43 0.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.179 0.99 . . . . 0.0 110.402 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.1 mt -86.4 -168.49 2.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.936 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -128.65 -40.29 1.58 Allowed 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.05 161.61 39.0 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.776 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.0 p -140.82 137.43 35.08 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.76 121.39 39.62 Favored 'General case' 0 N--CA 1.381 -3.917 0 CA-C-O 121.678 0.752 . . . . 0.0 110.248 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.48 ' HG ' HD22 ' A' ' 60' ' ' ASN . 1.4 tt -109.49 136.24 49.21 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -77.76 79.16 4.25 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.56 -13.12 1.81 Allowed Glycine 0 C--O 1.214 -1.107 0 CA-C-N 114.003 -1.453 . . . . 0.0 116.567 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -55.35 -24.31 28.65 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.537 1.135 . . . . 0.0 112.769 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -48.76 -49.3 39.16 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.282 1.033 . . . . 0.0 113.172 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -176.88 148.9 0.69 Allowed 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.514 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 9.1 tt0 -77.81 -48.85 15.55 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.421 1.105 . . . . 0.0 112.065 -168.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.82 -17.53 62.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.998 -174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.51 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.0 t80 -61.11 -45.0 96.49 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.89 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.63 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-O 121.779 0.799 . . . . 0.0 109.16 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.83 -20.46 66.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.226 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 89.3 m -83.9 -41.31 17.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.583 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -50.73 -38.37 47.09 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 123.684 0.794 . . . . 0.0 111.773 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -59.14 -34.32 71.92 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.209 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.08 -37.84 45.6 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.279 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.94 -18.96 26.4 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 102' ' ' ILE . 95.2 mt -96.46 141.32 22.93 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.364 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.38 165.8 31.34 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.07 1.846 . . . . 0.0 110.363 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -11.79 18.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.199 0.999 . . . . 0.0 112.126 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -79.15 -28.55 42.8 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.231 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.1 t -104.22 127.56 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.034 0 CA-C-O 121.44 0.638 . . . . 0.0 109.617 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 121' ' ' ASP . . . -111.37 172.58 6.8 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 96' ' ' LEU . 3.5 mp -128.21 130.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.459 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 37.6 m0 -116.94 155.76 28.56 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.96 113.68 26.43 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.89 2.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.41 -2.465 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.655 -175.523 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 67.9 m-85 . . . . . 0 N--CA 1.418 -2.048 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.03 166.71 22.49 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.8 m170 66.26 30.05 9.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.707 0.63 . . . . 0.0 112.543 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.8 m -103.72 149.6 7.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 24.3 t70 -85.67 -42.28 14.43 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.258 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -153.59 163.13 40.5 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.544 0.738 . . . . 0.0 111.442 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.74 135.78 49.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.311 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.2 163.45 29.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.5 tp . . . . . 0 C--N 1.294 -1.847 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 27' ' ' GLY . 9.5 ptmt -67.59 96.2 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.4 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.14 104.96 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.182 0.992 . . . . 0.0 111.53 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 169.2 10.16 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -31.34 109.47 0.03 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.29 147.58 2.0 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -136.42 -3.2 2.16 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.776 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.29 111.51 5.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.37 -58.07 5.39 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 124.57 1.081 . . . . 0.0 113.971 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.69 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -57.1 -19.9 22.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -92.0 -44.87 8.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.48 74.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.42 -23.37 65.78 Favored 'General case' 0 C--O 1.191 -2.007 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.176 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.64 -35.0 69.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.071 0.463 . . . . 0.0 110.967 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.33 56.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.727 0.775 . . . . 0.0 110.089 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -70.66 -35.95 73.11 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.364 177.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.95 -26.28 62.07 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.403 1.081 . . . . 0.0 111.067 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.09 -22.51 66.41 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.499 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.83 18.27 0.15 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.805 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.87 25.99 7.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.574 1.15 . . . . 0.0 111.727 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -57.93 -67.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.092 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.67 155.66 2.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -122.15 131.33 8.36 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -97.78 88.47 0.92 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -125.11 149.1 48.19 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 1.9 pt -117.69 157.87 18.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 49.6 m-85 -86.92 87.29 7.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 124.149 0.906 . . . . 0.0 112.114 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 54.7 t -121.86 116.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 169.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.46 113.26 1.35 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 124.447 1.092 . . . . 0.0 113.298 -173.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p 62.94 23.34 13.95 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.864 1.666 . . . . 0.0 113.885 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 78.9 p -86.62 149.27 48.33 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.48 13.73 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.752 1.635 . . . . 0.0 111.705 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 21.9 ptt180 -119.42 -8.56 10.02 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.014 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 59.5 m -145.51 172.89 12.56 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.21 137.31 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 109.071 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -103.61 164.91 11.36 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.45 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.0 p -51.51 -35.21 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 124.265 0.978 . . . . 0.0 111.57 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 7.9 mp0 -67.82 -39.2 83.94 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 124.36 1.064 . . . . 0.0 112.011 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 46' ' ' VAL . 51.6 mm-40 -67.33 -51.15 55.91 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 122.67 1.224 . . . . 0.0 107.914 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.44 66.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.462 -2.154 . . . . 0.0 114.449 -168.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.482 HE21 ' HB3' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -63.75 -31.2 72.3 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.81 -37.94 29.25 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.31 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 42' ' ' GLN . 44.8 t -65.63 -31.67 54.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.16 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 27.1 ptt? -67.83 -17.32 64.47 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.223 0.535 . . . . 0.0 111.76 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.63 46.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.427 0.632 . . . . 0.0 109.469 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.22 -40.62 6.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.305 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -137.94 98.75 9.41 Favored Pre-proline 0 N--CA 1.406 -2.656 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.11 59.91 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.057 2.504 . . . . 0.0 113.023 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.42 163.9 12.04 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.366 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.91 145.47 46.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.63 0.252 . . . . 0.0 110.576 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.74 140.79 47.98 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.2 p -133.57 144.0 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 30' ' ' PHE . . . -109.72 132.56 11.11 Favored Glycine 0 CA--C 1.475 -2.464 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 79' ' ' GLN . 7.3 p -140.09 104.05 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.053 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -167.88 178.75 5.03 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -173.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -86.3 93.42 9.08 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.42 117.99 26.57 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -85.77 -63.19 1.36 Allowed 'General case' 0 C--N 1.247 -3.89 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.711 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -89.44 125.32 35.12 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.032 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 67' ' ' VAL . 19.1 tt -63.4 -34.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.064 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.65 -20.11 62.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.62 0.724 . . . . 0.0 110.39 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 18.3 t70 -85.93 -39.48 16.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.158 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' ILE . 14.5 p -77.46 -32.21 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.823 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.2 t -59.9 -40.92 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 21.3 t70 -54.09 -50.93 65.68 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.534 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.1 mmtm -69.21 -42.1 76.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.139 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -66.37 -22.98 66.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -83.83 -61.74 1.75 Allowed 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 67.2 t -54.69 -56.68 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 123.894 0.746 . . . . 0.0 111.548 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HB2' HG23 ' A' ' 40' ' ' VAL . 59.2 tp -83.16 -19.52 36.46 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.69 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 12.7 t 60.09 82.83 0.15 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 122.333 1.063 . . . . 0.0 109.768 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.22 173.01 11.9 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.644 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.24 -31.54 5.95 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -151.54 161.45 42.67 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.921 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 66' ' ' VAL . 6.5 p -143.87 138.73 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.39 119.81 39.59 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 121.848 -0.533 . . . . 0.0 110.575 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.486 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -99.86 119.76 38.7 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.347 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -81.53 104.03 11.67 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.77 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.666 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -53.76 -12.25 2.46 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.739 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -55.24 -27.76 48.51 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 110.762 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -72.78 -47.58 45.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 123.076 0.235 . . . . 0.0 110.874 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.57 150.03 0.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.62 -44.31 24.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.507 1.146 . . . . 0.0 110.823 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 32.6 mt -80.71 -13.38 59.05 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.934 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 24.7 t80 -59.04 -42.96 91.51 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.381 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.527 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -59.51 -38.19 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.625 0.726 . . . . 0.0 109.476 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 18.8 t70 -63.06 -22.0 66.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.33 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.462 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 94.2 m -88.53 -45.14 10.15 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.658 1.183 . . . . 0.0 109.997 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -45.09 -47.16 11.98 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.48 -24.51 66.63 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.129 -177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 29.7 mt-10 -76.56 -37.74 56.08 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.384 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.1 -36.55 15.67 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.466 0.651 . . . . 0.0 112.255 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.31 121.2 75.24 Favored Pre-proline 0 C--N 1.272 -2.763 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.813 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.47 165.43 20.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.479 2.119 . . . . 0.0 111.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.28 -10.74 17.28 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.493 1.117 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -75.7 -29.56 59.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.448 HG21 ' HB1' ' A' ' 70' ' ' ALA . 61.6 t -100.56 129.73 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.335 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.99 164.88 11.77 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.338 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 80' ' ' LEU . 71.1 mt -116.94 132.66 66.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 45.4 m0 -122.31 158.94 28.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.728 174.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 105' ' ' ALA . 17.5 tptm -100.97 115.86 31.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -77.55 98.12 5.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--N 1.304 -1.406 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.634 -174.724 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.666 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 31.8 m-85 . . . . . 0 N--CA 1.41 -2.426 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -85.24 153.5 22.57 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 75.77 24.56 1.25 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.269 -2.242 . . . . 0.0 111.604 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.44 143.56 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.85 -32.2 21.84 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.183 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 40.2 ttmt -153.56 160.36 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.325 0.583 . . . . 0.0 109.638 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -111.63 134.76 52.98 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.383 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.31 -176.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.8 mt . . . . . 0 C--N 1.302 -1.497 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 -179.434 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 . . . . . 0 C--O 1.213 -0.849 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -51.03 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.598 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 7.6 p -99.86 103.22 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.957 0.884 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.81 168.53 11.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -6.62 106.41 0.01 OUTLIER Glycine 0 N--CA 1.484 1.88 0 C-N-CA 125.578 1.561 . . . . 0.0 116.942 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.54 145.68 51.91 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -125.45 8.74 7.77 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.118 0.961 . . . . 0.0 108.633 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 11' ' ' ARG . 64.9 mtt180 -125.32 107.35 10.61 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.227 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.69 -54.01 8.11 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 124.07 0.843 . . . . 0.0 113.177 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.735 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -63.45 -26.32 68.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 30.1 t70 -87.09 -23.11 25.02 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.087 0.946 . . . . 0.0 108.64 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.08 -22.75 60.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.558 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -61.19 -24.18 66.13 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.584 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.12 -34.4 60.21 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.289 0.368 . . . . 0.0 111.748 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.36 67.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.885 0.85 . . . . 0.0 110.047 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -36.15 81.74 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.976 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.24 -28.53 69.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.416 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.2 -23.03 59.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.904 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.32 -11.95 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 118.413 -1.851 . . . . 0.0 113.717 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.18 23.87 14.15 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 121.46 0.647 . . . . 0.0 109.771 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 24' ' ' ILE . 12.7 mt -57.8 -53.13 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.122 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 37.9 p90 -170.6 -172.09 1.16 Allowed 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.85 177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.26 122.06 1.64 Allowed Glycine 0 C--N 1.284 -2.306 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 171.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.99 100.63 1.97 Allowed Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.369 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -131.96 161.98 31.8 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 123.07 0.548 . . . . 0.0 109.893 -178.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 pt -117.4 153.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 86.7 m-85 -81.55 82.44 7.32 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -127.81 133.45 67.41 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.718 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.4 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . . . -70.88 136.16 48.45 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.533 0.682 . . . . 0.0 111.26 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p 53.73 9.63 0.2 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 127.204 2.202 . . . . 0.0 116.322 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -94.75 128.54 39.21 Favored Pre-proline 0 C--O 1.211 -0.928 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.863 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.32 0.16 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.345 2.696 . . . . 0.0 113.99 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -104.14 -8.01 19.76 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.304 0.573 . . . . 0.0 110.299 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 57.8 m -139.62 136.05 33.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.891 -0.506 . . . . 0.0 111.185 -171.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.492 ' O ' HD23 ' A' ' 28' ' ' LEU . 2.3 t -108.13 135.4 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 4.0 p30 -125.28 -170.06 2.1 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 99.1 t -46.92 -34.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 125.152 1.532 . . . . 0.0 111.286 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.84 -64.41 0.95 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 122.367 1.08 . . . . 0.0 111.353 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.3 mp0 -68.88 -49.45 58.18 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.716 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -24.0 66.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.782 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.36 -34.76 75.84 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.81 -50.37 8.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.075 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 42' ' ' GLN . 24.5 t -58.19 -30.82 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.995 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.1 ptm -68.13 -12.13 60.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.983 0.421 . . . . 0.0 111.646 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.64 -6.67 24.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -42.13 4.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.384 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.76 99.27 15.5 Favored Pre-proline 0 N--CA 1.396 -3.134 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -76.09 71.73 5.57 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 C-N-CA 121.899 1.733 . . . . 0.0 111.675 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.65 160.99 15.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.508 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HB3' ' HA ' ' A' ' 25' ' ' TYR 0.253 0.0 OUTLIER -75.71 122.42 23.98 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.103 1.361 . . . . 0.0 108.656 -176.643 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.45 ' HD2' HD11 ' A' ' 28' ' ' LEU . 91.5 m-85 -92.31 137.69 32.15 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.683 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -132.16 136.39 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.53 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -116.27 150.11 18.66 Favored Glycine 0 CA--C 1.481 -2.035 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.652 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 29' ' ' ILE . 41.4 t -130.05 133.79 63.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -172.4 159.49 4.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.588 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.526 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 16.3 ttm180 -104.44 97.01 7.0 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.98 148.11 25.75 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -97.65 -37.68 9.82 Favored 'General case' 1 C--N 1.238 -4.273 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.137 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' ASP . 9.5 t70 -97.68 126.0 42.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.844 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 HD13 ' A' ' 92' ' ' LEU . 7.6 tt -63.97 -34.44 68.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.149 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.61 -15.81 59.73 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.452 0.644 . . . . 0.0 109.772 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 12.3 t70 -75.93 -38.29 57.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.392 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.43 -46.7 69.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.316 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -59.42 -40.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.528 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.8 t70 -52.01 -56.17 15.96 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.08 176.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.5 mmtm -64.82 -43.18 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.347 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.35 85.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 124.182 0.926 . . . . 0.0 111.066 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.65 -52.14 8.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.54 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 68' ' ' ASP . 57.6 t -57.43 -57.51 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.886 0.375 . . . . 0.0 111.227 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -78.75 -12.8 60.04 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.709 -176.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 p 54.69 73.63 0.39 Allowed 'General case' 0 C--O 1.252 1.226 0 CA-C-O 122.309 1.052 . . . . 0.0 111.623 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.75 -174.31 4.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.793 -1.549 . . . . 0.0 111.858 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.66 -38.07 1.73 Allowed 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.678 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.79 159.64 42.54 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 173.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -144.74 137.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.425 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.616 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.76 112.11 24.91 Favored 'General case' 0 N--CA 1.391 -3.414 0 C-N-CA 123.102 0.561 . . . . 0.0 109.575 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.24 130.5 37.11 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.477 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -70.7 103.67 2.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.484 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.64 -31.87 53.38 Favored Glycine 0 CA--C 1.496 -1.122 0 CA-C-N 114.154 -1.385 . . . . 0.0 114.243 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -48.48 -25.55 1.72 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.534 1.134 . . . . 0.0 113.013 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD3' ' A' ' 59' ' ' ARG . 11.7 tp10 -66.06 -47.3 74.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.534 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -178.5 148.59 0.46 Allowed 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -77.88 -46.53 21.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.0 0.905 . . . . 0.0 112.16 -173.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -79.34 -21.74 45.43 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.245 -171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.8 t80 -52.43 -44.51 65.51 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.483 173.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.7 mp -64.17 -36.49 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.338 0.589 . . . . 0.0 110.152 -177.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.45 -17.41 58.11 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.67 0.748 . . . . 0.0 110.695 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 83.7 m -79.19 -42.17 26.67 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.176 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.563 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -43.92 -47.21 8.38 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.517 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 119' ' ' HIS . 4.0 mpt_? -52.47 -32.52 40.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -75.46 -29.03 59.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.023 0.439 . . . . 0.0 111.419 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.38 -1.66 28.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.01 0.909 . . . . 0.0 110.562 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 14.7 tp -91.3 133.27 31.85 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.076 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.14 163.53 38.89 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.591 1.527 . . . . 0.0 110.587 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.48 69.9 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.231 1.013 . . . . 0.0 112.67 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -79.66 -13.83 59.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.3 140.58 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.567 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.26 174.09 6.24 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -128.19 135.49 62.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.616 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 51.6 m0 -122.57 162.56 21.59 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.494 -0.882 . . . . 0.0 108.704 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 123' ' ' TYR . 18.6 tptm -100.82 116.0 31.68 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.445 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -74.56 98.94 3.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tt . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -173.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 22.3 m-85 . . . . . 0 N--CA 1.426 -1.627 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -96.75 174.17 6.94 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.964 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 20.9 m170 72.7 14.74 5.0 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.696 1.599 . . . . 0.0 110.778 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.89 150.33 6.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.237 0.542 . . . . 0.0 111.52 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.57 -29.44 59.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.942 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -159.75 158.54 31.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 104' ' ' LYS . 7.1 m-85 -109.14 128.85 55.36 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.41 -178.04 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 123.33 0.394 . . . . 0.0 109.939 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--N 1.313 -0.978 0 O-C-N 123.49 0.494 . . . . 0.0 110.589 -179.199 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.498 -1.033 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -16.84 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.376 2.27 . . . . 0.0 115.357 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.96 110.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.568 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.3 m -91.11 169.38 10.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -38.41 106.68 0.05 OUTLIER Glycine 0 N--CA 1.473 1.152 0 O-C-N 124.196 0.935 . . . . 0.0 114.539 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 11' ' ' ARG . 3.6 tt -138.37 146.23 42.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 p -111.12 -19.82 12.58 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.255 1.026 . . . . 0.0 110.575 -169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 9' ' ' LEU . 71.4 mtm180 -86.21 108.49 18.39 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.721 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.96 -39.43 89.16 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-O 122.181 0.878 . . . . 0.0 112.833 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -73.57 -18.23 61.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.833 -1.183 . . . . 0.0 110.756 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -92.91 -45.8 7.79 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -28.04 68.38 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.705 1.202 . . . . 0.0 112.175 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.81 -22.89 59.52 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.967 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.69 43.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.462 0.705 . . . . 0.0 112.288 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.25 47.69 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 110.784 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.8 -33.98 34.39 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.012 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.23 -23.41 55.76 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 125.828 1.651 . . . . 0.0 110.524 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.39 62.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.87 26.8 0.75 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.825 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.45 34.16 20.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.358 1.063 . . . . 0.0 111.743 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 21.9 mt -62.58 -69.05 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.233 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.444 ' HB2' ' CD ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.96 155.64 0.99 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.049 -173.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.96 138.43 11.03 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.44 75.83 0.23 Allowed Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.426 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -117.31 144.22 45.11 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 22.0 mt -117.1 152.65 18.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.372 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 4.9 m-85 -82.55 72.29 9.62 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 118.035 0.38 . . . . 0.0 110.245 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 66.1 t -95.76 121.99 46.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 118.459 -1.297 . . . . 0.0 107.692 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.53 108.43 0.17 Allowed 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.429 1.081 . . . . 0.0 112.864 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.2 p 57.82 29.04 16.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.701 1.6 . . . . 0.0 113.915 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -80.97 140.09 49.91 Favored Pre-proline 0 N--CA 1.423 -1.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.32 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.4 7.94 4.85 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 C-N-CA 121.596 1.53 . . . . 0.0 112.297 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -124.65 2.18 8.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 109.858 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 93.9 m -154.12 125.21 7.31 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.33 137.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.61 0.719 . . . . 0.0 111.634 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -104.0 170.95 7.62 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.873 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.32 -35.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.025 1.33 . . . . 0.0 113.224 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.33 -50.71 58.93 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.959 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.29 -32.39 49.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.992 0.901 . . . . 0.0 109.441 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.948 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -63.22 -25.87 68.53 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.796 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -39.13 70.35 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.882 0.873 . . . . 0.0 109.714 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -86.5 -46.12 10.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.002 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.948 HG12 ' HA ' ' A' ' 43' ' ' ALA . 7.0 p -60.82 -31.89 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.382 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 73' ' ' LEU . 26.5 ptt? -66.16 -27.06 67.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.983 0.42 . . . . 0.0 110.953 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.42 21.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.372 0.606 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.42 -47.26 34.88 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.342 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.0 101.41 22.84 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.33 66.4 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.969 1.779 . . . . 0.0 112.057 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.462 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.5 pp -107.73 176.41 5.15 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.408 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' TYR . 4.1 tt0 -76.73 131.83 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.664 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD11 ' A' ' 28' ' ' LEU . 61.0 m-85 -105.14 141.96 35.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.487 0.661 . . . . 0.0 110.768 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.6 p -129.11 160.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.88 139.25 10.24 Favored Glycine 0 C--N 1.277 -2.717 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.073 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HB ' HG23 ' A' ' 29' ' ' ILE . 61.8 t -113.28 127.89 70.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -154.22 147.0 24.3 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.489 -1.285 . . . . 0.0 110.511 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -86.26 102.19 13.73 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 167.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.4 HD22 HD11 ' A' ' 92' ' ' LEU . 2.2 m-20 -80.49 114.56 19.47 Favored 'General case' 0 N--CA 1.387 -3.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -105.43 -58.08 1.95 Allowed 'General case' 0 C--N 1.256 -3.463 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.85 116.35 30.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.297 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 67' ' ' VAL . 18.3 tt -64.63 -31.4 53.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 120.876 0.37 . . . . 0.0 111.168 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.81 -9.5 59.07 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.632 -0.667 . . . . 0.0 110.714 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 11.3 t70 -84.88 -39.13 18.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.72 -35.0 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -63.96 -36.47 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.3 t70 -53.71 -53.36 53.22 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.975 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 42.2 mmtm -64.72 -44.2 90.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.094 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -57.65 -33.49 68.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.666 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.28 -60.66 2.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.168 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.2 t -54.59 -59.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.647 0.779 . . . . 0.0 112.245 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HA ' ' SD ' ' A' ' 47' ' ' MET . 1.4 mm? -78.61 -14.21 59.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.888 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.6 t 57.13 73.58 0.45 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.945 0.879 . . . . 0.0 109.794 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.63 -178.8 4.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.208 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -128.06 -34.22 2.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -149.24 160.16 43.63 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.697 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.29 137.18 37.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.6 mp0 -96.46 118.33 32.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 89' ' ' ILE . 34.3 tp -99.78 125.86 45.76 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.734 -170.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.493 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 72.5 m80 -87.29 95.75 10.1 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -67.69 -12.95 62.73 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.74 -1.118 . . . . 0.0 114.74 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 81' ' ' HIS . 3.4 p-10 -56.36 -25.49 49.63 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.165 0.586 . . . . 0.0 112.438 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.86 82.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 112.887 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.7 tm-20 -171.46 141.5 1.53 Allowed 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.06 -42.01 33.61 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -168.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.02 -24.17 30.63 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-O 121.882 0.848 . . . . 0.0 109.959 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 91' ' ' THR . 36.7 t80 -51.43 -32.55 27.09 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 125.98 1.712 . . . . 0.0 112.13 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.508 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -60.07 -39.66 81.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.415 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 9.9 t70 -67.9 -14.74 63.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.47 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 75.2 m -88.13 -46.57 9.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.23 1.412 . . . . 0.0 109.367 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.469 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.91 -51.01 10.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.619 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -56.99 -29.96 63.73 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 121.219 0.533 . . . . 0.0 112.18 -178.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -76.15 -31.12 58.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.483 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -94.76 -23.79 17.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 92' ' ' LEU . 98.2 mt -76.7 131.44 73.92 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.688 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.04 165.2 10.84 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.724 2.283 . . . . 0.0 112.446 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.02 55.02 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.721 1.208 . . . . 0.0 113.099 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -85.86 -8.58 57.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.534 HG21 ' HB1' ' A' ' 70' ' ' ALA . 82.7 t -98.66 124.89 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-O 121.717 0.77 . . . . 0.0 109.263 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.96 172.73 6.66 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.034 -176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.08 130.94 73.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.2 m0 -119.9 159.38 24.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -101.18 117.94 36.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.325 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.11 105.72 3.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.3 tt . . . . . 0 N--CA 1.419 -1.998 0 CA-C-O 121.903 0.858 . . . . 0.0 109.772 -175.081 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.403 -2.796 0 N-CA-C 102.833 -3.025 . . . . 0.0 102.833 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.457 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 4.5 pt20 -136.22 172.52 12.89 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.457 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 88.9 m-70 69.41 36.55 2.24 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.576 1.551 . . . . 0.0 112.429 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 m -84.74 152.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.46 -47.28 11.55 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.706 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 67.6 mttm -151.06 163.85 37.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -110.94 162.39 14.88 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 125' ' ' LEU . 13.3 p -141.27 174.14 7.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.44 ' H ' HG22 ' A' ' 124' ' ' VAL . 28.4 tp . . . . . 0 C--N 1.297 -1.676 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 5.1 t30 . . . . . 0 CA--C 1.489 -1.372 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -37.05 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 112.673 -2.058 . . . . 0.0 112.116 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.58 121.4 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.988 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.55 170.73 9.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.03 135.68 3.42 Favored Glycine 0 C--N 1.357 1.749 0 CA-C-N 119.152 0.887 . . . . 0.0 114.321 -170.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.52 161.31 37.37 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -176.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -129.09 18.53 6.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -137.2 106.17 5.96 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.649 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.41 -48.77 27.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 124.765 1.174 . . . . 0.0 113.04 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.643 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.9 mp0 -63.22 -19.32 64.42 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 125.822 1.649 . . . . 0.0 112.444 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.0 -42.23 9.15 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.77 69.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.764 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.3 -23.06 67.25 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.52 69.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -77.08 -30.13 55.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 0.0 110.789 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.06 -34.46 50.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.02 -30.49 71.56 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.065 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -17.38 64.39 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.426 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.44 15.31 0.5 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.134 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.46 26.56 12.78 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.455 0.702 . . . . 0.0 110.837 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.67 -67.6 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.223 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -178.53 159.76 1.18 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.258 0.974 . . . . 0.0 108.815 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.6 142.83 14.28 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 108.459 -1.857 . . . . 0.0 108.459 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.62 78.8 0.27 Allowed Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.573 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.553 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -115.34 146.32 41.65 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.114 0.483 . . . . 0.0 109.734 -177.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 pt -117.37 155.01 19.12 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 38.5 m-85 -84.16 76.93 10.04 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.651 1.219 . . . . 0.0 109.689 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.28 121.93 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 98.79 0.02 OUTLIER 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.04 1.463 . . . . 0.0 113.82 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p 58.77 25.26 13.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.858 1.663 . . . . 0.0 114.97 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -90.76 116.07 65.6 Favored Pre-proline 0 C--O 1.199 -1.557 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.99 -7.3 2.33 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 124.273 3.315 . . . . 0.0 116.542 -171.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.23 11.54 27.29 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.637 1.208 . . . . 0.0 109.797 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 66.2 m -140.0 170.92 14.97 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.17 136.57 16.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 119.486 1.039 . . . . 0.0 109.869 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.41 166.87 10.51 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.263 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -42.96 -36.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 O-C-N 125.044 1.465 . . . . 0.0 113.843 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.9 -32.54 61.85 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 46' ' ' VAL . 16.2 mt-30 -83.38 -37.85 22.76 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.713 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.49 64.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.662 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -33.06 74.83 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -77.34 -46.23 23.58 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.75 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' GLN . 6.4 t -63.72 -34.4 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.649 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.24 -16.09 62.48 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.893 -0.504 . . . . 0.0 111.49 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.62 -19.67 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.24 -40.81 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.096 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.16 97.24 9.78 Favored Pre-proline 0 N--CA 1.408 -2.551 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -74.43 53.32 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.852 2.368 . . . . 0.0 113.544 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.1 pp -90.39 168.97 11.47 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.425 1.09 . . . . 0.0 109.14 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -71.75 140.34 49.47 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 122.964 0.505 . . . . 0.0 110.128 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.501 ' CD2' HD11 ' A' ' 28' ' ' LEU . 15.4 m-85 -112.29 137.84 49.85 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.521 0.677 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.18 148.86 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -122.31 143.74 15.7 Favored Glycine 0 C--N 1.283 -2.398 0 C-N-CA 119.783 -1.199 . . . . 0.0 112.147 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.495 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.3 t -134.97 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -172.59 163.39 5.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 13.9 ptm180 -96.64 93.87 6.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HB2' HG22 ' A' ' 66' ' ' VAL . 14.1 m120 -90.61 117.64 29.43 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.88 -38.47 70.0 Favored 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.487 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -99.24 129.27 45.46 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.567 HG13 HD13 ' A' ' 92' ' ' LEU . 15.3 tt -64.03 -31.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.081 0.467 . . . . 0.0 110.1 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.97 -11.83 60.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 110.784 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 35.6 t70 -85.39 -41.53 15.36 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 60' ' ' ASN . 21.7 t -63.02 -51.84 66.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.295 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.8 t -58.8 -38.25 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.965 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 72' ' ' VAL . 36.3 t70 -65.54 -43.97 88.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.007 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 56.8 mmtt -67.91 -44.81 76.06 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.02 -36.28 72.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.77 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -73.85 -59.59 2.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.8 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 68' ' ' ASP . 87.0 t -54.41 -58.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.56 -3.44 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.833 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 p 51.4 61.85 3.01 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.79 0.805 . . . . 0.0 111.796 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 174.52 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.542 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 53' ' ' GLN . . . -125.88 -29.42 3.1 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.362 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.25 155.22 43.1 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.28 136.51 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.25 110.37 22.31 Favored 'General case' 0 N--CA 1.384 -3.738 0 C-N-CA 123.019 0.527 . . . . 0.0 110.044 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.25 123.22 36.38 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.522 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 52.1 m-70 -74.25 94.02 2.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.61 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -55.69 -12.72 5.22 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 117.29 1.676 . . . . 0.0 117.29 -170.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -44.88 -25.48 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.613 1.165 . . . . 0.0 113.694 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.94 -48.24 82.75 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -172.18 150.04 2.39 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -77.44 -42.9 34.33 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.05 0.928 . . . . 0.0 111.933 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.06 -13.0 54.23 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.784 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 21.9 t80 -59.12 -40.98 87.07 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.308 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -63.52 -39.51 85.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.816 0.817 . . . . 0.0 109.229 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.53 -16.78 64.38 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.814 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.2 m -85.27 -39.99 17.11 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.677 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.09 -39.5 63.42 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 123.137 0.575 . . . . 0.0 110.702 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HD2' ' CD1' ' A' ' 102' ' ' ILE . 6.7 mmm180 -43.34 -43.75 5.2 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.659 1.224 . . . . 0.0 111.759 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -71.08 -46.3 62.12 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.354 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 -12.01 27.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.21 130.03 47.54 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HG2' HG23 ' A' ' 100' ' ' VAL . 37.3 Cg_endo -66.1 164.16 28.74 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.225 1.95 . . . . 0.0 111.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.05 -27.2 63.39 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 124.276 1.031 . . . . 0.0 113.338 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -85.34 -7.96 58.71 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.586 HG21 ' HB1' ' A' ' 70' ' ' ALA . 92.7 t -104.11 133.35 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -115.74 169.61 9.08 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.307 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.421 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 84.7 mt -123.14 130.02 74.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.585 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 42.0 m0 -121.14 159.9 24.84 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.416 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.71 115.5 30.6 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.72 103.77 2.66 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.781 0.676 . . . . 0.0 109.245 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 tp . . . . . 0 N--CA 1.421 -1.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 -178.691 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 50.1 m-85 . . . . . 0 N--CA 1.415 -2.204 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 13.9 pt20 -99.57 -169.07 1.7 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.564 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 94.3 m-70 70.42 34.36 2.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.47 164.36 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.617 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.08 -37.99 14.7 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 38.4 ttmt -161.12 162.66 31.56 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.957 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -107.42 142.83 36.65 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.792 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.9 163.74 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.9 mt . . . . . 0 C--N 1.28 -2.423 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -177.35 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.606 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.1 p-10 . . . . . 0 N--CA 1.439 -0.994 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.98 114.74 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.655 -173.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.591 ' H ' ' HA2' ' A' ' 26' ' ' GLY . 97.6 t -93.91 117.97 38.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.764 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 16.9 p -136.81 166.88 22.57 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.51 106.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.955 0 C-N-CA 126.055 1.788 . . . . 0.0 116.939 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -160.54 159.92 31.26 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -138.72 19.91 2.68 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.2 mtp180 -114.52 101.76 9.43 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.452 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.87 -44.03 55.26 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.274 0.94 . . . . 0.0 113.853 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.413 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.6 mp0 -75.14 -19.81 59.7 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.325 -0.937 . . . . 0.0 110.312 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 36.4 t70 -83.45 -38.33 22.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -63.42 -50.28 70.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.123 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 12.2 pttp -65.68 -23.77 66.85 Favored 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -26.19 67.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.4 -37.4 25.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.804 0.812 . . . . 0.0 109.417 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -67.83 -38.96 83.87 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.744 -0.598 . . . . 0.0 110.442 174.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -60.97 -32.74 72.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.056 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.16 62.92 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.735 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.49 -14.34 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.597 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.52 18.2 11.19 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.643 0.777 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.606 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 22.3 mt -63.14 -67.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.375 -170.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.6 p90 -174.03 161.89 3.73 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 123.627 0.579 . . . . 0.0 110.538 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.591 ' HA2' ' H ' ' A' ' 6' ' ' VAL . . . -129.97 122.45 3.71 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.52 88.67 1.25 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -116.42 147.4 41.71 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.285 4.6 pt -117.24 151.69 19.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.434 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 48.9 m-85 -85.12 73.98 10.56 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.605 -174.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HB ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -120.93 115.7 47.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.35 106.44 0.12 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 124.94 1.4 . . . . 0.0 113.901 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p 65.54 15.89 10.25 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.005 1.722 . . . . 0.0 115.05 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 24.9 t -74.85 138.28 73.24 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.89 -0.89 7.69 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 122.811 2.341 . . . . 0.0 113.727 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 58.6 ttp180 -114.18 -4.51 13.09 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 15.2 m -129.88 130.12 44.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.992 -169.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.63 134.94 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -118.25 179.25 4.16 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.275 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 73' ' ' LEU . 6.9 p -45.51 -31.74 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 O-C-N 124.666 1.229 . . . . 0.0 113.204 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.22 -61.97 1.61 Allowed 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 123.742 0.817 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -67.96 -37.8 81.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.22 0.534 . . . . 0.0 110.256 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.06 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.88 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 3.8 tp-100 -67.78 -39.49 84.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.027 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.88 -40.52 14.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.978 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.5 p -64.56 -22.9 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.748 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 21.6 ptp -67.8 -17.12 64.42 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.543 0.687 . . . . 0.0 110.931 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.37 3.15 40.27 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.499 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.83 -42.6 3.77 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.134 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -142.39 101.06 5.65 Favored Pre-proline 0 N--CA 1.4 -2.956 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.43 70.07 3.3 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 112.007 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -111.99 160.56 17.34 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.202 174.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 2.6 tt0 -67.16 134.93 52.7 Favored 'General case' 0 C--O 1.208 -1.079 0 C-N-CA 123.229 0.612 . . . . 0.0 109.89 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 61.3 m-85 -108.52 140.6 41.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.077 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 9.5 p -133.96 133.96 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -110.37 125.89 7.67 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.598 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 18.0 t -112.89 121.58 65.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -173.08 154.33 2.74 Favored 'General case' 0 CA--C 1.493 -1.223 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.361 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.56 104.9 15.74 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 122.458 1.123 . . . . 0.0 108.315 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.85 121.68 42.56 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 113.637 -1.619 . . . . 0.0 110.326 -171.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -99.64 -36.28 9.55 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.274 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.1 t70 -99.37 111.37 23.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 67' ' ' VAL . 13.6 tt -66.93 -33.6 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.156 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.42 62.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.344 0.593 . . . . 0.0 110.461 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.0 -33.22 24.59 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 62' ' ' ASP . 47.6 t -65.2 -43.46 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.2 t -59.05 -43.56 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.36 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -57.89 -61.33 2.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.887 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.17 -42.67 99.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.66 -29.46 70.03 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -82.8 -56.75 3.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.717 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.0 t -53.21 -59.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.429 0.692 . . . . 0.0 111.547 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 40' ' ' VAL . 1.8 mm? -72.34 -18.17 61.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.221 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 m 59.72 69.04 0.73 Allowed 'General case' 0 C--O 1.243 0.746 0 CA-C-O 122.336 1.065 . . . . 0.0 109.803 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.71 -176.39 5.35 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.253 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.13 -43.13 1.67 Allowed 'General case' 0 C--O 1.184 -2.35 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -136.25 155.0 50.74 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.79 170.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' C ' HE21 ' A' ' 79' ' ' GLN . 6.1 p -135.51 137.34 49.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.5 mm-40 -95.0 128.25 41.68 Favored 'General case' 0 N--CA 1.394 -3.231 0 CA-C-O 121.288 0.566 . . . . 0.0 110.846 -174.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 89' ' ' ILE . 40.4 tp -113.6 121.32 43.82 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.496 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -85.51 91.82 8.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.42 -12.87 41.45 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -167.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -48.8 -25.99 2.15 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.332 1.053 . . . . 0.0 113.498 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -51.69 -49.95 61.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -175.14 154.36 1.76 Allowed 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.3 mp0 -77.97 -46.49 20.97 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.791 0.805 . . . . 0.0 111.334 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.15 -17.46 54.97 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.244 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' O ' ' HB ' ' A' ' 91' ' ' THR . 28.3 t80 -59.84 -37.5 79.41 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.559 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 80' ' ' LEU . 1.7 mp -64.24 -37.44 79.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.542 0.687 . . . . 0.0 109.823 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -20.91 60.18 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.884 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 97.5 m -74.42 -43.39 56.51 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.095 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.518 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -48.59 -44.63 37.09 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.201 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.803 ' NH2' ' HB ' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -55.21 -25.97 36.43 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -86.35 -40.28 15.6 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.77 -18.47 31.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.544 0.687 . . . . 0.0 112.258 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.28 128.87 35.18 Favored Pre-proline 0 C--N 1.275 -2.633 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.82 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.76 165.12 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.221 1.947 . . . . 0.0 110.611 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.55 4.3 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.626 0.77 . . . . 0.0 112.126 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -84.13 -29.08 27.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 70' ' ' ALA . 79.4 t -107.89 132.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.324 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.4 160.66 15.47 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.803 ' HB ' ' NH2' ' A' ' 93' ' ' ARG . 4.1 mp -122.58 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.554 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 38.9 m0 -107.75 164.63 12.07 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.26 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -99.54 109.18 21.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.605 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.21 103.39 3.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.8 tp . . . . . 0 N--CA 1.425 -1.676 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.571 -175.709 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 89' ' ' ILE . 56.3 m-85 . . . . . 0 CA--C 1.497 -1.079 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -83.34 172.79 12.16 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.399 0.619 . . . . 0.0 112.453 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.4 m170 74.57 4.98 4.49 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.412 1.485 . . . . 0.0 114.777 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.643 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 20.7 m -68.04 154.34 8.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.984 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.62 -33.2 15.95 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.139 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.3 ttmt -159.24 163.32 35.97 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -124.88 142.97 51.09 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.21 169.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--N 1.31 -1.136 0 CA-C-N 118.82 0.736 . . . . 0.0 109.199 177.741 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 28.5 m-80 . . . . . 0 CA--C 1.5 -0.964 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 10.3 ptpp? -53.97 99.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.924 -173.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.05 125.07 40.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.951 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -90.82 170.41 10.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -36.93 115.93 0.32 Allowed Glycine 0 C--N 1.364 2.124 0 O-C-N 124.28 0.988 . . . . 0.0 114.108 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.0 tp -140.22 162.1 36.07 Favored 'General case' 0 N--CA 1.407 -2.593 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -139.04 21.88 2.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.163 0.982 . . . . 0.0 109.234 -173.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.612 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 55.4 mtt180 -125.75 110.36 13.65 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.2 -49.14 45.0 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 124.753 1.168 . . . . 0.0 114.826 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.9 mp0 -81.06 -19.96 42.64 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.478 0.656 . . . . 0.0 110.848 -174.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 43.6 t0 -80.86 -36.69 31.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.47 71.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.654 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.65 -22.69 64.12 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.79 -31.95 41.28 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.85 0.46 . . . . 0.0 111.853 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -78.13 -30.95 49.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.925 0.869 . . . . 0.0 110.62 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -30.69 33.81 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.1 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.02 -26.8 67.87 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.119 0.968 . . . . 0.0 109.296 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 -20.67 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.076 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.94 37.09 0.45 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.21 35.92 21.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.305 1.042 . . . . 0.0 110.768 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 -68.48 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.922 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.467 ' OH ' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -176.71 161.74 2.11 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 123.668 0.605 . . . . 0.0 109.78 -176.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.81 152.42 19.34 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 5' ' ' LYS . . . -128.81 80.95 0.35 Allowed Glycine 0 CA--C 1.491 -1.407 0 C-N-CA 119.386 -1.388 . . . . 0.0 112.412 -172.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.75 152.12 40.93 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.173 -0.514 . . . . 0.0 109.943 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.4 pt -114.0 155.45 15.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 54.8 m-85 -81.22 86.65 6.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.787 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -121.0 123.76 70.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.29 103.84 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.714 1.206 . . . . 0.0 114.206 -174.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p 61.93 21.84 12.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 115.077 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 135.89 36.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.884 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.87 21.17 0.74 Allowed 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.731 2.287 . . . . 0.0 112.524 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -125.12 -11.8 6.99 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 72.4 m -153.82 117.13 4.58 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.36 137.16 32.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 122.15 0.976 . . . . 0.0 110.945 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.33 171.78 7.14 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.244 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.7 p -43.85 -33.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.382 1.473 . . . . 0.0 113.405 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.55 -56.98 7.35 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.164 0.507 . . . . 0.0 111.08 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.9 mt-30 -69.77 -37.09 76.26 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.05 0.452 . . . . 0.0 110.296 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.49 -20.85 65.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.6 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -69.48 -23.78 63.68 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.47 -43.99 12.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.077 0.941 . . . . 0.0 108.664 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 42' ' ' GLN . 20.4 t -65.05 -33.42 63.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.05 -176.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.93 -17.8 65.08 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.084 0.469 . . . . 0.0 111.535 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.85 -25.38 21.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.781 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.47 -39.69 18.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.965 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 103.76 9.22 Favored Pre-proline 0 N--CA 1.398 -3.03 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.42 45.08 0.96 Allowed 'Trans proline' 0 CA--C 1.552 1.387 0 C-N-CA 123.298 2.666 . . . . 0.0 113.255 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -88.53 -179.62 6.1 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.694 0.797 . . . . 0.0 111.842 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 25' ' ' TYR . 4.4 tt0 -82.76 145.4 29.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.553 0.741 . . . . 0.0 110.936 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.17 146.26 43.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.458 0.647 . . . . 0.0 110.252 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 p -133.24 145.52 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.03 140.2 12.56 Favored Glycine 0 C--O 1.196 -2.241 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.006 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.2 t -128.26 122.46 58.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -169.36 156.07 6.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -90.64 93.33 9.22 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.99 0.9 . . . . 0.0 109.694 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -102.15 118.49 37.0 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -87.71 -28.19 21.93 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.579 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.59 122.49 40.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.09 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.2 -35.29 73.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.438 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.18 -17.54 61.36 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.486 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.32 -29.5 31.03 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.43 -47.63 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 63' ' ' ILE . 55.5 t -60.53 -37.2 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.879 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 72' ' ' VAL . 18.4 t70 -52.92 -61.33 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.472 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.48 -42.06 92.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.891 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -57.8 -38.92 76.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 124.288 0.992 . . . . 0.0 111.606 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.31 -53.11 5.98 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 123.224 0.328 . . . . 0.0 111.513 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 68' ' ' ASP . 50.0 t -55.08 -56.04 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 40' ' ' VAL . 40.6 tp -79.94 -21.87 43.33 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.3 m 63.23 79.38 0.26 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 122.213 1.006 . . . . 0.0 110.336 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.12 -179.03 6.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.007 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.6 -39.32 2.31 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.52 160.64 40.78 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.273 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.78 136.69 35.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.88 111.62 24.04 Favored 'General case' 0 N--CA 1.391 -3.418 0 C-N-CA 123.257 0.623 . . . . 0.0 109.446 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.99 154.51 19.16 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.205 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -93.47 96.38 9.86 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 172.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.497 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -72.64 -12.32 77.74 Favored Glycine 0 C--N 1.306 -1.107 0 CA-C-N 114.225 -1.352 . . . . 0.0 114.845 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -49.6 -25.83 3.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.584 1.154 . . . . 0.0 111.932 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -52.33 -45.56 65.69 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.544 0.738 . . . . 0.0 112.444 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.53 149.03 0.96 Allowed 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -77.56 -43.64 31.17 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.19 0.995 . . . . 0.0 110.416 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.18 -13.65 60.18 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.605 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.588 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.6 t80 -62.64 -41.13 98.87 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.385 174.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.497 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -61.35 -40.97 88.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.96 -19.17 65.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.836 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.4 m -83.04 -42.69 17.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.605 HD13 HG13 ' A' ' 63' ' ' ILE . 4.1 mm? -53.44 -44.01 68.51 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.453 0.701 . . . . 0.0 111.216 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' HD12 ' A' ' 102' ' ' ILE . 8.2 mmm180 -43.59 -37.5 2.56 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.245 1.418 . . . . 0.0 111.866 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.95 -45.54 18.33 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.024 -173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.0 -18.31 47.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.61 0.719 . . . . 0.0 112.379 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -99.9 134.7 20.78 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.446 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.18 165.42 31.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.391 2.06 . . . . 0.0 109.668 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.05 -11.3 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.239 0.543 . . . . 0.0 111.255 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.49 -29.41 62.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.872 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.75 127.56 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -105.91 167.4 9.81 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.445 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.443 HD12 ' HD2' ' A' ' 93' ' ' ARG . 93.6 mt -125.27 129.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.597 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.6 m0 -120.65 152.7 37.85 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.869 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.23 124.74 50.06 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.37 98.15 1.05 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.167 -173.375 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 . . . . . 0 N--CA 1.419 -2.025 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -78.43 166.16 22.94 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.768 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 m170 75.57 8.5 3.76 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.896 0.878 . . . . 0.0 112.47 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.57 143.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.08 -43.14 65.32 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.88 -173.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 39.4 ttmt -159.11 164.34 35.39 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -118.3 157.83 26.33 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.54 171.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp . . . . . 0 C--N 1.301 -1.535 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.025 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 . . . . . 0 C--O 1.207 -1.163 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -46.34 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.03 121.57 23.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.446 0.641 . . . . 0.0 111.497 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.7 p -101.33 168.35 9.6 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 9' ' ' LEU . . . -2.65 -110.9 0.0 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 125.178 1.371 . . . . 0.0 116.149 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' GLY . 54.4 tp 77.49 165.09 0.23 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.518 0.775 . . . . 0.0 111.229 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -138.07 -14.5 1.36 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.972 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.55 112.24 24.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.732 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.606 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -50.34 -41.4 40.03 Favored Glycine 0 C--O 1.209 -1.462 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.719 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.753 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -57.88 -39.94 79.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.513 1.125 . . . . 0.0 108.916 -178.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 9' ' ' LEU . 13.2 t70 -79.2 -30.71 43.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.325 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.35 63.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.808 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 9.5 mtmp? -61.02 -24.85 66.49 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.293 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -32.43 74.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.621 0.368 . . . . 0.0 111.507 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.97 72.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.648 1.213 . . . . 0.0 109.722 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -30.29 44.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.063 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.67 -23.1 66.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.375 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.09 65.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.971 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.26 13.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 114.449 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.27 26.48 13.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.852 0.861 . . . . 0.0 110.867 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 47.9 mt -63.93 -67.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.341 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -176.23 155.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -174.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.24 143.59 14.61 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.01 82.89 0.34 Allowed Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.036 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.478 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -118.64 141.93 48.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 120.847 0.356 . . . . 0.0 110.165 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.451 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -108.02 151.6 10.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -81.83 79.82 8.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.833 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 34' ' ' SER . 61.3 t -112.17 129.57 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.81 106.75 0.28 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p 65.38 16.72 10.68 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.958 1.703 . . . . 0.0 114.889 172.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 22.7 p -83.16 124.43 76.3 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.839 -0.538 . . . . 0.0 110.332 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -9.27 18.78 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.062 1.841 . . . . 0.0 114.886 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -112.74 12.65 19.67 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.485 -0.76 . . . . 0.0 111.662 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HB2' ' OG ' ' A' ' 34' ' ' SER . 85.8 m -152.58 118.09 5.31 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.37 138.37 26.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.2 1.0 . . . . 0.0 112.606 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -104.31 168.68 8.94 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.769 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.2 p -53.38 -30.01 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 124.063 0.852 . . . . 0.0 112.03 -171.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 54.6 mp0 -61.88 -55.64 27.58 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 124.541 1.137 . . . . 0.0 112.1 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 31.2 mt-30 -70.39 -38.22 74.64 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 121.464 0.65 . . . . 0.0 109.925 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -61.04 -27.16 68.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.501 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 47' ' ' MET . 2.3 tp-100 -61.42 -36.36 80.1 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.64 0.776 . . . . 0.0 112.101 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 13.1 pt-20 -86.07 -43.15 13.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.552 1.168 . . . . 0.0 109.011 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 6.9 t -55.22 -32.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.205 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 14.3 ptp -62.99 -31.42 72.54 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.37 0.605 . . . . 0.0 110.721 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.37 58.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.009 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.27 -48.1 7.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.74 99.58 15.32 Favored Pre-proline 0 N--CA 1.391 -3.394 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.23 55.49 3.54 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.811 2.34 . . . . 0.0 111.711 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -96.23 171.29 8.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.35 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 2.9 tt0 -72.29 142.9 48.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.263 0.225 . . . . 0.0 110.453 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB2' HD23 ' A' ' 75' ' ' LEU . 16.8 m-85 -115.11 139.89 49.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.3 p -129.41 146.89 33.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.64 129.66 6.95 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.842 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.6 t -114.37 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -148.81 152.98 37.46 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 29.0 ptt180 -86.29 93.74 9.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 4.7 m-20 -67.28 116.09 7.67 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 122.865 1.317 . . . . 0.0 112.124 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -108.19 -72.71 0.71 Allowed 'General case' 0 C--N 1.255 -3.515 0 CA-C-N 112.552 -2.113 . . . . 0.0 108.814 171.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.11 108.94 12.97 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.849 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -62.37 -34.71 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.038 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.71 -22.86 63.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.104 0.478 . . . . 0.0 110.7 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 12.7 t70 -85.67 -33.74 21.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.225 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.06 -32.4 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.046 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' ILE . 89.8 t -64.99 -33.52 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.2 t70 -56.89 -57.99 10.1 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.73 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -60.75 -40.84 93.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.16 -39.02 77.74 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.755 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -83.83 -53.58 5.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.616 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 68' ' ' ASP . 44.7 t -56.63 -56.55 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.232 0.613 . . . . 0.0 111.754 -174.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 40' ' ' VAL . 51.4 tp -80.41 -13.91 58.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.099 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 18.8 p 55.54 77.42 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.378 1.071 . . . . 0.0 112.272 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 54' ' ' TYR . 92.6 mt -74.77 175.08 8.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.867 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -122.79 -35.88 2.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.126 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.88 157.76 44.04 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -140.13 141.12 34.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -99.97 128.08 46.1 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.349 0.595 . . . . 0.0 112.053 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.461 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -98.25 122.42 41.39 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.389 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -84.52 98.9 10.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.652 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.63 -12.86 42.85 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.591 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.47 -33.19 1.62 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.172 1.389 . . . . 0.0 113.127 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 13.0 mm-40 -66.07 -48.24 71.66 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -179.61 149.89 0.39 Allowed 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.75 -44.86 26.37 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 112.45 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.65 -20.38 43.21 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.746 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.561 ' O ' ' HB ' ' A' ' 91' ' ' THR . 42.9 t80 -58.49 -36.05 73.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.931 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.652 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -61.17 -37.8 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.609 0.719 . . . . 0.0 109.137 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.622 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 14.7 t70 -70.07 -21.01 63.2 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.088 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.561 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.1 m -78.54 -42.44 29.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.514 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -48.51 -49.13 37.27 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.559 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.08 -33.09 37.73 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.229 0.538 . . . . 0.0 112.361 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 33.6 mt-10 -73.16 -42.59 62.61 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.105 -174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.95 25.87 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.86 135.64 42.5 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.698 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 165.13 33.63 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 121.972 1.781 . . . . 0.0 110.599 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.64 -15.85 54.01 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.034 0.934 . . . . 0.0 112.152 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.12 -30.12 66.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.2 t -107.33 129.5 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.235 0 CA-C-O 121.376 0.608 . . . . 0.0 110.629 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.71 170.83 8.29 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.461 HG23 HD23 ' A' ' 80' ' ' LEU . 73.6 mt -125.77 129.73 72.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.1 m0 -118.9 157.98 26.6 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.689 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -100.94 123.39 45.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.31 116.96 10.35 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp . . . . . 0 C--N 1.287 -2.15 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.254 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 82' ' ' GLY . 79.5 m-85 . . . . . 0 N--CA 1.417 -2.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.3 164.36 26.79 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.668 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 93' ' ' ARG . 23.3 m170 71.54 7.18 5.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.696 1.599 . . . . 0.0 112.201 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.64 152.1 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -81.4 -41.6 21.67 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 120.998 0.428 . . . . 0.0 111.349 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.0 mttt -145.78 163.03 36.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.301 0.64 . . . . 0.0 109.676 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -116.83 139.6 50.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.44 166.87 20.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--N 1.292 -1.907 0 CA-C-O 121.519 0.676 . . . . 0.0 111.72 -176.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.417 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 15.0 p-10 . . . . . 0 CA--C 1.504 -0.797 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -57.08 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.502 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -95.37 124.26 47.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.493 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.0 m -92.0 170.52 9.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.93 135.42 8.86 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 119.046 0.839 . . . . 0.0 115.06 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -150.07 153.12 35.92 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' HD13 ' A' ' 9' ' ' LEU . 8.6 t -118.51 8.03 11.97 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.641 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.433 ' H ' HD12 ' A' ' 9' ' ' LEU . 71.7 mtm180 -117.73 114.64 23.63 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.118 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.24 -39.44 71.4 Favored Glycine 0 C--O 1.216 -1.024 0 O-C-N 123.626 0.578 . . . . 0.0 113.639 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.663 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -66.2 -26.09 67.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 122.005 0.907 . . . . 0.0 109.264 -177.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -89.57 -51.96 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.493 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.13 69.53 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.99 -22.39 62.49 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.374 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.07 -30.78 27.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.971 0.508 . . . . 0.0 111.451 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 -43.28 64.77 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.542 0.687 . . . . 0.0 109.824 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -34.03 73.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.71 -23.46 66.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 125.172 1.389 . . . . 0.0 110.018 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.89 -13.94 59.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.94 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.53 10.4 0.27 Allowed Glycine 0 C--O 1.225 -0.458 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.535 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.2 19.37 8.74 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.491 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 37.8 mt -57.86 -67.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.16 -171.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.01 157.69 2.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -132.05 140.9 12.2 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.46 91.08 0.51 Allowed Glycine 0 CA--C 1.471 -2.673 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 155.88 34.73 Favored 'General case' 0 N--CA 1.401 -2.921 0 CA-C-N 114.567 -0.816 . . . . 0.0 109.182 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.602 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 3.5 pt -116.95 151.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.554 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 49.7 m-85 -84.19 79.02 9.67 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.427 1.079 . . . . 0.0 109.796 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.8 t -109.8 119.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.58 103.84 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.829 1.331 . . . . 0.0 113.483 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.6 p 59.39 29.28 18.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.638 1.575 . . . . 0.0 113.491 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -107.26 104.11 51.02 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.07 3.93 0.66 Allowed 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.776 2.984 . . . . 0.0 115.029 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -84.43 -10.64 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 46.6 m -138.4 172.13 13.35 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.89 136.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.57 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -106.7 164.09 12.38 Favored 'General case' 0 CA--C 1.465 -2.327 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.742 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 HD23 ' A' ' 73' ' ' LEU . 11.4 p -45.58 -35.44 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 124.806 1.316 . . . . 0.0 112.049 -174.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.97 -38.81 86.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.489 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.9 mt-30 -80.79 -34.94 33.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.339 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -62.38 -32.81 73.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.023 -175.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -62.98 -31.08 72.12 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.96 -47.3 59.73 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.116 0.96 . . . . 0.0 108.641 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 42' ' ' GLN . 40.9 t -65.0 -30.5 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.819 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 24.6 ptt? -67.08 -17.6 64.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.304 0.574 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.87 25.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.996 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.55 -43.33 6.9 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.298 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -127.52 93.76 39.74 Favored Pre-proline 0 N--CA 1.386 -3.628 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.75 57.06 3.02 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.455 2.104 . . . . 0.0 111.968 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.3 pp -96.71 179.26 5.04 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.471 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 5.4 tt0 -82.94 143.27 30.81 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 20.6 m-85 -113.65 138.08 50.69 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.8 p -132.41 139.86 49.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -125.18 141.13 12.82 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.541 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.602 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 29.2 t -124.43 134.82 65.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -167.09 159.64 13.25 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.661 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -85.93 93.59 8.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -87.99 125.67 34.66 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.834 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -94.94 -58.0 2.28 Favored 'General case' 1 C--N 1.241 -4.111 0 CA-C-N 112.775 -2.011 . . . . 0.0 108.96 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.87 123.37 43.08 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.559 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 92' ' ' LEU . 17.4 tt -64.23 -29.74 48.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.33 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.17 -13.82 58.95 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.078 0.466 . . . . 0.0 110.315 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 14.0 t70 -86.25 -39.25 16.75 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.816 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 80' ' ' LEU . 14.9 p -77.82 -37.63 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.293 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.13 -32.0 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 9.3 t70 -54.8 -55.64 27.93 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.472 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 43.2 mmtm -63.59 -41.56 98.33 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -56.98 -38.92 73.7 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.316 1.01 . . . . 0.0 110.996 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -81.96 -52.88 6.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.354 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 77.5 t -56.1 -54.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -82.9 -11.47 58.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.41 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t 61.97 74.67 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.683 0.754 . . . . 0.0 109.498 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.5 mt -82.74 179.91 7.63 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.439 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.74 -32.96 2.31 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.7 160.53 43.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.3 171.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 6.2 p -150.0 141.02 16.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.82 111.36 23.68 Favored 'General case' 0 N--CA 1.385 -3.691 0 CA-C-O 121.824 0.821 . . . . 0.0 109.353 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.592 HD13 ' HG ' ' A' ' 92' ' ' LEU . 36.3 mt -115.72 89.17 3.04 Favored 'General case' 0 CA--C 1.422 -3.945 0 N-CA-C 101.369 -3.567 . . . . 0.0 101.369 -169.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -98.04 174.37 6.58 Favored 'General case' 1 N--CA 1.362 -4.859 0 C-N-CA 117.873 -1.531 . . . . 0.0 113.299 -167.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -48.96 -10.51 0.14 Allowed Glycine 1 C--N 1.243 -4.584 0 CA-C-N 110.863 -2.881 . . . . 0.0 117.468 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -44.72 -44.73 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -49.72 6.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.956 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 1.1 tm-20 178.94 170.33 0.89 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -77.88 -49.85 13.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.519 1.152 . . . . 0.0 109.389 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 37.1 mt -72.97 -13.6 61.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.99 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.4 t80 -60.34 -48.99 79.36 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 1.9 mp -59.75 -36.69 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.687 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 24.4 t70 -60.08 -27.1 66.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.636 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.9 m -88.15 -43.68 11.47 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 124.708 1.203 . . . . 0.0 110.141 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 80' ' ' LEU . 4.1 mm? -43.93 -44.0 6.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.687 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 1.7 mpt_? -56.55 -29.74 62.31 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.271 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -77.95 -35.13 50.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.382 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.81 0.86 50.01 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.433 0.635 . . . . 0.0 110.806 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.415 HD22 HG13 ' A' ' 102' ' ' ILE . 27.2 tp -75.79 124.49 88.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 124.053 0.941 . . . . 0.0 109.479 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.01 161.57 44.41 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.078 1.852 . . . . 0.0 110.988 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.22 70.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 124.464 1.106 . . . . 0.0 113.354 -172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -88.86 -10.9 46.31 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.494 HG21 ' HB1' ' A' ' 70' ' ' ALA . 65.6 t -107.68 140.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.86 172.67 6.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.55 HG12 HD12 ' A' ' 80' ' ' LEU . 53.8 mt -116.41 131.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.652 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 40.8 m0 -121.02 159.17 26.19 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.393 171.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 120' ' ' VAL . 40.0 ttpt -100.73 115.18 29.66 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 107.63 5.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp . . . . . 0 N--CA 1.417 -2.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 -175.093 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 N--CA 1.424 -1.742 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -115.01 -178.64 3.41 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.625 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t60 65.44 28.42 11.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.221 1.408 . . . . 0.0 108.505 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 104' ' ' LYS . 27.3 m -87.26 149.99 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.77 -41.29 45.28 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.402 0.62 . . . . 0.0 111.058 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 45.2 mmtm -143.78 162.32 36.32 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -127.13 138.68 53.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.96 171.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--N 1.312 -1.044 0 O-C-N 123.411 0.445 . . . . 0.0 110.602 -179.339 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.72 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.191 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.18 98.06 0.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.935 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.12 124.7 53.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.736 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.1 p -91.99 169.8 10.36 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 37' ' ' CYS . . . -46.76 126.7 10.07 Favored Glycine 0 CA--C 1.493 -1.299 0 O-C-N 123.64 0.588 . . . . 0.0 113.771 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.3 tp -143.06 161.0 39.32 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -134.35 -18.9 1.95 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.683 0.754 . . . . 0.0 109.948 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.73 105.69 9.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.937 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 16' ' ' LYS . . . -48.37 -44.85 28.44 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 124.64 1.114 . . . . 0.0 114.224 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.7 mp0 -76.18 -22.27 55.53 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.335 0.588 . . . . 0.0 110.856 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.52 -30.46 23.41 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.15 48.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 17.5 ptpt -64.69 -22.51 67.0 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 -37.71 78.89 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.801 0.334 . . . . 0.0 110.567 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.98 -38.01 66.81 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 110.181 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HD1' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -67.72 -34.61 77.2 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.9 -31.29 72.42 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.486 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.28 64.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.069 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.32 -21.7 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.467 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB2' ' HD1' ' A' ' 19' ' ' TYR . . . 61.93 27.04 16.41 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.985 0.898 . . . . 0.0 109.019 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.72 ' HB ' HD21 ' A' ' 4' ' ' ASN . 28.5 mt -69.92 -59.64 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.909 -171.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -178.36 161.92 1.45 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 145.72 16.28 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.35 73.99 0.21 Allowed Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.482 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.79 154.94 26.55 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-O 121.172 0.511 . . . . 0.0 110.264 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 5.7 pt -116.78 152.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -79.57 79.43 6.04 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 124.741 1.275 . . . . 0.0 111.239 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.25 116.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 115.09 2.75 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.777 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.4 p 66.02 14.67 9.73 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.086 1.754 . . . . 0.0 115.126 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.8 m -93.58 114.67 63.58 Favored Pre-proline 0 C--O 1.197 -1.696 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.35 26.48 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 124.28 3.32 . . . . 0.0 115.285 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 20.4 ptt180 -124.92 -5.15 7.46 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 36' ' ' ARG . 60.8 m -136.65 166.75 22.83 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -143.94 136.4 23.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -102.46 170.52 8.0 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.685 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 73' ' ' LEU . 5.9 p -56.41 -31.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 123.809 0.693 . . . . 0.0 111.1 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 4.3 mp0 -70.88 -46.87 61.84 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 124.149 0.979 . . . . 0.0 111.505 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 49.7 mm-40 -61.76 -49.31 76.92 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -63.89 -21.47 66.48 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.287 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 47' ' ' MET . 3.8 tp-100 -63.99 -39.32 93.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.527 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.8 pt-20 -85.93 -45.41 11.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.754 0.788 . . . . 0.0 110.427 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 95.4 t -48.97 -35.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 125.307 1.443 . . . . 0.0 112.249 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 16.5 ptp -64.22 -20.56 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 120.823 0.344 . . . . 0.0 111.493 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.37 -28.74 28.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.34 -45.5 13.68 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.75 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -133.66 98.12 15.16 Favored Pre-proline 0 N--CA 1.397 -3.119 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.69 46.73 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.88 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -84.33 152.28 24.21 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.686 177.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.7 140.41 49.7 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.411 0.625 . . . . 0.0 112.428 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.04 143.73 39.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -113.46 128.78 8.5 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.782 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.585 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 21.2 t -113.74 106.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.57 146.59 15.09 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.471 -173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.406 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 59.0 mtm180 -93.11 93.37 8.26 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 15.4 m120 -90.25 154.91 19.38 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 122.656 1.217 . . . . 0.0 110.526 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' CD2' ' H ' ' A' ' 62' ' ' ASP . 16.1 p-80 -100.89 -73.43 0.64 Allowed 'General case' 0 C--N 1.245 -3.953 0 CA-C-N 111.445 -2.616 . . . . 0.0 112.17 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' H ' ' CD2' ' A' ' 61' ' ' HIS . 45.0 t0 -81.77 131.91 35.27 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 92' ' ' LEU . 5.9 tt -60.02 -32.68 50.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.041 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.61 -18.76 61.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.326 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.6 -35.21 53.11 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.436 0.636 . . . . 0.0 109.288 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.52 -44.05 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.7 t -60.55 -39.28 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.577 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 15.3 t70 -57.1 -61.79 2.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.172 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 45.6 mmtm -63.72 -39.7 94.93 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 -176.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.36 -35.02 76.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.812 0.695 . . . . 0.0 111.417 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -82.37 -56.54 3.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -53.32 -56.47 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.352 0.661 . . . . 0.0 111.628 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.718 ' HB2' HG23 ' A' ' 40' ' ' VAL . 45.4 tp -82.78 -17.31 44.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.488 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 39.9 m 60.59 80.55 0.21 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.226 1.012 . . . . 0.0 111.182 -176.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 73' ' ' LEU . 74.1 mt -85.46 -175.06 5.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.578 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -127.97 -36.79 1.96 Allowed 'General case' 0 C--O 1.193 -1.912 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -146.0 159.27 43.49 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.36 0.6 . . . . 0.0 111.534 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.4 p -140.58 138.64 35.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.611 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 13.2 mm-40 -98.46 105.59 17.75 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 123.459 0.703 . . . . 0.0 109.393 -175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HG ' ' A' ' 92' ' ' LEU . 75.2 mt -116.13 139.52 50.23 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.941 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 p80 175.54 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.121 0.888 . . . . 0.0 110.165 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 59' ' ' ARG . . . -74.71 -55.39 5.44 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 120.434 2.933 . . . . 0.0 120.434 -166.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ASN . 2.8 t-20 -82.79 -69.1 0.65 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.97 -48.93 12.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -168.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -177.89 172.0 1.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.566 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 21.6 mt-30 -78.44 -43.98 25.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 125.242 1.417 . . . . 0.0 107.235 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 54.7 mt -71.42 -14.39 62.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.326 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 22.9 t80 -65.38 -40.25 93.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.982 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.469 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.0 -30.38 49.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.628 0.728 . . . . 0.0 110.015 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.68 ' HA ' ' NH1' ' A' ' 93' ' ' ARG . 23.9 t70 -67.54 -22.64 65.4 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.47 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.9 m -89.63 -44.92 9.72 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.305 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 88' ' ' TYR . 3.2 mm? -47.89 -46.37 31.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.68 ' NH1' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.02 -24.33 64.42 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.069 -173.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.04 -34.43 38.28 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.988 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.96 -22.17 22.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.854 0.835 . . . . 0.0 111.409 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -88.09 140.13 30.74 Favored Pre-proline 0 C--N 1.276 -2.614 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.707 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.43 164.91 34.14 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 121.134 1.223 . . . . 0.0 109.018 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.1 3.95 6.28 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.496 0.665 . . . . 0.0 111.638 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -86.07 -24.85 26.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 70' ' ' ALA . 97.1 t -105.09 131.88 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.54 171.36 7.91 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 93' ' ' ARG . 65.1 mt -124.52 133.42 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.611 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.9 m0 -121.05 155.37 34.54 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.162 -1.415 . . . . 0.0 109.622 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -102.39 123.28 45.89 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 115.21 8.87 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 170.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 C--N 1.293 -1.867 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.062 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 33.3 m-85 . . . . . 0 N--CA 1.434 -1.27 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -110.12 157.16 19.67 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.4 m80 69.05 33.77 3.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 111.818 -2.446 . . . . 0.0 111.113 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.49 142.06 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.73 -43.09 66.46 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.379 0.609 . . . . 0.0 111.153 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.2 mttm -145.14 163.18 35.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -124.68 143.39 50.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.56 174.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--N 1.311 -1.081 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.932 178.894 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.619 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.2 p-10 . . . . . 0 CA--C 1.497 -1.086 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 21.3 pttp -67.89 91.99 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.11 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.36 125.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.169 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 70.0 m -91.38 169.26 10.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.519 ' H ' ' HA ' ' A' ' 37' ' ' CYS . . . -19.53 105.85 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 O-C-N 124.919 1.387 . . . . 0.0 116.037 -169.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.22 135.86 18.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 9.45 2.7 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.912 0.863 . . . . 0.0 110.123 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -86.41 112.52 21.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.34 -53.5 5.8 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.419 1.009 . . . . 0.0 114.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.23 -19.91 60.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.799 0.839 . . . . 0.0 111.871 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.73 -36.51 17.31 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.73 -47.96 67.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.805 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 21.5 ptmt -63.35 -23.45 67.42 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.828 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.3 69.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.229 0.537 . . . . 0.0 110.805 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.06 -37.41 58.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -72.13 -33.33 67.71 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.296 0.57 . . . . 0.0 109.926 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.92 -25.69 67.26 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.19 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.66 -24.09 56.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.905 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.63 1.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 119.103 -1.522 . . . . 0.0 113.884 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.08 11.72 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.768 0.827 . . . . 0.0 111.463 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.619 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 23.1 mt -63.57 -69.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.845 -172.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.82 156.26 1.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -176.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -121.7 146.68 17.17 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.67 72.08 0.21 Allowed Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.249 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.47 144.36 39.39 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 121.216 0.532 . . . . 0.0 109.6 -179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.649 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 31.3 mt -117.62 157.04 19.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.755 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.628 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 24.3 m-85 -83.59 56.14 3.49 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.677 0.672 . . . . 0.0 111.137 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.16 120.33 33.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -44.0 96.74 0.01 OUTLIER 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.083 1.489 . . . . 0.0 113.892 -172.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 p 55.85 23.78 6.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.577 1.551 . . . . 0.0 114.368 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -100.53 109.98 58.93 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.96 2.33 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.902 3.068 . . . . 0.0 115.079 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 12.4 ptm85 -74.19 -19.66 60.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -142.87 174.56 10.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.48 136.72 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 119.331 0.969 . . . . 0.0 110.292 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -101.15 167.45 10.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.001 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.3 p -51.57 -29.6 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.209 0.943 . . . . 0.0 112.996 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -65.96 -50.13 65.44 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.005 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.7 mt-30 -73.03 -40.04 65.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.231 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.92 64.6 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.834 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -37.68 70.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.076 0.95 . . . . 0.0 109.402 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.37 -43.19 17.71 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.032 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 42' ' ' GLN . 12.0 t -65.28 -39.07 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.928 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.413 ' SD ' HD12 ' A' ' 73' ' ' LEU . 27.6 ptt? -62.2 -24.02 66.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.445 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.86 -25.8 29.98 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.209 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.61 -42.51 14.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.126 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -130.23 99.93 19.08 Favored Pre-proline 0 N--CA 1.39 -3.472 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.47 50.04 2.23 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -91.98 174.76 7.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.616 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 17.8 mt-30 -71.33 127.87 34.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.701 0.286 . . . . 0.0 111.446 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' OH ' HG12 ' A' ' 46' ' ' VAL . 45.1 m-85 -100.93 141.52 33.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.2 p -127.03 158.73 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.51 135.25 7.47 Favored Glycine 0 CA--C 1.462 -3.228 0 C-N-CA 119.26 -1.448 . . . . 0.0 112.617 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.571 ' HB ' HG23 ' A' ' 29' ' ' ILE . 44.4 t -115.26 142.59 27.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.462 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 28.2 t80 -172.06 157.05 4.22 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.982 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -85.98 93.2 8.9 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 58' ' ' PHE . 50.0 m-80 -89.53 118.1 28.92 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -92.17 -59.47 2.09 Favored 'General case' 1 C--N 1.237 -4.311 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.573 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.88 125.39 38.48 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.001 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.551 HG13 HD13 ' A' ' 92' ' ' LEU . 15.6 tt -65.65 -29.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.258 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -19.32 59.06 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.812 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.05 -26.05 39.87 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.804 0.812 . . . . 0.0 108.875 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.06 -44.73 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.0 t -60.3 -36.77 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.3 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.8 t70 -54.86 -58.31 8.1 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.373 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -65.74 -40.91 92.6 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.63 -29.42 70.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.778 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -84.15 -59.96 2.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.954 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' ASP . 52.2 t -50.55 -59.83 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.502 0.721 . . . . 0.0 111.909 -176.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.611 ' HB2' HG23 ' A' ' 40' ' ' VAL . 33.3 tp -78.3 -21.26 49.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.6 m 59.56 73.65 0.47 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.006 0.908 . . . . 0.0 109.835 -173.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 HD23 ' A' ' 73' ' ' LEU . 73.2 mt -72.13 -179.14 2.69 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.835 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' CB ' ' HG2' ' A' ' 53' ' ' GLN . . . -127.7 -44.19 1.52 Allowed 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -137.25 157.61 46.26 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.717 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.6 p -141.83 140.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.07 124.7 49.03 Favored 'General case' 0 N--CA 1.395 -3.187 0 O-C-N 121.874 -0.516 . . . . 0.0 110.914 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -103.91 137.34 42.03 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.499 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.26 99.46 12.24 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -60.17 -12.98 25.98 Favored Glycine 0 C--N 1.312 -0.789 0 CA-C-N 114.811 -1.086 . . . . 0.0 115.494 -175.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.92 -26.3 62.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.948 0.404 . . . . 0.0 110.186 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.13 -47.27 85.33 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 39.5 tt0 178.31 146.44 0.14 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.451 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 47.8 mt-30 -76.12 -44.25 39.43 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 122.485 1.136 . . . . 0.0 109.594 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 45.6 mt -72.84 -13.33 61.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.092 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 29.5 t80 -64.97 -39.22 93.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.692 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -61.83 -38.74 81.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.727 0.775 . . . . 0.0 109.391 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.4 t70 -64.01 -22.12 66.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.096 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.9 m -86.29 -42.08 14.04 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.056 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.551 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -49.87 -38.29 34.9 Favored 'General case' 0 C--O 1.21 -1.007 0 C-N-CA 123.196 0.599 . . . . 0.0 111.953 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' NE ' HD13 ' A' ' 102' ' ' ILE . 18.2 mmm-85 -63.93 -27.18 68.97 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.906 0.86 . . . . 0.0 111.368 -176.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -79.65 -47.84 14.71 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.776 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.71 -22.78 29.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.38 130.15 31.56 Favored Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.179 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.73 165.85 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.639 2.226 . . . . 0.0 111.492 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.64 -17.56 47.96 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.986 0.914 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -70.73 -29.33 65.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.288 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' A' ' 70' ' ' ALA . 72.6 t -107.47 136.76 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -113.22 167.97 10.11 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.563 HG23 HD23 ' A' ' 80' ' ' LEU . 2.3 mp -125.72 133.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.543 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 43.0 m0 -121.96 164.71 17.15 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -115.36 124.64 51.75 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.57 107.54 4.5 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.802 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.2 tp . . . . . 0 C--N 1.28 -2.436 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.995 -177.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 94.7 m-85 . . . . . 0 N--CA 1.415 -2.217 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -76.14 163.63 26.9 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.601 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.2 m170 67.47 21.7 9.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.047 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.75 149.95 3.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -85.55 -45.52 11.69 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.497 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.7 mttm -146.14 161.95 39.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.064 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -106.98 145.4 32.31 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.47 161.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.4 mt . . . . . 0 C--N 1.301 -1.521 0 CA-C-O 121.221 0.534 . . . . 0.0 111.448 -177.718 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.24 0.555 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -57.24 99.79 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.106 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.6 131.19 51.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.857 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m -91.6 170.65 9.76 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.52 127.58 3.78 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.735 0.647 . . . . 0.0 114.076 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.504 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.4 tp -134.65 173.15 11.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -138.83 13.85 2.69 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.232 1.015 . . . . 0.0 109.467 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 99.1 mtt180 -124.62 112.66 17.06 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.537 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.12 -41.7 99.55 Favored Glycine 0 C--N 1.302 -1.345 0 CA-C-O 122.207 0.893 . . . . 0.0 112.816 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -69.51 -35.16 75.25 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.524 1.13 . . . . 0.0 109.407 -176.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 13.0 t70 -77.13 -30.29 55.06 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.38 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.12 -32.61 72.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.429 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 9.8 mtmp? -62.22 -31.93 72.53 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.568 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.772 0.32 . . . . 0.0 111.565 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.6 52.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.464 176.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.86 -30.42 71.41 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 124.168 0.987 . . . . 0.0 110.361 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.34 60.9 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.082 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.89 -19.17 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.636 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.95 25.48 15.08 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-O 121.832 0.825 . . . . 0.0 109.416 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.18 -67.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.026 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.71 157.63 1.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 124.124 0.89 . . . . 0.0 110.014 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -117.68 163.9 12.71 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.71 78.36 0.38 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.237 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.482 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.87 151.86 39.13 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 120.895 0.379 . . . . 0.0 110.026 -176.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.524 HG13 ' SG ' ' A' ' 37' ' ' CYS . 2.2 pt -116.97 154.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 176.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CE1' ' HA3' ' A' ' 56' ' ' GLY . 20.1 m-85 -84.6 86.72 7.28 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 124.16 0.913 . . . . 0.0 109.855 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 91.5 t -116.54 122.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.16 107.17 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 0.0 112.86 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p 62.2 27.33 16.42 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.598 1.559 . . . . 0.0 113.298 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -79.0 140.9 58.04 Favored Pre-proline 0 C--N 1.308 -1.21 0 O-C-N 121.885 -0.509 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.68 8.31 4.49 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 0.0 111.152 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -120.4 -4.92 9.87 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.807 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 61.6 m -153.27 128.28 9.65 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -173.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.46 137.9 30.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.353 0.597 . . . . 0.0 111.026 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.98 169.51 8.53 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.886 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -47.87 -30.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.256 1.022 . . . . 0.0 113.115 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.01 -36.74 67.06 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.2 mt-30 -86.0 -34.21 20.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -25.88 68.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.58 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -30.82 71.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.806 0.843 . . . . 0.0 109.211 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -78.46 -50.92 10.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' GLN . 43.0 t -58.6 -35.01 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.602 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -64.28 -26.74 68.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.74 -14.72 25.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.39 0.614 . . . . 0.0 110.028 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.98 -48.79 6.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.663 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -131.77 104.03 14.4 Favored Pre-proline 0 N--CA 1.398 -3.069 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -176.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.55 65.36 4.67 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.012 1.808 . . . . 0.0 112.395 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.66 162.41 13.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.599 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -81.2 151.82 28.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -177.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.92 148.71 42.65 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 121.978 -0.451 . . . . 0.0 110.248 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.2 p -133.5 154.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -129.92 141.73 12.93 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.153 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 25.6 t -136.43 126.67 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -173.04 173.75 3.62 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -87.48 120.15 28.49 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -95.64 117.35 30.3 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -99.23 -59.02 1.8 Allowed 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.2 114.14 26.58 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.389 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' HG22 ' A' ' 91' ' ' THR . 16.8 tt -65.8 -30.43 50.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.935 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.33 65.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.06 -41.51 22.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.8 -46.73 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.942 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.5 t -59.9 -41.22 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.678 0.611 . . . . 0.0 109.61 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.1 t70 -54.6 -60.75 2.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 123.841 0.713 . . . . 0.0 110.98 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -63.55 -47.77 80.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.239 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -60.3 -29.85 69.11 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 124.04 0.837 . . . . 0.0 111.855 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -84.04 -57.07 3.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.404 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 68' ' ' ASP . 66.2 t -51.26 -58.62 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.008 0.523 . . . . 0.0 112.179 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 tp -81.23 -19.44 43.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 31.6 t 61.01 77.69 0.32 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.165 0.986 . . . . 0.0 111.25 -175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -78.56 -167.62 1.14 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 124.822 1.249 . . . . 0.0 110.872 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.759 ' O ' ' HA ' ' A' ' 100' ' ' VAL . . . -127.69 -74.83 0.58 Allowed 'General case' 1 C--O 1.148 -4.256 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 170.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -104.3 158.06 16.71 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 118.352 -1.339 . . . . 0.0 111.875 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -139.75 138.6 38.76 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.79 132.67 43.19 Favored 'General case' 0 N--CA 1.392 -3.341 0 CA-C-O 121.591 0.71 . . . . 0.0 112.342 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -105.82 115.3 30.0 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.681 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -81.55 97.48 7.85 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.95 -11.73 3.24 Favored Glycine 0 C--N 1.313 -0.739 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -42.69 -29.7 0.32 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.469 1.508 . . . . 0.0 114.586 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.44 -48.62 69.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -178.37 154.08 0.79 Allowed 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.476 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -78.39 -46.07 20.85 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 122.208 1.004 . . . . 0.0 109.913 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.408 ' HB2' ' OE2' ' A' ' 85' ' ' GLU . 38.9 mt -77.58 -13.61 59.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.944 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.55 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.6 t80 -62.9 -35.91 81.61 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.983 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.58 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -64.82 -33.24 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.958 0.885 . . . . 0.0 109.646 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 93' ' ' ARG . 25.0 t70 -70.55 -15.66 62.79 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.878 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 92.5 m -89.32 -46.6 8.64 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 124.498 1.119 . . . . 0.0 110.208 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -44.54 -56.47 4.3 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.15 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -68.01 -6.44 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 40.4 mt-10 -88.41 -35.39 17.13 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.87 -16.04 27.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.955 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 97.8 mt -85.89 143.2 37.38 Favored Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.069 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.45 ' HG2' HG23 ' A' ' 100' ' ' VAL . 33.6 Cg_endo -66.65 165.99 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.729 2.286 . . . . 0.0 111.111 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -9.14 15.52 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.542 0.737 . . . . 0.0 112.65 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -82.24 -29.24 31.42 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 46.8 t -93.32 136.5 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -170.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -123.41 166.92 14.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.284 1.033 . . . . 0.0 108.367 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.489 HG23 HD23 ' A' ' 80' ' ' LEU . 1.8 mp -115.82 133.19 63.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.568 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.7 m0 -117.67 150.0 39.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.303 -1.359 . . . . 0.0 107.93 170.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.69 116.9 33.68 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.67 103.1 2.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp . . . . . 0 N--CA 1.427 -1.617 0 CA-C-O 121.456 0.646 . . . . 0.0 111.25 -171.092 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 26.2 m-85 . . . . . 0 N--CA 1.426 -1.648 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.42 178.56 5.32 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.867 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 m170 68.24 20.98 8.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 111.822 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 145.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.425 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.77 -41.48 17.55 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.949 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 65.1 mttp -145.54 162.81 36.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.029 0.442 . . . . 0.0 110.859 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -114.49 136.45 53.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.236 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 174.6 12.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD13 ' H ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.309 -1.169 0 CA-C-O 121.104 0.478 . . . . 0.0 111.56 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 2.9 p-10 . . . . . 0 CA--C 1.504 -0.819 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -38.49 98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.317 -2.22 . . . . 0.0 113.753 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 26' ' ' GLY . 3.1 m -84.5 112.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.135 173.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -91.0 169.02 11.23 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -40.66 119.78 1.47 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 -172.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -158.37 146.2 18.27 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -133.21 15.38 4.16 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.51 1.147 . . . . 0.0 110.367 -172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 81.2 mtt180 -107.56 115.65 30.53 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.44 -52.99 34.05 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-O 122.138 0.854 . . . . 0.0 111.784 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.619 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.8 mp0 -55.86 -25.21 41.26 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 126.107 1.763 . . . . 0.0 112.773 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 9.1 t0 -94.14 -43.86 8.28 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.01 73.34 Favored 'General case' 0 C--O 1.251 1.139 0 C-N-CA 124.583 1.153 . . . . 0.0 112.138 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.07 -24.4 64.55 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.881 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.73 -26.57 68.42 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 -45.36 12.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.427 0.632 . . . . 0.0 109.329 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -60.28 -35.59 75.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.184 176.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.96 -30.09 13.98 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.251 1.421 . . . . 0.0 111.862 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.61 -22.95 62.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.18 7.46 0.09 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.46 -1.353 . . . . 0.0 113.879 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.56 23.03 11.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.306 1.043 . . . . 0.0 111.765 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 36.7 mt -57.85 -66.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.471 -170.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.02 152.91 1.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.575 0.547 . . . . 0.0 110.642 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 6' ' ' VAL . . . -125.44 153.32 18.11 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.23 85.2 0.36 Allowed Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.533 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.21 150.47 32.28 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.31 0.576 . . . . 0.0 109.842 -177.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.3 pt -115.99 150.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.027 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -82.73 76.69 9.56 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.788 -171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 37' ' ' CYS . 52.3 t -119.36 120.42 63.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.74 97.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.554 1.542 . . . . 0.0 114.498 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.421 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 74.5 p 62.02 9.82 3.29 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 127.013 2.125 . . . . 0.0 116.021 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -68.51 136.49 90.75 Favored Pre-proline 0 C--O 1.206 -1.235 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.68 4.02 0.98 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.169 2.579 . . . . 0.0 115.429 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.648 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 2.6 tpm_? -124.93 9.77 8.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.611 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' HA3' ' A' ' 8' ' ' GLY . 65.9 m -141.3 154.13 45.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.4 t -136.22 137.14 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.712 0.767 . . . . 0.0 109.587 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -119.26 177.13 5.01 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.459 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 73' ' ' LEU . 68.9 t -38.37 -40.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.021 1.451 . . . . 0.0 113.423 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.12 -58.93 5.18 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.611 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 33' ' ' THR . 32.2 mt-30 -74.36 -33.89 63.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.072 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -65.1 -31.64 72.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -63.0 -35.6 80.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.85 -44.8 12.14 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.611 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.8 p -64.87 -30.61 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -69.47 -21.42 63.71 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.02 -9.29 58.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.196 0.522 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.99 -46.07 4.57 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.27 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.9 99.13 20.55 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.41 67.42 6.27 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.156 1.904 . . . . 0.0 112.247 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.98 165.88 10.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.528 174.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 161.67 27.62 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.679 0.218 . . . . 0.0 110.932 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.82 143.49 50.77 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 26' ' ' GLY . 10.2 p -133.65 156.26 41.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -126.34 136.54 9.59 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.767 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.511 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.5 t -123.94 128.54 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 32.8 t80 -171.59 162.04 6.33 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.258 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 83' ' ' ASN . 58.2 ttt180 -96.39 92.2 6.2 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 17.4 m120 -102.84 124.79 49.01 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.554 ' CD2' HD22 ' A' ' 83' ' ' ASN . 65.7 m80 -94.33 -46.09 7.19 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.184 178.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.67 124.61 29.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.67 -33.9 66.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.053 0.454 . . . . 0.0 110.278 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.93 64.2 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.684 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.78 -36.69 36.75 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.39 -48.37 77.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.506 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.3 t -60.23 -39.82 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.16 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 72' ' ' VAL . 20.8 t70 -54.34 -61.47 2.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 111.319 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.2 -38.93 92.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.253 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -35.08 79.89 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.492 0.495 . . . . 0.0 111.672 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.24 -50.98 11.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 54.8 t -61.26 -55.72 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.15 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 40' ' ' VAL . 86.7 mt -79.61 -8.51 59.23 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p 52.7 67.7 0.95 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.976 0.893 . . . . 0.0 111.907 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.18 -177.56 6.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.309 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.29 -36.92 1.88 Allowed 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.09 160.3 41.14 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 174.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.67 140.72 33.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.715 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -104.35 105.25 15.31 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.59 97.99 6.46 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -124.96 -22.77 4.4 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.154 0.502 . . . . 0.0 112.094 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.38 -55.96 1.62 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -168.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.554 HD22 ' CD2' ' A' ' 61' ' ' HIS . 20.6 p-10 -83.25 -69.91 0.6 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -159.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.308 36.0 mm-40 -88.67 -49.41 6.88 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -157.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -174.97 166.35 3.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 119.505 1.048 . . . . 0.0 109.448 -173.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.51 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 19.4 mm-40 -73.92 -48.45 30.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 71.4 mt -81.87 -12.8 58.29 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.138 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 91' ' ' THR . 23.3 t80 -59.62 -35.95 75.36 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.73 -34.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.727 0.775 . . . . 0.0 110.246 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 28.8 t70 -64.7 -22.96 67.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.594 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.1 m -83.54 -40.12 19.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.487 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.05 -43.65 66.81 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 122.976 0.51 . . . . 0.0 110.631 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.687 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.6 mmm180 -43.98 -39.2 3.92 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.438 1.495 . . . . 0.0 112.098 176.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.43 -44.45 35.81 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.091 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.39 -7.97 58.03 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.58 147.96 35.92 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.42 163.75 38.0 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.268 1.312 . . . . 0.0 109.2 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.46 66.88 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.146 0.579 . . . . 0.0 112.54 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -88.72 1.63 54.81 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.7 t -110.9 127.97 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -119.4 173.94 6.67 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.346 0.593 . . . . 0.0 111.99 -170.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.687 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.6 mp -126.05 133.08 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.502 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 49.2 m0 -121.52 157.31 30.95 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -100.4 116.22 31.85 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.6 110.78 4.39 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 169.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 121.765 0.793 . . . . 0.0 112.548 -170.36 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 85.7 m-85 . . . . . 0 N--CA 1.407 -2.603 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -72.02 136.64 46.77 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . 0.295 18.0 m170 79.48 33.35 0.21 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 111.816 -2.447 . . . . 0.0 112.596 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.78 137.95 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.97 -48.02 48.02 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.787 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -150.84 162.44 40.75 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -111.89 149.15 32.27 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.484 HG22 HD23 ' A' ' 125' ' ' LEU . 11.0 p -133.33 178.77 5.14 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 125' ' ' LEU . 1.9 pt? . . . . . 0 C--N 1.3 -1.573 0 CA-C-N 119.007 0.821 . . . . 0.0 109.944 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER . . . . . 0 CA--C 1.487 -1.459 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -57.88 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.861 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 m -91.26 138.0 20.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.67 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 73.6 m -91.09 170.0 10.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -31.35 106.61 0.02 OUTLIER Glycine 0 C--N 1.358 1.762 0 O-C-N 124.395 1.059 . . . . 0.0 115.725 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -120.02 144.02 47.76 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -113.82 -19.62 11.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.315 1.055 . . . . 0.0 110.583 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 98.9 mtt180 -92.48 117.49 29.99 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.197 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -64.84 -30.39 77.84 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.204 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 mm-40 -73.43 -23.74 60.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 122.762 1.268 . . . . 0.0 108.195 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 5.7 t0 -88.49 -39.94 13.82 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.466 -174.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.67 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.307 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 52.1 mtmt -61.12 -28.05 68.82 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.985 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.54 63.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.734 0.302 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 4' ' ' ASN . . . -78.91 -39.98 33.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.996 0.903 . . . . 0.0 109.143 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -67.68 -30.74 70.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.174 175.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.31 -25.1 21.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.963 1.305 . . . . 0.0 111.847 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -14.04 62.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.839 0.456 . . . . 0.0 111.516 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.37 31.9 0.88 Allowed Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.07 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.61 36.64 24.04 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.94 -69.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.663 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.8 161.36 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 124.032 0.833 . . . . 0.0 110.244 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.01 150.55 17.01 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.06 75.58 0.28 Allowed Glycine 0 CA--C 1.494 -1.274 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.628 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 153.27 34.88 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.649 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.1 pt -116.88 157.32 17.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 50.5 m-85 -80.31 77.13 7.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.825 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 59.0 t -109.54 118.43 56.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.06 112.07 1.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.273 0.983 . . . . 0.0 112.355 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.3 p 64.05 26.4 14.02 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.196 1.798 . . . . 0.0 112.979 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -84.6 139.05 37.99 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.78 7.66 4.24 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.786 1.657 . . . . 0.0 112.13 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 9.7 ptm180 -118.54 -6.05 10.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.175 0.512 . . . . 0.0 109.902 174.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 79.4 m -151.22 119.6 6.4 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.28 137.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 122.113 0.959 . . . . 0.0 111.25 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.7 p-10 -104.78 169.14 8.62 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.39 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 ' HD2' ' A' ' 69' ' ' LYS . 99.5 t -47.76 -35.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 124.922 1.289 . . . . 0.0 112.391 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 41.2 mt-10 -66.67 -48.47 69.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.29 -40.85 67.26 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.284 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.06 64.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.838 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -30.58 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.4 -51.51 6.18 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.3 -35.29 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.024 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -64.97 -24.29 67.47 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.68 19.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.04 -51.71 23.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.245 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -132.65 107.37 13.0 Favored Pre-proline 0 N--CA 1.407 -2.587 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.16 56.41 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.689 2.26 . . . . 0.0 113.397 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.7 pp -91.49 169.96 10.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -85.63 146.95 26.62 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.49 144.94 44.55 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.384 0.611 . . . . 0.0 111.761 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.26 163.59 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.04 128.74 3.99 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.347 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 43.5 t -105.42 123.16 59.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -149.91 151.5 33.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.13 109.54 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.17 117.13 27.93 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.86 -59.91 1.76 Allowed 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.377 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -95.44 115.08 26.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -63.95 -30.98 51.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.212 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.84 -16.8 60.68 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.212 0.53 . . . . 0.0 110.092 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.2 t70 -85.29 -31.95 22.79 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.55 -43.75 80.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.202 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 63' ' ' ILE . 97.5 t -57.41 -43.94 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.9 t70 -52.39 -61.26 2.39 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.902 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 40' ' ' VAL . 45.2 mmtm -62.15 -44.58 96.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.253 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -63.76 -27.45 69.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.348 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -84.16 -60.31 2.13 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.135 0.574 . . . . 0.0 110.915 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -54.91 -55.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.616 0.766 . . . . 0.0 111.813 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -82.48 -21.58 35.51 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 17.0 m 61.8 84.76 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.001 0.905 . . . . 0.0 110.77 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.0 -170.17 2.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.86 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.425 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -125.15 -40.53 2.14 Favored 'General case' 0 CA--C 1.462 -2.417 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.66 33.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.922 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.7 p -142.85 135.67 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.7 mp0 -101.29 116.98 34.05 Favored 'General case' 0 N--CA 1.386 -3.631 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.3 158.51 15.83 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.542 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -97.86 93.68 6.48 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -69.59 -12.83 67.62 Favored Glycine 0 C--N 1.311 -0.849 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -49.82 -26.57 4.09 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.072 0.949 . . . . 0.0 112.19 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -51.85 -45.78 64.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 37.1 tt0 -177.57 132.63 0.16 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.4 -35.53 79.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.085 0.945 . . . . 0.0 110.664 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.48 -15.62 57.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.591 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 38.8 t80 -68.62 -31.89 71.37 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.2 mp -64.34 -40.39 88.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.02 -13.64 62.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.79 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 93.9 m -86.98 -44.02 11.93 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.872 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -47.02 -48.08 22.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.783 0.433 . . . . 0.0 110.62 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.7 mpt_? -43.15 -31.1 0.53 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.24 -38.84 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.082 0.468 . . . . 0.0 111.419 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.99 -18.13 22.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.67 0.748 . . . . 0.0 112.496 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.42 129.3 30.75 Favored Pre-proline 0 C--N 1.27 -2.889 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.66 165.53 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.056 1.837 . . . . 0.0 110.264 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.54 -3.37 17.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.269 0.557 . . . . 0.0 111.139 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -79.87 -23.12 42.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.953 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.78 141.87 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.0 169.9 9.27 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.475 0.31 . . . . 0.0 110.37 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.615 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.0 mp -122.65 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.584 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.4 m0 -120.86 162.45 19.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -99.7 120.81 40.29 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.8 100.56 3.48 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp . . . . . 0 C--N 1.296 -1.751 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.676 -175.387 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 . . . . . 0 CA--C 1.475 -1.931 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -84.53 155.58 22.06 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.373 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 62.6 47.85 4.69 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.197 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.23 155.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.98 -25.4 34.81 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 103' ' ' TRP . 41.1 ttmt -169.76 163.41 9.86 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -127.9 144.46 51.1 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.48 175.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp . . . . . 0 C--N 1.308 -1.208 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.944 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 21' ' ' ALA . 34.3 t-20 . . . . . 0 CA--C 1.498 -1.021 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.97 130.48 15.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.558 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 26.3 t -100.74 109.15 24.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.351 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.2 m -93.76 168.68 10.84 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -23.56 106.63 0.01 OUTLIER Glycine 0 C--N 1.371 2.503 0 O-C-N 124.496 1.123 . . . . 0.0 115.795 -171.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.2 tp -154.37 141.55 19.45 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -136.17 8.68 3.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.82 0.819 . . . . 0.0 109.238 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 95.1 mtt180 -92.43 112.79 24.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.53 -37.1 80.8 Favored Glycine 0 C--N 1.298 -1.556 0 O-C-N 123.194 0.308 . . . . 0.0 113.131 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.629 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -68.58 -26.89 65.61 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.184 0.994 . . . . 0.0 109.391 -177.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.469 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 8.1 t0 -90.27 -39.01 13.02 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.105 -175.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.08 -42.45 89.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -62.34 -23.92 67.04 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.1 69.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.494 . . . . 0.0 110.28 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG ' ' A' ' 4' ' ' ASN . . . -79.01 -40.99 30.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.752 0.787 . . . . 0.0 110.346 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -68.9 -31.76 70.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.733 177.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.75 -16.18 47.26 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' HD22 ' A' ' 4' ' ' ASN . . . -78.08 -6.15 53.74 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.63 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 15.0 1.56 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.43 -1.366 . . . . 0.0 113.286 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.51 28.73 17.38 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.178 0.991 . . . . 0.0 110.783 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.69 -69.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.258 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.5 p90 -177.79 163.37 1.83 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 124.039 0.837 . . . . 0.0 109.184 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.96 126.8 5.56 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.93 85.25 0.82 Allowed Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -119.01 146.92 44.64 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CG2' ' HB ' ' A' ' 57' ' ' VAL 0.332 0.1 OUTLIER -116.92 148.92 19.32 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 179.653 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 52.8 m-85 -74.76 87.73 2.23 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.315 -174.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.7 t -117.59 120.86 66.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.02 106.56 0.17 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.537 1.148 . . . . 0.0 113.625 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.0 p 63.91 19.63 11.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.489 1.916 . . . . 0.0 114.189 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.8 p -87.15 146.57 40.57 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.749 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.28 13.52 2.07 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.049 1.833 . . . . 0.0 109.929 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -100.15 -25.84 14.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.123 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 82.8 m -155.97 141.75 17.97 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -106.16 137.7 35.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.287 -171.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.43 168.72 9.34 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.777 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 73' ' ' LEU . 4.5 p -52.76 -33.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 124.338 1.024 . . . . 0.0 111.781 -171.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -69.62 -42.1 74.8 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.704 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.8 mt-30 -74.35 -41.34 61.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.768 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.08 66.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.39 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -64.29 -30.83 71.87 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.87 -42.3 27.69 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 42' ' ' GLN . 22.1 t -64.22 -35.37 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.935 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -16.3 64.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.39 -17.02 37.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.649 . . . . 0.0 109.586 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.82 -32.2 11.47 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.429 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 93.9 11.54 Favored Pre-proline 0 N--CA 1.39 -3.462 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.68 61.74 5.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.503 2.135 . . . . 0.0 111.739 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 19' ' ' TYR . 1.1 pp -100.88 173.15 6.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.935 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' ALA . 35.8 tt0 -79.69 138.01 37.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.1 0.56 . . . . 0.0 111.101 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 28' ' ' LEU . 22.8 m-85 -108.89 140.62 42.1 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.99 137.82 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -108.66 122.07 6.48 Favored Glycine 0 N--CA 1.412 -2.913 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.645 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 79' ' ' GLN . 15.2 t -114.23 106.46 20.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -160.54 146.17 14.87 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.55 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -91.19 91.88 8.42 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.48 159.4 26.98 Favored 'General case' 0 N--CA 1.387 -3.622 0 CA-C-O 123.427 1.584 . . . . 0.0 111.911 -173.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -110.63 -73.68 0.67 Allowed 'General case' 1 C--N 1.23 -4.625 0 CA-C-N 110.792 -2.913 . . . . 0.0 111.105 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.01 132.78 36.76 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 92' ' ' LEU . 10.6 tt -67.44 -31.16 51.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.78 -19.72 65.13 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 18.6 t70 -82.42 -39.98 21.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.491 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -46.98 85.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.974 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 63' ' ' ILE . 75.5 t -60.39 -40.18 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.624 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -56.26 -61.64 2.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.78 177.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 44.1 mmtm -62.34 -40.36 96.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.382 0.273 . . . . 0.0 111.448 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.85 -41.1 97.42 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.299 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -80.46 -48.71 12.43 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.681 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 68' ' ' ASP . 81.3 t -56.13 -54.94 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 123.403 0.44 . . . . 0.0 111.286 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.623 ' HB2' HG23 ' A' ' 40' ' ' VAL . 47.7 tp -82.54 -14.26 55.22 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.302 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 t 61.95 63.9 1.06 Allowed 'General case' 0 C--O 1.254 1.317 0 CA-C-O 121.891 0.853 . . . . 0.0 109.279 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.479 HD21 HD23 ' A' ' 73' ' ' LEU . 92.3 mt -66.18 179.63 0.92 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.358 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.419 ' CB ' ' HG3' ' A' ' 53' ' ' GLN . . . -125.13 -39.73 2.21 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -142.01 156.35 45.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.417 173.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.3 p -140.38 141.95 32.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.653 HE22 ' HB2' ' A' ' 103' ' ' TRP . 15.3 mm-40 -104.12 109.45 21.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 122.971 0.508 . . . . 0.0 111.664 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 92' ' ' LEU . 3.2 mm? -114.48 136.99 52.4 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 175.88 -29.7 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.301 0 CA-C-O 121.678 0.751 . . . . 0.0 109.899 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.02 -55.67 1.95 Allowed Glycine 0 C--N 1.286 -2.228 0 N-CA-C 119.749 2.659 . . . . 0.0 119.749 -166.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -82.55 -69.76 0.6 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 119.316 3.08 . . . . 0.0 119.316 -160.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.52 -49.6 6.58 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -161.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 1.0 OUTLIER -168.09 172.27 8.88 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.511 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 36.3 mt-30 -76.87 -48.99 16.75 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.387 1.075 . . . . 0.0 108.867 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.2 mt -75.96 -13.97 60.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.691 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.472 ' O ' ' HB ' ' A' ' 91' ' ' THR . 25.9 t80 -59.03 -37.07 76.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.673 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 80' ' ' LEU . 1.8 mp -65.53 -34.45 70.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 21.4 t70 -69.1 -22.73 63.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 87.2 m -83.8 -44.33 14.48 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.115 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.54 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -44.86 -50.12 10.5 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -54.15 -29.18 44.48 Favored 'General case' 0 N--CA 1.516 2.825 0 CA-C-O 121.284 0.564 . . . . 0.0 112.258 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 28.5 mt-10 -76.72 -30.44 56.64 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.521 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 -9.25 19.02 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.559 0.695 . . . . 0.0 112.561 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.6 tp -94.85 129.29 36.4 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.525 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 17.9 Cg_endo -65.0 165.1 22.53 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.828 1.685 . . . . 0.0 111.153 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.93 -5.15 32.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.159 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 97' ' ' PRO . 6.0 m-70 -81.01 -29.4 35.17 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 70' ' ' ALA . 38.9 t -108.06 135.37 46.99 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.042 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.11 169.02 8.81 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 94.4 mt -122.94 128.27 75.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.653 ' HB2' HE22 ' A' ' 79' ' ' GLN . 41.8 m0 -116.74 161.01 19.92 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.221 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' HG11 ' A' ' 120' ' ' VAL . 7.9 tmtm? -102.5 112.21 24.84 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.85 115.56 13.43 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 tp . . . . . 0 C--N 1.283 -2.293 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.067 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 75.7 m-85 . . . . . 0 N--CA 1.431 -1.396 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -98.13 169.49 9.57 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HB3' ' NH2' ' A' ' 93' ' ' ARG . 37.3 t60 63.51 31.96 14.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 104' ' ' LYS . 31.5 m -83.15 154.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.947 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.76 -41.22 62.76 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.158 0.504 . . . . 0.0 110.454 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -150.32 163.02 39.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.48 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.83 137.43 54.93 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.59 171.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 C--N 1.303 -1.414 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.645 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.505 -0.787 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.61 -175.64 19.76 Favored Glycine 0 N--CA 1.425 -2.039 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.695 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.5 mp0 -50.09 -62.68 1.43 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 125.398 1.479 . . . . 0.0 111.501 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.578 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -149.28 25.83 0.88 Allowed 'General case' 0 CA--C 1.5 -0.977 0 CA-C-O 122.237 1.017 . . . . 0.0 108.607 -175.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 12.4 ptpt -91.55 97.6 11.15 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.8 p -106.46 146.74 12.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 113.082 -1.872 . . . . 0.0 109.741 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.5 p -87.7 170.13 11.52 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.29 122.12 2.36 Favored Glycine 0 CA--C 1.482 -1.98 0 O-C-N 124.117 0.886 . . . . 0.0 114.886 -166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 14' ' ' ASP . 25.1 tp -140.72 128.54 21.77 Favored 'General case' 0 N--CA 1.399 -2.978 0 N-CA-C 104.845 -2.28 . . . . 0.0 104.845 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -120.77 12.83 11.44 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 123.093 1.425 . . . . 0.0 109.439 -169.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 33.2 mtp85 -108.65 112.34 24.61 Favored 'General case' 0 N--CA 1.416 -2.13 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.504 176.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.23 -31.94 66.74 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 116.552 -0.295 . . . . 0.0 113.793 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.618 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -72.22 -20.03 61.63 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 122.274 1.035 . . . . 0.0 108.887 -177.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.508 ' HB3' HD21 ' A' ' 9' ' ' LEU . 1.3 m-20 -95.53 -45.3 7.13 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.659 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.36 72.53 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.81 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -59.11 -23.94 62.54 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.89 -30.27 71.26 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 111.241 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -83.04 -35.05 26.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 122.218 1.009 . . . . 0.0 108.772 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -68.43 -38.27 81.05 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.332 176.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.9 -26.19 62.22 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.219 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.46 -23.66 61.08 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.146 178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' HA3' HG13 ' A' ' 24' ' ' ILE . . . 176.0 -25.88 0.06 OUTLIER Glycine 0 N--CA 1.41 -3.07 0 C-N-CA 119.96 -1.114 . . . . 0.0 113.038 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 63.85 21.1 12.52 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-O 121.875 0.845 . . . . 0.0 109.597 -175.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.578 ' HB ' HD21 ' A' ' 4' ' ' ASN . 25.0 mt -70.52 -60.65 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.041 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -178.04 151.31 0.66 Allowed 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.707 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -117.8 159.62 14.09 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.54 79.98 0.26 Allowed Glycine 0 CA--C 1.505 -0.575 0 CA-C-N 117.535 0.667 . . . . 0.0 111.934 -174.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.59 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -117.44 149.3 40.79 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 121.135 0.493 . . . . 0.0 109.986 -174.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.3 mt -117.65 150.19 19.8 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.244 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.469 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 7.9 m-85 -81.87 75.47 8.81 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.194 0.308 . . . . 0.0 111.702 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 87.9 t -98.48 122.13 49.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 171.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.69 108.84 0.23 Allowed 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.271 1.028 . . . . 0.0 113.629 -174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.7 p 62.55 26.59 15.8 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 126.586 1.954 . . . . 0.0 114.234 172.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.4 m -90.56 139.83 26.6 Favored Pre-proline 0 N--CA 1.428 -1.538 0 C-N-CA 119.304 -0.958 . . . . 0.0 111.2 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -87.18 16.12 2.02 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.156 1.904 . . . . 0.0 111.244 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -125.57 -3.81 7.23 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.13 177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 87.4 m -156.7 120.72 4.35 Favored 'General case' 0 C--O 1.208 -1.086 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -102.0 137.45 29.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 122.27 1.033 . . . . 0.0 111.978 -171.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.4 p-10 -103.52 170.69 7.79 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 113.771 -1.559 . . . . 0.0 109.08 178.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 p -43.64 -39.02 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.611 1.194 . . . . 0.0 112.687 -177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 44.3 mt-10 -68.81 -48.66 63.02 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.626 -175.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.662 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.2 mt-30 -68.64 -40.15 80.41 Favored 'General case' 0 C--O 1.2 -1.504 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.526 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.54 -40.26 74.79 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -64.91 -29.65 70.61 Favored 'General case' 0 N--CA 1.404 -2.76 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 179.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.12 -45.16 24.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 114.801 -1.09 . . . . 0.0 108.894 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 42' ' ' GLN . 48.2 t -59.53 -36.37 64.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.124 -178.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -71.24 -8.1 51.32 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.0 -7.24 43.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.495 0.664 . . . . 0.0 109.304 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.23 -48.15 3.21 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.207 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -134.91 104.73 10.6 Favored Pre-proline 0 N--CA 1.41 -2.46 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -72.42 61.66 3.49 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 123.008 2.472 . . . . 0.0 113.073 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.79 144.39 28.92 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.306 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.629 ' NE2' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -73.5 154.93 39.7 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.131 0.972 . . . . 0.0 109.361 -175.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 65.5 m-85 -118.22 155.39 30.6 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-O 121.556 0.693 . . . . 0.0 112.494 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 26' ' ' GLY . 8.4 p -131.19 164.52 34.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 177.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.469 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.2 147.2 18.9 Favored Glycine 0 C--O 1.204 -1.778 0 C-N-CA 120.285 -0.959 . . . . 0.0 112.448 177.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.478 ' HA ' ' HB2' ' A' ' 79' ' ' GLN . 45.7 t -125.34 106.35 16.19 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.092 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -152.63 140.1 19.65 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.256 -1.778 . . . . 0.0 112.103 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 4.5 ptt180 -103.18 95.28 6.01 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 170.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -103.06 151.57 22.37 Favored 'General case' 1 N--CA 1.369 -4.515 0 CA-C-N 114.104 -1.407 . . . . 0.0 108.562 -170.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -85.22 -49.11 8.47 Favored 'General case' 1 C--N 1.233 -4.474 0 CA-C-N 113.286 -1.779 . . . . 0.0 108.394 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -99.1 129.08 45.34 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.998 -176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 67' ' ' VAL . 11.7 tt -67.55 -32.82 58.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.169 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -19.16 63.0 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.198 0.523 . . . . 0.0 110.485 -175.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.47 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 37.2 t70 -83.01 -27.1 30.61 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.277 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.5 t -76.03 -43.56 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 175.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 63' ' ' ILE . 50.9 t -59.54 -41.21 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.386 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.562 ' O ' HG23 ' A' ' 72' ' ' VAL . 19.3 t70 -50.72 -55.99 14.06 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.611 176.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 40.9 mmtm -66.02 -44.65 84.11 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.575 -176.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HA ' ' HG ' ' A' ' 75' ' ' LEU . . . -56.85 -35.28 68.68 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 123.973 0.796 . . . . 0.0 111.044 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -83.91 -58.46 2.78 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.474 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 68' ' ' ASP . 68.0 t -49.4 -58.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.447 0.699 . . . . 0.0 112.746 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -86.2 -16.59 37.28 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 118.74 -1.184 . . . . 0.0 110.532 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 27.7 t 62.28 88.84 0.09 Allowed 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 124.606 1.191 . . . . 0.0 109.059 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.489 ' HG ' ' HA ' ' A' ' 70' ' ' ALA . 77.7 mt -84.07 177.01 8.43 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.93 -178.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.629 ' HB2' ' NE2' ' A' ' 53' ' ' GLN . . . -115.6 -40.68 3.35 Favored 'General case' 0 CA--C 1.451 -2.85 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -147.05 164.76 31.99 Favored 'General case' 0 N--CA 1.406 -2.652 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.892 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.78 135.23 25.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.501 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.35 117.3 32.45 Favored 'General case' 0 N--CA 1.388 -3.559 0 CA-C-O 121.26 0.552 . . . . 0.0 110.064 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.22 129.98 45.49 Favored 'General case' 0 C--N 1.27 -2.853 0 CA-C-N 114.44 -1.254 . . . . 0.0 108.649 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 45.1 m-70 -82.76 103.03 11.94 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 170.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -61.42 -12.95 34.83 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 115.646 -0.706 . . . . 0.0 114.367 -172.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -58.97 -25.78 63.86 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 124.993 1.317 . . . . 0.0 111.364 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -59.82 -48.64 80.87 Favored 'General case' 0 CA--C 1.552 1.022 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -176.89 150.99 0.82 Allowed 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 49.4 mt-30 -76.2 -43.41 42.54 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.98 0.895 . . . . 0.0 111.73 -171.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.0 mt -82.45 -21.56 35.61 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.396 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.49 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.9 t80 -57.12 -46.81 82.34 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.853 176.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.492 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.0 mt -61.02 -38.71 80.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.388 0.613 . . . . 0.0 109.558 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.652 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 17.9 t70 -66.99 -19.54 65.73 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.705 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.6 m -89.17 -45.71 9.36 Favored 'General case' 0 N--CA 1.42 -1.932 0 CA-C-N 114.368 -1.287 . . . . 0.0 109.972 -176.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.521 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -43.41 -50.0 6.97 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 176.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -67.05 -14.23 62.7 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -176.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -82.42 -35.37 27.67 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.58 -36.98 20.07 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-O 122.013 0.911 . . . . 0.0 111.384 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.6 mp -82.64 118.17 70.95 Favored Pre-proline 0 C--N 1.271 -2.842 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.789 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.76 165.6 20.49 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 122.937 2.425 . . . . 0.0 111.076 179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.14 4.12 1.78 Allowed 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -175.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -84.81 -29.58 25.26 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.81 133.25 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -112.45 -179.74 3.75 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 88.2 mt -126.71 134.57 65.96 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.239 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.522 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.8 m0 -119.89 147.14 45.07 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 172.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.93 118.12 36.33 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.58 106.24 2.52 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.234 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 53.3 tp -91.15 107.57 19.29 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.2 t -76.03 143.14 41.59 Favored 'General case' 0 N--CA 1.419 -2.015 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.39 115.23 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-O 121.838 0.828 . . . . 0.0 110.129 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -121.31 179.01 16.37 Favored Glycine 0 N--CA 1.415 -2.763 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.656 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -74.04 -27.88 61.15 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.197 0.522 . . . . 0.0 110.214 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 21.8 p -121.14 147.12 46.0 Favored 'General case' 0 N--CA 1.425 -1.679 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -108.0 102.41 45.72 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -73.15 137.85 26.91 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.377 2.051 . . . . 0.0 111.466 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.7 -40.33 76.37 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.533 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -140.57 127.3 20.39 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 121.475 0.655 . . . . 0.0 110.675 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.32 -68.19 0.94 Allowed 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.454 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 72.9 m-85 -135.09 120.04 18.58 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -111.71 -170.85 1.73 Allowed 'General case' 0 C--N 1.288 -2.068 0 O-C-N 123.944 0.777 . . . . 0.0 110.546 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 45.4 m80 69.82 19.97 6.93 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.462 1.105 . . . . 0.0 109.469 -173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.3 m -96.95 156.55 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 CA-C-N 113.882 -1.508 . . . . 0.0 107.272 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.87 -40.8 38.86 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-O 120.843 0.354 . . . . 0.0 111.331 -175.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 64.0 mttp -147.99 161.28 41.67 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 120.972 0.415 . . . . 0.0 110.968 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -111.25 127.3 55.57 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 m -129.65 173.55 13.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 125' ' ' LEU . 2.4 pt? -81.73 167.18 19.39 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -82.74 125.13 30.92 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 120.977 0.418 . . . . 0.0 110.183 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -117.2 23.64 11.7 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.268 177.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -122.69 20.56 7.74 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.847 -176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 69.3 114.32 0.04 OUTLIER 'General case' 0 C--O 1.242 0.702 0 C-N-CA 125.233 1.413 . . . . 0.0 112.121 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.47 145.11 4.07 Favored Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 120.21 -0.995 . . . . 0.0 112.339 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -130.26 27.8 3.95 Favored Glycine 0 C--O 1.245 0.833 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -157.3 171.37 20.53 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -78.86 65.93 3.44 Favored Glycine 0 N--CA 1.447 -0.617 0 O-C-N 123.364 0.415 . . . . 0.0 113.403 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.3 m . . . . . 0 C--N 1.305 -1.351 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 175.685 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 C--O 1.246 0.893 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.11 178.7 15.51 Favored Glycine 0 N--CA 1.418 -2.566 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.435 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -82.79 161.85 21.87 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.91 0.386 . . . . 0.0 110.047 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.487 HD22 ' HA ' ' A' ' 18' ' ' ALA . 63.6 t30 -128.57 39.11 3.87 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HG3' ' HA3' ' A' ' 27' ' ' GLY . 37.6 ttpt -43.9 114.28 0.64 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 112.245 -2.252 . . . . 0.0 111.725 177.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 m -117.63 140.72 39.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.213 178.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.7 m -91.69 168.48 11.45 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 117.354 -1.307 . . . . 0.0 107.995 174.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.15 106.01 0.01 OUTLIER Glycine 0 C--N 1.385 3.257 0 O-C-N 125.3 1.625 . . . . 0.0 116.036 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 14' ' ' ASP . 0.6 OUTLIER -135.19 130.53 35.46 Favored 'General case' 0 N--CA 1.399 -2.988 0 N-CA-C 105.898 -1.89 . . . . 0.0 105.898 -174.32 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.5 t -126.4 -18.9 4.77 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.5 mtm180 -81.2 117.06 21.42 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.688 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -44.9 -59.3 4.47 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 124.184 0.897 . . . . 0.0 114.513 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.753 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -56.8 -25.92 56.72 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 177.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB2' HD11 ' A' ' 9' ' ' LEU . 1.8 m-20 -84.15 -34.87 23.95 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.423 ' HB2' HD12 ' A' ' 9' ' ' LEU . . . -67.08 -42.24 85.0 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.332 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 49.2 mtmt -58.9 -30.39 67.75 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.515 -178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.88 -30.21 70.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.622 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HA ' HD22 ' A' ' 4' ' ' ASN . . . -77.07 -35.96 56.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.909 0.861 . . . . 0.0 109.784 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.44 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -74.82 -30.56 61.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.841 178.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -61.8 -14.14 30.28 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.783 0.801 . . . . 0.0 112.102 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.66 -13.52 61.0 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.978 175.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 128.49 26.26 0.98 Allowed Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 177.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.12 27.64 11.79 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.45 1.1 . . . . 0.0 112.062 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.3 mt -57.97 -68.88 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.669 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.802 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.523 ' OH ' ' HD3' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -178.87 162.12 1.27 Allowed 'General case' 0 C--N 1.318 -0.785 0 O-C-N 124.314 1.009 . . . . 0.0 109.151 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.513 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.05 150.53 17.21 Favored Glycine 0 C--N 1.313 -0.708 0 N-CA-C 107.62 -2.192 . . . . 0.0 107.62 177.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 5' ' ' LYS . . . -116.84 71.29 0.28 Allowed Glycine 0 CA--C 1.475 -2.441 0 C-N-CA 118.612 -1.756 . . . . 0.0 112.559 -170.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.508 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -108.97 130.78 55.47 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.357 0.598 . . . . 0.0 110.233 -179.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.0 pt -102.39 155.7 4.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 -177.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -77.95 74.16 4.51 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.009 -174.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.7 t -103.2 117.35 48.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 170.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.91 114.24 1.65 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 124.71 1.256 . . . . 0.0 112.826 -171.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.9 p 69.72 17.95 7.63 Favored 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 126.181 1.792 . . . . 0.0 113.681 173.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.0 t -83.24 141.41 42.86 Favored Pre-proline 0 N--CA 1.419 -2.014 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -91.41 4.38 4.09 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 C-N-CA 121.683 1.589 . . . . 0.0 111.193 174.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.75 5.74 10.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.745 0.783 . . . . 0.0 110.298 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 80.7 m -156.17 117.81 3.93 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 103.949 -2.612 . . . . 0.0 103.949 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.417 ' H ' ' HB2' ' A' ' 28' ' ' LEU . 1.5 t -102.74 137.0 32.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 CA-C-O 121.947 0.88 . . . . 0.0 112.381 -168.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -106.46 166.34 10.62 Favored 'General case' 0 CA--C 1.475 -1.914 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.838 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.5 p -45.01 -31.93 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 125.315 1.446 . . . . 0.0 113.143 -175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.7 -59.69 3.96 Favored 'General case' 0 N--CA 1.413 -2.286 0 C-N-CA 123.294 0.637 . . . . 0.0 111.955 178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -70.52 -33.4 71.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.663 0.744 . . . . 0.0 110.12 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.923 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.45 -26.44 68.44 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.067 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB2' HE21 ' A' ' 44' ' ' GLN . 3.4 tp-100 -63.68 -32.97 74.62 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.921 0.867 . . . . 0.0 109.493 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -85.26 -43.25 13.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.434 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.923 HG12 ' HA ' ' A' ' 43' ' ' ALA . 9.5 p -70.42 -24.28 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.319 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -15.9 63.4 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.385 0.612 . . . . 0.0 111.468 177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.6 -24.95 28.93 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.585 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.43 -45.47 12.67 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.13 104.94 18.05 Favored Pre-proline 0 N--CA 1.394 -3.227 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.53 56.23 5.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.901 2.401 . . . . 0.0 111.963 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.7 pp -97.09 177.19 5.67 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.215 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -77.51 128.64 34.52 Favored 'General case' 0 CA--C 1.487 -1.464 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.752 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD2' HD11 ' A' ' 28' ' ' LEU . 66.6 m-85 -96.85 127.32 42.72 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 173.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 26' ' ' GLY . 9.8 p -119.14 149.04 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.302 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -121.04 128.14 7.27 Favored Glycine 0 C--N 1.285 -2.256 0 C-N-CA 120.068 -1.063 . . . . 0.0 111.321 179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.5 t -125.95 107.01 16.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -165.28 158.63 16.51 Favored 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 118.649 -1.22 . . . . 0.0 109.836 -175.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.506 ' HG2' ' HB2' ' A' ' 81' ' ' HIS . 47.2 mtm180 -90.16 93.42 9.36 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.446 ' HB2' HG22 ' A' ' 66' ' ' VAL . 16.3 m120 -96.75 117.6 31.39 Favored 'General case' 0 N--CA 1.392 -3.365 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.6 m-70 -80.25 -31.32 38.45 Favored 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.783 -1.553 . . . . 0.0 109.533 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -99.19 123.62 43.62 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.973 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.562 ' CD1' HG22 ' A' ' 91' ' ' THR . 7.8 tt -61.9 -34.55 63.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.4 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.88 -20.25 61.13 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.176 0.512 . . . . 0.0 110.014 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -81.38 -35.44 30.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.949 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 60' ' ' ASN . 26.1 t -64.9 -47.2 89.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 63' ' ' ILE . 80.5 t -60.1 -42.21 89.19 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.78 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 72' ' ' VAL . 31.1 t70 -53.87 -59.89 4.04 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.316 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -67.49 -39.84 85.23 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.298 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.661 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.96 -37.91 86.52 Favored 'General case' 0 C--O 1.242 0.665 0 O-C-N 123.633 0.583 . . . . 0.0 111.172 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -73.14 -60.6 2.16 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.604 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.6 t -55.69 -53.76 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.477 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.982 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 73' ' ' LEU . 1.5 tm? -72.9 -29.28 63.02 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.298 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.4 t 67.75 74.88 0.3 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-O 122.388 1.09 . . . . 0.0 108.638 -171.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 73' ' ' LEU . 91.6 mt -77.81 -168.4 1.22 Allowed 'General case' 0 C--O 1.249 1.074 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.633 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.7 -52.39 1.24 Allowed 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.19 162.4 31.87 Favored 'General case' 0 N--CA 1.436 -1.143 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.722 173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.83 136.65 30.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.561 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.1 mp0 -105.21 115.03 29.58 Favored 'General case' 0 N--CA 1.394 -3.259 0 C-N-CA 123.177 0.591 . . . . 0.0 110.69 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -99.74 123.31 43.86 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.506 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 46.8 m-70 -77.77 108.72 11.2 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.113 -1.439 . . . . 0.0 107.113 175.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.576 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -51.9 -11.78 1.03 Allowed Glycine 0 N--CA 1.468 0.794 0 N-CA-C 116.302 1.281 . . . . 0.0 116.302 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -51.62 -26.1 8.28 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 124.422 1.089 . . . . 0.0 111.932 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -69.12 -49.34 57.87 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.686 0.279 . . . . 0.0 111.718 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.5 147.88 0.32 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 -177.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -79.45 -46.0 18.33 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-O 122.078 0.942 . . . . 0.0 111.35 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 42.3 mt -78.98 -14.32 59.27 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.029 -1.442 . . . . 0.0 110.219 -173.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' THR . 24.2 t80 -60.78 -39.9 90.56 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.347 176.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.576 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -61.38 -38.07 79.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.894 0 CA-C-O 121.817 0.818 . . . . 0.0 109.967 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 18.2 t70 -65.99 -19.78 65.97 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.328 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.562 HG22 ' CD1' ' A' ' 63' ' ' ILE . 84.2 m -88.03 -41.94 12.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.922 -179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 2.6 mm? -51.77 -39.23 58.23 Favored 'General case' 0 C--O 1.214 -0.767 0 C-N-CA 122.602 0.361 . . . . 0.0 111.359 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.73 ' HD2' HD12 ' A' ' 102' ' ' ILE . 7.9 mmm180 -46.0 -39.92 9.76 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.734 1.214 . . . . 0.0 111.546 178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -81.07 -33.27 33.52 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.782 -1.554 . . . . 0.0 112.627 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -95.52 -21.04 18.54 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.057 -0.657 . . . . 0.0 112.705 -177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.62 141.88 42.2 Favored Pre-proline 0 C--N 1.285 -2.212 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.228 177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.45 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 35.5 Cg_endo -69.11 165.03 31.63 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 C-N-CA 121.968 1.778 . . . . 0.0 110.363 176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.99 -12.11 61.39 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.706 0.765 . . . . 0.0 110.343 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 97' ' ' PRO . 3.2 m-70 -76.26 -29.13 57.36 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.292 -178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.661 HG21 ' HB1' ' A' ' 70' ' ' ALA . 85.6 t -105.9 132.73 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.771 0 CA-C-O 121.196 0.522 . . . . 0.0 109.698 -177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -103.77 168.75 8.94 Favored 'General case' 0 C--N 1.29 -1.978 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.413 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.73 HD12 ' HD2' ' A' ' 93' ' ' ARG . 66.6 mt -123.95 132.34 71.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.561 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.7 m0 -120.58 157.65 29.04 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -100.61 111.53 23.78 Favored 'General case' 0 C--N 1.276 -2.587 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.26 110.39 4.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 28.9 tp -77.96 95.33 4.78 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.221 -173.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 25.4 m -73.05 168.86 18.18 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 168.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 ' O ' HG22 ' A' ' 111' ' ' THR . 17.4 m -41.43 115.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-O 122.021 0.915 . . . . 0.0 113.01 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -44.94 -56.05 6.06 Favored Glycine 0 CA--C 1.487 -1.713 0 CA-C-N 113.731 -1.577 . . . . 0.0 116.446 -169.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.78 -3.26 17.91 Favored 'General case' 0 C--N 1.283 -2.308 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 108' ' ' VAL . 4.6 t -90.71 -11.34 39.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 117.911 -1.516 . . . . 0.0 109.423 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -103.54 142.0 23.68 Favored Pre-proline 0 N--CA 1.436 -1.127 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.72 163.58 13.12 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.217 2.611 . . . . 0.0 111.154 174.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.03 -37.8 75.02 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.025 0.441 . . . . 0.0 111.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -116.49 118.91 33.97 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -132.07 -61.51 0.88 Allowed 'General case' 0 C--N 1.275 -2.668 0 CA-C-N 115.206 -0.906 . . . . 0.0 113.034 -172.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CE1' ' HA3' ' A' ' 82' ' ' GLY . 31.5 m-85 -127.58 96.1 4.44 Favored 'General case' 0 C--N 1.292 -1.918 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -93.7 167.17 11.83 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.454 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 36.5 m80 74.12 18.62 3.12 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 124.448 1.092 . . . . 0.0 111.668 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.0 m -90.06 147.13 5.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.4 -42.66 25.0 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-O 120.89 0.376 . . . . 0.0 111.909 -176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.1 ttmt -149.27 163.3 38.05 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -175.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -122.05 139.18 54.02 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.3 m -135.04 165.75 30.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 pp -67.14 146.52 54.17 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.137 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -60.63 120.58 10.3 Favored 'General case' 0 C--O 1.248 1.001 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -75.77 14.75 0.6 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -65.88 -31.08 78.54 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 170.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -93.63 115.54 28.02 Favored 'General case' 0 C--O 1.252 1.208 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.95 40.97 13.07 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 177.38 -90.83 0.08 OUTLIER Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 68.58 117.65 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 125.12 1.368 . . . . 0.0 112.542 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -137.76 -39.42 0.12 Allowed Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.61 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.44 -0.93 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.759 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 tpt . . . . . 0 CA--C 1.51 -0.595 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -78.1 92.87 1.17 Allowed Glycine 0 N--CA 1.435 -1.379 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.01 117.43 17.72 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.542 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -149.82 29.75 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -72.7 114.42 10.82 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 113.317 -1.765 . . . . 0.0 110.72 -174.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.426 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 41.5 t -90.4 118.86 36.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.319 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 14.4 p -99.38 169.16 9.53 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 104.665 -2.346 . . . . 0.0 104.665 168.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -32.08 106.55 0.02 OUTLIER Glycine 0 C--N 1.364 2.101 0 N-CA-C 116.012 1.165 . . . . 0.0 116.012 -171.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -138.63 134.12 33.3 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -175.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -133.78 14.48 4.0 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 122.54 1.162 . . . . 0.0 109.738 -174.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 65.9 mtt180 -107.13 112.22 25.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.32 -39.74 65.92 Favored Glycine 0 C--N 1.306 -1.13 0 C-N-CA 123.642 0.639 . . . . 0.0 113.963 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -81.44 -19.23 42.9 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 123.7 0.8 . . . . 0.0 111.082 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' HD11 ' A' ' 9' ' ' LEU . 9.7 t70 -87.71 -46.02 9.86 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.77 -35.11 72.25 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.646 1.178 . . . . 0.0 111.367 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.32 -22.39 66.02 Favored 'General case' 0 C--O 1.19 -2.036 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.15 71.32 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 117.853 0.297 . . . . 0.0 111.567 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.6 -35.75 39.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 122.279 1.038 . . . . 0.0 109.468 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -70.68 -31.11 67.89 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.687 174.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -66.05 -35.23 79.99 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.763 -1.108 . . . . 0.0 109.091 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.97 -24.0 64.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.137 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 168.65 -20.43 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.282 0 C-N-CA 119.222 -1.466 . . . . 0.0 113.373 175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 19' ' ' TYR . . . 64.78 26.77 13.02 Favored 'General case' 0 C--N 1.364 1.203 0 CA-C-O 121.75 0.786 . . . . 0.0 108.882 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.542 ' HB ' HD21 ' A' ' 4' ' ' ASN . 30.9 mt -67.28 -64.56 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.654 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.796 -172.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -177.41 154.8 1.04 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.735 -176.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -130.83 137.67 9.64 Favored Glycine 0 N--CA 1.425 -2.082 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.75 80.62 0.28 Allowed Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.985 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.493 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -104.84 150.2 25.03 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.557 0.694 . . . . 0.0 110.154 179.436 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.281 5.5 pt -105.91 151.71 7.89 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.968 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.441 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 78.1 m-85 -80.08 60.42 3.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 113.761 -1.563 . . . . 0.0 112.884 -172.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -97.33 113.85 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 C-N-CA 117.401 -1.719 . . . . 0.0 107.447 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.71 118.47 7.71 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.635 -172.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p 63.8 29.82 14.67 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 125.566 1.546 . . . . 0.0 112.91 175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.7 t -99.85 127.62 33.28 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 173.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -80.32 18.72 1.16 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.566 2.177 . . . . 0.0 111.682 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.7 mtp-105 -118.18 -8.26 10.66 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.899 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.589 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 62.0 m -140.54 171.13 14.55 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.473 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.2 t -136.61 136.29 48.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-N 119.245 0.93 . . . . 0.0 108.653 177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -111.85 174.68 5.76 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.447 -1.251 . . . . 0.0 110.105 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.9 p -45.82 -31.89 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 124.897 1.279 . . . . 0.0 113.122 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -65.58 -62.22 1.64 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 121.633 0.73 . . . . 0.0 110.659 -178.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' O ' HG23 ' A' ' 46' ' ' VAL . 25.0 mt-30 -64.47 -42.04 96.14 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.274 -176.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.66 -25.23 68.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.91 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.82 -24.28 64.36 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.558 0.694 . . . . 0.0 109.629 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.84 -49.93 7.07 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.594 HG23 ' O ' ' A' ' 42' ' ' GLN . 46.7 t -55.36 -35.34 36.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 114.305 -1.316 . . . . 0.0 111.786 -175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 16.4 ptp -58.9 -31.09 68.3 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.08 -21.6 29.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.408 0.623 . . . . 0.0 110.307 -177.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.32 -39.79 14.1 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.545 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -145.81 97.22 4.6 Favored Pre-proline 0 N--CA 1.401 -2.893 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -68.12 71.39 0.86 Allowed 'Trans proline' 0 C--O 1.243 0.757 0 C-N-CA 122.406 2.071 . . . . 0.0 113.114 179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.17 147.24 29.27 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.776 173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.99 145.42 48.37 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.515 0.726 . . . . 0.0 111.513 -173.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -112.64 142.03 45.72 Favored 'General case' 0 C--O 1.253 1.256 0 CA-C-O 121.838 0.828 . . . . 0.0 112.306 -176.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.57 152.24 34.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.441 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.48 149.85 17.0 Favored Glycine 0 C--O 1.2 -1.979 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.2 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.9 t -133.91 123.39 44.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.283 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -172.43 156.84 3.85 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.665 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 31.2 mtm180 -95.71 92.06 6.4 Favored 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 171.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.0 t-20 -104.27 121.17 42.76 Favored 'General case' 0 N--CA 1.406 -2.631 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -80.56 -31.92 36.78 Favored 'General case' 0 C--N 1.258 -3.378 0 CA-C-N 114.888 -1.051 . . . . 0.0 111.311 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -86.55 110.63 19.93 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.238 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.68 HG13 HD13 ' A' ' 92' ' ' LEU . 6.8 tt -58.32 -38.36 68.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-O 120.839 0.352 . . . . 0.0 111.521 177.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.71 -20.5 62.65 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.318 -177.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 16.9 t70 -86.22 -31.19 21.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.155 0.502 . . . . 0.0 109.994 -177.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.54 -46.15 95.81 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.527 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.0 t -62.57 -39.87 86.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.256 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 25.8 t70 -52.55 -58.82 5.55 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.879 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -66.98 -40.92 87.53 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.842 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.75 -30.77 71.0 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 123.367 0.667 . . . . 0.0 111.276 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -83.53 -58.74 2.69 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.794 178.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 59.0 t -54.4 -57.92 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 O-C-N 123.478 0.486 . . . . 0.0 111.291 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 75' ' ' LEU . 29.8 tp -77.76 -17.14 57.85 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.72 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.3 m 59.09 72.21 0.54 Allowed 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.985 0.897 . . . . 0.0 111.314 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 73' ' ' LEU . 71.4 mt -79.11 -172.44 3.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.206 -176.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.467 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -126.68 -35.13 2.35 Favored 'General case' 0 CA--C 1.478 -1.823 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.306 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -149.37 166.03 30.25 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.684 171.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -143.51 135.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.547 ' HA ' ' O ' ' A' ' 103' ' ' TRP . 1.5 mp0 -101.44 108.36 19.93 Favored 'General case' 0 N--CA 1.383 -3.785 0 CA-C-O 121.68 0.752 . . . . 0.0 109.602 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.565 HD11 ' HG ' ' A' ' 92' ' ' LEU . 72.5 mt -90.53 120.54 31.7 Favored 'General case' 0 C--N 1.268 -2.95 0 CA-C-N 114.102 -1.408 . . . . 0.0 107.595 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.453 ' HB3' ' CG ' ' A' ' 59' ' ' ARG . 8.8 t60 -83.37 85.85 7.16 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 172.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -49.22 -9.14 0.11 Allowed Glycine 0 N--CA 1.47 0.919 0 C-N-CA 128.325 2.869 . . . . 0.0 120.029 -168.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -39.0 -24.84 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -61.83 -48.72 79.32 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -175.11 148.65 1.01 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -174.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -78.12 -39.21 42.0 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 113.697 0.999 . . . . 0.0 113.697 -171.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.407 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.9 mt -82.69 -15.98 49.88 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.554 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.568 ' O ' ' HB ' ' A' ' 91' ' ' THR . 19.0 t80 -61.29 -39.63 91.15 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.425 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.43 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -63.73 -34.9 70.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.929 0.871 . . . . 0.0 109.626 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.0 t70 -69.56 -18.41 63.64 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.182 -1.372 . . . . 0.0 110.455 178.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.576 HG22 ' CD1' ' A' ' 63' ' ' ILE . 63.1 m -83.79 -41.45 17.56 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.299 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.68 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -52.69 -41.71 64.13 Favored 'General case' 0 CA--C 1.487 -1.452 0 C-N-CA 123.272 0.629 . . . . 0.0 110.806 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.742 ' HD2' HD12 ' A' ' 102' ' ' ILE . 4.2 mmm180 -43.74 -44.44 6.61 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 125.11 1.364 . . . . 0.0 112.4 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -75.25 -24.27 57.62 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.913 -171.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.453 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -103.18 -3.57 25.59 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.819 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 20.4 tp -80.55 130.61 64.12 Favored Pre-proline 0 C--N 1.299 -1.598 0 C-N-CA 124.567 1.147 . . . . 0.0 109.567 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.49 162.52 37.94 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.379 1.386 . . . . 0.0 109.404 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.82 64.88 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -76.15 -30.27 58.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.6 -177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.511 HG21 ' HB1' ' A' ' 70' ' ' ALA . 40.5 t -104.57 147.44 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.468 0 CA-C-O 121.112 0.482 . . . . 0.0 110.109 -171.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -121.13 174.67 6.52 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 123.796 0.838 . . . . 0.0 108.761 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.742 HD12 ' HD2' ' A' ' 93' ' ' ARG . 92.6 mt -127.91 128.72 69.41 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.547 ' O ' ' HA ' ' A' ' 79' ' ' GLN . 34.9 m0 -120.57 157.61 29.12 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.885 177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -101.81 116.64 33.16 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.79 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -75.3 98.8 3.9 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 172.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.65 115.76 27.28 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.113 -173.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.1 m -77.55 117.12 18.68 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.77 144.5 12.16 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.132 0.492 . . . . 0.0 111.443 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.54 -159.68 8.25 Favored Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 110.541 -1.024 . . . . 0.0 110.541 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -79.89 -44.55 20.22 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 56.1 m -97.07 134.29 40.62 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.748 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.3 130.54 65.2 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -60.68 136.57 67.63 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 122.961 2.441 . . . . 0.0 113.258 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.62 -31.89 72.88 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.813 0.816 . . . . 0.0 108.923 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -156.49 149.5 24.07 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 172.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -103.3 -85.07 0.46 Allowed 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 95.8 m-85 -149.24 122.63 9.04 Favored 'General case' 0 CA--C 1.474 -1.956 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 90' ' ' ASP . 3.7 pm0 -72.9 163.81 27.58 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.585 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.506 ' CE1' ' HG3' ' A' ' 93' ' ' ARG . 5.9 t-160 65.35 38.47 5.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.98 0.895 . . . . 0.0 110.641 176.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -102.17 155.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -86.83 -39.5 15.82 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.783 -176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -155.53 163.02 40.55 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 -177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -126.52 144.38 50.89 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.086 -1.046 . . . . 0.0 109.788 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.42 175.89 9.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -85.99 130.85 34.42 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 22.4 t70 -65.86 110.17 2.76 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.238 0.542 . . . . 0.0 110.793 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -98.65 142.38 30.3 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.89 37.53 Favored Glycine 0 N--CA 1.424 -2.108 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -178.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -122.2 137.28 54.89 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -152.37 179.31 28.98 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 151.88 147.19 4.52 Favored Glycine 0 N--CA 1.426 -2.031 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.75 -19.12 16.89 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.355 0.598 . . . . 0.0 109.718 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -171.18 97.01 0.11 Allowed Glycine 0 N--CA 1.43 -1.729 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.6 t . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -177.828 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tmm? . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 120.964 0.411 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.23 36.62 0.87 Allowed Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.406 -1.477 . . . . 0.0 109.406 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.6 110.69 20.0 Favored 'General case' 0 N--CA 1.412 -2.339 0 CA-C-O 121.849 0.833 . . . . 0.0 109.347 -177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.57 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.2 28.5 0.91 Allowed 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.537 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 15.0 ptpt -77.79 98.11 5.44 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 113.681 -1.599 . . . . 0.0 112.003 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 78.1 t -72.64 109.24 4.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.765 176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.7 m -92.07 170.94 9.44 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.553 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -50.61 116.3 4.13 Favored Glycine 0 C--N 1.356 1.65 0 C-N-CA 119.22 -1.467 . . . . 0.0 109.672 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.8 tp -123.57 176.65 6.08 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -169.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -123.93 -0.92 8.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.82 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 88.9 mtt180 -126.94 115.6 19.51 Favored 'General case' 0 N--CA 1.428 -1.565 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.372 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.91 -35.24 82.09 Favored Glycine 0 C--N 1.303 -1.271 0 CA-C-O 122.599 1.11 . . . . 0.0 112.32 174.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.466 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.3 mp0 -70.84 -40.18 72.52 Favored 'General case' 0 C--N 1.283 -2.29 0 C-N-CA 125.604 1.562 . . . . 0.0 108.96 -176.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 33.0 t70 -74.98 -26.85 59.88 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.507 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.43 -46.02 61.18 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.711 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 22.4 pttp -67.66 -23.61 65.35 Favored 'General case' 0 C--O 1.199 -1.555 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.681 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.27 -31.26 70.05 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.997 0.427 . . . . 0.0 110.693 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 4' ' ' ASN . . . -74.68 -42.46 58.41 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.101 0.953 . . . . 0.0 109.586 178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -68.44 -32.71 72.92 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.949 176.476 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.8 -32.11 70.37 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.024 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.17 -25.05 54.84 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.702 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.92 -28.91 0.02 OUTLIER Glycine 0 N--CA 1.415 -2.738 0 C-N-CA 119.093 -1.527 . . . . 0.0 113.009 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 19' ' ' TYR . . . 62.46 30.74 17.28 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.921 0.867 . . . . 0.0 108.78 -176.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.57 ' HB ' HD21 ' A' ' 4' ' ' ASN . 40.5 mt -70.75 -59.49 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.073 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.635 -173.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.473 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 2.3 p90 -176.2 160.53 2.21 Favored 'General case' 0 C--N 1.312 -1.024 0 O-C-N 123.899 0.749 . . . . 0.0 109.9 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -128.79 123.05 4.15 Favored Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.4 85.68 0.67 Allowed Glycine 0 N--CA 1.428 -1.885 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 -176.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -115.17 151.84 33.68 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . 0.25 4.9 pt -116.58 146.47 20.96 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.031 0 N-CA-C 113.955 1.095 . . . . 0.0 113.955 177.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -80.32 80.39 6.76 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.051 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 97.8 t -107.37 114.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 170.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.52 118.96 6.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.614 1.196 . . . . 0.0 110.874 -173.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 77.3 p 66.43 29.25 9.34 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 125.718 1.607 . . . . 0.0 113.136 175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 40.8 t -92.84 143.69 27.34 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -91.2 0.16 4.78 Favored 'Trans proline' 0 N--CA 1.441 -1.567 0 C-N-CA 121.52 1.48 . . . . 0.0 112.383 177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 69.7 ttt180 -122.33 6.46 9.63 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 122.17 0.986 . . . . 0.0 109.475 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 57.3 m -146.81 125.57 12.62 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.6 t -105.59 137.15 36.75 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 CA-C-O 121.918 0.865 . . . . 0.0 112.844 -172.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -107.4 172.63 6.72 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.593 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 6.4 p -49.64 -32.09 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.583 0.753 . . . . 0.0 112.5 -174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 53.1 mp0 -62.1 -60.8 3.07 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.736 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.6 mt-30 -69.97 -32.72 71.08 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.875 0.369 . . . . 0.0 111.188 177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.82 -23.65 67.44 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.258 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.66 -26.36 68.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 121.489 0.662 . . . . 0.0 109.396 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -83.28 -49.28 9.55 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' GLN . 32.3 t -61.47 -32.26 52.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.963 -174.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.667 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 22.9 ptm -64.35 -23.55 67.33 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.916 0.389 . . . . 0.0 111.868 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -91.57 -20.26 21.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.347 0.594 . . . . 0.0 109.482 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.49 -53.77 5.2 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.383 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -133.65 92.84 22.4 Favored Pre-proline 0 N--CA 1.391 -3.393 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -71.23 53.55 1.65 Allowed 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.818 2.345 . . . . 0.0 112.183 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.424 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -89.81 162.94 15.25 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.058 176.435 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 4.7 tt0 -64.23 131.53 47.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 123.512 0.725 . . . . 0.0 110.718 -175.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 54.5 m-85 -102.85 142.26 34.27 Favored 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.997 -0.681 . . . . 0.0 111.095 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.1 p -133.9 138.25 50.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -113.91 128.73 8.41 Favored Glycine 0 N--CA 1.426 -2.001 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.455 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -126.97 106.51 15.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -163.19 168.02 21.28 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.068 -1.053 . . . . 0.0 112.286 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -85.85 104.77 15.82 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -100.87 150.42 22.85 Favored 'General case' 1 N--CA 1.375 -4.181 0 CA-C-O 122.339 1.066 . . . . 0.0 109.479 -173.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -113.69 -65.97 1.13 Allowed 'General case' 1 C--N 1.235 -4.38 0 CA-C-N 112.165 -2.289 . . . . 0.0 110.402 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -89.32 119.73 30.04 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.823 0.82 . . . . 0.0 111.904 -177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.454 HG13 HD13 ' A' ' 92' ' ' LEU . 15.1 tt -66.86 -32.56 58.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.162 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.62 -17.6 61.66 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.242 0.544 . . . . 0.0 110.589 -177.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -85.5 -49.75 7.82 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.555 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.8 p -64.15 -35.76 74.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.039 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 78.1 t -68.87 -30.9 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.144 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 72' ' ' VAL . 24.2 t70 -72.1 -38.23 69.37 Favored 'General case' 0 C--O 1.21 -0.989 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.794 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm -65.68 -45.94 80.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.664 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -62.51 -23.67 67.08 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.231 178.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 68' ' ' ASP . 30.7 ttmt -80.41 -59.1 2.82 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 124.193 0.997 . . . . 0.0 109.784 176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 68' ' ' ASP . 65.5 t -59.13 -60.03 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.227 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . 1.4 mm? -78.3 -8.2 58.12 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.985 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 16.1 p 52.32 73.29 0.34 Allowed 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.719 0.771 . . . . 0.0 111.985 -172.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' CD2' ' HB2' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -66.41 173.55 3.22 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.243 -179.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -125.69 -34.63 2.61 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.837 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.51 156.52 46.3 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.486 168.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.68 135.61 39.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.562 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.42 117.22 33.96 Favored 'General case' 0 N--CA 1.399 -3.016 0 CA-C-O 121.134 0.492 . . . . 0.0 110.886 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -96.92 128.2 43.65 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.073 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -83.28 95.48 8.18 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 171.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.499 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -61.01 -12.93 31.87 Favored Glycine 0 C--N 1.309 -0.948 0 N-CA-C 117.064 1.585 . . . . 0.0 117.064 -171.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -54.75 -26.38 33.85 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 117.668 0.734 . . . . 0.0 112.532 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -56.08 -45.69 79.26 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' O ' HD12 ' A' ' 89' ' ' ILE . 10.3 tp10 -175.74 135.45 0.3 Allowed 'General case' 0 C--O 1.205 -1.264 0 C-N-CA 123.807 0.843 . . . . 0.0 109.007 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -66.28 -44.16 84.36 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 125.094 1.357 . . . . 0.0 111.06 -171.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 19.2 mt -79.73 -19.97 47.54 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 113.434 -1.712 . . . . 0.0 110.465 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . 32.6 t80 -65.07 -36.79 85.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.241 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 89' ' ' ILE . 4.9 mp -63.32 -41.51 93.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.51 -21.38 66.66 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.4 m -81.37 -45.12 16.59 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.457 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.06 -46.22 8.41 Favored 'General case' 0 C--O 1.216 -0.692 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.479 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 4.5 mpt_? -55.0 -23.78 21.07 Favored 'General case' 0 N--CA 1.509 2.505 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -83.2 -39.35 21.08 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.134 0.493 . . . . 0.0 111.452 -174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -90.33 -2.69 58.01 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 121.599 0.714 . . . . 0.0 110.412 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.14 120.57 82.25 Favored Pre-proline 0 C--N 1.308 -1.207 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.231 -177.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -74.35 163.66 35.81 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.485 1.457 . . . . 0.0 109.718 173.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.1 -7.64 37.89 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -80.69 -30.65 36.41 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.608 0.718 . . . . 0.0 109.753 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.664 HG21 ' HB1' ' A' ' 70' ' ' ALA . 18.9 t -104.0 146.81 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.524 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.274 -170.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -119.4 168.69 10.71 Favored 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.516 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.438 HG23 HD23 ' A' ' 80' ' ' LEU . 79.6 mt -123.07 129.72 74.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.562 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.0 m0 -125.0 164.37 20.31 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 174.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.01 130.96 53.39 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.44 106.87 2.25 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.961 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.29 93.81 4.71 Favored 'General case' 0 N--CA 1.417 -2.083 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.551 ' HA ' ' OD2' ' A' ' 126' ' ' ASP . 16.1 t -80.89 155.26 26.62 Favored 'General case' 0 N--CA 1.404 -2.734 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.521 -178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.9 m -64.04 157.25 4.75 Favored 'Isoleucine or valine' 0 C--O 1.25 1.09 0 CA-C-N 115.179 -0.918 . . . . 0.0 111.982 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.51 -178.12 47.87 Favored Glycine 0 N--CA 1.424 -2.138 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -77.43 -56.46 4.52 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 117.444 0.622 . . . . 0.0 110.38 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 p -111.05 122.29 47.51 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.417 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 83.4 mt -100.32 104.14 27.95 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -65.76 149.5 86.85 Favored 'Trans proline' 0 C--O 1.248 0.992 0 C-N-CA 122.846 2.364 . . . . 0.0 112.6 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.33 -44.91 61.97 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.568 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.39 120.82 32.11 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-O 121.708 0.766 . . . . 0.0 111.565 178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.08 -58.75 0.21 Allowed 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 114.162 -1.381 . . . . 0.0 109.463 174.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -122.19 94.58 4.34 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 172.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.411 ' H ' ' NE2' ' A' ' 118' ' ' GLN . 0.5 OUTLIER -108.37 177.04 4.91 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 114.33 -1.305 . . . . 0.0 109.418 -175.193 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.3 t60 73.25 28.42 1.83 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 123.212 1.482 . . . . 0.0 108.45 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.5 m -91.05 155.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.284 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -74.15 -40.91 62.27 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.209 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -158.14 161.96 37.94 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -99.61 154.89 17.91 Favored 'General case' 0 C--N 1.288 -2.086 0 C-N-CA 123.701 0.8 . . . . 0.0 109.586 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.4 p -157.76 168.13 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -98.68 165.4 11.82 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.551 ' OD2' ' HA ' ' A' ' 107' ' ' SER . 3.1 p30 -69.07 125.05 25.45 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.86 -15.99 40.06 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.106 0.479 . . . . 0.0 110.852 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 155.35 -153.62 24.91 Favored Glycine 0 N--CA 1.417 -2.614 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 132' ' ' ALA . 13.4 mm100 -81.81 82.44 7.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.366 0.603 . . . . 0.0 110.108 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.55 89.97 0.64 Allowed Glycine 0 N--CA 1.442 -0.94 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.918 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.1 3.88 90.12 Favored Glycine 0 C--N 1.314 -0.679 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 129' ' ' GLN . . . -94.36 178.93 5.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 105.73 -41.44 2.17 Favored Glycine 0 C--N 1.299 -1.497 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -175.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.422 -1.862 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 175.561 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' HD12 ' A' ' 125' ' ' LEU . 67.4 mtt . . . . . 0 CA--C 1.501 -0.923 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.73 114.62 2.39 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -86.2 -75.49 0.38 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.103 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -120.25 29.25 7.59 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -47.22 93.15 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 113.098 -1.864 . . . . 0.0 114.426 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -90.15 115.23 29.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 C-N-CA 120.19 -0.604 . . . . 0.0 112.191 172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 67.9 m -91.56 170.24 10.1 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -30.46 116.44 0.07 OUTLIER Glycine 0 C--N 1.351 1.414 0 N-CA-C 115.783 1.073 . . . . 0.0 115.783 -171.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.447 HD11 ' OD2' ' A' ' 14' ' ' ASP . 16.7 tp -145.69 148.0 32.57 Favored 'General case' 0 N--CA 1.402 -2.858 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 -177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.2 t -125.67 -6.72 6.85 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 118.639 -1.224 . . . . 0.0 111.111 -174.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -95.61 114.61 26.38 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -59.56 -30.5 68.72 Favored Glycine 0 C--O 1.217 -0.959 0 O-C-N 123.373 0.42 . . . . 0.0 112.06 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -67.8 -30.42 69.85 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-O 122.85 1.31 . . . . 0.0 108.045 -175.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.447 ' OD2' HD11 ' A' ' 9' ' ' LEU . 40.6 t0 -91.46 -33.62 15.14 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 112.637 -2.074 . . . . 0.0 108.766 -172.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.95 -34.68 78.29 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.304 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 51.0 mtmt -58.97 -25.51 63.63 Favored 'General case' 0 C--O 1.198 -1.656 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.016 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.2 -35.27 75.03 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.974 0.416 . . . . 0.0 111.386 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.53 -43.94 62.84 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.755 0.788 . . . . 0.0 109.693 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.426 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -66.17 -31.93 73.06 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.132 176.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -66.61 -29.76 69.88 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.309 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.69 -23.3 63.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.409 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.27 -2.88 0.05 OUTLIER Glycine 0 C--O 1.22 -0.766 0 C-N-CA 119.045 -1.55 . . . . 0.0 113.946 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.41 21.24 12.44 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.565 0.746 . . . . 0.0 110.309 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.1 mt -62.67 -67.93 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.436 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -163.78 -177.53 5.2 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 123.484 0.49 . . . . 0.0 110.48 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.465 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -140.11 140.88 11.01 Favored Glycine 0 N--CA 1.431 -1.692 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 174.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -116.84 87.84 0.44 Allowed Glycine 0 CA--C 1.487 -1.666 0 C-N-CA 120.309 -0.948 . . . . 0.0 111.93 -172.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.21 155.17 42.23 Favored 'General case' 0 N--CA 1.417 -2.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.074 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.567 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 4.7 pt -116.75 155.34 18.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.199 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.42 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 41.4 m-85 -81.48 81.29 7.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.321 -175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 37' ' ' CYS . 11.9 p -82.49 152.93 3.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -80.04 89.38 5.36 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 170.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 46.1 p 52.33 72.89 0.37 Allowed 'General case' 0 CA--C 1.568 1.635 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.507 ' H ' ' CG1' ' A' ' 31' ' ' VAL . 19.9 m -140.26 122.16 9.66 Favored Pre-proline 0 C--O 1.208 -1.089 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 168.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -65.67 5.83 0.53 Allowed 'Trans proline' 0 C--O 1.207 -1.026 0 C-N-CA 124.038 3.159 . . . . 0.0 115.413 -170.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -101.18 -0.64 35.65 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 121.598 0.713 . . . . 0.0 109.677 174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 63.2 m -136.8 166.73 22.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -133.21 137.16 53.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 119.524 1.056 . . . . 0.0 111.039 -178.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -115.19 171.15 7.86 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.89 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' CG2' ' HD2' ' A' ' 69' ' ' LYS . 89.0 t -46.64 -32.46 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 0.0 113.52 -174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.21 -56.25 24.44 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.723 0.773 . . . . 0.0 110.536 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -81.2 -35.29 31.55 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.668 -175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.907 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -62.46 -27.81 69.38 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.142 -178.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -38.19 80.24 Favored 'General case' 0 C--O 1.225 -0.187 0 CA-C-O 121.63 0.728 . . . . 0.0 109.459 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.82 -45.51 10.82 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.907 HG12 ' HA ' ' A' ' 43' ' ' ALA . 3.6 p -65.53 -24.24 34.29 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.744 -174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.3 ptm -67.8 -18.08 64.73 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.025 0.441 . . . . 0.0 111.347 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.36 -22.87 18.68 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.012 178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.47 -46.44 32.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.306 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.34 104.09 17.93 Favored Pre-proline 0 N--CA 1.399 -3.007 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.25 45.02 0.91 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.544 2.829 . . . . 0.0 113.247 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.8 pp -89.25 171.91 9.44 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.216 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -77.77 140.95 39.51 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 122.964 0.506 . . . . 0.0 110.102 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -108.74 137.53 46.53 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-O 121.514 0.673 . . . . 0.0 111.543 178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.4 p -129.43 146.16 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.89 133.61 8.35 Favored Glycine 0 N--CA 1.423 -2.174 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.541 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.567 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.2 t -111.6 131.22 63.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -159.64 151.09 19.94 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -85.39 105.06 15.75 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.17 116.7 17.11 Favored 'General case' 0 N--CA 1.411 -2.404 0 CA-C-O 122.495 1.14 . . . . 0.0 109.598 -171.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 70.3 m-70 -106.28 -74.65 0.65 Allowed 'General case' 0 C--N 1.253 -3.625 0 CA-C-N 113.18 -1.827 . . . . 0.0 109.246 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -91.39 119.55 31.49 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.524 HG13 HD13 ' A' ' 92' ' ' LEU . 15.9 tt -62.7 -32.05 54.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.659 -177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.6 -12.98 59.82 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.447 -177.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 33.1 t70 -82.41 -40.32 21.43 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -73.85 -34.74 40.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.895 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' ILE . 54.7 t -60.49 -39.95 82.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' O ' HG23 ' A' ' 72' ' ' VAL . 12.5 t70 -52.97 -51.13 62.56 Favored 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.906 176.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.453 ' HD2' ' CG2' ' A' ' 40' ' ' VAL . 38.4 mmtm -65.82 -45.46 82.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.001 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.88 -32.26 71.71 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.138 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 36.5 ttpt -76.76 -57.65 3.73 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.824 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.1 t -57.62 -57.01 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.517 0.727 . . . . 0.0 112.06 -175.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 89.6 mt -78.53 -8.82 58.98 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.73 -0.388 . . . . 0.0 112.042 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.0 p 49.27 68.3 0.74 Allowed 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.959 0.885 . . . . 0.0 110.863 -174.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -71.42 178.3 3.51 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.048 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.94 -36.4 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.794 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -141.23 155.57 46.01 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 120.829 0.347 . . . . 0.0 110.624 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.3 p -142.17 139.4 30.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.565 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -98.85 129.53 45.23 Favored 'General case' 0 N--CA 1.399 -3.011 0 CA-C-O 121.347 0.594 . . . . 0.0 111.564 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -92.02 124.6 36.25 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.378 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.456 ' CE1' ' HB3' ' A' ' 83' ' ' ASN . 26.9 t-80 -81.99 92.7 6.82 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 171.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -56.97 -19.68 31.16 Favored Glycine 0 N--CA 1.466 0.689 0 N-CA-C 115.617 1.007 . . . . 0.0 115.617 -173.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 81' ' ' HIS . 5.7 t30 -53.92 -29.86 43.88 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -63.98 -47.82 78.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -171.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.6 tm-20 -176.41 151.18 0.95 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 117' ' ' PHE . 24.9 mt-30 -77.93 -45.04 25.12 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 123.994 0.918 . . . . 0.0 111.966 -172.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.1 mt -83.75 -23.34 31.6 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.131 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.516 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.4 t80 -55.0 -40.19 69.85 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.395 175.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.528 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.6 mp -61.8 -36.97 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.341 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.74 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 23.4 t70 -68.7 -20.69 64.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.778 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.7 m -85.21 -43.18 14.02 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.614 -1.176 . . . . 0.0 108.927 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.524 HD13 HG13 ' A' ' 63' ' ' ILE . 3.5 mm? -47.08 -50.75 19.29 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 174.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.74 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -68.18 -10.76 56.69 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.014 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -78.72 -51.04 10.38 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.64 -24.12 58.79 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.092 -177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.7 mt -92.07 127.47 49.27 Favored Pre-proline 0 C--N 1.276 -2.59 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.308 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.15 165.87 29.98 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.542 2.162 . . . . 0.0 110.489 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.94 -16.63 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.158 0.504 . . . . 0.0 111.231 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -64.33 -29.14 70.22 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.886 0.874 . . . . 0.0 109.826 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.19 134.56 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.185 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -111.71 170.77 7.91 Favored 'General case' 0 C--N 1.279 -2.483 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 48.5 mt -123.67 135.42 63.46 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.565 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.8 m0 -121.96 156.55 33.18 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 173.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.67 129.83 54.75 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -74.19 102.19 4.2 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.8 tp -72.11 117.94 14.36 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 123.836 0.854 . . . . 0.0 109.554 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.3 m -59.02 107.28 0.51 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.768 0.794 . . . . 0.0 109.643 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' A' ' 125' ' ' LEU . 27.1 m -77.37 153.17 5.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -175.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.4 -79.56 1.5 Allowed Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 116.615 1.406 . . . . 0.0 116.615 167.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -90.1 -73.93 0.5 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -167.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 39.3 m -89.91 86.58 6.66 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 121.342 0.592 . . . . 0.0 110.976 -175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 54.8 tp -119.76 99.23 49.5 Favored Pre-proline 0 N--CA 1.432 -1.326 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.241 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.56 163.83 16.57 Favored 'Trans proline' 0 C--O 1.246 0.924 0 C-N-CA 123.374 2.716 . . . . 0.0 111.058 176.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -51.59 -35.81 42.93 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.049 0.94 . . . . 0.0 111.708 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -140.25 154.48 46.88 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 172.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -113.19 -69.69 0.85 Allowed 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 168.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.509 ' CD1' HD13 ' A' ' 89' ' ' ILE . 81.9 m-85 -145.12 122.89 11.89 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 175.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -110.71 -170.13 1.58 Allowed 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.287 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 69.35 27.68 4.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 123.005 1.383 . . . . 0.0 108.805 -174.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.5 m -102.03 155.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 113.259 -1.791 . . . . 0.0 107.39 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.31 -40.99 50.08 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.788 0.804 . . . . 0.0 111.093 -176.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 4.9 ttmp? -153.89 163.31 40.26 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -171.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -127.82 147.7 50.44 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.9 m -129.22 173.56 13.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.2 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.447 HD12 ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -78.13 151.64 33.21 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 118.403 0.547 . . . . 0.0 110.718 -179.051 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.494 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 33.8 t70 -66.95 89.0 0.16 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.361 0.6 . . . . 0.0 110.332 176.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -106.23 121.88 45.08 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.615 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -109.24 80.08 0.26 Allowed Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.91 145.3 46.93 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 138.23 -72.03 0.45 Allowed Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -82.17 -66.19 1.59 Allowed Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.939 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -156.99 134.78 10.89 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -80.83 -56.13 3.17 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--N 1.309 -1.153 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.729 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 CA--C 1.503 -0.845 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 143.1 -92.63 0.17 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 119.826 -1.178 . . . . 0.0 113.108 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.256 41.5 mt-10 68.54 111.05 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 122.699 1.238 . . . . 0.0 112.547 -173.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.626 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -148.52 37.9 0.84 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 179.564 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -67.47 109.71 3.32 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.852 -175.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 59.0 t -86.0 102.7 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.23 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 172.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.6 m -96.82 170.12 9.39 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 170.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.643 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -34.32 116.3 0.18 Allowed Glycine 0 N--CA 1.476 1.367 0 O-C-N 124.218 0.949 . . . . 0.0 114.712 -174.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.6 tp -146.73 157.48 43.7 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.2 t -138.32 14.8 2.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 122.344 1.069 . . . . 0.0 109.724 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.0 mtt180 -115.54 110.44 19.25 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.77 -35.5 74.86 Favored Glycine 0 C--N 1.301 -1.397 0 O-C-N 123.192 0.307 . . . . 0.0 113.39 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.601 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -70.5 -35.13 73.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 122.223 1.011 . . . . 0.0 108.945 -177.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 16.2 t0 -82.06 -22.63 36.26 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.724 -174.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.63 -44.77 27.15 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.569 177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 20.9 pttp -67.79 -23.28 65.19 Favored 'General case' 0 C--O 1.201 -1.494 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.889 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.44 74.69 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 122.676 0.39 . . . . 0.0 110.956 176.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.01 69.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.928 0.871 . . . . 0.0 109.91 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.461 ' CD1' ' HB2' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -69.09 -34.67 75.47 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.293 176.085 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -66.6 -32.15 73.3 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.489 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.23 -23.66 61.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.58 -178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.54 -20.97 0.06 OUTLIER Glycine 0 N--CA 1.423 -2.219 0 C-N-CA 119.933 -1.127 . . . . 0.0 113.063 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.477 ' HA ' ' HB3' ' A' ' 52' ' ' LEU . . . 60.24 30.68 20.05 Favored 'General case' 0 C--N 1.37 1.482 0 CA-C-O 121.68 0.752 . . . . 0.0 109.79 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.626 ' HB ' HD21 ' A' ' 4' ' ' ASN . 31.0 mt -70.62 -60.95 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.151 0 CA-C-N 113.866 -1.515 . . . . 0.0 110.034 -171.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -178.35 151.33 0.61 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 124.287 0.992 . . . . 0.0 108.701 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.74 132.49 9.49 Favored Glycine 0 N--CA 1.417 -2.622 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.08 81.11 1.08 Allowed Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.239 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -114.57 150.74 34.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 121.186 0.517 . . . . 0.0 110.133 177.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.647 HG23 ' HB ' ' A' ' 57' ' ' VAL . 14.3 mt -118.08 156.14 19.84 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.444 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 20.7 m-85 -82.78 69.3 9.54 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.432 0.56 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.3 t -95.57 118.63 42.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 C-N-CA 119.3 -0.96 . . . . 0.0 108.683 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -43.86 96.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.811 1.644 . . . . 0.0 114.24 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.0 p 56.48 23.54 7.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.626 1.57 . . . . 0.0 112.975 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' ARG . 14.8 m -103.32 111.09 64.87 Favored Pre-proline 0 N--CA 1.421 -1.899 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.74 19.9 0.12 Allowed 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 124.64 3.56 . . . . 0.0 114.386 -172.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' SER . 24.1 mmt180 -91.97 -21.6 20.45 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 170.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.554 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -141.29 174.17 10.8 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.643 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -134.18 136.91 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.495 -177.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -105.13 167.32 9.79 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.258 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 ' HD2' ' A' ' 69' ' ' LYS . 93.3 t -48.41 -34.58 5.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 124.925 1.29 . . . . 0.0 112.39 -174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 mp0 -62.0 -55.65 27.1 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 123.632 0.773 . . . . 0.0 111.988 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 46' ' ' VAL . 29.6 mt-30 -68.59 -42.22 78.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.076 0.465 . . . . 0.0 110.339 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.403 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -63.55 -20.12 65.37 Favored 'General case' 0 C--O 1.213 -0.824 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.109 -176.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.29 -31.61 72.81 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -86.44 -45.36 11.22 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.568 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 42' ' ' GLN . 14.9 t -64.09 -33.01 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.489 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -64.63 -25.38 67.93 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.167 0.508 . . . . 0.0 110.783 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.95 -24.38 33.02 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -81.45 -51.93 7.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.182 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.37 104.29 17.84 Favored Pre-proline 0 N--CA 1.395 -3.222 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.06 48.3 2.23 Favored 'Trans proline' 0 C--O 1.247 0.939 0 C-N-CA 122.709 2.273 . . . . 0.0 112.293 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.479 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.9 OUTLIER -85.07 168.57 14.76 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.909 -1.041 . . . . 0.0 108.527 175.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -79.65 140.43 37.07 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-O 120.616 0.246 . . . . 0.0 111.565 -177.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.483 ' CD2' HD11 ' A' ' 28' ' ' LEU . 33.2 m-85 -113.15 146.33 39.43 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 121.028 0.442 . . . . 0.0 111.077 -178.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.67 164.48 34.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.58 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -139.93 148.83 20.39 Favored Glycine 0 CA--C 1.481 -2.079 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.598 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.647 ' HB ' HG23 ' A' ' 29' ' ' ILE . 39.9 t -124.77 140.29 48.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -168.59 158.4 9.35 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 118.769 0.713 . . . . 0.0 109.981 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -86.15 94.72 9.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.48 HD22 ' HG ' ' A' ' 80' ' ' LEU . 84.3 m-20 -79.06 118.65 21.24 Favored 'General case' 0 N--CA 1.395 -3.184 0 CA-C-O 122.563 1.173 . . . . 0.0 110.327 -173.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -107.93 -61.43 1.58 Allowed 'General case' 0 C--N 1.247 -3.889 0 CA-C-N 112.521 -2.127 . . . . 0.0 106.127 173.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -84.22 110.45 18.55 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.759 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.583 HG13 HD13 ' A' ' 92' ' ' LEU . 14.6 tt -64.62 -32.04 56.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.084 178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.25 -22.32 63.85 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 121.212 0.529 . . . . 0.0 110.212 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.0 t70 -83.04 -34.82 26.16 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.7 t -63.05 -44.02 99.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 63' ' ' ILE . 63.4 t -59.81 -45.54 94.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.472 177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.5 t70 -52.22 -61.27 2.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.196 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.622 ' HD2' HG21 ' A' ' 40' ' ' VAL . 46.9 mmtm -64.16 -42.09 96.88 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.679 -176.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.485 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.03 -31.26 72.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.555 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -79.4 -57.81 3.52 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 123.422 0.451 . . . . 0.0 110.182 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.0 t -53.59 -55.69 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.987 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' HA ' HD22 ' A' ' 73' ' ' LEU . 0.3 OUTLIER -81.31 -16.54 52.15 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.437 -179.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.6 m 59.89 74.43 0.44 Allowed 'General case' 0 CA--C 1.544 0.746 0 CA-C-O 122.179 0.99 . . . . 0.0 110.402 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.1 mt -86.4 -168.49 2.26 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.574 -1.193 . . . . 0.0 111.936 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.461 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -128.65 -40.29 1.58 Allowed 'General case' 0 CA--C 1.464 -2.334 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.05 161.61 39.0 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.776 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.0 p -140.82 137.43 35.08 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 176.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.76 121.39 39.62 Favored 'General case' 0 N--CA 1.381 -3.917 0 CA-C-O 121.678 0.752 . . . . 0.0 110.248 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.48 ' HG ' HD22 ' A' ' 60' ' ' ASN . 1.4 tt -109.49 136.24 49.21 Favored 'General case' 0 N--CA 1.389 -3.49 0 N-CA-C 105.084 -2.191 . . . . 0.0 105.084 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -77.76 79.16 4.25 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 168.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -52.56 -13.12 1.81 Allowed Glycine 0 C--O 1.214 -1.107 0 CA-C-N 114.003 -1.453 . . . . 0.0 116.567 -170.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -55.35 -24.31 28.65 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.537 1.135 . . . . 0.0 112.769 -178.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -48.76 -49.3 39.16 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.282 1.033 . . . . 0.0 113.172 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -176.88 148.9 0.69 Allowed 'General case' 0 C--O 1.21 -0.979 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.514 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 9.1 tt0 -77.81 -48.85 15.55 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.421 1.105 . . . . 0.0 112.065 -168.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 40.0 mt -71.82 -17.53 62.14 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 113.419 -1.719 . . . . 0.0 109.998 -174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.51 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.0 t80 -61.11 -45.0 96.49 Favored 'General case' 0 N--CA 1.414 -2.228 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.89 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 mp -61.63 -38.69 80.87 Favored 'Isoleucine or valine' 0 C--O 1.245 0.85 0 CA-C-O 121.779 0.799 . . . . 0.0 109.16 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -65.83 -20.46 66.25 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.226 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 89.3 m -83.9 -41.31 17.56 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.857 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.583 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -50.73 -38.37 47.09 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 123.684 0.794 . . . . 0.0 111.773 177.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -59.14 -34.32 71.92 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.209 -176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -78.08 -37.84 45.6 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.279 -172.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.94 -18.96 26.4 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.43 HD12 HD11 ' A' ' 102' ' ' ILE . 95.2 mt -96.46 141.32 22.93 Favored Pre-proline 0 C--N 1.282 -2.363 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.364 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -71.38 165.8 31.34 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.07 1.846 . . . . 0.0 110.363 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -11.79 18.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 124.199 0.999 . . . . 0.0 112.126 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -79.15 -28.55 42.8 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.231 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.485 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.1 t -104.22 127.56 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.034 0 CA-C-O 121.44 0.638 . . . . 0.0 109.617 -175.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' A' ' 121' ' ' ASP . . . -111.37 172.58 6.8 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.338 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 96' ' ' LEU . 3.5 mp -128.21 130.03 69.42 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.459 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 37.6 m0 -116.94 155.76 28.56 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 174.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -99.96 113.68 26.43 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.68 103.89 2.68 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.09 101.33 12.35 Favored 'General case' 0 N--CA 1.41 -2.465 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.655 -175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.6 m -70.01 136.73 50.71 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.3 m -52.48 145.24 2.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 -171.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.22 132.86 1.39 Allowed Glycine 0 N--CA 1.419 -2.484 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.718 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -100.48 -16.35 17.58 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.96 0.886 . . . . 0.0 108.725 177.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 12.7 t -85.35 26.74 0.87 Allowed 'General case' 0 CA--C 1.563 1.447 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.382 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.77 158.29 37.03 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.18 156.36 22.83 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.228 1.952 . . . . 0.0 111.533 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.57 -30.22 56.95 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.383 0.611 . . . . 0.0 110.205 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -117.44 130.43 56.47 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 173.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -134.87 -60.44 0.78 Allowed 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.885 0.85 . . . . 0.0 109.697 -176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 67.9 m-85 -124.87 112.29 16.47 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.334 -173.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -78.03 166.71 22.49 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 1.8 m170 66.26 30.05 9.28 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 123.707 0.63 . . . . 0.0 112.543 -176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.8 m -103.72 149.6 7.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 170.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CB ' ' HB1' ' A' ' 101' ' ' ALA . 24.3 t70 -85.67 -42.28 14.43 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.258 -176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -153.59 163.13 40.5 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.544 0.738 . . . . 0.0 111.442 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -108.74 135.78 49.41 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.311 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 m -138.2 163.45 29.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.5 tp -82.48 148.21 28.26 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -56.56 102.74 0.09 Allowed 'General case' 0 C--O 1.243 0.734 0 O-C-N 123.973 0.796 . . . . 0.0 109.243 172.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -77.43 92.42 3.97 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-O 121.688 0.756 . . . . 0.0 110.585 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 164.65 -60.71 0.25 Allowed Glycine 0 N--CA 1.415 -2.763 0 N-CA-C 110.039 -1.225 . . . . 0.0 110.039 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 67.45 3.23 3.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.201 1.0 . . . . 0.0 112.324 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -98.64 135.43 12.14 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 95.02 -5.79 68.85 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.546 -1.021 . . . . 0.0 110.546 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.67 108.06 7.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 155.15 176.57 27.5 Favored Glycine 0 N--CA 1.423 -2.209 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -177.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.293 -1.882 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.029 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 C--O 1.241 0.647 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -93.16 -60.77 1.16 Allowed Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -110.77 175.19 5.52 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.205 0.526 . . . . 0.0 111.141 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -153.28 44.78 0.64 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.523 ' HA ' ' H ' ' A' ' 27' ' ' GLY . 9.5 ptmt -67.59 96.2 0.52 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.277 -1.783 . . . . 0.0 113.4 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.14 104.96 9.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 122.182 0.992 . . . . 0.0 111.53 175.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.5 m -95.86 169.2 10.16 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -31.34 109.47 0.03 OUTLIER Glycine 0 C--N 1.353 1.519 0 N-CA-C 116.835 1.494 . . . . 0.0 116.835 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.29 147.58 2.0 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 102.044 -3.317 . . . . 0.0 102.044 179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -136.42 -3.2 2.16 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.776 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -69.29 111.51 5.25 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.37 -58.07 5.39 Favored Glycine 0 C--N 1.31 -0.897 0 C-N-CA 124.57 1.081 . . . . 0.0 113.971 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.69 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -57.1 -19.9 22.3 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 176.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -92.0 -44.87 8.63 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.48 74.37 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.923 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -61.42 -23.37 65.78 Favored 'General case' 0 C--O 1.191 -2.007 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.176 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.64 -35.0 69.92 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.071 0.463 . . . . 0.0 110.967 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.73 -37.33 56.2 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.727 0.775 . . . . 0.0 110.089 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -70.66 -35.95 73.11 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.364 177.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -57.95 -26.28 62.07 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 124.403 1.081 . . . . 0.0 111.067 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.09 -22.51 66.41 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.499 177.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.83 18.27 0.15 Allowed Glycine 0 C--O 1.224 -0.486 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.805 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.87 25.99 7.33 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 124.574 1.15 . . . . 0.0 111.727 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -57.93 -67.61 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.092 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -173.67 155.66 2.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -175.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -122.15 131.33 8.36 Favored Glycine 0 N--CA 1.422 -2.263 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -97.78 88.47 0.92 Allowed Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -125.11 149.1 48.19 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -177.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.571 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 1.9 pt -117.69 157.87 18.72 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.673 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 174.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' HE2' ' HA3' ' A' ' 56' ' ' GLY . 49.6 m-85 -86.92 87.29 7.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 124.149 0.906 . . . . 0.0 112.114 -174.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 54.7 t -121.86 116.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 169.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.46 113.26 1.35 Allowed 'General case' 0 C--N 1.313 -0.994 0 O-C-N 124.447 1.092 . . . . 0.0 113.298 -173.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p 62.94 23.34 13.95 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 125.864 1.666 . . . . 0.0 113.885 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.455 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 78.9 p -86.62 149.27 48.33 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.48 13.73 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.752 1.635 . . . . 0.0 111.705 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.567 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 21.9 ptt180 -119.42 -8.56 10.02 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.014 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.571 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 59.5 m -145.51 172.89 12.56 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.21 137.31 41.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 109.071 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.0 p-10 -103.61 164.91 11.36 Favored 'General case' 0 C--N 1.265 -3.107 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.45 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.659 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.0 p -51.51 -35.21 16.47 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 124.265 0.978 . . . . 0.0 111.57 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 7.9 mp0 -67.82 -39.2 83.94 Favored 'General case' 0 N--CA 1.417 -2.109 0 C-N-CA 124.36 1.064 . . . . 0.0 112.011 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 46' ' ' VAL . 51.6 mm-40 -67.33 -51.15 55.91 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-O 122.67 1.224 . . . . 0.0 107.914 173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.31 -32.44 66.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 112.462 -2.154 . . . . 0.0 114.449 -168.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.482 HE21 ' HB3' ' A' ' 44' ' ' GLN . 0.3 OUTLIER -63.75 -31.2 72.3 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 -178.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -80.81 -37.94 29.25 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.31 175.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 42' ' ' GLN . 44.8 t -65.63 -31.67 54.8 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.16 -178.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 27.1 ptt? -67.83 -17.32 64.47 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-O 121.223 0.535 . . . . 0.0 111.76 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.63 46.7 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.427 0.632 . . . . 0.0 109.469 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -102.22 -40.62 6.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.305 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -137.94 98.75 9.41 Favored Pre-proline 0 N--CA 1.406 -2.656 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.11 59.91 2.36 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.057 2.504 . . . . 0.0 113.023 -179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -101.42 163.9 12.04 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.366 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -72.91 145.47 46.81 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.63 0.252 . . . . 0.0 110.576 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -113.74 140.79 47.98 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.356 0.598 . . . . 0.0 109.753 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.472 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.2 p -133.57 144.0 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' HE2' ' A' ' 30' ' ' PHE . . . -109.72 132.56 11.11 Favored Glycine 0 CA--C 1.475 -2.464 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 175.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 79' ' ' GLN . 7.3 p -140.09 104.05 1.76 Allowed 'Isoleucine or valine' 0 C--O 1.193 -1.912 0 CA-C-O 121.865 0.84 . . . . 0.0 111.053 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -167.88 178.75 5.03 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 -173.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -86.3 93.42 9.08 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 170.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -87.42 117.99 26.57 Favored 'General case' 0 N--CA 1.395 -3.202 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 31.7 m80 -85.77 -63.19 1.36 Allowed 'General case' 0 C--N 1.247 -3.89 0 CA-C-N 113.17 -1.832 . . . . 0.0 110.711 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -89.44 125.32 35.12 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 120.356 -0.538 . . . . 0.0 111.032 -177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.557 ' O ' HG23 ' A' ' 67' ' ' VAL . 19.1 tt -63.4 -34.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.064 178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.65 -20.11 62.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.62 0.724 . . . . 0.0 110.39 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.514 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 18.3 t70 -85.93 -39.48 16.9 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.158 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 63' ' ' ILE . 14.5 p -77.46 -32.21 18.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.823 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.2 t -59.9 -40.92 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 173.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.529 ' O ' HG23 ' A' ' 72' ' ' VAL . 21.3 t70 -54.09 -50.93 65.68 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.534 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.1 mmtm -69.21 -42.1 76.17 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.887 0.375 . . . . 0.0 110.139 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.617 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -66.37 -22.98 66.26 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.134 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -83.83 -61.74 1.75 Allowed 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 123.702 0.801 . . . . 0.0 110.199 176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 68' ' ' ASP . 67.2 t -54.69 -56.68 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 O-C-N 123.894 0.746 . . . . 0.0 111.548 -175.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HB2' HG23 ' A' ' 40' ' ' VAL . 59.2 tp -83.16 -19.52 36.46 Favored 'General case' 0 N--CA 1.436 -1.161 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.69 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 12.7 t 60.09 82.83 0.15 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 122.333 1.063 . . . . 0.0 109.768 -171.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 74.8 mt -76.22 173.01 11.9 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.644 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -115.24 -31.54 5.95 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -151.54 161.45 42.67 Favored 'General case' 0 N--CA 1.42 -1.933 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.921 175.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 66' ' ' VAL . 6.5 p -143.87 138.73 25.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.579 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.2 mp0 -103.39 119.81 39.59 Favored 'General case' 0 N--CA 1.409 -2.505 0 O-C-N 121.848 -0.533 . . . . 0.0 110.575 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.486 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -99.86 119.76 38.7 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.347 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.4 m80 -81.53 104.03 11.67 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.77 176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.666 ' HA3' ' CZ ' ' A' ' 117' ' ' PHE . . . -53.76 -12.25 2.46 Favored Glycine 0 N--CA 1.475 1.254 0 CA-C-N 114.826 -1.079 . . . . 0.0 114.739 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -55.24 -27.76 48.51 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 110.762 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -72.78 -47.58 45.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 123.076 0.235 . . . . 0.0 110.874 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.519 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -179.57 150.03 0.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -78.62 -44.31 24.21 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.507 1.146 . . . . 0.0 110.823 -173.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.473 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 32.6 mt -80.71 -13.38 59.05 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 113.966 -1.47 . . . . 0.0 109.934 -175.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 24.7 t80 -59.04 -42.96 91.51 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.381 173.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.527 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -59.51 -38.19 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.625 0.726 . . . . 0.0 109.476 178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 18.8 t70 -63.06 -22.0 66.55 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.33 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.462 ' HA ' ' OE1' ' A' ' 94' ' ' GLU . 94.2 m -88.53 -45.14 10.15 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 124.658 1.183 . . . . 0.0 109.997 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -45.09 -47.16 11.98 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 175.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -61.48 -24.51 66.63 Favored 'General case' 0 N--CA 1.515 2.8 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.129 -177.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 29.7 mt-10 -76.56 -37.74 56.08 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.384 -175.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.1 -36.55 15.67 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.466 0.651 . . . . 0.0 112.255 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.31 121.2 75.24 Favored Pre-proline 0 C--N 1.272 -2.763 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.813 -179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.47 165.43 20.24 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.479 2.119 . . . . 0.0 111.329 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.28 -10.74 17.28 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 124.493 1.117 . . . . 0.0 113.14 -175.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -75.7 -29.56 59.02 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.448 HG21 ' HB1' ' A' ' 70' ' ' ALA . 61.6 t -100.56 129.73 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.335 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.99 164.88 11.77 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.338 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 80' ' ' LEU . 71.1 mt -116.94 132.66 66.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.344 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.579 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 45.4 m0 -122.31 158.94 28.47 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 118.84 -1.144 . . . . 0.0 109.728 174.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.488 ' HE2' ' O ' ' A' ' 105' ' ' ALA . 17.5 tptm -100.97 115.86 31.47 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' O ' ' HE2' ' A' ' 104' ' ' LYS . . . -77.55 98.12 5.27 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 173.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.4 tp -81.2 115.41 20.59 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.634 -174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.428 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 4.6 m -76.16 132.72 40.15 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.8 m -58.49 127.82 18.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.97 163.59 10.38 Favored Glycine 0 N--CA 1.432 -1.588 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.122 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -98.73 11.99 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.917 0.865 . . . . 0.0 110.751 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 8.7 m -70.85 -19.76 62.61 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.817 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -97.65 131.34 27.16 Favored Pre-proline 0 N--CA 1.433 -1.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.429 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.98 163.18 37.48 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.925 2.416 . . . . 0.0 111.344 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.2 72.53 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 123.437 0.695 . . . . 0.0 111.727 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -120.61 138.63 53.8 Favored 'General case' 0 CA--C 1.496 -1.11 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.42 ' HB2' ' H ' ' A' ' 117' ' ' PHE . 26.5 mt-10 -136.23 -68.62 0.5 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -174.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.666 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 31.8 m-85 -112.55 120.2 40.79 Favored 'General case' 0 N--CA 1.41 -2.426 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -85.24 153.5 22.57 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.8 m-70 75.77 24.56 1.25 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-N 112.269 -2.242 . . . . 0.0 111.604 177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.4 m -79.44 143.56 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -85.85 -32.2 21.84 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 120.235 -0.586 . . . . 0.0 112.183 -174.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 40.2 ttmt -153.56 160.36 42.45 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.325 0.583 . . . . 0.0 109.638 -176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -111.63 134.76 52.98 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.383 174.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.1 m -135.31 -176.14 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 96.8 mt -91.21 162.65 14.56 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 120.905 0.383 . . . . 0.0 110.674 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 9.7 t70 -65.69 118.88 10.21 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 123.267 0.627 . . . . 0.0 110.032 177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.95 122.01 41.65 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.67 -80.17 0.19 Allowed Glycine 0 N--CA 1.428 -1.888 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.62 101.01 12.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.67 93.69 0.22 Allowed Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -160.84 25.71 0.27 Allowed Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 119.886 -1.15 . . . . 0.0 113.4 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.11 -28.36 42.95 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.423 0.63 . . . . 0.0 109.488 178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 162.06 53.62 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.681 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.317 -0.845 0 C-N-CA 124.351 1.06 . . . . 0.0 111.289 -176.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 tpp . . . . . 0 CA--C 1.499 -1.011 0 CA-C-O 121.038 0.446 . . . . 0.0 111.058 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 178.9 34.62 0.06 OUTLIER Glycine 0 N--CA 1.428 -1.886 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -121.16 118.3 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 121.631 0.729 . . . . 0.0 112.766 -174.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -130.51 24.09 5.11 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 168.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -51.03 101.49 0.03 OUTLIER 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.598 -175.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 7.6 p -99.86 103.22 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.957 0.884 . . . . 0.0 111.148 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.2 m -91.81 168.53 11.38 Favored 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -6.62 106.41 0.01 OUTLIER Glycine 0 N--CA 1.484 1.88 0 C-N-CA 125.578 1.561 . . . . 0.0 116.942 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.54 145.68 51.91 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -125.45 8.74 7.77 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 122.118 0.961 . . . . 0.0 108.633 -178.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 11' ' ' ARG . 64.9 mtt180 -125.32 107.35 10.61 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.227 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -45.69 -54.01 8.11 Favored Glycine 0 C--N 1.312 -0.804 0 C-N-CA 124.07 0.843 . . . . 0.0 113.177 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.735 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.3 OUTLIER -63.45 -26.32 68.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 178.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 30.1 t70 -87.09 -23.11 25.02 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 122.087 0.946 . . . . 0.0 108.64 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.08 -22.75 60.53 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.558 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -61.19 -24.18 66.13 Favored 'General case' 0 C--O 1.206 -1.213 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.584 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.12 -34.4 60.21 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 123.289 0.368 . . . . 0.0 111.748 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.36 67.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.885 0.85 . . . . 0.0 110.047 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -36.15 81.74 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.976 176.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -65.24 -28.53 69.43 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.792 -1.094 . . . . 0.0 110.416 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.2 -23.03 59.14 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.904 178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.32 -11.95 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 118.413 -1.851 . . . . 0.0 113.717 175.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.18 23.87 14.15 Favored 'General case' 0 C--N 1.356 0.865 0 CA-C-O 121.46 0.647 . . . . 0.0 109.771 -176.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 24' ' ' ILE . 12.7 mt -57.8 -53.13 49.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.122 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.602 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 37.9 p90 -170.6 -172.09 1.16 Allowed 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 113.645 -1.616 . . . . 0.0 108.85 177.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -145.26 122.06 1.64 Allowed Glycine 0 C--N 1.284 -2.306 0 N-CA-C 106.777 -2.529 . . . . 0.0 106.777 171.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.99 100.63 1.97 Allowed Glycine 0 CA--C 1.495 -1.215 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.369 -174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -131.96 161.98 31.8 Favored 'General case' 0 N--CA 1.421 -1.902 0 C-N-CA 123.07 0.548 . . . . 0.0 109.893 -178.275 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 57' ' ' VAL . 4.7 pt -117.4 153.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.507 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 86.7 m-85 -81.55 82.44 7.32 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -127.81 133.45 67.41 Favored 'Isoleucine or valine' 0 C--O 1.254 1.317 0 C-N-CA 119.549 -0.86 . . . . 0.0 108.718 168.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.4 ' HA ' ' ND2' ' A' ' 39' ' ' ASN . . . -70.88 136.16 48.45 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-O 121.533 0.682 . . . . 0.0 111.26 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.4 p 53.73 9.63 0.2 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 127.204 2.202 . . . . 0.0 116.322 177.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -94.75 128.54 39.21 Favored Pre-proline 0 C--O 1.211 -0.928 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.863 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.32 0.16 4.3 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.345 2.696 . . . . 0.0 113.99 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -104.14 -8.01 19.76 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.304 0.573 . . . . 0.0 110.299 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 57.8 m -139.62 136.05 33.95 Favored 'General case' 0 N--CA 1.433 -1.311 0 O-C-N 121.891 -0.506 . . . . 0.0 111.185 -171.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.492 ' O ' HD23 ' A' ' 28' ' ' LEU . 2.3 t -108.13 135.4 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.279 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.4 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 4.0 p30 -125.28 -170.06 2.1 Favored 'General case' 0 C--N 1.275 -2.66 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 99.1 t -46.92 -34.66 2.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 O-C-N 125.152 1.532 . . . . 0.0 111.286 176.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -58.84 -64.41 0.95 Allowed 'General case' 0 N--CA 1.422 -1.859 0 CA-C-O 122.367 1.08 . . . . 0.0 111.353 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.3 mp0 -68.88 -49.45 58.18 Favored 'General case' 0 N--CA 1.419 -2.015 0 CA-C-N 113.334 -1.757 . . . . 0.0 110.716 -175.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.7 -24.0 66.48 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.782 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -61.36 -34.76 75.84 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.81 -50.37 8.73 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.075 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 42' ' ' GLN . 24.5 t -58.19 -30.82 40.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.995 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 24.1 ptm -68.13 -12.13 60.35 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.983 0.421 . . . . 0.0 111.646 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -100.64 -6.67 24.87 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.85 177.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -42.13 4.66 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.384 -177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.76 99.27 15.5 Favored Pre-proline 0 N--CA 1.396 -3.134 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -76.09 71.73 5.57 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 C-N-CA 121.899 1.733 . . . . 0.0 111.675 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -109.65 160.99 15.82 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.195 -1.366 . . . . 0.0 110.508 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.602 ' HB3' ' HA ' ' A' ' 25' ' ' TYR 0.253 0.0 OUTLIER -75.71 122.42 23.98 Favored 'General case' 0 C--O 1.199 -1.563 0 C-N-CA 125.103 1.361 . . . . 0.0 108.656 -176.643 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.45 ' HD2' HD11 ' A' ' 28' ' ' LEU . 91.5 m-85 -92.31 137.69 32.15 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.683 -176.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.6 p -132.16 136.39 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.645 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.53 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.507 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -116.27 150.11 18.66 Favored Glycine 0 CA--C 1.481 -2.035 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.652 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 29' ' ' ILE . 41.4 t -130.05 133.79 63.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -172.4 159.49 4.63 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.588 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.526 ' HD3' ' OE1' ' A' ' 84' ' ' GLU . 16.3 ttm180 -104.44 97.01 7.0 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 172.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.98 148.11 25.75 Favored 'General case' 0 N--CA 1.383 -3.802 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -97.65 -37.68 9.82 Favored 'General case' 1 C--N 1.238 -4.273 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.137 177.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 65' ' ' ASP . 9.5 t70 -97.68 126.0 42.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.844 -176.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.563 HG13 HD13 ' A' ' 92' ' ' LEU . 7.6 tt -63.97 -34.44 68.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.149 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.61 -15.81 59.73 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.452 0.644 . . . . 0.0 109.772 -175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 12.3 t70 -75.93 -38.29 57.83 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.392 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.7 t -70.43 -46.7 69.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.316 176.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -59.42 -40.85 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.447 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.528 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.582 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.8 t70 -52.01 -56.17 15.96 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.08 176.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 41.5 mmtm -64.82 -43.18 93.96 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.347 -176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.93 -38.35 85.48 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 124.182 0.926 . . . . 0.0 111.066 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -79.65 -52.14 8.36 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.54 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 68' ' ' ASP . 57.6 t -57.43 -57.51 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 120.886 0.375 . . . . 0.0 111.227 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.496 HD13 ' O ' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -78.75 -12.8 60.04 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.714 -0.395 . . . . 0.0 110.709 -176.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 p 54.69 73.63 0.39 Allowed 'General case' 0 C--O 1.252 1.226 0 CA-C-O 122.309 1.052 . . . . 0.0 111.623 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.75 -174.31 4.68 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.793 -1.549 . . . . 0.0 111.858 -176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.66 -38.07 1.73 Allowed 'General case' 0 N--CA 1.415 -2.183 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.678 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.79 159.64 42.54 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.705 0.288 . . . . 0.0 110.81 173.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -144.74 137.36 21.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.425 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.616 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.76 112.11 24.91 Favored 'General case' 0 N--CA 1.391 -3.414 0 C-N-CA 123.102 0.561 . . . . 0.0 109.575 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.24 130.5 37.11 Favored 'General case' 0 C--N 1.267 -3.006 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.477 177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -70.7 103.67 2.62 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 120.004 -0.678 . . . . 0.0 109.484 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.658 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.64 -31.87 53.38 Favored Glycine 0 CA--C 1.496 -1.122 0 CA-C-N 114.154 -1.385 . . . . 0.0 114.243 -175.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -48.48 -25.55 1.72 Allowed 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 124.534 1.134 . . . . 0.0 113.013 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.526 ' OE1' ' HD3' ' A' ' 59' ' ' ARG . 11.7 tp10 -66.06 -47.3 74.76 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 116.703 -0.226 . . . . 0.0 111.534 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -178.5 148.59 0.46 Allowed 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.437 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -77.88 -46.53 21.08 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 122.0 0.905 . . . . 0.0 112.16 -173.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 39.9 mt -79.34 -21.74 45.43 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.245 -171.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.461 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.8 t80 -52.43 -44.51 65.51 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.483 173.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.658 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.7 mp -64.17 -36.49 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.686 0 CA-C-O 121.338 0.589 . . . . 0.0 110.152 -177.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -77.45 -17.41 58.11 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.67 0.748 . . . . 0.0 110.695 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.461 HG22 ' CD1' ' A' ' 63' ' ' ILE . 83.7 m -79.19 -42.17 26.67 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.176 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.563 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -43.92 -47.21 8.38 Favored 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.517 172.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.534 ' NH1' ' HB2' ' A' ' 119' ' ' HIS . 4.0 mpt_? -52.47 -32.52 40.17 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -75.46 -29.03 59.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.023 0.439 . . . . 0.0 111.419 -169.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.38 -1.66 28.27 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 122.01 0.909 . . . . 0.0 110.562 178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 14.7 tp -91.3 133.27 31.85 Favored Pre-proline 0 C--N 1.309 -1.17 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.076 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.14 163.53 38.89 Favored 'Trans proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.591 1.527 . . . . 0.0 110.587 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.48 69.9 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 124.231 1.013 . . . . 0.0 112.67 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -79.66 -13.83 59.21 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.1 t -100.3 140.58 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 C-N-CA 119.354 -0.938 . . . . 0.0 108.567 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.26 174.09 6.24 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 80.6 mt -128.19 135.49 62.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.616 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 51.6 m0 -122.57 162.56 21.59 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.494 -0.882 . . . . 0.0 108.704 177.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.49 ' HG2' ' CE2' ' A' ' 123' ' ' TYR . 18.6 tptm -100.82 116.0 31.68 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.968 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -74.56 98.94 3.48 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.9 tt -80.65 105.46 11.91 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -173.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.8 m -75.3 107.79 7.65 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 174.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 30.4 m -75.49 143.42 13.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.889 -176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.26 -79.82 0.05 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.847 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -100.29 -62.65 1.21 Allowed 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -175.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.5 t -161.93 -173.89 3.9 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.4 tp -110.68 118.84 47.81 Favored Pre-proline 0 N--CA 1.422 -1.858 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 173.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -52.09 162.21 2.08 Favored 'Trans proline' 0 C--O 1.248 1.02 0 C-N-CA 124.029 3.153 . . . . 0.0 114.269 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.34 -45.58 75.99 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 40.6 mtm180 -140.58 122.2 15.22 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 117' ' ' PHE . 0.5 OUTLIER -129.41 -89.04 0.51 Allowed 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.706 178.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.446 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 22.3 m-85 -125.58 95.06 4.31 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 -177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -96.75 174.17 6.94 Favored 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.156 -1.384 . . . . 0.0 111.964 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.534 ' HB2' ' NH1' ' A' ' 93' ' ' ARG . 20.9 m170 72.7 14.74 5.0 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.696 1.599 . . . . 0.0 110.778 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.89 150.33 6.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.906 0 CA-C-O 121.237 0.542 . . . . 0.0 111.52 -176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -75.57 -29.44 59.33 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.942 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -159.75 158.54 31.42 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 104' ' ' LYS . 7.1 m-85 -109.14 128.85 55.36 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.9 m -137.41 -178.04 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 O-C-N 123.33 0.394 . . . . 0.0 109.939 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 5.4 mp -72.29 150.49 43.52 Favored 'General case' 0 C--N 1.313 -0.978 0 O-C-N 123.49 0.494 . . . . 0.0 110.589 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.468 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 8.7 t70 -80.92 98.61 7.96 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 103.631 -2.729 . . . . 0.0 103.631 166.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -93.26 87.75 5.77 Favored 'General case' 0 N--CA 1.408 -2.534 0 CA-C-O 121.211 0.529 . . . . 0.0 110.068 -173.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.39 35.84 0.11 Allowed Glycine 0 C--N 1.299 -1.485 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -87.97 107.86 18.92 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -132.2 -51.37 0.09 OUTLIER Glycine 0 N--CA 1.432 -1.567 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.519 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 76.68 26.34 63.15 Favored Glycine 0 C--O 1.241 0.543 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -93.75 132.21 38.35 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.231 -0.485 . . . . 0.0 110.209 -177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.29 25.97 Favored Glycine 0 C--N 1.292 -1.892 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 31.4 m . . . . . 0 C--N 1.295 -1.776 0 O-C-N 123.694 0.291 . . . . 0.0 110.356 -179.031 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 121.067 0.46 . . . . 0.0 110.48 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.51 64.73 0.02 OUTLIER Glycine 0 CA--C 1.482 -1.974 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -69.33 143.31 53.81 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.431 -0.884 . . . . 0.0 112.272 -171.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.71 25.86 11.22 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -178.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -16.84 99.36 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 127.376 2.27 . . . . 0.0 115.357 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.96 110.47 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.568 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 68.3 m -91.11 169.38 10.9 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 175.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -38.41 106.68 0.05 OUTLIER Glycine 0 N--CA 1.473 1.152 0 O-C-N 124.196 0.935 . . . . 0.0 114.539 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 11' ' ' ARG . 3.6 tt -138.37 146.23 42.01 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 102.827 -3.027 . . . . 0.0 102.827 -177.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.0 p -111.12 -19.82 12.58 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 122.255 1.026 . . . . 0.0 110.575 -169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.446 ' H ' HD23 ' A' ' 9' ' ' LEU . 71.4 mtm180 -86.21 108.49 18.39 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.721 -177.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -56.96 -39.43 89.16 Favored Glycine 0 C--N 1.316 -0.546 0 CA-C-O 122.181 0.878 . . . . 0.0 112.833 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -73.57 -18.23 61.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.833 -1.183 . . . . 0.0 110.756 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -92.91 -45.8 7.79 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -28.04 68.38 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.705 1.202 . . . . 0.0 112.175 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -58.81 -22.89 59.52 Favored 'General case' 0 C--O 1.193 -1.894 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.967 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.27 -33.69 43.08 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.462 0.705 . . . . 0.0 112.288 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.22 -27.25 47.69 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.611 0.72 . . . . 0.0 110.784 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.8 -33.98 34.39 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.012 176.705 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.23 -23.41 55.76 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 125.828 1.651 . . . . 0.0 110.524 176.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 -16.39 62.21 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.523 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 130.87 26.8 0.75 Allowed Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.019 -1.086 . . . . 0.0 112.825 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 54.45 34.16 20.34 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.358 1.063 . . . . 0.0 111.743 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 21.9 mt -62.58 -69.05 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.233 -174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.444 ' HB2' ' CD ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.96 155.64 0.99 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.049 -173.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.96 138.43 11.03 Favored Glycine 0 N--CA 1.431 -1.635 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.44 75.83 0.23 Allowed Glycine 0 CA--C 1.493 -1.286 0 C-N-CA 120.092 -1.051 . . . . 0.0 112.426 -173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.508 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -117.31 144.22 45.11 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 22.0 mt -117.1 152.65 18.89 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.372 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.504 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 4.9 m-85 -82.55 72.29 9.62 Favored 'General case' 0 CA--C 1.507 -0.689 0 CA-C-N 118.035 0.38 . . . . 0.0 110.245 -176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 66.1 t -95.76 121.99 46.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 C-N-CA 118.459 -1.297 . . . . 0.0 107.692 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.53 108.43 0.17 Allowed 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 124.429 1.081 . . . . 0.0 112.864 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.2 p 57.82 29.04 16.87 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 125.701 1.6 . . . . 0.0 113.915 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -80.97 140.09 49.91 Favored Pre-proline 0 N--CA 1.423 -1.792 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.32 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -85.4 7.94 4.85 Favored 'Trans proline' 0 N--CA 1.441 -1.584 0 C-N-CA 121.596 1.53 . . . . 0.0 112.297 176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -124.65 2.18 8.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 109.858 175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 93.9 m -154.12 125.21 7.31 Favored 'General case' 0 C--O 1.203 -1.352 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 -177.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.33 137.94 29.67 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.61 0.719 . . . . 0.0 111.634 -173.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -104.0 170.95 7.62 Favored 'General case' 0 CA--C 1.483 -1.617 0 CA-C-N 114.773 -1.103 . . . . 0.0 109.873 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -43.32 -35.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.025 1.33 . . . . 0.0 113.224 -175.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -67.33 -50.71 58.93 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.959 -175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -78.29 -32.39 49.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.992 0.901 . . . . 0.0 109.441 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.948 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -63.22 -25.87 68.53 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.796 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -39.13 70.35 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 123.882 0.873 . . . . 0.0 109.714 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -86.5 -46.12 10.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.002 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.948 HG12 ' HA ' ' A' ' 43' ' ' ALA . 7.0 p -60.82 -31.89 50.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.382 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.704 ' SD ' ' HA ' ' A' ' 73' ' ' LEU . 26.5 ptt? -66.16 -27.06 67.73 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.983 0.42 . . . . 0.0 110.953 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.08 -24.42 21.15 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.372 0.606 . . . . 0.0 109.522 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.42 -47.26 34.88 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.188 -0.915 . . . . 0.0 111.342 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.0 101.41 22.84 Favored Pre-proline 0 N--CA 1.396 -3.157 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -73.33 66.4 4.43 Favored 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 121.969 1.779 . . . . 0.0 112.057 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.462 HD23 ' CB ' ' A' ' 19' ' ' TYR . 2.5 pp -107.73 176.41 5.15 Favored 'General case' 0 N--CA 1.426 -1.662 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.408 174.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' TYR . 4.1 tt0 -76.73 131.83 38.97 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.797 0.332 . . . . 0.0 110.664 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.508 ' CD2' HD11 ' A' ' 28' ' ' LEU . 61.0 m-85 -105.14 141.96 35.75 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.487 0.661 . . . . 0.0 110.768 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.6 p -129.11 160.92 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.613 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.504 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.88 139.25 10.24 Favored Glycine 0 C--N 1.277 -2.717 0 C-N-CA 120.245 -0.979 . . . . 0.0 112.073 174.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.496 ' HB ' HG23 ' A' ' 29' ' ' ILE . 61.8 t -113.28 127.89 70.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 173.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -154.22 147.0 24.3 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 118.489 -1.285 . . . . 0.0 110.511 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.0 mtp180 -86.26 102.19 13.73 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 104.731 -2.322 . . . . 0.0 104.731 167.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.4 HD22 HD11 ' A' ' 92' ' ' LEU . 2.2 m-20 -80.49 114.56 19.47 Favored 'General case' 0 N--CA 1.387 -3.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -173.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -105.43 -58.08 1.95 Allowed 'General case' 0 C--N 1.256 -3.463 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.85 116.35 30.88 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.297 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 67' ' ' VAL . 18.3 tt -64.63 -31.4 53.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-O 120.876 0.37 . . . . 0.0 111.168 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.81 -9.5 59.07 Favored 'General case' 0 C--N 1.317 -0.809 0 O-C-N 121.632 -0.667 . . . . 0.0 110.714 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 11.3 t70 -84.88 -39.13 18.61 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.72 -35.0 20.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.795 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.5 t -63.96 -36.47 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.561 ' O ' HG23 ' A' ' 72' ' ' VAL . 5.3 t70 -53.71 -53.36 53.22 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.975 174.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 42.2 mmtm -64.72 -44.2 90.96 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.094 -177.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.534 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -57.65 -33.49 68.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.666 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.28 -60.66 2.19 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.168 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.2 t -54.59 -59.86 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 123.647 0.779 . . . . 0.0 112.245 -174.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.704 ' HA ' ' SD ' ' A' ' 47' ' ' MET . 1.4 mm? -78.61 -14.21 59.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.888 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 36.6 t 57.13 73.58 0.45 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.945 0.879 . . . . 0.0 109.794 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.7 mt -76.63 -178.8 4.93 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.208 -175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.424 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -128.06 -34.22 2.14 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.083 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.499 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -149.24 160.16 43.63 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.697 174.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.29 137.18 37.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.6 mp0 -96.46 118.33 32.76 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.409 HD21 HG13 ' A' ' 89' ' ' ILE . 34.3 tp -99.78 125.86 45.76 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.734 -170.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.493 ' HB3' ' OD1' ' A' ' 83' ' ' ASN . 72.5 m80 -87.29 95.75 10.1 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.508 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -67.69 -12.95 62.73 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.74 -1.118 . . . . 0.0 114.74 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.493 ' OD1' ' HB3' ' A' ' 81' ' ' HIS . 3.4 p-10 -56.36 -25.49 49.63 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 123.165 0.586 . . . . 0.0 112.438 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -46.86 82.46 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.515 0.726 . . . . 0.0 112.887 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HB3' ' CB ' ' A' ' 88' ' ' TYR . 1.7 tm-20 -171.46 141.5 1.53 Allowed 'General case' 0 C--O 1.199 -1.59 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 177.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.06 -42.01 33.61 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -168.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.0 mt -84.02 -24.17 30.63 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-O 121.882 0.848 . . . . 0.0 109.959 -173.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.556 ' O ' ' HB ' ' A' ' 91' ' ' THR . 36.7 t80 -51.43 -32.55 27.09 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 125.98 1.712 . . . . 0.0 112.13 175.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.508 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -60.07 -39.66 81.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.415 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 9.9 t70 -67.9 -14.74 63.21 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.47 -178.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 75.2 m -88.13 -46.57 9.18 Favored 'General case' 0 N--CA 1.434 -1.249 0 C-N-CA 125.23 1.412 . . . . 0.0 109.367 -176.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.469 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -44.91 -51.01 10.12 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.619 ' HD3' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -56.99 -29.96 63.73 Favored 'General case' 0 N--CA 1.511 2.612 0 CA-C-O 121.219 0.533 . . . . 0.0 112.18 -178.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -76.15 -31.12 58.41 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.483 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.435 ' HB1' HG21 ' A' ' 67' ' ' VAL . . . -94.76 -23.79 17.37 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 92' ' ' LEU . 98.2 mt -76.7 131.44 73.92 Favored Pre-proline 0 C--N 1.288 -2.101 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.688 179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.04 165.2 10.84 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.724 2.283 . . . . 0.0 112.446 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -52.35 -37.02 55.02 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 124.721 1.208 . . . . 0.0 113.099 -173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -85.86 -8.58 57.98 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -176.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.534 HG21 ' HB1' ' A' ' 70' ' ' ALA . 82.7 t -98.66 124.89 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.55 0 CA-C-O 121.717 0.77 . . . . 0.0 109.263 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -106.96 172.73 6.66 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.034 -176.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.08 130.94 73.06 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.559 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 47.2 m0 -119.9 159.38 24.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.175 178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -101.18 117.94 36.0 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.325 177.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.11 105.72 3.48 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 172.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.3 tt -85.73 95.85 9.52 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 121.903 0.858 . . . . 0.0 109.772 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.471 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 49.0 m -67.69 117.87 10.2 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 114.299 -1.319 . . . . 0.0 109.923 176.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 16.6 m -60.55 127.5 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.518 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.16 142.1 3.48 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -79.6 89.56 5.12 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 122.225 1.012 . . . . 0.0 112.732 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 t -143.2 152.53 41.86 Favored 'General case' 0 N--CA 1.413 -2.323 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -121.71 93.38 48.69 Favored Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.08 122.1 3.27 Favored 'Trans proline' 0 N--CA 1.431 -2.2 0 C-N-CA 121.795 1.663 . . . . 0.0 109.799 174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.89 -34.59 73.75 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.434 ' HG2' ' N ' ' A' ' 116' ' ' GLU . 37.7 ttm180 -171.38 166.48 6.98 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' N ' ' HG2' ' A' ' 115' ' ' ARG . 40.1 mt-10 -144.86 -56.5 0.34 Allowed 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 102.55 -3.129 . . . . 0.0 102.55 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -133.09 165.99 23.46 Favored 'General case' 0 N--CA 1.403 -2.796 0 N-CA-C 102.833 -3.025 . . . . 0.0 102.833 175.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.457 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 4.5 pt20 -136.22 172.52 12.89 Favored 'General case' 0 C--N 1.259 -3.358 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.457 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 88.9 m-70 69.41 36.55 2.24 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.576 1.551 . . . . 0.0 112.429 178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 32.3 m -84.74 152.63 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.075 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 172.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -83.46 -47.28 11.55 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.706 -175.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 67.6 mttm -151.06 163.85 37.81 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -110.94 162.39 14.88 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.001 -0.68 . . . . 0.0 109.265 174.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 125' ' ' LEU . 13.3 p -141.27 174.14 7.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.523 ' HG ' ' H ' ' A' ' 126' ' ' ASP . 28.4 tp -76.61 -178.08 4.55 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.523 ' H ' ' HG ' ' A' ' 125' ' ' LEU . 26.6 t70 -69.69 99.99 1.41 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.251 0.548 . . . . 0.0 111.531 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -113.2 154.89 25.98 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.38 179.14 30.77 Favored Glycine 0 N--CA 1.434 -1.484 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -96.34 21.02 9.58 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.889 0.345 . . . . 0.0 110.558 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.75 77.27 1.47 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.912 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -152.8 33.79 0.81 Allowed Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.87 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.67 176.32 11.12 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.36 -76.11 2.27 Favored Glycine 0 C--N 1.31 -0.88 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--N 1.293 -1.85 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 177.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 N--CA 1.472 0.642 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.61 78.0 0.26 Allowed Glycine 0 N--CA 1.427 -1.937 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -80.65 178.48 8.32 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.415 0.626 . . . . 0.0 109.774 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 5.1 t30 -148.85 48.28 1.0 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 103.51 -2.774 . . . . 0.0 103.51 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -37.05 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 112.673 -2.058 . . . . 0.0 112.116 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.9 p -92.58 121.4 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.988 -174.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.7 m -90.55 170.73 9.94 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -42.03 135.68 3.42 Favored Glycine 0 C--N 1.357 1.749 0 CA-C-N 119.152 0.887 . . . . 0.0 114.321 -170.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.52 161.31 37.37 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 -176.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -129.09 18.53 6.02 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -137.2 106.17 5.96 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.649 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -48.41 -48.77 27.27 Favored Glycine 0 C--N 1.304 -1.223 0 C-N-CA 124.765 1.174 . . . . 0.0 113.04 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.643 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.9 mp0 -63.22 -19.32 64.42 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 125.822 1.649 . . . . 0.0 112.444 -179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -94.0 -42.23 9.15 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.92 -27.77 69.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.764 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -63.3 -23.06 67.25 Favored 'General case' 0 C--O 1.204 -1.331 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.68 -32.52 69.2 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -77.08 -30.13 55.29 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.301 0.572 . . . . 0.0 110.789 177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -78.06 -34.46 50.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -64.02 -30.49 71.56 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.065 176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.01 -17.38 64.39 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.426 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 140.44 15.31 0.5 Allowed Glycine 0 N--CA 1.44 -1.058 0 C-N-CA 119.539 -1.315 . . . . 0.0 114.134 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.46 26.56 12.78 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.455 0.702 . . . . 0.0 110.837 -178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 56.7 mt -57.67 -67.6 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.223 -174.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 0.2 OUTLIER -178.53 159.76 1.18 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.258 0.974 . . . . 0.0 108.815 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.6 142.83 14.28 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 108.459 -1.857 . . . . 0.0 108.459 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -105.62 78.8 0.27 Allowed Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.331 -0.938 . . . . 0.0 111.573 -174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.553 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -115.34 146.32 41.65 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-O 121.114 0.483 . . . . 0.0 109.734 -177.142 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.495 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 pt -117.37 155.01 19.12 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 38.5 m-85 -84.16 76.93 10.04 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 124.651 1.219 . . . . 0.0 109.689 -176.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.28 121.93 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.57 98.79 0.02 OUTLIER 'General case' 0 C--O 1.244 0.792 0 O-C-N 125.04 1.463 . . . . 0.0 113.82 -172.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p 58.77 25.26 13.25 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 125.858 1.663 . . . . 0.0 114.97 173.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 m -90.76 116.07 65.6 Favored Pre-proline 0 C--O 1.199 -1.557 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.99 -7.3 2.33 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 124.273 3.315 . . . . 0.0 116.542 -171.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -108.23 11.54 27.29 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-O 122.637 1.208 . . . . 0.0 109.797 175.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 66.2 m -140.0 170.92 14.97 Favored 'General case' 0 N--CA 1.419 -1.985 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -147.17 136.57 16.38 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 CA-C-N 119.486 1.039 . . . . 0.0 109.869 -179.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -101.41 166.87 10.51 Favored 'General case' 0 CA--C 1.462 -2.413 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.263 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.7 p -42.96 -36.89 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 O-C-N 125.044 1.465 . . . . 0.0 113.843 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -74.9 -32.54 61.85 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.588 ' O ' HG23 ' A' ' 46' ' ' VAL . 16.2 mt-30 -83.38 -37.85 22.76 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.713 174.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.56 -36.49 64.38 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.662 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.8 -33.06 74.83 Favored 'General case' 0 N--CA 1.405 -2.699 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -77.34 -46.23 23.58 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.75 177.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' GLN . 6.4 t -63.72 -34.4 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.649 -177.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.24 -16.09 62.48 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.893 -0.504 . . . . 0.0 111.49 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -86.62 -19.67 28.99 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.24 -40.81 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.096 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.16 97.24 9.78 Favored Pre-proline 0 N--CA 1.408 -2.551 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -74.43 53.32 3.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.852 2.368 . . . . 0.0 113.544 -176.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.1 pp -90.39 168.97 11.47 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 124.425 1.09 . . . . 0.0 109.14 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 0.0 OUTLIER -71.75 140.34 49.47 Favored 'General case' 0 C--N 1.293 -1.874 0 C-N-CA 122.964 0.505 . . . . 0.0 110.128 -178.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.501 ' CD2' HD11 ' A' ' 28' ' ' LEU . 15.4 m-85 -112.29 137.84 49.85 Favored 'General case' 0 C--O 1.251 1.161 0 CA-C-O 121.521 0.677 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.5 p -131.18 148.86 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.114 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -122.31 143.74 15.7 Favored Glycine 0 C--N 1.283 -2.398 0 C-N-CA 119.783 -1.199 . . . . 0.0 112.147 178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.495 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.3 t -134.97 118.13 23.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -172.59 163.39 5.32 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 81' ' ' HIS . 13.9 ptm180 -96.64 93.87 6.99 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 171.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HB2' HG22 ' A' ' 66' ' ' VAL . 14.1 m120 -90.61 117.64 29.43 Favored 'General case' 0 N--CA 1.397 -3.087 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.88 -38.47 70.0 Favored 'General case' 0 C--N 1.254 -3.565 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.487 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -99.24 129.27 45.46 Favored 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.341 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.567 HG13 HD13 ' A' ' 92' ' ' LEU . 15.3 tt -64.03 -31.95 55.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.081 0.467 . . . . 0.0 110.1 175.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.97 -11.83 60.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 110.784 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.508 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 35.6 t70 -85.39 -41.53 15.36 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 60' ' ' ASN . 21.7 t -63.02 -51.84 66.82 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.295 176.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.8 t -58.8 -38.25 71.37 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.965 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.51 ' O ' HG23 ' A' ' 72' ' ' VAL . 36.3 t70 -65.54 -43.97 88.27 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.007 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 56.8 mmtt -67.91 -44.81 76.06 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.586 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.02 -36.28 72.47 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.77 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -73.85 -59.59 2.65 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.8 177.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 68' ' ' ASP . 87.0 t -54.41 -58.05 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -84.56 -3.44 58.45 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 118.588 -1.245 . . . . 0.0 110.833 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 p 51.4 61.85 3.01 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.79 0.805 . . . . 0.0 111.796 -173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.9 mt -68.72 174.52 4.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.542 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB3' ' NE2' ' A' ' 53' ' ' GLN . . . -125.88 -29.42 3.1 Favored 'General case' 0 CA--C 1.482 -1.656 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.362 -179.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -145.25 155.22 43.1 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 170.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.28 136.51 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.25 110.37 22.31 Favored 'General case' 0 N--CA 1.384 -3.738 0 C-N-CA 123.019 0.527 . . . . 0.0 110.044 -178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -93.25 123.22 36.38 Favored 'General case' 0 C--N 1.272 -2.766 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.522 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 59' ' ' ARG . 52.1 m-70 -74.25 94.02 2.43 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 172.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.61 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -55.69 -12.72 5.22 Favored Glycine 0 C--O 1.217 -0.955 0 N-CA-C 117.29 1.676 . . . . 0.0 117.29 -170.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -44.88 -25.48 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.613 1.165 . . . . 0.0 113.694 -178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -60.94 -48.24 82.75 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -172.18 150.04 2.39 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -176.271 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.469 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 24.0 mt-30 -77.44 -42.9 34.33 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.05 0.928 . . . . 0.0 111.933 -176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.1 mt -84.06 -13.0 54.23 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.784 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 21.9 t80 -59.12 -40.98 87.07 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.308 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.1 mp -63.52 -39.51 85.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.816 0.817 . . . . 0.0 109.229 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.53 -16.78 64.38 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.814 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.2 m -85.27 -39.99 17.11 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.677 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.567 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.09 -39.5 63.42 Favored 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 123.137 0.575 . . . . 0.0 110.702 177.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.421 ' HD2' ' CD1' ' A' ' 102' ' ' ILE . 6.7 mmm180 -43.34 -43.75 5.2 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.659 1.224 . . . . 0.0 111.759 176.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -71.08 -46.3 62.12 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.354 -173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -94.88 -12.01 27.69 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 114.746 1.387 . . . . 0.0 114.746 -172.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.7 mt -88.21 130.03 47.54 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.442 ' HG2' HG23 ' A' ' 100' ' ' VAL . 37.3 Cg_endo -66.1 164.16 28.74 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.225 1.95 . . . . 0.0 111.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -58.05 -27.2 63.39 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 124.276 1.031 . . . . 0.0 113.338 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -85.34 -7.96 58.71 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.586 HG21 ' HB1' ' A' ' 70' ' ' ALA . 92.7 t -104.11 133.35 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.563 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -115.74 169.61 9.08 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.307 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.421 ' CD1' ' HD2' ' A' ' 93' ' ' ARG . 84.7 mt -123.14 130.02 74.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.585 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 42.0 m0 -121.14 159.9 24.84 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.351 -1.34 . . . . 0.0 109.416 175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -103.71 115.5 30.6 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.72 103.77 2.66 Favored 'General case' 0 C--N 1.311 -1.107 0 O-C-N 123.781 0.676 . . . . 0.0 109.245 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 66.6 tp -84.19 104.51 14.29 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 126' ' ' ASP . 23.3 t -57.39 120.52 8.34 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 172.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.0 m -47.88 129.81 4.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -173.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 132.35 118.88 1.99 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -71.98 -6.07 39.46 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.2 m -72.79 -24.8 60.97 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.36 114.54 30.57 Favored Pre-proline 0 CA--C 1.545 0.775 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 137.43 80.31 Favored 'Trans proline' 0 C--O 1.243 0.732 0 C-N-CA 123.177 2.585 . . . . 0.0 114.416 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.5 -16.09 59.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.298 177.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.46 118.57 30.62 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-O 121.678 0.751 . . . . 0.0 110.316 176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -160.63 -57.78 0.06 Allowed 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 102.772 -3.047 . . . . 0.0 102.772 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 50.1 m-85 -118.7 101.34 8.03 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 112.182 -2.281 . . . . 0.0 106.475 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.564 ' HG3' ' CD2' ' A' ' 119' ' ' HIS . 13.9 pt20 -99.57 -169.07 1.7 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.564 ' CD2' ' HG3' ' A' ' 118' ' ' GLN . 94.3 m-70 70.42 34.36 2.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.47 164.36 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.617 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -89.08 -37.99 14.7 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.502 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 38.4 ttmt -161.12 162.66 31.56 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.226 -0.59 . . . . 0.0 109.957 -174.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -107.42 142.83 36.65 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.792 174.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 p -146.9 163.74 7.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 89.9 mt -87.54 150.07 23.95 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-O 121.161 0.505 . . . . 0.0 111.233 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.462 ' HB3' ' HA ' ' A' ' 107' ' ' SER . 16.7 t70 -69.8 105.99 2.96 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.619 175.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -113.24 18.84 17.57 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.082 0.468 . . . . 0.0 109.815 176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -136.34 55.38 0.71 Allowed Glycine 0 N--CA 1.43 -1.701 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -61.76 113.15 2.59 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.309 0.576 . . . . 0.0 110.511 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -79.99 61.72 4.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.978 -177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -85.5 44.39 3.36 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -141.69 142.16 33.34 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -165.75 50.41 0.27 Allowed Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.5 m . . . . . 0 C--N 1.301 -1.509 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.928 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 C--O 1.237 0.444 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.46 91.09 0.34 Allowed Glycine 0 CA--C 1.481 -2.041 0 N-CA-C 105.849 -2.9 . . . . 0.0 105.849 -174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 67.8 -170.17 0.19 Allowed 'General case' 0 C--O 1.25 1.094 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -166.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.606 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.1 p-10 -156.97 41.04 0.33 Allowed 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.98 114.74 3.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.522 -1.217 . . . . 0.0 112.655 -173.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.591 ' H ' ' HA2' ' A' ' 26' ' ' GLY . 97.6 t -93.91 117.97 38.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.764 176.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 36' ' ' ARG . 16.9 p -136.81 166.88 22.57 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -6.51 106.23 0.01 OUTLIER Glycine 0 N--CA 1.5 2.955 0 C-N-CA 126.055 1.788 . . . . 0.0 116.939 -174.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -160.54 159.92 31.26 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -178.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -138.72 19.91 2.68 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 71.2 mtp180 -114.52 101.76 9.43 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.452 -174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.87 -44.03 55.26 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 124.274 0.94 . . . . 0.0 113.853 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.413 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.6 mp0 -75.14 -19.81 59.7 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.325 -0.937 . . . . 0.0 110.312 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 36.4 t70 -83.45 -38.33 22.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 9' ' ' LEU . . . -63.42 -50.28 70.41 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 113.987 -1.461 . . . . 0.0 111.123 178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.456 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 12.2 pttp -65.68 -23.77 66.85 Favored 'General case' 0 C--O 1.194 -1.84 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.013 -177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.46 -26.19 67.73 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.149 0.499 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.4 -37.4 25.59 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.804 0.812 . . . . 0.0 109.417 177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.443 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -67.83 -38.96 83.87 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.744 -0.598 . . . . 0.0 110.442 174.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -60.97 -32.74 72.28 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.205 0.526 . . . . 0.0 110.056 174.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.18 -23.16 62.92 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.735 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.49 -14.34 0.05 OUTLIER Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.22 -1.467 . . . . 0.0 113.597 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 65.52 18.2 11.19 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 123.643 0.777 . . . . 0.0 110.648 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.606 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 22.3 mt -63.14 -67.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-N 113.814 -1.539 . . . . 0.0 113.375 -170.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.6 p90 -174.03 161.89 3.73 Favored 'General case' 0 C--O 1.212 -0.873 0 O-C-N 123.627 0.579 . . . . 0.0 110.538 -178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.591 ' HA2' ' H ' ' A' ' 6' ' ' VAL . . . -129.97 122.45 3.71 Favored Glycine 0 N--CA 1.418 -2.552 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.52 88.67 1.25 Allowed Glycine 0 CA--C 1.493 -1.288 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 0.9 OUTLIER -116.42 147.4 41.71 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -175.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 37' ' ' CYS 0.285 4.6 pt -117.24 151.69 19.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 115.162 1.542 . . . . 0.0 115.162 178.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.434 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 48.9 m-85 -85.12 73.98 10.56 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.995 -1.002 . . . . 0.0 111.605 -174.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.423 ' HB ' ' SG ' ' A' ' 37' ' ' CYS . 52.6 t -120.93 115.7 47.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.35 106.44 0.12 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 124.94 1.4 . . . . 0.0 113.901 -173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.0 p 65.54 15.89 10.25 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.005 1.722 . . . . 0.0 115.05 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.41 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 24.9 t -74.85 138.28 73.24 Favored Pre-proline 0 C--N 1.314 -0.946 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.89 -0.89 7.69 Favored 'Trans proline' 0 N--CA 1.478 0.611 0 C-N-CA 122.811 2.341 . . . . 0.0 113.727 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 58.6 ttp180 -114.18 -4.51 13.09 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 15.2 m -129.88 130.12 44.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 C-N-CA 119.294 -0.962 . . . . 0.0 111.992 -169.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.63 134.94 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.053 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 175.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -118.25 179.25 4.16 Favored 'General case' 0 C--N 1.273 -2.746 0 CA-C-N 114.874 -1.057 . . . . 0.0 109.275 -178.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HA ' HD11 ' A' ' 73' ' ' LEU . 6.9 p -45.51 -31.74 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 O-C-N 124.666 1.229 . . . . 0.0 113.204 -176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -68.22 -61.97 1.61 Allowed 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 123.742 0.817 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -67.96 -37.8 81.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.22 0.534 . . . . 0.0 110.256 -176.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -64.06 -23.83 67.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.88 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 3.8 tp-100 -67.78 -39.49 84.07 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.027 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -86.88 -40.52 14.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.978 -178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.842 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.5 p -64.56 -22.9 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.555 -175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.748 ' HA ' ' OH ' ' A' ' 54' ' ' TYR . 21.6 ptp -67.8 -17.12 64.42 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.543 0.687 . . . . 0.0 110.931 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.37 3.15 40.27 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.499 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -111.83 -42.6 3.77 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.134 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.456 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -142.39 101.06 5.65 Favored Pre-proline 0 N--CA 1.4 -2.956 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.43 70.07 3.3 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.919 1.746 . . . . 0.0 112.007 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.443 HD23 ' CB ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -111.99 160.56 17.34 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.192 -1.367 . . . . 0.0 109.202 174.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' TYR . 2.6 tt0 -67.16 134.93 52.7 Favored 'General case' 0 C--O 1.208 -1.079 0 C-N-CA 123.229 0.612 . . . . 0.0 109.89 -175.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.748 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 61.3 m-85 -108.52 140.6 41.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.077 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 9.5 p -133.96 133.96 56.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -110.37 125.89 7.67 Favored Glycine 0 CA--C 1.479 -2.167 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.598 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 18.0 t -112.89 121.58 65.4 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -173.08 154.33 2.74 Favored 'General case' 0 CA--C 1.493 -1.223 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.361 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -85.56 104.9 15.74 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-O 122.458 1.123 . . . . 0.0 108.315 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -101.85 121.68 42.56 Favored 'General case' 0 N--CA 1.386 -3.645 0 CA-C-N 113.637 -1.619 . . . . 0.0 110.326 -171.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -99.64 -36.28 9.55 Favored 'General case' 0 C--N 1.258 -3.405 0 CA-C-N 112.617 -2.083 . . . . 0.0 108.274 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 66' ' ' VAL . 8.1 t70 -99.37 111.37 23.75 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.215 -177.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.53 ' O ' HG23 ' A' ' 67' ' ' VAL . 13.6 tt -66.93 -33.6 64.47 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.156 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.07 -17.42 62.0 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.344 0.593 . . . . 0.0 110.461 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -84.0 -33.22 24.59 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 62' ' ' ASP . 47.6 t -65.2 -43.46 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.2 t -59.05 -43.56 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.36 178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.539 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -57.89 -61.33 2.61 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.887 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -62.17 -42.67 99.49 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -65.66 -29.46 70.03 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -178.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -82.8 -56.75 3.65 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.717 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 68' ' ' ASP . 58.0 t -53.21 -59.67 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.429 0.692 . . . . 0.0 111.547 -176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 40' ' ' VAL . 1.8 mm? -72.34 -18.17 61.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.221 177.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.5 m 59.72 69.04 0.73 Allowed 'General case' 0 C--O 1.243 0.746 0 CA-C-O 122.336 1.065 . . . . 0.0 109.803 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.8 mt -79.71 -176.39 5.35 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.253 -175.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.13 -43.13 1.67 Allowed 'General case' 0 C--O 1.184 -2.35 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -136.25 155.0 50.74 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.79 170.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' C ' HE21 ' A' ' 79' ' ' GLN . 6.1 p -135.51 137.34 49.79 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 15.5 mm-40 -95.0 128.25 41.68 Favored 'General case' 0 N--CA 1.394 -3.231 0 CA-C-O 121.288 0.566 . . . . 0.0 110.846 -174.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 89' ' ' ILE . 40.4 tp -113.6 121.32 43.82 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.496 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -85.51 91.82 8.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.426 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.42 -12.87 41.45 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -167.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -48.8 -25.99 2.15 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 124.332 1.053 . . . . 0.0 113.498 -173.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -51.69 -49.95 61.42 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 -176.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -175.14 154.36 1.76 Allowed 'General case' 0 C--O 1.208 -1.099 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.422 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.3 mp0 -77.97 -46.49 20.97 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.791 0.805 . . . . 0.0 111.334 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.15 -17.46 54.97 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.244 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' O ' ' HB ' ' A' ' 91' ' ' THR . 28.3 t80 -59.84 -37.5 79.41 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.559 176.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 80' ' ' LEU . 1.7 mp -64.24 -37.44 79.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-O 121.542 0.687 . . . . 0.0 109.823 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.0 -20.91 60.18 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.884 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 97.5 m -74.42 -43.39 56.51 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.095 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.518 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -48.59 -44.63 37.09 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.201 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.803 ' NH2' ' HB ' ' A' ' 102' ' ' ILE . 0.6 OUTLIER -55.21 -25.97 36.43 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -86.35 -40.28 15.6 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.253 0.549 . . . . 0.0 110.743 -174.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.77 -18.47 31.03 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.544 0.687 . . . . 0.0 112.258 -176.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -96.28 128.87 35.18 Favored Pre-proline 0 C--N 1.275 -2.633 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.82 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.76 165.12 32.03 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.221 1.947 . . . . 0.0 110.611 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.55 4.3 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.626 0.77 . . . . 0.0 112.126 -176.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.5 m170 -84.13 -29.08 27.0 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.59 HG21 ' HB1' ' A' ' 70' ' ' ALA . 79.4 t -107.89 132.0 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.324 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.4 160.66 15.47 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.803 ' HB ' ' NH2' ' A' ' 93' ' ' ARG . 4.1 mp -122.58 127.29 74.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.554 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 38.9 m0 -107.75 164.63 12.07 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.899 -1.12 . . . . 0.0 110.26 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -99.54 109.18 21.73 Favored 'General case' 0 C--N 1.276 -2.599 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.605 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.21 103.39 3.91 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 172.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.8 tp -74.1 94.05 2.36 Favored 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.571 -175.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.6 m -70.23 113.03 7.0 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 104.251 -2.499 . . . . 0.0 104.251 169.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.34 116.34 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-O 122.295 1.045 . . . . 0.0 113.765 -170.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -93.3 135.49 12.64 Favored Glycine 0 N--CA 1.409 -3.131 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -71.56 -32.99 68.7 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 123.203 0.601 . . . . 0.0 109.838 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.2 m -142.5 101.59 3.91 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 174.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 95.8 mt -76.33 119.96 79.57 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 2.6 Cg_exo -77.73 162.13 30.1 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.864 2.376 . . . . 0.0 110.476 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.73 -30.56 28.99 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.465 0.65 . . . . 0.0 110.325 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -108.58 119.24 38.95 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 121.537 0.684 . . . . 0.0 110.039 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -139.24 -77.91 0.34 Allowed 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.022 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.461 ' HB3' HG12 ' A' ' 89' ' ' ILE . 56.3 m-85 -142.61 103.8 4.28 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -83.34 172.79 12.16 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-O 121.399 0.619 . . . . 0.0 112.453 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 41.4 m170 74.57 4.98 4.49 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 125.412 1.485 . . . . 0.0 114.777 175.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.643 ' HA ' ' NH2' ' A' ' 93' ' ' ARG . 20.7 m -68.04 154.34 8.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.984 178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -90.62 -33.2 15.95 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.139 -174.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 41.3 ttmt -159.24 163.32 35.97 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -124.88 142.97 51.09 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.21 169.01 19.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -71.57 151.9 43.41 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.82 0.736 . . . . 0.0 109.199 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -62.11 104.57 0.49 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -59.9 115.05 3.13 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.69 0.796 . . . . 0.0 111.616 -173.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -159.05 53.2 0.38 Allowed Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 111.415 -0.674 . . . . 0.0 111.415 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.24 127.75 33.87 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 85.3 41.74 7.3 Favored Glycine 0 N--CA 1.426 -1.976 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -161.89 42.47 0.38 Allowed Glycine 0 N--CA 1.427 -1.958 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -158.23 -90.58 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.78 -39.35 6.23 Favored Glycine 0 CA--C 1.491 -1.45 0 N-CA-C 107.607 -2.197 . . . . 0.0 107.607 174.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.41 -2.462 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 170.107 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ttt . . . . . 0 CA--C 1.509 -0.601 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.14 -141.51 4.31 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-O 121.619 0.566 . . . . 0.0 114.448 -174.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -78.18 141.05 38.93 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.562 0.696 . . . . 0.0 111.213 -175.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 28.5 m-80 -135.32 33.71 3.05 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HE3' ' OH ' ' A' ' 25' ' ' TYR . 10.3 ptpp? -53.97 99.83 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.924 -173.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.8 m -84.05 125.07 40.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.951 174.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 83.1 m -90.82 170.41 10.12 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -36.93 115.93 0.32 Allowed Glycine 0 C--N 1.364 2.124 0 O-C-N 124.28 0.988 . . . . 0.0 114.108 -172.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.0 tp -140.22 162.1 36.07 Favored 'General case' 0 N--CA 1.407 -2.593 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -172.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 t -139.04 21.88 2.62 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 122.163 0.982 . . . . 0.0 109.234 -173.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.612 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 55.4 mtt180 -125.75 110.36 13.65 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.2 -49.14 45.0 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 124.753 1.168 . . . . 0.0 114.826 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.434 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 1.9 mp0 -81.06 -19.96 42.64 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-O 121.478 0.656 . . . . 0.0 110.848 -174.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 43.6 t0 -80.86 -36.69 31.06 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 175.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.07 -35.47 71.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.654 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -60.65 -22.69 64.12 Favored 'General case' 0 C--O 1.183 -2.417 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.79 -31.95 41.28 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 122.85 0.46 . . . . 0.0 111.853 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 4' ' ' ASN . . . -78.13 -30.95 49.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.925 0.869 . . . . 0.0 110.62 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.32 -30.69 33.81 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.1 177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.02 -26.8 67.87 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 124.119 0.968 . . . . 0.0 109.296 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 -20.67 66.53 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.076 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 127.94 37.09 0.45 Allowed Glycine 0 CA--C 1.495 -1.166 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.21 35.92 21.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.305 1.042 . . . . 0.0 110.768 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.0 mt -63.65 -68.48 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.922 -174.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.467 ' OH ' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -176.71 161.74 2.11 Favored 'General case' 0 C--N 1.312 -1.051 0 O-C-N 123.668 0.605 . . . . 0.0 109.78 -176.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.81 152.42 19.34 Favored Glycine 0 C--N 1.31 -0.879 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 5' ' ' LYS . . . -128.81 80.95 0.35 Allowed Glycine 0 CA--C 1.491 -1.407 0 C-N-CA 119.386 -1.388 . . . . 0.0 112.412 -172.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.75 152.12 40.93 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.173 -0.514 . . . . 0.0 109.943 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.4 pt -114.0 155.45 15.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 54.8 m-85 -81.22 86.65 6.18 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.787 -174.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.6 t -121.0 123.76 70.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.29 103.84 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 124.714 1.206 . . . . 0.0 114.206 -174.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.7 p 61.93 21.84 12.6 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 126.074 1.75 . . . . 0.0 115.077 171.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.1 p -86.09 135.89 36.69 Favored Pre-proline 0 C--N 1.313 -0.99 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.884 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -78.87 21.17 0.74 Allowed 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 122.731 2.287 . . . . 0.0 112.524 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -125.12 -11.8 6.99 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.942 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 72.4 m -153.82 117.13 4.58 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -173.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.3 t -103.36 137.16 32.85 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 122.15 0.976 . . . . 0.0 110.945 -173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.33 171.78 7.14 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.244 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.7 p -43.85 -33.39 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 125.382 1.473 . . . . 0.0 113.405 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.55 -56.98 7.35 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 121.164 0.507 . . . . 0.0 111.08 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' O ' HG23 ' A' ' 46' ' ' VAL . 34.9 mt-30 -69.77 -37.09 76.26 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-O 121.05 0.452 . . . . 0.0 110.296 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.49 -20.85 65.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.6 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -69.48 -23.78 63.68 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -86.47 -43.99 12.34 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 122.077 0.941 . . . . 0.0 108.664 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 42' ' ' GLN . 20.4 t -65.05 -33.42 63.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.05 -176.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.93 -17.8 65.08 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.084 0.469 . . . . 0.0 111.535 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -89.85 -25.38 21.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.781 178.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.47 -39.69 18.62 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.965 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -136.68 103.76 9.22 Favored Pre-proline 0 N--CA 1.398 -3.03 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.42 45.08 0.96 Allowed 'Trans proline' 0 CA--C 1.552 1.387 0 C-N-CA 123.298 2.666 . . . . 0.0 113.255 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -88.53 -179.62 6.1 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 123.694 0.797 . . . . 0.0 111.842 -178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 25' ' ' TYR . 4.4 tt0 -82.76 145.4 29.57 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.553 0.741 . . . . 0.0 110.936 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -117.17 146.26 43.33 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 121.458 0.647 . . . . 0.0 110.252 176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.3 p -133.24 145.52 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.427 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -124.03 140.2 12.56 Favored Glycine 0 C--O 1.196 -2.241 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.006 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 40.2 t -128.26 122.46 58.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -169.36 156.07 6.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -90.64 93.33 9.22 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.99 0.9 . . . . 0.0 109.694 173.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -102.15 118.49 37.0 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 49.1 m-70 -87.71 -28.19 21.93 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.579 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -97.59 122.49 40.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.09 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.605 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.2 -35.29 73.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.438 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.18 -17.54 61.36 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.033 0.444 . . . . 0.0 110.486 -175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -82.32 -29.5 31.03 Favored 'General case' 0 C--O 1.246 0.9 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.43 -47.63 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 175.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 63' ' ' ILE . 55.5 t -60.53 -37.2 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.879 -177.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 72' ' ' VAL . 18.4 t70 -52.92 -61.33 2.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.472 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -65.48 -42.06 92.61 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.286 -0.416 . . . . 0.0 109.891 -175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -57.8 -38.92 76.39 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 124.288 0.992 . . . . 0.0 111.606 -177.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -83.31 -53.11 5.98 Favored 'General case' 0 N--CA 1.439 -0.988 0 O-C-N 123.224 0.328 . . . . 0.0 111.513 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 68' ' ' ASP . 50.0 t -55.08 -56.04 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -175.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' HB2' HG23 ' A' ' 40' ' ' VAL . 40.6 tp -79.94 -21.87 43.33 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.14 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.3 m 63.23 79.38 0.26 Allowed 'General case' 0 C--O 1.241 0.613 0 CA-C-O 122.213 1.006 . . . . 0.0 110.336 -173.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.5 mt -79.12 -179.03 6.46 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.007 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -124.6 -39.32 2.31 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.52 160.64 40.78 Favored 'General case' 0 N--CA 1.427 -1.625 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.273 171.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.78 136.69 35.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -102.88 111.62 24.04 Favored 'General case' 0 N--CA 1.391 -3.418 0 C-N-CA 123.257 0.623 . . . . 0.0 109.446 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 pp -102.99 154.51 19.16 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.205 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -93.47 96.38 9.86 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 172.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.497 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -72.64 -12.32 77.74 Favored Glycine 0 C--N 1.306 -1.107 0 CA-C-N 114.225 -1.352 . . . . 0.0 114.845 -170.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -49.6 -25.83 3.1 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.584 1.154 . . . . 0.0 111.932 -176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -52.33 -45.56 65.69 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.544 0.738 . . . . 0.0 112.444 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.53 149.03 0.96 Allowed 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -77.56 -43.64 31.17 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 122.19 0.995 . . . . 0.0 110.416 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 37.8 mt -76.18 -13.65 60.18 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 114.218 -1.356 . . . . 0.0 110.605 -177.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.588 ' O ' ' HB ' ' A' ' 91' ' ' THR . 17.6 t80 -62.64 -41.13 98.87 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.385 174.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.497 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.4 mp -61.35 -40.97 88.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.96 -19.17 65.83 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.836 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.588 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.4 m -83.04 -42.69 17.18 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.605 HD13 HG13 ' A' ' 63' ' ' ILE . 4.1 mm? -53.44 -44.01 68.51 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.453 0.701 . . . . 0.0 111.216 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HD2' HD12 ' A' ' 102' ' ' ILE . 8.2 mmm180 -43.59 -37.5 2.56 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 125.245 1.418 . . . . 0.0 111.866 178.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -79.95 -45.54 18.33 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.467 -1.242 . . . . 0.0 112.024 -173.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.0 -18.31 47.31 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.61 0.719 . . . . 0.0 112.379 -175.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.8 mt -99.9 134.7 20.78 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.446 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -70.18 165.42 31.51 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.391 2.06 . . . . 0.0 109.668 176.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -68.05 -11.3 58.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.239 0.543 . . . . 0.0 111.255 -176.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -73.49 -29.41 62.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.872 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.75 127.56 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.161 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -105.91 167.4 9.81 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.445 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.443 HD12 ' HD2' ' A' ' 93' ' ' ARG . 93.6 mt -125.27 129.54 73.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.597 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 41.6 m0 -120.65 152.7 37.85 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.869 176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -106.23 124.74 50.06 Favored 'General case' 0 N--CA 1.423 -1.785 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.37 98.15 1.05 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.6 tt -86.28 113.87 22.63 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.167 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.3 t -73.21 132.82 43.64 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.3 m -36.69 121.32 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.669 0 O-C-N 124.647 1.217 . . . . 0.0 113.455 -176.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.68 64.43 3.61 Favored Glycine 0 CA--C 1.501 -0.833 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.756 -177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -92.02 -66.45 0.92 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 t -104.08 -24.32 13.21 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.176 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.1 mt -89.47 157.82 46.66 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -80.54 156.34 21.67 Favored 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.484 2.122 . . . . 0.0 111.492 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -85.34 -37.72 19.59 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.554 0.692 . . . . 0.0 109.218 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -100.28 124.36 45.65 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -136.3 -62.3 0.67 Allowed 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -103.16 117.12 33.82 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.045 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -78.43 166.16 22.94 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.768 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 58.6 m170 75.57 8.5 3.76 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 123.896 0.878 . . . . 0.0 112.47 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 35.1 m -84.57 143.68 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 173.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -72.08 -43.14 65.32 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.88 -173.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TRP . 39.4 ttmt -159.11 164.34 35.39 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 -174.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -118.3 157.83 26.33 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.54 171.81 14.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.9 tp -76.14 143.46 41.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -80.03 112.56 17.44 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -110.58 19.26 18.89 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.362 0.601 . . . . 0.0 110.344 178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.61 -5.28 51.66 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.405 -0.678 . . . . 0.0 111.405 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -62.26 141.68 58.12 Favored 'General case' 0 C--O 1.249 1.063 0 C-N-CA 123.098 0.559 . . . . 0.0 111.509 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -130.93 -32.5 0.5 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.27 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 115.62 160.55 12.57 Favored Glycine 0 N--CA 1.44 -1.099 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.43 105.36 17.55 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -70.42 105.7 1.65 Allowed Glycine 0 N--CA 1.441 -0.978 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.35 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.424 -1.756 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 178.524 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ttt . . . . . 0 C--O 1.237 0.438 0 CA-C-O 120.445 0.164 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.07 -54.04 4.2 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 114.999 0.76 . . . . 0.0 114.999 173.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -47.21 121.58 3.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.412 1.085 . . . . 0.0 111.148 -177.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -146.04 43.19 1.23 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -46.34 96.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.803 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -73.03 121.57 23.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-O 121.446 0.641 . . . . 0.0 111.497 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.7 p -101.33 168.35 9.6 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 9' ' ' LEU . . . -2.65 -110.9 0.0 OUTLIER Glycine 0 C--N 1.361 1.921 0 C-N-CA 125.178 1.371 . . . . 0.0 116.149 -168.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 8' ' ' GLY . 54.4 tp 77.49 165.09 0.23 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 124.518 0.775 . . . . 0.0 111.229 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.6 t -138.07 -14.5 1.36 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.972 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -96.55 112.24 24.06 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.732 -176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.606 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -50.34 -41.4 40.03 Favored Glycine 0 C--O 1.209 -1.462 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.719 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.753 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -57.88 -39.94 79.06 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.513 1.125 . . . . 0.0 108.916 -178.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 9' ' ' LEU . 13.2 t70 -79.2 -30.71 43.49 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.547 -1.661 . . . . 0.0 109.325 -173.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.35 63.86 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.808 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 9.5 mtmp? -61.02 -24.85 66.49 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.293 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.43 -32.43 74.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.621 0.368 . . . . 0.0 111.507 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.09 -33.97 72.56 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 122.648 1.213 . . . . 0.0 109.722 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.94 -30.29 44.57 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.063 176.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -66.67 -23.1 66.1 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.559 0.695 . . . . 0.0 110.375 177.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.07 -23.09 65.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.971 176.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.26 13.34 0.11 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 119.374 -1.393 . . . . 0.0 114.449 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.27 26.48 13.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.852 0.861 . . . . 0.0 110.867 -178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 47.9 mt -63.93 -67.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.341 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.401 ' HB2' ' HG2' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -176.23 155.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -174.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -125.24 143.59 14.61 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.01 82.89 0.34 Allowed Glycine 0 CA--C 1.494 -1.261 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.036 -173.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.478 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -118.64 141.93 48.12 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-O 120.847 0.356 . . . . 0.0 110.165 -178.23 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.451 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.2 pt -108.02 151.6 10.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.252 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 177.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -81.83 79.82 8.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.833 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' HB ' ' OG ' ' A' ' 34' ' ' SER . 61.3 t -112.17 129.57 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.81 106.75 0.28 Allowed 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -173.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.2 p 65.38 16.72 10.68 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.958 1.703 . . . . 0.0 114.889 172.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.572 ' OG ' ' HB2' ' A' ' 37' ' ' CYS . 22.7 p -83.16 124.43 76.3 Favored Pre-proline 0 C--N 1.309 -1.174 0 O-C-N 121.839 -0.538 . . . . 0.0 110.332 -179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.09 -9.27 18.78 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.062 1.841 . . . . 0.0 114.886 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -112.74 12.65 19.67 Favored 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.485 -0.76 . . . . 0.0 111.662 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' HB2' ' OG ' ' A' ' 34' ' ' SER . 85.8 m -152.58 118.09 5.31 Favored 'General case' 0 C--O 1.217 -0.653 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.37 138.37 26.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-O 122.2 1.0 . . . . 0.0 112.606 -171.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -104.31 168.68 8.94 Favored 'General case' 0 CA--C 1.485 -1.545 0 CA-C-N 114.011 -1.45 . . . . 0.0 109.769 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 73' ' ' LEU . 10.2 p -53.38 -30.01 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 O-C-N 124.063 0.852 . . . . 0.0 112.03 -171.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 54.6 mp0 -61.88 -55.64 27.58 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 124.541 1.137 . . . . 0.0 112.1 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.66 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 31.2 mt-30 -70.39 -38.22 74.64 Favored 'General case' 0 C--O 1.209 -1.057 0 CA-C-O 121.464 0.65 . . . . 0.0 109.925 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -61.04 -27.16 68.14 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.501 -177.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' O ' ' HG2' ' A' ' 47' ' ' MET . 2.3 tp-100 -61.42 -36.36 80.1 Favored 'General case' 0 C--N 1.311 -1.106 0 C-N-CA 123.64 0.776 . . . . 0.0 112.101 177.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 13.1 pt-20 -86.07 -43.15 13.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 122.552 1.168 . . . . 0.0 109.011 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 6.9 t -55.22 -32.35 28.17 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.75 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.205 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 14.3 ptp -62.99 -31.42 72.54 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.37 0.605 . . . . 0.0 110.721 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -82.7 -11.37 58.39 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.009 -177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.27 -48.1 7.36 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.74 99.58 15.32 Favored Pre-proline 0 N--CA 1.391 -3.394 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -177.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.23 55.49 3.54 Favored 'Trans proline' 0 C--O 1.241 0.654 0 C-N-CA 122.811 2.34 . . . . 0.0 111.711 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.452 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -96.23 171.29 8.68 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.35 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.424 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 2.9 tt0 -72.29 142.9 48.87 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 122.263 0.225 . . . . 0.0 110.453 178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.401 ' HB2' HD23 ' A' ' 75' ' ' LEU . 16.8 m-85 -115.11 139.89 49.52 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 26' ' ' GLY . 14.3 p -129.41 146.89 33.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -125.64 129.66 6.95 Favored Glycine 0 N--CA 1.42 -2.396 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.842 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 41.6 t -114.37 116.5 52.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 175.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -148.81 152.98 37.46 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 59' ' ' ARG . 29.0 ptt180 -86.29 93.74 9.15 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 173.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 84' ' ' GLU . 4.7 m-20 -67.28 116.09 7.67 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-O 122.865 1.317 . . . . 0.0 112.124 -172.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -108.19 -72.71 0.71 Allowed 'General case' 0 C--N 1.255 -3.515 0 CA-C-N 112.552 -2.113 . . . . 0.0 108.814 171.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.11 108.94 12.97 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.849 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -62.37 -34.71 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.038 177.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.71 -22.86 63.37 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.104 0.478 . . . . 0.0 110.7 -178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.559 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 12.7 t70 -85.67 -33.74 21.49 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.225 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 12.1 p -77.06 -32.4 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.046 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 63' ' ' ILE . 89.8 t -64.99 -33.52 64.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.2 t70 -56.89 -57.99 10.1 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.73 173.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -60.75 -40.84 93.94 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.77 -177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -58.16 -39.02 77.74 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 124.625 1.17 . . . . 0.0 110.755 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -83.83 -53.58 5.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.616 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 68' ' ' ASP . 44.7 t -56.63 -56.55 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 123.232 0.613 . . . . 0.0 111.754 -174.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' HB2' HG23 ' A' ' 40' ' ' VAL . 51.4 tp -80.41 -13.91 58.75 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.099 178.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 18.8 p 55.54 77.42 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.378 1.071 . . . . 0.0 112.272 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.401 HD23 ' HB2' ' A' ' 54' ' ' TYR . 92.6 mt -74.77 175.08 8.3 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-N 114.416 -1.265 . . . . 0.0 111.867 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 53' ' ' GLN . . . -122.79 -35.88 2.98 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.126 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.408 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -144.88 157.76 44.04 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 172.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -140.13 141.12 34.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -99.97 128.08 46.1 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-O 121.349 0.595 . . . . 0.0 112.053 -178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.461 HD23 HG23 ' A' ' 102' ' ' ILE . 3.5 mm? -98.25 122.42 41.39 Favored 'General case' 0 N--CA 1.409 -2.477 0 CA-C-N 114.354 -1.294 . . . . 0.0 111.389 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -84.52 98.9 10.38 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 169.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.652 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -62.63 -12.86 42.85 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 114.945 -1.025 . . . . 0.0 114.591 -176.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.47 -33.19 1.62 Allowed 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 125.172 1.389 . . . . 0.0 113.127 175.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 13.0 mm-40 -66.07 -48.24 71.66 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -173.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -179.61 149.89 0.39 Allowed 'General case' 0 C--O 1.204 -1.294 0 N-CA-C 105.516 -2.031 . . . . 0.0 105.516 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -77.75 -44.86 26.37 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 124.144 0.978 . . . . 0.0 112.45 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.65 -20.38 43.21 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.746 -174.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.561 ' O ' ' HB ' ' A' ' 91' ' ' THR . 42.9 t80 -58.49 -36.05 73.17 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.931 176.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.652 HD11 ' HA2' ' A' ' 82' ' ' GLY . 3.5 mp -61.17 -37.8 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.609 0.719 . . . . 0.0 109.137 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.622 ' HA ' ' NE ' ' A' ' 93' ' ' ARG . 14.7 t70 -70.07 -21.01 63.2 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.088 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.561 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.1 m -78.54 -42.44 29.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 114.486 -1.234 . . . . 0.0 108.514 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.529 HD13 HG13 ' A' ' 63' ' ' ILE . 3.9 mm? -48.51 -49.13 37.27 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.559 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -52.08 -33.09 37.73 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 121.229 0.538 . . . . 0.0 112.361 178.867 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 33.6 mt-10 -73.16 -42.59 62.61 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-N 114.822 -1.081 . . . . 0.0 111.105 -174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -88.43 -19.95 25.87 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -177.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -83.86 135.64 42.5 Favored Pre-proline 0 C--N 1.288 -2.076 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.698 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.02 165.13 33.63 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 121.972 1.781 . . . . 0.0 110.599 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.64 -15.85 54.01 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.034 0.934 . . . . 0.0 112.152 -176.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -71.12 -30.12 66.11 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -177.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 70' ' ' ALA . 59.2 t -107.33 129.5 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.235 0 CA-C-O 121.376 0.608 . . . . 0.0 110.629 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -99.71 170.83 8.29 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.234 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.461 HG23 HD23 ' A' ' 80' ' ' LEU . 73.6 mt -125.77 129.73 72.54 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.585 ' CD1' ' HB2' ' A' ' 122' ' ' LYS . 39.1 m0 -118.9 157.98 26.6 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.689 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.4 ttpp -100.94 123.39 45.06 Favored 'General case' 0 N--CA 1.416 -2.137 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.31 116.96 10.35 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.3 tp -89.23 95.58 10.36 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.573 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 50.2 m -67.7 150.81 48.22 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.431 176.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.4 m -67.82 115.29 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.625 0 CA-C-O 122.563 1.173 . . . . 0.0 110.72 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.32 93.06 0.09 OUTLIER Glycine 0 N--CA 1.415 -2.712 0 N-CA-C 106.843 -2.503 . . . . 0.0 106.843 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -72.28 -12.55 61.2 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -170.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 19.1 m -102.22 8.54 40.51 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 122.129 0.966 . . . . 0.0 109.52 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 4.2 mm? -91.54 149.39 39.3 Favored Pre-proline 0 C--O 1.25 1.114 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 177.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 7.7 Cg_exo -71.39 148.36 54.53 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 121.803 1.669 . . . . 0.0 110.798 177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.37 -28.04 66.77 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.364 0.602 . . . . 0.0 110.115 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -112.55 127.25 56.02 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -131.46 -58.29 0.99 Allowed 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 82' ' ' GLY . 79.5 m-85 -99.37 111.94 24.22 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -73.3 164.36 26.79 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.248 -1.342 . . . . 0.0 112.668 -173.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 93' ' ' ARG . 23.3 m170 71.54 7.18 5.94 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.696 1.599 . . . . 0.0 112.201 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.7 m -72.64 152.1 7.88 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 175.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -81.4 -41.6 21.67 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-O 120.998 0.428 . . . . 0.0 111.349 -174.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.0 mttt -145.78 163.03 36.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 123.301 0.64 . . . . 0.0 109.676 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -116.83 139.6 50.42 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.4 p -139.44 166.87 20.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 7.5 mp -71.57 163.07 28.43 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 121.519 0.676 . . . . 0.0 111.72 -176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.573 ' HB2' ' HA ' ' A' ' 107' ' ' SER . 12.1 t70 -68.91 97.21 0.82 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.396 -178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -82.93 -47.35 11.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 64.65 -155.98 46.99 Favored Glycine 0 N--CA 1.442 -0.92 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.955 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 168.31 -27.43 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.091 2.156 . . . . 0.0 105.883 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 174.24 49.11 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.296 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -90.29 -143.26 10.46 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 121.473 -0.394 . . . . 0.0 112.369 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -111.79 108.02 17.28 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.867 0.365 . . . . 0.0 110.481 -177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.7 162.81 34.82 Favored Glycine 0 N--CA 1.432 -1.628 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 C--N 1.303 -1.444 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.763 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 CA--C 1.509 -0.634 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -130.28 73.46 0.46 Allowed Glycine 0 N--CA 1.432 -1.618 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -70.64 121.78 18.55 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.728 0.775 . . . . 0.0 111.612 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.417 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 15.0 p-10 -125.81 28.28 6.2 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 173.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 41.6 tttp -57.08 96.94 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.502 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 p -95.37 124.26 47.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-O 121.315 0.579 . . . . 0.0 111.493 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 80.0 m -92.0 170.52 9.79 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 174.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -45.93 135.42 8.86 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 119.046 0.839 . . . . 0.0 115.06 -171.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' H ' ' A' ' 11' ' ' ARG . 0.2 OUTLIER -150.07 153.12 35.92 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 102.312 -3.218 . . . . 0.0 102.312 178.521 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' HD13 ' A' ' 9' ' ' LEU . 8.6 t -118.51 8.03 11.97 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.641 -172.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.433 ' H ' HD12 ' A' ' 9' ' ' LEU . 71.7 mtm180 -117.73 114.64 23.63 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.118 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.24 -39.44 71.4 Favored Glycine 0 C--O 1.216 -1.024 0 O-C-N 123.626 0.578 . . . . 0.0 113.639 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.663 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.1 OUTLIER -66.2 -26.09 67.23 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 122.005 0.907 . . . . 0.0 109.264 -177.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -89.57 -51.96 5.26 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 114.305 -1.316 . . . . 0.0 108.493 -176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.92 -34.13 69.53 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.41 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -59.99 -22.39 62.49 Favored 'General case' 0 C--O 1.193 -1.914 0 CA-C-O 118.882 -0.58 . . . . 0.0 112.374 -178.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.07 -30.78 27.41 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.971 0.508 . . . . 0.0 111.451 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.18 -43.28 64.77 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.542 0.687 . . . . 0.0 109.824 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -34.03 73.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.71 -23.46 66.14 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 125.172 1.389 . . . . 0.0 110.018 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.89 -13.94 59.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.94 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.53 10.4 0.27 Allowed Glycine 0 C--O 1.225 -0.458 0 C-N-CA 119.589 -1.291 . . . . 0.0 113.535 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.2 19.37 8.74 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.06 0.944 . . . . 0.0 111.491 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 37.8 mt -57.86 -67.59 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.27 -1.332 . . . . 0.0 113.16 -171.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -174.01 157.69 2.97 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -176.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -132.05 140.9 12.2 Favored Glycine 0 N--CA 1.425 -2.045 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.46 91.08 0.51 Allowed Glycine 0 CA--C 1.471 -2.673 0 N-CA-C 110.599 -1.0 . . . . 0.0 110.599 -171.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pp -122.07 155.88 34.73 Favored 'General case' 0 N--CA 1.401 -2.921 0 CA-C-N 114.567 -0.816 . . . . 0.0 109.182 -174.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.602 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 3.5 pt -116.95 151.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.609 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.554 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 49.7 m-85 -84.19 79.02 9.67 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.427 1.079 . . . . 0.0 109.796 -176.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 56.8 t -109.8 119.17 58.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.58 103.84 0.06 Allowed 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.829 1.331 . . . . 0.0 113.483 -172.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.6 p 59.39 29.28 18.82 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 125.638 1.575 . . . . 0.0 113.491 173.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -107.26 104.11 51.02 Favored Pre-proline 0 N--CA 1.413 -2.322 0 N-CA-C 106.124 -1.806 . . . . 0.0 106.124 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.07 3.93 0.66 Allowed 'Trans proline' 0 C--O 1.2 -1.381 0 C-N-CA 123.776 2.984 . . . . 0.0 115.029 -171.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -84.43 -10.64 57.34 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 46.6 m -138.4 172.13 13.35 Favored 'General case' 0 N--CA 1.411 -2.38 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.89 136.22 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.57 178.547 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -106.7 164.09 12.38 Favored 'General case' 0 CA--C 1.465 -2.327 0 CA-C-N 114.117 -1.401 . . . . 0.0 107.742 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.598 HG23 HD23 ' A' ' 73' ' ' LEU . 11.4 p -45.58 -35.44 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 O-C-N 124.806 1.316 . . . . 0.0 112.049 -174.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -66.97 -38.81 86.77 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.489 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.9 mt-30 -80.79 -34.94 33.73 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.339 173.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB2' ' CG1' ' A' ' 38' ' ' VAL . . . -62.38 -32.81 73.67 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.138 -0.937 . . . . 0.0 113.023 -175.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 47' ' ' MET . 0.0 OUTLIER -62.98 -31.08 72.12 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 177.2 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -70.96 -47.3 59.73 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 122.116 0.96 . . . . 0.0 108.641 173.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 42' ' ' GLN . 40.9 t -65.0 -30.5 50.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.819 -175.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.557 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 24.6 ptt? -67.08 -17.6 64.95 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.304 0.574 . . . . 0.0 111.74 -178.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.82 -17.87 25.83 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.996 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.55 -43.33 6.9 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.298 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -127.52 93.76 39.74 Favored Pre-proline 0 N--CA 1.386 -3.628 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.75 57.06 3.02 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.455 2.104 . . . . 0.0 111.968 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.434 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.3 pp -96.71 179.26 5.04 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.471 175.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 5.4 tt0 -82.94 143.27 30.81 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 47' ' ' MET . 20.6 m-85 -113.65 138.08 50.69 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.8 p -132.41 139.86 49.01 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -125.18 141.13 12.82 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.541 -177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.602 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 29.2 t -124.43 134.82 65.68 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.272 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -167.09 159.64 13.25 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.293 -0.563 . . . . 0.0 109.661 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -85.93 93.59 8.98 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -87.99 125.67 34.66 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.834 -172.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -94.94 -58.0 2.28 Favored 'General case' 1 C--N 1.241 -4.111 0 CA-C-N 112.775 -2.011 . . . . 0.0 108.96 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -98.87 123.37 43.08 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.559 -176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 HG13 HD13 ' A' ' 92' ' ' LEU . 17.4 tt -64.23 -29.74 48.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.33 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.17 -13.82 58.95 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.078 0.466 . . . . 0.0 110.315 -178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 14.0 t70 -86.25 -39.25 16.75 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.816 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 80' ' ' LEU . 14.9 p -77.82 -37.63 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.293 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.13 -32.0 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 65' ' ' ASP . 9.3 t70 -54.8 -55.64 27.93 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.472 172.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 65' ' ' ASP . 43.2 mmtm -63.59 -41.56 98.33 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.494 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -56.98 -38.92 73.7 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 124.316 1.01 . . . . 0.0 110.996 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -81.96 -52.88 6.61 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.354 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 77.5 t -56.1 -54.6 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -175.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.598 HD23 HG23 ' A' ' 40' ' ' VAL . 0.2 OUTLIER -82.9 -11.47 58.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 119.999 -0.681 . . . . 0.0 111.41 -179.201 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.1 t 61.97 74.67 0.43 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.683 0.754 . . . . 0.0 109.498 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 73.5 mt -82.74 179.91 7.63 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.439 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.74 -32.96 2.31 Favored 'General case' 0 C--N 1.292 -1.891 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' HG23 ' A' ' 55' ' ' VAL . . . -148.7 160.53 43.08 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.3 171.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 6.2 p -150.0 141.02 16.84 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.652 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.82 111.36 23.68 Favored 'General case' 0 N--CA 1.385 -3.691 0 CA-C-O 121.824 0.821 . . . . 0.0 109.353 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.592 HD13 ' HG ' ' A' ' 92' ' ' LEU . 36.3 mt -115.72 89.17 3.04 Favored 'General case' 0 CA--C 1.422 -3.945 0 N-CA-C 101.369 -3.567 . . . . 0.0 101.369 -169.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -98.04 174.37 6.58 Favored 'General case' 1 N--CA 1.362 -4.859 0 C-N-CA 117.873 -1.531 . . . . 0.0 113.299 -167.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -48.96 -10.51 0.14 Allowed Glycine 1 C--N 1.243 -4.584 0 CA-C-N 110.863 -2.881 . . . . 0.0 117.468 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -44.72 -44.73 9.41 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -177.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.02 -49.72 6.6 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.953 -1.099 . . . . 0.0 112.956 -174.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.478 ' OE1' ' HB2' ' A' ' 87' ' ' LEU . 1.1 tm-20 178.94 170.33 0.89 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 -173.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -77.88 -49.85 13.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 122.519 1.152 . . . . 0.0 109.389 -176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.478 ' HB2' ' OE1' ' A' ' 85' ' ' GLU . 37.1 mt -72.97 -13.6 61.27 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.504 -1.68 . . . . 0.0 110.99 -175.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.568 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 25.4 t80 -60.34 -48.99 79.36 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.421 ' O ' ' HD2' ' A' ' 93' ' ' ARG . 1.9 mp -59.75 -36.69 67.41 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.687 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 24.4 t70 -60.08 -27.1 66.72 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.077 -1.42 . . . . 0.0 111.636 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 86.9 m -88.15 -43.68 11.47 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 124.708 1.203 . . . . 0.0 110.141 -176.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.592 ' HG ' HD13 ' A' ' 80' ' ' LEU . 4.1 mm? -43.93 -44.0 6.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 175.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.687 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 1.7 mpt_? -56.55 -29.74 62.31 Favored 'General case' 0 N--CA 1.513 2.68 0 CA-C-O 121.045 0.45 . . . . 0.0 111.271 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -77.95 -35.13 50.71 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.382 -171.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -96.81 0.86 50.01 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.433 0.635 . . . . 0.0 110.806 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.415 HD22 HG13 ' A' ' 102' ' ' ILE . 27.2 tp -75.79 124.49 88.69 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 124.053 0.941 . . . . 0.0 109.479 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -72.01 161.57 44.41 Favored 'Trans proline' 0 N--CA 1.445 -1.355 0 C-N-CA 122.078 1.852 . . . . 0.0 110.988 175.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.22 70.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 124.464 1.106 . . . . 0.0 113.354 -172.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -88.86 -10.9 46.31 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.494 HG21 ' HB1' ' A' ' 70' ' ' ALA . 65.6 t -107.68 140.28 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.725 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -113.86 172.67 6.85 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 177.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.55 HG12 HD12 ' A' ' 80' ' ' LEU . 53.8 mt -116.41 131.08 70.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.652 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 40.8 m0 -121.02 159.17 26.19 Favored 'General case' 0 C--N 1.288 -2.097 0 C-N-CA 117.796 -1.562 . . . . 0.0 109.393 171.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.432 ' HB2' HG11 ' A' ' 120' ' ' VAL . 40.0 ttpt -100.73 115.18 29.66 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.17 107.63 5.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.1 tp -78.48 95.38 5.13 Favored 'General case' 0 N--CA 1.417 -2.123 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.785 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.6 m -76.09 108.37 8.95 Favored 'General case' 0 N--CA 1.412 -2.365 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 173.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.1 m -65.23 141.32 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.286 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.68 -161.87 11.96 Favored Glycine 0 N--CA 1.426 -1.971 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.56 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -76.15 -26.61 56.45 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.938 0.399 . . . . 0.0 111.227 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 t -133.2 120.97 21.84 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.127 0.489 . . . . 0.0 110.072 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -106.17 96.68 13.78 Favored Pre-proline 0 N--CA 1.442 -0.859 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.51 154.51 21.07 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.894 2.396 . . . . 0.0 112.867 -175.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -87.69 -39.93 14.57 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.115 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 54.3 mtm180 -122.88 118.77 28.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -161.59 -58.93 0.05 OUTLIER 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 104.041 -2.577 . . . . 0.0 104.041 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -124.86 94.04 4.07 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -115.01 -178.64 3.41 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.625 -173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 7.8 t60 65.44 28.42 11.61 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.221 1.408 . . . . 0.0 108.505 -178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.432 HG11 ' HB2' ' A' ' 104' ' ' LYS . 27.3 m -87.26 149.99 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.827 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -76.77 -41.29 45.28 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 121.402 0.62 . . . . 0.0 111.058 -174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 45.2 mmtm -143.78 162.32 36.32 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -127.13 138.68 53.21 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 m -136.96 171.27 16.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.015 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -172.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 58.8 tp -71.35 140.11 50.09 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 123.411 0.445 . . . . 0.0 110.602 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.41 124.94 20.68 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.164 0.986 . . . . 0.0 110.724 178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -109.71 0.79 19.1 Favored 'General case' 0 CA--C 1.499 -1.008 0 C-N-CA 120.534 -0.466 . . . . 0.0 111.118 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -64.76 -47.0 88.02 Favored Glycine 0 CA--C 1.497 -1.059 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -132.47 -83.72 0.48 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 46.93 -107.65 0.22 Allowed Glycine 0 C--N 1.339 0.734 0 O-C-N 124.403 1.064 . . . . 0.0 113.735 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -171.12 -94.33 0.09 OUTLIER Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 58.5 -171.8 0.11 Allowed 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.989 0.916 . . . . 0.0 112.902 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 82.06 -75.96 2.27 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.063 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.296 -1.739 0 C-N-CA 123.372 0.669 . . . . 0.0 110.109 -178.394 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.78 42.5 25.71 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.119 -1.039 . . . . 0.0 112.392 177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.47 -162.72 1.06 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.72 HD21 ' HB ' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -166.92 46.95 0.06 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -172.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -66.18 98.06 0.43 Allowed 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.935 -177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.5 p -100.12 124.7 53.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.736 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.1 p -91.99 169.8 10.36 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 37' ' ' CYS . . . -46.76 126.7 10.07 Favored Glycine 0 CA--C 1.493 -1.299 0 O-C-N 123.64 0.588 . . . . 0.0 113.771 -174.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.3 tp -143.06 161.0 39.32 Favored 'General case' 0 N--CA 1.41 -2.456 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -172.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 t -134.35 -18.9 1.95 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.683 0.754 . . . . 0.0 109.948 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 50.8 mtp180 -77.73 105.69 9.06 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.937 176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 16' ' ' LYS . . . -48.37 -44.85 28.44 Favored Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 124.64 1.114 . . . . 0.0 114.224 -179.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 16' ' ' LYS . 1.7 mp0 -76.18 -22.27 55.53 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.335 0.588 . . . . 0.0 110.856 -175.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -85.52 -30.46 23.41 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -47.15 48.97 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 13' ' ' GLN . 17.5 ptpt -64.69 -22.51 67.0 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.47 -37.71 78.89 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 120.801 0.334 . . . . 0.0 110.567 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -72.98 -38.01 66.81 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 110.181 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' HD1' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -67.72 -34.61 77.2 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.9 -31.29 72.42 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.486 176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.04 -23.28 64.04 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.069 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.32 -21.7 0.06 OUTLIER Glycine 0 N--CA 1.432 -1.613 0 C-N-CA 119.373 -1.394 . . . . 0.0 113.467 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' HB2' ' HD1' ' A' ' 19' ' ' TYR . . . 61.93 27.04 16.41 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.985 0.898 . . . . 0.0 109.019 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.72 ' HB ' HD21 ' A' ' 4' ' ' ASN . 28.5 mt -69.92 -59.64 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.726 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.909 -171.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -178.36 161.92 1.45 Allowed 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -128.38 145.72 16.28 Favored Glycine 0 C--N 1.28 -2.544 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.35 73.99 0.21 Allowed Glycine 0 CA--C 1.496 -1.122 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.482 -175.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.498 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.79 154.94 26.55 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-O 121.172 0.511 . . . . 0.0 110.264 -178.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 5.7 pt -116.78 152.87 18.5 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 115.365 1.617 . . . . 0.0 115.365 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -79.57 79.43 6.04 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 124.741 1.275 . . . . 0.0 111.239 -175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 49.4 t -119.25 116.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 115.09 2.75 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.777 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.4 p 66.02 14.67 9.73 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 126.086 1.754 . . . . 0.0 115.126 172.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.8 m -93.58 114.67 63.58 Favored Pre-proline 0 C--O 1.197 -1.696 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.35 26.48 0.16 Allowed 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 124.28 3.32 . . . . 0.0 115.285 -173.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.569 ' HG3' ' SG ' ' A' ' 37' ' ' CYS . 20.4 ptt180 -124.92 -5.15 7.46 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 171.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.569 ' SG ' ' HG3' ' A' ' 36' ' ' ARG . 60.8 m -136.65 166.75 22.83 Favored 'General case' 0 N--CA 1.421 -1.892 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.437 HG13 ' HB2' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -143.94 136.4 23.32 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 1.8 p-10 -102.46 170.52 8.0 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.685 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.718 HG23 ' HB2' ' A' ' 73' ' ' LEU . 5.9 p -56.41 -31.75 34.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 O-C-N 123.809 0.693 . . . . 0.0 111.1 -172.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 4.3 mp0 -70.88 -46.87 61.84 Favored 'General case' 0 N--CA 1.41 -2.442 0 C-N-CA 124.149 0.979 . . . . 0.0 111.505 -179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.57 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 49.7 mm-40 -61.76 -49.31 76.92 Favored 'General case' 0 C--O 1.197 -1.66 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . . . -63.89 -21.47 66.48 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.287 -172.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.493 ' O ' ' HG2' ' A' ' 47' ' ' MET . 3.8 tp-100 -63.99 -39.32 93.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.527 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 11.8 pt-20 -85.93 -45.41 11.54 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.754 0.788 . . . . 0.0 110.427 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.554 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 95.4 t -48.97 -35.25 6.99 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 C-N-CA 125.307 1.443 . . . . 0.0 112.249 176.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' A' ' 44' ' ' GLN . 16.5 ptp -64.22 -20.56 66.12 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 120.823 0.344 . . . . 0.0 111.493 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.37 -28.74 28.74 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -83.34 -45.5 13.68 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.75 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -133.66 98.12 15.16 Favored Pre-proline 0 N--CA 1.397 -3.119 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.69 46.73 0.84 Allowed 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.96 2.44 . . . . 0.0 112.88 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 0.8 OUTLIER -84.33 152.28 24.21 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.686 177.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.64 151.16 42.44 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.345 -175.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -117.7 140.41 49.7 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-O 121.411 0.625 . . . . 0.0 112.428 -175.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.8 p -127.04 143.73 39.53 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 172.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -113.46 128.78 8.5 Favored Glycine 0 N--CA 1.416 -2.643 0 C-N-CA 120.29 -0.957 . . . . 0.0 111.782 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.585 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 21.2 t -113.74 106.58 20.98 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -160.57 146.59 15.09 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.471 -173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.406 ' HG2' ' HA3' ' A' ' 82' ' ' GLY . 59.0 mtm180 -93.11 93.37 8.26 Favored 'General case' 0 N--CA 1.413 -2.322 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.504 ' O ' ' HB3' ' A' ' 83' ' ' ASN . 15.4 m120 -90.25 154.91 19.38 Favored 'General case' 0 N--CA 1.405 -2.7 0 CA-C-O 122.656 1.217 . . . . 0.0 110.526 -174.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' CD2' ' H ' ' A' ' 62' ' ' ASP . 16.1 p-80 -100.89 -73.43 0.64 Allowed 'General case' 0 C--N 1.245 -3.953 0 CA-C-N 111.445 -2.616 . . . . 0.0 112.17 -177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' H ' ' CD2' ' A' ' 61' ' ' HIS . 45.0 t0 -81.77 131.91 35.27 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 HD13 ' A' ' 92' ' ' LEU . 5.9 tt -60.02 -32.68 50.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.041 176.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -73.61 -18.76 61.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.326 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -77.6 -35.21 53.11 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.436 0.636 . . . . 0.0 109.288 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 t -70.52 -44.05 77.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 63' ' ' ILE . 95.7 t -60.55 -39.28 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.577 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.509 ' O ' HG23 ' A' ' 72' ' ' VAL . 15.3 t70 -57.1 -61.79 2.21 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.858 -1.065 . . . . 0.0 111.172 177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.421 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 45.6 mmtm -63.72 -39.7 94.93 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.753 -0.203 . . . . 0.0 111.033 -176.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.36 -35.02 76.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.812 0.695 . . . . 0.0 111.417 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -82.37 -56.54 3.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.805 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -53.32 -56.47 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.352 0.661 . . . . 0.0 111.628 -174.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.718 ' HB2' HG23 ' A' ' 40' ' ' VAL . 45.4 tp -82.78 -17.31 44.59 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.488 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 39.9 m 60.59 80.55 0.21 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.226 1.012 . . . . 0.0 111.182 -176.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.406 HD21 HD23 ' A' ' 73' ' ' LEU . 74.1 mt -85.46 -175.06 5.51 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.578 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -127.97 -36.79 1.96 Allowed 'General case' 0 C--O 1.193 -1.912 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -146.0 159.27 43.49 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 121.36 0.6 . . . . 0.0 111.534 177.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.4 p -140.58 138.64 35.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.611 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 13.2 mm-40 -98.46 105.59 17.75 Favored 'General case' 0 N--CA 1.422 -1.847 0 C-N-CA 123.459 0.703 . . . . 0.0 109.393 -175.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.541 HD13 ' HG ' ' A' ' 92' ' ' LEU . 75.2 mt -116.13 139.52 50.23 Favored 'General case' 0 C--N 1.284 -2.279 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.941 -173.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.9 p80 175.54 -37.11 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 O-C-N 124.121 0.888 . . . . 0.0 110.165 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 59' ' ' ARG . . . -74.71 -55.39 5.44 Favored Glycine 0 C--N 1.303 -1.253 0 N-CA-C 120.434 2.933 . . . . 0.0 120.434 -166.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ASN . 2.8 t-20 -82.79 -69.1 0.65 Allowed 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 118.382 2.734 . . . . 0.0 118.382 -163.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -79.97 -48.93 12.59 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -168.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.566 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.5 OUTLIER -177.89 172.0 1.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -174.248 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.566 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 21.6 mt-30 -78.44 -43.98 25.86 Favored 'General case' 0 N--CA 1.419 -2.005 0 C-N-CA 125.242 1.417 . . . . 0.0 107.235 176.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 54.7 mt -71.42 -14.39 62.14 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 113.86 -1.518 . . . . 0.0 111.326 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CZ ' HD21 ' A' ' 92' ' ' LEU . 22.9 t80 -65.38 -40.25 93.26 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.982 177.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.469 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.0 -30.38 49.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-O 121.628 0.728 . . . . 0.0 110.015 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.68 ' HA ' ' NH1' ' A' ' 93' ' ' ARG . 23.9 t70 -67.54 -22.64 65.4 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.314 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.47 HG22 ' CD1' ' A' ' 63' ' ' ILE . 85.9 m -89.63 -44.92 9.72 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-N 114.178 -1.374 . . . . 0.0 110.305 -176.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 88' ' ' TYR . 3.2 mm? -47.89 -46.37 31.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.68 ' NH1' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -60.02 -24.33 64.42 Favored 'General case' 0 N--CA 1.51 2.545 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.069 -173.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -80.04 -34.43 38.28 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.988 -175.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -89.96 -22.17 22.07 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.854 0.835 . . . . 0.0 111.409 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -88.09 140.13 30.74 Favored Pre-proline 0 C--N 1.276 -2.614 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.707 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -71.43 164.91 34.14 Favored 'Trans proline' 0 N--CA 1.44 -1.669 0 C-N-CA 121.134 1.223 . . . . 0.0 109.018 174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -74.1 3.95 6.28 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.496 0.665 . . . . 0.0 111.638 -177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -86.07 -24.85 26.17 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.444 HG21 ' HB1' ' A' ' 70' ' ' ALA . 97.1 t -105.09 131.88 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.107 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -116.54 171.36 7.91 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.998 -176.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.597 HD12 ' HG3' ' A' ' 93' ' ' ARG . 65.1 mt -124.52 133.42 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.244 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.611 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 36.9 m0 -121.05 155.37 34.54 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 118.162 -1.415 . . . . 0.0 109.622 173.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -102.39 123.28 45.89 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.493 176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.92 115.21 8.87 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 170.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 17.7 tp -95.73 108.79 21.13 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -73.03 135.46 44.9 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 27.7 m -69.54 154.9 7.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 120.947 0.403 . . . . 0.0 111.241 -178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 155.62 -168.0 33.19 Favored Glycine 0 N--CA 1.416 -2.686 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.805 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.526 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -98.64 -36.81 9.75 Favored 'General case' 0 C--N 1.286 -2.178 0 C-N-CA 123.525 0.73 . . . . 0.0 110.023 -178.154 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.1 p -82.42 94.88 7.51 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.516 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 89.4 mt -83.75 140.08 40.73 Favored Pre-proline 0 C--N 1.309 -1.189 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.345 179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 144.47 68.43 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.491 2.128 . . . . 0.0 112.231 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.95 -45.67 12.91 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 179.52 118.73 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 124.531 1.132 . . . . 0.0 107.998 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 3.0 mm-40 -133.71 -60.65 0.82 Allowed 'General case' 0 C--N 1.277 -2.564 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -177.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 33.3 m-85 -111.03 106.63 15.77 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -110.12 157.16 19.67 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 -176.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 27.4 m80 69.05 33.77 3.3 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 111.818 -2.446 . . . . 0.0 111.113 -178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.49 142.06 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 171.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.73 -43.09 66.46 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 121.379 0.609 . . . . 0.0 111.153 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.2 mttm -145.14 163.18 35.14 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -124.68 143.39 50.77 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.56 174.7 12.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.42 144.77 39.78 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.932 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.88 135.06 47.78 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.255 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.72 -34.67 77.31 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.13 -64.13 2.49 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -114.02 87.83 2.71 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.651 0.739 . . . . 0.0 110.834 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -131.11 -27.43 0.7 Allowed Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.936 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 -69.68 0.51 Allowed Glycine 0 N--CA 1.432 -1.583 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -156.8 -28.1 0.09 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.255 0.55 . . . . 0.0 109.776 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.84 43.37 18.02 Favored Glycine 0 N--CA 1.429 -1.784 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 pmm? . . . . . 0 C--O 1.239 0.546 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -108.9 59.11 0.37 Allowed Glycine 0 CA--C 1.498 -1.021 0 N-CA-C 108.176 -1.969 . . . . 0.0 108.176 174.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 67.74 156.32 0.12 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.29 1.436 . . . . 0.0 110.917 -172.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.619 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 26.2 p-10 -115.13 25.37 10.93 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 26' ' ' GLY . 21.3 pttp -67.89 91.99 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.11 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.36 125.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.169 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 70.0 m -91.38 169.26 10.94 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 105.269 -2.123 . . . . 0.0 105.269 174.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' H ' ' HA ' ' A' ' 37' ' ' CYS . . . -19.53 105.85 0.01 OUTLIER Glycine 0 N--CA 1.479 1.559 0 O-C-N 124.919 1.387 . . . . 0.0 116.037 -169.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -150.22 135.86 18.29 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 9.45 2.7 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-O 121.912 0.863 . . . . 0.0 110.123 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -86.41 112.52 21.55 Favored 'General case' 0 N--CA 1.429 -1.522 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -43.34 -53.5 5.8 Favored Glycine 0 N--CA 1.468 0.817 0 C-N-CA 124.419 1.009 . . . . 0.0 114.88 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.23 -19.91 60.36 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 123.799 0.839 . . . . 0.0 111.871 -175.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -87.73 -36.51 17.31 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.73 -47.96 67.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.805 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 50' ' ' ALA . 21.5 ptmt -63.35 -23.45 67.42 Favored 'General case' 0 C--O 1.197 -1.681 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.828 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.06 -32.3 69.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.229 0.537 . . . . 0.0 110.805 177.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.06 -37.41 58.31 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.702 0.763 . . . . 0.0 109.636 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.452 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -72.13 -33.33 67.71 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.296 0.57 . . . . 0.0 109.926 177.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -65.92 -25.69 67.26 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.19 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.66 -24.09 56.34 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.905 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.63 1.32 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 119.103 -1.522 . . . . 0.0 113.884 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.66 24.08 11.72 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.768 0.827 . . . . 0.0 111.463 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.619 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 23.1 mt -63.57 -69.46 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.845 -172.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -177.82 156.26 1.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -176.384 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 5' ' ' LYS . . . -121.7 146.68 17.17 Favored Glycine 0 N--CA 1.428 -1.874 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.67 72.08 0.21 Allowed Glycine 0 CA--C 1.493 -1.309 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.249 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -110.47 144.36 39.39 Favored 'General case' 0 N--CA 1.413 -2.29 0 CA-C-O 121.216 0.532 . . . . 0.0 109.6 -179.296 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.649 ' O ' ' HB3' ' A' ' 37' ' ' CYS . 31.3 mt -117.62 157.04 19.0 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.755 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.628 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 24.3 m-85 -83.59 56.14 3.49 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.677 0.672 . . . . 0.0 111.137 -177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.7 t -82.16 120.33 33.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -44.0 96.74 0.01 OUTLIER 'General case' 0 C--O 1.238 0.458 0 O-C-N 125.083 1.489 . . . . 0.0 113.892 -172.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.1 p 55.85 23.78 6.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.577 1.551 . . . . 0.0 114.368 174.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -100.53 109.98 58.93 Favored Pre-proline 0 N--CA 1.423 -1.785 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.96 2.33 0.33 Allowed 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.902 3.068 . . . . 0.0 115.079 -174.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 12.4 ptm85 -74.19 -19.66 60.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 169.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.649 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 74.2 m -142.87 174.56 10.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -138.48 136.72 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-N 119.331 0.969 . . . . 0.0 110.292 -178.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -101.15 167.45 10.21 Favored 'General case' 0 CA--C 1.477 -1.834 0 CA-C-N 114.9 -1.045 . . . . 0.0 110.001 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.611 HG23 ' HB2' ' A' ' 73' ' ' LEU . 7.3 p -51.57 -29.6 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 O-C-N 124.209 0.943 . . . . 0.0 112.996 -173.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -65.96 -50.13 65.44 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.005 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.499 ' O ' HG23 ' A' ' 46' ' ' VAL . 32.7 mt-30 -73.03 -40.04 65.47 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.231 175.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.14 -20.92 64.6 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.834 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -37.68 70.66 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.076 0.95 . . . . 0.0 109.402 176.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -82.37 -43.19 17.71 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.032 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 42' ' ' GLN . 12.0 t -65.28 -39.07 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 114.324 -1.307 . . . . 0.0 110.928 -174.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.413 ' SD ' HD12 ' A' ' 73' ' ' LEU . 27.6 ptt? -62.2 -24.02 66.98 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.863 0.465 . . . . 0.0 111.445 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -83.86 -25.8 29.98 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.209 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -85.61 -42.51 14.28 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.126 -178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 16' ' ' LYS . . . -130.23 99.93 19.08 Favored Pre-proline 0 N--CA 1.39 -3.472 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.47 50.04 2.23 Favored 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.704 2.269 . . . . 0.0 112.355 178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.461 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.4 pp -91.98 174.76 7.16 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.616 175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.494 ' HB2' ' HA ' ' A' ' 25' ' ' TYR . 17.8 mt-30 -71.33 127.87 34.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.701 0.286 . . . . 0.0 111.446 177.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' OH ' HG12 ' A' ' 46' ' ' VAL . 45.1 m-85 -100.93 141.52 33.7 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 174.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.431 HG23 ' HB3' ' A' ' 77' ' ' ALA . 6.2 p -127.03 158.73 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 -175.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -137.51 135.25 7.47 Favored Glycine 0 CA--C 1.462 -3.228 0 C-N-CA 119.26 -1.448 . . . . 0.0 112.617 174.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.571 ' HB ' HG23 ' A' ' 29' ' ' ILE . 44.4 t -115.26 142.59 27.64 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 103.673 -2.714 . . . . 0.0 103.673 174.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.462 ' HB3' ' ND2' ' A' ' 60' ' ' ASN . 28.2 t80 -172.06 157.05 4.22 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.982 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -85.98 93.2 8.9 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 168.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 58' ' ' PHE . 50.0 m-80 -89.53 118.1 28.92 Favored 'General case' 0 N--CA 1.39 -3.459 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -92.17 -59.47 2.09 Favored 'General case' 1 C--N 1.237 -4.311 0 CA-C-N 113.506 -1.679 . . . . 0.0 107.573 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -93.88 125.39 38.48 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.001 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.551 HG13 HD13 ' A' ' 92' ' ' LEU . 15.6 tt -65.65 -29.35 46.75 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.258 -177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.79 -19.32 59.06 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.812 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -80.05 -26.05 39.87 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.804 0.812 . . . . 0.0 108.875 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.3 t -75.06 -44.73 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 63' ' ' ILE . 70.0 t -60.3 -36.77 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.3 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 72' ' ' VAL . 11.8 t70 -54.86 -58.31 8.1 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.666 -1.152 . . . . 0.0 111.373 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -65.74 -40.91 92.6 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -61.63 -29.42 70.05 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.778 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -84.15 -59.96 2.24 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.954 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 68' ' ' ASP . 52.2 t -50.55 -59.83 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.502 0.721 . . . . 0.0 111.909 -176.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.611 ' HB2' HG23 ' A' ' 40' ' ' VAL . 33.3 tp -78.3 -21.26 49.94 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.846 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 47.6 m 59.56 73.65 0.47 Allowed 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.006 0.908 . . . . 0.0 109.835 -173.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.451 HD21 HD23 ' A' ' 73' ' ' LEU . 73.2 mt -72.13 -179.14 2.69 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.835 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' CB ' ' HG2' ' A' ' 53' ' ' GLN . . . -127.7 -44.19 1.52 Allowed 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -137.25 157.61 46.26 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.717 172.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.6 p -141.83 140.26 30.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.3 mp0 -103.07 124.7 49.03 Favored 'General case' 0 N--CA 1.395 -3.187 0 O-C-N 121.874 -0.516 . . . . 0.0 110.914 -177.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.563 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -103.91 137.34 42.03 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.816 -1.083 . . . . 0.0 111.499 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.26 99.46 12.24 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -60.17 -12.98 25.98 Favored Glycine 0 C--N 1.312 -0.789 0 CA-C-N 114.811 -1.086 . . . . 0.0 115.494 -175.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -57.92 -26.3 62.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.948 0.404 . . . . 0.0 110.186 176.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -62.13 -47.27 85.33 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 39.5 tt0 178.31 146.44 0.14 Allowed 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.451 ' HG2' ' CE1' ' A' ' 117' ' ' PHE . 47.8 mt-30 -76.12 -44.25 39.43 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 122.485 1.136 . . . . 0.0 109.594 -176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 45.6 mt -72.84 -13.33 61.27 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.092 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.607 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . 29.5 t80 -64.97 -39.22 93.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.692 175.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.557 HD11 ' HA2' ' A' ' 82' ' ' GLY . 2.4 mp -61.83 -38.74 81.26 Favored 'Isoleucine or valine' 0 C--O 1.243 0.753 0 CA-C-O 121.727 0.775 . . . . 0.0 109.391 178.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 32.4 t70 -64.01 -22.12 66.79 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.096 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 98.9 m -86.29 -42.08 14.04 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.056 -178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.551 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -49.87 -38.29 34.9 Favored 'General case' 0 C--O 1.21 -1.007 0 C-N-CA 123.196 0.599 . . . . 0.0 111.953 176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' NE ' HD13 ' A' ' 102' ' ' ILE . 18.2 mmm-85 -63.93 -27.18 68.97 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-O 121.906 0.86 . . . . 0.0 111.368 -176.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -79.65 -47.84 14.71 Favored 'General case' 0 C--N 1.271 -2.828 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.776 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.71 -22.78 29.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 mp -96.38 130.15 31.56 Favored Pre-proline 0 C--N 1.28 -2.439 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.179 178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -65.73 165.85 21.98 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.639 2.226 . . . . 0.0 111.492 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.64 -17.56 47.96 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 123.986 0.914 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 20.4 m170 -70.73 -29.33 65.57 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.288 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.423 HG21 ' HB1' ' A' ' 70' ' ' ALA . 72.6 t -107.47 136.76 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.435 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -113.22 167.97 10.11 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.563 HG23 HD23 ' A' ' 80' ' ' LEU . 2.3 mp -125.72 133.28 69.47 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.543 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 43.0 m0 -121.96 164.71 17.15 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -115.36 124.64 51.75 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.57 107.54 4.5 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.061 -0.972 . . . . 0.0 108.802 177.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.2 tp -96.01 101.08 12.7 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.995 -177.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 m -67.06 144.39 56.16 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.5 m -59.78 149.05 7.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.95 0 CA-C-O 121.637 0.732 . . . . 0.0 112.444 -174.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 158.68 94.49 0.1 Allowed Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -174.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -70.07 -18.34 63.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.241 0.616 . . . . 0.0 112.601 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 m -78.39 -11.69 59.96 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-O 121.264 0.554 . . . . 0.0 110.568 178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 98.5 mt -73.66 134.99 78.43 Favored Pre-proline 0 C--O 1.243 0.73 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -71.19 153.56 62.16 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 121.752 1.635 . . . . 0.0 110.618 175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.78 68.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.12 122.5 42.42 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -126.27 -52.38 1.51 Allowed 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.502 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 94.7 m-85 -129.13 119.2 23.72 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.515 -179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -76.14 163.63 26.9 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.601 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 28.2 m170 67.47 21.7 9.53 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.218 -0.901 . . . . 0.0 113.047 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.1 m -90.75 149.95 3.89 Favored 'Isoleucine or valine' 0 C--O 1.25 1.093 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 171.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -85.55 -45.52 11.69 Favored 'General case' 0 C--N 1.283 -2.306 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.497 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 68.7 mttm -146.14 161.95 39.07 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.064 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -106.98 145.4 32.31 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 m -140.47 161.47 24.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 97.4 mt -80.84 174.54 11.52 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.221 0.534 . . . . 0.0 111.448 -177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.08 124.09 24.85 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.526 178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -134.6 12.98 3.75 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.843 174.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -147.22 -44.44 0.03 OUTLIER Glycine 0 C--N 1.338 0.654 0 C-N-CA 119.341 -1.409 . . . . 0.0 115.151 -172.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -149.79 109.86 4.13 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.777 0.789 . . . . 0.0 109.941 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -95.62 105.03 3.2 Favored Glycine 0 N--CA 1.435 -1.412 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -172.39 -149.58 6.8 Favored Glycine 0 N--CA 1.429 -1.827 0 C-N-CA 120.516 -0.849 . . . . 0.0 111.34 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . 56.82 74.44 0.41 Allowed 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.139 0.976 . . . . 0.0 110.99 -178.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 122.8 -41.4 1.81 Allowed Glycine 0 C--N 1.302 -1.313 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 62.3 m . . . . . 0 C--N 1.308 -1.209 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.232 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttm . . . . . 0 CA--C 1.511 -0.539 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.46 -167.55 19.43 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 110.654 -0.979 . . . . 0.0 110.654 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 67.18 145.67 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.717 1.207 . . . . 0.0 111.72 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -148.99 37.2 0.78 Allowed 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -57.24 99.79 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 113.257 -1.792 . . . . 0.0 113.106 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.6 131.19 51.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.857 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m -91.6 170.65 9.76 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 174.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -41.52 127.58 3.78 Favored Glycine 0 C--N 1.347 1.188 0 O-C-N 123.735 0.647 . . . . 0.0 114.076 -173.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.504 ' HG ' ' H ' ' A' ' 11' ' ' ARG . 33.4 tp -134.65 173.15 11.99 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.7 t -138.83 13.85 2.69 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 122.232 1.015 . . . . 0.0 109.467 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 99.1 mtt180 -124.62 112.66 17.06 Favored 'General case' 0 N--CA 1.421 -1.893 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.537 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.12 -41.7 99.55 Favored Glycine 0 C--N 1.302 -1.345 0 CA-C-O 122.207 0.893 . . . . 0.0 112.816 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.494 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 1.0 OUTLIER -69.51 -35.16 75.25 Favored 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 124.524 1.13 . . . . 0.0 109.407 -176.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 11' ' ' ARG . 13.0 t70 -77.13 -30.29 55.06 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.38 -177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.12 -32.61 72.11 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 114.563 -1.198 . . . . 0.0 109.429 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 13' ' ' GLN . 9.8 mtmp? -62.22 -31.93 72.53 Favored 'General case' 0 C--O 1.204 -1.331 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.568 178.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.11 -28.66 69.79 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.772 0.32 . . . . 0.0 111.565 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -76.15 -40.6 52.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.807 0.813 . . . . 0.0 109.481 178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.479 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -67.9 -32.71 73.38 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.464 176.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -64.86 -30.42 71.41 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 124.168 0.987 . . . . 0.0 110.361 177.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.64 -23.34 60.9 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.082 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.89 -19.17 0.04 OUTLIER Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 119.252 -1.451 . . . . 0.0 113.636 176.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.95 25.48 15.08 Favored 'General case' 0 C--N 1.364 1.202 0 CA-C-O 121.832 0.825 . . . . 0.0 109.416 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.18 -67.61 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.026 -172.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -177.71 157.63 1.24 Allowed 'General case' 0 C--N 1.315 -0.895 0 O-C-N 124.124 0.89 . . . . 0.0 110.014 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 55' ' ' VAL . . . -117.68 163.9 12.71 Favored Glycine 0 C--N 1.308 -1.01 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -126.71 78.36 0.38 Allowed Glycine 0 CA--C 1.495 -1.168 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.237 -174.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.482 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -120.87 151.86 39.13 Favored 'General case' 0 N--CA 1.415 -2.199 0 CA-C-O 120.895 0.379 . . . . 0.0 110.026 -176.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.524 HG13 ' SG ' ' A' ' 37' ' ' CYS . 2.2 pt -116.97 154.4 18.63 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 176.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.412 ' CE1' ' HA3' ' A' ' 56' ' ' GLY . 20.1 m-85 -84.6 86.72 7.28 Favored 'General case' 0 C--N 1.31 -1.148 0 O-C-N 124.16 0.913 . . . . 0.0 109.855 -175.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 91.5 t -116.54 122.82 70.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.16 107.17 0.16 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.465 1.103 . . . . 0.0 112.86 -174.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.5 p 62.2 27.33 16.42 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.598 1.559 . . . . 0.0 113.298 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 t -79.0 140.9 58.04 Favored Pre-proline 0 C--N 1.308 -1.21 0 O-C-N 121.885 -0.509 . . . . 0.0 110.047 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -86.68 8.31 4.49 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.598 1.532 . . . . 0.0 111.152 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -120.4 -4.92 9.87 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.807 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 61.6 m -153.27 128.28 9.65 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -173.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -103.46 137.9 30.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.353 0.597 . . . . 0.0 111.026 -175.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -102.98 169.51 8.53 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.886 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 13.1 p -47.87 -30.44 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 124.256 1.022 . . . . 0.0 113.115 -174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -73.01 -36.74 67.06 Favored 'General case' 0 N--CA 1.427 -1.605 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 46' ' ' VAL . 2.2 mt-30 -86.0 -34.21 20.86 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.3 -25.88 68.11 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.58 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -30.82 71.8 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 123.806 0.843 . . . . 0.0 109.211 177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -78.46 -50.92 10.79 Favored 'General case' 0 CA--C 1.507 -0.698 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 176.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 42' ' ' GLN . 43.0 t -58.6 -35.01 52.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.706 -1.588 . . . . 0.0 111.602 -175.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -64.28 -26.74 68.62 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -93.74 -14.72 25.96 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.39 0.614 . . . . 0.0 110.028 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.98 -48.79 6.98 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.663 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -131.77 104.03 14.4 Favored Pre-proline 0 N--CA 1.398 -3.069 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -176.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -73.55 65.36 4.67 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.012 1.808 . . . . 0.0 112.395 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.66 162.41 13.54 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 114.528 -1.214 . . . . 0.0 108.599 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -81.2 151.82 28.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 110.567 -0.16 . . . . 0.0 110.567 -177.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -118.92 148.71 42.65 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 121.978 -0.451 . . . . 0.0 110.248 -173.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 26' ' ' GLY . 12.2 p -133.5 154.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -129.92 141.73 12.93 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 120.302 -0.951 . . . . 0.0 113.153 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.524 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 25.6 t -136.43 126.67 40.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -173.04 173.75 3.62 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -87.48 120.15 28.49 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 176.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -95.64 117.35 30.3 Favored 'General case' 0 N--CA 1.398 -3.031 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -171.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.5 m80 -99.23 -59.02 1.8 Allowed 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -91.2 114.14 26.58 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.389 -176.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.505 ' CD1' HG22 ' A' ' 91' ' ' THR . 16.8 tt -65.8 -30.43 50.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.935 178.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.88 -24.33 65.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.624 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.06 -41.51 22.49 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -177.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.8 -46.73 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 CA-C-N 114.495 -1.23 . . . . 0.0 108.942 177.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 63' ' ' ILE . 88.5 t -59.9 -41.22 85.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.678 0.611 . . . . 0.0 109.61 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.1 t70 -54.6 -60.75 2.93 Favored 'General case' 0 CA--C 1.511 -0.536 0 O-C-N 123.841 0.713 . . . . 0.0 110.98 177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -63.55 -47.77 80.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.239 -175.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -60.3 -29.85 69.11 Favored 'General case' 0 C--O 1.214 -0.785 0 O-C-N 124.04 0.837 . . . . 0.0 111.855 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -84.04 -57.07 3.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.404 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 68' ' ' ASP . 66.2 t -51.26 -58.62 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 C-N-CA 123.008 0.523 . . . . 0.0 112.179 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.8 tp -81.23 -19.44 43.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.916 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 31.6 t 61.01 77.69 0.32 Allowed 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.165 0.986 . . . . 0.0 111.25 -175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -78.56 -167.62 1.14 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 124.822 1.249 . . . . 0.0 110.872 179.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.759 ' O ' ' HA ' ' A' ' 100' ' ' VAL . . . -127.69 -74.83 0.58 Allowed 'General case' 1 C--O 1.148 -4.256 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 170.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -104.3 158.06 16.71 Favored 'General case' 0 N--CA 1.394 -3.272 0 C-N-CA 118.352 -1.339 . . . . 0.0 111.875 -177.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.2 p -139.75 138.6 38.76 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 176.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.4 mp0 -97.79 132.67 43.19 Favored 'General case' 0 N--CA 1.392 -3.341 0 CA-C-O 121.591 0.71 . . . . 0.0 112.342 -176.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 102' ' ' ILE . 4.2 mm? -105.82 115.3 30.0 Favored 'General case' 0 N--CA 1.419 -1.987 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.681 -177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -81.55 97.48 7.85 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.035 -2.209 . . . . 0.0 105.035 166.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA2' HD11 ' A' ' 89' ' ' ILE . . . -54.95 -11.73 3.24 Favored Glycine 0 C--N 1.313 -0.739 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 -171.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -42.69 -29.7 0.32 Allowed 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 125.469 1.508 . . . . 0.0 114.586 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -66.44 -48.62 69.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -178.37 154.08 0.79 Allowed 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.476 ' HA ' ' CD1' ' A' ' 117' ' ' PHE . 2.1 mp0 -78.39 -46.07 20.85 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-O 122.208 1.004 . . . . 0.0 109.913 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.408 ' HB2' ' OE2' ' A' ' 85' ' ' GLU . 38.9 mt -77.58 -13.61 59.87 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.944 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.55 ' O ' ' HB ' ' A' ' 91' ' ' THR . 37.6 t80 -62.9 -35.91 81.61 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.983 174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.58 HD11 ' HA2' ' A' ' 82' ' ' GLY . 1.9 mp -64.82 -33.24 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.958 0.885 . . . . 0.0 109.646 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 93' ' ' ARG . 25.0 t70 -70.55 -15.66 62.79 Favored 'General case' 0 C--O 1.204 -1.312 0 CA-C-N 114.141 -1.391 . . . . 0.0 109.878 178.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 92.5 m -89.32 -46.6 8.64 Favored 'General case' 0 C--N 1.289 -2.025 0 C-N-CA 124.498 1.119 . . . . 0.0 110.208 -176.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -44.54 -56.47 4.3 Favored 'General case' 0 CA--C 1.492 -1.254 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.15 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -68.01 -6.44 22.5 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -176.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 90' ' ' ASP . 40.4 mt-10 -88.41 -35.39 17.13 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -91.87 -16.04 27.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.955 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.422 ' HB3' ' HB ' ' A' ' 100' ' ' VAL . 97.8 mt -85.89 143.2 37.38 Favored Pre-proline 0 C--N 1.281 -2.381 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.069 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.45 ' HG2' HG23 ' A' ' 100' ' ' VAL . 33.6 Cg_endo -66.65 165.99 23.6 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.729 2.286 . . . . 0.0 111.111 178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -9.14 15.52 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.542 0.737 . . . . 0.0 112.65 -174.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 21.9 m170 -82.24 -29.24 31.42 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 76' ' ' ALA . 46.8 t -93.32 136.5 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.283 0 N-CA-C 113.264 0.839 . . . . 0.0 113.264 -170.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -123.41 166.92 14.53 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.284 1.033 . . . . 0.0 108.367 176.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.489 HG23 HD23 ' A' ' 80' ' ' LEU . 1.8 mp -115.82 133.19 63.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.568 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.7 m0 -117.67 150.0 39.78 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.303 -1.359 . . . . 0.0 107.93 170.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.69 116.9 33.68 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.67 103.1 2.95 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp -78.97 95.52 5.5 Favored 'General case' 0 N--CA 1.427 -1.617 0 CA-C-O 121.456 0.646 . . . . 0.0 111.25 -171.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 m -61.27 148.46 41.05 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.541 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.53 157.27 6.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.645 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.48 122.15 1.39 Allowed Glycine 0 N--CA 1.431 -1.644 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -74.75 -34.32 62.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.213 0.53 . . . . 0.0 110.29 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.7 p -89.01 84.32 6.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.427 ' HA ' ' HD3' ' A' ' 113' ' ' PRO . 18.4 tp -135.09 133.89 21.18 Favored Pre-proline 0 N--CA 1.426 -1.668 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 112' ' ' LEU . 20.3 Cg_exo -67.78 153.42 75.81 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.64 2.227 . . . . 0.0 113.045 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.83 -33.63 76.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.369 0.604 . . . . 0.0 110.257 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -136.01 123.01 21.43 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.537 173.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -113.74 -51.9 2.77 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.496 ' CZ ' ' HA3' ' A' ' 82' ' ' GLY . 26.2 m-85 -127.65 109.69 11.94 Favored 'General case' 0 N--CA 1.426 -1.648 0 CA-C-N 113.679 -1.6 . . . . 0.0 107.503 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -96.42 178.56 5.32 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.867 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 18.2 m170 68.24 20.98 8.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.905 0.882 . . . . 0.0 111.822 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.7 m -94.48 145.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.425 175.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.77 -41.48 17.55 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.949 -176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.513 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 65.1 mttp -145.54 162.81 36.54 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.029 0.442 . . . . 0.0 110.859 -176.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -114.49 136.45 53.0 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.236 175.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.88 174.6 12.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD13 ' H ' ' A' ' 125' ' ' LEU . 0.0 OUTLIER -76.43 145.5 39.25 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.104 0.478 . . . . 0.0 111.56 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -79.26 149.75 31.75 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.681 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -84.59 95.01 8.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.18 119.67 6.11 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.139 -178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -110.32 -0.04 17.82 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 122.536 1.16 . . . . 0.0 107.922 174.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.25 160.5 33.34 Favored Glycine 0 N--CA 1.421 -2.349 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 156.6 -92.19 0.12 Allowed Glycine 0 N--CA 1.426 -1.975 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.491 178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.66 27.76 5.47 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.342 0.591 . . . . 0.0 109.817 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.32 -57.09 3.54 Favored Glycine 0 CA--C 1.503 -0.709 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.41 -2.428 0 C-N-CA 123.313 0.645 . . . . 0.0 109.292 176.178 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.502 -0.888 0 CA-C-O 120.711 0.291 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.23 139.57 16.89 Favored Glycine 0 N--CA 1.436 -1.36 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 175.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.407 ' HB3' ' HG3' ' A' ' 5' ' ' LYS . 8.9 mm-40 68.86 114.51 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.739 1.215 . . . . 0.0 109.406 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.48 ' OD1' ' HB ' ' A' ' 24' ' ' ILE . 2.9 p-10 -119.77 31.36 6.58 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HG3' ' HB3' ' A' ' 3' ' ' GLU . 9.8 mtmp? -38.49 98.34 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 112.317 -2.22 . . . . 0.0 113.753 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.446 HG22 ' HA3' ' A' ' 26' ' ' GLY . 3.1 m -84.5 112.07 21.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.273 -0.571 . . . . 0.0 111.135 173.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.5 p -91.0 169.02 11.23 Favored 'General case' 0 C--N 1.285 -2.196 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 37' ' ' CYS . . . -40.66 119.78 1.47 Allowed Glycine 0 C--N 1.347 1.194 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 -172.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.3 tp -158.37 146.2 18.27 Favored 'General case' 0 N--CA 1.409 -2.477 0 N-CA-C 104.728 -2.323 . . . . 0.0 104.728 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -133.21 15.38 4.16 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 122.51 1.147 . . . . 0.0 110.367 -172.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 81.2 mtt180 -107.56 115.65 30.53 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.44 -52.99 34.05 Favored Glycine 0 C--N 1.306 -1.108 0 CA-C-O 122.138 0.854 . . . . 0.0 111.784 176.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.619 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 1.8 mp0 -55.86 -25.21 41.26 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 126.107 1.763 . . . . 0.0 112.773 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.454 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 9.1 t0 -94.14 -43.86 8.28 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.51 -32.01 73.34 Favored 'General case' 0 C--O 1.251 1.139 0 C-N-CA 124.583 1.153 . . . . 0.0 112.138 -177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -60.07 -24.4 64.55 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.881 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.73 -26.57 68.42 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.48 -45.36 12.72 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 121.427 0.632 . . . . 0.0 109.329 179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -60.28 -35.59 75.9 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.184 176.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -50.96 -30.09 13.98 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 125.251 1.421 . . . . 0.0 111.862 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.61 -22.95 62.48 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.18 7.46 0.09 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 119.46 -1.353 . . . . 0.0 113.879 176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.56 23.03 11.69 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.306 1.043 . . . . 0.0 111.765 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 4' ' ' ASN . 36.7 mt -57.85 -66.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.471 -170.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -176.02 152.91 1.24 Allowed 'General case' 0 C--N 1.313 -1.008 0 O-C-N 123.575 0.547 . . . . 0.0 110.642 -175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 6' ' ' VAL . . . -125.44 153.32 18.11 Favored Glycine 0 N--CA 1.419 -2.452 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.23 85.2 0.36 Allowed Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.533 ' H ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -113.21 150.47 32.28 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.31 0.576 . . . . 0.0 109.842 -177.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 57' ' ' VAL . 3.3 pt -115.99 150.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.776 0 CA-C-N 115.461 -0.79 . . . . 0.0 113.027 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -82.73 76.69 9.56 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-N 114.324 -1.307 . . . . 0.0 112.788 -171.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.414 ' HB ' ' CB ' ' A' ' 37' ' ' CYS . 52.3 t -119.36 120.42 63.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.74 97.95 0.01 OUTLIER 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.554 1.542 . . . . 0.0 114.498 -171.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.421 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 74.5 p 62.02 9.82 3.29 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 127.013 2.125 . . . . 0.0 116.021 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 55.1 m -68.51 136.49 90.75 Favored Pre-proline 0 C--O 1.206 -1.235 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.68 4.02 0.98 Allowed 'Trans proline' 0 N--CA 1.475 0.403 0 C-N-CA 123.169 2.579 . . . . 0.0 115.429 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.648 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 2.6 tpm_? -124.93 9.77 8.19 Favored 'General case' 0 N--CA 1.422 -1.845 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.611 175.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' HA3' ' A' ' 8' ' ' GLY . 65.9 m -141.3 154.13 45.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG23 ' HA2' ' A' ' 8' ' ' GLY . 1.4 t -136.22 137.14 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.751 0 CA-C-O 121.712 0.767 . . . . 0.0 109.587 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -119.26 177.13 5.01 Favored 'General case' 0 CA--C 1.465 -2.31 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.459 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.505 ' HA ' HD21 ' A' ' 73' ' ' LEU . 68.9 t -38.37 -40.66 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 O-C-N 125.021 1.451 . . . . 0.0 113.423 -177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -64.12 -58.93 5.18 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.611 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.421 ' NE2' ' HA ' ' A' ' 33' ' ' THR . 32.2 mt-30 -74.36 -33.89 63.22 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.072 -176.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 46' ' ' VAL . . . -65.1 -31.64 72.95 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -63.0 -35.6 80.76 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -85.85 -44.8 12.14 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.611 -178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 43' ' ' ALA . 4.8 p -64.87 -30.61 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.873 -176.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -69.47 -21.42 63.71 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.02 -9.29 58.76 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.196 0.522 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -103.99 -46.07 4.57 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.27 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -129.9 99.13 20.55 Favored Pre-proline 0 N--CA 1.397 -3.085 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -177.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -75.41 67.42 6.27 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.156 1.904 . . . . 0.0 112.247 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.98 165.88 10.93 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.528 174.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 161.67 27.62 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 117.679 0.218 . . . . 0.0 110.932 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.82 143.49 50.77 Favored 'General case' 0 C--O 1.252 1.187 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 26' ' ' GLY . 10.2 p -133.65 156.26 41.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 78' ' ' VAL . . . -126.34 136.54 9.59 Favored Glycine 0 N--CA 1.435 -1.426 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.767 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.511 ' O ' HG22 ' A' ' 29' ' ' ILE . 46.5 t -123.94 128.54 74.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 175.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.455 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 32.8 t80 -171.59 162.04 6.33 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.258 -176.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 83' ' ' ASN . 58.2 ttt180 -96.39 92.2 6.2 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.455 ' OD1' ' HB3' ' A' ' 58' ' ' PHE . 17.4 m120 -102.84 124.79 49.01 Favored 'General case' 0 CA--C 1.476 -1.897 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.554 ' CD2' HD22 ' A' ' 83' ' ' ASN . 65.7 m80 -94.33 -46.09 7.19 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.184 178.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -81.67 124.61 29.73 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.132 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.648 HG13 HD13 ' A' ' 92' ' ' LEU . 10.3 tt -64.67 -33.9 66.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-O 121.053 0.454 . . . . 0.0 110.278 175.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.93 -19.93 64.2 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.684 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -79.78 -36.69 36.75 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.39 -48.37 77.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.506 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 63' ' ' ILE . 61.3 t -60.23 -39.82 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.16 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 72' ' ' VAL . 20.8 t70 -54.34 -61.47 2.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 123.76 0.824 . . . . 0.0 111.319 178.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -65.2 -38.93 92.02 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.253 -176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.66 -35.08 79.89 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 123.492 0.495 . . . . 0.0 111.672 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -77.24 -50.98 11.71 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.66 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 68' ' ' ASP . 54.8 t -61.26 -55.72 22.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.15 -176.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 40' ' ' VAL . 86.7 mt -79.61 -8.51 59.23 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 p 52.7 67.7 0.95 Allowed 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.976 0.893 . . . . 0.0 111.907 -174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.18 -177.56 6.14 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.309 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.29 -36.92 1.88 Allowed 'General case' 0 C--O 1.196 -1.717 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -144.09 160.3 41.14 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 174.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.1 p -140.67 140.72 33.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.715 175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.502 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.5 mp0 -104.35 105.25 15.31 Favored 'General case' 0 N--CA 1.417 -2.079 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.8 mt -115.59 97.99 6.46 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -124.96 -22.77 4.4 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.154 0.502 . . . . 0.0 112.094 -174.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.38 -55.96 1.62 Allowed Glycine 0 C--N 1.29 -2.0 0 N-CA-C 118.538 2.175 . . . . 0.0 118.538 -168.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.554 HD22 ' CD2' ' A' ' 61' ' ' HIS . 20.6 p-10 -83.25 -69.91 0.6 Allowed 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 121.77 3.989 . . . . 0.0 121.77 -159.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . 0.308 36.0 mm-40 -88.67 -49.41 6.88 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 120.764 3.616 . . . . 0.0 120.764 -157.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 0.4 OUTLIER -174.97 166.35 3.55 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 119.505 1.048 . . . . 0.0 109.448 -173.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.51 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 19.4 mm-40 -73.92 -48.45 30.64 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 71.4 mt -81.87 -12.8 58.29 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.138 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 91' ' ' THR . 23.3 t80 -59.62 -35.95 75.36 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.524 ' HA ' HD23 ' A' ' 92' ' ' LEU . 1.7 mp -63.73 -34.27 66.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.727 0.775 . . . . 0.0 110.246 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 87' ' ' LEU . 28.8 t70 -64.7 -22.96 67.1 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.594 176.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 99.1 m -83.54 -40.12 19.54 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.487 -178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.648 HD13 HG13 ' A' ' 63' ' ' ILE . 3.8 mm? -53.05 -43.65 66.81 Favored 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 122.976 0.51 . . . . 0.0 110.631 177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.687 ' HD2' HD13 ' A' ' 102' ' ' ILE . 6.6 mmm180 -43.98 -39.2 3.92 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.438 1.495 . . . . 0.0 112.098 176.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.43 -44.45 35.81 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 114.117 -1.401 . . . . 0.0 112.091 -174.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -86.39 -7.97 58.03 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 96.3 mt -106.58 147.96 35.92 Favored Pre-proline 0 C--N 1.288 -2.078 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 176.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.42 163.75 38.0 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 121.268 1.312 . . . . 0.0 109.2 173.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.46 66.88 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 123.146 0.579 . . . . 0.0 112.54 -173.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -88.72 1.63 54.81 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.7 t -110.9 127.97 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.424 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 168.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -119.4 173.94 6.67 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.346 0.593 . . . . 0.0 111.99 -170.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.687 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.6 mp -126.05 133.08 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.922 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.502 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 49.2 m0 -121.52 157.31 30.95 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 175.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -100.4 116.22 31.85 Favored 'General case' 0 N--CA 1.405 -2.7 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 173.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 126' ' ' ASP . . . -68.6 110.78 4.39 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 169.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -69.57 93.92 0.73 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.765 0.793 . . . . 0.0 112.548 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.0 m -78.81 125.18 29.03 Favored 'General case' 0 N--CA 1.41 -2.443 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 171.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 m -75.88 156.48 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 123.62 0.575 . . . . 0.0 111.554 -176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.81 139.91 2.75 Favored Glycine 0 N--CA 1.425 -2.092 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.89 153.73 21.08 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.9 m 76.89 25.97 0.81 Allowed 'General case' 0 CA--C 1.564 1.5 0 CA-C-O 122.541 1.162 . . . . 0.0 111.176 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.15 135.92 22.18 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.03 162.17 41.12 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 121.914 1.743 . . . . 0.0 111.176 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.57 -38.87 77.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -97.54 121.65 39.69 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.454 ' O ' ' HB3' ' A' ' 86' ' ' GLN . 27.6 mt-10 -125.41 -73.14 0.64 Allowed 'General case' 0 C--N 1.278 -2.503 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 86' ' ' GLN . 85.7 m-85 -87.52 102.49 14.63 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -72.02 136.64 46.77 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . 0.295 18.0 m170 79.48 33.35 0.21 Allowed 'General case' 0 N--CA 1.405 -2.698 0 CA-C-N 111.816 -2.447 . . . . 0.0 112.596 -178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.78 137.95 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 166.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -71.97 -48.02 48.02 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.787 -174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -150.84 162.44 40.75 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -111.89 149.15 32.27 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.484 HG22 HD23 ' A' ' 125' ' ' LEU . 11.0 p -133.33 178.77 5.14 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 125' ' ' LEU . 1.9 pt? -73.89 164.15 27.0 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 119.007 0.821 . . . . 0.0 109.944 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.407 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 10.6 t70 -65.85 109.67 2.57 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -105.51 19.21 20.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.951 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -94.38 175.52 34.67 Favored Glycine 0 N--CA 1.424 -2.124 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -146.67 106.97 4.03 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.05 114.83 2.67 Favored Glycine 0 N--CA 1.434 -1.495 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 105.08 139.01 9.68 Favored Glycine 0 C--N 1.298 -1.564 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -178.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -99.1 -27.58 13.76 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -114.64 177.27 17.41 Favored Glycine 0 N--CA 1.424 -2.162 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.172 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--N 1.292 -1.935 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 121.49 0.662 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.75 -41.94 1.42 Allowed Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.451 -1.859 . . . . 0.0 108.451 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 60.49 -166.81 0.19 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.252 1.421 . . . . 0.0 113.512 171.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.455 ' OD1' ' HA ' ' A' ' 18' ' ' ALA . 0.9 OUTLIER -132.02 38.46 3.51 Favored 'General case' 0 CA--C 1.487 -1.459 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 -179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -57.88 92.04 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.433 -1.258 . . . . 0.0 111.861 179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.1 m -91.26 138.0 20.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.67 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 36' ' ' ARG . 73.6 m -91.09 170.0 10.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 174.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -31.35 106.61 0.02 OUTLIER Glycine 0 C--N 1.358 1.762 0 O-C-N 124.395 1.059 . . . . 0.0 115.725 -169.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.5 tp -120.02 144.02 47.76 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -178.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.3 p -113.82 -19.62 11.43 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.315 1.055 . . . . 0.0 110.583 -170.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 98.9 mtt180 -92.48 117.49 29.99 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.197 -177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 16' ' ' LYS . . . -64.84 -30.39 77.84 Favored Glycine 0 N--CA 1.433 -1.504 0 CA-C-N 116.387 -0.369 . . . . 0.0 112.204 177.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.49 ' HA ' ' HE2' ' A' ' 16' ' ' LYS . 6.4 mm-40 -73.43 -23.74 60.16 Favored 'General case' 0 CA--C 1.486 -1.494 0 CA-C-O 122.762 1.268 . . . . 0.0 108.195 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.423 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 5.7 t0 -88.49 -39.94 13.82 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.466 -174.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.67 75.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.307 176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 52.1 mtmt -61.12 -28.05 68.82 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.985 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.45 -27.54 63.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.734 0.302 . . . . 0.0 110.868 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.455 ' HA ' ' OD1' ' A' ' 4' ' ' ASN . . . -78.91 -39.98 33.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.996 0.903 . . . . 0.0 109.143 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.453 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 0.1 OUTLIER -67.68 -30.74 70.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.174 175.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -54.31 -25.1 21.92 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.963 1.305 . . . . 0.0 111.847 178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.55 -14.04 62.58 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.839 0.456 . . . . 0.0 111.516 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.37 31.9 0.88 Allowed Glycine 0 CA--C 1.498 -1.01 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.07 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 53.61 36.64 24.04 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.969 0.908 . . . . 0.0 110.529 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 52.6 mt -62.94 -69.88 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.679 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.663 -172.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -179.8 161.36 0.98 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 124.032 0.833 . . . . 0.0 110.244 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -124.01 150.55 17.01 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 177.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -117.06 75.58 0.28 Allowed Glycine 0 CA--C 1.494 -1.274 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.628 -172.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.93 153.27 34.88 Favored 'General case' 0 N--CA 1.41 -2.449 0 CA-C-O 121.202 0.525 . . . . 0.0 110.649 -178.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.561 ' CG2' ' HB ' ' A' ' 57' ' ' VAL . 2.1 pt -116.88 157.32 17.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.331 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.437 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 50.5 m-85 -80.31 77.13 7.09 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.825 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 59.0 t -109.54 118.43 56.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.06 112.07 1.11 Allowed 'General case' 0 C--N 1.314 -0.943 0 O-C-N 124.273 0.983 . . . . 0.0 112.355 -172.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.3 p 64.05 26.4 14.02 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 126.196 1.798 . . . . 0.0 112.979 175.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.9 t -84.6 139.05 37.99 Favored Pre-proline 0 N--CA 1.429 -1.497 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -88.78 7.66 4.24 Favored 'Trans proline' 0 N--CA 1.437 -1.822 0 C-N-CA 121.786 1.657 . . . . 0.0 112.13 177.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 9.7 ptm180 -118.54 -6.05 10.72 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.175 0.512 . . . . 0.0 109.902 174.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 31' ' ' VAL . 79.4 m -151.22 119.6 6.4 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 -174.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.4 t -103.28 137.22 32.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 122.113 0.959 . . . . 0.0 111.25 -172.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' ND2' ' HB2' ' A' ' 41' ' ' GLU . 2.7 p-10 -104.78 169.14 8.62 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 113.809 -1.542 . . . . 0.0 109.39 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.482 HG21 ' HD2' ' A' ' 69' ' ' LYS . 99.5 t -47.76 -35.07 4.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 C-N-CA 124.922 1.289 . . . . 0.0 112.391 -176.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.485 ' HB2' ' ND2' ' A' ' 39' ' ' ASN . 41.2 mt-10 -66.67 -48.47 69.25 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.29 -40.85 67.26 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 119.531 -0.868 . . . . 0.0 110.284 174.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.75 -20.06 64.58 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.838 -178.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -30.58 68.88 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -86.4 -51.51 6.18 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 176.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.3 -35.29 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.024 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -64.97 -24.29 67.47 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 120.92 0.391 . . . . 0.0 111.412 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -90.74 -26.68 19.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.04 -51.71 23.75 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.245 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' A' ' 19' ' ' TYR . . . -132.65 107.37 13.0 Favored Pre-proline 0 N--CA 1.407 -2.587 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.16 56.41 3.74 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 122.689 2.26 . . . . 0.0 113.397 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 1.7 pp -91.49 169.96 10.34 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 175.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.425 ' OE1' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -85.63 146.95 26.62 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -176.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -117.49 144.94 44.55 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-O 121.384 0.611 . . . . 0.0 111.761 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.3 p -130.26 163.59 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 178.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -140.04 128.74 3.99 Favored Glycine 0 N--CA 1.414 -2.779 0 C-N-CA 119.295 -1.431 . . . . 0.0 113.347 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.561 ' HB ' ' CG2' ' A' ' 29' ' ' ILE . 43.5 t -105.42 123.16 59.56 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -149.91 151.5 33.52 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -172.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -86.13 109.54 18.93 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.17 117.13 27.93 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -171.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.86 -59.91 1.76 Allowed 'General case' 0 C--N 1.264 -3.131 0 CA-C-N 113.774 -1.557 . . . . 0.0 107.377 175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -95.44 115.08 26.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 67' ' ' VAL . 16.5 tt -63.95 -30.98 51.44 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.212 -178.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.84 -16.8 60.68 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 121.212 0.53 . . . . 0.0 110.092 -176.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 68' ' ' ASP . 20.2 t70 -85.29 -31.95 22.79 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.55 -43.75 80.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.202 175.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 63' ' ' ILE . 97.5 t -57.41 -43.94 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 175.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.55 ' O ' HG23 ' A' ' 72' ' ' VAL . 9.9 t70 -52.39 -61.26 2.39 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.902 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.482 ' HD2' HG21 ' A' ' 40' ' ' VAL . 45.2 mmtm -62.15 -44.58 96.3 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.253 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 74' ' ' SER . . . -63.76 -27.45 69.21 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.348 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -84.16 -60.31 2.13 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 123.135 0.574 . . . . 0.0 110.915 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 68' ' ' ASP . 60.5 t -54.91 -55.3 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 123.616 0.766 . . . . 0.0 111.813 -173.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -82.48 -21.58 35.51 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 17.0 m 61.8 84.76 0.13 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.001 0.905 . . . . 0.0 110.77 -176.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 mt -91.0 -170.17 2.59 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.86 -177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' HB2' ' OE1' ' A' ' 53' ' ' GLN . . . -125.15 -40.53 2.14 Favored 'General case' 0 CA--C 1.462 -2.417 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.43 163.66 33.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.922 175.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 56' ' ' GLY . 7.7 p -142.85 135.67 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 103' ' ' TRP . 1.7 mp0 -101.29 116.98 34.05 Favored 'General case' 0 N--CA 1.386 -3.631 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 -178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.3 158.51 15.83 Favored 'General case' 0 C--N 1.269 -2.93 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.542 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -97.86 93.68 6.48 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' CA ' HD11 ' A' ' 89' ' ' ILE . . . -69.59 -12.83 67.62 Favored Glycine 0 C--N 1.311 -0.849 0 N-CA-C 115.972 1.149 . . . . 0.0 115.972 -169.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -49.82 -26.57 4.09 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.072 0.949 . . . . 0.0 112.19 -177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -51.85 -45.78 64.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.483 1.113 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 88' ' ' TYR . 37.1 tt0 -177.57 132.63 0.16 Allowed 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -67.4 -35.53 79.48 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 122.085 0.945 . . . . 0.0 110.664 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.7 mt -79.48 -15.62 57.46 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.234 -1.348 . . . . 0.0 110.591 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' THR . 38.8 t80 -68.62 -31.89 71.37 Favored 'General case' 0 C--O 1.207 -1.172 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.466 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.455 HD11 ' CA ' ' A' ' 82' ' ' GLY . 2.2 mp -64.34 -40.39 88.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.02 -13.64 62.32 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.79 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 93.9 m -86.98 -44.02 11.93 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.872 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.552 HD13 HG13 ' A' ' 63' ' ' ILE . 4.0 mm? -47.02 -48.08 22.07 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.783 0.433 . . . . 0.0 110.62 174.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.615 ' HD2' HD13 ' A' ' 102' ' ' ILE . 1.7 mpt_? -43.15 -31.1 0.53 Allowed 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 173.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -84.24 -38.84 20.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.082 0.468 . . . . 0.0 111.419 -175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -93.99 -18.13 22.2 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.67 0.748 . . . . 0.0 112.496 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.42 129.3 30.75 Favored Pre-proline 0 C--N 1.27 -2.889 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 176.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.66 165.53 25.15 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.056 1.837 . . . . 0.0 110.264 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -70.54 -3.37 17.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.269 0.557 . . . . 0.0 111.139 -177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -79.87 -23.12 42.13 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.953 176.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.9 t -107.78 141.87 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.0 169.9 9.27 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 122.475 0.31 . . . . 0.0 110.37 -178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.615 HD13 ' HD2' ' A' ' 93' ' ' ARG . 3.0 mp -122.65 131.0 74.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.584 ' HB2' ' NE2' ' A' ' 79' ' ' GLN . 44.4 m0 -120.86 162.45 19.8 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 174.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -99.7 120.81 40.29 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.8 100.56 3.48 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 172.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.2 tp -87.69 107.35 18.59 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.676 -175.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.0 t -85.66 148.8 25.72 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.2 m -58.35 121.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.22 0.533 . . . . 0.0 112.272 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -124.05 128.35 6.82 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.95 -22.55 39.49 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.52 0.676 . . . . 0.0 110.552 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 26.4 m -91.81 138.42 31.56 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.4 tp -76.55 116.58 57.73 Favored Pre-proline 0 C--N 1.314 -0.939 0 O-C-N 123.018 0.199 . . . . 0.0 110.633 -178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -79.38 133.83 10.94 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.245 1.963 . . . . 0.0 110.822 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.96 -37.89 54.36 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -172.75 147.63 1.77 Allowed 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.158 177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -117.46 -63.09 1.48 Allowed 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -131.48 114.27 14.71 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 105.892 -1.892 . . . . 0.0 105.892 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -84.53 155.58 22.06 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.373 -175.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 62.6 47.85 4.69 Favored 'General case' 0 N--CA 1.416 -2.155 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.197 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.2 m -89.23 155.02 3.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 169.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -81.98 -25.4 34.81 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.526 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.433 ' HB3' ' CG ' ' A' ' 103' ' ' TRP . 41.1 ttmt -169.76 163.41 9.86 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -127.9 144.46 51.1 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 173.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.48 175.24 4.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 63.4 tp -71.18 135.38 47.55 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -71.27 115.16 10.11 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.016 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -111.41 151.42 28.53 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.873 176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.55 -58.27 0.28 Allowed Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.47 147.77 44.03 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 122.45 74.29 0.31 Allowed Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.061 -1.066 . . . . 0.0 112.627 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -72.83 -52.16 9.9 Favored Glycine 0 CA--C 1.503 -0.676 0 N-CA-C 107.6 -2.2 . . . . 0.0 107.6 173.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.96 79.64 1.47 Allowed 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 171.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 98.79 -62.83 0.79 Allowed Glycine 0 N--CA 1.434 -1.45 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -174.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 C--O 1.257 1.476 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.523 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 C--O 1.234 0.284 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.14 -112.02 3.49 Favored Glycine 0 CA--C 1.489 -1.581 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.02 156.09 39.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.014 174.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.43 HD22 ' HB2' ' A' ' 21' ' ' ALA . 34.3 t-20 -150.12 49.39 0.91 Allowed 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 175.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -47.97 130.48 15.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.558 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.554 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 26.3 t -100.74 109.15 24.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.203 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.351 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.2 m -93.76 168.68 10.84 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.459 ' HA2' HG23 ' A' ' 38' ' ' VAL . . . -23.56 106.63 0.01 OUTLIER Glycine 0 C--N 1.371 2.503 0 O-C-N 124.496 1.123 . . . . 0.0 115.795 -171.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 33.2 tp -154.37 141.55 19.45 Favored 'General case' 0 N--CA 1.416 -2.158 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -136.17 8.68 3.2 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.82 0.819 . . . . 0.0 109.238 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.469 ' HB2' ' CB ' ' A' ' 14' ' ' ASP . 95.1 mtt180 -92.43 112.79 24.86 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.53 -37.1 80.8 Favored Glycine 0 C--N 1.298 -1.556 0 O-C-N 123.194 0.308 . . . . 0.0 113.131 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.629 ' H ' ' NE2' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -68.58 -26.89 65.61 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.184 0.994 . . . . 0.0 109.391 -177.654 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.469 ' CB ' ' HB2' ' A' ' 11' ' ' ARG . 8.1 t0 -90.27 -39.01 13.02 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.275 -1.33 . . . . 0.0 108.105 -175.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.08 -42.45 89.34 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -62.34 -23.92 67.04 Favored 'General case' 0 C--O 1.205 -1.24 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.52 -29.1 69.7 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.136 0.494 . . . . 0.0 110.28 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' HA ' ' CG ' ' A' ' 4' ' ' ASN . . . -79.01 -40.99 30.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.752 0.787 . . . . 0.0 110.346 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.46 ' CB ' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -68.9 -31.76 70.9 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.733 177.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -61.75 -16.18 47.26 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' HB2' HD22 ' A' ' 4' ' ' ASN . . . -78.08 -6.15 53.74 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.63 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.03 15.0 1.56 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 119.43 -1.366 . . . . 0.0 113.286 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.51 28.73 17.38 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.178 0.991 . . . . 0.0 110.783 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.9 mt -58.69 -69.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.258 -170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 53' ' ' GLN . 1.5 p90 -177.79 163.37 1.83 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 124.039 0.837 . . . . 0.0 109.184 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -127.96 126.8 5.56 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 108.566 -1.814 . . . . 0.0 108.566 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.93 85.25 0.82 Allowed Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -119.01 146.92 44.64 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.438 ' CG2' ' HB ' ' A' ' 57' ' ' VAL 0.332 0.1 OUTLIER -116.92 148.92 19.32 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 179.653 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.411 ' CE2' ' HA3' ' A' ' 56' ' ' GLY . 52.8 m-85 -74.76 87.73 2.23 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.315 -174.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 37' ' ' CYS . 58.7 t -117.59 120.86 66.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.02 106.56 0.17 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.537 1.148 . . . . 0.0 113.625 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.0 p 63.91 19.63 11.83 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 126.489 1.916 . . . . 0.0 114.189 171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.8 p -87.15 146.57 40.57 Favored Pre-proline 0 N--CA 1.425 -1.698 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.749 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -91.28 13.52 2.07 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.049 1.833 . . . . 0.0 109.929 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -100.15 -25.84 14.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.123 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 29' ' ' ILE . 82.8 m -155.97 141.75 17.97 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.171 -1.788 . . . . 0.0 106.171 -175.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.459 HG23 ' HA2' ' A' ' 8' ' ' GLY . 0.9 OUTLIER -106.16 137.7 35.14 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.535 -0.866 . . . . 0.0 112.287 -171.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -101.43 168.72 9.34 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 114.157 -1.383 . . . . 0.0 108.777 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 73' ' ' LEU . 4.5 p -52.76 -33.62 18.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 124.338 1.024 . . . . 0.0 111.781 -171.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -69.62 -42.1 74.8 Favored 'General case' 0 N--CA 1.411 -2.407 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.704 -175.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.578 ' O ' HG23 ' A' ' 46' ' ' VAL . 35.8 mt-30 -74.35 -41.34 61.22 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 118.851 -1.139 . . . . 0.0 109.768 172.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.45 -36.08 66.16 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.39 -173.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 44' ' ' GLN . 0.6 OUTLIER -64.29 -30.83 71.87 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -178.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -78.87 -42.3 27.69 Favored 'General case' 0 C--N 1.278 -2.524 0 CA-C-N 114.88 -1.054 . . . . 0.0 108.523 177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 42' ' ' GLN . 22.1 t -64.22 -35.37 73.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.935 -177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.59 -16.3 64.11 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -85.39 -17.02 37.92 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.464 0.649 . . . . 0.0 109.586 177.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.82 -32.2 11.47 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.429 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -138.06 93.9 11.54 Favored Pre-proline 0 N--CA 1.39 -3.462 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.68 61.74 5.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.503 2.135 . . . . 0.0 111.739 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.46 HD23 ' CB ' ' A' ' 19' ' ' TYR . 1.1 pp -100.88 173.15 6.63 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.348 -1.296 . . . . 0.0 108.935 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.419 ' HG3' ' CB ' ' A' ' 76' ' ' ALA . 35.8 tt0 -79.69 138.01 37.22 Favored 'General case' 0 N--CA 1.414 -2.246 0 C-N-CA 123.1 0.56 . . . . 0.0 111.101 -177.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.586 ' CD2' HD11 ' A' ' 28' ' ' LEU . 22.8 m-85 -108.89 140.62 42.1 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.433 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.99 137.82 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 30' ' ' PHE . . . -108.66 122.07 6.48 Favored Glycine 0 N--CA 1.412 -2.913 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.645 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' A' ' 79' ' ' GLN . 15.2 t -114.23 106.46 20.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -160.54 146.17 14.87 Favored 'General case' 0 C--N 1.278 -2.515 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.55 -176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -91.19 91.88 8.42 Favored 'General case' 0 N--CA 1.401 -2.923 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 175.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -79.48 159.4 26.98 Favored 'General case' 0 N--CA 1.387 -3.622 0 CA-C-O 123.427 1.584 . . . . 0.0 111.911 -173.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -110.63 -73.68 0.67 Allowed 'General case' 1 C--N 1.23 -4.625 0 CA-C-N 110.792 -2.913 . . . . 0.0 111.105 -177.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -79.01 132.78 36.76 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.54 HG13 HD13 ' A' ' 92' ' ' LEU . 10.6 tt -67.44 -31.16 51.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 176.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.78 -19.72 65.13 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.502 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 18.6 t70 -82.42 -39.98 21.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.491 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 37.8 t -66.37 -46.98 85.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.974 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 63' ' ' ILE . 75.5 t -60.39 -40.18 83.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.624 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 72' ' ' VAL . 16.4 t70 -56.26 -61.64 2.26 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.81 -1.087 . . . . 0.0 110.78 177.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.432 ' HD2' ' HB ' ' A' ' 40' ' ' VAL . 44.1 mmtm -62.34 -40.36 96.1 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.382 0.273 . . . . 0.0 111.448 -176.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.52 ' HB1' HG21 ' A' ' 100' ' ' VAL . . . -61.85 -41.1 97.42 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.299 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -80.46 -48.71 12.43 Favored 'General case' 0 N--CA 1.411 -2.392 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.681 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 68' ' ' ASP . 81.3 t -56.13 -54.94 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 123.403 0.44 . . . . 0.0 111.286 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.623 ' HB2' HG23 ' A' ' 40' ' ' VAL . 47.7 tp -82.54 -14.26 55.22 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.302 -178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 38.3 t 61.95 63.9 1.06 Allowed 'General case' 0 C--O 1.254 1.317 0 CA-C-O 121.891 0.853 . . . . 0.0 109.279 -176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.479 HD21 HD23 ' A' ' 73' ' ' LEU . 92.3 mt -66.18 179.63 0.92 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.426 -1.261 . . . . 0.0 111.358 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.419 ' CB ' ' HG3' ' A' ' 53' ' ' GLN . . . -125.13 -39.73 2.21 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' ALA . . . -142.01 156.35 45.44 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.417 173.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' C ' HE21 ' A' ' 79' ' ' GLN . 7.3 p -140.38 141.95 32.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.653 HE22 ' HB2' ' A' ' 103' ' ' TRP . 15.3 mm-40 -104.12 109.45 21.25 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 122.971 0.508 . . . . 0.0 111.664 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HG ' ' HG ' ' A' ' 92' ' ' LEU . 3.2 mm? -114.48 136.99 52.4 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 43.3 p-80 175.88 -29.7 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.301 0 CA-C-O 121.678 0.751 . . . . 0.0 109.899 -173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -90.02 -55.67 1.95 Allowed Glycine 0 C--N 1.286 -2.228 0 N-CA-C 119.749 2.659 . . . . 0.0 119.749 -166.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -82.55 -69.76 0.6 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 119.316 3.08 . . . . 0.0 119.316 -160.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -89.52 -49.6 6.58 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 -161.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 86' ' ' GLN . 1.0 OUTLIER -168.09 172.27 8.88 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -171.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' H ' ' CD ' ' A' ' 85' ' ' GLU . 36.3 mt-30 -76.87 -48.99 16.75 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 124.387 1.075 . . . . 0.0 108.867 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 62.2 mt -75.96 -13.97 60.24 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.227 -1.351 . . . . 0.0 111.691 -174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.472 ' O ' ' HB ' ' A' ' 91' ' ' THR . 25.9 t80 -59.03 -37.07 76.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.673 175.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.412 HG13 ' HB3' ' A' ' 80' ' ' LEU . 1.8 mp -65.53 -34.45 70.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.659 ' HA ' ' CZ ' ' A' ' 93' ' ' ARG . 21.4 t70 -69.1 -22.73 63.96 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.213 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.472 ' HB ' ' O ' ' A' ' 88' ' ' TYR . 87.2 m -83.8 -44.33 14.48 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.071 -1.422 . . . . 0.0 109.115 -176.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.54 HD13 HG13 ' A' ' 63' ' ' ILE . 3.3 mm? -44.86 -50.12 10.5 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 174.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 90' ' ' ASP . 0.0 OUTLIER -54.15 -29.18 44.48 Favored 'General case' 0 N--CA 1.516 2.825 0 CA-C-O 121.284 0.564 . . . . 0.0 112.258 -178.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 91' ' ' THR . 28.5 mt-10 -76.72 -30.44 56.64 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.521 -174.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.96 -9.25 19.02 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.559 0.695 . . . . 0.0 112.561 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 19.6 tp -94.85 129.29 36.4 Favored Pre-proline 0 C--N 1.291 -1.952 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.525 -177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.406 ' HB2' ' CD2' ' A' ' 99' ' ' HIS . 17.9 Cg_endo -65.0 165.1 22.53 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.828 1.685 . . . . 0.0 111.153 176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -71.93 -5.15 32.59 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.159 -177.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.406 ' CD2' ' HB2' ' A' ' 97' ' ' PRO . 6.0 m-70 -81.01 -29.4 35.17 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG21 ' HB1' ' A' ' 70' ' ' ALA . 38.9 t -108.06 135.37 46.99 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.042 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ALA . . . -107.11 169.02 8.81 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.439 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' VAL . 94.4 mt -122.94 128.27 75.11 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.653 ' HB2' HE22 ' A' ' 79' ' ' GLN . 41.8 m0 -116.74 161.01 19.92 Favored 'General case' 0 C--N 1.279 -2.459 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.221 176.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' HG11 ' A' ' 120' ' ' VAL . 7.9 tmtm? -102.5 112.21 24.84 Favored 'General case' 0 N--CA 1.411 -2.385 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 176.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -73.85 115.56 13.43 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 tp -84.8 94.95 8.83 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.2 m -70.22 141.59 52.49 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.504 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.0 m -75.06 124.53 33.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.526 0.679 . . . . 0.0 111.017 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -163.9 173.21 39.93 Favored Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -92.19 -36.02 13.51 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 117.15 0.475 . . . . 0.0 112.218 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 t -83.38 120.86 26.4 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 88.9 mt -118.9 104.66 46.42 Favored Pre-proline 0 C--N 1.305 -1.369 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.592 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -76.99 144.46 23.98 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.455 2.103 . . . . 0.0 109.723 175.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.5 73.73 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 24.6 ptt180 -125.34 144.12 50.65 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -131.31 -70.94 0.58 Allowed 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 86' ' ' GLN . 75.7 m-85 -124.5 113.91 18.73 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.617 -1.994 . . . . 0.0 105.617 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -98.13 169.49 9.57 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -167.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.404 ' HB3' ' NH2' ' A' ' 93' ' ' ARG . 37.3 t60 63.51 31.96 14.52 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.079 1.352 . . . . 0.0 110.078 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.461 HG11 ' HB2' ' A' ' 104' ' ' LYS . 31.5 m -83.15 154.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.3 -0.863 . . . . 0.0 108.947 175.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -73.76 -41.22 62.76 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.158 0.504 . . . . 0.0 110.454 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.517 ' HB2' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -150.32 163.02 39.37 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.48 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.83 137.43 54.93 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 173.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 31.6 m -136.59 171.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.86 177.83 8.79 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.79 77.46 0.46 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -87.58 -4.82 58.95 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 122.243 1.02 . . . . 0.0 109.86 -176.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -178.58 160.32 26.12 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 106.162 -2.775 . . . . 0.0 106.162 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -158.47 128.91 6.09 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 118.715 1.258 . . . . 0.0 109.949 -178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.27 119.98 1.44 Allowed Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 165.68 -179.13 40.17 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.49 152.89 27.12 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.935 0.368 . . . . 0.0 110.175 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 158.28 -50.19 0.41 Allowed Glycine 0 C--N 1.298 -1.577 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.779 . . . . . . . . 0 0 . 1 stop_ save_